Citrus Sinensis ID: 005803
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 676 | 2.2.26 [Sep-21-2011] | |||||||
| Q8GYA4 | 669 | Cysteine-rich receptor-li | yes | no | 0.463 | 0.467 | 0.517 | 2e-96 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.531 | 0.423 | 0.477 | 4e-96 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.482 | 0.383 | 0.504 | 5e-96 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.461 | 0.370 | 0.504 | 7e-96 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.440 | 0.353 | 0.531 | 2e-94 | |
| Q9LW83 | 850 | G-type lectin S-receptor- | no | no | 0.455 | 0.362 | 0.538 | 2e-94 | |
| O64793 | 818 | G-type lectin S-receptor- | no | no | 0.489 | 0.404 | 0.5 | 3e-93 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.463 | 0.367 | 0.505 | 6e-91 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.403 | 0.321 | 0.551 | 6e-91 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.442 | 0.364 | 0.504 | 1e-89 |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 353 bits (907), Expect = 2e-96, Method: Compositional matrix adjust.
Identities = 179/346 (51%), Positives = 234/346 (67%), Gaps = 33/346 (9%)
Query: 362 NDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQ 421
+D T L++ D++TI ATD+F +N++GQGGFG VY G L DG E+A+KRLSKSSGQ
Sbjct: 326 DDITTADSLQL-DYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQ 384
Query: 422 GIVEFKNEAKLIAKLQHTNLT-----------------------------DSSRKSLLDW 452
G VEFKNE L+AKLQH NL D ++K LDW
Sbjct: 385 GEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDW 444
Query: 453 KKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512
+R+ II G+ +G+LYLH+ SRL IHRDLK SNILLD MNPKI+DFGMAR + +++ E
Sbjct: 445 TRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTE 504
Query: 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY 572
NT+RIVGT+GYMSPEY M+G SMKSDVYSFGVLVLEI+S KKN+ Y T+ +LV Y
Sbjct: 505 ENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSY 564
Query: 573 AWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTM 632
AW LW+ G+ LEL+DP + E+C +EV+RC+H+GLLCVQ+ A+R T+S +V MLT++T+
Sbjct: 565 AWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTV 624
Query: 633 ALPKPKQPAFFIN--ISSDYEEPDVTEIKLEVCSVNDVTISRMEGR 676
LP P+QP F I D + D T L + SV+D +I+ + R
Sbjct: 625 TLPVPRQPGLFFQSRIGKDPLDTDTTSKSL-LGSVDDASITDIHPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 352 bits (904), Expect = 4e-96, Method: Compositional matrix adjust.
Identities = 188/394 (47%), Positives = 255/394 (64%), Gaps = 35/394 (8%)
Query: 317 FYNFSYTSNEQERYLTYSVN-EDLLRELGHNVSLPIIFGNRKTQVHNDQTVKRDLKIFDF 375
F F + +Q+R +T DL+R ++ ++ +R ++T +L + ++
Sbjct: 455 FIIFHFWKRKQKRSITIQTPIVDLVRS-QDSLMNELVKASRSYTSKENKTDYLELPLMEW 513
Query: 376 QTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAK 435
+ +A AT+NFS N+LGQGGFG VY G LLDG+EIA+KRLSK S QG EF NE +LIAK
Sbjct: 514 KALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAK 573
Query: 436 LQHTNLT-----------------------------DSSRKSLLDWKKRFYIIEGIVQGL 466
LQH NL D +R S L+W+KRF II GI +GL
Sbjct: 574 LQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGL 633
Query: 467 LYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMS 526
LYLH+ SR R IHRDLK SN+LLD+ M PKISDFGMAR + E EANT R+VGT+GYMS
Sbjct: 634 LYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMS 693
Query: 527 PEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586
PEY M+GI SMKSDV+SFGVL+LEI+S K+N G Y++ R LNL+G+ W+ W EGK LE++
Sbjct: 694 PEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIV 753
Query: 587 DPTLDESCSSD----EVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQPAF 642
DP ++ SS+ E++RCI +GLLCVQ+RA DR MS V+ ML ++T A+P+PK+P F
Sbjct: 754 DPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGF 813
Query: 643 FINISSDYEEPDVTEIKLEVCSVNDVTISRMEGR 676
+ SS + + + + C+VN VT+S ++ R
Sbjct: 814 CVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 352 bits (904), Expect = 5e-96, Method: Compositional matrix adjust.
Identities = 181/359 (50%), Positives = 243/359 (67%), Gaps = 33/359 (9%)
Query: 351 IIFGNRKTQVHNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEI 410
++ +R+ + T +L + +F+ +A AT+NFS AN+LGQGGFG VY GKLLDGQE+
Sbjct: 492 VVISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEM 551
Query: 411 AIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT---------------------------- 442
A+KRLSK+S QG EFKNE KLIA+LQH NL
Sbjct: 552 AVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHL 611
Query: 443 -DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFG 501
D SR S L+W+ RF II GI +GLLYLH+ SR R IHRDLK SNILLD+ M PKISDFG
Sbjct: 612 FDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFG 671
Query: 502 MARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSY 561
MAR + +E EANT ++VGT+GYMSPEY M+GI SMKSDV+SFGVL+LEI+SSK+N G Y
Sbjct: 672 MARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFY 731
Query: 562 DTERPLNLVGYAWQLWNEGKALELMDPTLDESCSS---DEVMRCIHVGLLCVQDRAADRR 618
+++R LNL+G W+ W EGK LE++DP + +S S+ E++RCI +GLLCVQ+RA DR
Sbjct: 732 NSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRP 791
Query: 619 TMSDVVSMLTNDTMALPKPKQPAFFINISSDYEEPDVTEIK-LEVCSVNDVTISRMEGR 676
TMS V+ ML +++ +P+PK P + + S + ++ + E +VN +T+S ++ R
Sbjct: 792 TMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 352 bits (902), Expect = 7e-96, Method: Compositional matrix adjust.
Identities = 174/345 (50%), Positives = 235/345 (68%), Gaps = 33/345 (9%)
Query: 362 NDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQ 421
++Q ++L +F+FQ +A +TD+FS N+LGQGGFGPVY GKL +GQEIA+KRLS+ SGQ
Sbjct: 501 SNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQ 560
Query: 422 GIVEFKNEAKLIAKLQHTNLT-----------------------------DSSRKSLLDW 452
G+ E NE +I+KLQH NL D ++ +LDW
Sbjct: 561 GLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDW 620
Query: 453 KKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512
K RF I+EGI +GLLYLH+ SRL+ IHRDLK SNILLDE +NPKISDFG+AR + NE E
Sbjct: 621 KTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDE 680
Query: 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY 572
ANT R+VGT+GYMSPEY M G S KSDV+S GV+ LEI+S ++N+ S+ E LNL+ Y
Sbjct: 681 ANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAY 740
Query: 573 AWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTM 632
AW+LWN+G+A L DP + + C E+ +C+H+GLLCVQ+ A DR +S+V+ MLT + M
Sbjct: 741 AWKLWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQEVANDRPNVSNVIWMLTTENM 800
Query: 633 ALPKPKQPAFFINI-SSDYEEPDVTEIKLEVCSVNDVTISRMEGR 676
+L PKQPAF + +S+ E D + K+ S+NDV+++ + GR
Sbjct: 801 SLADPKQPAFIVRRGASEAESSDQSSQKV---SINDVSLTAVTGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 347 bits (891), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 176/331 (53%), Positives = 224/331 (67%), Gaps = 33/331 (9%)
Query: 379 AAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH 438
A AT+NFS N+LGQGGFG VY G+LLDG+EIA+KRLSK S QG EF NE +LIAKLQH
Sbjct: 513 ATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQH 572
Query: 439 TNLT-----------------------------DSSRKSLLDWKKRFYIIEGIVQGLLYL 469
NL D +R S L+W+KRF II GI +GLLYL
Sbjct: 573 INLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYL 632
Query: 470 HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEY 529
H+ SR R IHRDLK SN+LLD+ M PKISDFGMAR + E EANT R+VGT+GYMSPEY
Sbjct: 633 HQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEY 692
Query: 530 VMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589
M+GI SMKSDV+SFGVL+LEI+S K+N G Y++ R LNL+G+ W+ W EG LE++DP
Sbjct: 693 AMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPI 752
Query: 590 LDESCSSD----EVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQPAFFIN 645
+S SS E++RCI +GLLCVQ+RA DR MS V+ ML ++T A+P+PK+P F I
Sbjct: 753 NIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIG 812
Query: 646 ISSDYEEPDVTEIKLEVCSVNDVTISRMEGR 676
S + + + + C+VN +T+S ++ R
Sbjct: 813 RSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 347 bits (889), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 183/340 (53%), Positives = 231/340 (67%), Gaps = 32/340 (9%)
Query: 369 DLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKN 428
+L+IF F+++A ATD FS AN+LG+GGFGPVY G+L+DG+E+AIKRLS +SGQG+VEFKN
Sbjct: 511 ELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKN 570
Query: 429 EAKLIAKLQHTNLT-----------------------------DSSRKSLLDWKKRFYII 459
EA LIAKLQHTNL D RK +LDWK RF I+
Sbjct: 571 EAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIM 630
Query: 460 EGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIV 519
EGI+QGLLYLHKYSRL+ IHRD+K NILLDE MNPKISDFGMAR + E +ANT R+
Sbjct: 631 EGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVA 690
Query: 520 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNG-SYDTERPLNLVGYAWQLWN 578
GT GYMSPEY G+ S KSDV+SFGVL+LEI+ +KNN +D+E PLNL+ + W L+
Sbjct: 691 GTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLFK 750
Query: 579 EGKALELMDPTL-DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND-TMALPK 636
E + E++DP+L D + + +V+RC+ V LLCVQ A DR +M DVVSM+ D AL
Sbjct: 751 ENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALSL 810
Query: 637 PKQPAFFINISSDYEEPDVTEIKLEVCSVNDVTISRMEGR 676
PK+PAF+ E +V ++E S N VTI+ ME R
Sbjct: 811 PKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850
|
Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 343 bits (879), Expect = 3e-93, Method: Compositional matrix adjust.
Identities = 186/372 (50%), Positives = 240/372 (64%), Gaps = 41/372 (11%)
Query: 337 EDLLRELGHNVSLPIIFGNRKTQVHNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGF 396
E LLRELG + S N++ +L+IF F+++ +ATD+FS N+LG+GGF
Sbjct: 456 EMLLRELGIDRSC--------IHKRNERKSNNELQIFSFESVVSATDDFSDENKLGEGGF 507
Query: 397 GPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT-------------- 442
GPVY GKLL+G+E+AIKRLS +SGQG+VEFKNEA LIAKLQHTNL
Sbjct: 508 GPVYKGKLLNGEEVAIKRLSLASGQGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDEKML 567
Query: 443 ---------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNI 487
D RK++LDW RF I+EGI+QGLLYLHKYSRL+ IHRD+K SNI
Sbjct: 568 IYEYMQNKSLDYFLFDPLRKNVLDWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNI 627
Query: 488 LLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVL 547
LLDE MNPKISDFG+AR + E ANT R+ GT GYMSPEY G+ S KSDV+SFGVL
Sbjct: 628 LLDEDMNPKISDFGLARIFGAEETRANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVL 687
Query: 548 VLEIVSSKKNNG-SYDTERPLNLVGYAWQLWNEGKALELMDPTL-DESCSSDEVMRCIHV 605
+LEI+ +KNN +D E PLNL+ + W L+ E K E++D +L D + +V+RC+ V
Sbjct: 688 MLEIICGRKNNSFHHDLEGPLNLIVHVWNLFKENKIREVIDLSLRDSALDYPQVLRCVQV 747
Query: 606 GLLCVQDRAADRRTMSDVVSMLTND-TMALPKPKQPAFFINISSDYEEPDVTEIKLEVCS 664
LLCVQ+ A DR +M DVVSM+ + AL PK+PAF+ + E V + E S
Sbjct: 748 ALLCVQENAEDRPSMLDVVSMIYGEGNNALSLPKEPAFYDGPRRSFPEMKVEPQEPENVS 807
Query: 665 VNDVTISRMEGR 676
+ +TI+ +E R
Sbjct: 808 AS-ITITVLEAR 818
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 335 bits (859), Expect = 6e-91, Method: Compositional matrix adjust.
Identities = 174/344 (50%), Positives = 223/344 (64%), Gaps = 31/344 (9%)
Query: 363 DQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQG 422
D + D+ F+ +TI AT NFS AN+LGQGGFGPVY G QEIA+KRLS+ SGQG
Sbjct: 510 DDSQGIDVPSFELETILYATSNFSNANKLGQGGFGPVYKGMFPGDQEIAVKRLSRCSGQG 569
Query: 423 IVEFKNEAKLIAKLQHTNLT-----------------------------DSSRKSLLDWK 453
+ EFKNE LIAKLQH NL D LDWK
Sbjct: 570 LEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFDRKLCQRLDWK 629
Query: 454 KRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513
R II GI +GLLYLH+ SRLR IHRDLK SNILLDE+MNPKISDFG+AR + +E A
Sbjct: 630 MRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFGGSETSA 689
Query: 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYA 573
NTNR+VGT+GYMSPEY + G+ S KSDV+SFGV+V+E +S K+N G ++ E+ L+L+G+A
Sbjct: 690 NTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEKSLSLLGHA 749
Query: 574 WQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML-TNDTM 632
W LW + +EL+D L ESC ++ ++C++VGLLCVQ+ DR TMS+VV ML +++
Sbjct: 750 WDLWKAERGIELLDQALQESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVVFMLGSSEAA 809
Query: 633 ALPKPKQPAFFINISSDYEEPDVTEIKLEVCSVNDVTISRMEGR 676
LP PKQPAF + + K E CS N++TI+ +GR
Sbjct: 810 TLPTPKQPAFVLR-RCPSSSKASSSTKPETCSENELTITLEDGR 852
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 335 bits (859), Expect = 6e-91, Method: Compositional matrix adjust.
Identities = 167/303 (55%), Positives = 208/303 (68%), Gaps = 30/303 (9%)
Query: 369 DLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKN 428
+L +F IA AT++F N LG+GGFGPVY G L DG+EIA+KRLS SGQG+ EFKN
Sbjct: 513 ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKN 572
Query: 429 EAKLIAKLQHTNLT-----------------------------DSSRKSLLDWKKRFYII 459
E LIAKLQH NL D ++++L+DWK RF II
Sbjct: 573 EIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSII 632
Query: 460 EGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIV 519
EGI +GLLYLH+ SRLR IHRDLKVSN+LLD +MNPKISDFGMAR + N+ EANT R+V
Sbjct: 633 EGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVV 692
Query: 520 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNE 579
GT+GYMSPEY M G+ S+KSDVYSFGVL+LEIVS K+N +E +L+GYAW L+
Sbjct: 693 GTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHG-SLIGYAWYLYTH 751
Query: 580 GKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQ 639
G++ EL+DP + +CS E +RCIHV +LCVQD AA+R M+ V+ ML +DT L P+Q
Sbjct: 752 GRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQ 811
Query: 640 PAF 642
P F
Sbjct: 812 PTF 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 331 bits (849), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 171/339 (50%), Positives = 227/339 (66%), Gaps = 40/339 (11%)
Query: 368 RDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFK 427
++L +F+FQ +AAAT+NFS N+LGQGGFGPVY GKL +GQEIA+KRLS++SGQG+ E
Sbjct: 492 KELPLFEFQVLAAATNNFSLRNKLGQGGFGPVYKGKLQEGQEIAVKRLSRASGQGLEELV 551
Query: 428 NEAKLIAKLQHTNLT-----------------------------DSSRKSLLDWKKRFYI 458
NE +I+KLQH NL DS R LLDWK RF I
Sbjct: 552 NEVVVISKLQHRNLVKLLGCCIAGEERMLVYEFMPKKSLDYYLFDSRRAKLLDWKTRFNI 611
Query: 459 IEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRI 518
I GI +GLLYLH+ SRLR IHRDLK SNILLDE + PKISDFG+AR + NE EANT R+
Sbjct: 612 INGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNEDEANTRRV 671
Query: 519 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWN 578
VGT+GYM+PEY M G+ S KSDV+S GV++LEI+S ++N+ S L+ Y W +WN
Sbjct: 672 VGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIISGRRNSNS-------TLLAYVWSIWN 724
Query: 579 EGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPK 638
EG+ L+DP + + E+ +CIH+GLLCVQ+ A DR ++S V SML+++ +P+PK
Sbjct: 725 EGEINSLVDPEIFDLLFEKEIHKCIHIGLLCVQEAANDRPSVSTVCSMLSSEIADIPEPK 784
Query: 639 QPAFFI-NISSDYEEPDVTEIKLEVCSVNDVTISRMEGR 676
QPAF N + E + +++K S+N+VTI+ + GR
Sbjct: 785 QPAFISRNNVPEAESSENSDLKD---SINNVTITDVTGR 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 676 | ||||||
| 359480371 | 1314 | PREDICTED: LOW QUALITY PROTEIN: putative | 0.829 | 0.426 | 0.414 | 1e-121 | |
| 255550026 | 795 | Serine/threonine-protein kinase PBS1, pu | 0.452 | 0.384 | 0.617 | 1e-114 | |
| 359482600 | 789 | PREDICTED: G-type lectin S-receptor-like | 0.494 | 0.423 | 0.607 | 1e-114 | |
| 356556159 | 480 | PREDICTED: G-type lectin S-receptor-like | 0.497 | 0.7 | 0.560 | 1e-112 | |
| 359480375 | 757 | PREDICTED: G-type lectin S-receptor-like | 0.517 | 0.462 | 0.541 | 1e-108 | |
| 147840288 | 842 | hypothetical protein VITISV_016159 [Viti | 0.834 | 0.669 | 0.358 | 1e-108 | |
| 56561617 | 637 | S-receptor kinase-like protein 1 [Seneci | 0.465 | 0.494 | 0.567 | 1e-107 | |
| 359482602 | 682 | PREDICTED: G-type lectin S-receptor-like | 0.504 | 0.5 | 0.549 | 1e-107 | |
| 356577237 | 1050 | PREDICTED: G-type lectin S-receptor-like | 0.454 | 0.292 | 0.569 | 1e-107 | |
| 359480377 | 751 | PREDICTED: G-type lectin S-receptor-like | 0.510 | 0.459 | 0.537 | 1e-107 |
| >gi|359480371|ref|XP_003632440.1| PREDICTED: LOW QUALITY PROTEIN: putative serine/threonine-protein kinase receptor-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 444 bits (1141), Expect = e-121, Method: Compositional matrix adjust.
Identities = 290/700 (41%), Positives = 381/700 (54%), Gaps = 139/700 (19%)
Query: 14 LSLISFLLVLLPGLCYCQTDKLQQGQVLKDGEEL-VSAFGNFRLGFFSPYGTRNRYLAIY 72
L L L +LP + TD ++ G+ L+ E+L VSA G F LGFFS YL I+
Sbjct: 14 LCLSCMWLGVLPYISSAPTDTIKPGEELQFSEKLLVSAKGTFTLGFFSL--ESGSYLGIW 71
Query: 73 YKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPYSPAIKKQPVWIANRETPVLRNESAS 132
+ + D+ +K+ VW+ANR+ P+ A+
Sbjct: 72 F----------TIDA------------------------QKEKVWVANRDKPI-SGTDAN 96
Query: 133 LIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQ 192
L +D+ DG L I+ +G +PI ++S + A N+T ATLL +GN VL E NSD S++ LW+
Sbjct: 97 LTLDA-DGKLMIMHSGGDPIVLNSNQAARNST-ATLLDSGNFVLEEFNSD-RSVKEKLWE 153
Query: 193 SFDYPTHALLPGMKLGINLQTGHQWFLQS----SESAEGSYRLGLGTDPNMTSKLVIWKN 248
SFD PT LLPGMKLGINL+TG W L S A G++ L ++LV+ +
Sbjct: 154 SFDNPTDTLLPGMKLGINLKTGQNWSLASWINEQVPAPGTFTLEWNG-----TQLVMKRR 208
Query: 249 DKVVWTSAIWLNNSLPSYTRSSDDEINNSLPSYTRSSDDGINNCLPSYRGSRDDDSNYCC 308
W+S N S S D NN Y+ +S N SY S +
Sbjct: 209 GGTYWSSGTLKNRSFEFIPWLSFDTCNNI---YSFNSVANENEIYFSYSVPDGVVSEWAL 265
Query: 309 NP--------AIFDYGFYNFSYT---SNEQERYLTYSVNEDLLRELGHNVSLPIIFGN-- 355
N AI F++ +T + + R Y ++ R G++ + +I
Sbjct: 266 NSRGGLSDTKAITGCRFWSTKFTQTYAGDANREALYVLSSS--RVTGNSWWIWVIIAGVV 323
Query: 356 --------------RKTQ-------VHNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQG 394
RK++ V +D DLK+F F +I A++NFS N+LG+G
Sbjct: 324 LVVLLLMGFLYYLRRKSKSLSDSKDVDHDGKTAHDLKLFSFDSIVVASNNFSSENKLGEG 383
Query: 395 GFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT------------ 442
GFGPVY GKL +GQEIA+KRLS+ SGQG+VEFKNE +LIA+LQH NL
Sbjct: 384 GFGPVYKGKLPEGQEIAVKRLSRGSGQGLVEFKNEIRLIARLQHMNLVRLLGCCIKGEEK 443
Query: 443 -----------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVS 485
D + + +LDWK+R IIEGI QGLLYLHKYSRLR IHRDLK S
Sbjct: 444 MLIYEFMPNKSLDFFLFDPAXRKILDWKRRHNIIEGIAQGLLYLHKYSRLRIIHRDLKAS 503
Query: 486 NILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFG 545
NILLD +NPKISDFGMART+ N EANTNRIVGT+GYM PEY M GI S+KSDVYSFG
Sbjct: 504 NILLDHDLNPKISDFGMARTFGRNASEANTNRIVGTYGYMPPEYAMEGIFSVKSDVYSFG 563
Query: 546 VLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHV 605
VL+LEI AW+LW EG +L+L+DP L++ SS +++RCIH+
Sbjct: 564 VLLLEI---------------------AWELWKEGTSLQLVDPMLEDFHSSTQMLRCIHI 602
Query: 606 GLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQPAFFIN 645
LLCVQ+ AADR TMS V+SMLTN+T+ LP P PAF I+
Sbjct: 603 ALLCVQESAADRPTMSAVISMLTNETVPLPNPNLPAFSIH 642
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255550026|ref|XP_002516064.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223544969|gb|EEF46484.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 420 bits (1080), Expect = e-114, Method: Compositional matrix adjust.
Identities = 208/337 (61%), Positives = 250/337 (74%), Gaps = 31/337 (9%)
Query: 369 DLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKN 428
+L IF F+ IA AT F P N+LG+GGFGPVY GKLLDGQEIAIKRLS+SSGQG+VEFKN
Sbjct: 461 ELHIFCFEIIAIATKYFKPENKLGEGGFGPVYKGKLLDGQEIAIKRLSRSSGQGLVEFKN 520
Query: 429 EAKLIAKLQHTNLT-----------------------------DSSRKSLLDWKKRFYII 459
EA LIAKLQHTNL DS +KS LDWKKRF II
Sbjct: 521 EAILIAKLQHTNLVKLLGFCVDGEERILVYEYMPKKSLDIYLFDSHKKSELDWKKRFKII 580
Query: 460 EGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIV 519
+GI QGLLYLHKYSRL+ IHRDLK SNILLD++MNPKISDFGMAR + + E EANTNRIV
Sbjct: 581 DGITQGLLYLHKYSRLKVIHRDLKASNILLDDEMNPKISDFGMARIFGLKESEANTNRIV 640
Query: 520 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNE 579
GT+GYMSPEY MNG+VS K+DV+SFGVL+LEI+S +KN + +E P+NL+GYAW LW +
Sbjct: 641 GTYGYMSPEYAMNGVVSTKTDVFSFGVLLLEIISGRKNTSFHYSECPINLIGYAWLLWKD 700
Query: 580 GKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQ 639
+ LEL+DP LDE ++V+RCIH+GLLCVQD AADR T+ DVVSML+N+T+ L PKQ
Sbjct: 701 NRGLELIDPKLDEFLPQNQVLRCIHIGLLCVQDHAADRPTVFDVVSMLSNETILLATPKQ 760
Query: 640 PAFFINISSDYEEPDVTEIKLEVCSVNDVTISRMEGR 676
PAFF+N + +EP + + CS+N V+IS ME R
Sbjct: 761 PAFFVN--AVVQEPGEPRNRSDKCSINLVSISVMEAR 795
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482600|ref|XP_003632790.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase CES101-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 420 bits (1080), Expect = e-114, Method: Compositional matrix adjust.
Identities = 226/372 (60%), Positives = 266/372 (71%), Gaps = 38/372 (10%)
Query: 337 EDLLRELGHNVSLPIIFGNRKTQVHNDQTVK-RDLKIFDFQTIAAATDNFSPANRLGQGG 395
++LL ELG ++ P F ++ H K +L++F FQ++AAAT+NFS N+LG+GG
Sbjct: 424 QELLFELGA-ITKP--FTKHNSKKHEKVGKKTNELQLFSFQSLAAATNNFSIENKLGEGG 480
Query: 396 FGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT------------- 442
FGPVY GKLLDGQEIAIKRLSKSS QG+VEFKNE LIAKLQH NL
Sbjct: 481 FGPVYKGKLLDGQEIAIKRLSKSSRQGLVEFKNEIALIAKLQHDNLVKLLGCCIKEEEKI 540
Query: 443 ----------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSN 486
D S+K+LL+WKKR+ IIEGI QGLLYLHK+SRLR IHRDLK SN
Sbjct: 541 LIYEYLPNKSLDFFIFDPSKKNLLNWKKRYNIIEGITQGLLYLHKFSRLRVIHRDLKASN 600
Query: 487 ILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGV 546
ILLD +MNPKISDFGMAR + +E EANTNR+VGT+GYMSPEYVM GI S KSDV+SFGV
Sbjct: 601 ILLDNEMNPKISDFGMARIFGQDECEANTNRVVGTYGYMSPEYVMQGIFSTKSDVFSFGV 660
Query: 547 LVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVM-RCIHV 605
L+LEIVSSKKN+ +Y ERPLNL+GYAW+LW EGK LELMD TL + SS+ V+ RCIHV
Sbjct: 661 LLLEIVSSKKNHSNYHYERPLNLIGYAWELWKEGKELELMDQTLCDGPSSNNVVKRCIHV 720
Query: 606 GLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQPAFFI-NISSDYEEPDVTEIKLEVCS 664
GLLCVQ+ DR TMSDVV ML N++M L PKQPAFFI I + E P E CS
Sbjct: 721 GLLCVQENPKDRPTMSDVVLMLANESMQLSIPKQPAFFIRGIEQELEIPKRNS---ENCS 777
Query: 665 VNDVTISRMEGR 676
+N V+IS ME R
Sbjct: 778 LNIVSISVMEAR 789
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356556159|ref|XP_003546394.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase CES101-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 412 bits (1060), Expect = e-112, Method: Compositional matrix adjust.
Identities = 208/371 (56%), Positives = 261/371 (70%), Gaps = 35/371 (9%)
Query: 335 VNEDLLRELGHNVSLPIIFGNRKTQVHNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQG 394
+ + LL ++G N L +++G + + +N ++++F F TI AT+NFS AN+LG+G
Sbjct: 116 MQKKLLHDIGGNAMLAMVYG-KTIKSNNKGKTNNEVELFAFDTIVVATNNFSAANKLGEG 174
Query: 395 GFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT------------ 442
GFGPVY G L D QE+AIKRLSKSSGQG++EF NEAKL+AKLQHTNL
Sbjct: 175 GFGPVYKGNLSDQQEVAIKRLSKSSGQGLIEFTNEAKLMAKLQHTNLVKLLGFCIQRDER 234
Query: 443 -----------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVS 485
DS+RK LLDW+KR II GI QGLLYLHKYSRL+ IHRDLK S
Sbjct: 235 ILVYEYMSNKSLDFYLFDSARKDLLDWEKRLNIIGGIAQGLLYLHKYSRLKVIHRDLKAS 294
Query: 486 NILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFG 545
NILLD +MN KISDFGMAR + + E NTNR+VGT+GYM+PEY M G+VS+K+DV+SFG
Sbjct: 295 NILLDHEMNAKISDFGMARIFGVRVSEENTNRVVGTYGYMAPEYAMKGVVSIKTDVFSFG 354
Query: 546 VLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHV 605
VL+LEI+SSKKNN Y ++ PLNL+GY LWN G+ALEL+D TL+ CS +EV RCIH+
Sbjct: 355 VLLLEILSSKKNNSRYHSDHPLNLIGY---LWNAGRALELIDSTLNGLCSQNEVFRCIHI 411
Query: 606 GLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQPAFFINISSDYEEPDVTEIKLEVCSV 665
GLLCVQD+A DR TM D+VS L+NDT+ LP+P QPA+FIN EE ++ + E S
Sbjct: 412 GLLCVQDQATDRPTMVDIVSFLSNDTIQLPQPMQPAYFIN--EVVEESELPYNQQEFHSE 469
Query: 666 NDVTISRMEGR 676
NDVTIS R
Sbjct: 470 NDVTISSTRAR 480
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359480375|ref|XP_002268267.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 398 bits (1023), Expect = e-108, Method: Compositional matrix adjust.
Identities = 210/388 (54%), Positives = 256/388 (65%), Gaps = 38/388 (9%)
Query: 324 SNEQERYLTYSVNEDLLRELGHNVSLPII----FGNRKTQVHNDQTVKRDLKIFDFQTIA 379
+N++E Y+ S RE+ L + FG+ K H+ + DLK+F F +I
Sbjct: 373 ANQEELYVLSSSRVTGEREMEEAALLELATSDSFGDSKDDEHDGKRGAHDLKLFSFDSIV 432
Query: 380 AATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 439
AAT+NFSP N+LG+GGFGPVY GKLL+GQEIA+KRLS+ S QG+VEFKNE +LI KLQH
Sbjct: 433 AATNNFSPENKLGEGGFGPVYKGKLLEGQEIAVKRLSRGSSQGLVEFKNEIRLIVKLQHM 492
Query: 440 NLT-----------------------------DSSRKSLLDWKKRFYIIEGIVQGLLYLH 470
NL D +R+ +LDWK+R IIEGI QGLLYLH
Sbjct: 493 NLVRLLGCCIKGEEKMLIYEFMPNKSLDFFLFDPARRKILDWKRRHNIIEGIAQGLLYLH 552
Query: 471 KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYV 530
KYSRLR IHRDLK SNILLD +NPKISDFGMART+ N EANTNRIVGT+GYM PEY
Sbjct: 553 KYSRLRIIHRDLKASNILLDHDLNPKISDFGMARTFGRNASEANTNRIVGTYGYMPPEYA 612
Query: 531 MNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTER--PLNLVGYAWQLWNEGKALELMDP 588
M GI S+KSDVYSFGVL+LEIVS +KN + +NL YAW LW EG +LEL+DP
Sbjct: 613 MEGIFSVKSDVYSFGVLLLEIVSGRKNKSFHHNHGAFAINLAVYAWDLWKEGTSLELVDP 672
Query: 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQPAFFINISS 648
L++S S+ +++RCIH+ LLCVQ+RAADR TMS V+SMLTN+T+ LP P PAF +
Sbjct: 673 MLEDSYSTTQMLRCIHIALLCVQERAADRPTMSAVISMLTNETVPLPNPNLPAF--STHH 730
Query: 649 DYEEPDVTEIKLEVCSVNDVTISRMEGR 676
E D + E CS VTIS EGR
Sbjct: 731 KVSETDSHKGGPESCS-GSVTISETEGR 757
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147840288|emb|CAN63991.1| hypothetical protein VITISV_016159 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 398 bits (1022), Expect = e-108, Method: Compositional matrix adjust.
Identities = 253/705 (35%), Positives = 357/705 (50%), Gaps = 141/705 (20%)
Query: 21 LVLLPGLCY--CQ-TDKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPR 77
L+LL G C+ C D + Q +K E LVS F+LGFF+P + NRY+ I+Y P
Sbjct: 13 LLLLSGFCFGFCTPIDTITSTQFIKCPETLVSNGSAFKLGFFTPADSTNRYVGIWYSTPS 72
Query: 78 DRAADVSFDSYSRCRPVCYAIGNRPRKYPYSPAIKKQPVWIANRETPVLRNESASLIIDS 137
+W+ANR+ P+ + + ++ S
Sbjct: 73 LSTV----------------------------------IWVANRDKPL--TDFSGIVTIS 96
Query: 138 TDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYP 197
DGNL ++ K + S++ A +SA LL +GNLVL + + R W+S +P
Sbjct: 97 EDGNLLVMNGQKVIVWSSNLSNAAPNSSAQLLDSGNLVLRDNSG------RITWESIQHP 150
Query: 198 THALLPGMKLGINLQTGHQWFLQS----SESAEGSYRLGLGTDPNMTSKLVIWKNDKVVW 253
+H+ LP MK+ N TG + L S S+ + GS+ G+ +P ++ +W W
Sbjct: 151 SHSFLPKMKISTNTHTGEKVVLTSWKSPSDPSIGSFSAGI--NPLNIPQVFVWNGSHPYW 208
Query: 254 TSAIWLNNSLPSYTRSSDDEINNSLPSYTRSSDDGINNCLPSYRGSRDDDSNYCCNPAIF 313
S W E+N+ + + DD ++ N +IF
Sbjct: 209 RSGPWNGQIFIGVP-----EMNSVFLNGFQVVDDKEGTVYETFT---------LANSSIF 254
Query: 314 DY------GFYNFSYTSNEQERY-LTYSVNEDLLRELGHNVSLPIIFGNRKTQV------ 360
Y G +Y +E++ + + N++ R++ +S+ I+ G +
Sbjct: 255 LYYVLTPEGTVVKTYREFGKEKWQVAWKSNKNKKRDMKAIISVTIVIGTIAFGICTYFSW 314
Query: 361 --HNDQTVK--------------------------------RDLKIFDFQTIAAATDNFS 386
QTVK +L + + +A AT+NF
Sbjct: 315 RWRGKQTVKDKSKGILLSDRGDVYQIYDKNMLGDHANQVKFEELPLLALEKLATATNNFH 374
Query: 387 PANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT---- 442
AN LGQGGFGPVY GKL GQEIA+KRLS++S QG+ EF NE +I+K+QH NL
Sbjct: 375 EANMLGQGGFGPVYRGKLPGGQEIAVKRLSRASAQGLEEFMNEVMVISKIQHRNLVRLLG 434
Query: 443 -------------------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRA 477
D ++ LDW+KRF IIEGI +GLLYLH+ SRLR
Sbjct: 435 CCIEGDEKLLIYEYMPNKSLDAFLFDPLKREFLDWRKRFSIIEGIGRGLLYLHRDSRLRI 494
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSM 537
IHRDLK SNILLDE +N KI DFGMAR + N+ +ANT R+VGT+GYMSPEY M G S
Sbjct: 495 IHRDLKASNILLDEDLNAKIXDFGMARIFGSNQDQANTMRVVGTYGYMSPEYAMEGRFSE 554
Query: 538 KSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597
KSDV+SFGVL+LEIVS +KNNG E+ L+L+ YAW LW + EL+D T+ E+C +
Sbjct: 555 KSDVFSFGVLLLEIVSGRKNNGHQYDEQYLSLLVYAWTLWCKHNIKELIDETMAEACFQE 614
Query: 598 EVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQPAF 642
E+ RC+HVGLLCVQ+ A DR ++S V+SML+++ LP PKQP F
Sbjct: 615 EISRCVHVGLLCVQESAKDRPSISTVLSMLSSEIAHLPPPKQPPF 659
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|56561617|emb|CAG28412.1| S-receptor kinase-like protein 1 [Senecio squalidus] | Back alignment and taxonomy information |
|---|
Score = 396 bits (1018), Expect = e-107, Method: Compositional matrix adjust.
Identities = 197/347 (56%), Positives = 241/347 (69%), Gaps = 32/347 (9%)
Query: 359 QVHNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKS 418
Q+ ++ DL +F F +I AAT++FS N+LGQGGFGPVY GKL DG+EIAIKRLS++
Sbjct: 294 QLESNGGKGNDLLLFSFSSIMAATNDFSVENKLGQGGFGPVYKGKLSDGREIAIKRLSRT 353
Query: 419 SGQGIVEFKNEAKLIAKLQHTNLT-----------------------------DSSRKSL 449
SGQG+VEFKNE LIAKLQHTNL D +RK+
Sbjct: 354 SGQGLVEFKNELILIAKLQHTNLVRVLGCCIHGEEKMLIYEYMPNKSLDFFLFDENRKAE 413
Query: 450 LDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509
LDW KRF IIEGI QGLLYLHKYSR+R IHRDLK +NILLDE +NPKISDFGMAR + N
Sbjct: 414 LDWPKRFNIIEGIAQGLLYLHKYSRMRVIHRDLKANNILLDENLNPKISDFGMARIFKEN 473
Query: 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNL 569
E EA TNR+VGT+GYMSPEY M G S+KSD++SFGVL+LEIV+ +KN +R NL
Sbjct: 474 ETEAMTNRVVGTYGYMSPEYAMEGTFSIKSDIFSFGVLMLEIVTGRKNTSFVHLDRTFNL 533
Query: 570 VGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629
+GYAW+LW +G LEL DPTL E+C + +R +HV LLCVQ+ A DR T SD++SML N
Sbjct: 534 IGYAWELWQQGDTLELKDPTLGETCGIQQFLRSVHVALLCVQESATDRPTTSDMISMLLN 593
Query: 630 DTMALPKPKQPAFFINISSDYEEPDVTEIKLEVCSVNDVTISRMEGR 676
DT++LP P +PAF I E E K + CSVND+T++ MEGR
Sbjct: 594 DTISLPTPNKPAFVI---GKVESKSTDESKEKDCSVNDMTVTVMEGR 637
|
Source: Senecio squalidus Species: Senecio squalidus Genus: Senecio Family: Asteraceae Order: Asterales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482602|ref|XP_003632791.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase CES101-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 396 bits (1018), Expect = e-107, Method: Compositional matrix adjust.
Identities = 205/373 (54%), Positives = 257/373 (68%), Gaps = 32/373 (8%)
Query: 333 YSVNEDLLRELGHNVSLPIIFGNRKTQVHNDQTVKRDLKIFDFQTIAAATDNFSPANRLG 392
Y+ ++LL ELG +GN N ++ +L++F FQ+IA AT+NFS N+LG
Sbjct: 313 YNRQQELLFELGAITKSLTKYGNANKLEKNGKS-SNELQLFSFQSIATATNNFSTENKLG 371
Query: 393 QGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT---------- 442
+GGFGPVY G LLD QEIAIK+LS+ SGQG+ EFKNE LI KLQH NL
Sbjct: 372 EGGFGPVYKGVLLDKQEIAIKKLSRGSGQGLEEFKNEILLIGKLQHNNLVRLLGCCIKGE 431
Query: 443 -------------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLK 483
D +K+LLDWKKR+ IIEGI QGLLYLHKYSRL+ +HRDLK
Sbjct: 432 EKILIYEYLPNKSLDFFLFDPIQKNLLDWKKRYNIIEGIAQGLLYLHKYSRLKVVHRDLK 491
Query: 484 VSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYS 543
SNILLD +MNPKIS FGMAR + NE +ANT RIVGT+GYMSPEY M GI SMKSDV+S
Sbjct: 492 ASNILLDNEMNPKISYFGMARIFGRNESQANTKRIVGTYGYMSPEYAMEGIFSMKSDVFS 551
Query: 544 FGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCI 603
FGVL+LEIVS +KN +Y +R LNL+GYAW+LW EG+ LELMD T+ + C + + RCI
Sbjct: 552 FGVLLLEIVSGRKNYSNYYYKRLLNLIGYAWELWKEGRILELMDQTMGDLCPKNVIRRCI 611
Query: 604 HVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQPAFFINISSDYEEPDVTEIKLEVC 663
HVGLLCVQ+ DR T+S+V+SML+N++M L PKQPAFFI + +E + + E C
Sbjct: 612 HVGLLCVQENPIDRPTISEVLSMLSNESMQLSTPKQPAFFIGRT--VQESKIPTSRSENC 669
Query: 664 SVNDVTISRMEGR 676
S+N+V+IS +E R
Sbjct: 670 SLNNVSISVLEAR 682
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356577237|ref|XP_003556734.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 394 bits (1013), Expect = e-107, Method: Compositional matrix adjust.
Identities = 193/339 (56%), Positives = 244/339 (71%), Gaps = 32/339 (9%)
Query: 337 EDLLRELGHNVSLPIIFGNRKTQVHNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGF 396
++LL E+G N +G K +T+ ++++F + I AT NFSP N+LG+GGF
Sbjct: 436 KELLVEVGGNAMGN--YGKAKGSKKEGKTIN-EIEVFSLENIIVATHNFSPDNKLGEGGF 492
Query: 397 GPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT-------------- 442
GPVY G L+DGQEIAIKRLSKSSGQG+VEFKNEAK++AKLQHTNL
Sbjct: 493 GPVYKGTLIDGQEIAIKRLSKSSGQGLVEFKNEAKIMAKLQHTNLVRLLGFCIDSDERIL 552
Query: 443 ---------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNI 487
D+SR + L+W KR IIEG QGL+YLH+YSRL+ IHRDLK SNI
Sbjct: 553 VYEYMSNKSLDHYLFDASRNNELEWNKRLKIIEGTAQGLVYLHRYSRLKVIHRDLKASNI 612
Query: 488 LLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVL 547
LLDE+MNP+ISDFG+AR + + E NT+R+VGT+GYMSPEY +NG+VS+K+DVYSFGVL
Sbjct: 613 LLDEEMNPRISDFGLARIFGLKGSEENTSRVVGTYGYMSPEYAINGVVSVKTDVYSFGVL 672
Query: 548 VLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGL 607
+LEI+S KNN + P NL+ +AWQLWN+G+ALELMDP+L+ES SSDEV RCI +GL
Sbjct: 673 LLEIISGMKNNSCIHSNHPFNLIAHAWQLWNQGRALELMDPSLNESFSSDEVERCIQIGL 732
Query: 608 LCVQDRAADRRTMSDVVSMLTNDTMALPKPKQPAFFINI 646
LCVQD A +R TM DVV+ L+NDT L +PKQPAFF+ +
Sbjct: 733 LCVQDHAIERPTMEDVVTFLSNDTTQLGQPKQPAFFMYV 771
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359480377|ref|XP_003632441.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase CES101-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 394 bits (1013), Expect = e-107, Method: Compositional matrix adjust.
Identities = 210/391 (53%), Positives = 260/391 (66%), Gaps = 46/391 (11%)
Query: 325 NEQERYLTYS--------VNEDLLRELGHNVSLPIIFGNRKTQVHNDQTVKRDLKIFDFQ 376
N++ERY+ S + E +L EL + S F + K H+ DLK+F F
Sbjct: 368 NQEERYVLSSSRVTGEREMEEAMLPELATSNS----FSDSKDVEHDGTRGAHDLKLFSFD 423
Query: 377 TIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 436
+I AAT+ FS N+LG+GGFGPVY GKLL+G EIA+KRLS+ S QG+VEFKNE +LIAKL
Sbjct: 424 SIVAATNYFSSENKLGEGGFGPVYKGKLLEGHEIAVKRLSRGSSQGLVEFKNEIRLIAKL 483
Query: 437 QHTNLT-----------------------------DSSRKSLLDWKKRFYIIEGIVQGLL 467
QH NL D R+ +LDWK+R IIEG+ QGLL
Sbjct: 484 QHMNLVRLLGCCIQGEEKMLIYEFMPNKSLDFFLFDPDRRKILDWKRRHNIIEGVAQGLL 543
Query: 468 YLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSP 527
YLHKYSRLR IHRDLKVSNILLD +NPKISDFGMAR + N EANTNRIVGT+GYM+P
Sbjct: 544 YLHKYSRLRIIHRDLKVSNILLDHDLNPKISDFGMARIFGRNASEANTNRIVGTYGYMAP 603
Query: 528 EYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTER--PLNLVGYAWQLWNEGKALEL 585
EY M GI S+KSDVYSFGVL+LEIVS +KN + +NL GYAW+LW EG +LEL
Sbjct: 604 EYAMEGIFSVKSDVYSFGVLLLEIVSGRKNKSFHHNHGAFAINLAGYAWELWKEGTSLEL 663
Query: 586 MDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQPAFFIN 645
+DP L++S S+ +++RCIH+ LLCVQ+ AADR TMSDV+SMLTN++++LP P P+F +
Sbjct: 664 VDPMLEDSYSTTQMLRCIHIALLCVQESAADRPTMSDVISMLTNESVSLPDPNLPSF--S 721
Query: 646 ISSDYEEPDVTEIKLEVCSVNDVTISRMEGR 676
E D + E SVN VTIS MEGR
Sbjct: 722 AHHKVSELDSNKSGPESSSVN-VTISEMEGR 751
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 676 | ||||||
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.349 | 0.277 | 0.548 | 1.7e-137 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.341 | 0.274 | 0.542 | 1.9e-115 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.343 | 0.279 | 0.521 | 1.3e-114 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.341 | 0.295 | 0.540 | 1.6e-112 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.352 | 0.28 | 0.541 | 3.5e-111 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.337 | 0.279 | 0.502 | 4e-108 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.350 | 0.279 | 0.551 | 1e-107 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.347 | 0.276 | 0.535 | 9.2e-107 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.352 | 0.282 | 0.545 | 1.2e-106 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.346 | 0.275 | 0.529 | 5e-106 |
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 651 (234.2 bits), Expect = 1.7e-137, Sum P(4) = 1.7e-137
Identities = 131/239 (54%), Positives = 166/239 (69%)
Query: 441 LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDF 500
L D RK +LDWK RF I+EGI+QGLLYLHKYSRL+ IHRD+K NILLDE MNPKISDF
Sbjct: 612 LFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDF 671
Query: 501 GMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNG- 559
GMAR + E +ANT R+ GT GYMSPEY G+ S KSDV+SFGVL+LEI+ +KNN
Sbjct: 672 GMARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSF 731
Query: 560 SYDTERPLNLVGYAWQLWNEGKALELMDPTL-DESCSSDEVMRCIHVGLLCVQDRAADRR 618
+D+E PLNL+ + W L+ E + E++DP+L D + + +V+RC+ V LLCVQ A DR
Sbjct: 732 HHDSEGPLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRP 791
Query: 619 TMSDVVSMLTND-TMALPKPKQPAFFINISSDYEEPDVTEIKLEVCSVNDVTISRMEGR 676
+M DVVSM+ D AL PK+PAF+ E +V ++E S N VTI+ ME R
Sbjct: 792 SMLDVVSMIYGDGNNALSLPKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 633 (227.9 bits), Expect = 1.9e-115, Sum P(4) = 1.9e-115
Identities = 129/238 (54%), Positives = 164/238 (68%)
Query: 441 LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDF 500
L D S++ LDW+KR+ +I GI +GLLYLH+ SRL+ IHRDLK SNILLD +MNPKISDF
Sbjct: 610 LFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDF 669
Query: 501 GMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGS 560
GMAR + + ANT R+VGT+GYM+PEY M GI S KSDVYSFGVL+LEIVS +KN
Sbjct: 670 GMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSF 729
Query: 561 YDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTM 620
T+ +L+GYAW LW++GK E++DP + ++ E MRCIHVG+LC QD R M
Sbjct: 730 RGTDHG-SLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNM 788
Query: 621 SDVVSMLTNDTMALPKPKQPAF--FINISSDYEEPDVTEIKLEVCSVNDVTISRMEGR 676
V+ ML + T LP P+QP F F+N S D E + +V SVNDVT + + GR
Sbjct: 789 GSVLLMLESQTSQLPPPRQPTFHSFLN-SGDIE---LNFDGHDVASVNDVTFTTIVGR 842
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 642 (231.1 bits), Expect = 1.3e-114, Sum P(4) = 1.3e-114
Identities = 124/238 (52%), Positives = 174/238 (73%)
Query: 441 LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDF 500
L D ++ LLDWK RF II+GI +GL+YLH+ SRL+ IHRDLK SNILLDE +NPKISDF
Sbjct: 597 LFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDF 656
Query: 501 GMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGS 560
G+AR + NE E +T R+VGT+GYM+PEY M G+ S KSDV+S GV++LEIVS ++N+
Sbjct: 657 GLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSF 716
Query: 561 Y-DTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRT 619
Y D + P NL YAW+LWN G+ + L+DP + E C +E+ RC+HVGLLCVQD A DR +
Sbjct: 717 YNDGQNP-NLSAYAWKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPS 775
Query: 620 MSDVVSMLTNDTMALPKPKQPAFFINI-SSDYEEPDVTEIKLEVCSVNDVTISRMEGR 676
++ V+ ML+++ LP+PKQPAF +S+ E ++ + S+N+V+++++ GR
Sbjct: 776 VATVIWMLSSENSNLPEPKQPAFIPRRGTSEVESSGQSDPR---ASINNVSLTKITGR 830
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 609 (219.4 bits), Expect = 1.6e-112, Sum P(4) = 1.6e-112
Identities = 127/235 (54%), Positives = 165/235 (70%)
Query: 443 DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGM 502
D R+ LDW KR II+GI +G+LYLH+ SRLR IHRDLK SN+LLD MN KISDFG+
Sbjct: 552 DKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGL 611
Query: 503 ARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYD 562
ART +E EANT R+VGT+GYMSPEY ++G S+KSDV+SFGVLVLEIVS ++N G +
Sbjct: 612 ARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRN 671
Query: 563 TERPLNLVGYAWQLWNEGKALELMDPTLDESCSS-DEVMRCIHVGLLCVQDRAADRRTMS 621
E LNL+G+AW+ + E KA E++D ++ESC+ EV+R IH+GLLCVQ DR MS
Sbjct: 672 EEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMS 731
Query: 622 DVVSMLTNDTMALPKPKQPAFFINISSDYEEPDVTEIKLEVCSVNDVTISRMEGR 676
VV ML+++ M L P+QP FF + + D I LE+ S N T+S ++ R
Sbjct: 732 VVVLMLSSE-MLLLDPRQPGFFNERNLLFS--DTVSINLEIPSNNFQTMSVIDPR 783
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 674 (242.3 bits), Expect = 3.5e-111, Sum P(3) = 3.5e-111
Identities = 131/242 (54%), Positives = 177/242 (73%)
Query: 439 TNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKIS 498
++L D SR S L+W+ RF II GI +GLLYLH+ SR R IHRDLK SNILLD+ M PKIS
Sbjct: 609 SHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKIS 668
Query: 499 DFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNN 558
DFGMAR + +E EANT ++VGT+GYMSPEY M+GI SMKSDV+SFGVL+LEI+SSK+N
Sbjct: 669 DFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNK 728
Query: 559 GSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSS---DEVMRCIHVGLLCVQDRAA 615
G Y+++R LNL+G W+ W EGK LE++DP + +S S+ E++RCI +GLLCVQ+RA
Sbjct: 729 GFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAE 788
Query: 616 DRRTMSDVVSMLTNDTMALPKPKQPAFFINISS-DYEEPDVTEIKLEVCSVNDVTISRME 674
DR TMS V+ ML +++ +P+PK P + + S D + + E +VN +T+S ++
Sbjct: 789 DRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLD 848
Query: 675 GR 676
R
Sbjct: 849 AR 850
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 606 (218.4 bits), Expect = 4.0e-108, Sum P(4) = 4.0e-108
Identities = 118/235 (50%), Positives = 166/235 (70%)
Query: 443 DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGM 502
D R + LDWKKR II G+ +G+LYLH+ SRLR IHRDLK N+LLD MNPKISDFG+
Sbjct: 587 DERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGL 646
Query: 503 ARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYD 562
A+++ ++ E++TNR+VGT+GYM PEY ++G S+KSDV+SFGVLVLEI++ K N G
Sbjct: 647 AKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRH 706
Query: 563 TERPLNLVGYAWQLWNEGKALELMDPT-LDESCSSDEVMRCIHVGLLCVQDRAADRRTMS 621
+ LNL+G+ W++W E + +E+ + L+E+ EV+RCIHV LLCVQ + DR TM+
Sbjct: 707 ADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMA 766
Query: 622 DVVSMLTNDTMALPKPKQPAFFINISSDYEEPDVTEIKLEVCSVNDVTISRMEGR 676
VV M +D+ +LP P QP FF N + PD++ L + S N+V+I+ ++GR
Sbjct: 767 SVVLMFGSDS-SLPHPTQPGFFTNRNV----PDISS-SLSLRSQNEVSITMLQGR 815
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 693 (249.0 bits), Expect = 1.0e-107, Sum P(3) = 1.0e-107
Identities = 134/243 (55%), Positives = 181/243 (74%)
Query: 439 TNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKIS 498
++L D +R S L+W+KRF II GI +GLLYLH+ SR R IHRDLK SN+LLD+ M PKIS
Sbjct: 606 SHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKIS 665
Query: 499 DFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNN 558
DFGMAR + E EANT R+VGT+GYMSPEY M+GI SMKSDV+SFGVL+LEI+S K+N
Sbjct: 666 DFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNK 725
Query: 559 GSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD----EVMRCIHVGLLCVQDRA 614
G Y++ R LNL+G+ W+ W EGK LE++DP ++ SS+ E++RCI +GLLCVQ+RA
Sbjct: 726 GFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERA 785
Query: 615 ADRRTMSDVVSMLTNDTMALPKPKQPAFFINISS-DYEEPDVTEIKLEVCSVNDVTISRM 673
DR MS V+ ML ++T A+P+PK+P F + SS + + T+ + + C+VN VT+S +
Sbjct: 786 EDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQ-RDDECTVNQVTLSVI 844
Query: 674 EGR 676
+ R
Sbjct: 845 DAR 847
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 645 (232.1 bits), Expect = 9.2e-107, Sum P(3) = 9.2e-107
Identities = 127/237 (53%), Positives = 169/237 (71%)
Query: 441 LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDF 500
L D ++++L+DWK RF IIEGI +GLLYLH+ SRLR IHRDLKVSN+LLD +MNPKISDF
Sbjct: 614 LFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDF 673
Query: 501 GMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGS 560
GMAR + N+ EANT R+VGT+GYMSPEY M G+ S+KSDVYSFGVL+LEIVS K+N
Sbjct: 674 GMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSL 733
Query: 561 YDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTM 620
+E +L+GYAW L+ G++ EL+DP + +CS E +RCIHV +LCVQD AA+R M
Sbjct: 734 RSSEHG-SLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNM 792
Query: 621 SDVVSMLTNDTMALPKPKQPAFFINISSDYEEPDVTEIKLE-VCSVNDVTISRMEGR 676
+ V+ ML +DT L P+QP F + + + + + S N++T + + GR
Sbjct: 793 ASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 683 (245.5 bits), Expect = 1.2e-106, Sum P(3) = 1.2e-106
Identities = 132/242 (54%), Positives = 176/242 (72%)
Query: 439 TNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKIS 498
++L D +R S L+W+KRF II GI +GLLYLH+ SR R IHRDLK SN+LLD+ M PKIS
Sbjct: 602 SHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKIS 661
Query: 499 DFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNN 558
DFGMAR + E EANT R+VGT+GYMSPEY M+GI SMKSDV+SFGVL+LEI+S K+N
Sbjct: 662 DFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNK 721
Query: 559 GSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD----EVMRCIHVGLLCVQDRA 614
G Y++ R LNL+G+ W+ W EG LE++DP +S SS E++RCI +GLLCVQ+RA
Sbjct: 722 GFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERA 781
Query: 615 ADRRTMSDVVSMLTNDTMALPKPKQPAFFINISSDYEEPDVTEIKLEVCSVNDVTISRME 674
DR MS V+ ML ++T A+P+PK+P F I S + + + + C+VN +T+S ++
Sbjct: 782 EDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVID 841
Query: 675 GR 676
R
Sbjct: 842 AR 843
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 643 (231.4 bits), Expect = 5.0e-106, Sum P(4) = 5.0e-106
Identities = 125/236 (52%), Positives = 164/236 (69%)
Query: 441 LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDF 500
L + ++ LLDWKKRF IIEGI +GLLYLH+ SRLR +HRDLK SNILLD M PKISDF
Sbjct: 615 LFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDF 674
Query: 501 GMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGS 560
GMAR + ++ + NTNR+VGT GYMSPEY M GI S+KSDVY FGVL+LEI++ K+
Sbjct: 675 GMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSF 734
Query: 561 YDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTM 620
+ E LN+ GYAW+ WNE A EL+DP + SCS +V+RCIH+ LLCVQD A +R +
Sbjct: 735 HCHEDSLNIAGYAWRQWNEDNAAELIDPVIRASCSVRQVLRCIHIALLCVQDHADERPDI 794
Query: 621 SDVVSMLTNDTMALPKPKQPAFFINISSDYEEPDVTEIKLEVCSVNDVTISRMEGR 676
V+ ML+ND+ +LP P+ P + + E +E K S+ VT++++ GR
Sbjct: 795 PTVILMLSNDSSSLPNPRPPTLMLR-GREIESSKSSE-KDRSHSIGTVTMTQLHGR 848
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 676 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-33 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-32 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-29 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-22 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 2e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-20 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 1e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-19 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-17 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-13 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-10 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-08 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-06 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 3e-06 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.001 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 0.001 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.002 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 61/192 (31%), Positives = 93/192 (48%), Gaps = 36/192 (18%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN-------- 440
LG+GGFG VY + G+++AIK + K ++E E +++ KL H N
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 441 -----------------LTD--SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRD 481
L D + L + I+ I++GL YLH IHRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRD 117
Query: 482 LKVSNILLDE-QMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKS 539
LK NILLD K++DFG+++ + ++ IVGT YM+PE ++ G S KS
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 540 DVYSFGVLVLEI 551
D++S GV++ E+
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 60/194 (30%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 391 LGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLTD----- 443
LG+G FG VY + G+ +AIK + K + E E K++ KL+H N+
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 444 ----------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRD 481
R L + + RFY+ + I+ L YLH +HRD
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ-ILSALEYLHS---KGIVHRD 122
Query: 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 541
LK NILLDE + K++DFG+AR E VGT YM+PE ++ D+
Sbjct: 123 LKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGKGYGKAVDI 179
Query: 542 YSFGVLVLEIVSSK 555
+S GV++ E+++ K
Sbjct: 180 WSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 63/196 (32%), Positives = 90/196 (45%), Gaps = 35/196 (17%)
Query: 390 RLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL----- 441
+LG G FG VY K G+ +A+K L K S + + E +++ +L H N+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 442 --TDSSRKSL-------------------LDWKKRFYIIEGIVQGLLYLHKYSRLRAIHR 480
D L L + I I++GL YLH IHR
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH---SNGIIHR 122
Query: 481 DLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGI-VSMKS 539
DLK NILLDE KI+DFG+A+ + T VGT YM+PE ++ G K
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYGPKV 180
Query: 540 DVYSFGVLVLEIVSSK 555
DV+S GV++ E+++ K
Sbjct: 181 DVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 80/289 (27%), Positives = 118/289 (40%), Gaps = 76/289 (26%)
Query: 389 NRLGQGGFGPVYNGKLLDGQ----EIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL-- 441
+LG+G FG VY GKL E+A+K L + S + +F EA+++ KL H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 442 ---------------------------------TDSSRKSLLDWKKRFYIIEGIVQGLLY 468
S KS L K I +G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 469 LHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG----- 523
L + +HRDL N L+ E + KISDFG++R ++ + T G
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR-----DVYDDDYYRKKTGGKLPIR 172
Query: 524 YMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGS--YDTERPLNLVGYAWQLWNEGK 581
+M+PE + +GI + KSDV+SFGVL+ EI + G+ Y ++ Y +G
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFT----LGATPYPGLSNEEVLEYL----RKGY 224
Query: 582 ALELMDPTLDESCSSD--EVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628
L E C + E+M C Q DR T S++V L
Sbjct: 225 RLPKP-----EYCPDELYELMLS------CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 77/277 (27%), Positives = 114/277 (41%), Gaps = 66/277 (23%)
Query: 391 LGQGGFGPVYNGKLLD-----GQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL--- 441
LG+G FG VY GKL E+A+K L + +S Q I EF EA+++ KL H N+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 442 ----TDS--------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRA 477
T+ + L I +G+ YL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNF 123
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG---YMSPEYVMNGI 534
IHRDL N L+ E + KISDFG++R + + + R G +M+PE + G
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 535 VSMKSDVYSFGVLVLEIVSSKKNNGS--YDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592
+ KSDV+SFGVL+ EI + G Y ++ Y G L
Sbjct: 180 FTSKSDVWSFGVLLWEIFT----LGEQPYPGMSNEEVLEYL----KNGYRLPQP-----P 226
Query: 593 SCSSD--EVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
+C + ++M C + DR T S++V +L
Sbjct: 227 NCPPELYDLMLQ------CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 77/280 (27%), Positives = 113/280 (40%), Gaps = 71/280 (25%)
Query: 391 LGQGGFGPVYNGKLLDG-----QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL--- 441
LG+G FG VY G L E+A+K L + S Q I EF EA+++ KL H N+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 442 ----TDS---------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLR 476
T+ +R L I +G+ YL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG-----YMSPEYVM 531
IHRDL N L+ E + KISDFG++R + + G +M+PE +
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSR------DLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 532 NGIVSMKSDVYSFGVLVLEIVSSKKNNGS--YDTERPLNLVGYAWQLWNEGKALELMDPT 589
G + KSDV+SFGVL+ EI + G Y ++ Y +G L
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT----LGEEPYPGMSNAEVLEYL----KKGYRLPKP--- 226
Query: 590 LDESCSSD--EVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
+C + ++M L C + DR T S++V +L
Sbjct: 227 --PNCPPELYKLM------LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 36/199 (18%)
Query: 389 NRLGQGGFGPVYNGKLLD-GQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNL---- 441
LG+G FG VY D G+ +A+K LS S + + + E ++++ LQH N+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 442 -TDSSRK--------------SLLDWKKRF----------YIIEGIVQGLLYLHKYSRLR 476
++ + SL K+F Y + I++GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ-ILEGLAYLH---SNG 121
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVS 536
+HRD+K +NIL+D K++DFG A+ E T + GT +M+PE +
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181
Query: 537 MKSDVYSFGVLVLEIVSSK 555
+D++S G V+E+ + K
Sbjct: 182 RAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 36/195 (18%)
Query: 385 FSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT- 442
F ++G+GGFG VY + G+E+AIK + S + + NE +++ K +H N+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 443 --DS--------------SRKSLLD----WKKRF------YIIEGIVQGLLYLHKYSRLR 476
S S SL D + Y+ + +++GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---G 118
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV- 535
IHRD+K +NILL K+ DFG++ A N +VGT +M+PE V+NG
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLS---AQLSDTKARNTMVGTPYWMAPE-VINGKPY 174
Query: 536 SMKSDVYSFGVLVLE 550
K+D++S G+ +E
Sbjct: 175 DYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 57/201 (28%), Positives = 84/201 (41%), Gaps = 46/201 (22%)
Query: 391 LGQGGFGPVYNGKLLD-----GQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL--- 441
LG+G FG VY G L ++A+K L + + + EF EA ++ KL H N+
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 442 ----TDS--------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRA 477
T L K + I +G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGY-----MSPEYVMN 532
+HRDL N L+ E + KISDFG++R + + G M+PE + +
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRD-----IYEDDYYRKRGGGKLPIKWMAPESLKD 178
Query: 533 GIVSMKSDVYSFGVLVLEIVS 553
G + KSDV+SFGVL+ EI +
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 36/202 (17%)
Query: 384 NFSPANRLGQGGFGPVYNG-KLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN 440
N+ + +G+G FG VY G L G +AIK++S + + E L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 441 LT---DSSRK--------------SLLDWKKRF----------YIIEGIVQGLLYLHKYS 473
+ S SL K+F Y+ + ++QGL YLH+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-VLQGLAYLHEQG 119
Query: 474 RLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG 533
IHRD+K +NIL + K++DFG+A +N++ + +VGT +M+PE +
Sbjct: 120 ---VIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPEVIEMS 174
Query: 534 IVSMKSDVYSFGVLVLEIVSSK 555
S SD++S G V+E+++
Sbjct: 175 GASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 42/201 (20%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKR--LSKSSGQGIVEFKNEAKLIAKLQHTNLTDSSRK 447
+G+G FG VY + DG+ +K LS S + + NE K++ KL H N+ +
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII-KYYE 66
Query: 448 SLLDWKKRFYII----EG----------------------------IVQGLLYLHKYSRL 475
S + K + I+ +G + L YLH SR
Sbjct: 67 SFEE-KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--SR- 122
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
+ +HRD+K NI L K+ DFG+++ + A T +VGT Y+SPE N
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQNKPY 180
Query: 536 SMKSDVYSFGVLVLEIVSSKK 556
+ KSD++S G ++ E+ + K
Sbjct: 181 NYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 2e-22
Identities = 57/194 (29%), Positives = 85/194 (43%), Gaps = 43/194 (22%)
Query: 391 LGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKLIAKLQHTNL-- 441
LG+G FG V + D G+ A+K L K I++ K E +++++ H +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK---IIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 442 ------TD-------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLR 476
T+ S + + RFY E IV L YLH L
Sbjct: 58 LHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAE-IVLALEYLH---SLG 113
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVS 536
I+RDLK NILLD + K++DFG+A+ + NT GT Y++PE ++
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGYG 171
Query: 537 MKSDVYSFGVLVLE 550
D +S GVL+ E
Sbjct: 172 KAVDWWSLGVLLYE 185
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-21
Identities = 42/113 (37%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 113 KQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNG 172
+ VW+ANR P+ + S +LI+ +DGNL + + S+ G+ A L +G
Sbjct: 2 QTVVWVANRLNPLT-DSSYTLIL-QSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDG 59
Query: 173 NLVLYEMNSDGLSIRRGLWQSFDYPTHALLPGMKLGINLQTGHQWFLQSSESA 225
NLVLY + + LWQSFD+PT LLPG K G N+ G L S +S
Sbjct: 60 NLVLY---DNSGKV---LWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSN 105
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 50/225 (22%)
Query: 363 DQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIK--RLSKSS 419
++ +K LK D + + + ++G+G G VY G+E+AIK RL K +
Sbjct: 1 EEELKAALK--DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN 58
Query: 420 GQGIVEFKNEAKLIAKLQHTN-------------------------LTDSSRKSLLDWKK 454
+ I+ NE ++ +H N LTD ++
Sbjct: 59 KELII---NEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD-----IITQNF 110
Query: 455 RF-------YIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507
Y+ ++QGL YLH IHRD+K NILL + + K++DFG A
Sbjct: 111 VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQ-- 165
Query: 508 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIV 552
+ + ++ N +VGT +M+PE + K D++S G++ +E+
Sbjct: 166 LTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 52/188 (27%), Positives = 82/188 (43%), Gaps = 32/188 (17%)
Query: 391 LGQGGFGPVYNGKL-LDGQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLTDS---- 444
LGQG G VY + G+ A+K++ + + E K + + +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 445 ----------------SRKSLLDWKKRF------YIIEGIVQGLLYLHKYSRLRAIHRDL 482
S LL + YI I++GL YLH + IHRD+
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI--IHRDI 126
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
K SN+L++ + KI+DFG+++ + NT VGT YMSPE + S +D++
Sbjct: 127 KPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSPERIQGESYSYAADIW 184
Query: 543 SFGVLVLE 550
S G+ +LE
Sbjct: 185 SLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 62/195 (31%), Positives = 89/195 (45%), Gaps = 39/195 (20%)
Query: 390 RLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------- 441
+LG G FG V+ G ++A+K L K F EA+++ KL+H L
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 442 --------TDSSRK-SLLDWKKR-----------FYIIEGIVQGLLYLHKYSRLRAIHRD 481
T+ K SLLD+ K + I +G+ YL IHRD
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRD 128
Query: 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTH---GYMSPEYVMNGIVSMK 538
L NIL+ E + KI+DFG+AR +E A G + +PE G ++K
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGRFTIK 184
Query: 539 SDVYSFGVLVLEIVS 553
SDV+SFG+L+ EIV+
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 64/225 (28%), Positives = 92/225 (40%), Gaps = 58/225 (25%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFK-----NE----AKL 432
D+F +G+G F V K +E AIK L K Q I E K E +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58
Query: 433 -----IAKLQHTNLTDSSRKSLLDW----------KK---------RFYIIEGIVQGLLY 468
I KL +T + + +L++ +K RFY E I+ L Y
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAE-ILLALEY 117
Query: 469 LHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE---------------- 512
LH IHRDLK NILLD+ M+ KI+DFG A+ N
Sbjct: 118 LHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 513 --ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
VGT Y+SPE + SD+++ G ++ ++++ K
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-19
Identities = 46/159 (28%), Positives = 58/159 (36%), Gaps = 44/159 (27%)
Query: 39 QVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAI 98
L G+ LVS+ F LGFF Y I YK
Sbjct: 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKG----------------------- 38
Query: 99 GNRPRKYPYSPAIKKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVR 158
+ VW+ANR+ P S +L + S DGNL I + S+
Sbjct: 39 ------------SSRTVVWVANRDNPS--GSSCTLTLQS-DGNLVIYDGSGTVVWSSNTT 83
Query: 159 RAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYP 197
R LL +GNLVLY+ + LWQSFDYP
Sbjct: 84 RVNGNYVLVLLDDGNLVLYDSDG------NFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 60/191 (31%), Positives = 88/191 (46%), Gaps = 32/191 (16%)
Query: 390 RLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------ 443
+LG G FG V+ G ++AIK L K F EA L+ +LQH L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 444 ----------SSRKSLLDW-----------KKRFYIIEGIVQGLLYLHKYSRLRAIHRDL 482
SL+D+ K + I +G+ ++ R IHRDL
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
+ +NIL+ E + KI+DFG+AR NE A + +PE + G ++KSDV+
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDVW 187
Query: 543 SFGVLVLEIVS 553
SFG+L+ EIV+
Sbjct: 188 SFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 54/213 (25%)
Query: 391 LGQGGFGPVYNGKLL------DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL-- 441
LG+G FG VY G+L +AIK L ++ + EF+ EA+L++ LQH N+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 442 ----------------------------------------TDSSRKSLLDWKKRFYIIEG 461
D + KS LD +I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR-TYAMNELEANTNRIVG 520
I G+ YL S +HRDL N L+ E + KISDFG++R Y+ + + ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 521 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+M PE ++ G + +SD++SFGV++ EI S
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 87.1 bits (214), Expect = 3e-18
Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 46/206 (22%)
Query: 391 LGQGGFGPVYNGKLLDGQEIAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTN------- 440
LG+G FG VY + D + +A+K L+K S + + F E +++A L H
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 441 -----------------------LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRA 477
L RK L + +I+ I+ L YLH
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGI 122
Query: 478 IHRDLKVSNILLDEQMN-PKISDFGMARTYA----MNELEANTNRIVGTHGYMSPEYVM- 531
IHRD+K NILLD K+ DFG+A+ + + A + VGT GYM+PE ++
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 532 --NGIVSMKSDVYSFGVLVLEIVSSK 555
S SD++S G+ + E+++
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 57/195 (29%), Positives = 90/195 (46%), Gaps = 39/195 (20%)
Query: 390 RLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------- 441
+LG G FG V+ G + +A+K L K +F EA+++ KL+H L
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 442 --------TDSSRK-SLLDW----KKRFYIIEGIVQ-------GLLYLHKYSRLRAIHRD 481
T+ + SLL++ R + ++ G+ YL + IHRD
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRD 128
Query: 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTH---GYMSPEYVMNGIVSMK 538
L N+L+ E K++DFG+AR + EA G + +PE + S+K
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSIK 184
Query: 539 SDVYSFGVLVLEIVS 553
SDV+SFG+L+ EIV+
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 42/193 (21%)
Query: 391 LGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------T 442
+G+G FG V G GQ++A+K L K F EA ++ L+H NL
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 443 DS---------SRKSLLDW---KKRFYIIEG--------IVQGLLYLHKYSRLRAIHRDL 482
+ ++ SL+D+ + R I + +G+ YL + +HRDL
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDL 128
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTH--GYMSPEYVMNGIVSMKSD 540
N+L+ E + K+SDFG+A+ EA+ + G + +PE + S KSD
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKSD 181
Query: 541 VYSFGVLVLEIVS 553
V+SFG+L+ EI S
Sbjct: 182 VWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 8e-18
Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 44/200 (22%)
Query: 391 LGQGGFGPVY------NGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ------- 437
LG+GGFG V GK+ +++ KRL K G+ + NE K++ K+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58
Query: 438 ----------------------HTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRL 475
++ + + + FY + I+ GL +LH +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLH---QR 114
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
R ++RDLK N+LLD+ N +ISD G+A + + R GT GYM+PE + +
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGR-AGTPGYMAPEVLQGEVY 171
Query: 536 SMKSDVYSFGVLVLEIVSSK 555
D ++ G + E+++ +
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 45/205 (21%)
Query: 389 NRLGQGGFGPVY------NGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT 442
+G+G FG V +GK+L +EI +++ Q +V +E ++ +L+H N+
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIV 62
Query: 443 DSSRKSLLDWKKRFYII------------------------EGIV-----QGLLYLH--- 470
+ + + YI+ E + Q LL L+
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 471 --KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPE 528
+HRDLK +NI LD N K+ DFG+A+ + A T VGT YMSPE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPE 180
Query: 529 YVMNGIVSMKSDVYSFGVLVLEIVS 553
+ + KSD++S G L+ E+ +
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCA 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-17
Identities = 45/158 (28%), Positives = 63/158 (39%), Gaps = 45/158 (28%)
Query: 39 QVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAI 98
L G+ LVS F LGFF+ +N Y I YK
Sbjct: 2 NTLSSGQTLVSGNSLFELGFFTL-IMQNDYNLILYKS----------------------- 37
Query: 99 GNRPRKYPYSPAIKKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVR 158
+ VW+ANR+ PV ++S +L + S DGNL + + S+
Sbjct: 38 ------------SSRTVVWVANRDNPV--SDSCTLTLQS-DGNLVLYDGDGRVVWSSNTT 82
Query: 159 RAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDY 196
A LL +GNLV+Y+ + + LWQSFDY
Sbjct: 83 GANGNYVLVLLDDGNLVIYDSDGN------FLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 49/195 (25%), Positives = 86/195 (44%), Gaps = 39/195 (20%)
Query: 391 LGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN--------L 441
LG+G +G VY + GQ +AIK + + + E E ++ +
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 442 TDS-------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDL 482
++ L ++ I+ ++GL YLH + IHRD+
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDI 125
Query: 483 KVSNILLDEQMNPKISDFGMAR--TYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSD 540
K NILL+E+ K++DFG++ T M A N ++GT +M+PE + + K+D
Sbjct: 126 KAGNILLNEEGQAKLADFGVSGQLTDTM----AKRNTVIGTPFWMAPEVIQEIGYNNKAD 181
Query: 541 VYSFGVLVLEIVSSK 555
++S G+ +E+ K
Sbjct: 182 IWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 33/197 (16%)
Query: 385 FSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 441
F+ +LG G FG V+ G + +AIK L +F+ E + + +L+H +L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 442 -------------TDSSRK-SL-----------LDWKKRFYIIEGIVQGLLYLHKYSRLR 476
T+ K SL L + + +G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---N 124
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVS 536
+IHRDL NIL+ E + K++DFG+AR + ++ +I + + +PE +G S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFS 182
Query: 537 MKSDVYSFGVLVLEIVS 553
KSDV+SFG+L+ E+ +
Sbjct: 183 TKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 60/194 (30%), Positives = 92/194 (47%), Gaps = 32/194 (16%)
Query: 390 RLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------ 443
+LGQG FG V+ G ++AIK L K F EA+++ KL+H L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 444 ----------SSRKSLLDWKKR-----------FYIIEGIVQGLLYLHKYSRLRAIHRDL 482
+ SLLD+ K + I G+ Y+ R+ IHRDL
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDL 128
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
+ +NIL+ + + KI+DFG+AR NE A + +PE + G ++KSDV+
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 187
Query: 543 SFGVLVLEIVSSKK 556
SFG+L+ E+V+ +
Sbjct: 188 SFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 73/263 (27%), Positives = 115/263 (43%), Gaps = 56/263 (21%)
Query: 391 LGQGGFGPVYNG-KLLDGQEIAIKRLS-----KSSGQGIVEFKNEAKLIAKLQHTNL--- 441
LG G FG VY G L DG A+K +S ++ + + + + E L++KLQH N+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 442 ----TDSSR----------KSLLDWKKRF----------YIIEGIVQGLLYLHKYSRLRA 477
+ SL K++ Y I+ GL YLH R
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYT-RQILLGLEYLH--DR-NT 123
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM-NGIVS 536
+HRD+K +NIL+D K++DFGMA+ + G+ +M+PE + G
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEF---SFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 537 MKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSS 596
+ +D++S G VLE+ + K + G A ++ G++ EL P + + S
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLE--------GVA-AVFKIGRSKEL--PPIPDHL-S 228
Query: 597 DEVMRCIHVGLLCVQDRAADRRT 619
DE I L C+Q + R T
Sbjct: 229 DEAKDFI---LKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 51/212 (24%)
Query: 389 NRLGQGGFGPVYNGKLLD-------GQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTN 440
N LG G FG VY G D +A+K L K ++ Q EF EA L++ H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 441 ---------LTDS-------------------SRKS-----LLDWKKRFYIIEGIVQGLL 467
L + +R LL K+ I + +G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 468 YLHKYSRLRAIHRDLKVSNILLDEQMNP-----KISDFGMAR-TYAMNELEANTNRIVGT 521
YL ++ IHRDL N L+ E+ KI DFG+AR Y + ++
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 522 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+M+PE +++G + +SDV+SFGVL+ EI++
Sbjct: 178 R-WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 37/98 (37%), Positives = 61/98 (62%), Gaps = 6/98 (6%)
Query: 458 IIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517
I +++GL YLH + + IHRD+K SNIL++ + K+ DFG++ +N L A T
Sbjct: 105 IAVAVLKGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS-GQLVNSL-AKTF- 159
Query: 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
VGT YM+PE + S+KSD++S G+ ++E+ + +
Sbjct: 160 -VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 8e-17
Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 40/205 (19%)
Query: 384 NFSPANRLGQGGFGPVYNG-KLLDGQEIAIKR--LSKSSGQGIVEFKNEAKLIAKLQHT- 439
+F N++G+G FG V+ + D + A+K+ LSK + + E +EA+++AKL +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 440 ---------------------------NLTDSSRKSLL--DWKKRFYIIEGIVQGLLYLH 470
L R L D RF+I I+ GL +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QILLGLAHLH 118
Query: 471 KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYV 530
+ +HRD+K N+ LD N KI D G+A+ + N ANT IVGT Y+SPE
Sbjct: 119 SK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELC 173
Query: 531 MNGIVSMKSDVYSFGVLVLEIVSSK 555
+ + KSDV++ GV++ E + K
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 9e-17
Identities = 59/194 (30%), Positives = 91/194 (46%), Gaps = 32/194 (16%)
Query: 390 RLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------ 443
+LGQG FG V+ G +AIK L K F EA+++ KL+H L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 444 ----------SSRKSLLDWKKRFY-----------IIEGIVQGLLYLHKYSRLRAIHRDL 482
S+ SLLD+ K + I G+ Y+ R+ +HRDL
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 128
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
+ +NIL+ E + K++DFG+AR NE A + +PE + G ++KSDV+
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 187
Query: 543 SFGVLVLEIVSSKK 556
SFG+L+ E+ + +
Sbjct: 188 SFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 9e-17
Identities = 62/198 (31%), Positives = 94/198 (47%), Gaps = 39/198 (19%)
Query: 390 RLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------ 443
+LG G FG V+ G + ++A+K L K + F EA L+ LQH L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 444 -----------SSRKSLLDWKKRFYIIEG--------------IVQGLLYLHKYSRLRAI 478
++ SLLD+ K EG I +G+ Y+ + + I
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKS---DEGGKVLLPKLIDFSAQIAEGMAYIERKNY---I 125
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 538
HRDL+ +N+L+ E + KI+DFG+AR NE A + +PE + G ++K
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIK 184
Query: 539 SDVYSFGVLVLEIVSSKK 556
SDV+SFG+L+ EIV+ K
Sbjct: 185 SDVWSFGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 34/214 (15%)
Query: 385 FSPANRLGQGGFGPVYNGKLLD-GQEIAIKR--LSKSSGQGIVEFKNEAKLIAKLQHTNL 441
F+ +G+G FG VY Q +AIK L ++ + I + + E + +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61
Query: 442 T-------------------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLR 476
T D + LD +I+ ++ GL YLH+
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE---G 118
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVS 536
IHRD+K +NILL E+ + K++DFG++ + NT VGT +M+PE +
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQSGYD 176
Query: 537 MKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLV 570
K+D++S G+ +E+ + R L L+
Sbjct: 177 EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 54/213 (25%)
Query: 391 LGQGGFGPVYNGKL-LDGQE----IAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLT-- 442
LG+ FG +Y G L L G + +AIK L ++ Q EF+ EA L+A+L H N+
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 443 -----------------------------------------DSSRKSLLDWKKRFYIIEG 461
D + KS LD +I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR-TYAMNELEANTNRIVG 520
I G+ YL + +H+DL NIL+ EQ++ KISD G++R Y+ + ++
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 521 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+M PE +M G S SD++SFGV++ EI S
Sbjct: 190 IR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 54/213 (25%)
Query: 391 LGQGGFGPVYNGKLL------DGQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNLT- 442
LG+ FG VY G L Q +AIK L K+ G EFK+EA + ++LQH N+
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 443 -----------------------------------------DSSRKSLLDWKKRFYIIEG 461
D + KS L+ +I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR-TYAMNELEANTNRIVG 520
I G+ +L S +H+DL N+L+ +++N KISD G+ R YA + + N ++
Sbjct: 133 IAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 521 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+MSPE +M G S+ SD++S+GV++ E+ S
Sbjct: 190 IR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 42/204 (20%)
Query: 385 FSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 440
F+ +G G FG VY + + + +AIK++S S Q ++++ E + + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 441 LTD-------------------SSRKSLLDWKKR-------FYIIEGIVQGLLYLHKYSR 474
+ S +L+ K+ I G +QGL YLH + R
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM--- 531
IHRD+K NILL E K++DFG A L + N VGT +M+PE ++
Sbjct: 137 ---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPEVILAMD 187
Query: 532 NGIVSMKSDVYSFGVLVLEIVSSK 555
G K DV+S G+ +E+ K
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 61/216 (28%), Positives = 85/216 (39%), Gaps = 46/216 (21%)
Query: 381 ATDNFSPANRLGQGGFGPVYNGKL--LDG----QEIAIKRL-SKSSGQGIVEFKNEAKLI 433
D+ + LG G FG VY G DG ++A+K L S Q +F EA ++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 434 AKLQHTNLT---------------------------------DSSRKSLLDWKKRFYIIE 460
+K H N+ R S L K +
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 461 GIVQGLLYLHKYSRLRAIHRDLKVSNILLD---EQMNPKISDFGMARTYAMNELEANTNR 517
+ +G YL + IHRD+ N LL KI+DFGMAR R
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+ +M PE ++GI + K+DV+SFGVL+ EI S
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 60/194 (30%), Positives = 94/194 (48%), Gaps = 32/194 (16%)
Query: 390 RLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------ 443
+LG G FG V+ G ++A+K L K F EA+++ KL+H L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 444 ----------SSRKSLLDWKK----RFYIIEGIVQ-------GLLYLHKYSRLRAIHRDL 482
S+ SLLD+ K R + +V G+ Y+ R+ IHRDL
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 128
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
+ +NIL+ + + KI+DFG+AR NE A + +PE + G ++KSDV+
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 187
Query: 543 SFGVLVLEIVSSKK 556
SFG+L+ E+V+ +
Sbjct: 188 SFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 40/98 (40%), Positives = 62/98 (63%), Gaps = 6/98 (6%)
Query: 458 IIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517
I +V+GL YL Y+ R +HRD+K SNIL++ + K+ DFG++ +N + A+T
Sbjct: 108 IAVAVVEGLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSI-ADT-- 161
Query: 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
VGT YMSPE + G ++KSDV+S G+ ++E+ K
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 41/96 (42%), Positives = 58/96 (60%), Gaps = 7/96 (7%)
Query: 458 IIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517
I E +++GL YLH SR + IHRD+K SNILL + K+ DFG++ +N L A T
Sbjct: 110 IAESVLKGLSYLH--SR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGE-LVNSL-AGT-- 162
Query: 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
GT YM+PE + S+ SDV+S G+ +LE+
Sbjct: 163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQ 198
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 43/205 (20%)
Query: 391 LGQGGFGPVYNG-KLLDGQEIAIKRLSKSSGQG---------IVEFKNEAKLIAKLQHTN 440
+G G FG VY G G+ +A+K++ S + E L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 441 LTD--------------------SSRKSLLDWKKRF------YIIEGIVQGLLYLHKYSR 474
+ S +LL+ F + I++GL YLH +R
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH--NR 125
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA--NTNR--IVGTHGYMSPEYV 530
IHRD+K +NIL+D + KISDFG+++ N L N R + G+ +M+PE V
Sbjct: 126 -GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 531 MNGIVSMKSDVYSFGVLVLEIVSSK 555
+ K+D++S G LV+E+++ K
Sbjct: 185 KQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 54/199 (27%), Positives = 95/199 (47%), Gaps = 36/199 (18%)
Query: 389 NRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSG-QGI-VEFKNEAKLIAKLQHTNL---- 441
++G+G +G VY + G+ +A+K++ + +G + E KL+ KL+H N+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 442 ---TDSSRKS--------------LLDWKK-RF------YIIEGIVQGLLYLHKYSRLRA 477
T + S LLD + +F ++ +++GL YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGI 121
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV-S 536
+HRD+K SNIL++ K++DFG+AR Y TNR++ T Y PE ++
Sbjct: 122 LHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRYG 180
Query: 537 MKSDVYSFGVLVLEIVSSK 555
+ D++S G ++ E+ K
Sbjct: 181 PEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 60/201 (29%), Positives = 88/201 (43%), Gaps = 44/201 (21%)
Query: 384 NFSPANRLGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVEFK------NEAKLIAKL 436
+F +G+G FG V + D +++ A+K ++K Q VE NE +++ +L
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNK---QKCVEKGSVRNVLNERRILQEL 57
Query: 437 QH---TNL-------------TD-----------SSRKSLLDWKKRFYIIEGIVQGLLYL 469
H NL D S + + + +F+I E IV L YL
Sbjct: 58 NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICE-IVLALEYL 116
Query: 470 HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEY 529
H IHRD+K NILLDEQ + I+DF +A + T GT GYM+PE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEV 170
Query: 530 VMNGIVSMKSDVYSFGVLVLE 550
+ S+ D +S GV E
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYE 191
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 59/200 (29%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 389 NRLGQGGFGPVYNGKLL--DGQEI--AIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTD 443
LG G FG V G L G+E+ A+K L + G EF EA ++A+L H +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 444 ----------------SSRKSLLDWKKRFYIIEG---------IVQGLLYLHKYSRLRAI 478
+ LL + K+ I + G+ YL +
Sbjct: 61 LIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES---KHFV 117
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG-----YMSPEYVMNG 533
HRDL N+LL + KISDFGM+R A+ + T G + +PE + G
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSR--ALG--AGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 534 IVSMKSDVYSFGVLVLEIVS 553
S KSDV+S+GV + E S
Sbjct: 174 KFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 9e-16
Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 46/196 (23%)
Query: 391 LGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVEFK------NEAKLIAKLQHTNLT- 442
LG G FG V + + A+K LSK IV+ K NE +++ ++H L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSK---AKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 443 -------DSSRKSLLDW----------KK---------RFYIIEGIVQGLLYLHKYSRLR 476
DS+ ++++ +K RFY + +V L YLH L
Sbjct: 66 LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ-VVLALEYLH---SLD 121
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVS 536
++RDLK N+LLD KI+DFG A+ ++ T + GT Y++PE +++
Sbjct: 122 IVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGYG 176
Query: 537 MKSDVYSFGVLVLEIV 552
D ++ G+L+ E++
Sbjct: 177 KAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 57/206 (27%)
Query: 391 LGQGGFGPVYNGKLL-DGQ----EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTD- 443
LG G FG VY G + +G+ +AIK L + + + E +EA ++A + H ++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 444 -----SSR--------------------------KSLLDWKKRFYIIEGIVQGLLYLHKY 472
SS+ + LL+W + I +G+ YL +
Sbjct: 75 LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEEK 128
Query: 473 SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG-----YMSP 527
R +HRDL N+L+ + KI+DFG+A+ L+ + G +M+
Sbjct: 129 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKL-----LDVDEKEYHAEGGKVPIKWMAL 180
Query: 528 EYVMNGIVSMKSDVYSFGVLVLEIVS 553
E +++ I + KSDV+S+GV V E+++
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 57/196 (29%), Positives = 86/196 (43%), Gaps = 38/196 (19%)
Query: 391 LGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD-----SS 445
LG G FG V+ GK ++AIK + + + +F EAK++ KL H NL +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 446 RK------------SLLDWKKRFYIIEG----------IVQGLLYLHKYSRLRAIHRDLK 483
++ LL++ + G + + + YL IHRDL
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLA 127
Query: 484 VSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTH---GYMSPEYVMNGIVSMKSD 540
N L+ E K+SDFG+AR ++ ++ GT + PE S KSD
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 541 VYSFGVLVLEIVSSKK 556
V+SFGVL+ E+ S K
Sbjct: 184 VWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 32/213 (15%)
Query: 385 FSPANRLGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLT 442
F+ R+G+G FG VY G +E+ AIK + + +E + E ++++ +T
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 443 ---DSSRKSLLDWKKRFY----------------------IIEGIVQGLLYLHKYSRLRA 477
S K W Y I+ I++GL YLH R
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE---RK 122
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSM 537
IHRD+K +N+LL EQ + K++DFG+A +++ NT VGT +M+PE +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDF 180
Query: 538 KSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLV 570
K+D++S G+ +E+ + N R L L+
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 38/199 (19%)
Query: 391 LGQGGFGPVYNGKLLD-GQEIAIKR-----LSKSSGQGIVEFKNEAKLIAKLQHTN---- 440
LGQG FG VY +D G+E+A+K+ S + + + + E +L+ LQH
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 441 ----------------LTDSSRK-------SLLDWKKRFYIIEGIVQGLLYLHKYSRLRA 477
+ S K +L + R Y + I++G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ-ILEGVEYLH---SNMI 125
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMA-RTYAMNELEANTNRIVGTHGYMSPEYVMNGIVS 536
+HRD+K +NIL D N K+ DFG + R + + GT +MSPE +
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185
Query: 537 MKSDVYSFGVLVLEIVSSK 555
K+DV+S G V+E+++ K
Sbjct: 186 RKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 42/204 (20%)
Query: 385 FSPANRLGQGGFGPVYNGKLLDGQE-IAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 440
F+ +G G FG VY + + E +AIK++S S Q ++++ E K + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 441 LTD-------------------SSRKSLLDWKKR-------FYIIEGIVQGLLYLHKYSR 474
+ S LL+ K+ I G +QGL YLH ++
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN- 145
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM--- 531
IHRD+K NILL E K++DFG A + + N VGT +M+PE ++
Sbjct: 146 --MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPEVILAMD 197
Query: 532 NGIVSMKSDVYSFGVLVLEIVSSK 555
G K DV+S G+ +E+ K
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 42/204 (20%)
Query: 385 FSPANRLGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 440
FS +G G FG VY + + E+ AIK++S S Q ++++ E + + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 441 LTD-------------------SSRKSLLDWKKR-------FYIIEGIVQGLLYLHKYSR 474
S LL+ K+ + G +QGL YLH ++
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN- 135
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM--- 531
IHRD+K NILL E K+ DFG A + A N VGT +M+PE ++
Sbjct: 136 --MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVILAMD 187
Query: 532 NGIVSMKSDVYSFGVLVLEIVSSK 555
G K DV+S G+ +E+ K
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 38/194 (19%)
Query: 390 RLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------ 443
+LG G FG V+ ++A+K + K + F EA ++ LQH L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 444 ----------SSRKSLLDWKKRFYIIEG--------------IVQGLLYLHKYSRLRAIH 479
++ SLLD+ K EG I +G+ ++ + + IH
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKS---DEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IH 125
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 539
RDL+ +NIL+ + KI+DFG+AR NE A + +PE + G ++KS
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIKS 184
Query: 540 DVYSFGVLVLEIVS 553
DV+SFG+L++EIV+
Sbjct: 185 DVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 51/207 (24%)
Query: 389 NRLGQGGFGPVYNGK---LLDGQ--EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL- 441
+LG+G FG V + L D ++A+K L+ S Q +F+ E +++ L H N+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 442 ------TDSSRKSL----------------------LDWKKRFYIIEGIVQGLLYLHKYS 473
+SL ++ K+ I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS-- 127
Query: 474 RLRAIHRDLKVSNILLDEQMNPKISDFGMART-------YAMNELEANTNRIVGTHGYMS 526
R IHRDL NIL++ + KISDFG+A+ Y + E + + +
Sbjct: 128 -QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF------WYA 180
Query: 527 PEYVMNGIVSMKSDVYSFGVLVLEIVS 553
PE + S SDV+SFGV + E+ +
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 38/196 (19%)
Query: 391 LGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------- 443
+G G FG V+ G L+ +++AIK + + +F EA+++ KL H L
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 444 --------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLK 483
+++ + + + +G+ YL + IHRDL
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLA 127
Query: 484 VSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTH---GYMSPEYVMNGIVSMKSD 540
N L+ E K+SDFGM R ++ ++T GT + SPE S KSD
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 541 VYSFGVLVLEIVSSKK 556
V+SFGVL+ E+ S K
Sbjct: 184 VWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 40/105 (38%), Positives = 55/105 (52%), Gaps = 10/105 (9%)
Query: 455 RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFG------MARTYAM 508
R YI E IV L YLH IHRDLK NIL+D + K++DFG + R +
Sbjct: 96 RIYIAE-IVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151
Query: 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
N+ E RIVGT Y++PE ++ S D +S G ++ E +
Sbjct: 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 77/287 (26%), Positives = 107/287 (37%), Gaps = 82/287 (28%)
Query: 390 RLGQGGFGPVY-------NGKLLDGQEIAIKRLSKSSGQGIV-EFKNEAKLIAKLQHTN- 440
+LG G FG V GK++ +A+K L I+ +F EA ++ L H N
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVI---PVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 441 -------LTDS--------SRKSLLDW----KKRFYII-------EGIVQGLLYLHKYSR 474
LT SLLD ++I I G+ YL S+
Sbjct: 59 IRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE--SK 116
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMART-------YAMNELEANTNRIVGTHGYMSP 527
R IHRDL NILL KI DFG+ R Y M E + V + +P
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE-----HLKV-PFAWCAP 169
Query: 528 EYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587
E + S SDV+ FGV + E+ + E P W + + L+ +D
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTY--------GEEP-------WAGLSGSQILKKID 214
Query: 588 PTLD-----ESCSSD--EVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
+ E+C D VM L C ADR T + + L
Sbjct: 215 KEGERLERPEACPQDIYNVM------LQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 46/130 (35%), Positives = 72/130 (55%), Gaps = 13/130 (10%)
Query: 423 IVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDL 482
++E+ N L+ +Q + D +R RFY E I+ GL +LHK I+RDL
Sbjct: 74 VMEYLNGGDLMFHIQSSGRFDEARA-------RFYAAE-IICGLQFLHKKG---IIYRDL 122
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
K+ N+LLD+ + KI+DFGM + E +A+T GT Y++PE + + D +
Sbjct: 123 KLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKGQKYNESVDWW 180
Query: 543 SFGVLVLEIV 552
SFGVL+ E++
Sbjct: 181 SFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 75/293 (25%), Positives = 117/293 (39%), Gaps = 87/293 (29%)
Query: 391 LGQGGFGPVYNGKLLD------GQEIAIKRLSKSSGQG-IVEFKNEAK------------ 431
LGQG FG VY G +AIK +++++ +EF NEA
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 432 ---LIAKLQHT----------NLTDSSRKSLLDWK----------KRFYIIEG-IVQGLL 467
+++ Q T +L R + + ++F + I G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 468 YLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTH----G 523
YL + +HRDL N ++ E + KI DFGM R + E + R G
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186
Query: 524 YMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-------SKKNNGSYDTERPLNLVGYAWQL 576
+M+PE + +G+ + KSDV+SFGV++ E+ + N E L V
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------EEVLKFVI----- 235
Query: 577 WNEGKALELMDPTLDESCSSD--EVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
+G L+L P E+C E+MR +C Q R T ++VS L
Sbjct: 236 --DGGHLDL--P---ENCPDKLLELMR------MCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 54/193 (27%), Positives = 85/193 (44%), Gaps = 33/193 (17%)
Query: 390 RLGQGGFGPVYNGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSSRK 447
++G+G FG VY G L E+A+K R + +F EA+++ + H N+ +
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIV---KL 57
Query: 448 SLLDWKKR-FYIIEGIVQG---LLYLHKYS-RLR----------------------AIHR 480
+ +K+ YI+ +V G L +L K RL IHR
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHR 117
Query: 481 DLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSD 540
DL N L+ E KISDFGM+R + + +PE + G + +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 541 VYSFGVLVLEIVS 553
V+S+G+L+ E S
Sbjct: 178 VWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 41/197 (20%)
Query: 391 LGQGGFGPVYNGKLLDGQE-IAIKRLSKSSGQGIVEF-KNEAKLIAKLQHTNLTDS---- 444
+G G VY L E +AIKR+ Q V+ + E + +++ H N+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 445 -------------SRKSLLDWKKRFY------------IIEGIVQGLLYLHKYSRLRAIH 479
S SLLD K Y +++ +++GL YLH + IH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IH 125
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR--IVGTHGYMSPEYVM---NGI 534
RD+K NILL E + KI+DFG++ + A R VGT +M+PE VM +G
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQVHG- 183
Query: 535 VSMKSDVYSFGVLVLEI 551
K+D++SFG+ +E+
Sbjct: 184 YDFKADIWSFGITAIEL 200
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 40/192 (20%)
Query: 390 RLGQGGFGPVYNGKLLDGQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNL------- 441
+G+G FG V G+ GQ++A+K + + Q F E ++ KL H NL
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 442 ------------TDSSRKSLLDWKKRFYIIEG--------IVQGLLYLHKYSRLRAIHRD 481
+ + + L + R + + +G+ YL + +HRD
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRD 125
Query: 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 541
L NIL+ E K+SDFG+AR + + + +++ + +PE + + S KSDV
Sbjct: 126 LAARNILVSEDGVAKVSDFGLAR---VGSMGVDNSKL--PVKWTAPEALKHKKFSSKSDV 180
Query: 542 YSFGVLVLEIVS 553
+S+GVL+ E+ S
Sbjct: 181 WSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 36/215 (16%)
Query: 385 FSPANRLGQGGFGPVYNGKLLDG---QEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN 440
F+ R+G+G FG V+ G +D Q +AIK + + +E + E ++++
Sbjct: 6 FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 441 LT-------------------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRL 475
+T D R D + +++ I++GL YLH +
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK- 122
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
IHRD+K +N+LL EQ + K++DFG+A +++ NT VGT +M+PE +
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSAY 178
Query: 536 SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLV 570
K+D++S G+ +E+ + N R L L+
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 42/205 (20%)
Query: 391 LGQGGFGPVYNGKLLD-GQEIAIKRLS---------KSSGQGIVE-FKNEAKLIAKLQHT 439
+G+G +G VY + G+ +A+K++ S + +V+ ++E + + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 440 NLTD--------------------SSRKSLLDWKKRF------YIIEGIVQGLLYLHKYS 473
N+ S S L RF + E +++GL YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128
Query: 474 RLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG 533
+HRDLK N+L+D KISDFG+++ + G+ +M+PE + +
Sbjct: 129 ---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 534 I--VSMKSDVYSFGVLVLEIVSSKK 556
S K D++S G +VLE+ + ++
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 45/221 (20%)
Query: 384 NFSPANRLGQGGFGP--VY----NGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ 437
++ P LG+G FG +Y + L+ +E+ + RLS+ + NE +++ LQ
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQ 57
Query: 438 HTN--------LTDSS--------------------RKSLLDWKKRFYIIEGIVQGLLYL 469
H N + D++ + L + + + + IV + Y+
Sbjct: 58 HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI 117
Query: 470 HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEY 529
HK L HRD+K NI L + K+ DFG+++ A T +VGT YMSPE
Sbjct: 118 HKAGIL---HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPEL 172
Query: 530 VMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLV 570
+ KSD+++ G ++ E+++ K+ ++D PLNLV
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKR---TFDATNPLNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 51/217 (23%)
Query: 389 NRLGQGGFGPVY------NGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 441
N++G G FG VY G+L+ +EI I+ + + I +E K++ L+H NL
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEI---ADEMKVLELLKHPNLV 62
Query: 442 -------------------TDSSRKSLLDWKK-------RFYIIEGIVQGLLYLHKYSRL 475
+ + + LL+ + R Y ++ +++GL YLH +
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQ-LLEGLAYLHSH--- 118
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMA-----RTYAMNELEANTNRIVGTHGYMSPEYV 530
+HRD+K +NI LD K+ DFG A T M E + GT YM+PE +
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL---AGTPAYMAPEVI 175
Query: 531 MNGIVSMK---SDVYSFGVLVLEIVSSKKNNGSYDTE 564
G +D++S G +VLE+ + K+ D E
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 49/194 (25%), Positives = 90/194 (46%), Gaps = 35/194 (18%)
Query: 390 RLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQHTNL----- 441
++G+G +G VY + L G+ +AIK++ + E KL+ +L H N+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 442 ----------------TD-----SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHR 480
TD R+ L + ++QGL + H + +HR
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHR 122
Query: 481 DLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKS 539
DLK N+L++ + K++DFG+AR++ + + T+ +V T Y +PE ++ S
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFG-SPVRPYTHYVV-TRWYRAPELLLGDKGYSTPV 180
Query: 540 DVYSFGVLVLEIVS 553
D++S G + E++S
Sbjct: 181 DIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 42/204 (20%)
Query: 385 FSPANRLGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 440
F + +G G FG VY E+ A+K++S S Q ++++ E K + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 441 LTD-------------------SSRKSLLDWKKR-------FYIIEGIVQGLLYLHKYSR 474
+ S LL+ K+ I G +QGL YLH ++
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM--- 531
IHRD+K NILL E K++DFG A + N VGT +M+PE ++
Sbjct: 143 ---IHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMD 193
Query: 532 NGIVSMKSDVYSFGVLVLEIVSSK 555
G K DV+S G+ +E+ K
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 44/201 (21%)
Query: 391 LGQGGFGPVYNGKLLDGQ------EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN---- 440
+G+G FG V+ + Q +I +++++K +NE +++ L H N
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAA---QNECQVLKLLSHPNIIEY 64
Query: 441 ------------------------LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLR 476
SLLD I+ VQ LL LH
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT---ILHFFVQILLALHHVHTKL 121
Query: 477 AIHRDLKVSNILLDE-QMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
+HRDLK NILLD+ +M KI DFG+++ + ++ +A T +VGT Y+SPE
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYT--VVGTPCYISPELCEGKPY 178
Query: 536 SMKSDVYSFGVLVLEIVSSKK 556
+ KSD+++ G ++ E+ S K+
Sbjct: 179 NQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 52/215 (24%), Positives = 87/215 (40%), Gaps = 46/215 (21%)
Query: 384 NFSPANRLGQGGFGPVYNGKL----LDGQE--IAIKRLSKSSGQGI-VEFKNEAKLIAKL 436
N LG+G FG V+ K +G E + +K L K+ + + EF+ E + KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 437 QHTNLT-----------------------------------DSSRKSLLDWKKRFYIIEG 461
H N+ + + L K++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGT 521
I G+ +L S R +HRDL N L+ Q K+S +++ +E N ++
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 522 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKK 556
+++PE V S KSDV+SFGVL+ E+ + +
Sbjct: 183 R-WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 52/203 (25%), Positives = 79/203 (38%), Gaps = 58/203 (28%)
Query: 391 LGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVE------FKNEAKLIAKLQHTN--- 440
LG GGFG V K+ + A+K + K IVE +E +++ + H
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH---IVETGQQEHIFSEKEILEECNHPFIVK 57
Query: 441 -------------LTD-----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLR 476
L + R ++ RFYI +V YLH
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYI-ACVVLAFEYLH---NRG 113
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMA-------RTYAMNELEANTNRIVGTHGYMSPEY 529
I+RDLK N+LLD K+ DFG A +T+ GT Y++PE
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT----------FCGTPEYVAPEI 163
Query: 530 VMNGIVSMKSDVYSFGVLVLEIV 552
++N D +S G+L+ E++
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 64/215 (29%)
Query: 374 DFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVEFKNEAKL 432
DFQ + ++GQGG+G V+ K D EI A+KR+ KS ++ NE +
Sbjct: 2 DFQILT----------QVGQGGYGQVFLAKKKDTGEIVALKRMKKS----LLFKLNEVRH 47
Query: 433 IAKLQHTNLTDSSR---------------------------KSLL-------DWKKRFYI 458
+ + T S ++LL + RFY+
Sbjct: 48 VLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM 107
Query: 459 IEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR---TYAMNELEANT 515
E + + + LH L IHRDLK N L+D + K++DFG+++ TYA
Sbjct: 108 AE-MFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA-------- 155
Query: 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 550
N +VG+ YM+PE + D +S G ++ E
Sbjct: 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYE 190
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 76/306 (24%), Positives = 128/306 (41%), Gaps = 72/306 (23%)
Query: 391 LGQGGFGPVYNGKLLDGQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLT-- 442
LG G FG VY G + E +AIK L++++G + VEF +EA ++A + H +L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 443 ------------------------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKY 472
+ + LL+W + I +G++YL +
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEER 128
Query: 473 SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN 532
R +HRDL N+L+ + KI+DFG+AR +E E N + +M+ E +
Sbjct: 129 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 533 GIVSMKSDVYSFGVLVLEIVS--SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590
+ +SDV+S+GV + E+++ K +G E P L +G+ L P +
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP--------DLLEKGERLP--QPPI 235
Query: 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT----------NDTMALPKPKQP 640
C+ D M + ++ R + ++ M +D M LP P
Sbjct: 236 ---CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPNDS 292
Query: 641 AFFINI 646
FF N+
Sbjct: 293 KFFQNL 298
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 43/205 (20%)
Query: 391 LGQGGFGPV----YNGKLLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT-- 442
LG+G FG V Y+ L D G+ +A+K+L S+ + + +F+ E +++ LQH N+
Sbjct: 12 LGKGNFGSVELCRYD-PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 443 -----DSSRKSL----------------------LDWKKRFYIIEGIVQGLLYLHKYSRL 475
+ R++L LD +K I +G+ YL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL---GSK 127
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG--YMSPEYVMNG 533
R +HRDL NIL++ + KI DFG+ + ++ E R G + +PE +
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWYAPESLTES 186
Query: 534 IVSMKSDVYSFGVLVLEIVS-SKKN 557
S+ SDV+SFGV++ E+ + S K+
Sbjct: 187 KFSVASDVWSFGVVLYELFTYSDKS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 36/212 (16%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIV-EFKNEAKLIAKLQHTNLTDSSR-- 446
+G+G +G VY GK + G+ +A+K ++ + V + + E L+++L+ + + ++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 447 KSLLD----W--------------------KKRF--YIIEGIVQGLLYLHKYSRLRAIHR 480
S L W +++ II ++ L Y+HK IHR
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG---VIHR 125
Query: 481 DLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV-SMKS 539
D+K +NIL+ N K+ DFG+A N + +T VGT +M+PE + G K+
Sbjct: 126 DIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKYYDTKA 183
Query: 540 DVYSFGVLVLEIVSSKKNNGSYDTERPLNLVG 571
D++S G+ + E+ + D R + L+
Sbjct: 184 DIWSLGITIYEMATGNPPYSDVDAFRAMMLIP 215
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 47/201 (23%)
Query: 391 LGQGGFGPVYNGKL-LDGQE---IAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL---- 441
+G G FG V G+L L G++ +AIK L + SS + ++F EA ++ + H N+
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 442 ------------TDSSRKSLLD-----------WKKRFYIIEGIVQGLLYLHKYSRLRAI 478
T+ LD + ++ GI G+ YL S + +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMNYV 128
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG------YMSPEYVMN 532
HRDL NIL++ + K+SDFG++R LE ++ T G + +PE +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSR-----RLE-DSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 533 GIVSMKSDVYSFGVLVLEIVS 553
+ SDV+SFG+++ E++S
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 43/135 (31%), Positives = 69/135 (51%), Gaps = 12/135 (8%)
Query: 426 FKNEAKLIAKLQHTNLTD-----SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHR 480
F+ + KL L + N + R+ + + R YI E IV L +LH+ L I+R
Sbjct: 74 FQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAE-IVLALDHLHQ---LGIIYR 129
Query: 481 DLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS- 539
D+K+ NILLD + + ++DFG+++ + E E GT YM+PE + G
Sbjct: 130 DIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKA 188
Query: 540 -DVYSFGVLVLEIVS 553
D +S GVL E+++
Sbjct: 189 VDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 62/198 (31%), Positives = 94/198 (47%), Gaps = 42/198 (21%)
Query: 391 LGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------- 443
LG G FG V GK ++AIK + + S EF EAK++ KL H L
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 444 ----------SSRKSLLDW----KKRFYIIE------GIVQGLLYL--HKYSRLRAIHRD 481
S LL++ KRF + + +G+ YL ++ IHRD
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQF-----IHRD 125
Query: 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTH---GYMSPEYVMNGIVSMK 538
L N L+D+Q K+SDFG++R Y +++ ++ VG+ + PE ++ S K
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSR-YVLDDEYTSS---VGSKFPVRWSPPEVLLYSKFSSK 181
Query: 539 SDVYSFGVLVLEIVSSKK 556
SDV++FGVL+ E+ S K
Sbjct: 182 SDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 73/253 (28%), Positives = 112/253 (44%), Gaps = 55/253 (21%)
Query: 391 LGQGGFGPVY------NGKL-----LDGQEIAIKR-----------LSKSSGQG---IV- 424
+G+GGFG VY GK+ LD + I +K+ LS S IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 425 ---EFKNEAKLIAKLQHTNLTD-----SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLR 476
F KL L N D S + + RFY E I+ GL ++H +R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAE-IILGLEHMH--NRF- 117
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVS 536
++RDLK +NILLDE + +ISD G+A ++ + A+ VGTHGYM+PE + G+
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAY 173
Query: 537 MKS-DVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCS 595
S D +S G ++ +++ + T+ + + M L +S S
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----------DRMTLTMAVELPDSFS 223
Query: 596 SDEVMRCIHVGLL 608
+ +R + GLL
Sbjct: 224 PE--LRSLLEGLL 234
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 39/205 (19%)
Query: 384 NFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTN 440
+++ ++G+G +G VY G+ GQ +A+K++ +S +G+ E L+ +LQH N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 441 -------LTDSSRKSL------LDWKK----------------RFYIIEGIVQGLLYLHK 471
L SR L +D KK + Y+ + I+QG+L+ H
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQ-ILQGILFCH- 118
Query: 472 YSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM 531
R +HRDLK N+L+D + K++DFG+AR + + + T+ +V T Y +PE ++
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV-TLWYRAPEVLL 174
Query: 532 NGI-VSMKSDVYSFGVLVLEIVSSK 555
S D++S G + E+ + K
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 43/130 (33%), Positives = 69/130 (53%), Gaps = 13/130 (10%)
Query: 423 IVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDL 482
++E+ N L+ +Q + D R + FY E I+ GL +LH ++RDL
Sbjct: 74 VMEYLNGGDLMFHIQSCHKFDLPRAT-------FYAAE-IICGLQFLHSKG---IVYRDL 122
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
K+ NILLD + KI+DFGM + + +A T GT Y++PE ++ + D +
Sbjct: 123 KLDNILLDTDGHIKIADFGMCKENMLG--DAKTCTFCGTPDYIAPEILLGQKYNTSVDWW 180
Query: 543 SFGVLVLEIV 552
SFGVL+ E++
Sbjct: 181 SFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 41/200 (20%)
Query: 391 LGQGGFGPVY------NGKLLDGQEIAIKRLSKSSG-QG-IVEFKNEAKL----IAKLQ- 437
LG+GGFG V GKL +++ KRL K G +G +VE + AK+ I L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 438 ----------------------HTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRL 475
H D + + FY + I+ GL +LH+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ-IISGLEHLHQR--- 116
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
R I+RDLK N+LLD N +ISD G+A + + ++ T GT G+M+PE +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEEY 174
Query: 536 SMKSDVYSFGVLVLEIVSSK 555
D ++ GV + E+++++
Sbjct: 175 DFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 42/204 (20%)
Query: 384 NFSPANRLGQGGFGPVYNGK-LLDGQEIAIKR--LSKSSGQGIVEFKNEAKLIAKLQHTN 440
+F +LG+G +G VY K L D Q A+K L S + + NE +++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 441 LTDSSRKSLLDWKKRFYIIE-------------------------------GIVQGLLYL 469
+ S +++ LD K ++E +++GL L
Sbjct: 61 II-SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 470 HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEY 529
H+ + +HRDLK +NILL KI D G+++ + + A T +GT YM+PE
Sbjct: 120 HE---QKILHRDLKSANILLVANDLVKIGDLGISK--VLKKNMAKTQ--IGTPHYMAPEV 172
Query: 530 VMNGIVSMKSDVYSFGVLVLEIVS 553
S KSD++S G L+ E+ +
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMAT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 41/212 (19%)
Query: 375 FQTIAAATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN--EAK 431
F T+ T+ + +G G FG V + + L GQ +AIK++ K ++ + E K
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 432 LIAKLQHTNL----------------------TDSSRKSLLDWK---KRF--YIIEGIVQ 464
L+ L+H N+ TD R LL + K+F Y + I++
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHR--LLTSRPLEKQFIQYFLYQILR 119
Query: 465 GLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGY 524
GL Y+H +HRDLK SNIL++E + KI DFG+AR + V T Y
Sbjct: 120 GLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ-----DPQMTGYVSTRYY 171
Query: 525 MSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSK 555
+PE ++ ++ D++S G + E++ K
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 58/217 (26%)
Query: 391 LGQGGFGPVYNGK---LLDGQE---IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL-- 441
LG+G FG V+ G+ L + +A+K L +++ + F+ EA+L+ QH N+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 442 --------------------------------------TDSSRKSLLDWKKRFYIIEGIV 463
+ S L + I I
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 464 QGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTH- 522
G++YL + +HRDL N L+ + KI DFGM+R + R+ G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY----RVGGHTM 185
Query: 523 ---GYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKK 556
+M PE +M + +SDV+SFGV++ EI + K
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 52/208 (25%)
Query: 391 LGQGGFGPVYN-------GKLLDGQEI-----AIKRLSKSSGQGIVEFKNEAKLIAK-LQ 437
LG G FG VY LL +EI A + + + I + +E +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 438 HTNLTDSSRKSLLDWKKRFYIIEGIVQG-------------------------------- 465
H N+ K+ L+ R YI+ +++G
Sbjct: 68 HPNIV-RYYKTFLE-NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 466 LLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYM 525
L YLHK R+ +HRDL +NI+L E I+DFG+A+ + E+ +VGT Y
Sbjct: 126 LRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYS 180
Query: 526 SPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
PE V N K+DV++FG ++ ++ +
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 59/214 (27%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 431
NF ++G+G F VY LLDG+ +A+K++ I E + E
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ------IFEMMDAKARQDCLKEID 54
Query: 432 LIAKLQHTNLT----------------------DSSR--------KSLLD----WKKRFY 457
L+ +L H N+ D SR K L+ WK Y
Sbjct: 55 LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK---Y 111
Query: 458 IIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517
++ + L ++H S+ R +HRD+K +N+ + K+ D G+ R ++ A++
Sbjct: 112 FVQ-LCSALEHMH--SK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-- 165
Query: 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEI 551
+VGT YMSPE + + KSD++S G L+ E+
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 55/213 (25%), Positives = 84/213 (39%), Gaps = 49/213 (23%)
Query: 381 ATDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QH 438
T F +G+G +G VY + GQ +AIK + E K E ++ K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKYSNH 62
Query: 439 TNLTD--------SSR----------------------KSLLDWKKRF------YIIEGI 462
N+ + K L KR YI+
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 463 VQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTH 522
++GL YLH+ + IHRD+K NILL + K+ DFG++ NT +GT
Sbjct: 123 LRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--FIGTP 177
Query: 523 GYMSPEYVM-----NGIVSMKSDVYSFGVLVLE 550
+M+PE + + +SDV+S G+ +E
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 36/96 (37%), Positives = 57/96 (59%), Gaps = 11/96 (11%)
Query: 461 GIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVG 520
IV+ L YLH S+L IHRD+K SN+L++ K+ DFG++ Y ++ + A T G
Sbjct: 111 SIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS-GYLVDSV-AKTIDA-G 165
Query: 521 THGYMSPEYVMNGIVSM-----KSDVYSFGVLVLEI 551
YM+PE + N ++ KSDV+S G+ ++E+
Sbjct: 166 CKPYMAPERI-NPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 54/193 (27%), Positives = 87/193 (45%), Gaps = 32/193 (16%)
Query: 391 LGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------- 443
LG G FG V+ GK ++AIK +++ + +F EAK++ KL H L
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 444 ----------SSRKSLLDWKKRFY----------IIEGIVQGLLYLHKYSRLRAIHRDLK 483
LL++ ++ + + + +G+ YL + S IHRDL
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLA 127
Query: 484 VSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYS 543
N L+ K+SDFGM R Y +++ +++ + PE S KSDV+S
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 544 FGVLVLEIVSSKK 556
FGVL+ E+ + K
Sbjct: 187 FGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 69/254 (27%), Positives = 106/254 (41%), Gaps = 52/254 (20%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLS-KSSGQGIVE-----FKNEAKLIAKLQHTN-- 440
LG+G +G VY G GQ IA+K++ +S E + E L+ L+H N
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 441 ------LTDSSRKSLLDWK---------KRF---------YIIEGIVQGLLYLHKYSRLR 476
L D++ +++ RF + I+ G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--- 122
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIV----GTHGYMSPEYVMN 532
+HRD+K +N++L K+ DFG AR A L + ++ GT +M+PE +
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 533 GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592
KSD++S G V E+ + K S D L + Y G LM P L +
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPPLASMD---RLAAMFYI------GAHRGLM-PRLPD 232
Query: 593 SCSS---DEVMRCI 603
S S+ D V C+
Sbjct: 233 SFSAAAIDFVTSCL 246
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 39/196 (19%)
Query: 391 LGQGGFGPVYNGKLL----DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL--- 441
LGQG FG V+ + + GQ A+K L K++ + V K E ++A++ H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 442 -----TDSSRKSLLDWKK-------------------RFYIIEGIVQGLLYLHKYSRLRA 477
T+ +LD+ + +FY+ E + L +LH L
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLH---SLGI 119
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSM 537
I+RDLK NILLDE+ + K++DFG+++ +E +A + GT YM+PE V +
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGHTQ 177
Query: 538 KSDVYSFGVLVLEIVS 553
+D +SFGVL+ E+++
Sbjct: 178 SADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 57/197 (28%), Positives = 90/197 (45%), Gaps = 43/197 (21%)
Query: 391 LGQGGFGPVY------NGKLLDGQEIAIKRLSKSSGQGIV-------------------- 424
+G+GGFG VY GK+ + + KR+ G+ +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 425 ---EFKNEAKLIAKLQHTNLTD-----SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLR 476
F KL L N D S + + RFY E I+ GL ++H +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATE-IILGLEHMH--NRF- 117
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV- 535
++RDLK +NILLDE + +ISD G+A ++ + A+ VGTHGYM+PE + G
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGTAY 173
Query: 536 SMKSDVYSFGVLVLEIV 552
+D +S G ++ +++
Sbjct: 174 DSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 47/198 (23%), Positives = 81/198 (40%), Gaps = 51/198 (25%)
Query: 381 ATDNFSPANRLGQGGFGPVYNG-KLLDGQEIAIKRL---SKSSGQGIVEFKNEAKLIAKL 436
++ +LG+G FG VY ++ G+ +A+K++ ++ G I + E K++ KL
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64
Query: 437 QHTN---LTD---SSRKSLLDWKKRFYII----------------------------EGI 462
+H N L D + Y++ +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124
Query: 463 VQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTY---------AMNELEA 513
++G+ YLH+ +HRD+K +NIL+D Q KI+DFG+AR Y
Sbjct: 125 LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 514 NTNRIVGTHGYMSPEYVM 531
+V T Y PE ++
Sbjct: 182 KYTNLVVTRWYRPPELLL 199
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 6e-12
Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 32/194 (16%)
Query: 385 FSPANRLGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVE-FKNEAKLIAK------- 435
F+ ++G+G FG V+ G Q++ AIK + + +E + E ++++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 436 ------LQHTNL------------TDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRA 477
L+ T L D LD + I+ I++GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK--- 122
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSM 537
IHRD+K +N+LL E K++DFG+A + + + N VGT +M+PE +
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 538 KSDVYSFGVLVLEI 551
K+D++S G+ +E+
Sbjct: 181 KADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 50/213 (23%)
Query: 391 LGQGGFGPVYNGK---LLDGQE---IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT-- 442
LG+G FG V+ + LL Q+ +A+K L ++S +F+ EA+L+ LQH ++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 443 --------------------DSSR--------KSLLDWKK-----------RFYIIEGIV 463
D +R +L + I I
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 464 QGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG 523
G++YL + L +HRDL N L+ + + KI DFGM+R + R +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 524 YMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKK 556
+M PE ++ + +SD++SFGV++ EI + K
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 48/274 (17%)
Query: 390 RLGQGGFGPVYNG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN-------- 440
++GQG G VY + GQE+AIK+++ NE ++ + +H N
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 441 -----------------LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLK 483
LTD ++ +D + + +Q L +LH + IHRD+K
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIK 142
Query: 484 VSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYS 543
NILL + K++DFG + + +T +VGT +M+PE V K D++S
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 544 FGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCI 603
G++ +E+V + Y E PL + + + G EL +P + D + RC+
Sbjct: 201 LGIMAIEMVEGEP---PYLNENPLRAL---YLIATNGTP-ELQNPEKLSAIFRDFLNRCL 253
Query: 604 HVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKP 637
+ V+ R + + +L + + + KP
Sbjct: 254 EMD---VEKRGSAK-------ELLQHPFLKIAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 44/193 (22%)
Query: 393 QGGFGPVYNG-KLLDGQEIAIKRLSKSS------------GQGIVEFKNEAKLIAKLQHT 439
+G FG VY K G AIK L KS + I+ + E+ +AKL ++
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 440 ------------NLTDSSRKSLL--------DWKKRFYIIEGIVQGLLYLHKYSRLRAIH 479
L SL+ DW K+ YI E +V G+ LH+ IH
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQ-YIAE-VVLGVEDLHQRG---IIH 120
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 539
RD+K N+L+D+ + K++DFG++R N+ + VGT Y++PE ++ S
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVGDDKMS 174
Query: 540 DVYSFGVLVLEIV 552
D +S G ++ E +
Sbjct: 175 DWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 8e-12
Identities = 62/255 (24%), Positives = 108/255 (42%), Gaps = 38/255 (14%)
Query: 377 TIAAATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAK 435
+I ++ ++GQG G V+ + GQE+AIK+++ NE ++ +
Sbjct: 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 436 LQHTN-------------------------LTDSSRKSLLDWKKRFYIIEGIVQGLLYLH 470
L++ N LTD ++ +D + + +Q L +LH
Sbjct: 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 471 KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYV 530
+ IHRD+K N+LL + K++DFG + + +T +VGT +M+PE V
Sbjct: 133 AN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVV 187
Query: 531 MNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590
K D++S G++ +E+V + Y E PL A L EL +P
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEP---PYLNENPLR----ALYLIATNGTPELQNPEK 240
Query: 591 DESCSSDEVMRCIHV 605
D + RC+ +
Sbjct: 241 LSPIFRDFLNRCLEM 255
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 45/130 (34%), Positives = 69/130 (53%), Gaps = 13/130 (10%)
Query: 423 IVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDL 482
++EF N L+ +Q D R L ++ FY E IV GL +LH I+RDL
Sbjct: 74 VMEFLNGGDLMFHIQ-----DKGRFDL--YRATFYAAE-IVCGLQFLHSKG---IIYRDL 122
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
K+ N++LD + KI+DFGM + + A+T GT Y++PE + + D +
Sbjct: 123 KLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEILQGLKYTFSVDWW 180
Query: 543 SFGVLVLEIV 552
SFGVL+ E++
Sbjct: 181 SFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 10/94 (10%)
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGT 521
I+ G+ YLH R +HRD+K SN+L++ N KI+DFG++R A N++ VGT
Sbjct: 177 ILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGT 231
Query: 522 HGYMSPEYVMNGIVSMK-----SDVYSFGVLVLE 550
YMSPE + + D++S GV +LE
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-12
Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 40/199 (20%)
Query: 391 LGQGGFGPVYNGKLLDGQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----TDS 444
LG+G +G VY + L Q IAIK + + + + E L + L+H N+ +DS
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 445 ---------------SRKSLLDWK----------KRFYIIEGIVQGLLYLHKYSRLRAIH 479
S +LL K FY + I++GL YLH + +H
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-ILEGLKYLHD---NQIVH 131
Query: 480 RDLKVSNILLDEQMNP-KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGI--VS 536
RD+K N+L++ KISDFG ++ A + T GT YM+PE + G
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTETFTGTLQYMAPEVIDKGPRGYG 189
Query: 537 MKSDVYSFGVLVLEIVSSK 555
+D++S G ++E+ + K
Sbjct: 190 APADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 36/97 (37%), Positives = 54/97 (55%), Gaps = 6/97 (6%)
Query: 455 RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514
RFY E IV GL +LH+ I+RDLK+ N+LLD + + KI+DFGM + +
Sbjct: 99 RFYAAE-IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVT 152
Query: 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEI 551
T+ GT Y++PE + D ++ GVL+ E+
Sbjct: 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 70/293 (23%), Positives = 124/293 (42%), Gaps = 48/293 (16%)
Query: 371 KIFDFQTIAAATDNFSPANRLGQGGFGPVYNG-KLLDGQEIAIKRLS------------- 416
K+ ++ ++ ++GQG G VY + GQE+AIK+++
Sbjct: 7 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINE 66
Query: 417 -----KSSGQGIVEFKNEA-------KLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQ 464
++ IV + + ++ L +LTD ++ +D + + +Q
Sbjct: 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 126
Query: 465 GLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGY 524
L +LH + IHRD+K NILL + K++DFG + + +T +VGT +
Sbjct: 127 ALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYW 181
Query: 525 MSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584
M+PE V K D++S G++ +E+V + Y E PL A L E
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP---PYLNENPLR----ALYLIATNGTPE 234
Query: 585 LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKP 637
L +P + D + RC+ + + DRR + +L + + L KP
Sbjct: 235 LQNPERLSAVFRDFLNRCLEMDV--------DRRGSAK--ELLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 6/98 (6%)
Query: 456 FYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515
FY E I GL +LH I+RDLK+ N++LD + + KI+DFGM + T
Sbjct: 105 FYAAE-IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--GKTT 158
Query: 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
GT Y++PE + D ++FGVL+ E+++
Sbjct: 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 49/166 (29%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGT 521
I +G+ YL + ++ +HRDL N+L+ E KISDFG++R + ++
Sbjct: 136 ISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIP 192
Query: 522 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK 581
+M+ E + + I + +SDV+SFGVL+ EIV+ N Y P L + L G
Sbjct: 193 VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN--PYPGIAPERL----FNLLKTGY 246
Query: 582 ALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
+E E+C S+E+ + L C + R T +D+ L
Sbjct: 247 RME-----RPENC-SEEMYNLM---LTCWKQEPDKRPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 45/207 (21%)
Query: 385 FSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH------ 438
F +G G +G VY G+ + ++A ++ +G E K E ++ K H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 439 -----------------------------TNLTDSSRKSLLDWKKRFYIIEGIVQGLLYL 469
T+L +++ + L + YI I++GL +L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 470 HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEY 529
H++ + IHRD+K N+LL E K+ DFG++ ++ N +GT +M+PE
Sbjct: 128 HQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNTFIGTPYWMAPEV 182
Query: 530 VM-----NGIVSMKSDVYSFGVLVLEI 551
+ + KSD++S G+ +E+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 40/195 (20%)
Query: 391 LGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNLTDSSRKSL 449
LG+G FG V+ G L D +A+K + Q + ++F +EA+++ + H N+ +
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIV--KLIGV 60
Query: 450 LDWKKRFYIIEGIVQG---LLYLHK----------------------YSRLR-AIHRDLK 483
++ YI+ +V G L +L K Y + IHRDL
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLA 120
Query: 484 VSNILLDEQMNPKISDFGMAR-----TYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 538
N L+ E KISDFGM+R Y+ + L+ + + +PE + G S +
Sbjct: 121 ARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPEALNYGRYSSE 174
Query: 539 SDVYSFGVLVLEIVS 553
SDV+S+G+L+ E S
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 37/204 (18%)
Query: 384 NFSPANRLGQGGFGPVYNGKLLDGQEI-AIK--RLSKSSGQGIVEFKNEAKLIAKLQHTN 440
F NR+G+G +G VY + EI A+K R+ + E L+ L+H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 441 LT---------------------DSSRKSLLDWKKRFY-------IIEGIVQGLLYLHKY 472
+ + SLLD + ++ +++GL YLH
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH-- 125
Query: 473 SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN 532
IHRDLKVSN+LL ++ KI+DFG+ARTY + + T ++V T Y +PE ++
Sbjct: 126 -ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KPMTPKVV-TLWYRAPELLLG 182
Query: 533 GIVSMKS-DVYSFGVLVLEIVSSK 555
+ D+++ G ++ E+++ K
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 46/214 (21%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQH 438
D F ++G+G +G VY + D G+ +A+K++ ++ G I + E K++ +L H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNH 65
Query: 439 TNLTD-----SSRKSLLDWKKR---FYII-------------EGIV-------------- 463
N+ + + ++ LD+KK FY++ G+V
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 464 -QGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTH 522
+GL Y HK + L HRD+K SNILL+ + K++DFG+AR Y E TN+++ T
Sbjct: 126 LEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TL 181
Query: 523 GYMSPEYVM-NGIVSMKSDVYSFGVLVLEIVSSK 555
Y PE ++ DV+S G ++ E+ + K
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 44/201 (21%)
Query: 391 LGQGGFGPVYNGKLLD--GQEI--AIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL---- 441
+G+G FG VY+G L+D GQ+I A+K L++ + VE F E ++ H N+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 442 -----TDSSRKSLLDWKK----RFYI--------IEGIV-------QGLLYLHKYSRLRA 477
++ S +L + K R +I ++ ++ +G+ YL + +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKKF 119
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG-----YMSPEYVMN 532
+HRDL N +LDE K++DFG+AR E + N T +M+ E +
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH---TGAKLPVKWMALESLQT 176
Query: 533 GIVSMKSDVYSFGVLVLEIVS 553
+ KSDV+SFGVL+ E+++
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 58/221 (26%)
Query: 389 NRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN--------------EAKLI 433
LG+G +G V L G+ +AIK++ V E K++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 434 AKLQHTNLT-------------------DSSRKSLLDWKKRFY------IIEGIVQGLLY 468
+++H N+ S K ++D K R I+ I+ GL
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNV 134
Query: 469 LHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA-------------MNELEANT 515
LHK+ +HRDL +NI ++ + KI+DFG+AR Y M E T
Sbjct: 135 LHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 516 NRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSK 555
+++V T Y +PE +M D++S G + E+++ K
Sbjct: 192 SKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 42/198 (21%)
Query: 390 RLGQGGFGPVY---NGKLLDGQ------EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 440
RLG+G FG VY + K + + EI + L+ + V+ EA+L++KL H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKLDHPA 63
Query: 441 L----------------TDSSRKSLLDWKKRFY-----------IIEGIVQGLLYLHKYS 473
+ T+ LD K + E +Q LL +H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 474 RLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG 533
+ R +HRDLK NI L + KI DFG++R M + T GT YMSPE + +
Sbjct: 124 QRRILHRDLKAKNIFLKNNL-LKIGDFGVSR-LLMGSCDLATT-FTGTPYYMSPEALKHQ 180
Query: 534 IVSMKSDVYSFGVLVLEI 551
KSD++S G ++ E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 38/197 (19%)
Query: 391 LGQGGFGPV------YNGKLLDGQEIAIKRLSKSSGQGIVEFKNE------AKLIAKLQH 438
LG+GGFG V GK+ +++ KRL K SG+ + + E + I L +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 439 TNLTDSSR---KSL-----------------LDWKKRFYIIEGIVQGLLYLHKYSRLRAI 478
+ + SL L+ ++ + I G+L+LH + +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 538
+RD+K N+LLD+Q N ++SD G+A + + + T R GT+GYM+PE + S
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQR-AGTNGYMAPEILKEEPYSYP 174
Query: 539 SDVYSFGVLVLEIVSSK 555
D ++ G + E+V+ +
Sbjct: 175 VDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 73/280 (26%), Positives = 124/280 (44%), Gaps = 71/280 (25%)
Query: 391 LGQGGFGPVYNGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---- 441
+G G FG V +G+L L G+ +AIK L + + +F +EA ++ + H N+
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 442 ------------TDSSRKSLLD--WKK---RFYIIE------GIVQGLLYLHKYSRLRAI 478
T+ LD +K +F +I+ GI G+ YL S + +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYV 128
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG------YMSPEYVMN 532
HRDL NIL++ + K+SDFG++R LE + T G + +PE +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 533 GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG--KALE---LMD 587
+ SDV+S+G+++ E++S ERP W++ N+ KA+E +
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYG--------ERPY------WEMSNQDVIKAIEEGYRLP 229
Query: 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
+D + ++M L C Q +R +VS+L
Sbjct: 230 APMDCPAALHQLM------LDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 38/207 (18%)
Query: 391 LGQGGFGPVYNGKLLD-GQEIAIKRL-----SKSSGQGIVEFKNEAKLIAKLQHTN---- 440
LGQG FG VY +D G+E+A K++ S + + + + E +L+ LQH
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 441 ---LTDSSRKSLL------------DWKKRFYII---------EGIVQGLLYLHKYSRLR 476
L D + K+L D K + + I++G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---M 126
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR-IVGTHGYMSPEYVMNGIV 535
+HRD+K +NIL D N K+ DFG ++ + R + GT +MSPE +
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186
Query: 536 SMKSDVYSFGVLVLEIVSSKKNNGSYD 562
K+DV+S G V+E+++ K Y+
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPWAEYE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 39/201 (19%)
Query: 391 LGQGGFGPVY------NGKLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLT- 442
LG G F Y G L+ +++ R + S + +VE + E +L+A+L H ++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 443 -------DSSRKSLLDWKKRFYI------------------IEGIVQGLLYLHKYSRLRA 477
DS ++W + E +++GL YLH+ +
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QI 124
Query: 478 IHRDLKVSNILLDEQ-MNPKISDFGMARTYAMNELEAN--TNRIVGTHGYMSPEYVMNGI 534
IHRD+K +N+L+D +I+DFG A A A +++GT +M+PE +
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 535 VSMKSDVYSFGVLVLEIVSSK 555
DV+S G +++E+ ++K
Sbjct: 185 YGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 39/198 (19%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQHTNLTDSSRK 447
+G+G +G V + DG++ IK+L+ +S + + EA+L+++L+H N+ + R+
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-AYRE 66
Query: 448 SLLDWKKRFYIIEGIVQG------------------------------LLYLHKYSRLRA 477
S YI+ G +G L YLH+ L
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHIL-- 124
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSM 537
HRDLK N+ L K+ D G+AR A+T ++GT YMSPE N +
Sbjct: 125 -HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNY 181
Query: 538 KSDVYSFGVLVLEIVSSK 555
KSDV++ G V E+ + K
Sbjct: 182 KSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 39/206 (18%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQEI-AIKRL---SKSSGQGIVEFKNEAKLIAKLQH 438
D + NR+ +G +G VY + EI A+K+L + G I + E ++ KLQH
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63
Query: 439 TNLTDSSR---------------------KSLLDWKK-RFYIIE--GIVQGLL----YLH 470
N+ KSL++ K F E ++ LL +LH
Sbjct: 64 PNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH 123
Query: 471 KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYV 530
L HRDLK SN+LL+ + KI DFG+AR Y L+ T ++V T Y +PE +
Sbjct: 124 DNWIL---HRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYT-QLVVTLWYRAPELL 178
Query: 531 MN-GIVSMKSDVYSFGVLVLEIVSSK 555
+ S D++S G + E+++ K
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 55/192 (28%), Positives = 89/192 (46%), Gaps = 30/192 (15%)
Query: 390 RLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNLTDSSRK 447
R+G+G FG V++G+L D +A+K ++ + +F EA+++ + H N+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV--RLI 59
Query: 448 SLLDWKKRFYIIEGIVQG---LLYLH-KYSRLR----------------------AIHRD 481
+ K+ YI+ +VQG L +L + RL+ IHRD
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRD 119
Query: 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 541
L N L+ E+ KISDFGM+R + + +PE + G S +SDV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 542 YSFGVLVLEIVS 553
+SFG+L+ E S
Sbjct: 180 WSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 57/227 (25%), Positives = 86/227 (37%), Gaps = 64/227 (28%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQEI-AIKRLSKS----SGQGIVEFKNE-------- 429
D+F +G+G FG V+ + D ++ A+K L KS Q I + E
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADAD 59
Query: 430 ----AKLIAKLQHTN--------------LTDSSRKSLLDWK-KRFYIIEGIVQGLLYLH 470
KL Q + RK + + RFYI E +V L +H
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAE-LVLALDSVH 118
Query: 471 KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMA--------------------------- 503
K L IHRD+K NIL+D + K++DFG+
Sbjct: 119 K---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 504 RTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 550
R + N VGT Y++PE + ++ D +S GV++ E
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 40/133 (30%), Positives = 70/133 (52%), Gaps = 13/133 (9%)
Query: 423 IVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDL 482
++E+ N L+ ++Q + D R RFY E + L++LH++ I+RDL
Sbjct: 74 VMEYVNGGDLMFQIQRSRKFDEPRS-------RFYAAE-VTLALMFLHRHG---VIYRDL 122
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
K+ NILLD + + K++DFGM + +N T GT Y++PE + D +
Sbjct: 123 KLDNILLDAEGHCKLADFGMCKEGILN--GVTTTTFCGTPDYIAPEILQELEYGPSVDWW 180
Query: 543 SFGVLVLEIVSSK 555
+ GVL+ E+++ +
Sbjct: 181 ALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 60/200 (30%), Positives = 89/200 (44%), Gaps = 44/200 (22%)
Query: 391 LGQGGFGPV------YNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD- 443
LG+GGFG V GK+ +++ KR+ K G+ + NE +++ K+ +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 444 ----SSRKSLL---------DWK-------------KR--FYIIEGIVQGLLYLHKYSRL 475
++ +L D K +R FY E I GL LH R
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE-ITCGLEDLH---RE 121
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
R ++RDLK NILLD+ + +ISD G+A E VGT GYM+PE V N
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR---VGTVGYMAPEVVKNERY 178
Query: 536 SMKSDVYSFGVLVLEIVSSK 555
+ D + G L+ E++ K
Sbjct: 179 TFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (157), Expect = 3e-11
Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 50/196 (25%)
Query: 385 FSPANRLGQGGFGPVYNGK-LLDGQEIAIK--RLSKSSGQGIVEFKN---EAKLIAKLQH 438
+ +LG+G +G VY + G+ +A+K RL +GI E L+ +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGI--PSTALREISLLKELKH 57
Query: 439 TN-------LTDSSR------------KSLLDWKKRFYIIEG---------IVQGLLYLH 470
N + + K LD KR + +++GL Y H
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDMDLKKYLD--KRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 471 KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYV 530
S R +HRDLK NIL++ K++DFG+AR + + L T+ +V T Y +PE
Sbjct: 116 --SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVV-TLWYRAPE-- 168
Query: 531 MNGIVSMKSDVYSFGV 546
+ + S YS V
Sbjct: 169 ----ILLGSKHYSTAV 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 53/194 (27%), Positives = 86/194 (44%), Gaps = 34/194 (17%)
Query: 389 NRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD---- 443
++LG G +G VY G +A+K L K + EF EA ++ +++H NL
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 444 -------------SSRKSLLDWKKR-----------FYIIEGIVQGLLYLHKYSRLRAIH 479
+ +LLD+ + Y+ I + YL K + IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 539
RDL N L+ E K++DFG++R + A+ + +PE + S+KS
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKS 186
Query: 540 DVYSFGVLVLEIVS 553
DV++FGVL+ EI +
Sbjct: 187 DVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 384 NFSPANRLGQGGFGPVYNGK-LLDGQEIAIKR--LSKSSGQGIVEFKNEAKLIAKLQHTN 440
+ ++G+G FG +Y K D + IK L+K + K E L+AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 441 -------LTDSSRKSLL-------DWKKRFYIIEGI-----------VQGLLYLHKYSRL 475
++ R ++ D KR G+ VQ L L
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 476 RAIHRDLKVSNILLDEQ-MNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGI 534
+ +HRD+K NI L + M K+ DFG+AR +N+ VGT Y+SPE N
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQNRP 178
Query: 535 VSMKSDVYSFGVLVLEIVSSK 555
+ K+D++S G ++ E+ + K
Sbjct: 179 YNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 71/279 (25%), Positives = 118/279 (42%), Gaps = 69/279 (24%)
Query: 391 LGQGGFGPVYNGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---- 441
+G G FG V+ G L + G++ +AIK L + + +F +EA ++ + H N+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 442 ------------TDSSRKSLLDWKKRFY-----------IIEGIVQGLLYLHKYSRLRAI 478
T+ LD R + ++ GI G+ YL S + +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNYV 129
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG------YMSPEYVMN 532
HRDL NIL++ + K+SDFG++R LE + T G + +PE +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 533 GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592
+ SDV+SFG+++ E++S ERP W + N E+M +++
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFG--------ERPY------WDMSNH----EVMK-AIND 225
Query: 593 SCSSDEVMRC----IHVGLLCVQDRAADRRTMSDVVSML 627
M C + L C Q A R D+V++L
Sbjct: 226 GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 46/216 (21%)
Query: 381 ATDNFSPANRLGQGGFGPVYNG------KLLDGQEIAIKRLSKS-SGQGIVEFKNEAKLI 433
A + + + LGQG FG VY G K +AIK ++++ S + +EF NEA ++
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 434 AKLQ------------------------------------HTNLTDSSRKSLLDWKKRFY 457
+ + ++ ++ KK
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 458 IIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517
+ I G+ YL+ + +HRDL N ++ E KI DFGM R + +
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+ +MSPE + +G+ + SDV+SFGV++ EI +
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 42/199 (21%)
Query: 391 LGQGGFGPV------YNGKLLDGQEIAIKRLSKSSGQG-------IVEFKNEAKLIAKLQ 437
LG+GGFG V GK+ +++ KR+ K G+ I+E K ++ + L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILE-KVNSRFVVSLA 66
Query: 438 HTNLTDSSRKSLL---------------------DWKKRFYIIEGIVQGLLYLHKYSRLR 476
+ T + +L + + FY E I GL LH + R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLH---QER 122
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVS 536
++RDLK NILLD+ + +ISD G+A + E + R VGT GYM+PE V N +
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAPEVVKNERYT 179
Query: 537 MKSDVYSFGVLVLEIVSSK 555
D ++ G L+ E+++ +
Sbjct: 180 FSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 9/95 (9%)
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE---LEANTNRI 518
I G+ YLHK IH+D+ N ++DE++ KI+D ++R + L N NR
Sbjct: 126 IACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 519 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
V +M+ E ++N S SDV+SFGVL+ E+++
Sbjct: 183 V---KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 52/185 (28%), Positives = 76/185 (41%), Gaps = 50/185 (27%)
Query: 392 GQGGFGPVYNGKLL---DGQEIAIKRL--SKSSGQGIV-----------EFKNEAKLIAK 435
G+G +G VY K DG+E AIK+ K GI E K+E +
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHEN--VVS 66
Query: 436 LQHTNLTDSSRKS--LLDW--------------KKRFYIIEGIV--------QGLLYLHK 471
L L + + L D+ KR I +V G+ YLH
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 472 YSRLRAIHRDLKVSNILL----DEQMNPKISDFGMARTY-AMNELEANTNRIVGTHGYMS 526
+HRDLK +NIL+ E+ KI D G+AR + A + A+ + +V T Y +
Sbjct: 127 N---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRA 183
Query: 527 PEYVM 531
PE ++
Sbjct: 184 PELLL 188
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 60/259 (23%), Positives = 111/259 (42%), Gaps = 38/259 (14%)
Query: 371 KIFDFQTIAAATDNFSPANRLGQGGFGPVYNG-KLLDGQEIAIKRLS------------- 416
K+ ++ ++ ++GQG G VY + GQE+AI++++
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 417 -----KSSGQGIVEFKNEA-------KLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQ 464
++ IV + + ++ L +LTD ++ +D + + +Q
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 127
Query: 465 GLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGY 524
L +LH + IHRD+K NILL + K++DFG + ++ + +VGT +
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYW 182
Query: 525 MSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584
M+PE V K D++S G++ +E++ + Y E PL A L E
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLR----ALYLIATNGTPE 235
Query: 585 LMDPTLDESCSSDEVMRCI 603
L +P + D + RC+
Sbjct: 236 LQNPEKLSAIFRDFLNRCL 254
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 48/209 (22%)
Query: 384 NFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHT 439
NF ++G+G +G VY + L G+ +A+K++ +++ G + E L+ +L H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 59
Query: 440 NLTDSSRKSLLD---WKKRFYII-----------------EGI------------VQGLL 467
N+ LLD + + Y++ GI +QGL
Sbjct: 60 NIV-----KLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114
Query: 468 YLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSP 527
+ H + R +HRDLK N+L++ + K++DFG+AR + + + T+ +V T Y +P
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 169
Query: 528 EYVMNG-IVSMKSDVYSFGVLVLEIVSSK 555
E ++ S D++S G + E+V+ +
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 13/131 (9%)
Query: 423 IVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDL 482
++EF N L+ +Q + D +R RFY E I L++LH I+RDL
Sbjct: 74 VMEFVNGGDLMFHIQKSRRFDEARA-------RFYAAE-ITSALMFLHDKG---IIYRDL 122
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
K+ N+LLD + + K++DFGM + N +T GT Y++PE + + D +
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST--FCGTPDYIAPEILQEMLYGPSVDWW 180
Query: 543 SFGVLVLEIVS 553
+ GVL+ E++
Sbjct: 181 AMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 36/197 (18%)
Query: 390 RLGQGGFGPVYNGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNLT---- 442
++G+G +G VY + L G+ +A+K++ ++ +G+ E L+ +L H N+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 443 ---------------DSSRKSLLDWKKRFY----IIEG----IVQGLLYLHKYSRLRAIH 479
D K +D +I+ ++QG+ Y H S R +H
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SH-RVLH 122
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG-IVSMK 538
RDLK N+L+D + K++DFG+AR + + + T+ +V T Y +PE ++ S
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILLGSRQYSTP 180
Query: 539 SDVYSFGVLVLEIVSSK 555
D++S G + E+V+ +
Sbjct: 181 VDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 40/169 (23%), Positives = 75/169 (44%), Gaps = 35/169 (20%)
Query: 390 RLGQGGFGPVYNGKLLD-GQEIAIKRL-SKSSGQGI-VEFKNEAKLIAKLQHTNLTD--- 443
R+G+G G V+ K + G+ +A+K++ + GI + E K + QH +
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 444 ------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIH 479
+ L + + + Y+ +++G+ Y+H +H
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRM-LLKGVAYMHA---NGIMH 122
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPE 528
RDLK +N+L+ KI+DFG+AR ++ E +++ V T Y +PE
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 38/207 (18%)
Query: 384 NFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRL-----SKSSGQGIVEFKNEAKLIAKLQ 437
N+ LGQG FG VY D G+E+A+K++ S + + + + E +L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 438 HTN-------LTDSSRK------------SLLDWKKRFYII---------EGIVQGLLYL 469
H L D + S+ D K + + I++G+ YL
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 470 HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN-TNRIVGTHGYMSPE 528
H +HRD+K +NIL D N K+ DFG ++ L + GT +MSPE
Sbjct: 123 HSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 529 YVMNGIVSMKSDVYSFGVLVLEIVSSK 555
+ K+D++S G V+E+++ K
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 42/113 (37%), Positives = 61/113 (53%), Gaps = 16/113 (14%)
Query: 439 TNLTDSSRKSLL-DWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKI 497
T+L R ++L D KR YI+ +++ L Y+H S IHRDLK SNILL+ K+
Sbjct: 93 TDLHAVIRANILEDVHKR-YIMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKL 148
Query: 498 SDFGMARTYAMNELEANTNRI----VGTHGYMSPEYVMNGIVSMKSDVYSFGV 546
+DFG+AR+ + E E N + V T Y +PE + + S Y+ GV
Sbjct: 149 ADFGLARSLSELE-ENPENPVLTDYVATRWYRAPE------ILLGSTRYTKGV 194
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 40/195 (20%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD---S 444
R+G G +G VY + + E+ AIK + G + E ++ + +H N+ S
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 445 SRK--------------SLLDWKKRF----------YIIEGIVQGLLYLHKYSRLRAIHR 480
+ SL D + Y+ ++GL YLH+ + IHR
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK---IHR 125
Query: 481 DLKVSNILLDEQMNPKISDFGMAR--TYAMNELEANTNRIVGTHGYMSPEYV---MNGIV 535
D+K +NILL E + K++DFG++ T + A +GT +M+PE G
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATI----AKRKSFIGTPYWMAPEVAAVERKGGY 181
Query: 536 SMKSDVYSFGVLVLE 550
K D+++ G+ +E
Sbjct: 182 DGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 14/110 (12%)
Query: 458 IIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517
I +V+GL YL L+ +HRD+K SN+L++ + K+ DFG++ T +N + A T
Sbjct: 100 IAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVS-TQLVNSI-AKT-- 152
Query: 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK-------KNNGS 560
VGT+ YM+PE + + SDV+S G+ +E+ + KN GS
Sbjct: 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS 202
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 41/170 (24%), Positives = 73/170 (42%), Gaps = 37/170 (21%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRL---SKSSGQGIVEFK--NEAKLIAKLQHTNLTD- 443
LG+G + VY + G+ +AIK++ + + + F E KL+ +L+H N+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 444 ----SSRKSL------LDW--------KKRFY-------IIEGIVQGLLYLHKYSRLRAI 478
+ ++ ++ K + ++GL YLH L
Sbjct: 68 LDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWIL--- 124
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPE 528
HRDLK +N+L+ K++DFG+AR++ + V T Y +PE
Sbjct: 125 HRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ--VVTRWYRAPE 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 50/212 (23%)
Query: 391 LGQGGFGPVYNGKLL------DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN---- 440
LG+G FG V+ + D +A+K L +S +F EA+L+ LQH +
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 441 -----------------------------------LTDSSRKSLLDWKKRFYIIEGIVQG 465
+ + +R + L + +I + I G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 466 LLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR-TYAMNELEANTNRIVGTHGY 524
++YL + +HRDL N L+ E + KI DFGM+R Y+ + + ++ +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR-W 188
Query: 525 MSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKK 556
M PE +M + +SDV+S GV++ EI + K
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 42/196 (21%)
Query: 391 LGQGGFGPV------YNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT----- 439
LG+GGFG V GK+ +++ KR+ K G+ + NE +++ K+
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 440 NLTDSSRKSL-----------------------LDWKKRFYIIEGIVQGLLYLHKYSRLR 476
++ +L D ++ + + GL L R R
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RER 122
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVS 536
++RDLK NILLD++ + +ISD G+A + E E R VGT GYM+PE + N +
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGR-VGTVGYMAPEVINNEKYT 179
Query: 537 MKSDVYSFGVLVLEIV 552
D + G L+ E++
Sbjct: 180 FSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 62/201 (30%), Positives = 90/201 (44%), Gaps = 51/201 (25%)
Query: 391 LGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVEFK-----------------NEAKL 432
+G+G FG VY + D + I A+K LSK IV K +E+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE---IVAKKEVAHTIGERNILVRTLLDESPF 57
Query: 433 IAKLQHTNLTDSSRKSLLDWK-------------------KRFYIIEGIVQGLLYLHKYS 473
I L+ + TDS + D+ +FYI E +V L +LHKY
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAE-LVLALEHLHKYD 116
Query: 474 RLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN--TNRIVGTHGYMSPEYVM 531
++RDLK NILLD + + DFG+++ L N TN GT Y++PE ++
Sbjct: 117 ---IVYRDLKPENILLDATGHIALCDFGLSKA----NLTDNKTTNTFCGTTEYLAPEVLL 169
Query: 532 NGIVSMKS-DVYSFGVLVLEI 551
+ K D +S GVLV E+
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 60/219 (27%)
Query: 391 LGQGGFGPVYNGK---LLDGQE---IAIKRLSK-SSGQGIVEFKNEAKLIAK-------- 435
+GQG FG V+ + LL + +A+K L + +S +F+ EA L+A+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 436 --------------------------LQHTNLTDSSRKSLLDWKKRFY------------ 457
L+H + S R
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 458 --IIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART-YAMNELEAN 514
I + + G+ YL S + +HRDL N L+ E M KI+DFG++R Y+ + +A+
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
N + +M PE + + +SDV+++GV++ EI S
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 41/205 (20%)
Query: 384 NFSPANRLGQGGFGPVYNGK-LLDGQEIAIKR------LSKSSGQGIVEFKNEAKLIAKL 436
NF ++G+G F VY LLD + +A+K+ + + Q V+ E L+ +L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQL 59
Query: 437 QHTNLT----------------------DSSRKSLLDWKKRFYIIEGIVQGLLYL----- 469
H N+ D S+ K++ I E V
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 470 -HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPE 528
H +SR R +HRD+K +N+ + K+ D G+ R ++ A++ +VGT YMSPE
Sbjct: 120 EHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 176
Query: 529 YVMNGIVSMKSDVYSFGVLVLEIVS 553
+ + KSD++S G L+ E+ +
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 43/208 (20%)
Query: 384 NFSPANRLGQGGFGPVYNGKLLDGQE----IAIKRLSKSS-------------GQGIVEF 426
NF LG G +G V+ + + G + A+K L K++ + ++E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 427 KNEAKLIAKLQHTNLTDSSRKSLLDW------------KKRF-------YIIEGIVQGLL 467
++ + L + TD+ +LD+ ++RF Y E IV L
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGE-IVLALE 119
Query: 468 YLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSP 527
+LHK L I+RD+K+ NILLD + ++DFG+++ + +E+E GT YM+P
Sbjct: 120 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAP 175
Query: 528 EYVMNGIVSMKS--DVYSFGVLVLEIVS 553
+ V G D +S GVL+ E+++
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 36/119 (30%), Positives = 61/119 (51%), Gaps = 13/119 (10%)
Query: 440 NLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISD 499
N R+S L + + +G+ +L + IHRDL N+LL KI D
Sbjct: 128 NFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICD 184
Query: 500 FGMARTYAMNELEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
FG+AR ++ ++N +V + +M+PE + N + + +SDV+S+G+L+ EI S
Sbjct: 185 FGLAR-----DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 31/91 (34%), Positives = 58/91 (63%), Gaps = 8/91 (8%)
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL-EANTNRIVG 520
+++GL YL + + + +HRD+K SNIL++ + K+ DFG++ +L ++ N VG
Sbjct: 108 VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVG 160
Query: 521 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEI 551
T YMSPE + +++SD++S G+ ++E+
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 40/199 (20%)
Query: 390 RLGQGGFGPVY------NGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD 443
++G+G FG +GK +EI I ++S + E + E +++ ++H N+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIV- 62
Query: 444 SSRKSLLDWKKRFYII----EG-----------------------IVQGLLYLHKYSRLR 476
++S + YI+ EG VQ L L +
Sbjct: 63 QYQESF-EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVS 536
+HRD+K NI L + K+ DFG+AR +N +GT Y+SPE N +
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEICENRPYN 179
Query: 537 MKSDVYSFGVLVLEIVSSK 555
KSD+++ G ++ E+ + K
Sbjct: 180 NKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 42/209 (20%)
Query: 384 NFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRL-----SKSSGQGIVEFKNEAKLIAKLQ 437
N+ LG+G FG VY D G+E+A+K++ S+ + + + + E +L+ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 438 HTN-------LTDSSRK------------SLLDWKKRFYII---------EGIVQGLLYL 469
H L D K S+ D K + + I+QG+ YL
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 470 HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR---TYAMNELEANTNRIVGTHGYMS 526
H +HRD+K +NIL D N K+ DFG ++ T M+ + GT +MS
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS--GTGIKSVTGTPYWMS 177
Query: 527 PEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
PE + K+DV+S V+E+++ K
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 35/202 (17%)
Query: 384 NFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLS---KSSGQGIVEFKNEAKLIAKLQHT 439
NF ++G+G F VY LLDG +A+K++ + + E L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 440 NLT----------------------DSSRKSLLDWKKRFYIIEGIVQGLLYL------HK 471
N+ D SR K++ I E V H
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 472 YSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM 531
+SR R +HRD+K +N+ + K+ D G+ R ++ A++ +VGT YMSPE +
Sbjct: 123 HSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIH 179
Query: 532 NGIVSMKSDVYSFGVLVLEIVS 553
+ KSD++S G L+ E+ +
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 31/91 (34%), Positives = 57/91 (62%), Gaps = 6/91 (6%)
Query: 461 GIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVG 520
+++GL YL + ++ +HRD+K SNIL++ + K+ DFG++ +++ N VG
Sbjct: 111 AVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVG 164
Query: 521 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEI 551
T YMSPE + S++SD++S G+ ++E+
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 36/99 (36%), Positives = 57/99 (57%), Gaps = 11/99 (11%)
Query: 462 IVQGLLYL-HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVG 520
IV+ L YL K+ IHRD+K SNILLD N K+ DFG++ + + +A T R G
Sbjct: 123 IVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGR--LVDSKAKT-RSAG 176
Query: 521 THGYMSPEYV----MNGIVSMKSDVYSFGVLVLEIVSSK 555
YM+PE + N +++DV+S G+ ++E+ + +
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 42/207 (20%)
Query: 384 NFSPANRLGQGGFGPVYNGKLLDGQE----IAIKRLSKS-------------SGQGIVEF 426
NF LG G +G V+ + + G + A+K L K+ + + ++E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 427 KNEAKLIAKLQHTNLTDSSRKSLLDW-------------------KKRFYIIEGIVQGLL 467
++ + L + T++ +LD+ + RFY E I+ L
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE-IILALE 119
Query: 468 YLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSP 527
+LHK L ++RD+K+ NILLD + + ++DFG+++ + ++E + T GT YM+P
Sbjct: 120 HLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYMAP 175
Query: 528 EYVMNGIVSMKS-DVYSFGVLVLEIVS 553
E + K+ D +S G+L+ E+++
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 40/137 (29%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 432 LIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE 491
L+ LQ LTD ++ L+ ++ + E ++Q L YLH IHRD+K +ILL
Sbjct: 96 LMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTL 152
Query: 492 QMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEI 551
K+SDFG + + + + +VGT +M+PE + + D++S G++V+E+
Sbjct: 153 DGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210
Query: 552 VSSKKNNGSYDTERPLN 568
V + Y ++ P+
Sbjct: 211 VDGEP---PYFSDSPVQ 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 9e-10
Identities = 63/275 (22%), Positives = 109/275 (39%), Gaps = 46/275 (16%)
Query: 391 LGQGGFGPV----YNGKLLD-GQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL--- 441
LG+G FG V Y+ G+ +A+K L + GQ +K E ++ L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 442 ----TDSSRK------------SLLDWKKRFYI--------IEGIVQGLLYLHKYSRLRA 477
++ K SL D+ + + + I +G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ---HY 128
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL-----EANTNRIVGTHGYMSPEYVMN 532
IHRDL N+LLD KI DFG+A+ E + + + + E +
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----WYAVECLKE 184
Query: 533 GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592
S SDV+SFGV + E+++ + S + ++G + +EL++ +
Sbjct: 185 NKFSYASDVWSFGVTLYELLTHCDSKQSPPK-KFEEMIGPKQGQMTVVRLIELLERGMRL 243
Query: 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
C + + C + A R T ++ +L
Sbjct: 244 PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 39/206 (18%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 439
D + ++G+G +G VY + + + IA+K++ + +G+ E L+ ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 440 N---LTD--SSRKSL--------LDWKK---------------RFYIIEGIVQGLLYLHK 471
N L D S K L LD KK + Y+ + I++G+ Y H
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ-ILRGIAYCHS 120
Query: 472 YSRLRAIHRDLKVSNILLDEQMNP-KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYV 530
+ R +HRDLK N+L+D + N K++DFG+AR + + + T+ +V T Y +PE +
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-TLWYRAPEIL 175
Query: 531 MNG-IVSMKSDVYSFGVLVLEIVSSK 555
+ S D++S G + E+V+ K
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 31/78 (39%), Positives = 43/78 (55%)
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
+ IHRDL NILL E KI DFG+AR + +M+PE + + +
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVY 252
Query: 536 SMKSDVYSFGVLVLEIVS 553
+ +SDV+SFGVL+ EI S
Sbjct: 253 TTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 50/203 (24%)
Query: 391 LGQGGFGPV---YNGKLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTNL--- 441
+G G +G V ++ K G+++AIK+LS+ Q + K E +L+ + H N+
Sbjct: 23 VGSGAYGQVCSAFDTKT--GRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGL 79
Query: 442 -----TDSS-----------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYS 473
SS + L D +F ++ I++GL Y+H
Sbjct: 80 LDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQILRGLKYIHS-- 136
Query: 474 RLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG 533
IHRDLK SNI ++E KI DFG+AR + E V T Y +PE ++N
Sbjct: 137 -AGIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTG--YVATRWYRAPEIMLNW 190
Query: 534 IVSMKS-DVYSFGVLVLEIVSSK 555
+ ++ D++S G ++ E+++ K
Sbjct: 191 MHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 58/195 (29%), Positives = 98/195 (50%), Gaps = 35/195 (17%)
Query: 391 LGQGGFGPVYNGKLL-DGQEI----AIKRLSK-SSGQGIVEFKNEAKLIA--------KL 436
LG G FG VY G + DG+ + AIK L + +S + E +EA ++A +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 437 QHTNLTDSSR--------KSLLDW----KKRF---YIIEGIVQ---GLLYLHKYSRLRAI 478
LT + + LLD+ K R ++ VQ G+ YL + +R +
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLV 131
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 538
HRDL N+L+ + KI+DFG+AR ++E E + + +M+ E +++ + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQ 191
Query: 539 SDVYSFGVLVLEIVS 553
SDV+S+GV V E+++
Sbjct: 192 SDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 46/206 (22%)
Query: 391 LGQGGFGPVYNG---KLLDGQ---EIAIKRLSKS-SGQGIVEFKNEAKL----------- 432
LGQG FG VY G ++ G+ +A+K +++S S + +EF NEA +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 433 ----IAKLQHTN-----LTDSSRKSLL----------------DWKKRFYIIEGIVQGLL 467
++K Q T + KS L ++ + I G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 468 YLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSP 527
YL+ + +HRDL N ++ KI DFGM R + + + +M+P
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 528 EYVMNGIVSMKSDVYSFGVLVLEIVS 553
E + +G+ + SD++SFGV++ EI S
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 33/100 (33%), Positives = 58/100 (58%), Gaps = 6/100 (6%)
Query: 456 FYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515
FY E I GL +LH+ I+RDLK+ N++LD + + KI+DFGM + + ++ + T
Sbjct: 105 FYAAE-ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160
Query: 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
GT Y++PE + D +++GVL+ E+++ +
Sbjct: 161 --FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 44/200 (22%)
Query: 391 LGQGGFGPV------YNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT----- 439
LG+GGFG V GK+ + + KR+ K G+ + NE +++ K+
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 440 ------------------------NLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRL 475
++ + + + FY E I+ GL LH R
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDLH---RE 121
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
++RDLK NILLD+ + +ISD G+A + E E+ R VGT GYM+PE + N
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGR-VGTVGYMAPEVLNNQRY 178
Query: 536 SMKSDVYSFGVLVLEIVSSK 555
++ D + G L+ E++ +
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 58/193 (30%), Positives = 87/193 (45%), Gaps = 31/193 (16%)
Query: 391 LGQGGFG-PVYNGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNLT----- 442
+G+G FG + + Q+ A+K RL KSS + + + EA L+AK++H N+
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 443 -----------------DSSRKSLLDWKKRF---YIIEGIVQGLLYLHKYSRLRAIHRDL 482
D +K L K F I++ VQ L + R +HRD+
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDI 126
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
K NI L + K+ DFG AR A T VGT Y+ PE N + KSD++
Sbjct: 127 KSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKSDIW 184
Query: 543 SFGVLVLEIVSSK 555
S G ++ E+ + K
Sbjct: 185 SLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 71/277 (25%), Positives = 118/277 (42%), Gaps = 63/277 (22%)
Query: 391 LGQGGFGPVYNGKL-LDGQE---IAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTN----- 440
+G G FG V G+L L G+ +AIK L S + + +F +EA ++ + H N
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 441 -----------LTDSSRKSLLDWKKR-----FYIIE------GIVQGLLYLHKYSRLRAI 478
+T+ LD R F +I+ GI G+ YL S + +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNYV 128
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTH---GYMSPEYVMNGIV 535
HRDL NIL++ + K+SDFG++R + + +G + +PE +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188
Query: 536 SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG--KALEL---MDPTL 590
+ SDV+S+G+++ E++S ERP W + N+ A+E + P +
Sbjct: 189 TSASDVWSYGIVMWEVMSYG--------ERPY------WDMSNQDVINAIEQDYRLPPPM 234
Query: 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
D + ++M L C Q R +VS L
Sbjct: 235 DCPTALHQLM------LDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 45/185 (24%), Positives = 86/185 (46%), Gaps = 46/185 (24%)
Query: 389 NRLGQGGFGPVYNGK-LLDGQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLTD- 443
++GQG FG V+ + Q +A+K++ ++ G I + E K++ L+H N+ +
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 76
Query: 444 -----SSRKSLLDWKKRFY----------------------------IIEGIVQGLLYLH 470
+ +K FY +++ ++ GL Y+H
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 471 KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN---TNRIVGTHGYMSP 527
R + +HRD+K +NIL+ + K++DFG+AR +++++ TNR+V T Y P
Sbjct: 137 ---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYRPP 192
Query: 528 EYVMN 532
E ++
Sbjct: 193 ELLLG 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 51/227 (22%)
Query: 368 RDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEF 426
R L D + F +G G +G VY G+ + GQ AIK + + + E
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEI 59
Query: 427 KNEAKLIAKLQH-----------------------------------TNLTDSSRKSLL- 450
K E ++ K H T+L +++ + L
Sbjct: 60 KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK 119
Query: 451 -DWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509
DW YI I++GL +LH + + IHRD+K N+LL E K+ DFG++ ++
Sbjct: 120 EDWIA--YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LD 172
Query: 510 ELEANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEI 551
N +GT +M+PE + + +SD++S G+ +E+
Sbjct: 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 31/91 (34%), Positives = 57/91 (62%), Gaps = 6/91 (6%)
Query: 461 GIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVG 520
+++GL YL + ++ +HRD+K SNIL++ + K+ DFG++ +++ N VG
Sbjct: 111 AVLRGLAYLREKHQI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVG 164
Query: 521 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEI 551
T YMSPE + S++SD++S G+ ++E+
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 42/193 (21%)
Query: 391 LGQGGFGPVYNGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLTDSSRKSL 449
+G+G FG V G G ++A+K + + ++ Q F EA ++ +L+H+NL +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLV-QLLGVI 68
Query: 450 LDWKKRFYII-EGIVQGLLYLHKYSRLRA--------------------------IHRDL 482
++ K YI+ E + +G L + SR R+ +HRDL
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDL 128
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTH--GYMSPEYVMNGIVSMKSD 540
N+L+ E K+SDFG+ + EA++ + G + +PE + S KSD
Sbjct: 129 AARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 541 VYSFGVLVLEIVS 553
V+SFG+L+ EI S
Sbjct: 182 VWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 56/195 (28%), Positives = 98/195 (50%), Gaps = 35/195 (17%)
Query: 391 LGQGGFGPVYNGKLL-DGQEI----AIKRLSK-SSGQGIVEFKNEAKLIAKLQHTN---- 440
LG G FG VY G + +G+++ AIK L + +S + E +EA ++A + + +
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 441 ----LTDSSR--------KSLLDW----KKRF---YIIEGIVQ---GLLYLHKYSRLRAI 478
LT + + LLD+ K Y++ VQ G+ YL + R +
Sbjct: 75 LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLV 131
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 538
HRDL N+L+ + KI+DFG+A+ +E E + +M+ E +++ I + +
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQ 191
Query: 539 SDVYSFGVLVLEIVS 553
SDV+S+GV V E+++
Sbjct: 192 SDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 57/223 (25%), Positives = 88/223 (39%), Gaps = 69/223 (30%)
Query: 391 LGQGGFGPVY----------NGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 440
LG+G FG V+ K+L +A+K L + +F+ EA+L+ LQH +
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKML----VAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 441 ---------------------------------------LTDSS---RKSLLDWKKRFYI 458
L D K L + +I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 459 IEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRI 518
I G++YL + +HRDL N L+ + KI DFGM+R ++ +
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYR 180
Query: 519 VGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKK 556
VG H +M PE +M + +SDV+SFGV++ EI + K
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 40/200 (20%)
Query: 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 436
+F LG G FG V K G+ AIK L K + I++ K E ++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKK---REILKMKQVQHVAQEKSILMEL 75
Query: 437 QHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLR-------------------- 476
H + + S D + ++++E +V G L+ H R
Sbjct: 76 SHPFIV-NMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYL 134
Query: 477 ----AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN 532
I+RDLK N+LLD + + K++DFG A+ ++ T + GT Y++PE + +
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAPEVIQS 189
Query: 533 GIVSMKSDVYSFGVLVLEIV 552
D ++ GVL+ E +
Sbjct: 190 KGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 45/210 (21%)
Query: 385 FSPANRLGQGGFGPVYNGKLLD--GQEIAIKRL---SKSSGQGIVEFKNEAKL--IAKLQ 437
+ +G+G +G V+ + L G+ +A+KR+ + G + + A L + +
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 438 HTNL-----------TDSSRKSLL-----DWKKRFYI----------------IEGIVQG 465
H N+ TD K L D Y+ + +++G
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 466 LLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYM 525
L +LH + R +HRDLK NIL+ K++DFG+AR Y+ + +V T Y
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYR 176
Query: 526 SPEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
+PE ++ + D++S G + E+ K
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 31/81 (38%), Positives = 48/81 (59%), Gaps = 10/81 (12%)
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG-----YMSPEYVMN 532
IHRDL NILL KI DFG+AR ++ ++N +V + +M+PE + N
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKGNARLPVKWMAPESIFN 290
Query: 533 GIVSMKSDVYSFGVLVLEIVS 553
+ + +SDV+S+G+L+ EI S
Sbjct: 291 CVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 50/186 (26%), Positives = 83/186 (44%), Gaps = 24/186 (12%)
Query: 425 EFKNEAKLIAKLQHTNLTDS-SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLK 483
+F ++ ++ + H N S S +LL Y+ I G+ YL + L +HRDL
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLL------YMAVQIASGMKYL---ASLNFVHRDLA 156
Query: 484 VSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYS 543
N L+ KI+DFGM+R + R V +M+ E ++ G + SDV++
Sbjct: 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216
Query: 544 FGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWN-------EGKALELMDPTLDESCSS 596
FGV + E+ + K E+P +L+ + N +G+ + L L S
Sbjct: 217 FGVTLWEMFTLCK-------EQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVF 269
Query: 597 DEVMRC 602
+MRC
Sbjct: 270 KLMMRC 275
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 50/205 (24%), Positives = 88/205 (42%), Gaps = 44/205 (21%)
Query: 385 FSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSG-QGIVEFK-NEAKLIAKLQ---H 438
+ +G+G +G VY + L G+ +A+K++ +GI E L+ +L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 439 TNLT---------DSSRKSLL-------DWKKRFY----------------IIEGIVQGL 466
N+ + R+ L D Y ++ +++G+
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 467 LYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMS 526
+LH + R +HRDLK NIL+ KI+DFG+AR Y E +V T Y +
Sbjct: 121 DFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMALTSVVVTLWYRA 174
Query: 527 PEYVMNGIVSMKSDVYSFGVLVLEI 551
PE ++ + D++S G + E+
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 49/209 (23%), Positives = 84/209 (40%), Gaps = 44/209 (21%)
Query: 385 FSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQH--- 438
+ P +G G +G VY + G +A+K + + + + E L+ +L+
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 439 -----------TNLTDSSRKSLL-----DWKKRFYI----------------IEGIVQGL 466
T+ TD K L D R Y+ + ++GL
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 467 LYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMS 526
+LH +HRDLK NIL+ K++DFG+AR Y+ + +V T Y +
Sbjct: 122 DFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRA 175
Query: 527 PEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
PE ++ + D++S G + E+ K
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGT 521
+ +G+ +L + + IHRDL N+L+ E KI+DFG+AR + T
Sbjct: 141 VARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLP 197
Query: 522 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 198 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 34/116 (29%), Positives = 58/116 (50%), Gaps = 8/116 (6%)
Query: 438 HTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKI 497
+T LT SR L + I + I++GL YLH R IHRD+K NI +++ I
Sbjct: 144 YTYLTKRSRP--LPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCI 198
Query: 498 SDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
D G A+ + + GT +PE + + K+D++S G+++ E+++
Sbjct: 199 GDLGAAQ---FPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 49/198 (24%), Positives = 86/198 (43%), Gaps = 35/198 (17%)
Query: 384 NFSPANRLGQGGFGPVYNG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT 442
++ R+G G +G VY L G+ A+K + G + E ++ + +H N+
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 443 DS-----SRKSL---------------------LDWKKRFYIIEGIVQGLLYLHKYSRLR 476
SR+ L L + Y+ +QGL YLH ++
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKM- 128
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM---NG 533
HRD+K +NILL + + K++DFG+A + A +GT +M+PE NG
Sbjct: 129 --HRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKRKSFIGTPYWMAPEVAAVEKNG 184
Query: 534 IVSMKSDVYSFGVLVLEI 551
+ D+++ G+ +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 31/78 (39%), Positives = 44/78 (56%)
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
+ IHRDL NILL E KI DFG+AR + +M+PE + + +
Sbjct: 199 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 258
Query: 536 SMKSDVYSFGVLVLEIVS 553
+++SDV+SFGVL+ EI S
Sbjct: 259 TIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 4e-09
Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 62/212 (29%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAKLIAKLQHTN 440
+G G +G V + G+++AIK++S F + E KL+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 441 L--------------------------TD-----SSRKSLLDWKKRFYIIEGIVQGLLYL 469
+ TD S + L D Y + I++GL YL
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTD-DHIQYFLYQILRGLKYL 119
Query: 470 HKYSRLRA--IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRI---VGTHGY 524
H A IHRDLK SNIL++ + KI DFG+AR ++ E + V T Y
Sbjct: 120 H-----SANVIHRDLKPSNILVNSNCDLKICDFGLAR--GVDPDEDEKGFLTEYVVTRWY 172
Query: 525 MSPEYVMNGIVSMKS-DVYSFGVLVLEIVSSK 555
+PE +++ K+ D++S G + E+++ K
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 2/95 (2%)
Query: 463 VQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR-IVGT 521
+Q LL +H IHRD+K +NILL K+ DFG ++ YA + + R GT
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA-ATVSDDVGRTFCGT 208
Query: 522 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKK 556
Y++PE S K+D++S GVL+ E+++ K+
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 31/78 (39%), Positives = 43/78 (55%)
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
+ IHRDL NILL E KI DFG+AR + +M+PE + + +
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY 253
Query: 536 SMKSDVYSFGVLVLEIVS 553
+ +SDV+SFGVL+ EI S
Sbjct: 254 TTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 32/101 (31%), Positives = 59/101 (58%), Gaps = 13/101 (12%)
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGT 521
+ QG+ +L + IHRD+ N+LL + KI DFG+AR ++ ++N +V
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKG 272
Query: 522 HG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKN 557
+ +M+PE + + + +++SDV+S+G+L+ EI S K+
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 34/93 (36%), Positives = 58/93 (62%), Gaps = 5/93 (5%)
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR-TYAMNELEANTNRIVG 520
+ +G+ YL SR R IHRDL N+L+ E KI+DFG+AR + ++ + +N +
Sbjct: 143 VARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLP 199
Query: 521 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+M+PE + + + + +SDV+SFG+L+ EI +
Sbjct: 200 VK-WMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (140), Expect = 6e-09
Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 61/209 (29%)
Query: 390 RLGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVEFKN--------EAKLIAKLQ-HT 439
+LG G FG VY + + E+ AIK++ K +F + E K + KL H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKK-------KFYSWEECMNLREVKSLRKLNEHP 58
Query: 440 N---------------------------LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHK- 471
N L + II I+QGL ++HK
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 472 -YSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN---TNRIVGTHGYMSP 527
+ HRDLK N+L+ KI+DFG+AR E+ + T+ V T Y +P
Sbjct: 119 GF-----FHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD-YVSTRWYRAP 167
Query: 528 EYVM-NGIVSMKSDVYSFGVLVLEIVSSK 555
E ++ + S D+++ G ++ E+ + +
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 40/195 (20%)
Query: 391 LGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT------- 442
LG G FG VY + + G A K + S + + +F E ++++ +H N+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 443 -----------------DSSRKSL---LDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDL 482
DS L L + Y+ +++ L +LH + + IHRDL
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDL 129
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANT-NRIVGTHGYMSPEYVM-----NGIVS 536
K NILL + K++DFG++ A N+ + +GT +M+PE V +
Sbjct: 130 KAGNILLTLDGDVKLADFGVS---AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD 186
Query: 537 MKSDVYSFGVLVLEI 551
K+D++S G+ ++E+
Sbjct: 187 YKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 59/223 (26%), Positives = 88/223 (39%), Gaps = 54/223 (24%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAK--------LIAKLQHTNL 441
+G+G FG V K DG+ A+K L K + + K E K L+ ++H L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKA----ILKKKEQKHIMAERNVLLKNVKHPFL 58
Query: 442 TD---------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSR 474
+S + + RFY E I L YLH
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE-IASALGYLHS--- 114
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGI 534
L I+RDLK NILLD Q + ++DFG+ + E T+ GT Y++PE +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI--EHSKTTSTFCGTPEYLAPEVLRKQP 172
Query: 535 VSMKSDVYSFGVLVLEIVS------SKKNNGSYDT--ERPLNL 569
D + G ++ E++ S+ YD +PL L
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRL 215
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 34/93 (36%), Positives = 57/93 (61%), Gaps = 5/93 (5%)
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR-TYAMNELEANTNRIVG 520
+ +G+ YL + + IHRDL N+L+ E KI+DFG+AR + ++ + TN +
Sbjct: 149 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205
Query: 521 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 206 VK-WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 42/131 (32%), Positives = 66/131 (50%), Gaps = 13/131 (9%)
Query: 423 IVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDL 482
++ F N +L LQ D SR RFY E + L LHK++ I+RDL
Sbjct: 71 VLAFINGGELFHHLQREGRFDLSRA-------RFYTAELLC-ALENLHKFN---VIYRDL 119
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
K NILLD Q + + DFG+ + + + TN GT Y++PE ++ + D +
Sbjct: 120 KPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYLAPELLLGHGYTKAVDWW 177
Query: 543 SFGVLVLEIVS 553
+ GVL+ E+++
Sbjct: 178 TLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 34/100 (34%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 456 FYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515
FY E I GL +LH I+RDLK+ N++LD + + KI+DFGM + + + T
Sbjct: 105 FYAAE-IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TT 158
Query: 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
GT Y++PE + D ++FGVL+ E+++ +
Sbjct: 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 13/148 (8%)
Query: 423 IVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDL 482
++E+ N +L L S + + + RFY E IV L YLH ++RD+
Sbjct: 73 VMEYANGGELFFHL-------SRERVFTEERARFYGAE-IVSALEYLHSRD---VVYRDI 121
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
K+ N++LD+ + KI+DFG+ + + A GT Y++PE + + D +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179
Query: 543 SFGVLVLEIVSSKKNNGSYDTERPLNLV 570
GV++ E++ + + D ER L+
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 34/101 (33%), Positives = 55/101 (54%), Gaps = 9/101 (8%)
Query: 455 RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514
FY E IV L YLH ++RDLK NILLD++ + K++DFG A+ +L
Sbjct: 104 LFYASE-IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDR 154
Query: 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
T + GT Y++PE + + + D ++ G+L+ E++
Sbjct: 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 45/198 (22%)
Query: 391 LGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVE--FKNEAKLIAKLQHTNLTDSSRK 447
+G+G +G V K + GQ +AIK+ +S +V+ E +++ +L+H NL
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLV----- 63
Query: 448 SLLD---WKKRFYII----------------EG------------IVQGLLYLHKYSRLR 476
+L++ KKR Y++ G I++G+ + H ++
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVS 536
IHRD+K NIL+ + K+ DFG ART A E T+ V T Y +PE ++
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD-YVATRWYRAPELLVGDTKY 178
Query: 537 MKS-DVYSFGVLVLEIVS 553
++ D+++ G LV E+++
Sbjct: 179 GRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 33/123 (26%), Positives = 60/123 (48%), Gaps = 3/123 (2%)
Query: 431 KLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD 490
+ +++ + + + + + ++ I G+ YL S L +HRDL N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164
Query: 491 EQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 550
+ KI+DFGM+R + R V +MS E ++ G + SDV++FGV + E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 551 IVS 553
I++
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 37/98 (37%), Positives = 57/98 (58%), Gaps = 10/98 (10%)
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGT 521
V+ L YL + L+ IHRD+K SNILLD N K+ DFG++ ++ + A T R G
Sbjct: 116 TVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-GQLVDSI-AKT-RDAGC 170
Query: 522 HGYMSPEYV----MNGIVSMKSDVYSFGVLVLEIVSSK 555
YM+PE + +G ++SDV+S G+ + E+ + K
Sbjct: 171 RPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 56/217 (25%), Positives = 103/217 (47%), Gaps = 48/217 (22%)
Query: 376 QTIAAATDNFSPANRLGQGGFGPV---YNGKLLDGQEIAIKRLSKSSGQGIVEFKN---E 429
+TI + + + +G G +G V ++ K G +A+K+LS+ Q I+ K E
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSRPF-QSIIHAKRTYRE 66
Query: 430 AKLIAKLQHTN---LTD--SSRKSLLDWKKRF-------------------------YII 459
+L+ ++H N L D + +SL ++ + ++I
Sbjct: 67 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 126
Query: 460 EGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIV 519
I++GL Y+H IHRDLK SN+ ++E KI DFG+AR + +E+ V
Sbjct: 127 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 178
Query: 520 GTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIVSSK 555
T Y +PE ++N + + D++S G ++ E+++ +
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 55/213 (25%)
Query: 385 FSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAKLIA 434
+ P +G+G +G V + K +++AIK+++ + F N E KL+
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLR 59
Query: 435 KLQHTNL--------------------------TD-----SSRKSLLDWKKRFYIIEGIV 463
L H N+ TD S ++L D ++++ + ++
Sbjct: 60 HLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ-LL 118
Query: 464 QGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG 523
+GL Y+H + L HRDLK SN+LL+ + KI DFG+ART +E V T
Sbjct: 119 RGLKYIHSANVL---HRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVTRW 173
Query: 524 YMSPEYVMNGIVSMKS-DVYSFGVLVLEIVSSK 555
Y +PE ++N + DV+S G + E++ K
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 33/93 (35%), Positives = 57/93 (61%), Gaps = 5/93 (5%)
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR-TYAMNELEANTNRIVG 520
+ +G+ YL + + IHRDL N+L+ E KI+DFG+AR + ++ + TN +
Sbjct: 143 VARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLP 199
Query: 521 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 200 VK-WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 34/205 (16%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTN 440
+ + +G+G +G V + G ++AIK++S Q + E K++ + +H N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 441 ---LTDSSRKSLLDWKKRFYIIEGIV----------QGLLYLH----KYSRLRA------ 477
+ D R + YI++ ++ Q L H Y LR
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHS 124
Query: 478 ---IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRI---VGTHGYMSPEYVM 531
+HRDLK SN+LL+ + KI DFG+AR +T + V T Y +PE ++
Sbjct: 125 ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE--HDHTGFLTEYVATRWYRAPEIML 182
Query: 532 NGIVSMKS-DVYSFGVLVLEIVSSK 555
N K+ D++S G ++ E++S++
Sbjct: 183 NSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 33/93 (35%), Positives = 56/93 (60%), Gaps = 5/93 (5%)
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR-TYAMNELEANTNRIVG 520
+ +G+ YL + + IHRDL N+L+ E KI+DFG+AR ++ + TN +
Sbjct: 146 VARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP 202
Query: 521 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 203 VK-WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 41/198 (20%)
Query: 391 LGQGGFGPVYNGKLLDGQE----IAIKRLSKSS-------------GQGIVE-------- 425
LG+GG+G V+ + + G + A+K L K++ + I+E
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 426 -----FKNEAKLIAKLQHTN----LTDSSRKSL-LDWKKRFYIIEGIVQGLLYLHKYSRL 475
F+ KL L++ + R+ + ++ FY+ E I L +LH+
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE-ISLALEHLHQ---Q 119
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
I+RDLK NILLD Q + K++DFG+ + T+ GT YM+PE +M
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESI--HEGTVTHTFCGTIEYMAPEILMRSGH 177
Query: 536 SMKSDVYSFGVLVLEIVS 553
D +S G L+ ++++
Sbjct: 178 GKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 42/149 (28%), Positives = 76/149 (51%), Gaps = 15/149 (10%)
Query: 410 IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD--SSRKSLLDWKKRFYIIEGIVQGLL 467
IAI+ + + G +FK+ ++ L ++L S + L + R+++ + +++GL
Sbjct: 67 IAIRDILRPPGA---DFKD-VYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ-LLRGLK 121
Query: 468 YLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT--NRIVGTHGYM 525
Y+H + IHRDLK SN+L++E +I DFGMAR + + E V T Y
Sbjct: 122 YIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 526 SPE--YVMNGIVSMKSDVYSFGVLVLEIV 552
+PE + + D++S G + E++
Sbjct: 179 APELLLSLPE-YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 20/151 (13%)
Query: 426 FKNEAKLIAKLQHTNLTD-----SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHR 480
F+ E++L +++ N D ++ L + RFY E I L YLH+ I+R
Sbjct: 65 FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG---IIYR 120
Query: 481 DLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSD 540
DLK+ N+LLD + + K++D+GM + T+ GT Y++PE + D
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGL--RPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 178
Query: 541 VYSFGVLVLEIVSSKKNNGSYDTERPLNLVG 571
++ GVL+ E+++ + P ++VG
Sbjct: 179 WWALGVLMFEMMAGRS---------PFDIVG 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 42/207 (20%)
Query: 390 RLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTN-------- 440
++G+G +G VY K DG++ L + G GI + E L+ +L+H N
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 441 LTDSSRKS--LLDW------------------KKRFYIIEGIVQGLLY-----LHKYSRL 475
L+ + RK L D+ KK + G+V+ LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 476 RAIHRDLKVSNILL----DEQMNPKISDFGMARTY--AMNELEANTNRIVGTHGYMSPEY 529
+HRDLK +NIL+ E+ KI+D G AR + + L A+ + +V T Y +PE
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL-ADLDPVVVTFWYRAPEL 186
Query: 530 VMNGIVSMKS-DVYSFGVLVLEIVSSK 555
++ K+ D+++ G + E+++S+
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 32/115 (27%), Positives = 58/115 (50%), Gaps = 11/115 (9%)
Query: 441 LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDF 500
LTD + ++ ++ + +++ L +LH IHRD+K +ILL K+SDF
Sbjct: 103 LTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDF 159
Query: 501 GMARTYAMNELEANTNR---IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIV 552
G ++ R +VGT +M+PE + + D++S G++V+E+V
Sbjct: 160 GFC-----AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGT 521
I G+ YL S L +HRDL N L+ E + KI+DFGM+R + R V
Sbjct: 147 IASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP 203
Query: 522 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+M+ E ++ G + SDV++FGV + EI+
Sbjct: 204 IRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 41/198 (20%)
Query: 391 LGQGGFGPVYNG-KLLDGQEIAIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNL------ 441
+G G +G V + G+++AIK+LS+ I + E L+ +QH N+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 442 --TDSSRKSLLDW---------------------KKRFYIIEGIVQGLLYLHKYSRLRAI 478
+ S D+ K Y++ ++ GL Y+H I
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---II 139
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 538
HRDLK N+ ++E KI DFG+AR +A V T Y +PE ++N + +
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWMHYNQ 194
Query: 539 S-DVYSFGVLVLEIVSSK 555
+ D++S G ++ E+++ K
Sbjct: 195 TVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 47/207 (22%)
Query: 391 LGQGGFGPVYNGKLL--DG--QEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTN---- 440
LG+G FG V G+L DG ++A+K +L + I EF +EA + H N
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 441 ----LTDSSRKSL------LDWKK----RFYI----IEG----------------IVQGL 466
SS + + L + K ++ + G I G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 467 LYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMS 526
YL S IHRDL N +L E M ++DFG+++ + +++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 527 PEYVMNGIVSMKSDVYSFGVLVLEIVS 553
E + + + + KSDV++FGV + EI +
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 40/206 (19%)
Query: 385 FSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 440
P +G G FG V++ DG+ +A+K++ Q +V K E K++ +H N
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDN 60
Query: 441 ---LTDSSRKSLLDWKKRFYIIEGIVQ---------------------------GLLYLH 470
D + +D + Y++ ++Q GL YLH
Sbjct: 61 VLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH 120
Query: 471 KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYV 530
+HRD+K N+L++ KI DFG+AR +E + T +V T Y +PE +
Sbjct: 121 S---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPEIL 176
Query: 531 MNGI-VSMKSDVYSFGVLVLEIVSSK 555
M + D++S G + E++ +
Sbjct: 177 MGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 457 YIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516
YI+ G + GL +LH R IHRD+K +NILL + K+ DFG++ L NT+
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188
Query: 517 RIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEI 551
VGT +M+PE + + + DV+S G+ +E+
Sbjct: 189 --VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 47/199 (23%), Positives = 87/199 (43%), Gaps = 35/199 (17%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 441
++F R+G G +G VY + ++ G+ AIK + G+ + E ++ +H+N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 442 TDS-----SRKSL---------------------LDWKKRFYIIEGIVQGLLYLHKYSRL 475
R L L + Y+ +QGL YLH +
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK- 127
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM---N 532
+HRD+K +NILL + + K++DFG++ + A +GT +M+PE
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 533 GIVSMKSDVYSFGVLVLEI 551
G + D+++ G+ +E+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-08
Identities = 46/189 (24%), Positives = 77/189 (40%), Gaps = 45/189 (23%)
Query: 407 GQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKR-------- 455
G E+AIK L + + F+ E L A+L H N+ +LLD +
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIV-----ALLDSGEAPPGLLFAV 57
Query: 456 FYIIEGIV-------QGLLYLHKYSRLRA--------------IHRDLKVSNILL---DE 491
F + G G L + RL +HRDLK NI++
Sbjct: 58 FEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 492 QMNPKISDFGMAR----TYAMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGV 546
+ + K+ DFG+ + T ++GT Y +PE + V+ SD+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 547 LVLEIVSSK 555
+ LE ++ +
Sbjct: 178 IFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 32/87 (36%), Positives = 49/87 (56%), Gaps = 7/87 (8%)
Query: 469 LHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG--YMS 526
+ S + IHRDL N+L+ E + KI+DFG++R E + +G +M+
Sbjct: 132 MQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGE-----EVYVKKTMGRLPVRWMA 186
Query: 527 PEYVMNGIVSMKSDVYSFGVLVLEIVS 553
E + + + KSDV+SFGVL+ EIVS
Sbjct: 187 IESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 11/101 (10%)
Query: 457 YIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516
Y+ I G+ YL L +HRDL N L+ + KI+DFGM+R N ++
Sbjct: 134 YMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSSDYY 186
Query: 517 RIVGTH----GYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
R+ G +M+ E V+ G + KSDV++FGV + EI++
Sbjct: 187 RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 48/213 (22%), Positives = 94/213 (44%), Gaps = 50/213 (23%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKR-LSKSSGQGI----------VEFKNEA 430
D + ++G+G +G VY + G+ +A+K+ + +GI ++ +E+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 431 KLIAKLQHTNLTDSSR-KSLL---------DWKKRFYIIEG------------------- 461
I +L + K L D KK ++
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKK--FMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNP-KISDFGMARTYAMNELEANTNRIVG 520
+++G+ + HK+ +HRDLK N+L+D+Q KI+D G+ R +++ +++ T+ IV
Sbjct: 119 LLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV- 173
Query: 521 THGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIV 552
T Y +PE ++ S D++S G + E+
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 57/212 (26%)
Query: 391 LGQGGFGPVYNGKLL-DG--QEIAIKRLSKSSGQGI-VEFKNEAKLIAKL---------- 436
+G+G FG V ++ DG + AIKR+ + + + +F E +++ KL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 437 ----------------QHTNLTDSSRKS-----------------LLDWKKRFYIIEGIV 463
H NL D RKS L ++ + +
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 464 QGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG 523
+G+ YL S+ + IHRDL NIL+ E KI+DFG++R E + +G
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-----EVYVKKTMGRLP 186
Query: 524 --YMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+M+ E + + + SDV+S+GVL+ EIVS
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 12/148 (8%)
Query: 423 IVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDL 482
++E+ N +L L + R RFY E IV L YLH S ++RDL
Sbjct: 73 VMEYANGGELFFHLSRERVFSEDRA-------RFYGAE-IVSALDYLH--SEKNVVYRDL 122
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
K+ N++LD+ + KI+DFG+ + + A GT Y++PE + + D +
Sbjct: 123 KLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 180
Query: 543 SFGVLVLEIVSSKKNNGSYDTERPLNLV 570
GV++ E++ + + D E+ L+
Sbjct: 181 GLGVVMYEMMCGRLPFYNQDHEKLFELI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 10/91 (10%)
Query: 465 GLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG- 523
G+ YL S+ + IHRDL NIL+ E KI+DFG++R E + +G
Sbjct: 124 GMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-----EVYVKKTMGRLPV 175
Query: 524 -YMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+M+ E + + + SDV+S+GVL+ EIVS
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 8e-08
Identities = 49/199 (24%), Positives = 81/199 (40%), Gaps = 44/199 (22%)
Query: 390 RLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNLTDSSR 446
+G+G +G V + G+ +AIK+ +S V+ E K++ +L+H N+
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIV---- 63
Query: 447 KSLLD---WKKRFY----------------------------IIEGIVQGLLYLHKYSRL 475
+L + K R Y I ++Q + Y H
Sbjct: 64 -NLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---SH 119
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
IHRD+K NIL+ E K+ DFG AR T+ V T Y +PE ++
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-YVATRWYRAPELLVGDTN 178
Query: 536 SMKS-DVYSFGVLVLEIVS 553
K DV++ G ++ E++
Sbjct: 179 YGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 40/151 (26%), Positives = 69/151 (45%), Gaps = 19/151 (12%)
Query: 423 IVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDL 482
++E+ N +L L + R RFY E IV L YLH ++RDL
Sbjct: 73 VMEYANGGELFFHLSRERVFSEDRA-------RFYGAE-IVSALGYLH---SCDVVYRDL 121
Query: 483 KVSNILLDEQMNPKISDFGMAR---TYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 539
K+ N++LD+ + KI+DFG+ + + A GT Y++PE + +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDG-----ATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 540 DVYSFGVLVLEIVSSKKNNGSYDTERPLNLV 570
D + GV++ E++ + + D E+ L+
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 50/200 (25%)
Query: 391 LGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSSRKSL 449
LG G FG VY K + G A K + S + + ++ E +++A H + L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIV-----KL 74
Query: 450 LD---WKKRFYII-----------------------------EGIVQGLLYLHKYSRLRA 477
L W + +I+ +++ L YLH ++
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKI 131
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMN-ELEANTNRIVGTHGYMSPEYVM----- 531
IHRDLK N+LL + K++DFG++ A N + + +GT +M+PE VM
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVS---AKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 532 NGIVSMKSDVYSFGVLVLEI 551
+ K+D++S G+ ++E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 60/220 (27%)
Query: 391 LGQGGFGPVYNG-KLLDGQEIAIKRLSKS-SGQGIVE--FKNEAKLIAKLQH-------T 439
+G+GG G VY + + +A+K++ + S +++ F EAK+ A L H +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 440 NLTDS-------------SRKSLLD--WKKR---------------FYIIEGIVQGLLYL 469
+D + KSLL W+K I I + Y+
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV 129
Query: 470 HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE-----LEANTN-------- 516
H L HRDLK NILL I D+G A + E ++ +
Sbjct: 130 HSKGVL---HRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 517 ---RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+IVGT YM+PE ++ S +D+Y+ GV++ ++++
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 42/141 (29%), Positives = 68/141 (48%), Gaps = 7/141 (4%)
Query: 412 IKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHK 471
I L+ + Q +E + L+ +L NL L D ++ Y++ ++ G+ +LH
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMEL-DHERMSYLLYQMLCGIKHLHS 141
Query: 472 YSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM 531
IHRDLK SNI++ KI DFG+ART N + V T Y +PE ++
Sbjct: 142 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM---MTPYVVTRYYRAPEVIL 195
Query: 532 NGIVSMKSDVYSFGVLVLEIV 552
D++S G ++ E+V
Sbjct: 196 GMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 36/197 (18%)
Query: 389 NRLGQGGFGPVYNGK-LLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNLTD-- 443
++LG+G + VY G+ L +A+K RL G + E L+ L+H N+
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 444 ---SSRKSL------LDWKKRFYI---------------IEGIVQGLLYLHKYSRLRAIH 479
+ KSL LD + Y+ + +++GL Y H R + +H
Sbjct: 71 DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLH 127
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGI-VSMK 538
RDLK N+L++E+ K++DFG+AR ++ + +N +V T Y P+ ++ S +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYRPPDILLGSTDYSTQ 185
Query: 539 SDVYSFGVLVLEIVSSK 555
D++ G + E+ + +
Sbjct: 186 IDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 42/207 (20%)
Query: 390 RLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTN-------- 440
++G+G +G VY K DG++ L + G GI + E L+ +L+H N
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 441 LTDSSRKS--LLDW------------------KKRFYIIEGIVQGLLY-----LHKYSRL 475
L+ S RK L D+ KK + +V+ LLY +H
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 476 RAIHRDLKVSNILL----DEQMNPKISDFGMARTY--AMNELEANTNRIVGTHGYMSPEY 529
+HRDLK +NIL+ E+ KI+D G AR + + L A+ + +V T Y +PE
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL-ADLDPVVVTFWYRAPEL 186
Query: 530 VMNGIVSMKS-DVYSFGVLVLEIVSSK 555
++ K+ D+++ G + E+++S+
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 45/197 (22%), Positives = 80/197 (40%), Gaps = 41/197 (20%)
Query: 391 LGQGGFGPVYNG--KLLDGQEI--AIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL---- 441
+G+G FG VY G + ++I A+K + + E F EA ++ + H ++
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 442 ---TDS-------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIH 479
T++ K LD + L YL R +H
Sbjct: 74 GVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVH 130
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELE---ANTNRIVGTHGYMSPEYVMNGIVS 536
RD+ N+L+ K+ DFG++R + + A+ ++ +M+PE + +
Sbjct: 131 RDIAARNVLVSSPDCVKLGDFGLSR--YLEDESYYKASKGKL--PIKWMAPESINFRRFT 186
Query: 537 MKSDVYSFGVLVLEIVS 553
SDV+ FGV + EI+
Sbjct: 187 SASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 49/194 (25%), Positives = 93/194 (47%), Gaps = 38/194 (19%)
Query: 390 RLGQGGFGPVYNG-KLLDGQEIAIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNL----- 441
+LG+G + VY G ++GQ +A+K +S + +G V F EA L+ L+H N+
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHD 70
Query: 442 ----------------TDSSR------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIH 479
TD ++ L + R ++ + +++GL Y+H +H
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQ-LLRGLAYIH---GQHILH 126
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGI-VSMK 538
RDLK N+L+ K++DFG+AR ++ + ++ +V T Y P+ ++ S
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPS-QTYSSEVV-TLWYRPPDVLLGATDYSSA 184
Query: 539 SDVYSFGVLVLEIV 552
D++ G + +E++
Sbjct: 185 LDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 36/132 (27%), Positives = 54/132 (40%), Gaps = 9/132 (6%)
Query: 435 KLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN 494
K + T R L ++ I +++ L YLH IHRD+K NI LDE N
Sbjct: 167 KYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPEN 223
Query: 495 PKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS- 553
+ DFG A + GT SPE + K+D++S G+++ E+
Sbjct: 224 AVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVK 283
Query: 554 -----SKKNNGS 560
K+ S
Sbjct: 284 NVTLFGKQVKSS 295
|
Length = 392 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 37/135 (27%), Positives = 69/135 (51%), Gaps = 11/135 (8%)
Query: 426 FKNEAKLIAKLQHTNLTD-----SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHR 480
F+ ++L +++ N D ++ L + RFY E I L +LH+ I+R
Sbjct: 65 FQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAE-ICIALNFLHERG---IIYR 120
Query: 481 DLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSD 540
DLK+ N+LLD + K++D+GM + + + T+ GT Y++PE + D
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKE-GLGPGD-TTSTFCGTPNYIAPEILRGEEYGFSVD 178
Query: 541 VYSFGVLVLEIVSSK 555
++ GVL+ E+++ +
Sbjct: 179 WWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 33/103 (32%), Positives = 56/103 (54%), Gaps = 18/103 (17%)
Query: 458 IIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN--- 514
I +V+GL +L + IHRD+K +N+L++ K+ DFG++ L A+
Sbjct: 107 ITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAK 159
Query: 515 TNRIVGTHGYMSPEYVM------NGIVSMKSDVYSFGVLVLEI 551
TN +G YM+PE + N +++SDV+S G+ +LE+
Sbjct: 160 TN--IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 32/146 (21%)
Query: 390 RLGQGGFGPVYNGKLLDGQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTN---LTD 443
++G+G +G V+ K + EI A+KR+ +G+ E L+ +L+H N L D
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 444 ---SSRKSLL-------DWKKRFYIIEG-------------IVQGLLYLHKYSRLRAIHR 480
S +K L D KK F G +++GL + H + +HR
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHR 123
Query: 481 DLKVSNILLDEQMNPKISDFGMARTY 506
DLK N+L+++ K++DFG+AR +
Sbjct: 124 DLKPQNLLINKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 50/202 (24%), Positives = 95/202 (47%), Gaps = 48/202 (23%)
Query: 391 LGQGGFGPV---YNGKLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQH------ 438
+G G +G V Y+ +L Q++A+K+LS+ Q ++ + E +L+ ++H
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGL 79
Query: 439 -------------------TNLTDSSRKSLLDWKKRF-----YIIEGIVQGLLYLHKYSR 474
TNL + +++ +K ++I +++GL Y+H
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG- 138
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGI 534
IHRDLK SN+ ++E +I DFG+AR + + V T Y +PE ++N +
Sbjct: 139 --IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEIMLNWM 191
Query: 535 -VSMKSDVYSFGVLVLEIVSSK 555
+ D++S G ++ E++ K
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 457 YIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516
YI+ + GL +LH + IHRD+K +NILL + K+ DFG++ L NT+
Sbjct: 128 YILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 184
Query: 517 RIVGTHGYMSPEYV-----MNGIVSMKSDVYSFGVLVLEI 551
VGT +M+PE + ++ + DV+S G+ +E+
Sbjct: 185 --VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 38/201 (18%)
Query: 383 DNFSPANRLGQGGFGPVYNGKL-LDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHT 439
D++ +LG+G + VY GK ++G+ +A+K RL + G + EA L+ L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 440 NLT---------------------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKY 472
N+ D L + ++ + +++GL Y+H+
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQ-LLRGLSYIHQR 122
Query: 473 SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN 532
L HRDLK N+L+ + K++DFG+AR ++ +N +V T Y P+ ++
Sbjct: 123 YIL---HRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNEVV-TLWYRPPDVLLG 177
Query: 533 GI-VSMKSDVYSFGVLVLEIV 552
S D++ G + +E++
Sbjct: 178 STEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 36/197 (18%)
Query: 389 NRLGQGGFGPVYNGKL-LDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNLTD-- 443
+LG+G + V+ G+ L +A+K RL G + E L+ L+H N+
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 444 ---SSRKSL------LDWKKRFYI---------------IEGIVQGLLYLHKYSRLRAIH 479
+ KSL LD + Y+ + I++GL Y H R + +H
Sbjct: 71 DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLH 127
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM-NGIVSMK 538
RDLK N+L++E+ K++DFG+AR ++ + +N +V T Y P+ ++ + S +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSSEYSTQ 185
Query: 539 SDVYSFGVLVLEIVSSK 555
D++ G + E+ S +
Sbjct: 186 IDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 13/148 (8%)
Query: 423 IVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDL 482
++E+ N +L L + R RFY E IV L YLH + ++RDL
Sbjct: 73 VMEYVNGGELFFHLSRERVFSEDRT-------RFYGAE-IVSALDYLHSG---KIVYRDL 121
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
K+ N++LD+ + KI+DFG+ + + A GT Y++PE + + D +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179
Query: 543 SFGVLVLEIVSSKKNNGSYDTERPLNLV 570
GV++ E++ + + D E+ L+
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 44/155 (28%), Positives = 70/155 (45%), Gaps = 21/155 (13%)
Query: 423 IVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDL 482
++++ N +L LQ + L+ + RFY E I L YLH L ++RDL
Sbjct: 74 VLDYINGGELFYHLQR-------ERCFLEPRARFYAAE-IASALGYLHS---LNIVYRDL 122
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
K NILLD Q + ++DFG+ + E T+ GT Y++PE + D +
Sbjct: 123 KPENILLDSQGHIVLTDFGLCKENI--EHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWW 180
Query: 543 SFGVLVLEIV------SSKKNNGSYDT--ERPLNL 569
G ++ E++ S+ YD +PL L
Sbjct: 181 CLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL 215
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 6/97 (6%)
Query: 455 RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514
FY +V GL YLH+ + ++RDLK+ N+LLD + KI+DFG+ + M
Sbjct: 104 VFYAAC-VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKE-GMG-FGDR 157
Query: 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEI 551
T+ GT +++PE + + D + GVL+ E+
Sbjct: 158 TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 194
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 36/169 (21%)
Query: 390 RLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFK---NEAKLIAKLQHTNLTD-- 443
++G+G +G V+ + + GQ +AIK+ +S +++ K E +++ +L+H NL +
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIALREIRMLKQLKHPNLVNLI 66
Query: 444 ----SSRK----------SLLDWKKRF----------YIIEGIVQGLLYLHKYSRLRAIH 479
RK ++L+ ++ II +Q + + HK++ IH
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIH 123
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPE 528
RD+K NIL+ +Q K+ DFG AR + + V T Y +PE
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 42/144 (29%), Positives = 70/144 (48%), Gaps = 7/144 (4%)
Query: 412 IKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHK 471
I L+ + Q +E + L+ +L NL + L D ++ Y++ ++ G+ +LH
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS 137
Query: 472 YSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM 531
IHRDLK SNI++ KI DFG+ART + + V T Y +PE ++
Sbjct: 138 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVIL 191
Query: 532 NGIVSMKSDVYSFGVLVLEIVSSK 555
D++S G ++ E+V K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 30/100 (30%), Positives = 56/100 (56%), Gaps = 9/100 (9%)
Query: 457 YIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516
+++ +++GL Y+H IHRDLK N+ ++E KI DFG+AR + ++
Sbjct: 122 FLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMT 173
Query: 517 RIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIVSSK 555
V T Y +PE ++N + + D++S G ++ E+++ K
Sbjct: 174 GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 37/102 (36%), Positives = 54/102 (52%), Gaps = 14/102 (13%)
Query: 458 IIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517
++ + G+ YL + + +HRDL N+LL Q KISDFG+++ L A+ N
Sbjct: 100 LVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LGADENY 151
Query: 518 I-VGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
THG + +PE + S KSDV+SFGVL+ E S
Sbjct: 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 37/211 (17%)
Query: 383 DNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN- 440
DNF ++G+G G V + G+ +A+K++ Q NE ++ QH N
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 441 ------------------------LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLR 476
LTD + ++ ++ + +++ L LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG--- 136
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVS 536
IHRD+K +ILL K+SDFG +++ +VGT +M+PE +
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 537 MKSDVYSFGVLVLEIVSSKKNNGSYDTERPL 567
+ D++S G++V+E+V + Y E PL
Sbjct: 195 PEVDIWSLGIMVIEMVDGEP---PYFNEPPL 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 35/103 (33%), Positives = 56/103 (54%), Gaps = 8/103 (7%)
Query: 457 YIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516
I I+ GL Y+H + +HRDLK N+L++ KI DFG+AR ++ N E N
Sbjct: 109 SFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE-NAG 164
Query: 517 RI---VGTHGYMSPEYVMNGIVSMKS-DVYSFGVLVLEIVSSK 555
+ V T Y +PE +++ K+ DV+S G ++ E++ K
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 13/130 (10%)
Query: 423 IVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDL 482
++++ N +L LQ + L+ + RFY E + + YLH L I+RDL
Sbjct: 74 VLDYVNGGELFFHLQR-------ERCFLEPRARFYAAE-VASAIGYLHS---LNIIYRDL 122
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
K NILLD Q + ++DFG+ + E E T+ GT Y++PE + D +
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGV--EPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWW 180
Query: 543 SFGVLVLEIV 552
G ++ E++
Sbjct: 181 CLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 36/132 (27%), Positives = 65/132 (49%), Gaps = 8/132 (6%)
Query: 436 LQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNP 495
L+ LTD + ++ ++ + +++ L YLH IHRD+K +ILL
Sbjct: 101 LEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRI 157
Query: 496 KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
K+SDFG +++ +VGT +M+PE + + D++S G++V+E++ +
Sbjct: 158 KLSDFGFCAQ--VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
Query: 556 KNNGSYDTERPL 567
Y E PL
Sbjct: 216 P---PYFNEPPL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 35/106 (33%), Positives = 53/106 (50%), Gaps = 10/106 (9%)
Query: 451 DWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510
W RFY E +V L +H IHRD+K N+LLD+ + K++DFG N
Sbjct: 142 KWA-RFYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196
Query: 511 LEANTNRIVGTHGYMSPEYVMN----GIVSMKSDVYSFGVLVLEIV 552
+ + VGT Y+SPE + + G + D +S GV + E++
Sbjct: 197 M-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 51/205 (24%), Positives = 100/205 (48%), Gaps = 40/205 (19%)
Query: 384 NFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTN- 440
NF +LG+G + VY G+ G+ +A+K + + +G E L+ +L+H N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 441 --LTD---SSRKSLLDWK------KRFYIIEG----------------IVQGLLYLHKYS 473
L D + K +L ++ K++ G +++G+ + H+
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN- 119
Query: 474 RLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT--NRIVGTHGYMSPEYVM 531
R +HRDLK N+L++++ K++DFG+AR + + NT N +V T Y +P+ ++
Sbjct: 120 --RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVV-TLWYRAPDVLL 173
Query: 532 NGIVSMKS-DVYSFGVLVLEIVSSK 555
S D++S G ++ E+++ +
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 47/201 (23%)
Query: 391 LGQGGFGPVYNGKLL-DGQEI----AIKRLSKSSGQ-------------GIVEFKNEAKL 432
LG G FG V+ G + +G I AIK + SG+ G ++ +L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 433 I-----AKLQ-------HTNLTDSSRKS--------LLDWKKRFYIIEGIVQGLLYLHKY 472
+ A LQ +L D R+ LL+W + I +G+ YL ++
Sbjct: 75 LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEEH 128
Query: 473 SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN 532
R +HR+L NILL +I+DFG+A ++ + + +M+ E ++
Sbjct: 129 ---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185
Query: 533 GIVSMKSDVYSFGVLVLEIVS 553
G + +SDV+S+GV V E++S
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSM 537
+HRDL N+L+ E KI DFG+AR + + +M+PE + N + +
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 538 KSDVYSFGVLVLEIVSSKKNNGSYDTERPLN 568
SDV+SFG+L+ EI + G+ E P+N
Sbjct: 321 LSDVWSFGILLWEIFTL---GGTPYPELPMN 348
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 33/198 (16%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQ--EIAIKRLSKSS---GQGIVEFKNEAKLIAKLQ 437
++F+ LG G FG V + +AIKR KS + + +E K++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 438 H---TNLTDSSRK-----------------SLLDWKKRFYIIEGI---VQGLLYLHKYSR 474
H NL S + + L KRF G Q +L
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGI 534
L ++RDLK N+LLD+ K++DFG A+ ++ T + GT Y++PE ++N
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPEILLNVG 204
Query: 535 VSMKSDVYSFGVLVLEIV 552
+D ++ G+ + EI+
Sbjct: 205 HGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 35/145 (24%)
Query: 390 RLGQGGFGPVYNGK-LLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTN------ 440
+LG+G + VY G+ L GQ +A+K RL G + EA L+ L+H N
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 441 -------LT------DSSRKSLLDW--------KKRFYIIEGIVQGLLYLHKYSRLRAIH 479
LT D+ K +D R ++ + +++GL Y H+ R +H
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQ-LLRGLAYCHQR---RVLH 126
Query: 480 RDLKVSNILLDEQMNPKISDFGMAR 504
RDLK N+L+ E+ K++DFG+AR
Sbjct: 127 RDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 38/198 (19%)
Query: 389 NRLGQGGFGPVYNGKL-LDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNLT--- 442
++LG+G + V+ G+ L +A+K RL G + E L+ L+H N+
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 443 ----------------DSSRKSLLD--------WKKRFYIIEGIVQGLLYLHKYSRLRAI 478
DS K LD + ++ + +++GL Y HK + +
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQ-LLRGLSYCHKR---KIL 125
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGI-VSM 537
HRDLK N+L++E+ K++DFG+AR ++ + +N +V T Y P+ ++ S
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 538 KSDVYSFGVLVLEIVSSK 555
D++ G ++ E+ + +
Sbjct: 184 PIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 26/76 (34%), Positives = 42/76 (55%)
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSM 537
+HRDL N+LL + KI DFG+AR + + +M+PE + + + +
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318
Query: 538 KSDVYSFGVLVLEIVS 553
SDV+S+G+L+ EI S
Sbjct: 319 LSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 22/149 (14%)
Query: 423 IVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDL 482
++EF + L+ +Q ++ L + RFY E I L +LH+ I+RDL
Sbjct: 74 VIEFVSGGDLMFHMQR-------QRKLPEEHARFYSAE-ISLALNFLHERG---IIYRDL 122
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
K+ N+LLD + + K++D+GM + T+ GT Y++PE + D +
Sbjct: 123 KLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWW 180
Query: 543 SFGVLVLEIVSSKKNNGSYDTERPLNLVG 571
+ GVL+ E+++ + P ++VG
Sbjct: 181 ALGVLMFEMMAGRS---------PFDIVG 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 11/104 (10%)
Query: 455 RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514
+FY+ E ++ +H ++ +HRD+K N+L+D + K++DFG A N++ N
Sbjct: 105 QFYLAELVLA----IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VN 159
Query: 515 TNRIVGTHGYMSPEY--VMNG----IVSMKSDVYSFGVLVLEIV 552
+ VGT Y++PE MNG ++ D +S GV+ E++
Sbjct: 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 56/267 (20%), Positives = 114/267 (42%), Gaps = 42/267 (15%)
Query: 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT----- 442
N + +G G Y GK + +G + +K ++ + E + + KLQH N+
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGL 751
Query: 443 ------------DSSRKSL------LDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKV 484
K+L L W++R I GI + L +LH + +L
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811
Query: 485 SNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSF 544
I++D + P + ++ L + + Y++PE ++ KSD+Y F
Sbjct: 812 EKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGF 864
Query: 545 GVLVLEIVSSKKNNGSYDTERPLN--LVGYAWQLWNEGKALELMDPTL--DESCSSDEVM 600
G++++E+++ K D E ++ +V +A +++ +DP++ D S + +E++
Sbjct: 865 GLILIELLTGK---SPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIV 921
Query: 601 RCIHVGLLCVQDRAADRRTMSDVVSML 627
+++ L C R +DV+ L
Sbjct: 922 EVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 45/238 (18%)
Query: 391 LGQGGFGPVYNGKLLD---GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN------- 440
LG G G V++ +D + +A+K++ + Q + E K+I +L H N
Sbjct: 13 LGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 441 LTDSSRKSLLDWKKRF-----YIIEGIV---------QGLL-----YLHKYSRLRA---- 477
L S D YI++ + QG L L Y LR
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYI 130
Query: 478 -----IHRDLKVSNILLD-EQMNPKISDFGMARTYAMN-ELEANTNRIVGTHGYMSPEYV 530
+HRDLK +N+ ++ E + KI DFG+AR + + + + T Y SP +
Sbjct: 131 HSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLL 190
Query: 531 MNGIVSMKS-DVYSFGVLVLEIVSSKK-NNGSYDTERPLNLVGYAWQLWNEGKALELM 586
++ K+ D+++ G + E+++ K G+++ E+ + L+ + + E EL+
Sbjct: 191 LSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVPVVREEDRNELL 247
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 34/108 (31%), Positives = 56/108 (51%), Gaps = 14/108 (12%)
Query: 449 LLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508
LD ++ Y++ ++ G+ +LH IHRDLK SNI++ KI DFG+ART
Sbjct: 114 DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--- 167
Query: 509 NELEANTNRI----VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIV 552
A T+ + V T Y +PE ++ D++S G ++ E++
Sbjct: 168 ----AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 13/130 (10%)
Query: 423 IVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDL 482
+++F N +L LQ +S + + RFY E I L YLH + ++RDL
Sbjct: 74 VLDFVNGGELFFHLQ-------RERSFPEPRARFYAAE-IASALGYLHS---INIVYRDL 122
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
K NILLD Q + ++DFG+ + T GT Y++PE + D +
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGI--AQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWW 180
Query: 543 SFGVLVLEIV 552
G ++ E++
Sbjct: 181 CLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGT 521
I G+ YL S IHRDL N +L+E MN ++DFG+++ N RI
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKK-IYNGDYYRQGRIAKM 176
Query: 522 H-GYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+++ E + + + + KSDV+SFGV + EI +
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 12/103 (11%)
Query: 455 RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMA-RTYAMNELEA 513
RFY+ E + L + +L +HRD+K N+LLD+ + +++DFG R A +++
Sbjct: 105 RFYLAEMV----LAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160
Query: 514 NTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEI 551
N VGT Y+SPE + G + D +S GV + E+
Sbjct: 161 NV--AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 32/106 (30%), Positives = 54/106 (50%), Gaps = 6/106 (5%)
Query: 450 LDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509
LD ++ Y++ ++ G+ +LH IHRDLK SNI++ KI DFG+ART +
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
+ V T Y +PE ++ D++S G ++ E++
Sbjct: 180 FM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 3e-06
Identities = 15/48 (31%), Positives = 27/48 (56%)
Query: 629 NDTMALPKPKQPAFFINISSDYEEPDVTEIKLEVCSVNDVTISRMEGR 676
++T +P+PKQP F + S + + + E +VN VT+S ++ R
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 50/200 (25%)
Query: 391 LGQGGFGPVYNGKLLDGQEIAI-KRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSSRKSL 449
LG G FG VY + + +A K + S + + ++ E ++A H N+ L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV-----KL 67
Query: 450 LD---WKKRFYII-----------------------------EGIVQGLLYLHKYSRLRA 477
LD ++ +I+ + ++ L YLH+ +
Sbjct: 68 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KI 124
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE-ANTNRIVGTHGYMSPEYVM----- 531
IHRDLK NIL + K++DFG++ A N + +GT +M+PE VM
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVS---AKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 532 NGIVSMKSDVYSFGVLVLEI 551
+ K+DV+S G+ ++E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 39/199 (19%)
Query: 391 LGQGGFGPV----YNGKLLD-GQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNLT-- 442
LG+G FG V Y+ + + G+++A+K L +S G I + K E +++ L H N+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 443 --------DSSRKSLLDW-------------------KKRFYIIEGIVQGLLYLHKYSRL 475
+ K ++++ K++ I +G+ YL SR
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG--SR- 128
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN-ELEANTNRIVGTHGYMSPEYVMNGI 534
+ +HRDL N+L++ + KI DFG+ + + E + + + +PE ++
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 535 VSMKSDVYSFGVLVLEIVS 553
+ SDV+SFGV + E+++
Sbjct: 189 FYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 36/134 (26%), Positives = 55/134 (41%), Gaps = 40/134 (29%)
Query: 455 RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGM------------ 502
RFYI E I L + +L IHRD+K N+LLD + + K+SDFG+
Sbjct: 104 RFYIAETI----LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159
Query: 503 ARTYAMNELEANT------------------NRI------VGTHGYMSPEYVMNGIVSMK 538
R + NR VGT Y++PE + + +
Sbjct: 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE 219
Query: 539 SDVYSFGVLVLEIV 552
D +S GV++ E++
Sbjct: 220 CDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 39/141 (27%), Positives = 71/141 (50%), Gaps = 9/141 (6%)
Query: 422 GIV----EFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIVQGLLY-----LHKY 472
GIV +FK++ KL+ +++ + D +++ K+ E V L Y L +
Sbjct: 126 GIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV 185
Query: 473 SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN 532
+ +HRDLK +NI L K+ DFG ++ Y+ + + GT Y++PE
Sbjct: 186 HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER 245
Query: 533 GIVSMKSDVYSFGVLVLEIVS 553
S K+D++S GV++ E+++
Sbjct: 246 KRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 10/103 (9%)
Query: 455 RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514
RFYI E + L +H +L +HRD+K N+LLD + +++DFG +
Sbjct: 105 RFYIAEMV----LAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLK-MNQDGTVQ 159
Query: 515 TNRIVGTHGYMSPEYVMN-----GIVSMKSDVYSFGVLVLEIV 552
++ VGT Y+SPE + G + D +S GV + E++
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 53/216 (24%), Positives = 85/216 (39%), Gaps = 53/216 (24%)
Query: 385 FSPANRLGQGGFGPVYNGKLL----DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 438
F+ LG+G FG V +L Q++A+K L S I EF EA + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 439 TNLTDSSRKSLLDWKK----------------------------------------RFYI 458
N+ SL K RF I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 459 IEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART-YAMNELEANTNR 517
I G+ YL S IHRDL N +L+E M ++DFG+++ Y+ +
Sbjct: 121 --DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+ +++ E + + + + SDV++FGV + EI++
Sbjct: 176 KLPVK-WLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 30/111 (27%), Positives = 56/111 (50%), Gaps = 17/111 (15%)
Query: 455 RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN----- 509
R Y E ++ L YLH Y +HRDLK N+L+ + K++DFG+++ M+
Sbjct: 104 RMYFAETVL-ALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159
Query: 510 ---ELEANT-----NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIV 552
+E +T ++ GT Y++PE ++ D ++ G+++ E +
Sbjct: 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 34/125 (27%), Positives = 55/125 (44%), Gaps = 31/125 (24%)
Query: 455 RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMA----------- 503
RFY E ++ L YLH L ++RDLK NILL E + +SDF ++
Sbjct: 106 RFYAAE-VLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161
Query: 504 -------RTYAMNELE---------ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVL 547
R ++N + +N VGT Y++PE + D ++ G+L
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGIL 221
Query: 548 VLEIV 552
+ E++
Sbjct: 222 LYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 26/78 (33%), Positives = 41/78 (52%), Gaps = 3/78 (3%)
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTH--GYMSPEYVMNGIV 535
+HRDL N+LL Q KISDFG+++ ++ R G + +PE +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECINFRKF 175
Query: 536 SMKSDVYSFGVLVLEIVS 553
S +SDV+S+G+ + E S
Sbjct: 176 SSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 46/188 (24%), Positives = 82/188 (43%), Gaps = 29/188 (15%)
Query: 391 LGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVEFKN--EAKLIAKLQHTNLTDSSRK 447
+G+G +G V + + +EI AIK+ S V+ E K++ L+ N+ + ++
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVEL-KE 67
Query: 448 SLLDWKKRFYIIEGIVQGLLYL---------------HKYSRLRAI---------HRDLK 483
+ K + + E + + +L L + Y ++AI HRD+K
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK 127
Query: 484 VSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYS 543
N+L+ K+ DFG AR + AN V T Y SPE ++ D++S
Sbjct: 128 PENLLISHNDVLKLCDFGFARNLSEGS-NANYTEYVATRWYRSPELLLGAPYGKAVDMWS 186
Query: 544 FGVLVLEI 551
G ++ E+
Sbjct: 187 VGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 10/110 (9%)
Query: 450 LDWKKR------FYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMA 503
DWK R I++ ++ + Y+H + IHRD+K+ NI L+ + DFG A
Sbjct: 258 FDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 504 RTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+ E EA VGT SPE + +D++S G+++L+++S
Sbjct: 315 MPFE-KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 34/139 (24%), Positives = 56/139 (40%), Gaps = 45/139 (32%)
Query: 455 RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGM------------ 502
RFYI E + + +HK + IHRD+K NIL+D + K++DFG+
Sbjct: 104 RFYIAE-LTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 503 ------ARTYAM---NELEANTNR--------------------IVGTHGYMSPEYVMNG 533
R +M E +VGT Y++PE ++
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 534 IVSMKSDVYSFGVLVLEIV 552
+ D +S GV++ E++
Sbjct: 220 GYTQLCDWWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 10/103 (9%)
Query: 455 RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514
RFY+ E ++ + +L +HRD+K NIL+D + +++DFG M +
Sbjct: 105 RFYLAEMVIA----IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQ 159
Query: 515 TNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIV 552
++ VGT Y+SPE + G + D +S GV + E++
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 10/105 (9%)
Query: 452 WKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511
W K FY E +V L +H + IHRD+K N+LLD+ + K++DFG +
Sbjct: 143 WAK-FYTAE-VVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197
Query: 512 EANTNRIVGTHGYMSPEYVM----NGIVSMKSDVYSFGVLVLEIV 552
+ VGT Y+SPE + +G + D +S GV + E++
Sbjct: 198 -VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 455 RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN-ELEA 513
RFY E +V L +H + IHRD+K N+LLD+ + K++DFG MN E
Sbjct: 145 RFYTAE-VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMV 198
Query: 514 NTNRIVGTHGYMSPEYVM----NGIVSMKSDVYSFGVLVLEIV 552
+ VGT Y+SPE + +G + D +S GV + E++
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 14/81 (17%)
Query: 455 RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMA--------RTY 506
RFY+ E V + +HK L IHRD+K NIL+D + K+SDFG++ Y
Sbjct: 104 RFYMAE-CVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159
Query: 507 AMNELE--ANTNRIVGTHGYM 525
L+ +N NRI +
Sbjct: 160 YQKLLQGKSNKNRIDNRNSVA 180
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 21/58 (36%), Positives = 33/58 (56%), Gaps = 4/58 (6%)
Query: 455 RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512
YI E + L YLH++ IHRDLK N+L+ + + K++DFG+++ EL
Sbjct: 107 VKYISE-VALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELN 160
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 38/140 (27%), Positives = 61/140 (43%), Gaps = 37/140 (26%)
Query: 446 RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMA-- 503
+ +L + + +FYI E + L + +L IHRD+K N+LLD + + K+SDFG+
Sbjct: 95 KDTLTEEETQFYIAETV----LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG 150
Query: 504 -----RTYAMNEL-----------EANTNR---------------IVGTHGYMSPEYVMN 532
RT L N+ R VGT Y++PE M
Sbjct: 151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ 210
Query: 533 GIVSMKSDVYSFGVLVLEIV 552
+ D +S GV++ E++
Sbjct: 211 TGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 39/140 (27%), Positives = 60/140 (42%), Gaps = 37/140 (26%)
Query: 446 RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMA-- 503
+ +L + +FYI E + L + +L IHRD+K N+LLD + + K+SDFG+
Sbjct: 95 KDTLSEEATQFYIAETV----LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTG 150
Query: 504 -----RTYAMNELEAN--------------------TNR------IVGTHGYMSPEYVMN 532
RT L N NR VGT Y++PE M
Sbjct: 151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ 210
Query: 533 GIVSMKSDVYSFGVLVLEIV 552
+ D +S GV++ E++
Sbjct: 211 TGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 5e-04
Identities = 32/99 (32%), Positives = 48/99 (48%), Gaps = 22/99 (22%)
Query: 476 RAIHRDLKVSNILLD----------EQMN-------PKISDFGMARTYAMNELEANTNRI 518
R +HRDLK NI L Q N KI DFG+++ +E+ +
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG---IESMAHSC 201
Query: 519 VGTHGYMSPEYVMNGIVSM--KSDVYSFGVLVLEIVSSK 555
VGT Y SPE +++ S KSD+++ G ++ E+ S K
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 30/123 (24%), Positives = 59/123 (47%), Gaps = 17/123 (13%)
Query: 458 IIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517
I +++ + YLH+ R IHRD+K NI ++ + + DFG A ++ N N+
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGA----ACFPVDINANK 239
Query: 518 IVGTHGYM---SPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKN-------NGSYDTERPL 567
G G + +PE + D++S G+++ E+ + + +G D++R +
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI 299
Query: 568 NLV 570
L+
Sbjct: 300 KLI 302
|
Length = 391 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 45/203 (22%)
Query: 391 LGQGGFGPVYNGKLLDG---QEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTD--- 443
+G G FG V G++ G ++ +K L S+ Q ++F EA+ LQH+NL
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 444 -------------------------SSRKSLL---DWKKRFYIIEGIVQGLLYLHKYSRL 475
S RK+ L D + I GLL+LHK +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYV----M 531
IH DL + N LL + KI D+G++ + +++ +++PE V
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 532 NGIV---SMKSDVYSFGVLVLEI 551
N +V + +S+V+S GV + E+
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 49/197 (24%), Positives = 82/197 (41%), Gaps = 39/197 (19%)
Query: 389 NRLGQGGFGPVYNGK-LLDGQEIAIKRLSK---SSGQ--------------------GIV 424
++G+G F V + G+ AIK + K S Q ++
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 425 EFKNEAK-----LIAKLQHTNLTD--SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRA 477
E + K L+ +L NL + RK L K+ + +++ L ++H R
Sbjct: 65 EVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGI 121
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM-NGIVS 536
HRD+K NIL+ K++DFG R + T I T Y +PE ++ +G
Sbjct: 122 FHRDIKPENILIK-DDILKLADFGSCRG--IYSKPPYTEYI-STRWYRAPECLLTDGYYG 177
Query: 537 MKSDVYSFGVLVLEIVS 553
K D+++ G + EI+S
Sbjct: 178 PKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 53/240 (22%), Positives = 98/240 (40%), Gaps = 61/240 (25%)
Query: 355 NRKTQVHNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQE-IAIK 413
N ++ + D+ + ++ N +G G FG VY +D E +AIK
Sbjct: 45 NAGEDEDEEKMIDNDIN-------RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK 97
Query: 414 RLSKSSGQGIVEFKNEAKLIAK-LQHTNL--------TDSSRKSLLDWKKRFY---IIEG 461
++ + ++KN LI K L H N+ T+ +K+ +K + ++E
Sbjct: 98 KVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN----EKNIFLNVVMEF 148
Query: 462 IVQG------------------LLYLHKYSRLRAI---------HRDLKVSNILLDEQMN 494
I Q L+ L+ Y RA+ HRDLK N+L+D +
Sbjct: 149 IPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH 208
Query: 495 P-KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIV 552
K+ DFG A+ + + + + Y +PE ++ + D++S G ++ E++
Sbjct: 209 TLKLCDFGSAKNLLAGQRSVS---YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 48/197 (24%), Positives = 82/197 (41%), Gaps = 40/197 (20%)
Query: 391 LGQGGFGPVYNG--KLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---- 441
LG G FG + G KL +E +AI L S + F EA + + H+N+
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 442 ------------TDSSRKSLLDWKKRFY-----------IIEGIVQGLLYLHKYSRLRAI 478
T+ LD R + ++ G+ G+ YL S + +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYV 129
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG--YMSPEYVMNGIVS 536
H+ L +L++ + KIS F + ++ EA + G + +PE + S
Sbjct: 130 HKGLAAHKVLVNSDLVCKISGFRRLQE---DKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 537 MKSDVYSFGVLVLEIVS 553
SDV+SFG+++ E++S
Sbjct: 187 SASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 50/205 (24%), Positives = 86/205 (41%), Gaps = 47/205 (22%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSK-----SSGQGIVEFKNEAKLIAKLQHTNLTD- 443
+G+G +G V + G+++AIK+++ S I+ E KL+ L+H ++ +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR---EIKLLRLLRHPDIVEI 64
Query: 444 ------SSRKSLLDWKKRFYIIEG-----------------------IVQGLLYLHKYSR 474
SR+ D F ++E +++ L Y+H +
Sbjct: 65 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN- 123
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT--NRIVGTHGYMSPEYVMN 532
HRDLK NIL + KI DFG+AR A N+ V T Y +PE +
Sbjct: 124 --VFHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 533 --GIVSMKSDVYSFGVLVLEIVSSK 555
+ D++S G + E+++ K
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 27/98 (27%), Positives = 46/98 (46%), Gaps = 12/98 (12%)
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART-YAMNELEANTNRIVG 520
+ GLL+LH + IH DL + N L ++ KI D+G+A Y + V
Sbjct: 109 VASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP 165
Query: 521 THGYMSPEYV-------MNGIVSMKSDVYSFGVLVLEI 551
+++PE V + + KS+++S GV + E+
Sbjct: 166 LR-WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 676 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.98 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.98 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.98 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.98 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.98 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.98 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.98 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.98 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.98 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.98 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.98 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.98 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.94 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.93 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.93 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.92 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.92 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.92 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.92 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.9 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.89 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.87 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.87 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.86 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.85 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.79 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.66 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.61 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.61 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.58 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.57 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.52 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.5 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.49 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.43 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.36 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.36 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.33 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.32 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.29 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.2 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.13 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.92 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.88 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.87 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.76 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.7 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.63 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.63 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.56 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.55 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.48 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.3 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.19 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.13 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.12 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.05 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 98.02 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.01 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 97.98 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.91 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.87 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 97.84 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.41 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.39 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.38 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.2 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.18 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.15 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.1 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.01 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 96.91 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.72 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.39 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.34 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.06 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.04 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.0 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 95.95 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.78 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 95.47 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 95.45 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.37 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.17 | |
| PLN02236 | 344 | choline kinase | 95.07 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 95.07 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 94.84 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 94.64 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 94.59 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.23 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.22 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 92.5 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 92.37 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.1 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 91.95 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 91.59 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 89.69 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 89.09 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 88.38 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 87.48 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 87.32 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 86.79 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 86.22 | |
| PTZ00384 | 383 | choline kinase; Provisional | 85.44 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=398.98 Aligned_cols=261 Identities=42% Similarity=0.703 Sum_probs=228.4
Q ss_pred cCccccHHHHHHHhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc----
Q 005803 369 DLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS---- 444 (676)
Q Consensus 369 ~~~~f~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~---- 444 (676)
..+.|++.+|..||++|...+.||+|+||.||+|.+.+++.||||++.....+...+|.+|+.++.+++|||+|..
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 6788999999999999999999999999999999999999999999876543315669999999999999999831
Q ss_pred ------------------------cccC-cCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEec
Q 005803 445 ------------------------SRKS-LLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISD 499 (676)
Q Consensus 445 ------------------------~~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~D 499 (676)
.... .++|..|++||.++|+||+|||+...++||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 1111 789999999999999999999999888899999999999999999999999
Q ss_pred cCcceecccccccccccee-eccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHh
Q 005803 500 FGMARTYAMNELEANTNRI-VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWN 578 (676)
Q Consensus 500 FGla~~~~~~~~~~~~~~~-~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 578 (676)
||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||++|+++.+.........++.|++..+.
T Consensus 221 FGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999754431 1111112 799999999999999999999999999999999999999887665666679999999999
Q ss_pred cCCccccCCcccC-CCCCh-HHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 579 EGKALELMDPTLD-ESCSS-DEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 579 ~~~~~~~~d~~l~-~~~~~-~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
++.+.+++|+.+. ..... +++.++..++.+|++.+|.+||+|.||+++|+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 9999999999987 55554 78999999999999999999999999999996654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=345.98 Aligned_cols=222 Identities=24% Similarity=0.419 Sum_probs=185.5
Q ss_pred cCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
.+|...+.||+|||+.||+++. ..|+.||+|++.+. .....+.+.+|+++.++|+|||||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5689999999999999999997 77999999999764 4456678999999999999999983
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
....+.+++.++.+++.||+.||.|||+.+ |||||||..|+|++++.++||+|||+|..+..+...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 235678999999999999999999999998 999999999999999999999999999987755433
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
..+.+|||.|+|||++.....+..+||||+|||+|.||.|++||+...-.+ .+..+......
T Consensus 175 --k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------ty~~Ik~~~Y~--------- 236 (592)
T KOG0575|consen 175 --KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------TYNKIKLNEYS--------- 236 (592)
T ss_pred --cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------HHHHHHhcCcc---------
Confidence 344899999999999999999999999999999999999999998543222 22222222111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+.....+..+|+..+|+.||.+|||+++|+..
T Consensus 237 -~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 237 -MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122333456788889999999999999999964
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=336.77 Aligned_cols=230 Identities=30% Similarity=0.432 Sum_probs=182.4
Q ss_pred cceeeccCCCccEEEEEEcCCcEEEEEEeccCCch--hhHHHHHHHHHHHHccCCcccc---------------------
Q 005803 387 PANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQ--GIVEFKNEAKLIAKLQHTNLTD--------------------- 443 (676)
Q Consensus 387 ~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~--------------------- 443 (676)
+.+.||+|+||+||+|.+.....||||++...... ..++|.+|+.+|.+++|||||.
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 35569999999999999865555999999764322 2568999999999999999982
Q ss_pred ------cc--ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC-CeEEeccCcceeccccccccc
Q 005803 444 ------SS--RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM-NPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ------~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~-~vkL~DFGla~~~~~~~~~~~ 514 (676)
.. ....+++..++.++.|||+|+.|||+++. ||||||||+|||++.++ ++||+|||+++...... ..
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~ 200 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS 200 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence 11 35789999999999999999999999873 99999999999999997 99999999998754322 22
Q ss_pred cceeeccCCccChhhhc--cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 515 TNRIVGTHGYMSPEYVM--NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~--~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.....||+.|||||++. ...|+.|+||||||+++|||+||+.||...... ..+......+. .+
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------~~~~~v~~~~~-----Rp---- 265 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------QVASAVVVGGL-----RP---- 265 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcCC-----CC----
Confidence 23368999999999999 569999999999999999999999999865431 11222221221 12
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCC
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALP 635 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~ 635 (676)
..+......+..++.+||+.||+.||++.+++..|+.......
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 2222345568888889999999999999999999997754333
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=310.05 Aligned_cols=231 Identities=25% Similarity=0.386 Sum_probs=186.5
Q ss_pred cCCCcceeeccCCCccEEEEE-EcCCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~-~~~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
.+|+++++||+|.||.||++. +.+|..||.|.+.-. .....+.+..|+.+|++|+|||||+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468889999999999999997 568999999998632 4455677899999999999999982
Q ss_pred ----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcC-CCceEeeccccCceEEcCCCCeEEeccCcceec
Q 005803 444 ----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYS-RLRAIHRDLKVSNILLDEQMNPKISDFGMARTY 506 (676)
Q Consensus 444 ----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~ 506 (676)
...+..+++..+++++.|++.||.++|++- +..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 245677899999999999999999999842 123999999999999999999999999999988
Q ss_pred cccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 507 AMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 507 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
...... ..+.+|||.||+||.+.+.+|+.|+||||+||++|||..-++||... ++.. ..+.+.+++...+.
T Consensus 179 ~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~-L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 179 SSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLS-LCKKIEQGDYPPLP 249 (375)
T ss_pred cchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHH-HHHHHHcCCCCCCc
Confidence 755432 34589999999999999999999999999999999999999999754 1211 23334444332221
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.......+..|+..|+..||+.||+...+++.+...
T Consensus 250 --------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 250 --------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred --------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 134556688888899999999999976666666553
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=313.41 Aligned_cols=238 Identities=21% Similarity=0.313 Sum_probs=185.7
Q ss_pred cCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCc-h-hhHHHHHHHHHHHHccCCcccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSG-Q-GIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~-~-~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
+.|+.+.++|+|+||.||+++.++ |+.||||++..+.+ . -.+-.++|+++|++++|+|+|.
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 467888999999999999999765 99999999976533 2 2345689999999999999982
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......++.+...+++.|++.|+.|+|+++ +|||||||+||||+.++.+||||||+|+.+... ..
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd 156 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GD 156 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC--cc
Confidence 123345777888999999999999999998 999999999999999999999999999987642 23
Q ss_pred ccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHH--------HHHHhcCCcc-
Q 005803 514 NTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYA--------WQLWNEGKAL- 583 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~--------~~~~~~~~~~- 583 (676)
..+.++.|+.|+|||.+.+ ..|+..+||||+||++.||++|.+.|++..+.++..++... ...+....+.
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 4455789999999999987 68999999999999999999999999988776655444332 2222222211
Q ss_pred ccCCcccC-----CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 584 ELMDPTLD-----ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 584 ~~~d~~l~-----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.+.-|... ..--+....-+++++..||+.||++|++-+|++.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111 1111233446789999999999999999999874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=323.19 Aligned_cols=228 Identities=22% Similarity=0.301 Sum_probs=178.3
Q ss_pred HhcCCCcceeeccCCCccEEEEE-EcCCcEEEEEEeccCCch-------hhHHHHHHHHHHHHccCCcccc---------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQ-------GIVEFKNEAKLIAKLQHTNLTD--------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~-~~~~~~VAvK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~--------- 443 (676)
..+.|.+.+.||+|+||.|-+|. ..+|+.||||++++.... ......+|+++|++|+|||||+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 44678889999999999999997 457999999999764221 2233579999999999999983
Q ss_pred -----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC---CCeEEeccCcc
Q 005803 444 -----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ---MNPKISDFGMA 503 (676)
Q Consensus 444 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~---~~vkL~DFGla 503 (676)
....+.+.+.....++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchh
Confidence 123345667777889999999999999999 9999999999999755 77999999999
Q ss_pred eeccccccccccceeeccCCccChhhhccCC---CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcC
Q 005803 504 RTYAMNELEANTNRIVGTHGYMSPEYVMNGI---VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG 580 (676)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 580 (676)
+..+. .....+.+||+.|.|||++.+.. +..++|+||+||+||-+|+|.+||........ + .+.+..|
T Consensus 327 K~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l----~eQI~~G 397 (475)
T KOG0615|consen 327 KVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--L----KEQILKG 397 (475)
T ss_pred hcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--H----HHHHhcC
Confidence 98653 23345689999999999998654 34588999999999999999999986544331 1 2233344
Q ss_pred CccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 581 KALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 581 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+.... .....+..++.++++.++|..||++|||+.|+++.
T Consensus 398 ~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 398 RYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 43321 11223455678899999999999999999998864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.32 Aligned_cols=224 Identities=24% Similarity=0.326 Sum_probs=176.4
Q ss_pred CcceeeccCCCccEEEEEEc-CCcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCccccc-------------------
Q 005803 386 SPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTDS------------------- 444 (676)
Q Consensus 386 ~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~~------------------- 444 (676)
+..+.||+|..|+||+++++ +++.+|+|.+... .....+++.+|++++++.+||+||+.
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34689999999999999976 5788899999544 44556789999999999999999831
Q ss_pred --------cccCcCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 445 --------SRKSLLDWKKRFYIIEGIVQGLLYLHK-YSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 445 --------~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
...+.+++...-+|+.++++||.|||+ .+ ||||||||+|||++..|++||||||.++.+... ..
T Consensus 162 gGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a 234 (364)
T KOG0581|consen 162 GGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IA 234 (364)
T ss_pred CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh----hc
Confidence 111347777788999999999999996 55 999999999999999999999999999876544 34
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCS 595 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 595 (676)
.+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+..... .......... .+..+ ..|.+...
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~-~Iv~~-----ppP~lP~~-- 305 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLC-AIVDE-----PPPRLPEG-- 305 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHH-HHhcC-----CCCCCCcc--
Confidence 568999999999999999999999999999999999999999986511 1111111111 11111 11223222
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 596 SDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 596 ~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
....++..++..||+.||.+||++.|+++.
T Consensus 306 -~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 -EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 244458888999999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=313.47 Aligned_cols=216 Identities=26% Similarity=0.369 Sum_probs=171.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
.++|++.+.||+|+||+||+++.. +++.+|+|++++.. ....+....|..+|.+++||.||+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 468999999999999999999865 48899999998652 234567889999999999999983
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+.-.+.+|+.||.|||+++ ||||||||+|||||++|+++|+|||+++.....
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-- 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-- 178 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC--
Confidence 334566777777777778999999999999 999999999999999999999999999864332
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
...+.+.+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+... ..+....++..
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-------~~~~I~~~k~~-------- 243 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-------MYDKILKGKLP-------- 243 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-------HHHHHhcCcCC--------
Confidence 223445899999999999999999999999999999999999999998654322 12222222211
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCC
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRR 618 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP 618 (676)
..+.-...+..+++.+.|+.||++|.
T Consensus 244 -~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 -LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 01111223466788899999999995
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.71 Aligned_cols=239 Identities=26% Similarity=0.341 Sum_probs=188.1
Q ss_pred HHhcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHH--HHHHHHHHHcc-CCcccc------------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEF--KNEAKLIAKLQ-HTNLTD------------ 443 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~--~~E~~~l~~l~-H~niv~------------ 443 (676)
...++|.++++||.|.||.||+|+. .++..||||++++.-.. .++. .+|++.|++|+ ||||++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 3457899999999999999999984 46899999999765333 3443 68999999999 999972
Q ss_pred ---------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 444 ---------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
..+..++++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+....
T Consensus 86 ~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 86 YFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 234778999999999999999999999999 99999999999999888999999999998664
Q ss_pred cccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHH-----HHhcC--
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQ-----LWNEG-- 580 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~-----~~~~~-- 580 (676)
.. ..+.++.|+.|+|||++.. +.|+.+.|+||+|||++|+.+-++.|++..+.++...+..+.. .|.++
T Consensus 163 kp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 163 KP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred CC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 33 3455789999999998874 6799999999999999999999999998776655444333211 11111
Q ss_pred -------CccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 581 -------KALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 581 -------~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
...+...-.+.. ..+....++++++.+|+..||++|||++|.+++
T Consensus 240 La~~mnf~~P~~~~~~l~~-L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKD-LLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHH-hCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 011111111111 122356678899999999999999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.06 Aligned_cols=177 Identities=28% Similarity=0.474 Sum_probs=153.9
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
..++|...++||+|+||+||+|++. ++.+||||.+.+. .....+.+..|+.+|+.++|||||.
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3468999999999999999999975 5899999999776 4455667889999999999999983
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC------CCeEEeccCccee
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ------MNPKISDFGMART 505 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~------~~vkL~DFGla~~ 505 (676)
......+++.....++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|+.
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 233457899999999999999999999999 9999999999999864 4589999999998
Q ss_pred ccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCC
Q 005803 506 YAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDT 563 (676)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~ 563 (676)
+.... ...+.+|++.|||||+++.+.|+.|+|+||+|+|||+|++|+.||.....
T Consensus 165 L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 165 LQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred CCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 87443 23457999999999999999999999999999999999999999985543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=323.21 Aligned_cols=235 Identities=28% Similarity=0.396 Sum_probs=189.0
Q ss_pred cCccccHHHHHHHhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-----
Q 005803 369 DLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----- 443 (676)
Q Consensus 369 ~~~~f~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~----- 443 (676)
+...++.+++.- ++.||+|.||.||.|+++....||+|.++.. ....+.|.+|+++|++|+|+|||+
T Consensus 199 d~wei~r~~l~l-------~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~ 270 (468)
T KOG0197|consen 199 DPWEIPREELKL-------IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVC 270 (468)
T ss_pred CCeeecHHHHHH-------HHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEE
Confidence 334455555543 6899999999999999988889999999764 445678999999999999999983
Q ss_pred -----------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEecc
Q 005803 444 -----------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDF 500 (676)
Q Consensus 444 -----------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DF 500 (676)
...+..+...+.+.++.|||+|++||++++ +|||||.++||||+++..+||+||
T Consensus 271 ~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDF 347 (468)
T KOG0197|consen 271 TKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDF 347 (468)
T ss_pred ecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccc
Confidence 234567778888999999999999999998 999999999999999999999999
Q ss_pred CcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhc
Q 005803 501 GMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNE 579 (676)
Q Consensus 501 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~ 579 (676)
|+|+....+....... ..-...|.|||.+..+.++.|||||||||+||||+| |+.|++.+...+ +.+.+.+
T Consensus 348 GLAr~~~d~~Y~~~~~-~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-------v~~~le~ 419 (468)
T KOG0197|consen 348 GLARLIGDDEYTASEG-GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-------VLELLER 419 (468)
T ss_pred ccccccCCCceeecCC-CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-------HHHHHhc
Confidence 9999554443322221 233567999999999999999999999999999999 888887665433 2223333
Q ss_pred CCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 580 GKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 580 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
|. +-..|..++..+.+|+..||+.+|++|||++.+...|+...
T Consensus 420 Gy---------Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 420 GY---------RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred cC---------cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 33 23345556667889999999999999999999999998764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=290.30 Aligned_cols=255 Identities=21% Similarity=0.263 Sum_probs=190.6
Q ss_pred cCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCch--hhHHHHHHHHHHHHccCCcccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQ--GIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
++|..+++||+|.||.||+|+. .+|+.||||+++..... -.....+|++.|+.++|+||++
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999985 46999999999754221 2345789999999999999873
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+.......++.++++||+|||++. |+||||||.|+|++.+|.+||+|||+|+.+.......
T Consensus 82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 223445677778899999999999999998 9999999999999999999999999999887654333
Q ss_pred ccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCc---ccc----
Q 005803 514 NTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKA---LEL---- 585 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~---~~~---- 585 (676)
.. .+-|+.|+|||.+.+ ..|+..+|+||.|||+.||+-|.+-|.+..+-++...+-.+.....+... .++
T Consensus 159 ~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 159 TH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred cc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 22 377999999999987 46999999999999999999999988876665554443332211111111 111
Q ss_pred ----CCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCCCCCCCccce
Q 005803 586 ----MDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQPAFFI 644 (676)
Q Consensus 586 ----~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~~p~~P~~~~ 644 (676)
.........-+.....+++++..++..||.+|++++|.+++= -. .+.|.|..|..+.
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf-~~~P~pt~~~~lp 297 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YF-KSLPLPTPPSKLP 297 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch-hh-hcCCCCCChhhCc
Confidence 111111113334455678999999999999999999998762 11 2456665555443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.35 Aligned_cols=239 Identities=24% Similarity=0.342 Sum_probs=183.2
Q ss_pred cCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
+.|+.+++||+|.||.||+|+. .+|+.||+|++.... .....-..+|+.||++|+||||++
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4566688999999999999984 569999999987653 334455789999999999999973
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
....-.+++.++..++.||+.||+|||+++ |+|||||.+|||||.+|.+||+|||+|+++.....
T Consensus 197 FeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 197 FEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 122346888999999999999999999999 99999999999999999999999999998776554
Q ss_pred ccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHH-----HHHhcCCcc--
Q 005803 512 EANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAW-----QLWNEGKAL-- 583 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~-----~~~~~~~~~-- 583 (676)
.. .+..+-|..|+|||.+.+. .|+.++|+||.||||.||+.|++.|....+.++...+.... ..|...++.
T Consensus 274 ~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 274 AP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred cc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 43 3346779999999999975 69999999999999999999999999877665554443221 111111111
Q ss_pred ccCCcc------cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 584 ELMDPT------LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 584 ~~~d~~------l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
..+.+. +.+. ........++|+..+|..||++|.|+.++++.
T Consensus 353 ~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111111 1110 11122356788889999999999999998854
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.91 Aligned_cols=242 Identities=26% Similarity=0.398 Sum_probs=185.0
Q ss_pred HHHHHHhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc----------
Q 005803 376 QTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD---------- 443 (676)
Q Consensus 376 ~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~---------- 443 (676)
++.....+...+.+.||+|.||+||+|++. -.||||+++.. ..+..+.|++|+..+++-+|.||+-
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 333344456677899999999999999873 47999999765 3456788999999999999999871
Q ss_pred ----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 444 ----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 444 ----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
...+..++..+.+.|++||++|+.|||.++ |||||||..||++.+++.|||+|||++..-.
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeee
Confidence 122355777888999999999999999999 9999999999999999999999999997543
Q ss_pred ccccccccceeeccCCccChhhhcc---CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccc
Q 005803 508 MNELEANTNRIVGTHGYMSPEYVMN---GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584 (676)
Q Consensus 508 ~~~~~~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (676)
.-..........|...|||||++.. .+|++.+||||||+|+|||++|..||.....+..... .|+-.-
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm---------VGrG~l 610 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM---------VGRGYL 610 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE---------eccccc
Confidence 3222222334567889999999873 4799999999999999999999999984333322211 111111
Q ss_pred cCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCC
Q 005803 585 LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMAL 634 (676)
Q Consensus 585 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l 634 (676)
..|... ......+++.+|+..||..++++||.+.+|+..|+.+...+
T Consensus 611 ~pd~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 611 MPDLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred Cccchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 111111 12244556888889999999999999999999998876333
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=316.16 Aligned_cols=228 Identities=24% Similarity=0.349 Sum_probs=181.5
Q ss_pred HHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHc-cCCcccc----------
Q 005803 379 AAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLTD---------- 443 (676)
Q Consensus 379 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~---------- 443 (676)
+....+|.+.+.||+|+|++|++|+.. .++++|||++.+. .+...+.+..|-..|.+| .||.|++
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 345578999999999999999999854 6999999999764 233445577899999999 8999883
Q ss_pred ----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 444 ----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 444 ----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
......|++.....++.+|+.||+|||+.| ||||||||+|||||+++++||+|||.|+.+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 223456788888899999999999999999 9999999999999999999999999999876
Q ss_pred ccccc---------cc--cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHH
Q 005803 508 MNELE---------AN--TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQL 576 (676)
Q Consensus 508 ~~~~~---------~~--~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~ 576 (676)
..... .. ...++||..|.+||++.....+..+|+|+||||||+|+.|.+||....+.... +.
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF-------qk 298 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF-------QK 298 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH-------HH
Confidence 53222 11 14589999999999999999999999999999999999999999865432111 11
Q ss_pred HhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 577 WNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 577 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+.. ++-.+...++ +.+.+|+.+.|..||.+|++.+||.+.
T Consensus 299 I~~------l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 299 IQA------LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHH------hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 100 1222222333 457778889999999999999999876
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=314.31 Aligned_cols=232 Identities=26% Similarity=0.372 Sum_probs=176.9
Q ss_pred hcCCCcceeeccCCCccEEEEEE------cCCcEEEEEEeccCC-chhhHHHHHHHHHHHHc-cCCccccccc-------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL------LDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLTDSSR------- 446 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~------~~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~------- 446 (676)
.++|++.++||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.++ +||||+....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46799999999999999999974 235679999987543 23346789999999999 8999873100
Q ss_pred --------------------------------------------------------------------------------
Q 005803 447 -------------------------------------------------------------------------------- 446 (676)
Q Consensus 447 -------------------------------------------------------------------------------- 446 (676)
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence
Q ss_pred --cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCc
Q 005803 447 --KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGY 524 (676)
Q Consensus 447 --~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y 524 (676)
...+++.+...++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 123566777889999999999999998 999999999999999999999999999865332222222234556789
Q ss_pred cChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHH
Q 005803 525 MSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCI 603 (676)
Q Consensus 525 ~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 603 (676)
+|||++.+..++.++|||||||++|||++ |..||........ .......+... .. +......+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~-----~~----~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTRM-----RA----PENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCCC-----CC----CCCCCHHHH
Confidence 99999999999999999999999999997 9999975432211 11122222211 11 112234578
Q ss_pred HHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 604 HVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 604 ~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+++.+||+.||++|||+.||++.|+.+.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 8999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=298.63 Aligned_cols=235 Identities=23% Similarity=0.353 Sum_probs=181.1
Q ss_pred hcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
.++|++.+.||.|.-+.||+|+. +.+..||||++.-+.. ...+.+.+|+..|+.++||||+.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 46899999999999999999984 5689999999975533 33688999999999999999972
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
..-...+++..+..|++++++||.|||.+| .||||||+.||||+.+|.+||+|||.+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 122344888888999999999999999999 99999999999999999999999998876544332
Q ss_pred cc--ccceeeccCCccChhhhcc--CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 512 EA--NTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 512 ~~--~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
.. .....+||+.|||||+++. ..|+.|+||||||++..||.+|..||....+.... -+-.++....+.-
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-------l~tLqn~pp~~~t 254 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-------LLTLQNDPPTLLT 254 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-------HHHhcCCCCCccc
Confidence 11 1145789999999999654 46999999999999999999999999876543311 1111222221111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
..+..+........+.+++..||+.||.+|||++++++.
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 122222222333467788889999999999999998864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=302.34 Aligned_cols=230 Identities=24% Similarity=0.363 Sum_probs=177.6
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSSR-------------- 446 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~-------------- 446 (676)
..+|...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+...
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3457778999999999999998654 8999999987654444677899999999999999983111
Q ss_pred ---------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC-CCCeEEeccCcceeccc-c
Q 005803 447 ---------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE-QMNPKISDFGMARTYAM-N 509 (676)
Q Consensus 447 ---------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~-~~~vkL~DFGla~~~~~-~ 509 (676)
+..+++..+..+..||++||+|||+++ ||||||||+|||++. ++.+||+|||+++.... .
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 115889999999999999999999998 999999999999999 79999999999987653 1
Q ss_pred ccccccceeeccCCccChhhhccCC-CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
..........||+.|||||++.++. ...++|||||||++.||+||++||... . ............. .-|
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~---~~~~~~~~ig~~~-----~~P 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--F---EEAEALLLIGRED-----SLP 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--c---chHHHHHHHhccC-----CCC
Confidence 1122233478999999999999643 345999999999999999999999864 1 1111111111111 111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
. ++........+++..|++.||++|||+.++++..-
T Consensus 243 ~----ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 243 E----IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred C----CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 2 23334445778888999999999999999998753
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.83 Aligned_cols=225 Identities=26% Similarity=0.387 Sum_probs=184.0
Q ss_pred cCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
..|...++||+|+.|.||.++. .+++.||||++........+-+.+|+.+|+..+|+|||.
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4677778999999999999974 468999999998876666677899999999999999982
Q ss_pred -------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccc
Q 005803 444 -------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516 (676)
Q Consensus 444 -------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 516 (676)
......+++.++..|+++++.||+|||.++ |+|||||.+|||++.+|.+||+|||++..+..... ...
T Consensus 353 ~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~ 427 (550)
T KOG0578|consen 353 EGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRS 427 (550)
T ss_pred CCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccc
Confidence 233445788899999999999999999999 99999999999999999999999999988766554 334
Q ss_pred eeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCCh
Q 005803 517 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSS 596 (676)
Q Consensus 517 ~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 596 (676)
+.+||+.|||||+.....|++|+||||||++++||+-|++||-...+-....++ ..+|. +.+ ..+.
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI------a~ng~------P~l--k~~~ 493 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGT------PKL--KNPE 493 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH------hhcCC------CCc--CCcc
Confidence 489999999999999999999999999999999999999999753322221111 11221 111 1233
Q ss_pred HHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 597 DEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 597 ~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.....+.+++.+||+.|+++||++.|+|+.
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 344567888899999999999999999975
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=308.86 Aligned_cols=238 Identities=26% Similarity=0.395 Sum_probs=188.0
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+.. +...+.+.+|++|++.++||||+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57889999999999999999865 58899999997643 334566899999999999999983
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......++++....|+.+++.||.|||+.+ |+|||+||.|||++..+.+|+||||+|+.+.... ..
T Consensus 82 ~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--~v 156 (808)
T KOG0597|consen 82 YAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--SV 156 (808)
T ss_pred hhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc--ee
Confidence 234567899999999999999999999998 9999999999999999999999999999766432 33
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
...+.||+.|||||...+++|+..+|.||+|||+|||++|++||-... +...+.... . |+. .+
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~-~-------d~v---~~ 219 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSIL-K-------DPV---KP 219 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHh-c-------CCC---CC
Confidence 455789999999999999999999999999999999999999996321 111111111 1 111 12
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcCcCCCCCCCCCcc
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTNDTMALPKPKQPAF 642 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~~~~l~~p~~P~~ 642 (676)
+......+..++...|+.||.+|.+..+++.. .++.......|..|.+
T Consensus 220 p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~ 269 (808)
T KOG0597|consen 220 PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAF 269 (808)
T ss_pred cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccc
Confidence 33555678889999999999999999998864 3443333344444433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=325.28 Aligned_cols=228 Identities=28% Similarity=0.431 Sum_probs=188.5
Q ss_pred CCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCCch-hhHHHHHHHHHHHHccCCcccc--------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
-...++||+|.||+||+|+.. +.+.||||.++..... ...+|++|++++..++|||||+
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 344789999999999999843 2467999999877655 7789999999999999999982
Q ss_pred ----------------------ccc----cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEE
Q 005803 444 ----------------------SSR----KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKI 497 (676)
Q Consensus 444 ----------------------~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL 497 (676)
... ...|+..+.+.||.|||.|++||-++. +|||||..+|+||.++..|||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEe
Confidence 112 334888999999999999999999988 999999999999999999999
Q ss_pred eccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHH
Q 005803 498 SDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQL 576 (676)
Q Consensus 498 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~ 576 (676)
+|||+++..-..+.......-.-..+|||||.++.++|+.+||||||||+|||+++ |+.|+.....++ +.+.
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VIe~ 717 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VIEC 717 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HHHH
Confidence 99999986554444333322334678999999999999999999999999999998 999998776554 3344
Q ss_pred HhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 577 WNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 577 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+.+|++. +++..++.++.+|+..||+.+|++||+++||-..|+...
T Consensus 718 i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 718 IRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred HHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 4455553 345566677999999999999999999999999998875
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=278.17 Aligned_cols=234 Identities=22% Similarity=0.262 Sum_probs=187.0
Q ss_pred HhcCCCcceeeccCCCccEEEEE-EcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~-~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
..++|.+.++||+|||+.||+++ ..+++.+|+|++.....++.+..++|++..++++|||+++
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34689999999999999999998 4568899999998877788889999999999999999861
Q ss_pred -------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcce
Q 005803 444 -------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR 504 (676)
Q Consensus 444 -------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~ 504 (676)
...+..+++.+.+.|+.+|++||++||+.. .+++||||||.|||+.+++.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 234557889999999999999999999986 469999999999999999999999999987
Q ss_pred ecccccc-------ccccceeeccCCccChhhhc---cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHH
Q 005803 505 TYAMNEL-------EANTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAW 574 (676)
Q Consensus 505 ~~~~~~~-------~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~ 574 (676)
...-.-. .........|..|+|||.+. +...++++|||||||+||+|+.|..||+....
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------- 246 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------- 246 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence 5432110 01112246789999999885 45689999999999999999999999974322
Q ss_pred HHHhcCCc--cccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 575 QLWNEGKA--LELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 575 ~~~~~~~~--~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.|.- ..+..+.+.-.......+.+.+++.+|++.||.+||++.+++..++.+
T Consensus 247 ----~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 ----QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111 122222332222333667789999999999999999999999998765
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=294.26 Aligned_cols=233 Identities=21% Similarity=0.280 Sum_probs=172.6
Q ss_pred CCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc------------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------------ 444 (676)
.|...+++|.|+||.||+|++.. ++.||||+.-.... .-.+|+.+|+++.|||||+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 45567999999999999998654 78999999854332 22579999999999999831
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC-CCeEEeccCcceecc
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ-MNPKISDFGMARTYA 507 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~-~~vkL~DFGla~~~~ 507 (676)
..+..++...+.-+..||.+||+|||+.+ |+||||||+|+|+|.+ |.+||||||.|+.+.
T Consensus 101 leymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 101 LEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 01223333444557889999999999988 9999999999999965 899999999999876
Q ss_pred ccccccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHH-----HHhc--
Q 005803 508 MNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQ-----LWNE-- 579 (676)
Q Consensus 508 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~-----~~~~-- 579 (676)
..+. ..++..|+.|+|||.+.+. .|+.+.||||.|||+.||+-|++.|.+.+..++...+..+.. .+..
T Consensus 178 ~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 178 KGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred cCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 5443 2447889999999999875 699999999999999999999999998655544333322211 1111
Q ss_pred CCccccCCcccCCC-----CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 580 GKALELMDPTLDES-----CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 580 ~~~~~~~d~~l~~~-----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
....+.-.+.+... .......+.++++.++|+.+|.+|.++.|++..
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11112222222211 222344567889999999999999999998854
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=297.17 Aligned_cols=223 Identities=25% Similarity=0.385 Sum_probs=182.9
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
..|+..++||+|.||.||+|... .++.||+|++... .....+.+++|+.+|.+++++||.+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35667789999999999999854 5889999999754 4456678999999999999999851
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
...+..+++.+..-|+++++.||.|||.++ .+|||||+.|||+..+|.+||+|||++..+.......
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 223344577777889999999999999998 9999999999999999999999999998776544333
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
.+.+||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+.....++ .+-..|.+.+.
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI------------pk~~PP~L~~~- 234 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI------------PKSAPPRLDGD- 234 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec------------cCCCCCccccc-
Confidence 5589999999999999889999999999999999999999999987765544332 12223344443
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
....+.+++..||..||+.||++.++++.
T Consensus 235 ---~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 235 ---FSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ---cCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 33457888889999999999999999865
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=286.25 Aligned_cols=256 Identities=23% Similarity=0.267 Sum_probs=188.3
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCch--hhHHHHHHHHHHHHccCCcccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQ--GIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
..+.|+.+++|++|.||.||+|+.+ +++.||+|+++...+. -.-.-.+|+.+|.+++|||||.
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3456888899999999999999865 5889999999764321 1223589999999999999982
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
..-...+...+..-+..|+++||+|||... |+||||||+|+|+.+.|.+||+|||+|+.++..
T Consensus 154 ~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 154 IVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 122356778888899999999999999998 999999999999999999999999999987654
Q ss_pred ccccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc-----
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL----- 583 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~----- 583 (676)
. ...+..+-|..|+|||.+.+. .|++++|+||+|||+.||+++++.|....+.++...+........+....
T Consensus 231 ~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 231 L--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred c--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 2 223446779999999999875 69999999999999999999999998876655444332211100110000
Q ss_pred ---------ccCCcccCCCCChH-HHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCCCCCCCccc
Q 005803 584 ---------ELMDPTLDESCSSD-EVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQPAFF 643 (676)
Q Consensus 584 ---------~~~d~~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~~p~~P~~~ 643 (676)
+..-..+...+... ..+.-.+|+...|..||.+|.|++|-++. +-..+.|.|..|.++
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~~ 376 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSMF 376 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhhc
Confidence 00001111111111 22455678888999999999999988764 233466666666554
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=296.99 Aligned_cols=235 Identities=23% Similarity=0.362 Sum_probs=173.8
Q ss_pred cCCCcceeeccCCCccEEEEEEcC-----------------CcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD-----------------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~-----------------~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~ 444 (676)
++|++.++||+|+||.||++.+.+ +..||+|.+.... .....++.+|+.++.+++||||++.
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999997532 3469999987543 3345678999999999999998720
Q ss_pred ----------------c-----------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEe
Q 005803 445 ----------------S-----------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIH 479 (676)
Q Consensus 445 ----------------~-----------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH 479 (676)
. ....+++...+.++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 0 0023566778899999999999999998 999
Q ss_pred eccccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh--CCcC
Q 005803 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS--SKKN 557 (676)
Q Consensus 480 ~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt--G~~p 557 (676)
|||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543322222233455788999999998899999999999999999997 4566
Q ss_pred CCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 558 NGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 558 f~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
|....... ............... . ....++.....+.+++.+||+.||++|||+.+|.+.|++
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRDQGRQ-V-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhhcccc-c-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 66433221 121111111111100 0 001112234568889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=289.86 Aligned_cols=255 Identities=24% Similarity=0.300 Sum_probs=189.5
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEecc--CCchhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSK--SSGQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
.....|..++.||+|+||.|..+... +|+.||||++.. ......++..+|+++|++++|+||+.
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34556777899999999999999864 689999999973 34556778899999999999999872
Q ss_pred -----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceec
Q 005803 444 -----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTY 506 (676)
Q Consensus 444 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~ 506 (676)
...+..|+......++.||++||.|+|+.+ ++||||||+|+|++.+..+||+|||+|+..
T Consensus 99 ~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 99 NDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred ceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeec
Confidence 123344888888999999999999999998 999999999999999999999999999987
Q ss_pred cccccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHH--------HHH
Q 005803 507 AMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAW--------QLW 577 (676)
Q Consensus 507 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~--------~~~ 577 (676)
.........+.++-|+.|+|||++.. ..|+.+.||||.|||+.||++|++.|.+.+.-++..++.... ..+
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 54422333455788999999998875 579999999999999999999999999876555444332211 111
Q ss_pred hcCCccccC---CcccCCC---CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcCcCCCCCC
Q 005803 578 NEGKALELM---DPTLDES---CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTNDTMALPKP 637 (676)
Q Consensus 578 ~~~~~~~~~---d~~l~~~---~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~~~~l~~p 637 (676)
........+ ....... .-+......++|+.+||..||.+|+|++|.++. |+.....-..|
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 100111000 0000000 011223357889999999999999999999875 55544333333
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=297.12 Aligned_cols=232 Identities=23% Similarity=0.316 Sum_probs=181.8
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--------------hhhHHHHHHHHHHHHccCCcccc-
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--------------QGIVEFKNEAKLIAKLQHTNLTD- 443 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~- 443 (676)
...++|++++.||+|.||.|-+|+.. +++.||||++.+... ...+...+|+.+|++++|||||+
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 35578999999999999999999854 689999999975411 12357899999999999999983
Q ss_pred --------------------------ccccCc-CCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeE
Q 005803 444 --------------------------SSRKSL-LDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPK 496 (676)
Q Consensus 444 --------------------------~~~~~~-l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vk 496 (676)
....+. +.+.++.++++++..||+|||.++ ||||||||+|+||+++|++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEE
Confidence 112233 888999999999999999999999 99999999999999999999
Q ss_pred EeccCcceecccc---ccccccceeeccCCccChhhhccCC----CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccch
Q 005803 497 ISDFGMARTYAMN---ELEANTNRIVGTHGYMSPEYVMNGI----VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNL 569 (676)
Q Consensus 497 L~DFGla~~~~~~---~~~~~~~~~~gt~~Y~APE~~~~~~----~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l 569 (676)
|+|||.+...... .........+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-.....+
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~---- 326 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE---- 326 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH----
Confidence 9999999866321 1222333478999999999988733 3578899999999999999999996432111
Q ss_pred HHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 570 VGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 570 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
... .++...+.....++..+.+.+|+.++|+.||.+|.+..+|....--
T Consensus 327 ---l~~--------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 327 ---LFD--------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred ---HHH--------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 111 2223333333344567788899999999999999999999877533
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.24 Aligned_cols=234 Identities=21% Similarity=0.308 Sum_probs=169.9
Q ss_pred cCCCcceeeccCCCccEEEEEEc--CCcEEEEEEeccCC--chhhHHHHHHHHHHHHc---cCCcccccc----------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL--DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKL---QHTNLTDSS---------- 445 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~~~---------- 445 (676)
++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.+++++ .||||++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47899999999999999999863 46889999986432 22234566787777766 699987311
Q ss_pred ----------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcc
Q 005803 446 ----------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMA 503 (676)
Q Consensus 446 ----------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla 503 (676)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 1123677888999999999999999998 999999999999999999999999999
Q ss_pred eeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHh---cC
Q 005803 504 RTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWN---EG 580 (676)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~---~~ 580 (676)
...... .......|++.|+|||.+.+..++.++|||||||++|||++|++||......+.... ...... ..
T Consensus 158 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~---i~~~~~~~~~~ 231 (290)
T cd07862 158 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---ILDVIGLPGEE 231 (290)
T ss_pred EeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHHhCCCChh
Confidence 865432 122335789999999999988999999999999999999999999986543221111 110000 00
Q ss_pred Cc-------cccCCcccCC---CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 581 KA-------LELMDPTLDE---SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 581 ~~-------~~~~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.. ...+.+.... ...+.....+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 0000000000 001122345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=291.48 Aligned_cols=228 Identities=29% Similarity=0.458 Sum_probs=176.9
Q ss_pred cCCCcceeeccCCCccEEEEEEcC------CcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccccc----------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDSS---------- 445 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~------~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~---------- 445 (676)
++|++.+.||+|+||.||+|.... .+.||+|.+.... .....++.+|+.++.+++||||+...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998543 2579999986543 23456789999999999999987200
Q ss_pred --------------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC
Q 005803 446 --------------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM 493 (676)
Q Consensus 446 --------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~ 493 (676)
....+++.+.+.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 0034677788899999999999999998 99999999999999999
Q ss_pred CeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHH
Q 005803 494 NPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGY 572 (676)
Q Consensus 494 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~ 572 (676)
.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999986543322222233456788999999998899999999999999999998 999987543221
Q ss_pred HHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 573 AWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 573 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
....+..+... ..+......+.+|+.+||+.||++||++.||++.|++
T Consensus 235 ~~~~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11222222211 1122344568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=300.69 Aligned_cols=223 Identities=23% Similarity=0.326 Sum_probs=177.2
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC----Cc-hhhHHHHHHHHHHHHcc-CCcccc---------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS----SG-QGIVEFKNEAKLIAKLQ-HTNLTD--------- 443 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~--------- 443 (676)
...++|.+.+.||+|+||+|+.|+.. +++.||||++.+. .. ...+.+.+|+.+++++. ||||++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45678999999999999999999754 6899999987653 11 23456678999999999 999973
Q ss_pred -----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC-CCeEEeccCccee
Q 005803 444 -----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ-MNPKISDFGMART 505 (676)
Q Consensus 444 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~-~~vkL~DFGla~~ 505 (676)
......+.+.+...+++|++.|++|||+++ |+||||||+|||++.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 112467888899999999999999999998 9999999999999999 9999999999997
Q ss_pred ccccccccccceeeccCCccChhhhccCC-CC-chhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 506 YAMNELEANTNRIVGTHGYMSPEYVMNGI-VS-MKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s-~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
.. .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...... . ....+..+.+.
T Consensus 171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---~----l~~ki~~~~~~ 241 (370)
T KOG0583|consen 171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---N----LYRKIRKGEFK 241 (370)
T ss_pred cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---H----HHHHHhcCCcc
Confidence 63 1223344579999999999999877 85 7899999999999999999999862211 1 11112222211
Q ss_pred ccCCcccCCCCChHH-HHHHHHHHHHhcccCcCCCCCHHHHH
Q 005803 584 ELMDPTLDESCSSDE-VMRCIHVGLLCVQDRAADRRTMSDVV 624 (676)
Q Consensus 584 ~~~d~~l~~~~~~~~-~~~l~~L~~~Cl~~dP~~RPs~~eVl 624 (676)
++... ...+..++.+||..||.+|+++.+|+
T Consensus 242 ----------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 242 ----------IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ----------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11111 45678899999999999999999999
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=291.72 Aligned_cols=239 Identities=20% Similarity=0.249 Sum_probs=175.7
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++|+||+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999876 58889999986532 2345678899999999999998720
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-A 156 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc-c
Confidence 12245788888999999999999999998 99999999999999999999999999986543221 1
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHH--------HHHH-hcCCccc
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYA--------WQLW-NEGKALE 584 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~--------~~~~-~~~~~~~ 584 (676)
......|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+... ...+ .......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 222357899999999999888999999999999999999999999764322211100000 0000 0000000
Q ss_pred cCCcccCC------CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 585 LMDPTLDE------SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 585 ~~d~~l~~------~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
...+.... .........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 001112345889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=303.54 Aligned_cols=235 Identities=16% Similarity=0.147 Sum_probs=170.4
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
.++|++.++||+|+||.||++... +++.||+|... ...+.+|+.++++++||||++.
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999864 58899999753 2346889999999999999831
Q ss_pred ---------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 445 ---------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 445 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 165 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~ 240 (391)
T PHA03212 165 YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKY 240 (391)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-cccc
Confidence 12235778888999999999999999998 9999999999999999999999999997533211 1122
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCcc----chHHHHHHHHhcC----------C
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPL----NLVGYAWQLWNEG----------K 581 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~----~l~~~~~~~~~~~----------~ 581 (676)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ............. .
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 2357999999999999999999999999999999999999886543211100 0000000000000 0
Q ss_pred ccc---------cCCcccCCC--CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 582 ALE---------LMDPTLDES--CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 582 ~~~---------~~d~~l~~~--~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
..+ ...+..... ........+.+++.+||+.||++|||++|+++.
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 000000000 001233467889999999999999999999853
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=298.34 Aligned_cols=230 Identities=23% Similarity=0.381 Sum_probs=175.1
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCc----EEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQ----EIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~----~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
.+|++.+.||+|+||.||+|++. +++ .||||+++... ....+++.+|+.+++.++||||++.
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 46889999999999999999854 333 48999986543 3445678999999999999999731
Q ss_pred --------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 445 --------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.....+++...+.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCC
Confidence 11234677788899999999999999998 9999999999999999999999999998765332
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
.........++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ .......+... .
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~-----~ 231 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERL-----P 231 (316)
T ss_pred cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhCCCCC-----C
Confidence 2211122234668999999999999999999999999999998 999986432111 11111111110 0
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.+......+.+++.+||+.+|++||++.+++..|....
T Consensus 232 ----~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 232 ----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01112235778999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=305.52 Aligned_cols=231 Identities=24% Similarity=0.345 Sum_probs=174.8
Q ss_pred hcCCCcceeeccCCCccEEEEEE------cCCcEEEEEEeccCC-chhhHHHHHHHHHHHHc-cCCccccccc-------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL------LDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLTDSSR------- 446 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~------~~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~------- 446 (676)
.++|++.+.||+|+||.||+|+. .++..||||+++... ....+.+.+|+.++..+ +||||++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688899999999999999963 235689999986542 33456788999999999 8999973110
Q ss_pred --------------------------------------------------------------------------------
Q 005803 447 -------------------------------------------------------------------------------- 446 (676)
Q Consensus 447 -------------------------------------------------------------------------------- 446 (676)
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence
Q ss_pred --------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 447 --------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 447 --------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 114677888999999999999999998 999999999999999999999999999865433221
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...+....+.... .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~-----~- 338 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGYRML-----S- 338 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCccCC-----C-
Confidence 11222344667999999999999999999999999999998 888886543221 1122222221110 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
+......+.+++.+||+.||++||++.||+++|++.
T Consensus 339 ---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 339 ---PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111224578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=306.15 Aligned_cols=230 Identities=24% Similarity=0.368 Sum_probs=173.7
Q ss_pred cCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCC-chhhHHHHHHHHHHHHc-cCCccccccc--------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLTDSSR-------- 446 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~-------- 446 (676)
++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.+++.+ +|+||+....
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 47888999999999999998732 24579999997543 23345688999999999 8999873100
Q ss_pred --------------------------------------------------------------------------------
Q 005803 447 -------------------------------------------------------------------------------- 446 (676)
Q Consensus 447 -------------------------------------------------------------------------------- 446 (676)
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence
Q ss_pred --------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccccee
Q 005803 447 --------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRI 518 (676)
Q Consensus 447 --------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 518 (676)
...+++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 123667788899999999999999998 999999999999999999999999999765432211111223
Q ss_pred eccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChH
Q 005803 519 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597 (676)
Q Consensus 519 ~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 597 (676)
.++..|+|||++.+..++.++|||||||++|||++ |+.||........ .......+. .... +..
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~-----~~~~----~~~ 339 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGY-----QMSR----PDF 339 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHccc-----CccC----CCC
Confidence 35567999999998899999999999999999997 9999975432211 111111111 1111 111
Q ss_pred HHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 598 EVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 598 ~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
....+.+++.+||+.||++||++.+|+++|+++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 234578889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=293.85 Aligned_cols=238 Identities=19% Similarity=0.309 Sum_probs=172.3
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
++|++.++||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++++++||||++.
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999865 58899999986543 2234567899999999999998731
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 85 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~ 159 (288)
T cd07871 85 LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--T 159 (288)
T ss_pred CCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--c
Confidence 11234677888899999999999999998 99999999999999999999999999976432211 1
Q ss_pred cceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHH-----HHHhc----CCccc
Q 005803 515 TNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAW-----QLWNE----GKALE 584 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~-----~~~~~----~~~~~ 584 (676)
.....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.... ..+.. .....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 223567899999998875 568999999999999999999999997543322111110000 00000 00001
Q ss_pred cCCcccCCC----CChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 585 LMDPTLDES----CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 585 ~~d~~l~~~----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
...+..... ........+.+++.+||+.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 111110000 00112235778999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=314.04 Aligned_cols=230 Identities=22% Similarity=0.307 Sum_probs=185.7
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCC-cEEEEEEeccCCchhhHHHHHHHHHHHHcc-CCcccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDG-QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLTD---------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~-~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~---------------- 443 (676)
..++++.+.|.+|||+.||+|....+ ..||+|++-...+...+.+.+|+++|++|. |+|||.
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34567789999999999999997765 999999987777788889999999999997 999982
Q ss_pred -------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcce
Q 005803 444 -------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR 504 (676)
Q Consensus 444 -------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~ 504 (676)
......|++.++++|+.++++|+++||... ++|||||||-|||||..+++.||||||.|.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 011233888999999999999999999985 779999999999999999999999999997
Q ss_pred ecccccccc-------ccceeeccCCccChhhh---ccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHH
Q 005803 505 TYAMNELEA-------NTNRIVGTHGYMSPEYV---MNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAW 574 (676)
Q Consensus 505 ~~~~~~~~~-------~~~~~~gt~~Y~APE~~---~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~ 574 (676)
......... ..-...-|+.|+|||++ .+.++++|+|||+|||+||-|+....||+....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------- 263 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------- 263 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence 532221000 00112458999999987 467899999999999999999999999985422
Q ss_pred HHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 575 QLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 575 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
..++.....-...+.....+..||..||+.||++||++-||++.+-.+.
T Consensus 264 --------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 264 --------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred --------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 1223333333334578888999999999999999999999999987764
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.55 Aligned_cols=244 Identities=20% Similarity=0.268 Sum_probs=174.5
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
+|++.++||+|+||.||+|+.. +++.||||++... ......++.+|+.++++++||||+..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999865 5899999998643 22344568899999999999998731
Q ss_pred --------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 445 --------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 11234778888899999999999999998 9999999999999999999999999997543221
Q ss_pred c-ccccceeeccCCccChhhhcc--CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH--------HHHHHhc
Q 005803 511 L-EANTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY--------AWQLWNE 579 (676)
Q Consensus 511 ~-~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~--------~~~~~~~ 579 (676)
. ........|++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.. ....+..
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 1 111233578999999999876 6789999999999999999999999975432111100000 0000000
Q ss_pred CCccc---cCCcccCCC---CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcC
Q 005803 580 GKALE---LMDPTLDES---CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTND 630 (676)
Q Consensus 580 ~~~~~---~~d~~l~~~---~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~ 630 (676)
....+ .+.+..... ..+.....+.+++.+||+.||++|||++|+++. +++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 00000 000000000 001122356789999999999999999999965 5444
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=286.42 Aligned_cols=226 Identities=28% Similarity=0.419 Sum_probs=176.7
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
++|++.++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++++++|+||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 578899999999999999999888889999998653 334678899999999999999872
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~- 160 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA- 160 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec-
Confidence 011234677788899999999999999988 9999999999999999999999999998754322111
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 593 (676)
.....++..|+|||.+....++.++|||||||++|||++ |+.||....... .......+.. ....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~-----~~~~-- 226 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGYR-----MPRM-- 226 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCC-----CCCC--
Confidence 122345678999999988889999999999999999998 999986432211 1111111111 1111
Q ss_pred CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 594 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
......+.+++.+||+.+|++||+++++.+.|+.
T Consensus 227 --~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 --ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1223457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=290.42 Aligned_cols=237 Identities=21% Similarity=0.312 Sum_probs=171.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
.++|++.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999875 588999999875432 23346788999999999999872
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 158 (303)
T cd07869 84 YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--H 158 (303)
T ss_pred CCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC--c
Confidence 011244778888999999999999999998 9999999999999999999999999987543221 1
Q ss_pred ccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC---c-----cc
Q 005803 514 NTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK---A-----LE 584 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~---~-----~~ 584 (676)
......+++.|+|||++.+ ..++.++|||||||++|||++|+.||....... .............. . ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhhcc
Confidence 1223567899999999875 458899999999999999999999997543211 11111111100000 0 00
Q ss_pred cCCcc-cC--CCCCh-------HHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 585 LMDPT-LD--ESCSS-------DEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 585 ~~d~~-l~--~~~~~-------~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
..++. .. ..... .....+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00 00000 01235678999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=290.80 Aligned_cols=224 Identities=24% Similarity=0.336 Sum_probs=171.9
Q ss_pred CCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
.|+..+.||+|+||.||++.. .+++.||||.+.... ......+.+|+.++.+++|+|++.
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377789999999999999986 468999999986532 223346789999999999999872
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 011235778888999999999999999998 9999999999999999999999999998653221
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........... .........
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~~~---------- 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE---VDRRVKEDQ---------- 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH---HHHHhhccc----------
Confidence 12235789999999999999999999999999999999999999986443221111 111111100
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRT-----MSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~eVl~~ 626 (676)
...+......+.+|+.+||+.||.+||+ ++++++.
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1112223345778899999999999997 7888863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=277.18 Aligned_cols=210 Identities=26% Similarity=0.328 Sum_probs=170.8
Q ss_pred cCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|+.++.||.|+||.|.+++.+. |..+|+|++++.. ..+.+...+|..+|+.+.||.++.
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 468889999999999999999764 7889999997652 334566789999999999999873
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+.-++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS----- 195 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec-----
Confidence 223346788888889999999999999998 9999999999999999999999999999754
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
..+.+.+||+.|+|||+++..+|+.++|.|||||++|||+.|.+||....+.. .++.+.++++.
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~KI~~~~v~--------- 259 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYEKILEGKVK--------- 259 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHHHHHhCccc---------
Confidence 33566899999999999999999999999999999999999999998655422 23333344332
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCC
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADR 617 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~R 617 (676)
++......+.+|+...|+.|-.+|
T Consensus 260 -fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 -FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -CCcccCHHHHHHHHHHHhhhhHhh
Confidence 222222346667778888888888
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=290.21 Aligned_cols=220 Identities=19% Similarity=0.278 Sum_probs=172.1
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEeccCCchh---hHHHHHHHHHHHHccCCccccc--------------------
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQHTNLTDS-------------------- 444 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~~-------------------- 444 (676)
...||+|++|.||+|+. +|+.||||+++...... .+.+.+|+.+|.+++||||++.
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46799999999999988 78999999997643322 4678899999999999998731
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKY-SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++..+..++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 1123467788899999999999999985 5 8899999999999999999999999987643221
Q ss_pred ccceeeccCCccChhhhcc--CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 514 NTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+ + ......+.. ...
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~----~~~i~~~~~----~~~-- 242 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---I----YDLIINKNN----SLK-- 242 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---H----HHHHHhcCC----CCC--
Confidence 22467889999999976 689999999999999999999999997543211 1 111111111 111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.+......+.+++.+||+.||++|||+.||++.|+...
T Consensus 243 --~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 243 --LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred --CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 12223446888999999999999999999999998754
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=284.23 Aligned_cols=228 Identities=26% Similarity=0.394 Sum_probs=177.4
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
.++|++.+.||+|++|.||+|...+++.||||.++.. ....+++.+|+.++++++|+|++.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 4568889999999999999999877889999998653 334567899999999999999872
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 111235788899999999999999999998 9999999999999999999999999998765322111
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
......+..|+|||.+.+..++.++||||||+++|||++ |+.||....... .......... .
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~---------~ 223 (261)
T cd05068 161 -REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGYR---------M 223 (261)
T ss_pred -cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC---------C
Confidence 111223457999999998899999999999999999999 999986432111 1111111110 0
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
..+......+.+++.+|++.+|++||++.++++.|+..
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 11222345688899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=299.74 Aligned_cols=231 Identities=26% Similarity=0.381 Sum_probs=177.0
Q ss_pred cCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCCc-hhhHHHHHHHHHHHHc-cCCccccccc--------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKL-QHTNLTDSSR-------- 446 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~~-------- 446 (676)
++|++.+.||+|+||.||+|... .++.||+|+++.... ...+.+..|+.++.++ +|+||+....
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 57999999999999999999632 247899999875432 3345678899999999 8999862100
Q ss_pred --------------------------------------------------------------------------------
Q 005803 447 -------------------------------------------------------------------------------- 446 (676)
Q Consensus 447 -------------------------------------------------------------------------------- 446 (676)
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence
Q ss_pred cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccC
Q 005803 447 KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMS 526 (676)
Q Consensus 447 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~A 526 (676)
...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 125678888999999999999999998 99999999999999999999999999986543322222233456778999
Q ss_pred hhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHH
Q 005803 527 PEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHV 605 (676)
Q Consensus 527 PE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L 605 (676)
||++.+..++.++|||||||++|||++ |..||......+. .......+.... .+......+.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRMR---------APEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCCC---------CCccCCHHHHHH
Confidence 999999999999999999999999998 9999875332211 111111221110 111233468889
Q ss_pred HHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 606 GLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 606 ~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+.+||+.+|++||++.||+++|+.+.
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=313.03 Aligned_cols=232 Identities=21% Similarity=0.259 Sum_probs=180.0
Q ss_pred HHHHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccc--------
Q 005803 376 QTIAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDS-------- 444 (676)
Q Consensus 376 ~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~-------- 444 (676)
.+.....++|.+.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++..++|+|++..
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 344556689999999999999999999854 6899999998653 23445678899999999999987621
Q ss_pred ------------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC
Q 005803 445 ------------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN 494 (676)
Q Consensus 445 ------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~ 494 (676)
.....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 01124566777889999999999999998 999999999999999999
Q ss_pred eEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHH
Q 005803 495 PKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAW 574 (676)
Q Consensus 495 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~ 574 (676)
+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ..
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~-~~ 254 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------E-VM 254 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------H-HH
Confidence 9999999998765432223334467999999999999999999999999999999999999999743211 1 11
Q ss_pred HHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 575 QLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 575 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.....+... . .+......+.+++.+||+.||.+||++.++++.
T Consensus 255 ~~~~~~~~~-----~----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 255 HKTLAGRYD-----P----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHhcCCCC-----C----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111122111 1 122233457889999999999999999999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=291.98 Aligned_cols=219 Identities=21% Similarity=0.263 Sum_probs=172.4
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47889999999999999999875 58999999986432 234566889999999999999872
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 112235678888899999999999999998 999999999999999999999999999765321
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....... .......+.. .+
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~------~~-- 217 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-------IYEKILAGKL------EF-- 217 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCc------CC--
Confidence 223578999999999999889999999999999999999999997543211 1111112211 11
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRT-----MSDVVSM 626 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~eVl~~ 626 (676)
+......+.+++.+||+.||.+||+ ++++++.
T Consensus 218 --~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 218 --PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1112335778999999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=289.13 Aligned_cols=227 Identities=29% Similarity=0.427 Sum_probs=173.5
Q ss_pred CCCcceeeccCCCccEEEEEEcC------CcEEEEEEeccCCch-hhHHHHHHHHHHHHccCCcccccc-----------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLLD------GQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLTDSS----------- 445 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~~------~~~VAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~----------- 445 (676)
+|.+.++||+|+||.||+|+..+ ++.||||+++..... ....+.+|+.++.+++||||++..
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46778899999999999998532 578999999754332 346688999999999999987210
Q ss_pred -------------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC
Q 005803 446 -------------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN 494 (676)
Q Consensus 446 -------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~ 494 (676)
....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 0123677778899999999999999998 999999999999999999
Q ss_pred eEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHH
Q 005803 495 PKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYA 573 (676)
Q Consensus 495 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~ 573 (676)
+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......+ .
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~ 235 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------V 235 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------H
Confidence 99999999886543322222223445778999999988889999999999999999998 888876432211 1
Q ss_pred HHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 574 WQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 574 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
......+... ..+......+.+++..||+.+|++||++.+|++.|+.
T Consensus 236 ~~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1222222211 1122334457889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=295.62 Aligned_cols=219 Identities=24% Similarity=0.296 Sum_probs=172.1
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
++|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++++++||||+..
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57889999999999999999875 58899999986532 2345678899999999999999731
Q ss_pred ------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 445 ------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 445 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
.....+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 12235677788889999999999999998 999999999999999999999999999865332
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .......++... +
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~~------~-- 234 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-------RIYEKILAGRLK------F-- 234 (329)
T ss_pred --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-------HHHHHHhcCCcC------C--
Confidence 22357899999999999999999999999999999999999999643211 111222222111 1
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRT-----MSDVVSM 626 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~eVl~~ 626 (676)
+......+.+++.+||+.||.+||+ ++++++.
T Consensus 235 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 235 --PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1112235678899999999999997 6777744
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=286.33 Aligned_cols=228 Identities=26% Similarity=0.408 Sum_probs=176.1
Q ss_pred cCCCcceeeccCCCccEEEEEEcC------CcEEEEEEeccCCch-hhHHHHHHHHHHHHccCCccccc-----------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD------GQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLTDS----------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~------~~~VAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~~----------- 444 (676)
++|.+.+.||+|+||.||+|+..+ ++.||||.++..... ..+.+.+|++++++++|+|++..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468889999999999999998633 478999999765443 45789999999999999998621
Q ss_pred -----------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCe
Q 005803 445 -----------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNP 495 (676)
Q Consensus 445 -----------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~v 495 (676)
.....+++.....++.||+.||.|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 01134677788899999999999999998 9999999999999999999
Q ss_pred EEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHH
Q 005803 496 KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAW 574 (676)
Q Consensus 496 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~ 574 (676)
||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||....... ..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------~~ 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------VI 234 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HH
Confidence 9999999976433222111222345778999999999999999999999999999998 999986543221 11
Q ss_pred HHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 575 QLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 575 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
.....+.... .+......+.+++.+||+.||++||++.||++.|++
T Consensus 235 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 ECITQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1122222111 111233457889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=283.27 Aligned_cols=227 Identities=25% Similarity=0.386 Sum_probs=175.8
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
.+|++.++||+|+||.||+|... .++.||+|.+... .....++.+|++++++++|+||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35778899999999999999865 4889999998653 345677899999999999999872
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 111234788888999999999999999988 9999999999999999999999999998654322111
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||......+ .......+. ...
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~-----~~~--- 225 (263)
T cd05052 162 -HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKGY-----RME--- 225 (263)
T ss_pred -cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCC-----CCC---
Confidence 111233567999999998899999999999999999998 899986432211 112221111 111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.+......+.+++.+||+.+|++||++.+++++|+.+
T Consensus 226 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 -RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1222334578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=296.24 Aligned_cols=226 Identities=25% Similarity=0.366 Sum_probs=168.9
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
++|+..++||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++|+||++.
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34566789999999999999865 589999999865432 345678999999999999998731
Q ss_pred ------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccccee
Q 005803 445 ------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRI 518 (676)
Q Consensus 445 ------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 518 (676)
.......+.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++..+.... ......
T Consensus 154 ~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~ 228 (353)
T PLN00034 154 MDGGSLEGTHIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCNSS 228 (353)
T ss_pred CCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc--cccccc
Confidence 11223456677889999999999999998 9999999999999999999999999998654321 112235
Q ss_pred eccCCccChhhhcc-----CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCC
Q 005803 519 VGTHGYMSPEYVMN-----GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593 (676)
Q Consensus 519 ~gt~~Y~APE~~~~-----~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 593 (676)
.||..|+|||.+.. ...+.++|||||||++|||++|+.||..........+. ... .... .+.
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~-~~~~-----~~~---- 295 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM---CAI-CMSQ-----PPE---- 295 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH---HHH-hccC-----CCC----
Confidence 78999999998743 23456899999999999999999999733222111110 000 0000 011
Q ss_pred CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 594 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
........+.+++.+||+.||++||++.||++.
T Consensus 296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112233457889999999999999999999976
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=282.52 Aligned_cols=227 Identities=29% Similarity=0.434 Sum_probs=178.0
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
.++|++.++||+|+||.||+|...+++.||+|.+.... .....+.+|+.++++++|+|++.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCC
Confidence 35788899999999999999998889999999987533 34567899999999999999862
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~- 159 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA- 159 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCccc-
Confidence 112335778888999999999999999988 9999999999999999999999999997654322111
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 593 (676)
.....++..|+|||.+....++.++||||||+++|||++ |+.||....... .......+... ..
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~-----~~--- 224 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-------VIQNLERGYRM-----PR--- 224 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHHcCCCC-----CC---
Confidence 112345678999999998889999999999999999999 999997543211 11111111111 11
Q ss_pred CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 594 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
+......+.+++.+||+.+|++||+++++++.|+.
T Consensus 225 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 -PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11223458889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=282.27 Aligned_cols=226 Identities=27% Similarity=0.452 Sum_probs=176.5
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+|++.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCC
Confidence 5788899999999999999998888899999987533 34567899999999999999862
Q ss_pred --------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 444 --------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 444 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
......+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++..+....... .
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~ 160 (260)
T cd05070 85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA-R 160 (260)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc-c
Confidence 011234788889999999999999999998 9999999999999999999999999998654322111 1
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
....++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ....+..+. .. ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~-----~~----~~ 224 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-------VLEQVERGY-----RM----PC 224 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC-----CC----CC
Confidence 11234567999999988889999999999999999999 888886432211 111111111 01 11
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
+......+.+++.+|++.+|++|||+.++.+.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 22334468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=284.32 Aligned_cols=228 Identities=21% Similarity=0.293 Sum_probs=174.6
Q ss_pred cCCCcceeeccCCCccEEEEEEc----CCcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL----DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~----~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
++|++.+.||+|+||.||+|.+. .+..||+|.++.... .....+.+|+.++.+++||||++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888999999999999999753 356899999876432 33457899999999999999872
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+|++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 011235788999999999999999999998 9999999999999999999999999876532221
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
.. ......++..|+|||.+.+..++.++|||||||++||+++ |+.||....... ..+...++.. ..
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~-----~~ 228 (266)
T cd05064 162 IY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDGFR-----LP 228 (266)
T ss_pred hh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCC-----CC
Confidence 11 1111234678999999999999999999999999999875 999997543211 1111122111 11
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.+......+.+++..||+.+|++||++.+|++.|++.
T Consensus 229 ----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 ----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1222344578899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=283.13 Aligned_cols=229 Identities=25% Similarity=0.411 Sum_probs=181.2
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
...+|++.++||.|+||.||+|...+++.+|+|.+.........++.+|+.+++.++|+|+++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 345788899999999999999998889999999998765556778999999999999999872
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 112345788889999999999999999998 999999999999999999999999999765432211
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+ .......+. .
T Consensus 161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~---------~ 222 (261)
T cd05148 161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-------VYDQITAGY---------R 222 (261)
T ss_pred --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHHhCC---------c
Confidence 112345678999999988899999999999999999998 899986543211 111111111 1
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
...+......+.+++.+||+.||.+|||+.++++.|++.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111223345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=286.45 Aligned_cols=230 Identities=24% Similarity=0.366 Sum_probs=174.9
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCc----EEEEEEeccCCc-hhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQ----EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~----~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
++|++.+.||+|+||.||+|+.. +++ .|++|.+..... ....++..|+..++++.||||++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 46778899999999999999864 344 478888754322 23467788888999999999873
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++.....++.||+.||.|||+++ ++||||||+|||+++++.+||+|||+++......
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 012345788888999999999999999998 9999999999999999999999999998654332
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
.........++..|+|||.+.+..++.++|||||||++|||++ |+.||....... ....+..+.... .+.
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~--~~~ 234 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERLA--QPQ 234 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCC--CCC
Confidence 2222233456778999999998899999999999999999998 999986542211 112222222111 111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
. ....+.+++.+||..||++|||+.|+++.|+...
T Consensus 235 ---~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 235 ---I----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred ---C----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1 1234677888999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=297.35 Aligned_cols=238 Identities=23% Similarity=0.318 Sum_probs=173.4
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
+|++.+.||+|+||.||+++.. +++.||||++... .....+++.+|+.+++.++|+||+..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999864 6899999998653 22345678899999999999998731
Q ss_pred --------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 445 --------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 11234678888999999999999999998 9999999999999999999999999998654322
Q ss_pred cccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH----------------H
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY----------------A 573 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~----------------~ 573 (676)
.. ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+.. .
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 158 SK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred cc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 11 12234678899999998874 479999999999999999999999976543221111100 0
Q ss_pred HHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 574 WQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 574 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
...+............ ...........+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 237 RAHILRGPHKPPSLPV-LYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHhCCCCCCchHH-hcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000000000 000111224467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=280.82 Aligned_cols=225 Identities=28% Similarity=0.397 Sum_probs=173.8
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
++|++.+.||+|+||.||+++..++..+|+|.+... ......+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457888999999999999999888889999998643 334567899999999999999872
Q ss_pred --------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 444 --------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 444 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
......+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||.+.......... .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~-~ 158 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-S 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec-c
Confidence 011234788889999999999999999998 9999999999999999999999999987643322111 1
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ . ......+... ..+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~----~~~i~~~~~~--~~~~----- 224 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---V----VEMISRGFRL--YRPK----- 224 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCCCC--CCCC-----
Confidence 11234568999999988889999999999999999999 899986433211 1 1112222111 1111
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
.....+.+++.+||+.+|++||+++++++.|.
T Consensus 225 --~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 --LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=281.83 Aligned_cols=227 Identities=23% Similarity=0.354 Sum_probs=172.8
Q ss_pred CCcceeeccCCCccEEEEEEcC-Cc--EEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccccc--------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLLD-GQ--EIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDSS-------------- 445 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~~-~~--~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~-------------- 445 (676)
|.+.++||+|+||.||+|+..+ ++ .||+|.++.. .....+.+.+|+.+++.++|+||++..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999998754 33 5899988653 234466789999999999999987310
Q ss_pred ------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccC
Q 005803 446 ------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFG 501 (676)
Q Consensus 446 ------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFG 501 (676)
....+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 1123567778899999999999999988 9999999999999999999999999
Q ss_pred cceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcC
Q 005803 502 MARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEG 580 (676)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~ 580 (676)
+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... ........+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-------EIYDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcC
Confidence 9987543322111122345678999999998899999999999999999999 78888643221 112222222
Q ss_pred CccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 581 KALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 581 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.... .+......+.+++.+||+.||++|||+.+|++.|+++
T Consensus 231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2111 1112334578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=288.06 Aligned_cols=231 Identities=26% Similarity=0.378 Sum_probs=180.3
Q ss_pred cCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|+.++++++|+||++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46788899999999999999742 34568999987665556678999999999999999872
Q ss_pred ---cc--------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC
Q 005803 444 ---SS--------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN 494 (676)
Q Consensus 444 ---~~--------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~ 494 (676)
.. ....+++..++.++.||+.||+|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 00 1123788899999999999999999998 999999999999999999
Q ss_pred eEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHH
Q 005803 495 PKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYA 573 (676)
Q Consensus 495 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~ 573 (676)
+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |+.||....... .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999976543322222223456788999999999899999999999999999999 999986543211 1
Q ss_pred HHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcC
Q 005803 574 WQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTM 632 (676)
Q Consensus 574 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 632 (676)
.+....+...+. .......+.+++.+||+.+|++||++.+|+++|+.+.+
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 122222222211 11223457889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=297.21 Aligned_cols=228 Identities=25% Similarity=0.379 Sum_probs=182.9
Q ss_pred CcCccccHHHHHHHhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc----
Q 005803 368 RDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD---- 443 (676)
Q Consensus 368 ~~~~~f~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~---- 443 (676)
.++....|++|.. ++-||.|+.|.||+|++ .++.||||+++... ..+++-|++|+|+||+.
T Consensus 116 ~e~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 116 EELWEIPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred hhhccCCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeee
Confidence 3566677777755 57899999999999998 57899999985432 45788999999999973
Q ss_pred ----------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccC
Q 005803 444 ----------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFG 501 (676)
Q Consensus 444 ----------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFG 501 (676)
...+..+.......+..+||.|+.|||.+. |||||||.-||||..+..+||+|||
T Consensus 181 CtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 181 CTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred ecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEecccc
Confidence 233455666677789999999999999998 9999999999999999999999999
Q ss_pred cceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC
Q 005803 502 MARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK 581 (676)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 581 (676)
-++..... .....+.||..|||||++.+.+.++|+|||||||||||||||..||..-+.....
T Consensus 258 TS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII-------------- 320 (904)
T KOG4721|consen 258 TSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII-------------- 320 (904)
T ss_pred chHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE--------------
Confidence 99876543 2234589999999999999999999999999999999999999999754322111
Q ss_pred ccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 582 ALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 582 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
-.+-...|.-..+..+++-+.-|+..||+..|..||++.+|+..|+=..
T Consensus 321 -wGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 321 -WGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred -EeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 0111122333345556666777888999999999999999999997654
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=281.57 Aligned_cols=228 Identities=25% Similarity=0.400 Sum_probs=177.6
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
.++|++.++||+|+||.||+|+..+...||+|+++.. ....+++.+|+.++++++|+||+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCC
Confidence 3579999999999999999998877778999999753 334567899999999999999862
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||.+......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~ 159 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-A 159 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-c
Confidence 011234678888999999999999999998 999999999999999999999999999765433211 1
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 593 (676)
.....++..|+|||...+..++.++|||||||++|||++ |..||....... .......+.. ..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~~~~---------~~ 223 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYR---------MP 223 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-------HHHHHhcCCC---------CC
Confidence 112345678999999988899999999999999999999 888886442211 1111111110 01
Q ss_pred CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 594 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
...+....+.+++.+|++.+|++||+++++++.|+..
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1223445678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.85 Aligned_cols=219 Identities=23% Similarity=0.341 Sum_probs=179.4
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHcc-CCcccc-----------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQ-HTNLTD----------- 443 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~----------- 443 (676)
...++|.++++||+|.||+|+++..+ +++.+|||++++. ..+..+..+.|.+++.... ||-|+.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 35578999999999999999999876 4788999999876 3556777889999988886 998872
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
......+++..+.-++..|+.||.|||+++ ||+||||.+|||||.+|++||+|||+++.....
T Consensus 445 ~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCC
Confidence 233466888888889999999999999999 999999999999999999999999999964322
Q ss_pred ccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
...+.+.+||+.|||||++.+..|+.++|.|||||+|||||.|..||...++++...-+ .. |
T Consensus 522 --g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI-------~~-------d-- 583 (694)
T KOG0694|consen 522 --GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI-------VN-------D-- 583 (694)
T ss_pred --CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------hc-------C--
Confidence 23566799999999999999999999999999999999999999999876544322111 00 1
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCH
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTM 620 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~ 620 (676)
...++.-...+.+.|+.+.|..+|++|.-+
T Consensus 584 -~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 -EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 112344455567889999999999999876
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=287.04 Aligned_cols=230 Identities=27% Similarity=0.402 Sum_probs=178.6
Q ss_pred cCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|+.++++++|+||+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46888999999999999999742 245689999977665667789999999999999998720
Q ss_pred ---------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEE
Q 005803 445 ---------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKI 497 (676)
Q Consensus 445 ---------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL 497 (676)
.....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 01124788899999999999999999998 999999999999999999999
Q ss_pred eccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHH
Q 005803 498 SDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQL 576 (676)
Q Consensus 498 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~ 576 (676)
+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence 99999976533222112222345778999999998889999999999999999998 888886443211 1122
Q ss_pred HhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 577 WNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 577 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
...+.... .... ....+.+++.+||+.||.+|||+.+|++.|+++.
T Consensus 235 i~~~~~~~-----~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 ITQGRVLQ-----RPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHcCCcCC-----CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 22222211 1111 2235788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=297.05 Aligned_cols=227 Identities=21% Similarity=0.319 Sum_probs=175.3
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.++..++||||+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47899999999999999999876 48899999997542 234566889999999999999873
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 112345778888899999999999999998 99999999999999999999999999976432
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ....... ..+......
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-------~~i~~~~--~~~~~~~~~ 223 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW-------ENLKYWK--ETLQRPVYD 223 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH-------HHHHhcc--ccccCCCCC
Confidence 223467899999999999999999999999999999999999999754322111 1111100 011111100
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.........+.+++.+||+.+|.+||++.++++.
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0011233457788899999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=282.03 Aligned_cols=227 Identities=23% Similarity=0.363 Sum_probs=173.7
Q ss_pred CCcceeeccCCCccEEEEEEcC----CcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccccc-------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLLD----GQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDSS------------- 445 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~~----~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~------------- 445 (676)
|.+.+.||+|+||.||+|.... +..||||+++... .....++.+|+..++.++|+|+++..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998643 3679999987532 33456789999999999999987310
Q ss_pred -------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEecc
Q 005803 446 -------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDF 500 (676)
Q Consensus 446 -------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DF 500 (676)
....+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 1124677778889999999999999988 999999999999999999999999
Q ss_pred CcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhc
Q 005803 501 GMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNE 579 (676)
Q Consensus 501 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~ 579 (676)
|+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+ . ......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~----~~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---I----YDYLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHc
Confidence 99986544332222222334678999999988889999999999999999999 888886433211 1 111112
Q ss_pred CCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 580 GKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 580 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
+... . .+......+.+++.+||+.||++||++.||++.|+++
T Consensus 231 ~~~~-----~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRL-----K----QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC-----C----CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2111 1 1222344688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=284.41 Aligned_cols=231 Identities=24% Similarity=0.370 Sum_probs=176.0
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCc----EEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc-----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQ----EIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS----------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~----~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~----------- 444 (676)
.++|++.++||+|+||.||+|+.. +++ .||+|++.... .....++.+|+.++..++|+|++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l 85 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL 85 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEE
Confidence 357888999999999999999853 444 48999986542 3345678899999999999998620
Q ss_pred ---------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 445 ---------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 445 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
.....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 11345788889999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
..........++..|+|||...+..++.++|||||||++|||++ |..||....... + ...+..+....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~~---- 231 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---I----PDLLEKGERLP---- 231 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCCcCC----
Confidence 22111111234678999999998899999999999999999998 889986432211 1 11122211111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.+......+.+++.+||+.||++||++.++++.|+.+.
T Consensus 232 -----~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 232 -----QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred -----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11122345778999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=283.83 Aligned_cols=230 Identities=26% Similarity=0.412 Sum_probs=173.9
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc---------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS--------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~--------- 444 (676)
++++|++.+.||+|+||.||+|... .+..||||++.... .....++.+|+.+++.++|+||++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999753 24679999986432 2345678899999999999998720
Q ss_pred -------cc--------------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEE
Q 005803 445 -------SR--------------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKI 497 (676)
Q Consensus 445 -------~~--------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL 497 (676)
.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 00 122456778889999999999999988 999999999999999999999
Q ss_pred eccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHH
Q 005803 498 SDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQL 576 (676)
Q Consensus 498 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~ 576 (676)
+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLRF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence 99999875443222111122345678999999998899999999999999999999 688886432211 1111
Q ss_pred HhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 577 WNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 577 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
..++.... . +......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 234 ~~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 22221111 1 11223467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=305.54 Aligned_cols=233 Identities=18% Similarity=0.263 Sum_probs=170.1
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSS-------------- 445 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~~-------------- 445 (676)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++|+||+...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4568999999999999999999865 58899999885432 2345799999999999987410
Q ss_pred -----------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC-CeEEeccC
Q 005803 446 -----------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM-NPKISDFG 501 (676)
Q Consensus 446 -----------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~-~vkL~DFG 501 (676)
....+++.....++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 140 ~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 140 IFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred eEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 1234566677889999999999999998 99999999999999664 69999999
Q ss_pred cceeccccccccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhc-
Q 005803 502 MARTYAMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNE- 579 (676)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~- 579 (676)
+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||......+.... .......
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~---i~~~~~~p 290 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVR---IIQVLGTP 290 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCC
Confidence 998654322 12235789999999998764 689999999999999999999999975433221111 1110000
Q ss_pred ---------CCccc-----cCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 580 ---------GKALE-----LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 580 ---------~~~~~-----~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
....+ .....+...++......+.+++.+||+.||.+|||+.|+++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000 000111111122233568899999999999999999999854
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=295.13 Aligned_cols=216 Identities=23% Similarity=0.327 Sum_probs=167.5
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc---------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD--------------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~--------------------- 443 (676)
+.||+|+||.||+++.. +++.||||+++... ......+.+|+.++++++||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 58999999987532 234456788999999999999872
Q ss_pred -----ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccccee
Q 005803 444 -----SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRI 518 (676)
Q Consensus 444 -----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 518 (676)
......+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTF 155 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccce
Confidence 112345778888899999999999999998 9999999999999999999999999987532211 122346
Q ss_pred eccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHH
Q 005803 519 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDE 598 (676)
Q Consensus 519 ~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 598 (676)
.||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+. ..+ +...
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~~~~~~------~~~----p~~~ 218 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEE------IRF----PRTL 218 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCC------CCC----CCCC
Confidence 79999999999999999999999999999999999999996432111 111111111 111 1222
Q ss_pred HHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 005803 599 VMRCIHVGLLCVQDRAADRR-----TMSDVVSM 626 (676)
Q Consensus 599 ~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~ 626 (676)
...+.+++.+||+.||++|| ++.++++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 34577888999999999999 79998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=285.52 Aligned_cols=232 Identities=24% Similarity=0.327 Sum_probs=178.9
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC-----CcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCccccc-----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD-----GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTDS----------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~-----~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~~----------- 444 (676)
.++|++.+.||+|+||.||+|...+ +..|++|++... .......+.+|+.++++++|+|++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4688999999999999999998765 688999998654 23345678899999999999998720
Q ss_pred ------------------c------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEecc
Q 005803 445 ------------------S------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDF 500 (676)
Q Consensus 445 ------------------~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DF 500 (676)
. ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 0 0135778888999999999999999988 999999999999999999999999
Q ss_pred CcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhc
Q 005803 501 GMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNE 579 (676)
Q Consensus 501 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~ 579 (676)
|+++.+.............++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .+ ......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~----~~~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EM----AAYLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HH----HHHHHc
Confidence 99986543322211222345678999999998889999999999999999999 99998653221 11 111111
Q ss_pred CCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcC
Q 005803 580 GKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTM 632 (676)
Q Consensus 580 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 632 (676)
+. .... .......+.+++.+||+.+|++|||+.+|++.|+.+.+
T Consensus 235 ~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 GY-----RLAQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CC-----CCCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11 0011 11223457889999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=284.96 Aligned_cols=228 Identities=31% Similarity=0.430 Sum_probs=173.7
Q ss_pred cCCCcceeeccCCCccEEEEEE-----cCCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKL-----LDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~-----~~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
++|++.++||+|+||.||+|+. .+++.||+|.+.... .....++.+|+.++++++|+||++.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999974 246789999987533 3344678899999999999998720
Q ss_pred ----c---------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC
Q 005803 445 ----S---------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM 493 (676)
Q Consensus 445 ----~---------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~ 493 (676)
. ....+++...+.++.|++.||.|||+++ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 0 0123667778889999999999999998 99999999999999999
Q ss_pred CeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHH
Q 005803 494 NPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGY 572 (676)
Q Consensus 494 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~ 572 (676)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~---- 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---E---- 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---H----
Confidence 999999999986543322222223445678999999988889999999999999999998 88888643211 1
Q ss_pred HHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 573 AWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 573 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
..+......... .+......+.+++.+||+.||++||++.+|+++|..
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111221211111 111223457888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=291.76 Aligned_cols=174 Identities=24% Similarity=0.323 Sum_probs=146.4
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
.++|++.+.||+|+||.||+++.. ++..||+|.+.... .....++.+|++++++++||||+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 368999999999999999999875 58889999987542 2345678999999999999999731
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc----
Confidence 11234677888899999999999999853 3999999999999999999999999998765322
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSY 561 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~ 561 (676)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 122357899999999999989999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=286.82 Aligned_cols=245 Identities=24% Similarity=0.335 Sum_probs=177.0
Q ss_pred cCC-CcceeeccCCCccEEEEEE-----cCCcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCccccc-----------
Q 005803 383 DNF-SPANRLGQGGFGPVYNGKL-----LDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTDS----------- 444 (676)
Q Consensus 383 ~~y-~~~~~LG~G~fG~Vy~~~~-----~~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~~----------- 444 (676)
++| ++.+.||+|+||.||++.. .+++.||+|.+..... .....+.+|++++++++||||+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 7889999999999988652 3578899999875432 345678899999999999998731
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 11234778889999999999999999998 99999999999999999999999999986543
Q ss_pred ccccc-ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 509 NELEA-NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 509 ~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
..... ......++..|+|||.+.+..++.++||||||+++|||++|..|+......- .................+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhh
Confidence 22111 1111235567999999988889999999999999999999999986432210 000000000000001111111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.......+......+.+++..||+.+|++|||+++|+++|+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111222334456888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=281.10 Aligned_cols=229 Identities=26% Similarity=0.389 Sum_probs=176.1
Q ss_pred cCCCcceeeccCCCccEEEEEEcC----CcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD----GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~----~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
++|++.+.||+|+||.||+|++.. ...||||.++... .....++.+|+.++.+++|+||++.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578899999999999999998642 4579999987543 3345678999999999999998620
Q ss_pred --------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 445 --------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.....+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 11235788899999999999999999988 9999999999999999999999999998764222
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
.........++..|+|||.+.+..++.++||||||+++|||++ |..||....... .......+...
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~------ 227 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGYRL------ 227 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCC------
Confidence 1111112234578999999998899999999999999999998 999986432211 11111111111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
..+......+.+++.+||+.+|++||++.||+++|+++
T Consensus 228 ---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ---PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01122345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=285.83 Aligned_cols=236 Identities=23% Similarity=0.341 Sum_probs=175.3
Q ss_pred cCCCcceeeccCCCccEEEEEEc-----CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-----DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-----~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
++|++.+.||+|+||.||++... +++.||||++........+.+.+|++++++++|||++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57888999999999999999742 478999999977666667789999999999999998721
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
.....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 11234678888899999999999999998 99999999999999999999999999986543
Q ss_pred ccccc-ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCC--------c-cchHHHHHHHHh
Q 005803 509 NELEA-NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTER--------P-LNLVGYAWQLWN 578 (676)
Q Consensus 509 ~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~--------~-~~l~~~~~~~~~ 578 (676)
..... ......++..|+|||.+.+..++.++|||||||++|||++|..++......- . ............
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 22111 1111223446999999998889999999999999999999887654321100 0 000000001111
Q ss_pred cCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 579 EGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 579 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.+ .....+......+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 241 ~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 241 NN---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 10 01111222334688899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=283.31 Aligned_cols=222 Identities=32% Similarity=0.469 Sum_probs=168.2
Q ss_pred cceeeccCCCccEEEEEEc-----CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 387 PANRLGQGGFGPVYNGKLL-----DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 387 ~~~~LG~G~fG~Vy~~~~~-----~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
+.+.||.|.||.||+|.+. .+..|+||.++... ....+++.+|++.+++++||||++
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4689999999999999876 25789999996543 334788999999999999999872
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..|+.||++||.|||+++ ++|+||+++||+++.++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 111356889999999999999999999998 999999999999999999999999999876322222
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
...........|+|||.+.+..++.++||||||+++|||++ |+.||...... . ....+.++....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~------~-~~~~~~~~~~~~------- 225 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE------E-IIEKLKQGQRLP------- 225 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH------H-HHHHHHTTEETT-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc------c-ccccccccccce-------
Confidence 22223456778999999999999999999999999999999 77887654211 1 112222222211
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~L 627 (676)
.+......+.+++..||+.+|++||++.+|++.|
T Consensus 226 --~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 --IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112334577899999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=306.54 Aligned_cols=242 Identities=21% Similarity=0.237 Sum_probs=171.1
Q ss_pred HHHHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcc------cc-----
Q 005803 376 QTIAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------TD----- 443 (676)
Q Consensus 376 ~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ni------v~----- 443 (676)
+++...+++|++.++||+|+||.||+|... .++.||||+++.. .....++..|+.++..++|.++ +.
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556789999999999999999999865 5788999999653 2334456778888888876652 21
Q ss_pred ---------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeeccccCceEEcCCC--------
Q 005803 444 ---------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKY-SRLRAIHRDLKVSNILLDEQM-------- 493 (676)
Q Consensus 444 ---------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLKp~NILl~~~~-------- 493 (676)
......+++..+..|+.||+.||.|||++ + ||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 201 QNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred EcCCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccc
Confidence 01123577788889999999999999984 7 99999999999998665
Q ss_pred --------CeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCC
Q 005803 494 --------NPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTER 565 (676)
Q Consensus 494 --------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~ 565 (676)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred cccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 49999999876422 12234689999999999999999999999999999999999999997654322
Q ss_pred ccchHHHHH-----------------HHHhc-CCccccCCcc----c-CCC--CChHHHHHHHHHHHHhcccCcCCCCCH
Q 005803 566 PLNLVGYAW-----------------QLWNE-GKALELMDPT----L-DES--CSSDEVMRCIHVGLLCVQDRAADRRTM 620 (676)
Q Consensus 566 ~~~l~~~~~-----------------~~~~~-~~~~~~~d~~----l-~~~--~~~~~~~~l~~L~~~Cl~~dP~~RPs~ 620 (676)
....+.... ..+.. +......++. + ... ........+++|+.+||+.||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 111111000 00000 0000000000 0 000 000112457799999999999999999
Q ss_pred HHHHHH
Q 005803 621 SDVVSM 626 (676)
Q Consensus 621 ~eVl~~ 626 (676)
+|+++.
T Consensus 433 ~e~L~H 438 (467)
T PTZ00284 433 RQMTTH 438 (467)
T ss_pred HHHhcC
Confidence 999973
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=286.19 Aligned_cols=170 Identities=26% Similarity=0.409 Sum_probs=137.4
Q ss_pred ceeeccCCCccEEEEEEc---CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccccc-------------------
Q 005803 388 ANRLGQGGFGPVYNGKLL---DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSS------------------- 445 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~---~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~~------------------- 445 (676)
.++||+|+||.||+|+.. +++.||+|.+.... ....+.+|+.++++++||||++..
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 46789999986532 234578999999999999997310
Q ss_pred -----------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE----cCCCCeEEeccCcce
Q 005803 446 -----------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL----DEQMNPKISDFGMAR 504 (676)
Q Consensus 446 -----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl----~~~~~vkL~DFGla~ 504 (676)
....+++..+..++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||++.
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 0123677778899999999999999998 9999999999999 456789999999998
Q ss_pred ecccccc-ccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCC
Q 005803 505 TYAMNEL-EANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYD 562 (676)
Q Consensus 505 ~~~~~~~-~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~ 562 (676)
....... ........||+.|+|||++.+ ..++.++||||+||++|||++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 6543221 112234678999999999976 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=284.93 Aligned_cols=229 Identities=24% Similarity=0.365 Sum_probs=174.5
Q ss_pred CCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCcccccc-----------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTDSS----------- 445 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~----------- 445 (676)
+|++.+.||+|+||.||+|+.. ....+|+|.+..... ....++.+|+.+++.++||||++..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999753 235789998865432 3456789999999999999987310
Q ss_pred ---------------------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCc
Q 005803 446 ---------------------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSN 486 (676)
Q Consensus 446 ---------------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~N 486 (676)
....+++...+.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 0124677888999999999999999988 9999999999
Q ss_pred eEEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCC
Q 005803 487 ILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTER 565 (676)
Q Consensus 487 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~ 565 (676)
||+++++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999976533222111222345678999999988889999999999999999998 999986433211
Q ss_pred ccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 566 PLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 566 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.+.....+. .. ..+......+.+++.+||+.+|++||++.++++.|+++.
T Consensus 238 -------~~~~~~~~~-----~~----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 -------LFNLLKTGY-----RM----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred -------HHHHHhCCC-----CC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 112221111 11 111223346788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=282.56 Aligned_cols=236 Identities=23% Similarity=0.351 Sum_probs=176.2
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC-----------------CcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD-----------------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~-----------------~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 443 (676)
.++|++.+.||+|+||.||+|+... +..||+|.+.... .....++.+|++++++++|+|++.
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999987542 2458999987543 335667899999999999999862
Q ss_pred c--------------------------c-----------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCc
Q 005803 444 S--------------------------S-----------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSN 486 (676)
Q Consensus 444 ~--------------------------~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~N 486 (676)
. . ....+++..++.++.|++.||+|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 0 0 0125788899999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh--CCcCCCCCCCC
Q 005803 487 ILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS--SKKNNGSYDTE 564 (676)
Q Consensus 487 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt--G~~pf~~~~~~ 564 (676)
|+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999976543332222233456778999999988889999999999999999998 66777543221
Q ss_pred CccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 565 RPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 565 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
.........+........ ...+......+.+++.+||+.||++|||+.||++.|++
T Consensus 241 ---~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 ---QVIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---HHHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111111111111111 11122233568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=295.52 Aligned_cols=237 Identities=19% Similarity=0.215 Sum_probs=174.7
Q ss_pred hcCCCcceeeccCCCccEEEEEEc---CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL---DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~---~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
..+|.+.+.||+|+||.||++... .++.||||.+... ....+|++++++++||||++.
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 3578999988543 235689999999999999731
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 166 e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 166 PKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred hhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 12346788899999999999999999998 9999999999999999999999999997655433322
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc--c-------
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL--E------- 584 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~--~------- 584 (676)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......................... .
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence 3334679999999999999999999999999999999999999997654332111111111111000000 0
Q ss_pred ----cCCcccCCCCC-------hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 585 ----LMDPTLDESCS-------SDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 585 ----~~d~~l~~~~~-------~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
........... ......+.+++.+||+.||++|||+.|++..
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0112346778889999999999999999876
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=281.88 Aligned_cols=230 Identities=28% Similarity=0.406 Sum_probs=173.2
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcC------CcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc---------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLD------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS--------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~------~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~--------- 444 (676)
.+++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......+.+|+.++++++|+||++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678999999999999999998653 5678999886543 3334568999999999999998720
Q ss_pred ------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC---CeEE
Q 005803 445 ------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM---NPKI 497 (676)
Q Consensus 445 ------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~---~vkL 497 (676)
.....+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 01124788888999999999999999998 99999999999998654 5899
Q ss_pred eccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHH
Q 005803 498 SDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQL 576 (676)
Q Consensus 498 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~ 576 (676)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||....... . ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~----~~~ 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---V----MEF 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHH
Confidence 99999986533222111112233567999999999999999999999999999997 999987543221 1 111
Q ss_pred HhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 577 WNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 577 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
...... ...+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 234 ~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 234 VTGGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 111110 11122233567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=298.23 Aligned_cols=239 Identities=21% Similarity=0.280 Sum_probs=179.7
Q ss_pred cCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHcc-CCc-----cc-------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTN-----LT------------- 442 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~n-----iv------------- 442 (676)
.+|.+.+.||+|.||.|-+|.. .+++.||||+++. ...-..+...|+.+|.+|+ |.+ +|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 3899999999999999999975 4599999999976 4455667789999999997 432 33
Q ss_pred --------------cccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC--CCeEEeccCcceec
Q 005803 443 --------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ--MNPKISDFGMARTY 506 (676)
Q Consensus 443 --------------~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~--~~vkL~DFGla~~~ 506 (676)
+......++......|+.||+.||.+||+.+ |||+|||||||||.+. ..+||+|||.++..
T Consensus 265 iVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 265 IVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 2344556888999999999999999999988 9999999999999754 36999999999875
Q ss_pred cccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHH-----HH-----
Q 005803 507 AMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAW-----QL----- 576 (676)
Q Consensus 507 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~-----~~----- 576 (676)
.... .+++.++.|+|||++.+.+|+.+.||||||||+.||++|.+.|.+..+.++...+.... .+
T Consensus 342 ~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 SQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred CCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 4322 25788999999999999999999999999999999999999998766554433222211 00
Q ss_pred -----Hhc-CCcc------c-----------------cCC---c----ccCCCCChHHHHHHHHHHHHhcccCcCCCCCH
Q 005803 577 -----WNE-GKAL------E-----------------LMD---P----TLDESCSSDEVMRCIHVGLLCVQDRAADRRTM 620 (676)
Q Consensus 577 -----~~~-~~~~------~-----------------~~d---~----~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~ 620 (676)
+.. .... + ..+ | .+........-..+++++.+||+.||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 001 0000 0 000 0 00000111334567899999999999999999
Q ss_pred HHHHHH--HhcC
Q 005803 621 SDVVSM--LTND 630 (676)
Q Consensus 621 ~eVl~~--Le~~ 630 (676)
.|.++. |.+.
T Consensus 497 ~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 497 AQALNHPFLTGT 508 (586)
T ss_pred HHHhcCcccccc
Confidence 999976 5544
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=278.91 Aligned_cols=225 Identities=27% Similarity=0.389 Sum_probs=174.3
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------------ 444 (676)
++|.+.+.||+|+||.||+|+..++..||||.+... .....++.+|+.++.+++||||++.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 467889999999999999998877778999998653 3345678999999999999998720
Q ss_pred ---------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 445 ---------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 445 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
.....+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++......... .
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~-~ 158 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS-S 158 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee-c
Confidence 11235788889999999999999999998 9999999999999999999999999987654322111 1
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||....... .......+... . .
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~-----~----~ 222 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLRL-----Y----R 222 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCCC-----C----C
Confidence 11234567999999988889999999999999999998 999986443211 11111111111 0 0
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1112356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=292.17 Aligned_cols=241 Identities=24% Similarity=0.251 Sum_probs=175.9
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccccc----------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDSSR---------- 446 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~---------- 446 (676)
...++|++.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35578999999999999999999864 5889999998753 2334567889999999999999873211
Q ss_pred -------------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 447 -------------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 447 -------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 112566777889999999999999998 9999999999999999999999999997643
Q ss_pred ccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHH----------------
Q 005803 508 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVG---------------- 571 (676)
Q Consensus 508 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~---------------- 571 (676)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 171 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 171 TSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred Ccc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 221 1223578999999999999899999999999999999999999997543211100000
Q ss_pred HHHHHHhc-CCccccCCcc-----c---CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 572 YAWQLWNE-GKALELMDPT-----L---DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 572 ~~~~~~~~-~~~~~~~d~~-----l---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
........ ........+. + ...........+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 0000000000 0 001111223467889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=276.19 Aligned_cols=226 Identities=27% Similarity=0.424 Sum_probs=175.5
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
++|.+.++||+|++|.||+|....+..||+|.+... ....+.+.+|+.++++++|+|++.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 568889999999999999999877778999988653 334567889999999999999862
Q ss_pred --------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 444 --------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 444 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
......+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.......... .
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~-~ 160 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA-R 160 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc-c
Confidence 011234678888999999999999999988 9999999999999999999999999998654322111 1
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
....++..|+|||...+..++.++||||||+++|||++ |+.||....... .......+.. . ..
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~-----~----~~ 224 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-------VLEQVERGYR-----M----PC 224 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC-----C----CC
Confidence 12345678999999988889999999999999999999 889987532211 1111111110 1 11
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
+......+.+++.+||+.||++||++++|++.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 22234567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=280.97 Aligned_cols=228 Identities=25% Similarity=0.376 Sum_probs=175.0
Q ss_pred cCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
++|...++||+|+||.||++... ++..+|+|.+..........+.+|+++++.++|+||++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999642 356789999877666667789999999999999998720
Q ss_pred ----c-------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCe
Q 005803 445 ----S-------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNP 495 (676)
Q Consensus 445 ----~-------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~v 495 (676)
. ....+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 0 0124778889999999999999999998 9999999999999999999
Q ss_pred EEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHH
Q 005803 496 KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAW 574 (676)
Q Consensus 496 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~ 574 (676)
||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||......+. .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~ 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-------I 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-------H
Confidence 9999999976543222122222345678999999999999999999999999999998 8999864332111 1
Q ss_pred HHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 575 QLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 575 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
.....+... .. +......+.+++.+||+.||.+||++.+|++.|+.
T Consensus 235 ~~~~~~~~~-----~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGREL-----ER----PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCccC-----CC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111111111 11 11223457789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=316.09 Aligned_cols=230 Identities=31% Similarity=0.436 Sum_probs=183.9
Q ss_pred cCCCcceeeccCCCccEEEEEEcC--Cc----EEEEEEeccC-CchhhHHHHHHHHHHHHccCCcccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD--GQ----EIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTD------------ 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~--~~----~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~------------ 443 (676)
++-+..+.||+|.||.||.|...+ +. .||||.+++. +.+...+|.+|..+|++++|||||+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 344567889999999999998643 43 3899999765 4566788999999999999999982
Q ss_pred ---------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCc
Q 005803 444 ---------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGM 502 (676)
Q Consensus 444 ---------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGl 502 (676)
......+.....+.++.|||+|+.||++++ +|||||..+|+||++...+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 122567888999999999999999999998 99999999999999999999999999
Q ss_pred ceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCC
Q 005803 503 ARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGK 581 (676)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~ 581 (676)
|+.+...+.........-...|||||.+..+.++.|+|||||||+|||++| |..||......+.. ..+.++.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~-------~~~~~gg 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL-------LDVLEGG 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH-------HHHHhCC
Confidence 995443333322222233457999999999999999999999999999999 88999876543322 1122222
Q ss_pred ccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 582 ALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 582 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+| +.+..+++.+.+|+..||+.+|++||++..|++.+..+.
T Consensus 922 -------RL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 922 -------RL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred -------cc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 11 235566677889999999999999999999999988775
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=290.66 Aligned_cols=230 Identities=20% Similarity=0.269 Sum_probs=174.8
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc------------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD------------ 443 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~------------ 443 (676)
...++|++++.||+|+||.||+++.+ +|..+|+|+++++. ..+.+.++.|-.+|....+++||+
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 36689999999999999999999855 59999999998763 345566889999999999999983
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
......|++......+.+++.|+..||+.| +|||||||+|+|||..|++||+|||++..+...
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhh
Confidence 233456777777777778999999999999 999999999999999999999999999643210
Q ss_pred ----------------------cccc-----------------------ccceeeccCCccChhhhccCCCCchhHHHHH
Q 005803 510 ----------------------ELEA-----------------------NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSF 544 (676)
Q Consensus 510 ----------------------~~~~-----------------------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSl 544 (676)
+... .....+|||.|+|||++.+..|+..+|.|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 0012589999999999999999999999999
Q ss_pred HHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCC---HH
Q 005803 545 GVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRT---MS 621 (676)
Q Consensus 545 Gvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs---~~ 621 (676)
|||+||||.|.+||....+......+..-...+ ..........+..+|+.+|+. ||++|.- ++
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l-------------~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~ 440 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETL-------------KFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAE 440 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-------------cCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHH
Confidence 999999999999998765544322221111111 111111122557788888888 9999975 66
Q ss_pred HHHHH
Q 005803 622 DVVSM 626 (676)
Q Consensus 622 eVl~~ 626 (676)
||-++
T Consensus 441 EIK~H 445 (550)
T KOG0605|consen 441 EIKKH 445 (550)
T ss_pred HHhcC
Confidence 66544
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=277.77 Aligned_cols=221 Identities=26% Similarity=0.344 Sum_probs=169.6
Q ss_pred eeccCCCccEEEEEE---cCCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc---------------------
Q 005803 390 RLGQGGFGPVYNGKL---LDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD--------------------- 443 (676)
Q Consensus 390 ~LG~G~fG~Vy~~~~---~~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~--------------------- 443 (676)
+||+|+||.||+|.+ .+++.+|+|+++... ....+++.+|+.+++.+.|+||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 689999999999964 357889999986443 234567899999999999999872
Q ss_pred ----ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc-cccee
Q 005803 444 ----SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA-NTNRI 518 (676)
Q Consensus 444 ----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~ 518 (676)
......+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.......... .....
T Consensus 82 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 82 LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 112235778888999999999999999998 9999999999999999999999999998654332111 11112
Q ss_pred eccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChH
Q 005803 519 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597 (676)
Q Consensus 519 ~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 597 (676)
.++..|+|||.+....++.++|||||||++|||++ |+.||....... .......+... . .+..
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~i~~~~~~-----~----~~~~ 222 (257)
T cd05116 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQMIESGERM-----E----CPQR 222 (257)
T ss_pred CCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCC-----C----CCCC
Confidence 34578999999988889999999999999999998 999997532211 11122222211 1 1222
Q ss_pred HHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 598 EVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 598 ~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
....+.+++.+||+.||++||++.+|.+.|++
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 33457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=277.85 Aligned_cols=231 Identities=22% Similarity=0.361 Sum_probs=178.0
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
++|++.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+.+++.++|||++..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999864 6899999987542 23334568899999999999998720
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
.....++......++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 11234677788899999999999999988 99999999999999999999999999887543
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
... ......++..|+|||.+.+..++.++|+||||+++|||++|+.||...... .... ........ .+
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~-~~~~~~~~-----~~ 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSL-CQKIEQCD-----YP 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHH-HHHHhcCC-----CC
Confidence 321 112246788999999998888999999999999999999999998643211 1111 11111111 11
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.. ........+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 227 ~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 PL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 11 11223456788999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=279.11 Aligned_cols=241 Identities=22% Similarity=0.286 Sum_probs=176.9
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCch--hhHHHHHHHHHHHHccCCc-ccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQ--GIVEFKNEAKLIAKLQHTN-LTD-------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~-------------- 443 (676)
...|...++||+|+||+||+|+.. +|+.||+|++.....+ ......+|+.++++++|+| |+.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 344666788999999999999854 6899999999765432 2345689999999999999 761
Q ss_pred -------------------cccc--CcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCc
Q 005803 444 -------------------SSRK--SLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGM 502 (676)
Q Consensus 444 -------------------~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGl 502 (676)
.... ..++...+..++.||+.||+|||+++ |+||||||+||||+++|.+||+|||+
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 0011 34566778899999999999999998 99999999999999999999999999
Q ss_pred ceeccccccccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhc--
Q 005803 503 ARTYAMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNE-- 579 (676)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~-- 579 (676)
|+...-.. ......++|..|+|||++.+. .|+...||||+|||+.||+++++.|....+.++... ..+.+..
T Consensus 167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~---If~~lGtP~ 241 (323)
T KOG0594|consen 167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFR---IFRLLGTPN 241 (323)
T ss_pred HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHH---HHHHcCCCC
Confidence 98654222 223446789999999999986 799999999999999999999999987665332222 2222111
Q ss_pred -CCc---cccCCc--ccCCCC-----Ch---HHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcC
Q 005803 580 -GKA---LELMDP--TLDESC-----SS---DEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTND 630 (676)
Q Consensus 580 -~~~---~~~~d~--~l~~~~-----~~---~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~ 630 (676)
... ..+.+- ...... .. .......+++.+||+.+|.+|.|++..+++ +...
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 100 001111 110000 00 111357789999999999999999999886 5443
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=290.68 Aligned_cols=213 Identities=21% Similarity=0.305 Sum_probs=163.9
Q ss_pred eccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc-----------------------
Q 005803 391 LGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD----------------------- 443 (676)
Q Consensus 391 LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~----------------------- 443 (676)
||+|+||.||+|+.. +++.||+|++... .......+.+|+.++.+++||||+.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 4889999998653 2344567889999999999999873
Q ss_pred ---ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeec
Q 005803 444 ---SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVG 520 (676)
Q Consensus 444 ---~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~g 520 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 155 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCG 155 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccC
Confidence 112345788888999999999999999998 9999999999999999999999999997543221 12233679
Q ss_pred cCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHH
Q 005803 521 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVM 600 (676)
Q Consensus 521 t~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 600 (676)
|+.|+|||.+.+..++.++|||||||++|||++|+.||...... .. ......+.. . .+.....
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~-~~~~~~~~~------~----~~~~~~~ 218 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EM-YRKILQEPL------R----FPDGFDR 218 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HH-HHHHHcCCC------C----CCCcCCH
Confidence 99999999999999999999999999999999999999743211 11 111111111 1 1122234
Q ss_pred HHHHHHHHhcccCcCCCCC---HHHHHH
Q 005803 601 RCIHVGLLCVQDRAADRRT---MSDVVS 625 (676)
Q Consensus 601 ~l~~L~~~Cl~~dP~~RPs---~~eVl~ 625 (676)
.+.+++.+||+.||++||+ +.|+++
T Consensus 219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 5778889999999999986 455544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=281.58 Aligned_cols=233 Identities=21% Similarity=0.297 Sum_probs=168.4
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--hhhHHHHHHHHHHHHc---cCCcccccc------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKL---QHTNLTDSS------------ 445 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~~~------------ 445 (676)
+|++.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.+++++ +||||++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999865 588999999865322 2233556777777665 699987310
Q ss_pred --------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 446 --------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 446 --------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 1123678888999999999999999998 99999999999999999999999999986
Q ss_pred ccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhc---CCc
Q 005803 506 YAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNE---GKA 582 (676)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~---~~~ 582 (676)
..... ......|+..|+|||.+.+..++.++|||||||++|||++|++||.......... ........ ...
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~---~~~~~~~~~~~~~~ 231 (288)
T cd07863 158 YSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG---KIFDLIGLPPEDDW 231 (288)
T ss_pred ccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH---HHHHHhCCCChhhC
Confidence 54322 1223567899999999998899999999999999999999999986543221110 01110000 000
Q ss_pred c-------ccCCccc---CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 583 L-------ELMDPTL---DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 583 ~-------~~~d~~l---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
. ....+.. .....++..+.+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0000000 00111223345788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=276.60 Aligned_cols=221 Identities=26% Similarity=0.387 Sum_probs=167.5
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc-----------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD----------------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~----------------------- 443 (676)
+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|+||++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999865 68999999876432 334567899999999999999872
Q ss_pred ----ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceee
Q 005803 444 ----SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIV 519 (676)
Q Consensus 444 ----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 519 (676)
......+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++................
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 011235788889999999999999999998 9999999999999999999999999987543221111111112
Q ss_pred ccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHH
Q 005803 520 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDE 598 (676)
Q Consensus 520 gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 598 (676)
.+..|+|||.+.++.++.++|||||||++|||++ |..||....... ......... ....+...
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~---------~~~~~~~~ 221 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGV---------RLPCPELC 221 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCC---------CCCCcccC
Confidence 3456999999998889999999999999999998 888886432211 111111110 11112223
Q ss_pred HHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 599 VMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 599 ~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
...+.+++.+||+.+|++||++.+|+++|+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 446788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=277.92 Aligned_cols=225 Identities=28% Similarity=0.367 Sum_probs=172.6
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------------ 444 (676)
.+|++.+.||+|+||.||+|+..++..+|+|.+... ......+.+|++++++++|+||++.
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 357788999999999999998877788999998653 2344578899999999999998720
Q ss_pred ---------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 445 ---------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 445 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
.....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......... .
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-~ 158 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-S 158 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc-c
Confidence 11235678888999999999999999998 9999999999999999999999999987654322111 1
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ . ......+. ... .
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~----~~~~~~~~-----~~~----~ 222 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---V----VESVSAGY-----RLY----R 222 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---H----HHHHHcCC-----cCC----C
Confidence 11223457999999998899999999999999999999 888886543211 1 11111111 111 1
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
+......+.+++.+||+.+|++|||+.||++.|.
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1223446888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=293.64 Aligned_cols=237 Identities=22% Similarity=0.293 Sum_probs=173.7
Q ss_pred HHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccccc----------
Q 005803 379 AAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDSS---------- 445 (676)
Q Consensus 379 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~---------- 445 (676)
....++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++|+||+...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345688999999999999999999864 58899999986532 22345678999999999999987311
Q ss_pred --------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 446 --------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 446 --------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 91 ~~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 91 NFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred ccCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcccee
Confidence 1234778888999999999999999998 99999999999999999999999999986
Q ss_pred ccccccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhc-----
Q 005803 506 YAMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNE----- 579 (676)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~----- 579 (676)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 168 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 239 (343)
T cd07878 168 ADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ---LKRIMEVVGTPSPEV 239 (343)
T ss_pred cCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCCCHHH
Confidence 5322 223578999999999877 5689999999999999999999999975332111 0000000000
Q ss_pred ------CCccccCC--cccCCC----CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 580 ------GKALELMD--PTLDES----CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 580 ------~~~~~~~d--~~l~~~----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
......+. +..... ........+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 000000 000112246789999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=290.27 Aligned_cols=240 Identities=22% Similarity=0.235 Sum_probs=175.1
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccccc-----------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDSSR----------- 446 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~----------- 446 (676)
..++|++.+.||+|+||.||+++.. +++.||||++... ......++.+|+.+++.++||||++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999864 5899999998643 2334567889999999999999873110
Q ss_pred ------------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 447 ------------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 447 ------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 123567778889999999999999998 99999999999999999999999999975432
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccch------------HH----H
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNL------------VG----Y 572 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l------------~~----~ 572 (676)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+....... .. .
T Consensus 176 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 176 NF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred Cc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 21 12235789999999999999999999999999999999999999975432111000 00 0
Q ss_pred HHHHHhcC-Cc-----cccCCcccC---CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 573 AWQLWNEG-KA-----LELMDPTLD---ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 573 ~~~~~~~~-~~-----~~~~d~~l~---~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
........ .. .+....... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 00 000000000 00011123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=291.82 Aligned_cols=240 Identities=23% Similarity=0.243 Sum_probs=175.5
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccccc-----------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDSSR----------- 446 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~----------- 446 (676)
..++|++.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999864 5889999998753 2334567889999999999999873210
Q ss_pred ------------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 447 ------------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 447 ------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 112567778889999999999999998 99999999999999999999999999976433
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH--------HH------
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY--------AW------ 574 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~--------~~------ 574 (676)
.. ......+|..|+|||++.+..++.++|||||||++|||++|+.||...........+.. ..
T Consensus 179 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 179 SF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 21 12235789999999999999999999999999999999999999975432211110000 00
Q ss_pred --HHHhcC-Ccc-----ccCCccc---CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 575 --QLWNEG-KAL-----ELMDPTL---DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 575 --~~~~~~-~~~-----~~~d~~l---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
...... ... ......+ ...........+.+++.+||+.||.+|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 000 0000000 000111123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=291.00 Aligned_cols=216 Identities=23% Similarity=0.321 Sum_probs=167.4
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc---------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD--------------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~--------------------- 443 (676)
+.||+|+||.||+++.. +++.||||++.+. .......+.+|+.+++.++||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 5899999999753 2334567889999999999999872
Q ss_pred -----ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccccee
Q 005803 444 -----SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRI 518 (676)
Q Consensus 444 -----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 518 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTF 155 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccc
Confidence 112345778888999999999999999998 9999999999999999999999999987532211 112335
Q ss_pred eccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHH
Q 005803 519 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDE 598 (676)
Q Consensus 519 ~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 598 (676)
.||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......... ..+ +...
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-------~~~~~~~~~------~~~----p~~~ 218 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMED------IKF----PRTL 218 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-------HHHHhccCC------ccC----CCCC
Confidence 78999999999998899999999999999999999999996532211 011111111 111 1122
Q ss_pred HHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 005803 599 VMRCIHVGLLCVQDRAADRR-----TMSDVVSM 626 (676)
Q Consensus 599 ~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~ 626 (676)
...+.+++.+||+.||++|| ++.|+++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 34577888899999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=295.67 Aligned_cols=237 Identities=18% Similarity=0.204 Sum_probs=171.0
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
...+|.+.+.||+|+||.||++.... ++.||||... ...+.+|++++++++|+||++.
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 35689999999999999999998764 7899999642 2345789999999999999731
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 241 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 241 KYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 11235888999999999999999999998 9999999999999999999999999998654332222
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCC-CccchHHHHHHHHhcCCcc--ccC----
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTE-RPLNLVGYAWQLWNEGKAL--ELM---- 586 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~-~~~~l~~~~~~~~~~~~~~--~~~---- 586 (676)
......||..|+|||++.+..++.++|||||||+||||++|..++-..... ..........+.+...... +..
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 223357999999999999999999999999999999999988665332211 1111111111111111110 000
Q ss_pred ---------------CcccCC-CCC--hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 587 ---------------DPTLDE-SCS--SDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 587 ---------------d~~l~~-~~~--~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+.... .+. ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 000 0111256788999999999999999999875
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=289.54 Aligned_cols=226 Identities=21% Similarity=0.289 Sum_probs=169.9
Q ss_pred CCCcceeeccCCCccEEEEEE----cCCcEEEEEEeccC----CchhhHHHHHHHHHHHHc-cCCcccc-----------
Q 005803 384 NFSPANRLGQGGFGPVYNGKL----LDGQEIAIKRLSKS----SGQGIVEFKNEAKLIAKL-QHTNLTD----------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~----~~~~~VAvK~l~~~----~~~~~~~~~~E~~~l~~l-~H~niv~----------- 443 (676)
+|++.+.||+|+||.||+++. .+++.||+|++.+. .....+.+.+|+.++.++ +|+||+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588899999999999999975 35789999998643 123345678899999999 4888862
Q ss_pred ---------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 444 ---------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
......+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 112345788888999999999999999998 99999999999999999999999999976433
Q ss_pred cccccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........... ....... .+
T Consensus 158 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---~~~~~~~------~~ 227 (332)
T cd05614 158 EEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE---VSRRILK------CD 227 (332)
T ss_pred cCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH---HHHHHhc------CC
Confidence 221 122235799999999999865 478999999999999999999999975433221111 1111111 11
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRR-----TMSDVVSM 626 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~ 626 (676)
+.+.. .....+.+++.+||+.||++|| +++++++.
T Consensus 228 ~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 PPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 22222 2234567888999999999999 77788754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=277.23 Aligned_cols=229 Identities=21% Similarity=0.295 Sum_probs=173.5
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
++|++.+.||+|+||.||+|... +++.||+|.+... ......++.+|++++++++|||++..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46788999999999999999864 6889999998654 23345678999999999999998731
Q ss_pred ------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccccee
Q 005803 445 ------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRI 518 (676)
Q Consensus 445 ------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 518 (676)
.....+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~ 153 (279)
T cd06619 81 MDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTY 153 (279)
T ss_pred CCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCC
Confidence 11123567788899999999999999998 9999999999999999999999999997653221 2235
Q ss_pred eccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHH
Q 005803 519 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDE 598 (676)
Q Consensus 519 ~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 598 (676)
.|+..|+|||.+.+..++.++|||||||++|+|++|+.||....................... .+.+.. ...
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~---~~~ 225 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLPV---GQF 225 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCCC---CcC
Confidence 789999999999988899999999999999999999999975432221111101111111111 111111 112
Q ss_pred HHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 599 VMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 599 ~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
...+.+++.+||+.+|++||+++|+++.
T Consensus 226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 226 SEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 2357788999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=286.45 Aligned_cols=239 Identities=20% Similarity=0.323 Sum_probs=172.3
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
++|.+.++||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.++++++|+||+.
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999865 578899999875432 23346788999999999999872
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........ .
T Consensus 86 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 160 (309)
T cd07872 86 LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--T 160 (309)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc--c
Confidence 012234677888889999999999999998 99999999999999999999999999976433221 1
Q ss_pred cceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHH--------HHHHhcCC-ccc
Q 005803 515 TNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYA--------WQLWNEGK-ALE 584 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~--------~~~~~~~~-~~~ 584 (676)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+... +..+.... ...
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 122467899999998865 46899999999999999999999999765433221111100 00000000 000
Q ss_pred cCCcccCC----CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 585 LMDPTLDE----SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 585 ~~d~~l~~----~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.-.+.... .........+.+++.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000000 0001123356789999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=296.74 Aligned_cols=221 Identities=26% Similarity=0.303 Sum_probs=180.0
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
+-|++++.||.|+-|.|-+|++. +|+.+|||++.+. .......+.+|+.+|+.+.|||++.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 56788999999999999999864 6999999999765 2233456889999999999999872
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
....+.+.+.+..+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|.....+.
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-- 166 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-- 166 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCc--
Confidence 234567888999999999999999999998 9999999999999999999999999998654332
Q ss_pred cccceeeccCCccChhhhccCCC-CchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
...+.+|++.|.|||++.+.+| +.++||||.|||||.||+|+.||+.. +...+ ......|.+.
T Consensus 167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---Nir~L----LlKV~~G~f~-------- 230 (786)
T KOG0588|consen 167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---NIRVL----LLKVQRGVFE-------- 230 (786)
T ss_pred -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---cHHHH----HHHHHcCccc--------
Confidence 3345799999999999999988 57899999999999999999999832 21122 2223333332
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+.....++.+|+.+|+..||+.|.|++||++.
T Consensus 231 --MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 231 --MPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred --CCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 222334457788899999999999999999987
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=284.05 Aligned_cols=232 Identities=24% Similarity=0.388 Sum_probs=177.7
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcC------CcEEEEEEeccCC-chhhHHHHHHHHHHHHc-cCCccccc--------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLD------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLTDS-------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~------~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~-------- 444 (676)
..++|++.+.||+|+||.||++.... ...+|+|.+.... .....++.+|+.++.++ +|+||++.
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34578889999999999999998542 3679999987532 33446688999999999 79998720
Q ss_pred ----------------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc
Q 005803 445 ----------------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD 490 (676)
Q Consensus 445 ----------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~ 490 (676)
.....+++..++.++.|++.||.|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 11245778888999999999999999988 99999999999999
Q ss_pred CCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccch
Q 005803 491 EQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNL 569 (676)
Q Consensus 491 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l 569 (676)
+++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 242 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 242 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----
Confidence 999999999999986544322222222334678999999988899999999999999999998 888886432211
Q ss_pred HHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 570 VGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 570 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.......+... ..+......+.+++.+||+.||++|||+.||++.|+++.
T Consensus 243 ---~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 ---LFKLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11222221111 112233456888999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=289.13 Aligned_cols=216 Identities=23% Similarity=0.334 Sum_probs=166.6
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc---------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD--------------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~--------------------- 443 (676)
+.||+|+||.||+++.. +++.||+|++... .......+.+|+.+++.++||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 5899999998753 2234456788999999999999872
Q ss_pred -----ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccccee
Q 005803 444 -----SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRI 518 (676)
Q Consensus 444 -----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 518 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTF 155 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccccc
Confidence 112345788889999999999999999998 9999999999999999999999999987532211 112235
Q ss_pred eccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHH
Q 005803 519 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDE 598 (676)
Q Consensus 519 ~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 598 (676)
.||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......... .+.. ..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~~~~~~~~~~------~~p~----~~ 218 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI------RFPR----TL 218 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCC------CCCC----CC
Confidence 78999999999999999999999999999999999999997543211 1111111111 1111 22
Q ss_pred HHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 005803 599 VMRCIHVGLLCVQDRAADRR-----TMSDVVSM 626 (676)
Q Consensus 599 ~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~ 626 (676)
...+.+++.+||+.||++|| ++.++++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 34567888899999999998 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=281.50 Aligned_cols=235 Identities=22% Similarity=0.325 Sum_probs=171.7
Q ss_pred cCCCcceeeccCCCccEEEEEEcC---------------CcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCccccc--
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD---------------GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTDS-- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~---------------~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~~-- 444 (676)
++|++.++||+|+||.||+++... ...||+|.++.. .......+.+|++++++++|+|++..
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578999999999999999987532 224899998754 23345678999999999999998621
Q ss_pred --------------cc----------------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceE
Q 005803 445 --------------SR----------------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNIL 488 (676)
Q Consensus 445 --------------~~----------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NIL 488 (676)
.. ...+++..++.++.|++.||+|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 00 013577788999999999999999998 999999999999
Q ss_pred EcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh--CCcCCCCCCCCCc
Q 005803 489 LDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS--SKKNNGSYDTERP 566 (676)
Q Consensus 489 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt--G~~pf~~~~~~~~ 566 (676)
+++++.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 99999999999999976433222222222345678999999998899999999999999999998 556665432211
Q ss_pred cchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 567 LNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 567 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
.+......+........ ...+......+.+++.+||+.||++||++.+|++.|+.
T Consensus 241 --~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 --VIENTGEFFRNQGRQIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --HHHHHHHhhhhcccccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111111100000 00111223468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=274.25 Aligned_cols=227 Identities=27% Similarity=0.403 Sum_probs=177.0
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
.++|.+.+.||+|+||.||+|...+++.||||.+... .....++.+|+.++++++|+|++.
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 4688999999999999999999888889999998753 344577999999999999999872
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++..........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 111235788888999999999999999998 9999999999999999999999999998654322111
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+. ....
T Consensus 161 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~~-----~~~~-- 225 (261)
T cd05034 161 -REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-------VLEQVERGY-----RMPR-- 225 (261)
T ss_pred -hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC-----CCCC--
Confidence 111234568999999998889999999999999999998 999986432211 111111110 0111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
+......+.+++.+||+.+|++||+++++++.|+.
T Consensus 226 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 --PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11223467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=282.83 Aligned_cols=230 Identities=27% Similarity=0.412 Sum_probs=173.8
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCc----EEEEEEeccCCc-hhhHHHHHHHHHHHHccCCccccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQ----EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~----~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
++|+..+.||+|+||.||+|... ++. .||+|.+..... ....++.+|+.++++++|+||++.
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 46778899999999999999854 344 579998865432 234468899999999999998731
Q ss_pred --------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 445 --------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.....+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++......
T Consensus 87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCcc
Confidence 11224677788999999999999999998 9999999999999999999999999998654332
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
.........++..|+|||.+.+..++.++|||||||++|||++ |+.||....... .......+....
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~----- 231 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGERLP----- 231 (303)
T ss_pred cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCCC-----
Confidence 2222222345678999999998899999999999999999997 889986432111 111121111110
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
. +......+.+++..||..+|++||++.++++.|+.+.
T Consensus 232 ~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 232 Q----PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 1112345778899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=301.21 Aligned_cols=223 Identities=18% Similarity=0.177 Sum_probs=173.2
Q ss_pred CCCcceeeccCCCccEEEEEEc-C-CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-D-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~-~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||++.
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999753 3 67889998765555555678889999999999999720
Q ss_pred -------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 445 -------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 445 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
.....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 11234677888899999999999999998 99999999999999999999999999987654322
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .......+.... .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~-~~~~~~~~~~~~-----~- 291 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------E-IMQQVLYGKYDP-----F- 291 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCCCC-----C-
Confidence 22234467999999999999999999999999999999999999999643211 1 111111121110 1
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
+......+.+++.+||+.||++||++.++++
T Consensus 292 ---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 ---PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1122345788899999999999999999864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=264.82 Aligned_cols=222 Identities=25% Similarity=0.327 Sum_probs=178.6
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
+.++|++.+.||+|.||.||+|+.+ ++-.||+|++.++. .+...++.+|+++.+.|+||||.+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3468999999999999999999865 57789999987642 334567899999999999999872
Q ss_pred ---------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 444 ---------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
......+++.....++.|+|.||.|+|.++ +|||||||+|+|++..+.+||+|||-+..-.
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 123456778888899999999999999998 9999999999999999999999999987543
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
.....+.+||..|.+||...+..++.++|+|++|++.||++.|.+||......+ .++.+..- ++.+
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-------tYkrI~k~---~~~~- 241 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-------TYKRIRKV---DLKF- 241 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-------HHHHHHHc---cccC-
Confidence 223345899999999999999999999999999999999999999998654222 11222111 1111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+......+.+++.+|+..+|.+|.+..||+..
T Consensus 242 ------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 ------PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ------CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 22333457788999999999999999999864
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=287.67 Aligned_cols=220 Identities=25% Similarity=0.346 Sum_probs=167.5
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCc-ccc---------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTN-LTD--------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~n-iv~--------------- 443 (676)
+|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+..|..++..+.|++ |+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999865 4789999998753 2334567788999999998765 431
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-- 155 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--
Confidence 012234678888999999999999999998 9999999999999999999999999987532211
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ........ ..+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~----~~~i~~~~------~~~-- 220 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---L----FQSIMEHN------VSY-- 220 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H----HHHHHcCC------CCC--
Confidence 12234578999999999999999999999999999999999999997543211 1 11111111 111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCH-----HHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTM-----SDVVS 625 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~-----~eVl~ 625 (676)
+......+.+++.+||+.||.+||+. .++++
T Consensus 221 --~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 221 --PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred --CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11223457788899999999999976 55554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=289.39 Aligned_cols=227 Identities=25% Similarity=0.343 Sum_probs=174.3
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..++|+||+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999875 58999999987532 2345678899999999999998731
Q ss_pred ------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc--
Q 005803 445 ------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE-- 510 (676)
Q Consensus 445 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~-- 510 (676)
.....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 11246788888999999999999999988 9999999999999999999999999998654322
Q ss_pred -------------------------cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCC
Q 005803 511 -------------------------LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTER 565 (676)
Q Consensus 511 -------------------------~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~ 565 (676)
.........||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 0011233578999999999999999999999999999999999999997543211
Q ss_pred ccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCC-HHHHHHH
Q 005803 566 PLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRT-MSDVVSM 626 (676)
Q Consensus 566 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-~~eVl~~ 626 (676)
......... +.+. +.. .......+.+++.+|++ ||.+||+ ++++++.
T Consensus 238 -------~~~~i~~~~--~~~~--~p~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 -------TYNKIINWK--ESLR--FPP--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -------HHHHHhccC--Cccc--CCC--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111111100 0000 000 11123457788889997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=290.66 Aligned_cols=236 Identities=23% Similarity=0.313 Sum_probs=179.4
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC--CcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD--GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~--~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
.++|++.+.||+|+||.||+|.... +..||+|++... .......+.+|+.+++.++||||++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3578999999999999999998543 368999998643 2234567889999999999999873
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 112345778888899999999999999998 999999999999999999999999999865321
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+.. .+
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~~------~~ 247 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGII------YF 247 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCC------CC
Confidence 23467999999999999988999999999999999999999999753221 11112222211 01
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH--HhcC------cCCCCCCCCCcc
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRR-----TMSDVVSM--LTND------TMALPKPKQPAF 642 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~--Le~~------~~~l~~p~~P~~ 642 (676)
+......+.+++.+||+.||++|+ +++++++. +++. ...++.|..|.+
T Consensus 248 ----p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~ 308 (340)
T PTZ00426 248 ----PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKY 308 (340)
T ss_pred ----CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 111223467888899999999995 89998875 3322 124555656654
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=278.10 Aligned_cols=229 Identities=26% Similarity=0.421 Sum_probs=175.6
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC------CcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS---------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~------~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~---------- 444 (676)
.++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++..++|+|+++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578889999999999999998642 3689999986542 2345678899999999999998721
Q ss_pred --------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEe
Q 005803 445 --------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKIS 498 (676)
Q Consensus 445 --------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~ 498 (676)
.....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 01123567788899999999999999988 9999999999999999999999
Q ss_pred ccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHH
Q 005803 499 DFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLW 577 (676)
Q Consensus 499 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~ 577 (676)
|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHHHH
Confidence 9999876543332222233456788999999988889999999999999999998 898886433211 11122
Q ss_pred hcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 578 NEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 578 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
..+.... . +......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 235 ~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHLD-----L----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCCC-----C----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 2221111 1 11224568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=272.00 Aligned_cols=231 Identities=23% Similarity=0.357 Sum_probs=179.3
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|++.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999876 6899999988632 2234567899999999999999862
Q ss_pred ---------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 444 ---------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
......+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 011234678888999999999999999998 99999999999999999999999999876543
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
.... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... .... .......+....
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~-~~~~~~~~~~~~---- 227 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYS-LCKKIEKCDYPP---- 227 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHH-HHhhhhcCCCCC----
Confidence 2211 2234678899999999988899999999999999999999999864321 1111 111111111111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.. .......+.+++.+||+.+|++||++.+|+++|+++.
T Consensus 228 -~~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 -LP---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -CC---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11 1123346778999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=274.37 Aligned_cols=231 Identities=23% Similarity=0.363 Sum_probs=177.7
Q ss_pred cCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
++|++.+.||+|+||.||++.. .+++.+|||.+... ......++.+|+.+++.++|+||+..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999985 46899999987643 22344678899999999999998720
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
.....+++.....++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 11345788888999999999999999998 99999999999999999999999999876543
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
.... .....++..|+|||.+.+..++.++||||||+++|||++|..||....... .. ...... ....+
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~----~~~~~~-----~~~~~ 226 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YS----LCKKIE-----QCDYP 226 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HH----Hhhhhh-----cCCCC
Confidence 2211 122468889999999988889999999999999999999999986432110 00 011111 11111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.+. .......+.+++.+||+.||++||||.+|++++++..
T Consensus 227 ~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 227 PLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 111 1123446788899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=273.92 Aligned_cols=221 Identities=24% Similarity=0.335 Sum_probs=171.9
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
++|++.+.||+|+||.||++.. .+..||+|.++.. ...+.+.+|+.++++++|+|++.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4788899999999999999976 4788999998643 34567899999999999999872
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 011223677888999999999999999998 9999999999999999999999999987543221
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .. .......+.. +..
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~-~~~~~~~~~~-----~~~-- 220 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KD-VVPRVEKGYK-----MDA-- 220 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHhcCCC-----CCC--
Confidence 12334567999999998889999999999999999998 9998864321 11 1111111111 111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.......+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 221 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 --PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred --CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 122334578889999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=277.09 Aligned_cols=220 Identities=28% Similarity=0.392 Sum_probs=182.1
Q ss_pred cCCCcceeeccCCCccEEEEE-EcCCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~-~~~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
.+|++.+.||+|.||+|-+|. +..|+.||||.+++. .++....+.+|++||+.|+||||+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 468888999999999999997 467999999999765 4556667899999999999999872
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......|++.+...+++||..|+.|+|.++ ++|||||.+|||+|.++++||+|||++..+....
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k-- 207 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK-- 207 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcccc--
Confidence 234466889999999999999999999988 9999999999999999999999999998876443
Q ss_pred cccceeeccCCccChhhhccCCC-CchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
...+++|++.|.+||++.+.+| ++.+|-|||||+||.|+.|..||+..+... ..+.+..|...+.-
T Consensus 208 -fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~-------lvrQIs~GaYrEP~----- 274 (668)
T KOG0611|consen 208 -FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR-------LVRQISRGAYREPE----- 274 (668)
T ss_pred -HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-------HHHHhhcccccCCC-----
Confidence 2445899999999999999888 578999999999999999999998764321 22333444444321
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+....-|+.|||..||+.|-|+.+|...
T Consensus 275 ------~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 275 ------TPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ------CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 12235668889999999999999999876
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=287.02 Aligned_cols=220 Identities=23% Similarity=0.330 Sum_probs=166.8
Q ss_pred CCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHH---HHccCCcccc--------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLI---AKLQHTNLTD-------------- 443 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l---~~l~H~niv~-------------- 443 (676)
|++.+.||+|+||.||+|+.. +++.||||++++.. ....+.+.+|+.++ +.++||||++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999865 58999999997532 23345566776655 5667999873
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-- 155 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-- 155 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--
Confidence 112346888999999999999999999998 9999999999999999999999999987532211
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||....... .......+.. ..
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~~------~~-- 220 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-------VFDSIVNDEV------RY-- 220 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC------CC--
Confidence 12234678999999999999999999999999999999999999997543211 1111111111 11
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRR-----TMSDVVSM 626 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~ 626 (676)
+......+.+++.+||+.||++|| ++.++++.
T Consensus 221 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 221 --PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred --CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 112234567889999999999999 56666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=283.12 Aligned_cols=231 Identities=24% Similarity=0.379 Sum_probs=175.6
Q ss_pred hcCCCcceeeccCCCccEEEEEEc--------CCcEEEEEEeccCC-chhhHHHHHHHHHHHHc-cCCccccc-------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL--------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLTDS------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~--------~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~------- 444 (676)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+.... .....++.+|+.+++.+ +||||++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 457888999999999999999741 24579999986532 34456789999999999 89998720
Q ss_pred ---------c--------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE
Q 005803 445 ---------S--------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL 489 (676)
Q Consensus 445 ---------~--------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl 489 (676)
. ....+++..+..++.||+.||.|||+++ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 0 1124667788899999999999999998 9999999999999
Q ss_pred cCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccc
Q 005803 490 DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLN 568 (676)
Q Consensus 490 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~ 568 (676)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---- 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 246 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----
Confidence 9999999999999987643322222222345678999999998889999999999999999998 77887543211
Q ss_pred hHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 569 LVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 569 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
. .......+... ..+......+.+++.+||+.+|++||++.||++.|+++.
T Consensus 247 --~-~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 247 --E-LFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred --H-HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 1 11122222111 111223456788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=278.50 Aligned_cols=235 Identities=22% Similarity=0.358 Sum_probs=172.1
Q ss_pred cCCCcceeeccCCCccEEEEEEc-----------------CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-----------------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-----------------~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~ 444 (676)
++|++.++||+|+||.||++... +...||+|++.... .....++.+|+.++++++|+||+..
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57899999999999999998532 23468999987542 3345678999999999999998620
Q ss_pred -------------------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCce
Q 005803 445 -------------------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNI 487 (676)
Q Consensus 445 -------------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NI 487 (676)
.....+++.....++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 00123566788999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh--CCcCCCCCCCCC
Q 005803 488 LLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS--SKKNNGSYDTER 565 (676)
Q Consensus 488 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt--G~~pf~~~~~~~ 565 (676)
|++.++.+||+|||++..+.............++..|+|||...++.++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999976543222111222344678999999888899999999999999999998 667776433222
Q ss_pred ccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 566 PLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 566 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
............... ...+ .+......+.+++.+||+.||++||++.+|++.|+.
T Consensus 242 ---~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 ---VIENTGEFFRDQGRQ-VYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHHhhcccc-ccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111111100 0001 111223567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=293.17 Aligned_cols=232 Identities=21% Similarity=0.322 Sum_probs=176.3
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC------CcEEEEEEeccCCc-hhhHHHHHHHHHHHHcc-CCccccc---------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD------GQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQ-HTNLTDS--------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~------~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~~--------- 444 (676)
.++|.+.++||+|+||.||+|+... +..||||++..... ...+.+.+|+++++++. ||||++.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4578889999999999999997521 34699999975432 33467899999999996 9998720
Q ss_pred -------c------------------------------------------------------------------------
Q 005803 445 -------S------------------------------------------------------------------------ 445 (676)
Q Consensus 445 -------~------------------------------------------------------------------------ 445 (676)
.
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 0
Q ss_pred ----------------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC
Q 005803 446 ----------------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE 491 (676)
Q Consensus 446 ----------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~ 491 (676)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 0123667777889999999999999998 999999999999999
Q ss_pred CCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchH
Q 005803 492 QMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLV 570 (676)
Q Consensus 492 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~ 570 (676)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~---- 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---- 348 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence 99999999999986543322222223456778999999998899999999999999999997 9999875432111
Q ss_pred HHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 571 GYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 571 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.......+.. .. .+......+.+++.+||+.||++||++.+|+++|+.+.
T Consensus 349 --~~~~~~~~~~-----~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 --FYNKIKSGYR-----MA----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred --HHHHHhcCCC-----CC----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1111111111 11 11223456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=282.51 Aligned_cols=230 Identities=24% Similarity=0.388 Sum_probs=175.1
Q ss_pred cCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCC-chhhHHHHHHHHHHHHc-cCCccccc----------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLTDS---------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~---------- 444 (676)
++|.+.+.||+|+||.||++... .+..||||+++... ....+.+.+|+.+++++ +|+||++.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 57889999999999999999742 24579999987543 23346789999999999 79998720
Q ss_pred ------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceec
Q 005803 445 ------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTY 506 (676)
Q Consensus 445 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~ 506 (676)
.....+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||++...
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccc
Confidence 11123788899999999999999999998 999999999999999999999999999865
Q ss_pred cccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCcccc
Q 005803 507 AMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALEL 585 (676)
Q Consensus 507 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (676)
.............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ........+..
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~~~--- 262 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEGYR--- 262 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcCCc---
Confidence 43221111222345678999999998899999999999999999998 999986543211 11111111111
Q ss_pred CCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 586 MDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 586 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.. .+......+.+++.+||+.+|++||++.||++.|++.
T Consensus 263 --~~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 --MA----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --CC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 1112234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=286.45 Aligned_cols=166 Identities=24% Similarity=0.344 Sum_probs=139.1
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
...+|++.+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++|+||++.
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4468999999999999999999875 4778999975432 23569999999999999831
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 138 ~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 211 (357)
T PHA03209 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--- 211 (357)
T ss_pred ccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc---
Confidence 12345788999999999999999999998 9999999999999999999999999997532211
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNN 558 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf 558 (676)
......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 122356899999999999999999999999999999999866554
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=288.56 Aligned_cols=232 Identities=25% Similarity=0.372 Sum_probs=174.2
Q ss_pred hcCCCcceeeccCCCccEEEEEE------cCCcEEEEEEeccCC-chhhHHHHHHHHHHHHc-cCCccccccc-------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL------LDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLTDSSR------- 446 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~------~~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~------- 446 (676)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +|+||+....
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35799999999999999999963 347889999997543 23445688999999999 6899862100
Q ss_pred --------------------------------------------------------------------------------
Q 005803 447 -------------------------------------------------------------------------------- 446 (676)
Q Consensus 447 -------------------------------------------------------------------------------- 446 (676)
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence
Q ss_pred -------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceee
Q 005803 447 -------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIV 519 (676)
Q Consensus 447 -------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 519 (676)
...+++.....++.||++||+|||+++ |+||||||+|||++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 012566777889999999999999998 9999999999999999999999999997653322111222234
Q ss_pred ccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHH
Q 005803 520 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDE 598 (676)
Q Consensus 520 gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 598 (676)
++..|+|||.+.+..++.++||||||+++|||++ |..||........ .......+.... ... ..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~~~-----~~~----~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMR-----APD----YT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCCCC-----CCC----CC
Confidence 5678999999998899999999999999999997 8899865322110 111122221111 111 11
Q ss_pred HHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 599 VMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 599 ~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
...+.+++..||+.||++||++.||++.|+.+.
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 235788899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=274.11 Aligned_cols=227 Identities=26% Similarity=0.418 Sum_probs=176.3
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
.++|++.++||+|+||.||++...++..+|+|.+... ......+.+|+.++++++|+|++.
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCC
Confidence 3678899999999999999999877888999988653 334567899999999999999872
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~ 159 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-A 159 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-c
Confidence 111234677788899999999999999988 999999999999999999999999999765432211 1
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 593 (676)
.....++..|+|||++....++.++|+|||||++|++++ |+.||....... .......+....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~~--------- 223 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYRMP--------- 223 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCCCCC---------
Confidence 112345677999999998889999999999999999999 899987432211 111111211111
Q ss_pred CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 594 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
........+.+++.+|++.+|++||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 112233457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=286.86 Aligned_cols=216 Identities=25% Similarity=0.354 Sum_probs=165.3
Q ss_pred eeeccCCCccEEEEEE----cCCcEEEEEEeccCC----chhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 389 NRLGQGGFGPVYNGKL----LDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~----~~~~~VAvK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
+.||+|+||.||+++. ..++.||||+++... ......+.+|+.+++.++||||+..
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 357899999986531 2234567889999999999999731
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+.+.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 156 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--V 156 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--c
Confidence 12234566777889999999999999998 99999999999999999999999999875332221 1
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....... .......+.. .+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-------~~~~~~~~~~------~~---- 219 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-------TIDKILKGKL------NL---- 219 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC------CC----
Confidence 223578999999999998889999999999999999999999997533211 1111111111 11
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRR-----TMSDVVSM 626 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~ 626 (676)
+......+.+++.+||+.+|++|| ++.++++.
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 122234577889999999999999 78888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=281.01 Aligned_cols=228 Identities=25% Similarity=0.364 Sum_probs=171.4
Q ss_pred cCCCcceeeccCCCccEEEEEEcC-Cc--EEEEEEeccC-CchhhHHHHHHHHHHHHc-cCCcccccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD-GQ--EIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNLTDSS------------ 445 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~-~~--~VAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~------------ 445 (676)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|+.++.++ +||||++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998654 33 4788888643 233456789999999999 799987210
Q ss_pred ------------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCe
Q 005803 446 ------------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNP 495 (676)
Q Consensus 446 ------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~v 495 (676)
....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 0123677788999999999999999988 9999999999999999999
Q ss_pred EEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHH
Q 005803 496 KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAW 574 (676)
Q Consensus 496 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~ 574 (676)
||+|||++...... ........+..|+|||.+.+..++.++|||||||++|||++ |..||......+ ..
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LY 228 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence 99999998642211 01111123457999999988889999999999999999997 999996543211 11
Q ss_pred HHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcC
Q 005803 575 QLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTM 632 (676)
Q Consensus 575 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 632 (676)
.....+. ... .+......+.+++.+||+.+|.+||++++|++.|+....
T Consensus 229 ~~~~~~~-----~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 229 EKLPQGY-----RME----KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HHHhcCC-----CCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111 111 111223457889999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=280.00 Aligned_cols=170 Identities=27% Similarity=0.413 Sum_probs=137.0
Q ss_pred ceeeccCCCccEEEEEEcC---CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc--------------------
Q 005803 388 ANRLGQGGFGPVYNGKLLD---GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS-------------------- 444 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~---~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~-------------------- 444 (676)
..+||+|+||.||+|+..+ +..||+|.+.... ....+.+|+.++++++||||+..
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4689999999999998653 5789999986532 33467899999999999998721
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE----cCCCCeEEeccCcce
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL----DEQMNPKISDFGMAR 504 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl----~~~~~vkL~DFGla~ 504 (676)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 01123677778899999999999999998 9999999999999 566789999999998
Q ss_pred eccccccc-cccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCC
Q 005803 505 TYAMNELE-ANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYD 562 (676)
Q Consensus 505 ~~~~~~~~-~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~ 562 (676)
........ .......+|+.|+|||.+.+ ..++.++|||||||++|||++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 65433211 12233578999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=274.28 Aligned_cols=227 Identities=23% Similarity=0.348 Sum_probs=172.2
Q ss_pred CCcceeeccCCCccEEEEEEc----CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccccc------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLL----DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDSSR------------ 446 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~----~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~------------ 446 (676)
|.+.+.||+|+||.||+|... +++.||||++... .....+++.+|+.++++++|||+++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999753 3688999998654 2344667889999999999999863110
Q ss_pred --------------------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEecc
Q 005803 447 --------------------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDF 500 (676)
Q Consensus 447 --------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DF 500 (676)
...+++.....++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 012456677889999999999999988 999999999999999999999999
Q ss_pred CcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhc
Q 005803 501 GMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNE 579 (676)
Q Consensus 501 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~ 579 (676)
|++................++..|++||.+.+..++.++|||||||++|||++ |+.||...... .+ ......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~----~~~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EI----YNYLIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HH----HHHHHc
Confidence 99986543222111222345678999999998889999999999999999999 88888643221 11 111111
Q ss_pred CCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 580 GKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 580 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
+.... .+......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 231 ~~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11110 1122345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=270.15 Aligned_cols=220 Identities=27% Similarity=0.387 Sum_probs=169.4
Q ss_pred eeeccCCCccEEEEEEcCCcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCcccc------------------------
Q 005803 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTD------------------------ 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~------------------------ 443 (676)
+.||+|+||.||+|...+++.||+|.+..... .....+.+|+.++++++||||+.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988899999999875433 23456889999999999999872
Q ss_pred ---ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeec
Q 005803 444 ---SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVG 520 (676)
Q Consensus 444 ---~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~g 520 (676)
......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......... ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCC
Confidence 011234688889999999999999999998 999999999999999999999999998754322111 1111234
Q ss_pred cCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHH
Q 005803 521 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEV 599 (676)
Q Consensus 521 t~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 599 (676)
+..|+|||++.+..++.++||||||+++|||++ |..||....... .......+... ..+....
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~ 220 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGYRM---------SCPQKCP 220 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCCC---------CCCCCCC
Confidence 567999999998889999999999999999998 999986432211 11111111111 1122234
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 600 MRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 600 ~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
..+.+++.+|++.+|++||++.|+++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 56888999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=277.71 Aligned_cols=229 Identities=24% Similarity=0.415 Sum_probs=174.2
Q ss_pred hcCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccccc---------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDSS--------- 445 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~--------- 445 (676)
.++|++.+.||+|+||.||+|+.. ++..||+|.+.... .....++.+|+.++++++|||+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999853 46789999987543 23456789999999999999987200
Q ss_pred ---------------------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCc
Q 005803 446 ---------------------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSN 486 (676)
Q Consensus 446 ---------------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~N 486 (676)
....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 0123567778899999999999999998 9999999999
Q ss_pred eEEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCC
Q 005803 487 ILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTER 565 (676)
Q Consensus 487 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~ 565 (676)
|++++++.+||+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875433221111122334667999999998899999999999999999997 878875432211
Q ss_pred ccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 566 PLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 566 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
.......+.... .+......+.+++.+||+.+|++|||+.||++.|++
T Consensus 241 -------~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 -------VIYYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -------HHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111222222211 111233568889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=272.05 Aligned_cols=223 Identities=26% Similarity=0.363 Sum_probs=175.3
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
.++|++.+.||+|+||.||+|.. .++.||||.+..... ..+++.+|+.++++++|+|+++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 35788899999999999999986 478999999976543 5678999999999999999872
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 011125788899999999999999999998 99999999999999999999999999986532211
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
....+..|+|||.+....++.++||||||+++|||++ |+.||....... .......+.. ...
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~-----~~~-- 220 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGYR-----MEA-- 220 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCC-----CCC--
Confidence 1234567999999988889999999999999999997 999986442111 1111111111 111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
+......+.+++.+||+.+|++||++.+++++|+++
T Consensus 221 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 221 --PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred --ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 112234678899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=275.33 Aligned_cols=224 Identities=26% Similarity=0.320 Sum_probs=171.9
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
+|++.++||+|+||.||++... +++.||||++.... ......+.+|+.++++++|+||+.
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999864 58899999986532 222345778999999999999872
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 011235788888999999999999999998 99999999999999999999999999986532221
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||......... .......... .
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~----------~ 221 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKED----------Q 221 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhc----------c
Confidence 12346899999999999889999999999999999999999999754322111 1111111110 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRR-----TMSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~ 626 (676)
...+......+.+++.+||+.||++|| +++++++.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 112223344578899999999999999 88888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=289.22 Aligned_cols=224 Identities=22% Similarity=0.339 Sum_probs=182.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
.++|..++.+|+|+||.+++++++ +++.+++|.+... .....+...+|+.++++++|||||.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367888999999999999999865 5788999998644 3444556789999999999999982
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
...+..++++....++.||+.|+.|||++. |+|||||+.||+++.+..+||+|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 223467888999999999999999999887 999999999999999999999999999988765
Q ss_pred ccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
.. ...+.+||+.|+.||++.+.+|+.|+|||||||++|||++-+++|...+-.. ++ .+.. .+.
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li---~ki~-~~~-------- 222 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LI---LKIN-RGL-------- 222 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HH---HHHh-hcc--------
Confidence 42 3445899999999999999999999999999999999999999998543221 11 1111 111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
....+......+..++..|++.+|..||++.+++.+
T Consensus 223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 122344455668888899999999999999999876
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=273.52 Aligned_cols=226 Identities=27% Similarity=0.429 Sum_probs=171.0
Q ss_pred CCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCchhhH--HHHHHHHHHHHccCCcccc------------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~~~~--~~~~E~~~l~~l~H~niv~------------------ 443 (676)
|++.+.||+|+||.||+++... ++.||+|.+......... ...+|+.++++++|+||+.
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6778999999999999999765 678999999775433322 3456999999999999872
Q ss_pred --------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 444 --------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 444 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
......+++..+..++.||++||.+||+.+ |+|+||||+||++++++.++|+|||.+..... .....
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNENF 155 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSEB
T ss_pred cccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--ccccc
Confidence 113466888999999999999999999998 99999999999999999999999999976411 11223
Q ss_pred ceeeccCCccChhhhc-cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 516 NRIVGTHGYMSPEYVM-NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~-~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
....++..|+|||++. +..++.++||||+|+++|+|++|..||......+..... .... ...... ....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~---~~~~-~~~~~~----~~~~-- 225 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII---EKIL-KRPLPS----SSQQ-- 225 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH---HHHH-HTHHHH----HTTS--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh---hhcc-cccccc----cccc--
Confidence 3457889999999998 788999999999999999999999999855111111111 1110 000000 0000
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.......+.+++.+||+.||++||++.++++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011267889999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=270.57 Aligned_cols=222 Identities=25% Similarity=0.352 Sum_probs=169.7
Q ss_pred eeeccCCCccEEEEEEcCCcEEEEEEeccCCch-hhHHHHHHHHHHHHccCCcccc----------------c-------
Q 005803 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLTD----------------S------- 444 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~----------------~------- 444 (676)
++||+|+||.||++...+++.||+|.+...... ....+.+|++++++++|+||+. .
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998764433 5568899999999999999862 0
Q ss_pred ----cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeec
Q 005803 445 ----SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVG 520 (676)
Q Consensus 445 ----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~g 520 (676)
.....+++..+..++.+++.||.|||+++ ++||||||+||+++.++.+||+|||++.................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 11234677788899999999999999998 99999999999999999999999999976542211111111233
Q ss_pred cCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHH
Q 005803 521 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEV 599 (676)
Q Consensus 521 t~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 599 (676)
+..|+|||.+.++.++.++|||||||++|||++ |..||....... .......+. ....+....
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~~~---------~~~~~~~~~ 221 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESGY---------RMPAPQLCP 221 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhcCC---------CCCCCccCC
Confidence 567999999988899999999999999999999 888886543211 111111110 001122234
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 600 MRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 600 ~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
..+.+++.+||+.+|++||++.||++.|+.
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 468889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=284.75 Aligned_cols=174 Identities=24% Similarity=0.344 Sum_probs=145.1
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
.++|++.++||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++|+||+..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368999999999999999999876 58889999886542 3345678999999999999998731
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++.....++.|++.||.|||+.+ +|+|+||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----
Confidence 11234677778899999999999999752 3999999999999999999999999998754321
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSY 561 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~ 561 (676)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 122356899999999999888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=274.24 Aligned_cols=229 Identities=23% Similarity=0.359 Sum_probs=173.0
Q ss_pred cCCCcceeeccCCCccEEEEEEcC-C---cEEEEEEeccC-CchhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD-G---QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~-~---~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
.+|++.+.||+|+||.||+|+... + ..||||.+... ......+|..|+.++++++||||++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357889999999999999998653 3 36999998754 3344678999999999999999872
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 012345778889999999999999999998 9999999999999999999999999987654322
Q ss_pred cccccceee---ccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 511 LEANTNRIV---GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 511 ~~~~~~~~~---gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
......... .+..|+|||.+.+..++.++|||||||++|||++ |..||......+ . ....... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~----~~~i~~~-----~ 228 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---V----INAIEQD-----Y 228 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---H----HHHHHcC-----C
Confidence 111111111 1347999999998899999999999999999886 999986443211 1 1111111 0
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
... .+.+....+.+++.+||+.+|++||++.+|+++|++.
T Consensus 229 ~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 RLP----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 101 1122334578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=276.94 Aligned_cols=232 Identities=25% Similarity=0.411 Sum_probs=173.8
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccccc--------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDSS-------- 445 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~-------- 445 (676)
..++|++.++||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++|+|+++..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999743 24579999986443 23345678999999999999987200
Q ss_pred ----------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEE
Q 005803 446 ----------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKI 497 (676)
Q Consensus 446 ----------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL 497 (676)
....+.+.....++.|++.||.|||+++ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 0122345567789999999999999998 999999999999999999999
Q ss_pred eccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHH
Q 005803 498 SDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQL 576 (676)
Q Consensus 498 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~ 576 (676)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+ ....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-------~~~~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKF 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence 99999875433222111222345678999999998899999999999999999998 788886432211 1111
Q ss_pred HhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 577 WNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 577 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
...+.... . +......+.+++.+||+.+|++|||+.++++.|++..
T Consensus 234 ~~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGYLD-----Q----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCCCC-----C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111111 1 1122356889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=273.45 Aligned_cols=230 Identities=25% Similarity=0.394 Sum_probs=174.6
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC-C---cEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD-G---QEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~-~---~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
.++|+..+.||+|+||.||+|+... + ..+|+|.+.... .....++.+|++++++++|+|+++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3467888999999999999998653 3 368999986542 334567899999999999999862
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 012245788889999999999999999998 999999999999999999999999999765432
Q ss_pred cccccc-ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 510 ELEANT-NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 510 ~~~~~~-~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
...... .....+..|+|||.+.+..++.++|||||||++|||++ |+.||....... .......+..
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i~~~~~----- 228 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDGFR----- 228 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhcCCC-----
Confidence 211111 11123457999999988889999999999999999997 999986432211 1122211110
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.....+....+.+++.+||+.+|++||++.+|++.|+++
T Consensus 229 ----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 ----LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011112334678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=275.66 Aligned_cols=225 Identities=27% Similarity=0.435 Sum_probs=171.7
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCccccc-------------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTDS------------- 444 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~~------------- 444 (676)
.+++.|++.+.||+|+||.||+|... +++.||+|.+... ......+.+|+.++.++ +|+|++..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 46778999999999999999999865 5888999998654 34456788999999998 69998720
Q ss_pred ---------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcc
Q 005803 445 ---------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMA 503 (676)
Q Consensus 445 ---------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla 503 (676)
.....+++..+..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 01234678888899999999999999998 999999999999999999999999999
Q ss_pred eeccccccccccceeeccCCccChhhhc-----cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHh
Q 005803 504 RTYAMNELEANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWN 578 (676)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 578 (676)
....... .......|+..|+|||++. +..++.++|||||||++|||++|+.||........ .. ...
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~------~~-~~~ 229 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------LF-LIP 229 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH------HH-HHh
Confidence 7653221 1223357889999999986 34688899999999999999999999964322110 01 111
Q ss_pred cCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 579 EGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 579 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.... ..+. .......+.+++.+||+.+|.+|||+.+|++
T Consensus 230 ~~~~-----~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 RNPA-----PRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cCCC-----CCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1111 1111 1112235778999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=273.02 Aligned_cols=229 Identities=23% Similarity=0.380 Sum_probs=173.2
Q ss_pred hcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+.
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999986 468899999997655555667889999999999999873
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........ .
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~ 162 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--K 162 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc--c
Confidence 011235677888899999999999999988 99999999999999999999999999986542211 1
Q ss_pred cceeeccCCccChhhhc---cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 515 TNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.....++..|+|||.+. ...++.++|||||||++|||++|+.||.......... ...... ...+...
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~---~~~~~~~ 232 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSN---FQPPKLK 232 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCC---CCCCCCc
Confidence 12356888999999874 3457889999999999999999999986432211100 000000 0111111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~L 627 (676)
. .......+.+++.+||+.+|++||++++|++.|
T Consensus 233 ~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 D--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred c--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1 112234678899999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=290.61 Aligned_cols=227 Identities=22% Similarity=0.309 Sum_probs=170.0
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..++|+||+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999875 58999999996532 234456788999999999999873
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 112345788889999999999999999998 999999999999999999999999998754321100
Q ss_pred c------------------------------------ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCc
Q 005803 513 A------------------------------------NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKK 556 (676)
Q Consensus 513 ~------------------------------------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~ 556 (676)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0 0112468999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCC---HHHHHHH
Q 005803 557 NNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRT---MSDVVSM 626 (676)
Q Consensus 557 pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs---~~eVl~~ 626 (676)
||....... ........... + .... .......+.+++.+|+. +|.+|++ +.|+++.
T Consensus 238 Pf~~~~~~~-------~~~~i~~~~~~--~--~~~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 238 PFCSDNPQE-------TYRKIINWKET--L--QFPD--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCHHH-------HHHHHHcCCCc--c--CCCC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 997543211 11111111100 0 0000 00112345677778886 9999998 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=287.83 Aligned_cols=216 Identities=23% Similarity=0.321 Sum_probs=166.4
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc---------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD--------------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~--------------------- 443 (676)
+.||+|+||.||+++.. +++.||+|++.+. ......++.+|++++..++||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 5899999999753 2234456788999999999999872
Q ss_pred -----ccccCcCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccce
Q 005803 444 -----SSRKSLLDWKKRFYIIEGIVQGLLYLHK-YSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 444 -----~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
......+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 155 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKT 155 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--cccc
Confidence 1123457888899999999999999997 66 99999999999999999999999999875332211 1223
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChH
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 597 (676)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......... ..+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-------~~~~i~~~~------~~~p~~---- 218 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEE------IRFPRT---- 218 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-------HHHHHhcCC------CCCCCC----
Confidence 579999999999999999999999999999999999999996543211 111111111 111111
Q ss_pred HHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 005803 598 EVMRCIHVGLLCVQDRAADRR-----TMSDVVSM 626 (676)
Q Consensus 598 ~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~ 626 (676)
....+.+++.+||+.||++|+ ++.++++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 233577888999999999996 89999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=277.83 Aligned_cols=236 Identities=25% Similarity=0.345 Sum_probs=176.4
Q ss_pred cCCCcceeeccCCCccEEEEEEc-----CCcEEEEEEeccCCch-hhHHHHHHHHHHHHccCCccccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-----DGQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-----~~~~VAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
++|++.+.||+|+||.||+|+.. +++.||||.+...... ....+.+|+++++.++|+||+..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999853 3678999999765443 56789999999999999998631
Q ss_pred -----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 445 -----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 445 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
.....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 01123778888999999999999999998 9999999999999999999999999998765
Q ss_pred ccccc-cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCcc--------chHHHHHHHHh
Q 005803 508 MNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPL--------NLVGYAWQLWN 578 (676)
Q Consensus 508 ~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~--------~l~~~~~~~~~ 578 (676)
..... .......++..|+|||.+.+..++.++||||||++++||++|+.|+......... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 32111 1111123456799999998889999999999999999999999987643221100 00111111111
Q ss_pred cCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 579 EGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 579 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.+ .....+......+.+++.+||+.+|++||+|.||+++|+++
T Consensus 241 ~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11 11111122335688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=274.15 Aligned_cols=218 Identities=22% Similarity=0.315 Sum_probs=166.1
Q ss_pred eccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCccccc----------------------
Q 005803 391 LGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTDS---------------------- 444 (676)
Q Consensus 391 LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~~---------------------- 444 (676)
||+|+||.||++... +++.||||.+.... ....+.+..|+.++++++|+||+..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999865 58899999986532 2234567889999999999998720
Q ss_pred --------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccc
Q 005803 445 --------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516 (676)
Q Consensus 445 --------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 516 (676)
.....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 12235778888999999999999999998 99999999999999999999999999976543322 122
Q ss_pred eeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCCh
Q 005803 517 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSS 596 (676)
Q Consensus 517 ~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 596 (676)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||.......... ...... ..... ..+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~--------~~~~~--~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK---ELKQRI--------LNDSV--TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH---HHHHhh--------cccCC--CCcc
Confidence 3578999999999999999999999999999999999999997543221110 000000 11110 1122
Q ss_pred HHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 005803 597 DEVMRCIHVGLLCVQDRAADRR-----TMSDVVSM 626 (676)
Q Consensus 597 ~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~ 626 (676)
.....+.+++.+||+.||++|| +++++++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 3344577888999999999999 77888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=285.78 Aligned_cols=176 Identities=25% Similarity=0.361 Sum_probs=146.5
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|++.+.||+|+||.||+++.. +++.||||++.+.. ......+.+|+.++.+++|+||+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999865 58899999996532 233456788999999999999872
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc-
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL- 511 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~- 511 (676)
......+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 112345788888999999999999999998 99999999999999999999999999875432110
Q ss_pred --------------------------------ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCC
Q 005803 512 --------------------------------EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNG 559 (676)
Q Consensus 512 --------------------------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~ 559 (676)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 000123579999999999999999999999999999999999999997
Q ss_pred CC
Q 005803 560 SY 561 (676)
Q Consensus 560 ~~ 561 (676)
..
T Consensus 238 ~~ 239 (363)
T cd05628 238 SE 239 (363)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=281.21 Aligned_cols=231 Identities=25% Similarity=0.367 Sum_probs=174.4
Q ss_pred hcCCCcceeeccCCCccEEEEEEc--------CCcEEEEEEeccCC-chhhHHHHHHHHHHHHc-cCCcccccc------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL--------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLTDSS------ 445 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~--------~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~------ 445 (676)
.++|.+.+.||+|+||.||+++.. +...+|+|.+.... .....++.+|+.++.++ +|+||++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357999999999999999999742 23569999987542 34456788999999999 799986200
Q ss_pred ------------------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE
Q 005803 446 ------------------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL 489 (676)
Q Consensus 446 ------------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl 489 (676)
....+++.+++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 1124788889999999999999999988 9999999999999
Q ss_pred cCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccc
Q 005803 490 DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLN 568 (676)
Q Consensus 490 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~ 568 (676)
+.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence 9999999999999876543221111111234568999999998889999999999999999998 88888543211
Q ss_pred hHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 569 LVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 569 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
........+... ..+......+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 250 ---~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 250 ---ELFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred ---HHHHHHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 111122222111 112223346778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=269.88 Aligned_cols=222 Identities=27% Similarity=0.333 Sum_probs=174.3
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
+|++.+.||+|++|.||+|+.. +++.|++|.+... ......++.+|++++++++|||+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999865 5899999998643 3345677899999999999999872
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 111345778888999999999999999988 999999999999999999999999999865543221
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.....|+..|+|||++.+..++.++|+|||||+++||++|+.||...... . .......+... .+
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~----~~~~~~~~~~~-----~~-- 221 (256)
T cd08529 158 --ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---A----LILKIIRGVFP-----PV-- 221 (256)
T ss_pred --hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---H----HHHHHHcCCCC-----CC--
Confidence 12346788999999999989999999999999999999999999754311 1 11111111111 11
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+......+.+++.+||+.+|++||++.++++.
T Consensus 222 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 --SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11233458889999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=271.82 Aligned_cols=222 Identities=24% Similarity=0.341 Sum_probs=169.2
Q ss_pred eeccCCCccEEEEEEc---CCcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCcccc----------------------
Q 005803 390 RLGQGGFGPVYNGKLL---DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTD---------------------- 443 (676)
Q Consensus 390 ~LG~G~fG~Vy~~~~~---~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~---------------------- 443 (676)
.||+|+||.||+|.+. .+..||+|++..... ...+++.+|+.++++++|+||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 4899999999999753 355799999875432 33467899999999999999872
Q ss_pred ----ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc-ccee
Q 005803 444 ----SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN-TNRI 518 (676)
Q Consensus 444 ----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~-~~~~ 518 (676)
......+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++........... ....
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 012345788889999999999999999998 99999999999999999999999999975543221111 1112
Q ss_pred eccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChH
Q 005803 519 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597 (676)
Q Consensus 519 ~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 597 (676)
.++..|+|||.+.+..++.++|||||||++|||++ |..||....... .......+... ..+..
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~ 222 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKRL---------DCPAE 222 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCC---------CCCCC
Confidence 23568999999988889999999999999999996 999987543211 11222222111 12223
Q ss_pred HHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 598 EVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 598 ~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
....+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 345677899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=288.62 Aligned_cols=226 Identities=20% Similarity=0.306 Sum_probs=171.1
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
++|.+.+.||+|+||.||+++.. +++.||||+++... ......+.+|+.+++.++|+||+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999865 58999999997532 2345668899999999999998721
Q ss_pred -------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 445 -------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 445 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
.....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 11145778888899999999999999998 99999999999999999999999999987543322
Q ss_pred ccccceeeccCCccChhhhc------cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcccc
Q 005803 512 EANTNRIVGTHGYMSPEYVM------NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALEL 585 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~------~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (676)
. ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ..............
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~~ 230 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFLKF 230 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCccCC
Confidence 1 122346899999999987 4567899999999999999999999997543211 11111111111110
Q ss_pred CCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 586 MDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 586 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.........+.+++..||+ +|++||++.++++.
T Consensus 231 -------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 231 -------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0011223446778888997 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=277.01 Aligned_cols=226 Identities=22% Similarity=0.362 Sum_probs=176.0
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
..+|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.+.|+|++..
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 358899999999999999999854 588999999976655566788999999999999998721
Q ss_pred ---------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 445 ---------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 445 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
.....+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++......... .
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~ 173 (296)
T cd06654 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--R 173 (296)
T ss_pred cCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc--c
Confidence 11234677888999999999999999998 999999999999999999999999998754332211 1
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCS 595 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 595 (676)
....+++.|+|||.+.+..++.++|||||||++|+|++|+.||........ .......+ . +.+ ..+
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~~~~~~-~-----~~~--~~~ 239 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG-T-----PEL--QNP 239 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHHHhcCC-C-----CCC--CCc
Confidence 224688899999999988899999999999999999999999965432111 01111111 0 011 112
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 596 SDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 596 ~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
......+.+++.+||..+|++||++.+|++.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 2233457789999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=279.27 Aligned_cols=238 Identities=19% Similarity=0.295 Sum_probs=171.0
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
++|.+.++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++|+||+..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57899999999999999999865 58899999986443 2234567889999999999998720
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++.....++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++........ .
T Consensus 86 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~ 160 (301)
T cd07873 86 LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--T 160 (301)
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--c
Confidence 11234677888899999999999999998 99999999999999999999999999975432211 1
Q ss_pred cceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH--------HHHHHhcC-Cccc
Q 005803 515 TNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY--------AWQLWNEG-KALE 584 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~--------~~~~~~~~-~~~~ 584 (676)
.....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.. .+..+... ....
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 122456889999998875 4578999999999999999999999975543211110000 00000000 0000
Q ss_pred cCCcccCCC----CChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 585 LMDPTLDES----CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 585 ~~d~~l~~~----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.-.+..... ........+.+++.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000 01112335678999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=282.54 Aligned_cols=215 Identities=26% Similarity=0.359 Sum_probs=161.3
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHH-ccCCcccc--------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAK-LQHTNLTD-------------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~-l~H~niv~-------------------- 443 (676)
+.||+|+||.||+|+.. +++.||||.++... ....+.+..|..++.. .+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 48899999987532 2334455667777765 48999872
Q ss_pred ------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccce
Q 005803 444 ------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 444 ------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
......+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAST 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccccc
Confidence 112345777888889999999999999998 9999999999999999999999999997643222 22234
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChH
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 597 (676)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ........ .+.+ +..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~------~~~~----~~~ 218 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-------LFDSILND------RPHF----PRW 218 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcC------CCCC----CCC
Confidence 678999999999999899999999999999999999999997543211 11111111 1111 112
Q ss_pred HHHHHHHHHHHhcccCcCCCCCHH-HHHH
Q 005803 598 EVMRCIHVGLLCVQDRAADRRTMS-DVVS 625 (676)
Q Consensus 598 ~~~~l~~L~~~Cl~~dP~~RPs~~-eVl~ 625 (676)
....+.+++.+||+.||++||++. ++++
T Consensus 219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 219 ISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 233467888899999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=282.40 Aligned_cols=223 Identities=22% Similarity=0.319 Sum_probs=166.3
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHc-cCCcccc--------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLTD-------------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~-------------------- 443 (676)
+.||+|+||.||+|+.. +++.||+|++++. .......+.+|+.++.++ +||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 5889999999754 223445678899888877 7999873
Q ss_pred ------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccce
Q 005803 444 ------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 444 ------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTST 155 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccccc
Confidence 112345778888999999999999999998 9999999999999999999999999987532211 12233
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCc--cchHHHHHHHHhcCCccccCCcccCCCCC
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERP--LNLVGYAWQLWNEGKALELMDPTLDESCS 595 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 595 (676)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+.......... . .+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~----~p 225 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R----IP 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------C----CC
Confidence 6789999999999999999999999999999999999999964322211 1111222222222111 1 12
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCC------HHHHHHH
Q 005803 596 SDEVMRCIHVGLLCVQDRAADRRT------MSDVVSM 626 (676)
Q Consensus 596 ~~~~~~l~~L~~~Cl~~dP~~RPs------~~eVl~~ 626 (676)
......+.+++.+||+.||++||+ +.++++.
T Consensus 226 ~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 226 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 222345778899999999999998 4666543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=282.08 Aligned_cols=223 Identities=22% Similarity=0.310 Sum_probs=168.0
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHc-cCCcccc--------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLTD-------------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~-------------------- 443 (676)
+.||+|+||.||+++.. +++.||||++++. .......+..|..++.++ +||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 5889999999753 223445678899999998 6999872
Q ss_pred ------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccce
Q 005803 444 ------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 444 ------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTST 155 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Ccccc
Confidence 112346788899999999999999999998 9999999999999999999999999987422111 12233
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCC--ccchHHHHHHHHhcCCccccCCcccCCCCC
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTER--PLNLVGYAWQLWNEGKALELMDPTLDESCS 595 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 595 (676)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+.......... .+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~--- 226 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPR--- 226 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCC---
Confidence 678999999999999999999999999999999999999997433222 11111222222222211 1111
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCC------HHHHHHH
Q 005803 596 SDEVMRCIHVGLLCVQDRAADRRT------MSDVVSM 626 (676)
Q Consensus 596 ~~~~~~l~~L~~~Cl~~dP~~RPs------~~eVl~~ 626 (676)
.....+.+++.+||+.||.+||+ ++++++.
T Consensus 227 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 227 -SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred -CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 22335778899999999999997 6777643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=274.99 Aligned_cols=235 Identities=17% Similarity=0.192 Sum_probs=163.0
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC----CcEEEEEEeccCCchhhH-----------HHHHHHHHHHHccCCcccccc-
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD----GQEIAIKRLSKSSGQGIV-----------EFKNEAKLIAKLQHTNLTDSS- 445 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~----~~~VAvK~l~~~~~~~~~-----------~~~~E~~~l~~l~H~niv~~~- 445 (676)
.++|.+.++||+|+||.||+|...+ +..+|+|+.......... ....+...+..+.|+|++...
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999998654 345666654322211111 112233445566888875310
Q ss_pred ----------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEE
Q 005803 446 ----------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKI 497 (676)
Q Consensus 446 ----------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL 497 (676)
.....++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEE
Confidence 0112455667789999999999999998 999999999999999999999
Q ss_pred eccCcceecccccc-----ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH
Q 005803 498 SDFGMARTYAMNEL-----EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY 572 (676)
Q Consensus 498 ~DFGla~~~~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~ 572 (676)
+|||+++.+..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||........ +...
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~--~~~~ 245 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN--LIHA 245 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH--HHHH
Confidence 99999986543211 1112234699999999999999999999999999999999999999986532221 1111
Q ss_pred HHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 573 AWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 573 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
....+ ...+....+.. ......+.+++..|++.+|++||++.++++.|+
T Consensus 246 ~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 246 AKCDF----IKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHH----HHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11000 00001111111 111345778888999999999999999999874
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=283.01 Aligned_cols=220 Identities=24% Similarity=0.338 Sum_probs=166.5
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHcc-CCcccc---------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQ-HTNLTD--------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~-H~niv~--------------- 443 (676)
+|.+.+.||+|+||.||+|+.. +++.||||++.+.. ......+..|..++..+. |++|+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999865 47899999987532 223445677888888775 666541
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-- 155 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC--
Confidence 112245778888999999999999999998 9999999999999999999999999997543221
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... + .........
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~----~~~i~~~~~---------- 218 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L----FQSIMEHNV---------- 218 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---H----HHHHHhCCC----------
Confidence 12233578999999999999999999999999999999999999997543211 1 111111111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCH-----HHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTM-----SDVVS 625 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~-----~eVl~ 625 (676)
..+......+.+++.+||+.+|.+|++. .++.+
T Consensus 219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 219 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 1112233457788999999999999984 56653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=269.68 Aligned_cols=225 Identities=28% Similarity=0.421 Sum_probs=173.2
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
.+|++.+.||+|+||.||+|...+++.+|+|.+... .....++.+|++++++++|||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 467888999999999999998877889999998653 234567899999999999999872
Q ss_pred --------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 444 --------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 444 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......... .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~-~ 158 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-S 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc-c
Confidence 011234678888999999999999999998 9999999999999999999999999987653322111 1
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ......++. ....+..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~--~~~~~~~---- 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETINAGF--RLYKPRL---- 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHhCCC--CCCCCCC----
Confidence 11234568999999998889999999999999999998 999986432211 111111111 1111111
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
....+.+++.+||+.+|++||++.+|++.|.
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2346888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=289.96 Aligned_cols=227 Identities=21% Similarity=0.308 Sum_probs=166.5
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
.|.+++.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++.+++|+||+.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999864 58899999996532 234567889999999999999873
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc--
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL-- 511 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~-- 511 (676)
......+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 112234677778889999999999999998 99999999999999999999999999764311000
Q ss_pred -------------------------------------------ccccceeeccCCccChhhhccCCCCchhHHHHHHHHH
Q 005803 512 -------------------------------------------EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLV 548 (676)
Q Consensus 512 -------------------------------------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl 548 (676)
........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 0001235799999999999988999999999999999
Q ss_pred HHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHH--hcccCcCCCCCHHHHHHH
Q 005803 549 LEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLL--CVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 549 ~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~--Cl~~dP~~RPs~~eVl~~ 626 (676)
|||++|+.||........ ............. ......+ ..+.+++.+ |+..+|..||++.++++.
T Consensus 239 ~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~---~~~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 239 FEMLVGQPPFLAPTPTET------QLKVINWENTLHI---PPQVKLS----PEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHhCCCCCcCCCHHHH------HHHHHccccccCC---CCCCCCC----HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999975432111 0111110000000 0011122 234555555 667777789999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=283.53 Aligned_cols=216 Identities=23% Similarity=0.331 Sum_probs=165.3
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHc-cCCcccc--------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLTD-------------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~-------------------- 443 (676)
+.||+|+||.||+|+.. +++.||||++... .......+..|.+++..+ +||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 4789999998753 233445677899998876 7999862
Q ss_pred ------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccce
Q 005803 444 ------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 444 ------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........ ....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTT 155 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--cccc
Confidence 112345778888899999999999999998 99999999999999999999999999875332221 1233
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChH
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 597 (676)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+.. . .+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-------~~~~i~~~~~------~----~p~~ 218 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-------LFESILHDDV------L----YPVW 218 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC------C----CCCC
Confidence 578999999999999899999999999999999999999997543211 1111111111 0 1111
Q ss_pred HHHHHHHHHHHhcccCcCCCC-------CHHHHHHH
Q 005803 598 EVMRCIHVGLLCVQDRAADRR-------TMSDVVSM 626 (676)
Q Consensus 598 ~~~~l~~L~~~Cl~~dP~~RP-------s~~eVl~~ 626 (676)
....+.+++.+||+.||++|| ++.++++.
T Consensus 219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 224577888999999999999 88888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=291.41 Aligned_cols=230 Identities=23% Similarity=0.272 Sum_probs=172.8
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCccccc-----------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTDS----------- 444 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~~----------- 444 (676)
...++|++.++||+|+||.||+++.. +++.||+|++.+. .......+.+|+.+++.++||||+..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34678999999999999999999865 5889999998643 22334557889999999999998731
Q ss_pred --------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 445 --------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.....++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 11234667778889999999999999998 9999999999999999999999999998654322
Q ss_pred cccccceeeccCCccChhhhccC----CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNG----IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~----~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
.. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... . ...........
T Consensus 197 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~-~~~~i~~~~~~--- 265 (370)
T cd05596 197 MV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------G-TYSKIMDHKNS--- 265 (370)
T ss_pred cc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------H-HHHHHHcCCCc---
Confidence 11 12235799999999998753 4789999999999999999999999754321 1 11111111100
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCcCC--CCCHHHHHHH
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAAD--RRTMSDVVSM 626 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~eVl~~ 626 (676)
+...........+.+++.+||+.+|++ ||++.|+++.
T Consensus 266 ---~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 ---LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000011122345778889999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=270.25 Aligned_cols=224 Identities=29% Similarity=0.414 Sum_probs=170.8
Q ss_pred eeeccCCCccEEEEEEcC----CcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCccccc-------------------
Q 005803 389 NRLGQGGFGPVYNGKLLD----GQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTDS------------------- 444 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~----~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~~------------------- 444 (676)
++||+|+||.||+|+... +..||+|.+..... ...+++.+|+.+++.+.|+|+++.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 479999999999997432 26899999876543 345678999999999999998731
Q ss_pred ------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc-ccce
Q 005803 445 ------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA-NTNR 517 (676)
Q Consensus 445 ------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~ 517 (676)
.....+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||++.......... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 11235788889999999999999999998 9999999999999999999999999998654332111 1111
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCCh
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSS 596 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 596 (676)
..++..|+|||.+.+..++.++|||||||++|||++ |..||...... .. ......+... ..+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~----~~~~~~~~~~---------~~~~ 221 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EV----IAMLESGERL---------PRPE 221 (257)
T ss_pred ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HH----HHHHHcCCcC---------CCCC
Confidence 223467999999998899999999999999999998 99998754321 11 1112222111 1112
Q ss_pred HHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 597 DEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 597 ~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.....+.+++.+||+.+|++||++.+|++.|++..
T Consensus 222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 22346788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=271.35 Aligned_cols=226 Identities=24% Similarity=0.356 Sum_probs=171.9
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-----chhhHHHHHHHHHHHHccCCccccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-----GQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
++|.+.+.||+|++|.||++... +++.||+|.+.... ......+.+|+.++++++||||+..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999864 58999999986432 1234568899999999999998721
Q ss_pred --------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 445 --------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.....+++.....++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 11234667778899999999999999998 9999999999999999999999999997654321
Q ss_pred cccc-cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 511 LEAN-TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 511 ~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .......... ..+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~-----~~~~ 227 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQP-----TNPQ 227 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccC-----CCCC
Confidence 1111 12345788999999999888999999999999999999999998643211 1011111110 0111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+......+.+++.+||+.+|.+||++.++++.
T Consensus 228 ----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 ----LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 122233457788899999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=284.53 Aligned_cols=246 Identities=21% Similarity=0.284 Sum_probs=177.6
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCcccccc-------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTDSS------------- 445 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~------------- 445 (676)
.+++|++.++||+|+||.||+|+.. +++.||||.++.. .......+.+|+.++++++|+||+...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999864 5899999998643 233456688899999999999987311
Q ss_pred ----------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 446 ----------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 446 ----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 83 VYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 1234677888899999999999999998 999999999999999999999999999765432
Q ss_pred ccc-cccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcC-------
Q 005803 510 ELE-ANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG------- 580 (676)
Q Consensus 510 ~~~-~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~------- 580 (676)
... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ............
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHHH
Confidence 211 11223568899999998764 568999999999999999999999996533211 000000000000
Q ss_pred ----Ccc---ccCCcccCC---CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcCcC
Q 005803 581 ----KAL---ELMDPTLDE---SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTNDTM 632 (676)
Q Consensus 581 ----~~~---~~~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~~~ 632 (676)
... ......... ...+.....+.+++.+||+.+|++|||+.|+++. |+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 000 000000000 0001123457899999999999999999999987 665543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=271.30 Aligned_cols=229 Identities=20% Similarity=0.293 Sum_probs=176.2
Q ss_pred cCCCcceeeccCCCccEEEEEEcC----CcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD----GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~----~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
++|.+.++||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++|+|+++.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 468889999999999999998643 2468999987554 3456689999999999999998731
Q ss_pred -------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 445 -------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 445 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 11234788889999999999999999988 99999999999999999999999999986544322
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
... ....++..|+|||.+....++.++||||||+++|||++ |..||......+. ......+... ..
T Consensus 163 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------~~~~~~~~~~-----~~ 229 (270)
T cd05056 163 YKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-------IGRIENGERL-----PM 229 (270)
T ss_pred eec-CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHcCCcC-----CC
Confidence 111 12234567999999988889999999999999999996 9999975432211 1111121111 11
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+......+.+++.+|+..+|++|||+.++++.|++..
T Consensus 230 ----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 230 ----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred ----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1222346788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=280.58 Aligned_cols=217 Identities=22% Similarity=0.309 Sum_probs=165.3
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHc-cCCcccc--------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL-QHTNLTD-------------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~-------------------- 443 (676)
+.||+|+||.||+|+.. +++.||+|++++.. ......+.+|+.++.++ +|+||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 57899999997542 23445688999999888 5999862
Q ss_pred ------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccce
Q 005803 444 ------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 444 ------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTST 155 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cceec
Confidence 112345888899999999999999999998 9999999999999999999999999987532211 12233
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChH
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 597 (676)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........................ .+ +..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~----p~~ 225 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RI----PRF 225 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CC----CCC
Confidence 67899999999999999999999999999999999999999754433332322223333222111 11 112
Q ss_pred HHHHHHHHHHHhcccCcCCCCCH
Q 005803 598 EVMRCIHVGLLCVQDRAADRRTM 620 (676)
Q Consensus 598 ~~~~l~~L~~~Cl~~dP~~RPs~ 620 (676)
....+.+++.+||+.||++||++
T Consensus 226 ~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 226 LSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCHHHHHHHHHHhccCHHHcCCC
Confidence 22446788899999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=287.12 Aligned_cols=212 Identities=26% Similarity=0.332 Sum_probs=163.1
Q ss_pred eeeccCCCccEEEEEE----cCCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc------------------
Q 005803 389 NRLGQGGFGPVYNGKL----LDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS------------------ 444 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~----~~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~------------------ 444 (676)
+.||+|+||.||+++. .+++.||+|++.... ......+.+|++++++++||||++.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 357899999997532 2234567789999999999998731
Q ss_pred --------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccc
Q 005803 445 --------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516 (676)
Q Consensus 445 --------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 516 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... ....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~ 156 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAY 156 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Ccee
Confidence 12335788889999999999999999998 9999999999999999999999999987643321 1223
Q ss_pred eeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCCh
Q 005803 517 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSS 596 (676)
Q Consensus 517 ~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 596 (676)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||....... .......... . .+.
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-------~~~~i~~~~~------~----~p~ 219 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-------TMTMILKAKL------G----MPQ 219 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-------HHHHHHcCCC------C----CCC
Confidence 3578999999999998889999999999999999999999997543211 1111111111 1 111
Q ss_pred HHHHHHHHHHHHhcccCcCCCCCHHH
Q 005803 597 DEVMRCIHVGLLCVQDRAADRRTMSD 622 (676)
Q Consensus 597 ~~~~~l~~L~~~Cl~~dP~~RPs~~e 622 (676)
.....+.+++.+||+.||++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 22345678889999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=279.15 Aligned_cols=230 Identities=24% Similarity=0.377 Sum_probs=174.1
Q ss_pred cCCCcceeeccCCCccEEEEEEcC--------CcEEEEEEeccCC-chhhHHHHHHHHHHHHc-cCCccccc--------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD--------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLTDS-------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~--------~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~-------- 444 (676)
.+|.+.+.||+|+||.||+++... ...||+|.+.... .....++.+|+.++.++ +|+||+..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468889999999999999997421 2368999886532 33457889999999999 79998720
Q ss_pred ----------------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc
Q 005803 445 ----------------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD 490 (676)
Q Consensus 445 ----------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~ 490 (676)
.....+++..++.++.|++.||.|||+++ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 01123677788889999999999999998 99999999999999
Q ss_pred CCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccch
Q 005803 491 EQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNL 569 (676)
Q Consensus 491 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l 569 (676)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence 999999999999986543222111222334567999999999999999999999999999998 888886432111
Q ss_pred HHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 570 VGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 570 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.......+...+ .+......+.+++.+||+.+|++||++.|+++.|+...
T Consensus 245 ---~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 245 ---LFKLLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ---HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 111222211111 11223346788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=267.98 Aligned_cols=221 Identities=32% Similarity=0.466 Sum_probs=174.0
Q ss_pred eeeccCCCccEEEEEEcC----CcEEEEEEeccCCch-hhHHHHHHHHHHHHccCCcccc--------------------
Q 005803 389 NRLGQGGFGPVYNGKLLD----GQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLTD-------------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~----~~~VAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~-------------------- 443 (676)
+.||+|+||.||+|.... +..||+|.+...... ..+.+.+|++++..++|+|+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998653 788999999765433 3678899999999999999872
Q ss_pred ------ccc---------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 444 ------SSR---------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ------~~~---------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
... ...+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 011 367899999999999999999999988 99999999999999999999999999987654
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
...........++..|+|||.+....++.++||||||+++|||++ |..||....... .......+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~---- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYRL---- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC----
Confidence 332222333567889999999988889999999999999999999 699987652211 11122121111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
..+......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 227 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111222456888999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=302.83 Aligned_cols=229 Identities=27% Similarity=0.421 Sum_probs=169.4
Q ss_pred HHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 379 AAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 379 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
.+...+|+.++.||+||||.||+++.+ ||+.+|||++... .......+.+|+++|++|+|||+|+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 456678899999999999999999865 8999999999754 3444567889999999999999870
Q ss_pred --------------------------------------------------------------------------------
Q 005803 444 -------------------------------------------------------------------------------- 443 (676)
Q Consensus 444 -------------------------------------------------------------------------------- 443 (676)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ---------------------------------------------------ccccCcC--CHHHHHHHHHHHHHHHHHHH
Q 005803 444 ---------------------------------------------------SSRKSLL--DWKKRFYIIEGIVQGLLYLH 470 (676)
Q Consensus 444 ---------------------------------------------------~~~~~~l--~~~~~~~i~~qia~gL~yLH 470 (676)
......+ .-...++++++|++||+|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0000111 12344679999999999999
Q ss_pred hcCCCceEeeccccCceEEcCCCCeEEeccCcceecc----c------------cccccccceeeccCCccChhhhccC-
Q 005803 471 KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA----M------------NELEANTNRIVGTHGYMSPEYVMNG- 533 (676)
Q Consensus 471 ~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~----~------------~~~~~~~~~~~gt~~Y~APE~~~~~- 533 (676)
++| ||||||||.||+++++..|||+|||+|+... . .......+..+||.-|+|||++.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 9999999999999999999999999998621 0 0111133457899999999999764
Q ss_pred --CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcc
Q 005803 534 --IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQ 611 (676)
Q Consensus 534 --~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~ 611 (676)
.|+.|+|+|||||||+||+. ||.... +... ....++.+.+... ..+...+...-.+++.++++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~----iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERAS----ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchH--HHHH----HHHhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence 49999999999999999985 454321 1111 1122223333222 12223333445678899999
Q ss_pred cCcCCCCCHHHHHH
Q 005803 612 DRAADRRTMSDVVS 625 (676)
Q Consensus 612 ~dP~~RPs~~eVl~ 625 (676)
.||.+|||+.|++.
T Consensus 857 hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 857 HDPSKRPTATELLN 870 (1351)
T ss_pred CCCccCCCHHHHhh
Confidence 99999999999875
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=267.71 Aligned_cols=225 Identities=25% Similarity=0.345 Sum_probs=162.2
Q ss_pred eeeccCCCccEEEEEEcC---CcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCccccc-----------------c--
Q 005803 389 NRLGQGGFGPVYNGKLLD---GQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTDS-----------------S-- 445 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~---~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~~-----------------~-- 445 (676)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++|||+++. .
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998643 45799999865432 334578899999999999998721 0
Q ss_pred ------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 446 ------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 446 ------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 0112345566789999999999999998 9999999999999999999999999997543322222
Q ss_pred ccceeeccCCccChhhhccC-------CCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCcccc
Q 005803 514 NTNRIVGTHGYMSPEYVMNG-------IVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALEL 585 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~-------~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (676)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+. . .....+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~----~~~~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---L----TYTVREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---H----HHHhhcccCCC
Confidence 22234567889999988642 35789999999999999996 9999975432211 1 01111112222
Q ss_pred CCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 586 MDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 586 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
.++.+... ....+.+++..|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 23332222 2234667888898 58999999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=278.94 Aligned_cols=230 Identities=25% Similarity=0.385 Sum_probs=174.3
Q ss_pred cCCCcceeeccCCCccEEEEEEc--------CCcEEEEEEeccCC-chhhHHHHHHHHHHHHc-cCCcccccc-------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL--------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLTDSS------- 445 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~--------~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~------- 445 (676)
++|.+.++||+|+||.||+++.. ....||+|.++... .....++.+|+.+++++ +||||++..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57888999999999999999742 24568999987542 33456788999999999 699987210
Q ss_pred -----------------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc
Q 005803 446 -----------------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD 490 (676)
Q Consensus 446 -----------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~ 490 (676)
....+++.++..++.||+.||.|||+++ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 1134778888999999999999999988 99999999999999
Q ss_pred CCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccch
Q 005803 491 EQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNL 569 (676)
Q Consensus 491 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l 569 (676)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---- 244 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---- 244 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence 999999999999986543222111111234467999999998899999999999999999999 888886432211
Q ss_pred HHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 570 VGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 570 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.......+...+ .+......+.+++.+||+.+|++||++.++++.|++..
T Consensus 245 ---~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 245 ---LFKLLREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ---HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 112222221111 11222345778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=281.81 Aligned_cols=210 Identities=23% Similarity=0.354 Sum_probs=161.6
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHc-cCCcccc--------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLTD-------------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~-------------------- 443 (676)
+.||+|+||.||+|+.. +++.||||++.+. .......+..|..++..+ +||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 5889999998653 233455677888888876 6999872
Q ss_pred ------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccce
Q 005803 444 ------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 444 ------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
......+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTST 155 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Ccccc
Confidence 112345778888999999999999999998 9999999999999999999999999987532221 12233
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChH
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 597 (676)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+.. .+ +..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~------~~----~~~ 218 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEV------VY----PTW 218 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCC------CC----CCC
Confidence 578999999999999899999999999999999999999997543211 1111212111 01 111
Q ss_pred HHHHHHHHHHHhcccCcCCCCCH
Q 005803 598 EVMRCIHVGLLCVQDRAADRRTM 620 (676)
Q Consensus 598 ~~~~l~~L~~~Cl~~dP~~RPs~ 620 (676)
....+.+++.+||+.||++||++
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCHHHHHHHHHHcccCHHHCCCC
Confidence 23457788899999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=280.66 Aligned_cols=216 Identities=25% Similarity=0.348 Sum_probs=166.4
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHc-cCCccccc-------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLTDS------------------- 444 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~------------------- 444 (676)
+.||+|+||.||+|+.. +++.||||++++. .......+..|..++..+ +||||+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 4789999999753 233455677899999888 69998731
Q ss_pred -------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccce
Q 005803 445 -------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 445 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTST 155 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccccc
Confidence 12235788889999999999999999998 9999999999999999999999999987532211 12233
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChH
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 597 (676)
..|++.|+|||++.+..++.++|||||||++|||++|+.||....... .......... .. +..
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-------~~~~i~~~~~------~~----~~~ 218 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-------LFQSILEDEV------RY----PRW 218 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCC------CC----CCc
Confidence 578999999999999999999999999999999999999997433111 1111111111 11 112
Q ss_pred HHHHHHHHHHHhcccCcCCCCCH-----HHHHHH
Q 005803 598 EVMRCIHVGLLCVQDRAADRRTM-----SDVVSM 626 (676)
Q Consensus 598 ~~~~l~~L~~~Cl~~dP~~RPs~-----~eVl~~ 626 (676)
....+.+++.+||+.||++||++ .++++.
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 23457889999999999999999 888754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=266.80 Aligned_cols=222 Identities=24% Similarity=0.380 Sum_probs=174.8
Q ss_pred cCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
++|++.+.||+|+||.||+|+..+ ++.||+|.+..... .+++.+|++++++++|+|++..
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678999999999999999998765 88999999865422 6789999999999999998720
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence 12456788999999999999999999998 99999999999999999999999999986543321 1
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||......... ..... ...+.+. .
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~-----~~~~~~~--~ 221 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPN-----KPPPTLS--D 221 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhcc-----CCCCCCC--c
Confidence 22345788999999999889999999999999999999999999754322110 00000 0001111 1
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
+......+.+++.+||+.||++|||+.||++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 2223346788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=291.63 Aligned_cols=226 Identities=29% Similarity=0.393 Sum_probs=174.5
Q ss_pred ceeeccCCCccEEEEEEcC--C--cE-EEEEEecc---CCchhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 388 ANRLGQGGFGPVYNGKLLD--G--QE-IAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~--~--~~-VAvK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
.++||+|+||.||+|++.. + .. ||||..+. .......+|.+|+++|++++|||||+
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 5899999999999998653 2 23 89999875 24567789999999999999999982
Q ss_pred ----------c-cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 ----------S-SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 ----------~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
. .....++..+++.++.+.|.||+|||+++ +|||||-.+|+|++.++.+||+|||+++.-..-.
T Consensus 242 l~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~-- 316 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV-- 316 (474)
T ss_pred ecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCccee--
Confidence 1 11225889999999999999999999998 9999999999999999999999999987543111
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHH-hcCCccccCCccc
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLW-NEGKALELMDPTL 590 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~-~~~~~~~~~d~~l 590 (676)
.......-...|+|||.+..+.|+.++|||||||++||+++ |..||......+ +.... .++...
T Consensus 317 ~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-------v~~kI~~~~~r~------- 382 (474)
T KOG0194|consen 317 MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-------VKAKIVKNGYRM------- 382 (474)
T ss_pred eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-------HHHHHHhcCccC-------
Confidence 11111123568999999999999999999999999999999 888987654321 11111 222211
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCC
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMAL 634 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l 634 (676)
..+...+..+..++..||..+|++||+|.+|.+.|+.+....
T Consensus 383 --~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 383 --PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred --CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 122233445667777999999999999999999998886433
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=278.38 Aligned_cols=214 Identities=25% Similarity=0.366 Sum_probs=161.8
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHc-cCCcccc--------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL-QHTNLTD-------------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~-------------------- 443 (676)
+.||+|+||.||+|+.. +++.||||.++... ......+..|..++..+ +||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 58899999997532 23445567788888754 8999872
Q ss_pred ------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccce
Q 005803 444 ------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 444 ------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAST 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cceec
Confidence 112235677888899999999999999998 9999999999999999999999999987432111 12233
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChH
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 597 (676)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+....+ .+.+.. .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-------~~~~~~~~------~~~~~~----~ 218 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-------LFESIRVD------TPHYPR----W 218 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhC------CCCCCC----C
Confidence 678999999999999999999999999999999999999997443211 11111111 111111 1
Q ss_pred HHHHHHHHHHHhcccCcCCCCCHH-HHH
Q 005803 598 EVMRCIHVGLLCVQDRAADRRTMS-DVV 624 (676)
Q Consensus 598 ~~~~l~~L~~~Cl~~dP~~RPs~~-eVl 624 (676)
....+.+++.+||+.||++||++. +++
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 233567888899999999999984 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=273.81 Aligned_cols=227 Identities=24% Similarity=0.360 Sum_probs=176.5
Q ss_pred HhcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
..++|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+|++..
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 346899999999999999999986 4699999999976555566778999999999999998731
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++.........
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-- 171 (297)
T cd06656 97 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 171 (297)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC--
Confidence 11234677888999999999999999998 999999999999999999999999998765433211
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||........... ....+ .+.+ ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~------~~~~--~~ 237 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG------TPEL--QN 237 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC------CCCC--CC
Confidence 1234678899999999998899999999999999999999999965432211100 00000 0011 01
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+......+.+++.+||+.+|++||++.+|++.
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12233456788899999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=269.67 Aligned_cols=229 Identities=24% Similarity=0.367 Sum_probs=173.8
Q ss_pred cCCCcceeeccCCCccEEEEEEc-C---CcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-D---GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~---~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
.+|++.+.||+|+||.||+|+.. + +..+|+|.++... ....+.+.+|+.++.+++||||++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999999864 2 3379999986543 3345678999999999999998720
Q ss_pred --------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 445 --------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.....+++.+++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 11235688888999999999999999998 9999999999999999999999999998654322
Q ss_pred cccc-cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 511 LEAN-TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 511 ~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
.... .....++..|+|||.+.+..++.++||||||+++||+++ |..||......+ . .....++. ..
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~----~~~~~~~~-----~~ 228 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---V----IKAIEEGY-----RL 228 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---H----HHHHhCCC-----cC
Confidence 1111 111223467999999998889999999999999999887 999987543221 1 11111111 01
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
. .+......+.+++.+|++.+|.+||+|.++++.|++.
T Consensus 229 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 P----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred C----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1 1112234578899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=270.94 Aligned_cols=236 Identities=23% Similarity=0.310 Sum_probs=169.0
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
+|++.+.||+|++|.||+|+.. +++.||||++.... ......+.+|+.++++++|||+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5788999999999999999875 58999999986432 223467889999999999999872
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-- 155 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc--
Confidence 011245788888999999999999999998 9999999999999999999999999997643221
Q ss_pred cccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHH-----HHHHhcC------
Q 005803 513 ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYA-----WQLWNEG------ 580 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~-----~~~~~~~------ 580 (676)
.......+++.|+|||.+.+. .++.++|||||||++|||++|+.||............... ...+...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 111224568899999988754 5789999999999999999999999754321100000000 0000000
Q ss_pred --CccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 581 --KALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 581 --~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.........+. ........++.+++.+||+.||++|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 001112345678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=268.87 Aligned_cols=220 Identities=25% Similarity=0.394 Sum_probs=171.7
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
++|++.+.||+|+||.||++.. .++.||+|.++.. .....+.+|+.++++++|||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCC
Confidence 4688899999999999999975 6788999998653 23467899999999999999872
Q ss_pred --------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 444 --------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 444 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 111234678888999999999999999988 9999999999999999999999999987543211
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
.....+..|+|||.+.+..++.++|+|||||++|||++ |+.||....... .......+...+ .
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~ 218 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGYRME---------P 218 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCCCCCC---------C
Confidence 11234567999999988899999999999999999998 999986443211 111222211111 1
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
+......+.+++.+||+.+|++||++++|++.|++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11233457789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=270.06 Aligned_cols=235 Identities=19% Similarity=0.262 Sum_probs=169.1
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
+|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++|+|+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5788999999999999999875 58999999986532 223356788999999999999872
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......+++.....++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (284)
T cd07839 81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--C 155 (284)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--C
Confidence 012345788899999999999999999998 99999999999999999999999999976533211 1
Q ss_pred cceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcC------CccccCC
Q 005803 515 TNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG------KALELMD 587 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~------~~~~~~d 587 (676)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.|+....... ............. ...+..+
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhccc
Confidence 1224578899999998764 47899999999999999999998864322211 0000000000000 0000000
Q ss_pred c----ccCC-----CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 588 P----TLDE-----SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 588 ~----~l~~-----~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
. .... ...+.....+.+++.+||+.||.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 0000 011122346778999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=276.08 Aligned_cols=236 Identities=23% Similarity=0.361 Sum_probs=174.6
Q ss_pred cCCCcceeeccCCCccEEEEEE-----cCCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKL-----LDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~-----~~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
+.|++.+.||+|+||.||+++. .++..||+|.++... ......+.+|+.++++++|+|++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3567899999999999999974 247889999987543 3345678999999999999998620
Q ss_pred -----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 445 -----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 445 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
.....+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccc
Confidence 11124688888999999999999999998 9999999999999999999999999998654
Q ss_pred ccccc-cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCC--------CccchHHHHHHHHh
Q 005803 508 MNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTE--------RPLNLVGYAWQLWN 578 (676)
Q Consensus 508 ~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~--------~~~~l~~~~~~~~~ 578 (676)
..... .......++..|+|||.+.+..++.++|||||||++|||++++.|....... ..............
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 32211 1112345677899999998888999999999999999999987764321100 00000011111111
Q ss_pred cCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 579 EGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 579 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.+... .........+.+++.+||+.+|++||++.++++.|+.+
T Consensus 241 ~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111 11122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=272.08 Aligned_cols=230 Identities=25% Similarity=0.385 Sum_probs=175.1
Q ss_pred cCCCcceeeccCCCccEEEEEEcC-Cc----EEEEEEeccCCc-hhhHHHHHHHHHHHHccCCccccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD-GQ----EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~-~~----~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
.+|++.+.||+|+||.||+|...+ ++ .||+|.+..... ....++.+|+.++++++|+|++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 567888999999999999998643 33 589998875533 345678999999999999998731
Q ss_pred --------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 445 --------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.....+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++......
T Consensus 87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 11234788899999999999999999988 9999999999999999999999999998654322
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
.........++..|+|||.+....++.++|+||||+++||+++ |+.||......+ .......+...
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~------ 230 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGERL------ 230 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhCCCCC------
Confidence 2111111223567999999988889999999999999999998 999987543211 11111111110
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
..+......+.+++.+||..+|++||++.++++.|+...
T Consensus 231 ---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 231 ---PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 011112235778889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=279.47 Aligned_cols=215 Identities=27% Similarity=0.386 Sum_probs=162.8
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHH-ccCCcccc--------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAK-LQHTNLTD-------------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~-l~H~niv~-------------------- 443 (676)
+.||+|+||.||+|+.. +++.||||+++... ......+..|..++.. ++||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 47899999987542 2334556778888876 48999872
Q ss_pred ------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccce
Q 005803 444 ------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 444 ------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCT 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cceee
Confidence 112245788888999999999999999998 9999999999999999999999999987532211 12234
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChH
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 597 (676)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......... +... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~------~~~~----~~ 218 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-------LFQSIRMDN------PCYP----RW 218 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC------CCCC----cc
Confidence 578999999999999899999999999999999999999997543211 111111111 1111 11
Q ss_pred HHHHHHHHHHHhcccCcCCCCCHH-HHHH
Q 005803 598 EVMRCIHVGLLCVQDRAADRRTMS-DVVS 625 (676)
Q Consensus 598 ~~~~l~~L~~~Cl~~dP~~RPs~~-eVl~ 625 (676)
....+.+++.+||+.||++||++. ++.+
T Consensus 219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 LTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 223567888999999999999997 6643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=288.23 Aligned_cols=232 Identities=21% Similarity=0.277 Sum_probs=171.0
Q ss_pred HHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCccccc---------
Q 005803 378 IAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTDS--------- 444 (676)
Q Consensus 378 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~~--------- 444 (676)
+....++|++.+.||+|+||.||+++.. +++.||+|.+.+. .......+.+|+.+++.++||||++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3445678999999999999999999875 4889999998642 22234567899999999999998731
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 11234677788889999999999999998 99999999999999999999999999987543
Q ss_pred cccccccceeeccCCccChhhhccC----CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccc
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNG----IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~----~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (676)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..............
T Consensus 195 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~ 267 (370)
T cd05621 195 TGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNSLN 267 (370)
T ss_pred CCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCcccC
Confidence 221 112346799999999998754 3789999999999999999999999754321 11111111111000
Q ss_pred cCCcccCCCCChHHHHHHHHHHHHhcccCcCC--CCCHHHHHHH
Q 005803 585 LMDPTLDESCSSDEVMRCIHVGLLCVQDRAAD--RRTMSDVVSM 626 (676)
Q Consensus 585 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~eVl~~ 626 (676)
... .......+.+++..|++.++.. ||++.|+++.
T Consensus 268 -----~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 -----FPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----CCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111 1122334667777888755543 8999999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=265.76 Aligned_cols=222 Identities=26% Similarity=0.352 Sum_probs=173.3
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
+|++.+.||+|++|.||+++.. +++.||+|++.... ....+.+.+|++++++++|+|++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5888999999999999999865 47889999986532 2345678899999999999998720
Q ss_pred -------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 445 -------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 445 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
.....+++.++..++.+++.||++||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 11234678888999999999999999998 99999999999999999999999999986643221
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
......+++.|+|||.+.+..++.++||||||++++||++|+.||..... ..... ....+... .
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~-~~~~~~~~-----~-- 221 (257)
T cd08223 158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVY-RIIEGKLP-----P-- 221 (257)
T ss_pred --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHH-HHHhcCCC-----C--
Confidence 22235678899999999999999999999999999999999999864321 11111 11122111 1
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 222 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 --MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 122334568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=288.76 Aligned_cols=227 Identities=21% Similarity=0.283 Sum_probs=167.1
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
++|.+.++||+|+||.||+++.. +++.||||++.+. .......+.+|++++++++||||++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999864 6899999998643 22345678899999999999998731
Q ss_pred ------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 445 ------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 445 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
.....+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 12345677788889999999999999998 999999999999999999999999998643210000
Q ss_pred ---------------------------------------------cccceeeccCCccChhhhccCCCCchhHHHHHHHH
Q 005803 513 ---------------------------------------------ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVL 547 (676)
Q Consensus 513 ---------------------------------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvv 547 (676)
......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 00012469999999999999999999999999999
Q ss_pred HHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCC---CCHHHHH
Q 005803 548 VLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADR---RTMSDVV 624 (676)
Q Consensus 548 l~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R---Ps~~eVl 624 (676)
+|||++|+.||......+. ............. .. .......+.+++.+||+ +|.+| +++.|++
T Consensus 238 l~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~-----p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 238 MFECLIGWPPFCSENSHET------YRKIINWRETLYF-----PD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred hhhhhcCCCCCCCCCHHHH------HHHHHccCCccCC-----CC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 9999999999975432111 0111110000110 00 01122346678888997 67765 5999988
Q ss_pred HH
Q 005803 625 SM 626 (676)
Q Consensus 625 ~~ 626 (676)
+.
T Consensus 304 ~h 305 (377)
T cd05629 304 SH 305 (377)
T ss_pred cC
Confidence 75
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=267.64 Aligned_cols=222 Identities=23% Similarity=0.305 Sum_probs=172.7
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
+|++.++||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.+++.++|+|++.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999865 5889999998643 2344567889999999999999862
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......++......++.||+.||.|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 112234678888899999999999999998 99999999999999999999999999976543221
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 593 (676)
......|+..|+|||++.+..++.++|+||||+++|+|++|+.||...... .. ......+.... +
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~-~~~~~~~~~~~-----~--- 220 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NL-ILKVCQGSYKP-----L--- 220 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HH-HHHHhcCCCCC-----C---
Confidence 122356888999999999888999999999999999999999999743211 11 11111222111 1
Q ss_pred CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 594 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+......+.+++.+||+.||++||++.+|+..
T Consensus 221 -~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 -PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11223357788999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=268.99 Aligned_cols=213 Identities=20% Similarity=0.292 Sum_probs=161.2
Q ss_pred eeeccCCCccEEEEEEcC-------------CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-----------
Q 005803 389 NRLGQGGFGPVYNGKLLD-------------GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS----------- 444 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~-------------~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~----------- 444 (676)
+.||+|+||.||+|+..+ ...||+|.+..........+.+|+.+++.++||||+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 22589998876555556678899999999999998721
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC-------eEEeccC
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN-------PKISDFG 501 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~-------vkL~DFG 501 (676)
.....+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 12345788889999999999999999998 999999999999986654 8999999
Q ss_pred cceeccccccccccceeeccCCccChhhhc-cCCCCchhHHHHHHHHHHHHH-hCCcCCCCCCCCCccchHHHHHHHHhc
Q 005803 502 MARTYAMNELEANTNRIVGTHGYMSPEYVM-NGIVSMKSDVYSFGVLVLEIV-SSKKNNGSYDTERPLNLVGYAWQLWNE 579 (676)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwSlGvvl~ell-tG~~pf~~~~~~~~~~l~~~~~~~~~~ 579 (676)
++...... ....++..|+|||.+. +..++.++|||||||++|||+ .|+.|+......+. .....
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--------~~~~~ 223 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--------ERFYE 223 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--------HHHHh
Confidence 98754321 2245788999999887 467899999999999999998 57777754321110 01111
Q ss_pred CCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 580 GKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 580 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
+.. . . .......+.+++.+||+.||.+||++.+|++.|+
T Consensus 224 ~~~-~-----~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 GQC-M-----L----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCc-c-----C----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 111 0 0 1112345778999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=268.86 Aligned_cols=224 Identities=26% Similarity=0.356 Sum_probs=164.6
Q ss_pred eeeccCCCccEEEEEEcC----CcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCccccc-------------------
Q 005803 389 NRLGQGGFGPVYNGKLLD----GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTDS------------------- 444 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~----~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~~------------------- 444 (676)
+.||+|+||.||+|...+ ...||+|++... .....+.+.+|+.+++.++|||++..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 457999998543 23445678899999999999998731
Q ss_pred ---------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc--c
Q 005803 445 ---------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE--A 513 (676)
Q Consensus 445 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~--~ 513 (676)
.....+.+...+.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 01123456677889999999999999988 999999999999999999999999999754322111 1
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhC-CcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSS-KKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG-~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
......++..|+|||.+.+..++.++|||||||++|||++| .+||..... ..+. . ....+.. ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~---~-~~~~~~~-----~~~-- 223 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDIT---V-YLLQGRR-----LLQ-- 223 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH---H-HHhcCCC-----CCC--
Confidence 11123456789999999888999999999999999999995 455543211 1111 1 1111111 000
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+......+.+++..||+.+|++||++.+|++.|++..
T Consensus 224 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 --PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1112345788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=266.32 Aligned_cols=225 Identities=24% Similarity=0.325 Sum_probs=159.4
Q ss_pred eeeccCCCccEEEEEEcC---CcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccccc-------------------
Q 005803 389 NRLGQGGFGPVYNGKLLD---GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDSS------------------- 445 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~---~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~------------------- 445 (676)
++||+|+||.||+|...+ ...+|+|.+.... ......+.+|+.+++.++|+||++..
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 4568899876433 23345688999999999999987310
Q ss_pred ------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 446 ------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 446 ------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 0112345667889999999999999998 9999999999999999999999999986543222111
Q ss_pred ccceeeccCCccChhhhcc-------CCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCcccc
Q 005803 514 NTNRIVGTHGYMSPEYVMN-------GIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALEL 585 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~-------~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (676)
......++..|+|||++.. ..++.++|||||||++|||++ |..||......+ . ..... .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~---~~~~~-~~~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---V---LKQVV-REQDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---H---HHHHh-hccCccC
Confidence 1122345678999998753 356889999999999999999 778886442211 1 11111 1222222
Q ss_pred CCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 586 MDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 586 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
.++.+... ....+.+++..|+ .||++||++++|++.|.
T Consensus 231 ~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 23333222 2234556777888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=289.81 Aligned_cols=227 Identities=20% Similarity=0.276 Sum_probs=166.3
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
.+|++.+.||+|+||.||+++.. +++.||||++.+.. ......+.+|+.++++++|+||+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 37899999999999999999865 58999999986432 233456889999999999999873
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc--
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE-- 510 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~-- 510 (676)
......+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 112235677777889999999999999998 9999999999999999999999999975321000
Q ss_pred ---------------------------------------cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHH
Q 005803 511 ---------------------------------------LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEI 551 (676)
Q Consensus 511 ---------------------------------------~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~el 551 (676)
.........||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00001134799999999999999999999999999999999
Q ss_pred HhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCC---CHHHHHHH
Q 005803 552 VSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRR---TMSDVVSM 626 (676)
Q Consensus 552 ltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP---s~~eVl~~ 626 (676)
++|+.||......+. ... ....... ......... ...+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 238 l~G~~Pf~~~~~~~~------~~~-i~~~~~~--~~~~~~~~~----s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAET------QLK-VINWETT--LHIPSQAKL----SREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHH------HHH-HhccCcc--ccCCCCCCC----CHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999975432111 011 1111000 000001112 223555666665 4999999 88998866
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=270.57 Aligned_cols=224 Identities=25% Similarity=0.407 Sum_probs=175.1
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
++|++.+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|+|++.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999865 58899999987543 344567889999999999999872
Q ss_pred --------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 444 --------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 444 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
......+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~ 155 (274)
T cd06609 81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KR 155 (274)
T ss_pred eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc--cc
Confidence 111236788999999999999999999998 99999999999999999999999999987654321 22
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCS 595 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 595 (676)
....++..|+|||.+.+..++.++||||||+++|||++|+.||....... . ......+ ..+.+...
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~----~~~~~~~-----~~~~~~~~-- 221 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---V----LFLIPKN-----NPPSLEGN-- 221 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---H----HHHhhhc-----CCCCCccc--
Confidence 23567889999999998889999999999999999999999996543211 1 1111111 11111111
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 596 SDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 596 ~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.....+.+++.+||+.+|++||+++++++.
T Consensus 222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 -KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 023357788899999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=266.75 Aligned_cols=222 Identities=27% Similarity=0.370 Sum_probs=170.4
Q ss_pred eeeccCCCccEEEEEEcC--C--cEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCcccccc------------------
Q 005803 389 NRLGQGGFGPVYNGKLLD--G--QEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTDSS------------------ 445 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~--~--~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~------------------ 445 (676)
++||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|+.++++++|+||+...
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 468999999999998643 3 3689999987655 5667899999999999999987310
Q ss_pred --------cc-CcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc-ccc
Q 005803 446 --------RK-SLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE-ANT 515 (676)
Q Consensus 446 --------~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~ 515 (676)
.. ..+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++......... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 11 35788889999999999999999998 999999999999999999999999999876442211 111
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ . ........... ..
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~---~~~~~~~~~~~---------~~ 222 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---I---LKKIDKEGERL---------ER 222 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHHHHhcCCcC---------CC
Confidence 22456788999999998899999999999999999998 999986432211 1 11111111100 01
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
+......+.+++.+||+.+|++||++.+|++.|.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1123346788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=302.29 Aligned_cols=232 Identities=22% Similarity=0.284 Sum_probs=172.6
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccccc-------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTDSS------------- 445 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~------------- 445 (676)
++|++.++||+|+||.||+|+.. +++.||||++.... ....+++.+|++++++++||||+...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 58999999999999999999865 58999999986532 23346789999999999999987310
Q ss_pred ---c---------------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccC
Q 005803 446 ---R---------------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFG 501 (676)
Q Consensus 446 ---~---------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFG 501 (676)
. ...+++...+.++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 0 112344566789999999999999998 9999999999999999999999999
Q ss_pred cceecccccc----------------ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCC
Q 005803 502 MARTYAMNEL----------------EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTER 565 (676)
Q Consensus 502 la~~~~~~~~----------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~ 565 (676)
+++....... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 001123569999999999999999999999999999999999999997532211
Q ss_pred ccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCC-CHHHHHHHHhcCc
Q 005803 566 PLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRR-TMSDVVSMLTNDT 631 (676)
Q Consensus 566 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-s~~eVl~~Le~~~ 631 (676)
.. . .... .++.-. ....+....+.+++.+||+.||++|| +++++++.|+...
T Consensus 239 i~------~----~~~i---~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 239 IS------Y----RDVI---LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred hh------h----hhhc---cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 10 0 0000 000000 00112234577888999999999995 6777877777653
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=271.11 Aligned_cols=222 Identities=27% Similarity=0.425 Sum_probs=172.5
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+.
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4666788999999999999865 57889999986443 344567899999999999999872
Q ss_pred -------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccc
Q 005803 444 -------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516 (676)
Q Consensus 444 -------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 516 (676)
......+++..+..++.|+++||.|||+++ ++|+||+|+||++++++.+||+|||++........ ...
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~ 159 (277)
T cd06642 85 GGGSALDLLKPGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRN 159 (277)
T ss_pred CCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--hhh
Confidence 112245778888999999999999999988 99999999999999999999999999976543221 122
Q ss_pred eeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCCh
Q 005803 517 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSS 596 (676)
Q Consensus 517 ~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 596 (676)
...++..|+|||.+.+..++.++|||||||++|||++|+.|+......... .....+ ..+.+ ..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~-----~~~~~----~~ 223 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-------FLIPKN-----SPPTL----EG 223 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-------hhhhcC-----CCCCC----Cc
Confidence 246788999999999888999999999999999999999998644322110 001111 11111 22
Q ss_pred HHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 597 DEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 597 ~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.....+.+++.+||+.+|++||++.+|++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 234457889999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=274.96 Aligned_cols=225 Identities=22% Similarity=0.343 Sum_probs=175.7
Q ss_pred cCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
.+|++.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+|++.
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4699999999999999999985 468999999997655556678899999999999999872
Q ss_pred -------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccc
Q 005803 444 -------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516 (676)
Q Consensus 444 -------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 516 (676)
......+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++......... ..
T Consensus 99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~ 173 (296)
T cd06655 99 AGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RS 173 (296)
T ss_pred CCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc--CC
Confidence 111235788999999999999999999998 999999999999999999999999998765432211 12
Q ss_pred eeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCCh
Q 005803 517 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSS 596 (676)
Q Consensus 517 ~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 596 (676)
...++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ..... ...... +. .+.
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~-~~~~~~-----~~--~~~ 239 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIA-TNGTPE-----LQ--NPE 239 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-hcCCcc-----cC--Ccc
Confidence 24678899999999988899999999999999999999999965432111 01111 111100 10 111
Q ss_pred HHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 597 DEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 597 ~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.....+.+++.+||+.||.+||++.+|++.
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 223357788899999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=288.69 Aligned_cols=175 Identities=24% Similarity=0.374 Sum_probs=143.4
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
+|+++++||+|+||.||+|+.. +++.||||++.+.. ......+.+|+.++++++|+||+.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999864 58899999986532 234557889999999999999872
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc---
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE--- 510 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~--- 510 (676)
......+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 112234677778889999999999999998 9999999999999999999999999975321100
Q ss_pred ------------------------------------------cccccceeeccCCccChhhhccCCCCchhHHHHHHHHH
Q 005803 511 ------------------------------------------LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLV 548 (676)
Q Consensus 511 ------------------------------------------~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl 548 (676)
........+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 00001234789999999999999999999999999999
Q ss_pred HHHHhCCcCCCCC
Q 005803 549 LEIVSSKKNNGSY 561 (676)
Q Consensus 549 ~elltG~~pf~~~ 561 (676)
|||++|+.||...
T Consensus 239 ~elltG~~Pf~~~ 251 (382)
T cd05625 239 YEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=279.04 Aligned_cols=215 Identities=23% Similarity=0.345 Sum_probs=163.6
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCC-cccc---------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHT-NLTD--------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~-niv~--------------- 443 (676)
+|+..+.||+|+||.||+|+.. +++.||||++.+. .....+.+..|..++..+.|+ +|+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999865 5889999998753 223445678899999888764 4431
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~- 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV- 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence 012245788899999999999999999998 99999999999999999999999999875332211
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......... .
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~~------~--- 219 (323)
T cd05615 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHNV------S--- 219 (323)
T ss_pred -cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC------C---
Confidence 1223568999999999999899999999999999999999999997543211 1111111111 1
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTM 620 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~ 620 (676)
.+......+.+++.+||+.+|.+|++.
T Consensus 220 -~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 -YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111223457788899999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=264.86 Aligned_cols=227 Identities=22% Similarity=0.373 Sum_probs=176.6
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
.++|++.+.||+|+||.||+|... +++.+|+|.+........+.+.+|+.++++++|||++..
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367899999999999999999865 578899999987655667889999999999999998720
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++.....++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 11246788888999999999999999988 99999999999999999999999999876543211
Q ss_pred ccceeeccCCccChhhhccC---CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 514 NTNRIVGTHGYMSPEYVMNG---IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~---~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ... ...... ..+.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~~-~~~~~~---~~~~~ 226 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LFL-ISKSNF---PPPKL 226 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhccC---CCccc
Confidence 11235678899999999776 889999999999999999999999975432111 011 111100 01111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
. ........+.+++.+||+.+|.+||++++|+.
T Consensus 227 ~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 K--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 12234456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=267.97 Aligned_cols=229 Identities=25% Similarity=0.386 Sum_probs=171.7
Q ss_pred HHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 379 AAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 379 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
..+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++|+||++.
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 445666666789999999999999865 578899999877666677789999999999999998720
Q ss_pred --------------cccCcC--CHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC-CCCeEEeccCcceecc
Q 005803 445 --------------SRKSLL--DWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE-QMNPKISDFGMARTYA 507 (676)
Q Consensus 445 --------------~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~-~~~vkL~DFGla~~~~ 507 (676)
.....+ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 011223 66677788999999999999988 999999999999986 6789999999987653
Q ss_pred ccccccccceeeccCCccChhhhccCC--CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcccc
Q 005803 508 MNELEANTNRIVGTHGYMSPEYVMNGI--VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALEL 585 (676)
Q Consensus 508 ~~~~~~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (676)
.... ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||........ .. +. .. .. .
T Consensus 161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~--~~---~~-~~-~ 228 (268)
T cd06624 161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AM--FK---VG-MF-K 228 (268)
T ss_pred cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hH--hh---hh-hh-c
Confidence 3221 122245788999999987643 78999999999999999999999864322110 00 00 00 00 0
Q ss_pred CCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 586 MDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 586 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
..+ ..+......+.+++.+||+.+|++|||+.||++.
T Consensus 229 ~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 IHP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cCC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 011 1222334457888999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=276.06 Aligned_cols=227 Identities=24% Similarity=0.376 Sum_probs=170.3
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCc--EEEEEEeccC-CchhhHHHHHHHHHHHHc-cCCcccccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQ--EIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNLTDSS------------ 445 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~--~VAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~------------ 445 (676)
++|++.+.||+|+||.||+|... ++. .+|+|.++.. ......++.+|++++.++ +|+||++..
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888999999999999999864 344 4688877643 233456788999999999 899987210
Q ss_pred ------------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCe
Q 005803 446 ------------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNP 495 (676)
Q Consensus 446 ------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~v 495 (676)
....+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 0124678889999999999999999988 9999999999999999999
Q ss_pred EEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHH
Q 005803 496 KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAW 574 (676)
Q Consensus 496 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~ 574 (676)
||+|||++...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+ ..
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~ 233 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LY 233 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-------HH
Confidence 99999998642211 11111233567999999988889999999999999999998 999986433211 11
Q ss_pred HHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 575 QLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 575 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.....+. ... .+......+.+++.+||+.+|++||+++++++.|+...
T Consensus 234 ~~~~~~~-----~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 234 EKLPQGY-----RLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HHHhcCC-----cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111110 001 11112335788999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=279.60 Aligned_cols=211 Identities=23% Similarity=0.300 Sum_probs=158.5
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHH-HHHHHccCCccccc-------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEA-KLIAKLQHTNLTDS------------------- 444 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~-~~l~~l~H~niv~~------------------- 444 (676)
+.||+|+||.||+|+.. +++.||+|++.+.. ......+..|. .+++.++||||++.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 58899999986532 22233455555 46788999999831
Q ss_pred -------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccce
Q 005803 445 -------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 445 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
.....+.+.....++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTST 155 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Ccccc
Confidence 12234667778889999999999999998 9999999999999999999999999987532211 12233
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChH
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 597 (676)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...... . ......... + ..+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~-~~~~i~~~~--------~--~~~~~ 218 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------Q-MYDNILHKP--------L--QLPGG 218 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------H-HHHHHhcCC--------C--CCCCC
Confidence 57899999999999889999999999999999999999999753211 1 111111111 0 11222
Q ss_pred HHHHHHHHHHHhcccCcCCCCCHH
Q 005803 598 EVMRCIHVGLLCVQDRAADRRTMS 621 (676)
Q Consensus 598 ~~~~l~~L~~~Cl~~dP~~RPs~~ 621 (676)
....+.+++.+||+.||.+||++.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCC
Confidence 344578899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=270.80 Aligned_cols=238 Identities=23% Similarity=0.306 Sum_probs=171.9
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--hhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
++|++.++||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++|+|+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47888999999999999999875 489999999865322 23456889999999999999872
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-- 155 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--
Confidence 012234788999999999999999999998 99999999999999999999999999886543321
Q ss_pred ccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH--------HHHHHhcCCc-c
Q 005803 514 NTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY--------AWQLWNEGKA-L 583 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~--------~~~~~~~~~~-~ 583 (676)
......++..|+|||++.+ ..++.++||||||+++|||++|++||......+....+.. .......... .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 1223467889999999875 4578899999999999999999999864332110000000 0000000000 0
Q ss_pred ccCCcccCC-----CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 584 ELMDPTLDE-----SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 584 ~~~d~~l~~-----~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
....+.... ...+.....+.+++.+||+.+|++||++.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 001123456889999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=269.52 Aligned_cols=222 Identities=30% Similarity=0.459 Sum_probs=167.8
Q ss_pred eeeccCCCccEEEEEEcC-------CcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 389 NRLGQGGFGPVYNGKLLD-------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~-------~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
+.||+|+||.||+|+..+ ++.||||.+.... .....++.+|+.+++.++||||++.
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2579999886543 2456678999999999999998720
Q ss_pred -----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC-----CeEEeccCc
Q 005803 445 -----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM-----NPKISDFGM 502 (676)
Q Consensus 445 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~-----~vkL~DFGl 502 (676)
.....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 01233677888899999999999999988 99999999999999877 899999999
Q ss_pred ceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCC
Q 005803 503 ARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGK 581 (676)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~ 581 (676)
+................++..|+|||.+.++.++.++|||||||++|||++ |+.||...... .. ......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~----~~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EV----LQHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HH----HHHHhcCC
Confidence 976543322222222345678999999999999999999999999999998 99998643211 11 11111111
Q ss_pred ccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 582 ALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 582 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
.. ..+......+.+++.+||+.+|.+||++.+|++.|++
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 1122234567889999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=286.19 Aligned_cols=231 Identities=22% Similarity=0.332 Sum_probs=173.6
Q ss_pred cCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCCc-hhhHHHHHHHHHHHHcc-CCcccccc---------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQ-HTNLTDSS--------- 445 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~~~--------- 445 (676)
++|.+.++||+|+||.||+|++. .++.||||+++.... ...+.+.+|++++.++. ||||+...
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 46777899999999999999853 246899999975432 23457889999999998 99987200
Q ss_pred --------------------------------------------------------------------------------
Q 005803 446 -------------------------------------------------------------------------------- 445 (676)
Q Consensus 446 -------------------------------------------------------------------------------- 445 (676)
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence
Q ss_pred -----------------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc
Q 005803 446 -----------------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD 490 (676)
Q Consensus 446 -----------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~ 490 (676)
....+++...+.++.||+.||.|||+.+ ++||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence 0013556667889999999999999988 99999999999999
Q ss_pred CCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccch
Q 005803 491 EQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNL 569 (676)
Q Consensus 491 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l 569 (676)
+++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||......+
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~---- 349 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE---- 349 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH----
Confidence 999999999999986533221111222456788999999998889999999999999999998 888986543211
Q ss_pred HHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 570 VGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 570 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
........+.. .. .+......+.+++.+||+.+|.+||++++|++.|+++.
T Consensus 350 --~~~~~~~~~~~-----~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 --QFYNAIKRGYR-----MA----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --HHHHHHHcCCC-----CC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111111111 11 11222346788899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=280.99 Aligned_cols=211 Identities=25% Similarity=0.312 Sum_probs=159.2
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHH-HHHHccCCccccc-------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAK-LIAKLQHTNLTDS------------------- 444 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~~------------------- 444 (676)
+.||+|+||.||+|+.. +++.||||++.+.. .....++..|.. +++.++||||++.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999875 58999999986532 222344555544 5678999998731
Q ss_pred -------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccce
Q 005803 445 -------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 445 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTST 155 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Ccccc
Confidence 12345777888889999999999999998 9999999999999999999999999987532211 12233
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChH
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 597 (676)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......+.. .+.. .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~------~~~~----~ 218 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-------MYDNILNKPL------RLKP----N 218 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCCC------CCCC----C
Confidence 578999999999999999999999999999999999999997542111 1111111111 1111 2
Q ss_pred HHHHHHHHHHHhcccCcCCCCCHH
Q 005803 598 EVMRCIHVGLLCVQDRAADRRTMS 621 (676)
Q Consensus 598 ~~~~l~~L~~~Cl~~dP~~RPs~~ 621 (676)
....+.+++.+||+.||.+||++.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 234577889999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=280.12 Aligned_cols=236 Identities=23% Similarity=0.338 Sum_probs=186.0
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCch-hhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
+...+.++||+|.||.|.++....+..||||+++..... ...+|.+|+++|.+++||||++.
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 455678999999999999999988899999999876544 45889999999999999999831
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....++-.....|+.||+.|++||.+.. +|||||.+.|+|+|.++++||+|||+++-+-..+...
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 01111344556789999999999999987 9999999999999999999999999999766555555
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh--CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS--SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt--G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
...+.+-...|||||.+..++++.++|||+||+++||+++ ...||....+++. ++.+...+..+.... .
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~------~ 765 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQV------V 765 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCcce------e
Confidence 5555667789999999999999999999999999999865 7788886654432 222222222221111 1
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
...+.-+...+.+++++||..|-++||+++++...|...
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 122344556788999999999999999999999998765
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=271.49 Aligned_cols=223 Identities=25% Similarity=0.334 Sum_probs=168.6
Q ss_pred CCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++|+|++.
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667889999999999999864 58899999986532 222345788999999999999862
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 011235788899999999999999999998 9999999999999999999999999987643221
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
......|+..|+|||.+.+..++.++|+|||||++|||++|+.||......... ........... ..
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~~------~~--- 223 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLETE------EV--- 223 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhccc------cc---
Confidence 112356899999999999889999999999999999999999999754321111 11111111110 01
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRT-----MSDVVSM 626 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~eVl~~ 626 (676)
........+.+++..||+.||++||+ +.++++.
T Consensus 224 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 224 -YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11122334678888999999999999 6676664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=286.06 Aligned_cols=234 Identities=21% Similarity=0.262 Sum_probs=171.8
Q ss_pred HHHHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCccccc-------
Q 005803 376 QTIAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTDS------- 444 (676)
Q Consensus 376 ~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~~------- 444 (676)
.++....++|++.+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.+++.++||||+..
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344556689999999999999999999876 5889999998642 22334557889999999999998731
Q ss_pred ------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceec
Q 005803 445 ------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTY 506 (676)
Q Consensus 445 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~ 506 (676)
.....++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 11234567777889999999999999998 999999999999999999999999999865
Q ss_pred cccccccccceeeccCCccChhhhccC----CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCc
Q 005803 507 AMNELEANTNRIVGTHGYMSPEYVMNG----IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKA 582 (676)
Q Consensus 507 ~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~ 582 (676)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ............
T Consensus 193 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~ 265 (371)
T cd05622 193 NKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNS 265 (371)
T ss_pred CcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCc
Confidence 432211 12346799999999998754 3789999999999999999999999753221 111111111111
Q ss_pred cccCCcccCCCCChHHHHHHHHHHHHhcccCcCC--CCCHHHHHHH
Q 005803 583 LELMDPTLDESCSSDEVMRCIHVGLLCVQDRAAD--RRTMSDVVSM 626 (676)
Q Consensus 583 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~eVl~~ 626 (676)
.... ........+.+++.+||+.++.+ ||++.|+++.
T Consensus 266 ~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 266 LTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1111 11123345677888899844433 7899998885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=269.41 Aligned_cols=219 Identities=23% Similarity=0.307 Sum_probs=163.1
Q ss_pred eccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCccccc----------------------
Q 005803 391 LGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTDS---------------------- 444 (676)
Q Consensus 391 LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~~---------------------- 444 (676)
||+|+||.||+++.. +++.||+|.+.... ......+..|++++++++||||+..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999865 58999999986421 1223455679999999999998720
Q ss_pred ------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccccee
Q 005803 445 ------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRI 518 (676)
Q Consensus 445 ------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 518 (676)
.....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 11224677788889999999999999998 9999999999999999999999999987654322 11234
Q ss_pred eccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHH
Q 005803 519 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDE 598 (676)
Q Consensus 519 ~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 598 (676)
.|+..|+|||++.+..++.++|||||||++|||++|+.||........ ..... ....... +... .. ..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~-~~~~~~~----~~~~-~~----~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELK-RRTLEDE----VKFE-HQ----NF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHH-HHhhccc----cccc-cc----cC
Confidence 688999999999988899999999999999999999999975432111 11101 1111111 1000 01 12
Q ss_pred HHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 005803 599 VMRCIHVGLLCVQDRAADRRTMSDVVSML 627 (676)
Q Consensus 599 ~~~l~~L~~~Cl~~dP~~RPs~~eVl~~L 627 (676)
...+.+++.+||+.||++||++.|+++.+
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 33477889999999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=266.94 Aligned_cols=223 Identities=26% Similarity=0.402 Sum_probs=170.5
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCch---------hhHHHHHHHHHHHHccCCccccc---------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQ---------GIVEFKNEAKLIAKLQHTNLTDS--------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~---------~~~~~~~E~~~l~~l~H~niv~~--------- 444 (676)
+|.+.+.||+|++|.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999864 5889999988643221 22567899999999999998720
Q ss_pred -----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 445 -----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 445 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
.....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 11245677888899999999999999988 9999999999999999999999999998664
Q ss_pred ccccc----cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 508 MNELE----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 508 ~~~~~----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
..... .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....... .... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~---- 226 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ------AIFK-IGE---- 226 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH------HHHH-Hhc----
Confidence 22111 11122457889999999998889999999999999999999999997532111 0111 111
Q ss_pred ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 584 ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 584 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
...+.+ +......+.+++.+||+.||.+||++.||++
T Consensus 227 -~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 -NASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -cCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111122 2223345778889999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=275.27 Aligned_cols=223 Identities=20% Similarity=0.338 Sum_probs=182.2
Q ss_pred HhcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCc--hhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
+.+-|.+.+.||+|.|+.|-+|++ -+|..||||++.+..- .....+.+|++.|+.++|||||+
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 445678889999999999999975 4799999999987543 33457899999999999999983
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc-CCCCeEEeccCcceecccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD-EQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~-~~~~vkL~DFGla~~~~~~ 509 (676)
......+.+....+++.||+.|+.|+|+.+ +|||||||+||.+- .-|-+||.|||++..+.+.
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 123345777888899999999999999998 99999999998764 6688999999999876543
Q ss_pred ccccccceeeccCCccChhhhccCCCC-chhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVS-MKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s-~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
. ...+.+|+..|.|||++.+..|+ +++||||||||||.|++|+.||....+.+.... ++|-
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------ImDC 234 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------IMDC 234 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh---------------hhcc
Confidence 3 34457999999999999998886 678999999999999999999987665543322 2232
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.. ..+.....++.+|+..||..||.+|.+.+||+..
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 22 2455667789999999999999999999999864
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=268.53 Aligned_cols=228 Identities=23% Similarity=0.393 Sum_probs=172.5
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
.++|++.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+..
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888899999999999999864 588999999876555555678899999999999998721
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++.+...++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....... ..
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~ 162 (267)
T cd06645 88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK 162 (267)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence 12345788888999999999999999998 9999999999999999999999999987654321 11
Q ss_pred cceeeccCCccChhhhc---cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 515 TNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.....|+..|+|||.+. ...++.++|||||||++|||++|+.||......... .. ....... .+...
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~-~~~~~~~---~~~~~ 232 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FL-MTKSNFQ---PPKLK 232 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------Hh-hhccCCC---CCccc
Confidence 22357899999999874 456889999999999999999999998643321110 00 0011110 11111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
. .......+.+++.+||+.+|++||++++|++.
T Consensus 233 ~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 233 D--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred c--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 1 01122357788999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=270.78 Aligned_cols=223 Identities=23% Similarity=0.362 Sum_probs=170.8
Q ss_pred CCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-------------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------------- 444 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------------- 444 (676)
|++.+.||+|+||.||+|.... +..+|+|.+..........+.+|+++++.++|+|++..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5678899999999999998764 77889999876555667788999999999999998720
Q ss_pred --------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccc
Q 005803 445 --------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516 (676)
Q Consensus 445 --------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 516 (676)
.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence 12345788899999999999999999998 9999999999999999999999999987543221 1122
Q ss_pred eeeccCCccChhhhc-----cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 517 RIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 517 ~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
...++..|+|||++. +..++.++|||||||++|||++|++||....... ...... ........
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~-~~~~~~~~----- 229 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIA-KSEPPTLA----- 229 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHh-hcCCCCCC-----
Confidence 356889999999884 3457889999999999999999999986533211 111111 11111111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+......+.+++.+||+.||.+||++.++++.
T Consensus 230 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 --QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223457788999999999999999998765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=271.23 Aligned_cols=225 Identities=23% Similarity=0.357 Sum_probs=173.3
Q ss_pred cCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
+.|++.++||+|+||.||+|+... ++.||+|.+........+.+.+|+.++++++|+|++..
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 578899999999999999998754 88999999987666667789999999999999998720
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~ 166 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QR 166 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--cc
Confidence 11345788889999999999999999988 9999999999999999999999999987533221 11
Q ss_pred cceeeccCCccChhhhc-----cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 515 TNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
.....++..|+|||++. ...++.++|||||||++|||++|+.||...... ... ........ +.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~-~~~~~~~~-----~~ 234 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVL-LKIAKSEP-----PT 234 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHH-HHHhcCCC-----cc
Confidence 22356788999999884 345788999999999999999999998643211 111 11111111 11
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+. .+......+.+++.+||+.+|++||++++|++.
T Consensus 235 ~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 235 LS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 10 111223457788999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=261.20 Aligned_cols=226 Identities=24% Similarity=0.321 Sum_probs=172.5
Q ss_pred HhcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccccc------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDSS------------ 445 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~------------ 445 (676)
.++.|++.+.||+|.|+.||+... .+|+.+|+|++... ...+.+++.+|+.|-+.|+||||++..
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356788899999999999999864 56999999987532 344678899999999999999998421
Q ss_pred --------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC---CCCeEEeccCcceeccc
Q 005803 446 --------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE---QMNPKISDFGMARTYAM 508 (676)
Q Consensus 446 --------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~---~~~vkL~DFGla~~~~~ 508 (676)
.+..+++...-..++||+++|.|+|.++ |||||+||+|+++.. .--+||+|||+|..+..
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 1122344445567899999999999998 999999999999953 33589999999998772
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
.. .....+||++|||||++...+|+..+|||+.|||||-|+.|.+||...+... .++.+..+.+. +++
T Consensus 166 g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-------lye~I~~g~yd--~~~ 233 (355)
T KOG0033|consen 166 GE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYEQIKAGAYD--YPS 233 (355)
T ss_pred cc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-------HHHHHhccccC--CCC
Confidence 22 2233789999999999999999999999999999999999999997533221 22333333332 112
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
+- -+...++..+|+.+||..||++|.|+.|.+.
T Consensus 234 ~~----w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 234 PE----WDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cc----cCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11 1223345677888999999999999988653
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=267.40 Aligned_cols=224 Identities=26% Similarity=0.386 Sum_probs=166.3
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-----chhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-----GQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
.+|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++|+||+.
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999865 58999999886432 223456889999999999999862
Q ss_pred ---------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 444 ---------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
......+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 011234677778889999999999999988 99999999999999999999999999875432
Q ss_pred ccc-ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 509 NEL-EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 509 ~~~-~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
... ........++..|+|||.+.+..++.++|||||||++|||++|+.||...... ......... ...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~-----~~~ 227 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQ-----PTN 227 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcC-----CCC
Confidence 111 11112245788999999999888999999999999999999999999743211 111111100 011
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
+.+ +......+..++ +||..+|++||+++||++
T Consensus 228 ~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 PQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111 111222334444 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=281.15 Aligned_cols=215 Identities=22% Similarity=0.282 Sum_probs=159.0
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHH-HHHHHccCCccccc-------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEA-KLIAKLQHTNLTDS------------------- 444 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~-~~l~~l~H~niv~~------------------- 444 (676)
+.||+|+||.||+|+.. +++.||+|++.+.. ......+..|. .+++.++|+||+..
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 47889999986532 12223444444 45788999999731
Q ss_pred -------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccce
Q 005803 445 -------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 445 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
.....+.+.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~ 155 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTST 155 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCccc
Confidence 11234666777889999999999999998 9999999999999999999999999987532211 12234
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChH
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 597 (676)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......... .+ .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~~------~~----~~~ 218 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-------MYDNILNKPL------QL----KPN 218 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-------HHHHHHhCCc------CC----CCC
Confidence 679999999999999999999999999999999999999997433211 1111111111 11 112
Q ss_pred HHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 598 EVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 598 ~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
....+.+++.+||+.||.+||++.+.+.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 219 ITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 2345778888999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=270.59 Aligned_cols=234 Identities=24% Similarity=0.337 Sum_probs=175.2
Q ss_pred cHHHHHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCcccccc------
Q 005803 374 DFQTIAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTDSS------ 445 (676)
Q Consensus 374 ~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~------ 445 (676)
.+..+..+.++|++.+.||+|+||.||+++.. +++.+|+|.+... .....++.+|+.++.++ +|+|++...
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34556678899999999999999999999865 5889999988653 23345688999999999 699987310
Q ss_pred -----------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeE
Q 005803 446 -----------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPK 496 (676)
Q Consensus 446 -----------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vk 496 (676)
....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence 1123556667789999999999999988 99999999999999999999
Q ss_pred EeccCcceeccccccccccceeeccCCccChhhhcc-----CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHH
Q 005803 497 ISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN-----GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVG 571 (676)
Q Consensus 497 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~ 571 (676)
|+|||++........ ......|+..|+|||++.. ..++.++|||||||++|||++|+.||.........
T Consensus 165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~---- 238 (286)
T cd06638 165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL---- 238 (286)
T ss_pred EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH----
Confidence 999999986543221 1223468999999998753 45789999999999999999999998754321100
Q ss_pred HHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 005803 572 YAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627 (676)
Q Consensus 572 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~L 627 (676)
. ...........+ +......+.+++.+||+.||++||++.||++.+
T Consensus 239 --~-~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 --F-KIPRNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --h-hccccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 000111011111 111223578899999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=269.45 Aligned_cols=238 Identities=22% Similarity=0.302 Sum_probs=173.1
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+|++.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47889999999999999999876 58999999986432 223456789999999999999872
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-- 155 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence 112335788999999999999999999988 99999999999999999999999999987643321
Q ss_pred ccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHH--------HHHHhcCCc-c
Q 005803 514 NTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYA--------WQLWNEGKA-L 583 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~--------~~~~~~~~~-~ 583 (676)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+........ ...+..... .
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 1122457889999999876 56789999999999999999999999754432211110000 000000000 0
Q ss_pred ccCCcccCCCCC-----hHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 584 ELMDPTLDESCS-----SDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 584 ~~~d~~l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
....+......+ ......+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000011100001 112346788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=272.06 Aligned_cols=234 Identities=21% Similarity=0.267 Sum_probs=170.7
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
++|++.++||+|+||.||++... ++..+|+|.+.... .....++.+|++++.+++||||+..
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999865 57889999986542 2334568899999999999998731
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKY-SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++.....++.|+++||.|||+. + ++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 153 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 153 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc----
Confidence 1124467788889999999999999984 5 999999999999999999999999998754322
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCc-----------
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKA----------- 582 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~----------- 582 (676)
......++..|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 122356889999999998888999999999999999999999998643321110000000000000000
Q ss_pred -------------cccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 583 -------------LELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 583 -------------~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.....+.+.. ......+.+++.+||+.+|++||++.+|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 0123357889999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=269.82 Aligned_cols=223 Identities=25% Similarity=0.331 Sum_probs=168.8
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
.|++.+.||+|+||.||++... +++.||||.+.... ......+.+|+.++++++|++++.
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677899999999999999865 58899999986532 222345778999999999999862
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 011224777888899999999999999988 99999999999999999999999999876432221
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||........... ....... .....
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~~------~~~~~- 224 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKE------VQEEY- 224 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhhh------hhhhc-
Confidence 1224689999999999998999999999999999999999999975432211100 1111000 00111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRT-----MSDVVS 625 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~eVl~ 625 (676)
+......+.+++..||+.||++||| +.|+++
T Consensus 225 ---~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 ---SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1122334778889999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=279.30 Aligned_cols=226 Identities=23% Similarity=0.305 Sum_probs=182.8
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCch---hhHHHHHHHHHHHHcc-CCcccc------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQ---GIVEFKNEAKLIAKLQ-HTNLTD------------ 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~---~~~~~~~E~~~l~~l~-H~niv~------------ 443 (676)
....|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ....+.+|+.+|+++. ||||+.
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45678889999999999999998765 999999999776443 3458899999999999 999872
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC----CCCeEEeccCccee
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE----QMNPKISDFGMART 505 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~----~~~vkL~DFGla~~ 505 (676)
.... .+++.....++.||+.++.|||+.+ |+||||||+|+|+.. ++.+|++|||++..
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 0111 2888899999999999999999988 999999999999963 35799999999998
Q ss_pred ccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcccc
Q 005803 506 YAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALEL 585 (676)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (676)
... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.......... ....++.
T Consensus 189 ~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~--- 255 (382)
T KOG0032|consen 189 IKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF--- 255 (382)
T ss_pred ccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC---
Confidence 765 233455899999999999999999999999999999999999999998655433211 2223332
Q ss_pred CCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 586 MDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 586 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
......-+...+.+.+++..|+..||.+|+|+.++++.
T Consensus 256 ---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 22222333445667888899999999999999999995
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=281.68 Aligned_cols=212 Identities=22% Similarity=0.303 Sum_probs=159.9
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHH-HHHHccCCcccc--------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAK-LIAKLQHTNLTD-------------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~-~l~~l~H~niv~-------------------- 443 (676)
+.||+|+||.||+|+.. +++.||||++.+. ......++..|.. +++.++||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 5899999998653 1223345555654 577899999872
Q ss_pred ------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccce
Q 005803 444 ------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 444 ------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~ 155 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTT 155 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCccc
Confidence 112345778888999999999999999998 9999999999999999999999999987532211 12234
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChH
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 597 (676)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......... .+ .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~~~~~~~------~~----~~~ 218 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-------MYDNILHKPL------VL----RPG 218 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-------HHHHHHcCCc------cC----CCC
Confidence 678999999999999999999999999999999999999997543211 1111111111 11 112
Q ss_pred HHHHHHHHHHHhcccCcCCCCCHHH
Q 005803 598 EVMRCIHVGLLCVQDRAADRRTMSD 622 (676)
Q Consensus 598 ~~~~l~~L~~~Cl~~dP~~RPs~~e 622 (676)
....+.+++.+|++.+|.+||++.+
T Consensus 219 ~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 219 ASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCHHHHHHHHHHhccCHHhcCCCCC
Confidence 2345678889999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=264.41 Aligned_cols=225 Identities=23% Similarity=0.327 Sum_probs=173.9
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
+|++.+.||.|+||.||++... +++.||+|.+... .....+++.+|+.++++++|+|+++.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5788999999999999999854 5889999998643 23445678899999999999998720
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcC--CCceEeeccccCceEEcCCCCeEEeccCcceec
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYS--RLRAIHRDLKVSNILLDEQMNPKISDFGMARTY 506 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~ 506 (676)
.....+++..++.++.||+.||.|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 01245677888999999999999999332 223999999999999999999999999999876
Q ss_pred cccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 507 AMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 507 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
...... .....++..|+|||.+.+..++.++|+||||+++++|++|+.||...... . .......+...
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~----~~~~~~~~~~~--- 228 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---Q----LASKIKEGKFR--- 228 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---H----HHHHHhcCCCC---
Confidence 543221 22356889999999999888999999999999999999999999754311 1 11112222111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
..+......+.+++.+||+.+|++||++.+|++.
T Consensus 229 ------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1222334568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=270.60 Aligned_cols=235 Identities=24% Similarity=0.342 Sum_probs=178.1
Q ss_pred cccHHHHHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCccccc-----
Q 005803 372 IFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTDS----- 444 (676)
Q Consensus 372 ~f~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~~----- 444 (676)
.+.+.++..++++|++.+.||+|+||.||++... +++.+|+|.+... .....++.+|+.++.++ +|+|+++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3555677778999999999999999999999864 5889999998653 23345678899999999 79998731
Q ss_pred ------------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC
Q 005803 445 ------------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN 494 (676)
Q Consensus 445 ------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~ 494 (676)
.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 01245677888899999999999999988 999999999999999999
Q ss_pred eEEeccCcceeccccccccccceeeccCCccChhhhccC-----CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccch
Q 005803 495 PKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG-----IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNL 569 (676)
Q Consensus 495 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l 569 (676)
+||+|||++......... .....|+..|+|||.+... .++.++|||||||++|||++|+.||........
T Consensus 167 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--- 241 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--- 241 (291)
T ss_pred EEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH---
Confidence 999999998765432211 1224678899999988643 368899999999999999999999875422110
Q ss_pred HHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 570 VGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 570 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.. ...........+ +......+.+++.+||+.+|++||++.|+++.
T Consensus 242 ---~~-~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 ---LF-KIPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ---HH-HHhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 111111111111 12233458889999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=293.12 Aligned_cols=173 Identities=24% Similarity=0.362 Sum_probs=133.5
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcC--CcEEEEE------------------EeccCCchhhHHHHHHHHHHHHccCCc
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLD--GQEIAIK------------------RLSKSSGQGIVEFKNEAKLIAKLQHTN 440 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~--~~~VAvK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~n 440 (676)
..++|+++++||+|+||.||++.... +..+++| .+. ........+.+|+.+|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987532 2222222 111 12233456889999999999999
Q ss_pred cccccc------------------------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc
Q 005803 441 LTDSSR------------------------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD 490 (676)
Q Consensus 441 iv~~~~------------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~ 490 (676)
|+.... ...........++.||+.||.|||+++ ||||||||+|||++
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 984110 011123456679999999999999998 99999999999999
Q ss_pred CCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCC
Q 005803 491 EQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNN 558 (676)
Q Consensus 491 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf 558 (676)
.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999876433221 122357999999999999999999999999999999999988543
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=268.90 Aligned_cols=231 Identities=26% Similarity=0.396 Sum_probs=174.6
Q ss_pred cHHHHHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCccccc-------
Q 005803 374 DFQTIAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTDS------- 444 (676)
Q Consensus 374 ~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~~------- 444 (676)
+..++....+.|++.+.||+|+||.||+|+.. +++.||+|.+... .....++..|+.++.++ +|+|+++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 55666778899999999999999999999864 5889999998653 33456788999999998 69998721
Q ss_pred ---------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEE
Q 005803 445 ---------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKI 497 (676)
Q Consensus 445 ---------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL 497 (676)
.....+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 01123566677889999999999999998 999999999999999999999
Q ss_pred eccCcceeccccccccccceeeccCCccChhhhc-----cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH
Q 005803 498 SDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY 572 (676)
Q Consensus 498 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~ 572 (676)
+|||++....... .......|+..|+|||.+. +..++.++|||||||++|||++|+.||..........
T Consensus 163 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---- 236 (282)
T cd06636 163 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---- 236 (282)
T ss_pred eeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh----
Confidence 9999987543211 1123356889999999876 3468889999999999999999999996433211110
Q ss_pred HHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 573 AWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 573 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
. ... ...+.+. .......+.+++.+||+.||.+||++.||++
T Consensus 237 --~-~~~-----~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 --L-IPR-----NPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --h-Hhh-----CCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 000 0011111 1122345788999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=265.81 Aligned_cols=225 Identities=25% Similarity=0.370 Sum_probs=171.3
Q ss_pred CCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCC------chhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSS------GQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
+|.+.+.||+|+||.||+|...+++.+|||.+.... ......+.+|+.++++++|+||++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999988789999999886432 123356889999999999999872
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc-
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE- 510 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~- 510 (676)
......+++.....++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 111235678888899999999999999988 9999999999999999999999999987543211
Q ss_pred ---cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 511 ---LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 511 ---~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
.........++..|+|||.+.+..++.++|||||||++|||++|+.||........ .. ..... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~-~~~~~---~~~~ 227 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA------MF-YIGAH---RGLM 227 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH------HH-Hhhhc---cCCC
Confidence 11112235688899999999988899999999999999999999999974322110 00 00000 0011
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
+.+. ......+.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 PRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1122 223345788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=280.23 Aligned_cols=227 Identities=25% Similarity=0.373 Sum_probs=174.9
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEecc--CCchhhHHHHHHHHHHHHcc-CCcccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSK--SSGQGIVEFKNEAKLIAKLQ-HTNLTD-------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~--~~~~~~~~~~~E~~~l~~l~-H~niv~-------------- 443 (676)
....|+++++||+||.+.||++...+.+.+|+|++.. ...+...-|.+|+.+|.+|+ |.+|+.
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3456888999999999999999988888999988753 34556778999999999996 777762
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.......+| .+..+..|++.++.++|++| |||.||||.|+|+-. |.+||+|||+|..+..+.
T Consensus 439 mE~Gd~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 439 MECGDIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred eecccccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 111222334 55668899999999999999 999999999999864 689999999999887776
Q ss_pred cccccceeeccCCccChhhhccCC-----------CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGI-----------VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNE 579 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~-----------~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 579 (676)
........+||+.||+||.+.... .+.++||||||||||+|+.|+.||..... .+
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---------~~----- 579 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---------QI----- 579 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---------HH-----
Confidence 666666689999999999986422 56899999999999999999999974321 11
Q ss_pred CCccccCCcccCCCCCh-HHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 580 GKALELMDPTLDESCSS-DEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 580 ~~~~~~~d~~l~~~~~~-~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.++..+.+|.-.-+++. ....++++++..||+.||++||++.|+++.
T Consensus 580 aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 12233444432212111 011128899999999999999999999875
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=275.81 Aligned_cols=240 Identities=23% Similarity=0.275 Sum_probs=175.7
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccccc-----------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDSSR----------- 446 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~----------- 446 (676)
..++|++.+.||+|+||.||+|+.. +++.||||.+... ......++.+|+.++++++|+||++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999865 6899999998643 2334456788999999999999874210
Q ss_pred ------------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 447 ------------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 447 ------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
...++......++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 112567778889999999999999998 99999999999999999999999999986543
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchH------------H---HH
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLV------------G---YA 573 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~------------~---~~ 573 (676)
... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+ . ..
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 171 SFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred CCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 221 22346788999999999999999999999999999999999999754321110000 0 00
Q ss_pred HHHH-hcCC------ccccCCccc----CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 574 WQLW-NEGK------ALELMDPTL----DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 574 ~~~~-~~~~------~~~~~d~~l----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.... .... ..+.....+ ...........+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 0000 001111100 000111234567899999999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=270.20 Aligned_cols=239 Identities=21% Similarity=0.328 Sum_probs=175.2
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
++|++.+.||+|+||.||+|+.. +++.||||+++.. .....+.+.+|++++++++|+|++.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46889999999999999999876 4889999998653 2334567899999999999999872
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~ 156 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA-S 156 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-c
Confidence 112234778888999999999999999998 99999999999999999999999999987554332 1
Q ss_pred ccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHH--------HHHHh-cCCcc
Q 005803 514 NTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYA--------WQLWN-EGKAL 583 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~--------~~~~~-~~~~~ 583 (676)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+........ ...+. .....
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 22235678899999999887 7899999999999999999999999754321110000000 00000 00000
Q ss_pred --ccCCc---c-cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 584 --ELMDP---T-LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 584 --~~~d~---~-l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
+..+. . +....+......+.+++.+||+.+|++||++++|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 0 000111222566889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=267.98 Aligned_cols=239 Identities=21% Similarity=0.273 Sum_probs=173.8
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCch-----hhHHHHHHHHHHHHccCCcccc--------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQ-----GIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
+|++.+.||+|+||.||+|... +++.||||.+...... ....+..|++++++++|+|++.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999865 5899999999754322 2345678999999999999872
Q ss_pred -----------cccc-CcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 -----------SSRK-SLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 -----------~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
.... ..+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++........
T Consensus 81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 0111 25889999999999999999999998 99999999999999999999999999986543321
Q ss_pred ccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhc---------CC
Q 005803 512 EANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNE---------GK 581 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~---------~~ 581 (676)
......++..|+|||.+.+ ..++.++|||||||++|||++|.++|......+ ........... ..
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 158 --KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred --cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhhccc
Confidence 1122356778999998865 467899999999999999999988776443221 11111110000 00
Q ss_pred ccccCCcccCCC-----CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcC
Q 005803 582 ALELMDPTLDES-----CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTND 630 (676)
Q Consensus 582 ~~~~~d~~l~~~-----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~ 630 (676)
............ ........+.+++.+||+.+|++|||+.||++. +++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 000000000000 112234578899999999999999999999986 5554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=270.96 Aligned_cols=223 Identities=21% Similarity=0.318 Sum_probs=171.4
Q ss_pred CCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc--------------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD-------------------- 443 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~-------------------- 443 (676)
|.....||+|+||.||++... +++.||||.+........+.+.+|+.++++++|+|++.
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333567999999999999864 58899999987655556677899999999999999862
Q ss_pred -----ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccccee
Q 005803 444 -----SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRI 518 (676)
Q Consensus 444 -----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 518 (676)
......+++.+...++.||+.||.|||+++ |+||||||+||++++++.+||+|||++....... ......
T Consensus 104 ~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~ 178 (292)
T cd06658 104 GALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSL 178 (292)
T ss_pred CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCcee
Confidence 111235678889999999999999999998 9999999999999999999999999987543222 112335
Q ss_pred eccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHH
Q 005803 519 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDE 598 (676)
Q Consensus 519 ~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 598 (676)
.|+..|+|||.+.+..++.++||||||+++|||++|+.||....... .. ..... .+.+.+.. ....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~----~~~~~-----~~~~~~~~--~~~~ 244 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AM----RRIRD-----NLPPRVKD--SHKV 244 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHh-----cCCCcccc--cccc
Confidence 78899999999988889999999999999999999999987432211 10 11111 11111111 1112
Q ss_pred HHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 599 VMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 599 ~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
...+..++.+||+.||.+|||++++++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2356778889999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=283.81 Aligned_cols=219 Identities=26% Similarity=0.428 Sum_probs=177.0
Q ss_pred eeeccCCCccEEEEEEcC-CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-----------------------
Q 005803 389 NRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS----------------------- 444 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~----------------------- 444 (676)
-+||+|.||+||.|++.+ ...+|||.+.....+..+-+.+|+.+.++|+|.|||+.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 369999999999999765 55689999988777777889999999999999999831
Q ss_pred ----cccCcC--CHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc-CCCCeEEeccCcceeccccccccccce
Q 005803 445 ----SRKSLL--DWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD-EQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 445 ----~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
..-.++ ++...-...+||++||.|||++. |||||||-+|||++ -.|.+||+|||-++.+.. ....+.+
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTET 735 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCccccc
Confidence 111233 55666778899999999999998 99999999999996 688999999999987653 3344556
Q ss_pred eeccCCccChhhhccC--CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCC
Q 005803 518 IVGTHGYMSPEYVMNG--IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCS 595 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~--~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 595 (676)
+.||..|||||++-.+ .|+.++|||||||++.||.||++||-....... .+++-|-.. ....++
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGmyK------vHP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGMYK------VHPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhccee------cCCCCc
Confidence 8899999999999865 489999999999999999999999976544321 112222111 123456
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 596 SDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 596 ~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+..+++..++++|+..||.+||+++++++.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 7778889999999999999999999999864
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=262.33 Aligned_cols=223 Identities=30% Similarity=0.480 Sum_probs=170.8
Q ss_pred CCcceeeccCCCccEEEEEEcC-----CcEEEEEEeccCCch-hhHHHHHHHHHHHHccCCccccc--------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLLD-----GQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~~-----~~~VAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
+++.+.||+|+||.||+++..+ +..||+|.+...... ....+..|+.++..++|+|++..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998654 378999999765433 56789999999999999998720
Q ss_pred ------------cccC-c-CCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 445 ------------SRKS-L-LDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 ------------~~~~-~-l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.... . +++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 0111 1 788889999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
..... ...++..|+|||.+.+..++.++||||||++++||++ |+.||....... .......+....
T Consensus 158 ~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~----- 224 (258)
T smart00219 158 YYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE-------VLEYLKKGYRLP----- 224 (258)
T ss_pred ccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCCCCC-----
Confidence 21111 1236788999999988889999999999999999998 788876422111 111111221111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~L 627 (676)
.+......+.+++.+|+..+|++|||+.|+++.|
T Consensus 225 ----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 ----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111344578899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=266.30 Aligned_cols=228 Identities=25% Similarity=0.327 Sum_probs=173.7
Q ss_pred cCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCCch-hhHHHHHHHHHHHHccCCcccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLTD------------ 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~------------ 443 (676)
++|++.+.||+|+||.||+|+.. +.+.||+|.+...... ...++.+|+.++++++|+||+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999853 2467999998654433 4577999999999999999862
Q ss_pred --------------ccccC---------cCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEecc
Q 005803 444 --------------SSRKS---------LLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDF 500 (676)
Q Consensus 444 --------------~~~~~---------~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DF 500 (676)
..... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 00111 5788999999999999999999998 999999999999999999999999
Q ss_pred CcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhc
Q 005803 501 GMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNE 579 (676)
Q Consensus 501 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~ 579 (676)
|++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .......
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~~~~~ 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQA 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHHHHHc
Confidence 99875432211 11222456778999999988888999999999999999999 778886432211 1111111
Q ss_pred CCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 580 GKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 580 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
+.... . ........+.+++.+||+.+|++||++.|++++|++
T Consensus 234 ~~~~~----~----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 234 GKLEL----P----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCcCC----C----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 21111 0 111223468889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=268.81 Aligned_cols=226 Identities=25% Similarity=0.379 Sum_probs=174.3
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
.++|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|++++++++|+|+++.
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467899999999999999999875 588999999976666666789999999999999998721
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 11245788899999999999999999998 99999999999999999999999999875432211
Q ss_pred ccceeeccCCccChhhhc-----cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 514 NTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
......++..|+|||.+. ...++.++||||||+++|||++|+.||....... . ......+.. +
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~-~~~~~~~~~-----~ 226 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------V-LLKILKSEP-----P 226 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------H-HHHHhcCCC-----C
Confidence 122356889999999875 3457789999999999999999999997543211 0 111111111 1
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+. .+......+.+++..||+.+|.+||++.+|++.
T Consensus 227 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 111 111223357788899999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=268.77 Aligned_cols=226 Identities=23% Similarity=0.332 Sum_probs=170.2
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHcc-CCcccccc---------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQ-HTNLTDSS--------------- 445 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~~~--------------- 445 (676)
+|...+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||++..
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556789999999999999865 58999999986543 234567889999999996 99987310
Q ss_pred ---------------ccCcCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 446 ---------------RKSLLDWKKRFYIIEGIVQGLLYLHKY-SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 446 ---------------~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
....+++.....++.+++.||+|||+. + ++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 123467788889999999999999975 6 999999999999999999999999998754332
Q ss_pred ccccccceeeccCCccChhhhccC---CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNG---IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~---~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
.. .....|+..|+|||.+.+. .++.++|||||||++|||++|+.||.... ......... ..+ .
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~-~~~-----~ 227 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQV-VKG-----D 227 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhh-cCC-----C
Confidence 11 1224678899999998765 68999999999999999999999997532 111111111 011 1
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+.+...........+.+++.+||+.+|++|||+.+|++.
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122222222344568899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=265.85 Aligned_cols=223 Identities=26% Similarity=0.401 Sum_probs=174.6
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
..|+..++||.|+||.||+|... +++.||||.+.... ......+.+|+.+++++.|+|++.
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777899999999999999865 58899999987543 345567899999999999999872
Q ss_pred --------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 444 --------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 444 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
......+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 84 ~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 158 (277)
T cd06640 84 LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KR 158 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--cc
Confidence 112234677788899999999999999988 99999999999999999999999999976543221 12
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCS 595 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 595 (676)
....++..|+|||.+.+..++.++|+|||||++|||++|..||......... ..... .......
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~---------~~~~~~~ 222 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-------FLIPK---------NNPPTLT 222 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-------hhhhc---------CCCCCCc
Confidence 2246788999999998888999999999999999999999998754322110 00000 1111223
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 596 SDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 596 ~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
......+.+++.+||+.+|++||++.++++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 3455678899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=262.89 Aligned_cols=228 Identities=25% Similarity=0.408 Sum_probs=174.9
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
++|++.+.||.|+||.||+|... ++..+|+|++.... ......+.+|+++++.++|+|++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999864 58899999986532 3356778999999999999998720
Q ss_pred -------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 445 -------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 445 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
.....+++.....++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 01235788888999999999999999998 99999999999999999999999999876554322
Q ss_pred c--cccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 512 E--ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 512 ~--~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
. .......|+..|+|||.+... .++.++|+|||||++|||++|+.||........ ..... .. ..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~-~~-----~~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTL-QN-----DPP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHh-cC-----CCC
Confidence 1 122335688999999998876 789999999999999999999999975433211 11111 11 011
Q ss_pred ccCCCC-ChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 589 TLDESC-SSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 589 ~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.+.... .......+.+++.+||+.||++||++.+|++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111111 1123456788999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=270.24 Aligned_cols=240 Identities=20% Similarity=0.277 Sum_probs=171.5
Q ss_pred CCCcceeeccCCCccEEEEEEc---CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL---DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~---~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
+|.+.++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++.+++||||+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999864 47899999997632 3345677899999999999998720
Q ss_pred -------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC----CCCeEEeccC
Q 005803 445 -------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE----QMNPKISDFG 501 (676)
Q Consensus 445 -------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~----~~~vkL~DFG 501 (676)
.....++......++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 00124667778899999999999999998 999999999999999 8999999999
Q ss_pred cceecccccc-ccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccch------HHHH
Q 005803 502 MARTYAMNEL-EANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNL------VGYA 573 (676)
Q Consensus 502 la~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l------~~~~ 573 (676)
++........ ........++..|+|||.+.+ ..++.++|||||||+++||++|+.||........... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9986543221 112223567889999998876 4588999999999999999999999976543321000 0000
Q ss_pred HHHHh-----------c-CCccccCCcccCCCCC----h-------HHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 574 WQLWN-----------E-GKALELMDPTLDESCS----S-------DEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 574 ~~~~~-----------~-~~~~~~~d~~l~~~~~----~-------~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
...+. + .......+.......+ . .....+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 0 0000000000000001 0 223457889999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=293.54 Aligned_cols=228 Identities=24% Similarity=0.384 Sum_probs=186.3
Q ss_pred CCCcceeeccCCCccEEEEEEcC----CcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLLD----GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~~----~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
.-.+.+.||.|.||.|++|+++- ...||||.++.. .+.+..+|+.|+.||.+++||||++
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 34678899999999999998753 346899999865 3456678999999999999999872
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+.+.+...++++||.|+.||-+.+ +|||||..+|||++.+...|++|||+++.+.++.
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~- 785 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP- 785 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC-
Confidence 122345777888899999999999999998 9999999999999999999999999999776544
Q ss_pred ccccceeec--cCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 512 EANTNRIVG--THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 512 ~~~~~~~~g--t~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
....++..| ..+|.|||.+...+++.++||||||+|+||.++ |.+||-.+.+.+..+- ++.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka----------------Ie~ 849 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA----------------IEQ 849 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH----------------HHh
Confidence 222222333 357999999999999999999999999999887 9999987665443221 222
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
..+-..+++++..|.+|++.|||.|-.+||.+.||+.+|.++.
T Consensus 850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 3333457788888999999999999999999999999998864
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=265.49 Aligned_cols=221 Identities=25% Similarity=0.391 Sum_probs=165.1
Q ss_pred eeeccCCCccEEEEEEcC-Cc--EEEEEEeccCC-chhhHHHHHHHHHHHHc-cCCcccccc------------------
Q 005803 389 NRLGQGGFGPVYNGKLLD-GQ--EIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLTDSS------------------ 445 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~-~~--~VAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~------------------ 445 (676)
+.||+|+||.||+|+..+ +. .+|+|.++... ......+.+|++++.++ +|||+++..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754 43 46889886532 34456788999999999 799986210
Q ss_pred ------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccC
Q 005803 446 ------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFG 501 (676)
Q Consensus 446 ------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFG 501 (676)
....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 0123678888999999999999999988 9999999999999999999999999
Q ss_pred cceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcC
Q 005803 502 MARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEG 580 (676)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~ 580 (676)
++...... ........+..|+|||++....++.++|||||||++|||++ |..||....... .......+
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~ 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQG 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-------HHHHHhCC
Confidence 98532211 01111223567999999988889999999999999999997 999986432211 11111111
Q ss_pred CccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 581 KALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 581 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
...+ .+......+.+++.+||+.+|.+|||+.++++.|+++.
T Consensus 228 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111 11122345788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=271.33 Aligned_cols=237 Identities=23% Similarity=0.326 Sum_probs=171.2
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--hhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
.++|++.+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++++++|+|+++.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999875 589999999864322 223356789999999999998721
Q ss_pred --------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 445 --------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.....+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 01244778888999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHh-----------
Q 005803 511 LEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWN----------- 578 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~----------- 578 (676)
. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... ........
T Consensus 163 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 163 K--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL---DLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred C--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCChhhchhhh
Confidence 1 1122345778999999875 56789999999999999999999999754322211 11111000
Q ss_pred cCCccccC--C-cccCC--CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 579 EGKALELM--D-PTLDE--SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 579 ~~~~~~~~--d-~~l~~--~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
........ . ..... .........+.+++.+||+.||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 0 00000 0000123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=270.93 Aligned_cols=223 Identities=22% Similarity=0.310 Sum_probs=171.3
Q ss_pred CCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc--------------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD-------------------- 443 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~-------------------- 443 (676)
|....+||+|+||.||++... +++.||+|.+........+.+.+|+.++..++|||++.
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334568999999999999864 68999999987655555677889999999999999872
Q ss_pred -----ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccccee
Q 005803 444 -----SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRI 518 (676)
Q Consensus 444 -----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 518 (676)
......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ .....
T Consensus 103 ~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~ 177 (297)
T cd06659 103 GALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSL 177 (297)
T ss_pred CCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccce
Confidence 111235778888999999999999999998 99999999999999999999999999875433221 12235
Q ss_pred eccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHH
Q 005803 519 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDE 598 (676)
Q Consensus 519 ~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 598 (676)
.|+..|+|||++.+..++.++|||||||++|||++|+.||....... . ...+...... ... .....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~----~~~~~~~~~~-----~~~--~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---A----MKRLRDSPPP-----KLK--NAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H----HHHHhccCCC-----Ccc--ccCCC
Confidence 68899999999998889999999999999999999999997432211 1 1111111100 000 01112
Q ss_pred HHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 599 VMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 599 ~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
...+.+++.+||+.+|++||++++|++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 3347788899999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=276.81 Aligned_cols=245 Identities=24% Similarity=0.326 Sum_probs=177.3
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccccc------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDSS------------ 445 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~------------ 445 (676)
..++|.+.+.||+|+||.||+|+.. +++.||||.+... ......++.+|+.++++++|+||++..
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3468999999999999999999864 5899999998653 233445678899999999999997310
Q ss_pred ------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 446 ------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 446 ------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
....+++.....++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....
T Consensus 83 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 83 DVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred cEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 1245778888999999999999999998 9999999999999999999999999998654
Q ss_pred ccccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHH--------HHHHh
Q 005803 508 MNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYA--------WQLWN 578 (676)
Q Consensus 508 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~--------~~~~~ 578 (676)
... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||............... +....
T Consensus 160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 160 EKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 322 11223467889999998875 46899999999999999999999999754321111000000 00000
Q ss_pred cCCcc-------ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcCc
Q 005803 579 EGKAL-------ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTNDT 631 (676)
Q Consensus 579 ~~~~~-------~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~~ 631 (676)
..... ...++... ...+.....+.+++.+||+.+|++|||++++++. ++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred chhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00000 00000000 0111234567899999999999999999999987 65543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=262.60 Aligned_cols=225 Identities=20% Similarity=0.314 Sum_probs=159.3
Q ss_pred eeeccCCCccEEEEEEcCC---cEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccccc-------------------
Q 005803 389 NRLGQGGFGPVYNGKLLDG---QEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDSS------------------- 445 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~~---~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~------------------- 445 (676)
+.||+|+||.||+|+..++ ..+++|.+.... ....+.+.+|+.+++.++||||++..
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975443 346677765433 23456899999999999999997310
Q ss_pred -----------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 446 -----------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 446 -----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
....++......++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 0122344556788999999999999988 99999999999999999999999999864322211112
Q ss_pred cceeeccCCccChhhhcc-------CCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 515 TNRIVGTHGYMSPEYVMN-------GIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~-------~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...... .. ......+....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~----~~~~~~~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EV----LNHVIKDQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHhhcccccC
Confidence 223567889999998753 245789999999999999997 46677543221 11 1111122233344
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
++.+...+. ..+.+++..|| .+|++||++++|++.|.
T Consensus 231 ~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 444443333 34666778899 57999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=278.33 Aligned_cols=219 Identities=31% Similarity=0.433 Sum_probs=174.4
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
.|+-++.||.|+||.||-|++. +.+.||||+++-. .......+..|+..|.++.|||++.
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3555788999999999999864 5788999999744 3344567899999999999999873
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
....+++.+.++..|..+.+.||+|||+.+ .||||||..|||+.+.|.|||+|||.|....+
T Consensus 107 YClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----- 178 (948)
T KOG0577|consen 107 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP----- 178 (948)
T ss_pred HHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence 123466777888889999999999999998 99999999999999999999999999986543
Q ss_pred ccceeeccCCccChhhhc---cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 514 NTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
.++++|||.|||||++. .+.|+-|+||||||++..||.-.++|...+..... ...+.. --.|.|
T Consensus 179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-------LYHIAQ-----NesPtL 245 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHIAQ-----NESPTL 245 (948)
T ss_pred -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-------HHHHHh-----cCCCCC
Confidence 34589999999999986 47899999999999999999999999875543221 111111 112233
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
. ..+-...+..++-.||+.-|.+|||.+++++.
T Consensus 246 q---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 246 Q---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred C---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 2 23445567888889999999999999887653
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=259.80 Aligned_cols=212 Identities=22% Similarity=0.344 Sum_probs=162.0
Q ss_pred eeeccCCCccEEEEEEcCCc-----------EEEEEEeccCCchhhHHHHHHHHHHHHccCCcccccc------------
Q 005803 389 NRLGQGGFGPVYNGKLLDGQ-----------EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSS------------ 445 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~~~-----------~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~~------------ 445 (676)
+.||+|+||.||+|.+.+.. .|++|.+...... ...+.+|+.++++++|+|++...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEE
Confidence 46999999999999875432 5788887654332 67889999999999999987311
Q ss_pred --------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC-------CeEEeccCcce
Q 005803 446 --------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM-------NPKISDFGMAR 504 (676)
Q Consensus 446 --------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~-------~vkL~DFGla~ 504 (676)
....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++.
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 1125778888999999999999999988 99999999999999887 79999999998
Q ss_pred eccccccccccceeeccCCccChhhhccC--CCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCC
Q 005803 505 TYAMNELEANTNRIVGTHGYMSPEYVMNG--IVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGK 581 (676)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~ 581 (676)
.... .....++..|+|||++.+. .++.++||||||+++|||++ |..|+......... ..+....
T Consensus 157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-------~~~~~~~ 223 (259)
T cd05037 157 TVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-------RFYQDQH 223 (259)
T ss_pred cccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-------HHHhcCC
Confidence 6433 1124567789999999876 78999999999999999999 56777544321110 1111100
Q ss_pred ccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 582 ALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 582 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
. .. ......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 224 ~-------~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 R-------LP----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C-------CC----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00 011156788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=263.56 Aligned_cols=225 Identities=24% Similarity=0.344 Sum_probs=169.1
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-----chhhHHHHHHHHHHHHccCCccccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-----GQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
.+|++.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.+++++.|+||+..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999865 48999999875321 1234578899999999999998720
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
.....+++.....++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 11134566777889999999999999998 99999999999999999999999999875432
Q ss_pred cccc-cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 509 NELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 509 ~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
.... .......++..|+|||.+.+..++.++|||||||++|||++|+.||...... ......... ..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~-----~~- 226 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQ-----PT- 226 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHHHHHhcC-----CC-
Confidence 2111 1122345888999999998888999999999999999999999998643211 101111100 00
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
....+......+..++.+|+. +|++||+++||++.
T Consensus 227 ---~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 ---NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111233444567778888884 99999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=267.40 Aligned_cols=213 Identities=22% Similarity=0.349 Sum_probs=160.6
Q ss_pred eeeccCCCccEEEEEEcC--------CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 389 NRLGQGGFGPVYNGKLLD--------GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~--------~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
+.||+|+||.||+|.... ...||+|.+........+++.+|+.+++.++|||++.
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997532 2348889886655555678899999999999999872
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC--------eEEeccCccee
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN--------PKISDFGMART 505 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~--------vkL~DFGla~~ 505 (676)
......+++..++.++.||+.||+|||+++ |+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 011235788888999999999999999998 999999999999987765 59999998865
Q ss_pred ccccccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCC-cCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 506 YAMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSK-KNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~-~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
.... ....++..|+|||.+.+ ..++.++|||||||++|||++|. .|+....... . ...... .
T Consensus 158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~----~~~~~~-~-- 221 (258)
T cd05078 158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---K----LQFYED-R-- 221 (258)
T ss_pred cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---H----HHHHHc-c--
Confidence 4321 22467889999999986 45799999999999999999995 5554322111 0 001110 0
Q ss_pred ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 584 ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 584 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
..+ +......+.+++.+||+.||++|||+++|++.|+
T Consensus 222 ----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ----HQL----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----ccC----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011 1122245788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=266.41 Aligned_cols=233 Identities=20% Similarity=0.277 Sum_probs=168.6
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
+|++.+.||.|++|.||+|+.. +++.||||++.... ......+.+|++++++++||||++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5888999999999999999865 58999999986432 2233578899999999999998731
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 155 (284)
T cd07860 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-- 155 (284)
T ss_pred cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--
Confidence 12345788889999999999999999998 99999999999999999999999999875532211
Q ss_pred ccceeeccCCccChhhhccCC-CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcC------------
Q 005803 514 NTNRIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG------------ 580 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~------------ 580 (676)
......++..|+|||.+.+.. ++.++|||||||++|||++|+.||........ ... ........
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFR-IFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHH-HHHHhCCCChhhhhhhhHHH
Confidence 112235678899999887644 68899999999999999999999975432111 000 00000000
Q ss_pred ----CccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 581 ----KALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 581 ----~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.........+. ...+.....+.+++.+||+.||++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 000112234678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=266.95 Aligned_cols=229 Identities=24% Similarity=0.341 Sum_probs=174.3
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||++.
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56888899999999999999865 58899999886542 3445778999999999999998721
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKY-SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++.....++.+++.||.|||+. + ++|+||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---- 157 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---- 157 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh----
Confidence 1123567888899999999999999974 5 999999999999999999999999998654221
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCc-----cchHHHHHHHHhcCCccccCCc
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERP-----LNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~-----~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
......|+..|+|||.+.+..++.++|||||||++|+|++|+.||........ ............. . .+
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~~ 231 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-P-----PP 231 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-c-----CC
Confidence 12235789999999999888999999999999999999999999986543211 1111111111100 0 11
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~L 627 (676)
.+. .......+.+++.+||+.||++||++.||+++.
T Consensus 232 ~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 232 RLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111 112334578899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=265.50 Aligned_cols=224 Identities=21% Similarity=0.344 Sum_probs=170.4
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
++|++.+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++.+++|+||++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999876 6899999988653 2334567899999999999999862
Q ss_pred --------c-cc---cCcCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 --------S-SR---KSLLDWKKRFYIIEGIVQGLLYLHKY-SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 --------~-~~---~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
. .. ...+++..+..++.||+.||.|||+. + |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 0 01 12678889999999999999999974 5 9999999999999999999999999987653221
Q ss_pred cccccceeeccCCccChhhhccC------CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNG------IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~------~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (676)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||......... . .......+..
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~-~~~~~~~~~~-- 227 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF---A-QLSAIVDGDP-- 227 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH---H-HHHHHhhcCC--
Confidence 2224578899999998543 3588999999999999999999999653221111 0 1111111111
Q ss_pred cCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 585 LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 585 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+ ..+......+.+++.+||+.+|++||++.++++.
T Consensus 228 ---~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 ---P----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---C----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1 1222344557789999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=309.58 Aligned_cols=239 Identities=21% Similarity=0.387 Sum_probs=185.6
Q ss_pred HhcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
....|...+.||+|+||.||+|+. .+++.||||++..... ....|++.+++++||||++.
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 345677889999999999999986 4689999999865332 12356889999999999831
Q ss_pred -cc-c------CcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccc
Q 005803 445 -SR-K------SLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516 (676)
Q Consensus 445 -~~-~------~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 516 (676)
.. + ..++|..+..++.||++||+|||..+..+|+||||||+||+++.++.+++. ||.+..... ..
T Consensus 764 y~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~ 836 (968)
T PLN00113 764 YIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DT 836 (968)
T ss_pred CCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CC
Confidence 00 1 237899999999999999999996655569999999999999999888875 665543211 11
Q ss_pred eeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC--CC
Q 005803 517 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE--SC 594 (676)
Q Consensus 517 ~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~ 594 (676)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... .......++............+|+.+.. ..
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 23678999999999999999999999999999999999999954322 2234555555444444455556666543 23
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
..++..++.+++.+||+.||++||+|.||+++|++..
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 4567778899999999999999999999999999875
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=253.74 Aligned_cols=229 Identities=25% Similarity=0.298 Sum_probs=175.8
Q ss_pred HHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-----ch---hhHHHHHHHHHHHHc-cCCcccc-----
Q 005803 379 AAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-----GQ---GIVEFKNEAKLIAKL-QHTNLTD----- 443 (676)
Q Consensus 379 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-----~~---~~~~~~~E~~~l~~l-~H~niv~----- 443 (676)
+..-..|...+.||+|..+.|-+..++ +++++|+|++.... +. -.+.-.+|+.||+++ .||+|++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 334456788899999999999888654 68999999985321 11 123456799999998 5999973
Q ss_pred ---------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCc
Q 005803 444 ---------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGM 502 (676)
Q Consensus 444 ---------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGl 502 (676)
....-.+++++...|++|+.+|++|||..+ ||||||||+|||+|++.++||+|||+
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 122334778888999999999999999998 99999999999999999999999999
Q ss_pred ceeccccccccccceeeccCCccChhhhcc------CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHH
Q 005803 503 ARTYAMNELEANTNRIVGTHGYMSPEYVMN------GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQL 576 (676)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~ 576 (676)
++.+..... ....+||++|+|||.+.- ..|+..+|+||.|||+|.|+.|.+||-... -....++
T Consensus 170 a~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR~ 239 (411)
T KOG0599|consen 170 ACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLRM 239 (411)
T ss_pred eeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHHH
Confidence 998765432 344799999999998853 358899999999999999999999985321 1112334
Q ss_pred HhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 577 WNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 577 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+.+|+..-- ...-.+......+|+.+||+.||.+|.|++|+++.
T Consensus 240 ImeGkyqF~------speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 240 IMEGKYQFR------SPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHhcccccC------CcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 445554321 11122344567789999999999999999998854
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=266.30 Aligned_cols=238 Identities=21% Similarity=0.297 Sum_probs=169.7
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCch-hhHHHHHHHHHHHHccCCcccc---------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++++|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.+++.++|+||+.
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4678999999999999999999864 5889999998654322 2346789999999999999862
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+.+..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 158 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ- 158 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence 011234567778889999999999999998 99999999999999999999999999875432211
Q ss_pred cccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhc------------
Q 005803 513 ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNE------------ 579 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~------------ 579 (676)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||...... .......+..+..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhhhc
Confidence 11224568899999998753 5788999999999999999999999754321 1111111110000
Q ss_pred CC-ccccCCcccCCCC-----ChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 580 GK-ALELMDPTLDESC-----SSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 580 ~~-~~~~~d~~l~~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.. ..+.......... .......+.+++.+|++.||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 0000000000000 0011345678889999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=263.32 Aligned_cols=224 Identities=26% Similarity=0.378 Sum_probs=170.5
Q ss_pred CCCcceeeccCCCccEEEEEEcC--CcEEEEEEeccC----------CchhhHHHHHHHHHHHH-ccCCcccc-------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLLD--GQEIAIKRLSKS----------SGQGIVEFKNEAKLIAK-LQHTNLTD------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~~--~~~VAvK~l~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~------- 443 (676)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++|+|++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999998765 688999987532 12234557788888865 79999872
Q ss_pred -----------------------ccccCcCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeeccccCceEEcCCCCeEEec
Q 005803 444 -----------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHK-YSRLRAIHRDLKVSNILLDEQMNPKISD 499 (676)
Q Consensus 444 -----------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLKp~NILl~~~~~vkL~D 499 (676)
......+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 0123356778889999999999999996 55 99999999999999999999999
Q ss_pred cCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhc
Q 005803 500 FGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNE 579 (676)
Q Consensus 500 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 579 (676)
||++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ......+
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-------~~~~~~~ 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-------LATKIVE 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-------HHHHHhh
Confidence 99998754432 2233568889999999998889999999999999999999999986432111 1111111
Q ss_pred CCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 580 GKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 580 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
+... +.... .....+.+++.+||+.||++||++.||.++|+
T Consensus 228 ~~~~----~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 AVYE----PLPEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCC----cCCcc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111 11111 12245778889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=260.28 Aligned_cols=223 Identities=24% Similarity=0.340 Sum_probs=174.2
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
+|+..+.||+|+||.||.++.. +++.+++|.+... ......++.+|+.++++++|+||+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999854 5889999987643 3445667899999999999999872
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 011235778888999999999999999988 99999999999999999999999999986543331
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...... .... ....+.....
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~-~~~~~~~~~~------- 221 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVV-KIVQGNYTPV------- 221 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHH-HHHcCCCCCC-------
Confidence 223356889999999998888899999999999999999999998643221 1111 1112221111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~L 627 (676)
.......+.+++.+||+.+|++||++.++++.+
T Consensus 222 --~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 --VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 122234577888999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=266.72 Aligned_cols=212 Identities=22% Similarity=0.302 Sum_probs=159.5
Q ss_pred eeccCCCccEEEEEEcC-------------------------CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-
Q 005803 390 RLGQGGFGPVYNGKLLD-------------------------GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD- 443 (676)
Q Consensus 390 ~LG~G~fG~Vy~~~~~~-------------------------~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~- 443 (676)
.||+|+||.||+|.+.. ...||+|++.........++.+|+.++++++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 1358999987655555567889999999999999872
Q ss_pred --------------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC----
Q 005803 444 --------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM---- 493 (676)
Q Consensus 444 --------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~---- 493 (676)
......+++..++.++.||++||+|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence 012345788889999999999999999988 99999999999997643
Q ss_pred ---CeEEeccCcceeccccccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHH-hCCcCCCCCCCCCccc
Q 005803 494 ---NPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIV-SSKKNNGSYDTERPLN 568 (676)
Q Consensus 494 ---~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~ell-tG~~pf~~~~~~~~~~ 568 (676)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.........
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~- 231 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE- 231 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-
Confidence 3799999988643221 12356788999998875 56899999999999999995 689988754322110
Q ss_pred hHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 569 LVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 569 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
...... ..+... ....+.+++.+||+.+|++||++.+|++.|+
T Consensus 232 ------~~~~~~-------~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 232 ------RFYEKK-------HRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ------HHHHhc-------cCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 011100 011111 1235788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=264.15 Aligned_cols=229 Identities=22% Similarity=0.359 Sum_probs=170.0
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc----------hhhHHHHHHHHHHHHccCCcccc---------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG----------QGIVEFKNEAKLIAKLQHTNLTD--------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~----------~~~~~~~~E~~~l~~l~H~niv~--------- 443 (676)
+|.+.+.||+|+||.||+|... +++.||||.++.... ...+.+.+|+.++++++|+|++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5778899999999999999854 589999998753211 11346788999999999999862
Q ss_pred -----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceec
Q 005803 444 -----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTY 506 (676)
Q Consensus 444 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~ 506 (676)
......+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 112245788888999999999999999988 999999999999999999999999999764
Q ss_pred cccccccccceeeccCCccChhhhccCC--CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccc
Q 005803 507 AMNELEANTNRIVGTHGYMSPEYVMNGI--VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584 (676)
Q Consensus 507 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (676)
.............++..|+|||.+.... ++.++|+||||+++|||++|..||...... ....... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~ 231 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLG-NKRSAP 231 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhh-ccccCC
Confidence 3322111223356788999999987654 889999999999999999999998633211 1111111 111111
Q ss_pred cCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 585 LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 585 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+.. .........+.+++.+||+.+|++||++.+|++.
T Consensus 232 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 232 PIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111 1112234567888999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=269.68 Aligned_cols=225 Identities=21% Similarity=0.292 Sum_probs=172.2
Q ss_pred cCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCc---hhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|++.+.||+|+||.||++...+ ++.||+|.+..... .....+.+|++++.+++|+||+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 478889999999999999998754 89999999876432 24567889999999999999872
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 112245788888899999999999999988 9999999999999999999999999987543211
Q ss_pred cc---------------------------cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCC
Q 005803 511 LE---------------------------ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDT 563 (676)
Q Consensus 511 ~~---------------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~ 563 (676)
.. .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 00 011234678899999999988899999999999999999999999975432
Q ss_pred CCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCC----HHHHHH
Q 005803 564 ERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRT----MSDVVS 625 (676)
Q Consensus 564 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs----~~eVl~ 625 (676)
... ..... . ..............+.+++.+||+.||++||+ ++|+++
T Consensus 238 ~~~------~~~~~-~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DET------FSNIL-K--------KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHH------HHHHh-c--------CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 211 01111 1 11111111113456888999999999999999 666666
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=267.64 Aligned_cols=238 Identities=24% Similarity=0.302 Sum_probs=172.1
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--hhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
++|++.+.||+|+||.||+|... +++.+|+|.++.... .....+.+|+.++.+++||||+..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888999999999999999876 588999999865432 223456789999999999998731
Q ss_pred -------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 445 -------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 445 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
.....+++.....++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 85 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 11234788889999999999999999998 99999999999999999999999999986554321
Q ss_pred ccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH--------HHHHHhc---
Q 005803 512 EANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY--------AWQLWNE--- 579 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~--------~~~~~~~--- 579 (676)
......++..|+|||.+.+. .++.++|+||||+++|||++|+.||...........+.. .+..+..
T Consensus 162 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 162 --PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred --ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 12224578899999998754 468999999999999999999999975432211110000 0000000
Q ss_pred ---CCccccCCcccCCCCChH-HHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 580 ---GKALELMDPTLDESCSSD-EVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 580 ---~~~~~~~d~~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
..........+...++.. ....+.+++.+||+.+|++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000001111111111111 2445778899999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=282.20 Aligned_cols=177 Identities=25% Similarity=0.368 Sum_probs=146.3
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|++.+.||+|+||.||+++.. +++.||||++... .......+.+|+.++..++|+||+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999865 5899999998643 2334566888999999999999872
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc-
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL- 511 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~- 511 (676)
......+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 112345778888899999999999999998 99999999999999999999999999875432110
Q ss_pred --------------------------------ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCC
Q 005803 512 --------------------------------EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNG 559 (676)
Q Consensus 512 --------------------------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~ 559 (676)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 000123579999999999999999999999999999999999999997
Q ss_pred CCC
Q 005803 560 SYD 562 (676)
Q Consensus 560 ~~~ 562 (676)
...
T Consensus 238 ~~~ 240 (360)
T cd05627 238 SET 240 (360)
T ss_pred CCC
Confidence 543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=261.16 Aligned_cols=222 Identities=23% Similarity=0.339 Sum_probs=172.2
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
+|++.++||+|+||.||+++.. +++.||+|.+... ......++.+|+.++++++|+|++.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999864 5899999998643 2334567899999999999999862
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 011224677888999999999999999988 999999999999999999999999999865432211
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.....|+..|+|||++.+..++.++|+|||||++++|++|+.||..... ....... ..+... .
T Consensus 158 --~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~-~~~~~~-----~--- 220 (256)
T cd08218 158 --ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKI-IRGSYP-----P--- 220 (256)
T ss_pred --hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHH-hcCCCC-----C---
Confidence 1224578899999999988899999999999999999999999864321 1111111 111111 1
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+......+.+++.+||+.+|++||++.+|++.
T Consensus 221 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 -VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 112233457889999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=260.73 Aligned_cols=221 Identities=26% Similarity=0.412 Sum_probs=171.2
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-----chhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-----GQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|+.+++.++|+|+++.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999876 68999999986533 2345678999999999999998720
Q ss_pred -------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 445 -------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 445 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
.....+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 11234778888899999999999999998 9999999999999999999999999988654332
Q ss_pred ccccceeeccCCccChhhhccCC-CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
......++..|+|||.+.... ++.++|+||||+++|+|++|+.||....... ........... +.
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~-----~~- 222 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSKEL-----PP- 222 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhcccC-----CC-
Confidence 123356788999999988766 8999999999999999999999997543111 11111110111 11
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.+......+.+++.+||+.+|++||++.++++
T Consensus 223 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 ---IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11222345778899999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=274.54 Aligned_cols=242 Identities=22% Similarity=0.291 Sum_probs=174.2
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDSS------------- 445 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~------------- 445 (676)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++|+||++..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 489999999999999999999864 68999999986532 22345678999999999999987311
Q ss_pred ----------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 446 ----------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 446 ----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 94 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~ 170 (342)
T cd07879 94 DFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE 170 (342)
T ss_pred eEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence 1125677888899999999999999998 999999999999999999999999998754221
Q ss_pred ccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHH--------HHHHhcC
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYA--------WQLWNEG 580 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~--------~~~~~~~ 580 (676)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+... .+.....
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 171 -----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred -----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 123467889999999876 46889999999999999999999999753221110000000 0000000
Q ss_pred Ccccc---CCcccCCC---CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcCc
Q 005803 581 KALEL---MDPTLDES---CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTNDT 631 (676)
Q Consensus 581 ~~~~~---~d~~l~~~---~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~~ 631 (676)
..... ........ ..+.....+.+++.+||+.||++||+++++++. ++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00000 00000000 001123457789999999999999999999955 66654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=262.45 Aligned_cols=236 Identities=19% Similarity=0.271 Sum_probs=173.1
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
+|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++|+|+++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999865 58999999987543 3345678999999999999998721
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++.++..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (286)
T cd07832 81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RL 156 (286)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Cc
Confidence 11245788889999999999999999998 99999999999999999999999999986543321 11
Q ss_pred cceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcC------------C
Q 005803 515 TNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG------------K 581 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~------------~ 581 (676)
.....++..|+|||.+.+. .++.++||||||+++|||++|.++|....... ............ .
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcch
Confidence 2235688899999988654 46899999999999999999988876433211 111111110000 0
Q ss_pred ccccCCcccC----CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 582 ALELMDPTLD----ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 582 ~~~~~d~~l~----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
......+... ....++....+.+++.+||+.+|++||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 00111233678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=266.13 Aligned_cols=226 Identities=24% Similarity=0.377 Sum_probs=175.9
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
.++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++|||++..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 368899999999999999999854 588999999876555556778999999999999998731
Q ss_pred ---------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 445 ---------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 445 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
.....+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........ ..
T Consensus 98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~ 172 (293)
T cd06647 98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 172 (293)
T ss_pred CCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc--cc
Confidence 11234678888999999999999999998 99999999999999999999999999876543322 11
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCS 595 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 595 (676)
....+++.|+|||.+.+..++.++||||||+++|+|++|+.||............ ...+. +.. ...
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~~------~~~--~~~ 238 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGT------PEL--QNP 238 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCCC------CCC--CCc
Confidence 2246888999999998888999999999999999999999999754332211100 00000 001 111
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 596 SDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 596 ~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
......+.+++.+||+.+|++||++.+++.+
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2233457788999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=269.78 Aligned_cols=237 Identities=24% Similarity=0.329 Sum_probs=172.2
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--hhhHHHHHHHHHHHHccCCcccccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLTDSS------------- 445 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~------------- 445 (676)
.++|++.++||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++|+||++..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999865 588999999864322 2234578899999999999987411
Q ss_pred ---------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcce
Q 005803 446 ---------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR 504 (676)
Q Consensus 446 ---------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~ 504 (676)
....+++..+..++.|+++||.|||+++ |+|+||||+||++++++.+||+|||++.
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccch
Confidence 1235788888999999999999999998 9999999999999999999999999997
Q ss_pred eccccccc---------cccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHH
Q 005803 505 TYAMNELE---------ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAW 574 (676)
Q Consensus 505 ~~~~~~~~---------~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~ 574 (676)
........ .......+++.|+|||.+.+. .++.++|||||||++|||++|++||........... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~---~~ 240 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL---IF 240 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH
Confidence 65432111 111234678889999988654 588999999999999999999999975433211111 11
Q ss_pred HHHhc---------CCccccC--------CcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 575 QLWNE---------GKALELM--------DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 575 ~~~~~---------~~~~~~~--------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
..... ....... .+.+.. ........+.+++.+||+.||++|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 10000 0000000 000000 00112246788999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=275.13 Aligned_cols=242 Identities=21% Similarity=0.326 Sum_probs=176.0
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++|+||+..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999865 58999999987542 2345667889999999999998731
Q ss_pred ---------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 445 ---------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 445 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
.....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 12345788899999999999999999998 999999999999999999999999999765432
Q ss_pred ccc--cccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH--------HHHHHh
Q 005803 510 ELE--ANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY--------AWQLWN 578 (676)
Q Consensus 510 ~~~--~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~--------~~~~~~ 578 (676)
... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.. ......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 211 11123478889999999865 4588999999999999999999999975432211100000 000000
Q ss_pred cCCccccCCc-ccCCC-----CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 579 EGKALELMDP-TLDES-----CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 579 ~~~~~~~~d~-~l~~~-----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.....+..+. ..... ..+.....+.+++.+||+.+|++||+++++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 00000 112234568899999999999999999998875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=270.25 Aligned_cols=228 Identities=22% Similarity=0.296 Sum_probs=165.1
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
++|++.+.||+|+||.||+++.. +++.||||++.+. .......+.+|+.++..++|+||+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999865 5899999998642 22344568899999999999998720
Q ss_pred -------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 445 -------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 445 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 11345777888899999999999999998 99999999999999999999999999876543221
Q ss_pred ccccceeeccCCccChhhhcc-----CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMN-----GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ...............
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~- 229 (331)
T cd05597 158 V-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQF- 229 (331)
T ss_pred c-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCcccC-
Confidence 1 1122468999999999873 45788999999999999999999999643211 111111111111111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhc--ccCcCCCCCHHHHHHH
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCV--QDRAADRRTMSDVVSM 626 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl--~~dP~~RPs~~eVl~~ 626 (676)
.+. .. .....+.+++.+|+ ..++..||++.++++.
T Consensus 230 ~~~-~~----~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 PPD-VT----DVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCc-cC----CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 110 01 12233555666655 4444458899999877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=268.72 Aligned_cols=241 Identities=20% Similarity=0.319 Sum_probs=170.1
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDSS------------- 445 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~------------- 445 (676)
.++|++.++||+|+||.||+|+.. +++.||||.+.... ......+.+|+.++++++||||++..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999865 58999999886432 22234567899999999999987311
Q ss_pred ---------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcce
Q 005803 446 ---------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR 504 (676)
Q Consensus 446 ---------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~ 504 (676)
....+++.+...++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++.
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 1124678888999999999999999998 9999999999999999999999999998
Q ss_pred eccccccc--cccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHH-----H
Q 005803 505 TYAMNELE--ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQ-----L 576 (676)
Q Consensus 505 ~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~-----~ 576 (676)
........ .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+..... .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 65432211 112234578889999988764 478899999999999999999999875432211111111000 0
Q ss_pred HhcCCccccCCc-ccCCCC---------ChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 577 WNEGKALELMDP-TLDESC---------SSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 577 ~~~~~~~~~~d~-~l~~~~---------~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
+......+..+. .+.... .......+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000000000 000000 0011235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=267.42 Aligned_cols=236 Identities=20% Similarity=0.320 Sum_probs=168.6
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCch-hhHHHHHHHHHHHHccCCccccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
++|++.+.||+|++|.||+|+.. +++.||||.+...... ....+.+|++++++++|+||+..
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999875 5889999998654322 23456789999999999998720
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++.....++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-- 159 (291)
T cd07844 85 LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT-- 159 (291)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCcc--
Confidence 11235677888999999999999999998 999999999999999999999999998753321111
Q ss_pred cceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC------------
Q 005803 515 TNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK------------ 581 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~------------ 581 (676)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...............
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 112346788999998875 45889999999999999999999999654311 011111111100000
Q ss_pred cccc----C-CcccCCCC-ChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 582 ALEL----M-DPTLDESC-SSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 582 ~~~~----~-d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.... . ...+.... .......+.+++.+||+.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 0 00000000 0111245678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=276.06 Aligned_cols=242 Identities=22% Similarity=0.304 Sum_probs=175.1
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHc-cCCcccccc-----------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKL-QHTNLTDSS----------- 445 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~~~----------- 445 (676)
..++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.++.++ +|+||+...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999875 5889999988542 233455678899999999 999987311
Q ss_pred ---------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 446 ---------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 446 ---------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
....+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 85 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 85 YLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 0125688888899999999999999998 9999999999999999999999999998654332
Q ss_pred cc---cccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHH--------HHHHh
Q 005803 511 LE---ANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYA--------WQLWN 578 (676)
Q Consensus 511 ~~---~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~--------~~~~~ 578 (676)
.. .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+........ ...+.
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 11 12233568999999998765 45789999999999999999999999754322111000000 00000
Q ss_pred cCCccccCC-------cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 579 EGKALELMD-------PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 579 ~~~~~~~~d-------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
......+++ ..+. .........+.+++.+||+.+|++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLD-ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhhHHHhhhhcccccccchh-hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000110 0000 0111134567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=264.02 Aligned_cols=223 Identities=23% Similarity=0.332 Sum_probs=165.9
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHH-HHHccCCcccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKL-IAKLQHTNLTD---------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~-l~~l~H~niv~---------------- 443 (676)
++|++.+.||+|+||.||+|+.. +++.||||+++... .....++..|+.+ ++.++|||+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999875 58999999987542 2233455566664 66778999872
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKY-SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
......+++..+..++.||+.||.|||++ + ++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 01223578888999999999999999987 6 999999999999999999999999998765322
Q ss_pred ccccccceeeccCCccChhhhcc----CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcccc
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMN----GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALEL 585 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~----~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (676)
. ......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||...... . ....... .+.
T Consensus 158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~---~~~~~~~-~~~---- 224 (283)
T cd06617 158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--F---QQLKQVV-EEP---- 224 (283)
T ss_pred c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--H---HHHHHHH-hcC----
Confidence 1 1122467889999998864 45688999999999999999999998643211 0 0011111 111
Q ss_pred CCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 586 MDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 586 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.+.+.. ......+.+++.+||+.+|++||++.+|++
T Consensus 225 -~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 -SPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 112345788999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=269.50 Aligned_cols=229 Identities=18% Similarity=0.257 Sum_probs=164.0
Q ss_pred cceeeccC--CCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 387 PANRLGQG--GFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 387 ~~~~LG~G--~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
+.++||+| +|++||+++.. +++.||||++.... ......+.+|+.+++.++||||++.
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 67899999864 68999999987542 2334567789999999999999720
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc-
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE- 512 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~- 512 (676)
.....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 11234788889999999999999999998 999999999999999999999999875433211110
Q ss_pred ----cccceeeccCCccChhhhcc--CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 513 ----ANTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 513 ----~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... ... ..+......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~~-~~~~~~~~~ 231 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML------LEK-LNGTVPCLL 231 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH------HHH-hcCCccccc
Confidence 01122356778999999976 46899999999999999999999999753221100 000 001100000
Q ss_pred C-------------------ccc-----------------CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 587 D-------------------PTL-----------------DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 587 d-------------------~~l-----------------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
+ ... ...........+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0 000 00011122346788999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=259.56 Aligned_cols=227 Identities=24% Similarity=0.398 Sum_probs=172.3
Q ss_pred CCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCC------chhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSS------GQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
+|+..+.||+|++|.||+|+. .+++.||+|.+.... ....+.+.+|++++++++|+||+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999985 468999999986432 123467899999999999999872
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC-CeEEeccCcceecccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM-NPKISDFGMARTYAMN 509 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~-~vkL~DFGla~~~~~~ 509 (676)
......+++.....++.|++.||.|||+++ ++|+||||+||+++.++ .+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 011245677888999999999999999998 99999999999998776 5999999998766433
Q ss_pred ccc--cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 510 ELE--ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 510 ~~~--~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
... .......++..|+|||.+.+..++.++||||+|+++++|++|+.||........... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~-------- 226 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIASA-------- 226 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhcc--------
Confidence 111 112235678899999999888899999999999999999999999964432221111 1111000
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
......+......+.+++.+||+.+|++||++.++++
T Consensus 227 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 -TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0011223334456888999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=260.97 Aligned_cols=227 Identities=22% Similarity=0.306 Sum_probs=173.5
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
++|+..+.||+|+||.||++... +++.||+|.+.... .....++.+|++++++++||||+..
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46788899999999999999876 58999999987653 3445678999999999999998621
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHK-YSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
.....++......++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 111567778888999999999999999 77 99999999999999999999999999876532211
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ...... ....... .+.+..
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~-----~~~~~~ 226 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELL-QYIVNEP-----PPRLPS 226 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHH-HHHhcCC-----CCCCCh
Confidence 115678899999999988999999999999999999999999975432111 111111 1111111 111111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
. .....+.+++.+||..+|++|||+.++++.
T Consensus 227 ~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 227 G---KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred h---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1 133457788999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=261.86 Aligned_cols=226 Identities=27% Similarity=0.388 Sum_probs=172.7
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCcccccc------------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTDSS------------ 445 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~------------ 445 (676)
..+++|++.+.||+|+||.||+|+.. +++.+++|++.... ...+++.+|+.+++++ +|+|+++..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45789999999999999999999875 57899999987643 3456789999999999 699976210
Q ss_pred ----------------------c--cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccC
Q 005803 446 ----------------------R--KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFG 501 (676)
Q Consensus 446 ----------------------~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFG 501 (676)
. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 0 235677788889999999999999998 9999999999999999999999999
Q ss_pred cceeccccccccccceeeccCCccChhhhcc-----CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHH
Q 005803 502 MARTYAMNELEANTNRIVGTHGYMSPEYVMN-----GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQL 576 (676)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~ 576 (676)
++........ ......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||....... . ...
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~----~~~ 229 (275)
T cd06608 159 VSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR---A----LFK 229 (275)
T ss_pred cceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH---H----HHH
Confidence 9876543221 1223568899999998753 346789999999999999999999996432211 0 011
Q ss_pred HhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 577 WNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 577 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
...... +.+. .+......+.+++.+||..||++|||+.+|++
T Consensus 230 ~~~~~~-----~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRNPP-----PTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhccCC-----CCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111 1111 11223456788999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=263.84 Aligned_cols=234 Identities=22% Similarity=0.299 Sum_probs=171.0
Q ss_pred CCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++|+|++..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667899999999999999876 48899999997653 3344568899999999999998721
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~- 156 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA- 156 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-
Confidence 01136788889999999999999999998 999999999999999999999999999866543211
Q ss_pred ccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcC------Cccc--
Q 005803 514 NTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG------KALE-- 584 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~------~~~~-- 584 (676)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... .......... ....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL---EKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCchhhccccccch
Confidence 1222456788999998765 45789999999999999999999999754422111 1111100000 0000
Q ss_pred ---------cCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 585 ---------LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 585 ---------~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.....+.......+...+.+++.+||+.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000001112456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=257.87 Aligned_cols=221 Identities=25% Similarity=0.363 Sum_probs=170.6
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
+|++.+.||+|+||.||++... +++.+|||.+... .......+.+|+.++++++|+|++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999864 5889999998653 23446678999999999999998620
Q ss_pred ------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC-CCeEEeccCcceecccccc
Q 005803 445 ------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ-MNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 445 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~-~~vkL~DFGla~~~~~~~~ 511 (676)
.....+++..+..++.+++.||.|||+++ ++|+||||+||+++++ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 11234788888999999999999999998 9999999999999855 4589999999987543221
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... . ... ...+.... +
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~---~~~-~~~~~~~~-----~- 221 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---L---VLK-IMSGTFAP-----I- 221 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---H---HHH-HHhcCCCC-----C-
Confidence 122567889999999998889999999999999999999999986543211 1 111 11111111 1
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+......+.+++.+||+.+|++|||+.|+++.
T Consensus 222 ---~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 ---SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11223457788999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=262.53 Aligned_cols=233 Identities=21% Similarity=0.271 Sum_probs=172.5
Q ss_pred CCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--hhhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
|++.+.||+|++|.||+++.. +++.+|+|.+..... .....+.+|+.++++++|+|+++.
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567889999999999999865 688999999875432 245678899999999999998720
Q ss_pred ---------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 445 ---------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 445 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
.....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||.+....... ...
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~ 155 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPY 155 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccc
Confidence 11236788889999999999999999998 9999999999999999999999999998765433 111
Q ss_pred ceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcC------Cccc----
Q 005803 516 NRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG------KALE---- 584 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~------~~~~---- 584 (676)
....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+.... ........ ...+
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcccchhhhhh
Confidence 224577889999998876 789999999999999999999999975432211111 10100000 0000
Q ss_pred ----cCCccc--CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 585 ----LMDPTL--DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 585 ----~~d~~l--~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
..+... .....+.....+.+++.+||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 00111234557889999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=265.11 Aligned_cols=235 Identities=19% Similarity=0.239 Sum_probs=168.2
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHcc-CCcccccc-------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQ-HTNLTDSS------------- 445 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~~~------------- 445 (676)
++|++.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.+++++. |+|+++..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47889999999999999999865 58999999876532 223457888999999995 58886200
Q ss_pred ----------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC-CCCeEEeccCc
Q 005803 446 ----------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE-QMNPKISDFGM 502 (676)
Q Consensus 446 ----------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~-~~~vkL~DFGl 502 (676)
....+++..+..++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeeccc
Confidence 0234688889999999999999999998 999999999999998 88999999999
Q ss_pred ceeccccccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC
Q 005803 503 ARTYAMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK 581 (676)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 581 (676)
+........ ......+++.|+|||++.+ ..++.++||||||+++|||++|..||........ ............
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (295)
T cd07837 158 GRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ---LLHIFKLLGTPT 232 (295)
T ss_pred ceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHhCCCC
Confidence 876532211 1122356788999998865 4578999999999999999999999975332111 000001000000
Q ss_pred c------cccC--------CcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 582 A------LELM--------DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 582 ~------~~~~--------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
. .... .+.......+.....+.+++.+||+.||.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0000 000000001123445788999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=260.19 Aligned_cols=232 Identities=24% Similarity=0.284 Sum_probs=173.4
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCcccccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTDSS--------------- 445 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~--------------- 445 (676)
++|...++||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||+...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999975 588999999875432 3456789999999999999987310
Q ss_pred -----------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 446 -----------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 446 -----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
....++......++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 1123556667789999999999999998 99999999999999999999999999875432
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
.. .....++..|+|||.+.+..++.++|||||||++|||++|+.||........ ..... ...........+.+
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~- 230 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIEL-LSYIVNMPNPELKD- 230 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHH-HHHHhcCCchhhcc-
Confidence 21 1124578889999999988999999999999999999999999986533111 11111 11111111111111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
... ........+.+++.+||+.+|++|||+.||++.
T Consensus 231 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 231 EPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 111 011234567899999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=267.00 Aligned_cols=221 Identities=29% Similarity=0.439 Sum_probs=170.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
.+.|.+.+.||+|+||.||+|+.. +++.||+|.+.... .....++.+|+++++.++|||++..
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888999999999999999865 58999999986432 2334568899999999999998731
Q ss_pred -------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 445 -------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 445 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
.....+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++......
T Consensus 94 ~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 94 MEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 11345788889999999999999999998 999999999999999999999999998754322
Q ss_pred ccccceeeccCCccChhhhc---cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 512 EANTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
....++..|+|||.+. ...++.++||||||+++|||++|+.||....... .... ...... +
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~-~~~~~~-----~ 232 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH-IAQNDS-----P 232 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHH-HhcCCC-----C
Confidence 2246788999999874 4568899999999999999999999986432111 0111 111110 1
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+. .......+.+++.+||+.+|++||++.+|++.
T Consensus 233 ~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 233 TLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111 11234468889999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=297.32 Aligned_cols=227 Identities=21% Similarity=0.298 Sum_probs=170.6
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccc------------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
...++|.+.++||+|+||.||+++.. .++.||+|.+... .......+..|+.++.+++||||+..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999865 4778999988643 23345678999999999999998731
Q ss_pred --------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCC----CceEeeccccCceEEcC---------
Q 005803 445 --------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSR----LRAIHRDLKVSNILLDE--------- 491 (676)
Q Consensus 445 --------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~----~~iiH~DLKp~NILl~~--------- 491 (676)
.....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 011357888889999999999999998541 34999999999999964
Q ss_pred --------CCCeEEeccCcceeccccccccccceeeccCCccChhhhcc--CCCCchhHHHHHHHHHHHHHhCCcCCCCC
Q 005803 492 --------QMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIVSSKKNNGSY 561 (676)
Q Consensus 492 --------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~elltG~~pf~~~ 561 (676)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2348999999998654322 1223578999999999864 45889999999999999999999999643
Q ss_pred CCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 562 DTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 562 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.... . ....+..+. .+.. ......+.+|+..||+.+|.+||++.|+++
T Consensus 247 ~~~~-----q-li~~lk~~p-------~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFS-----Q-LISELKRGP-------DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHH-----H-HHHHHhcCC-------CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 2211 1 111111111 1110 112345788999999999999999999984
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=273.75 Aligned_cols=214 Identities=23% Similarity=0.339 Sum_probs=157.5
Q ss_pred eccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHc---cCCcccc--------------------
Q 005803 391 LGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL---QHTNLTD-------------------- 443 (676)
Q Consensus 391 LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l---~H~niv~-------------------- 443 (676)
||+|+||.||+|+.. +++.||||++.+.. ......+..|..++.++ .||||+.
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 58999999986432 12233455677777665 6999862
Q ss_pred ------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccce
Q 005803 444 ------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 444 ------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~ 155 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNT 155 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccC
Confidence 112345778888999999999999999998 9999999999999999999999999987532221 12233
Q ss_pred eeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCCh
Q 005803 518 IVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSS 596 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 596 (676)
..||..|+|||.+.+. .++.++|||||||++|||++|+.||....... .......+.. .+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~------~~~~~--- 219 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKV------RFPKN--- 219 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCC------CCCCc---
Confidence 6799999999998764 48999999999999999999999996532211 1112222211 11111
Q ss_pred HHHHHHHHHHHHhcccCcCCCC----CHHHHHH
Q 005803 597 DEVMRCIHVGLLCVQDRAADRR----TMSDVVS 625 (676)
Q Consensus 597 ~~~~~l~~L~~~Cl~~dP~~RP----s~~eVl~ 625 (676)
.....+.+++.+||+.||++|| ++.++++
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1223467888899999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=258.25 Aligned_cols=226 Identities=28% Similarity=0.455 Sum_probs=172.4
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--hhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
+|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.++++++|+||++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999865 688999999876544 35678999999999999999872
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 112234778888999999999999999998 99999999999999999999999999987544322111
Q ss_pred --cceeeccCCccChhhhccCC---CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 515 --TNRIVGTHGYMSPEYVMNGI---VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 515 --~~~~~gt~~Y~APE~~~~~~---~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
.....++..|+|||++.+.. ++.++||||||++++||++|+.||....... ...... ..+ ..+.
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~~-~~~-----~~~~ 226 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHV-GAG-----HKPP 226 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHHH-hcC-----CCCC
Confidence 11246788999999998766 8899999999999999999999997543111 001110 111 1111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
+... ......+.+++.+||+.+|.+||++.+++.
T Consensus 227 ~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 IPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111 112345678889999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=257.84 Aligned_cols=226 Identities=25% Similarity=0.354 Sum_probs=177.8
Q ss_pred cCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
++|++.+.||+|++|.||+|+... ++.||||++..... .....+.+|+..+.+++|+|+++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999998764 89999999876543 45678999999999999999872
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHK-YSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++..+..++.|+++||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 1122567888889999999999999999 88 999999999999999999999999999876433222
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 593 (676)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||............ ....... .+.+
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~----~~~~~~~-----~~~~--- 223 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM----QAICDGP-----PPSL--- 223 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH----HHHhcCC-----CCCC---
Confidence 12356788999999999889999999999999999999999999765431111111 1111111 1111
Q ss_pred CChH-HHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 594 CSSD-EVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 594 ~~~~-~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+.. ....+.+++.+||+.+|++||++.++++.
T Consensus 224 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 -PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 112 34568889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=262.44 Aligned_cols=232 Identities=21% Similarity=0.291 Sum_probs=168.5
Q ss_pred CCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
|++.+.||.|++|.||+|... +++.||+|++.... ......+.+|++++++++|+|+++.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677899999999999999865 69999999986543 2234568899999999999998720
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++..+..++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~ 155 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--T 155 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--c
Confidence 11125788999999999999999999988 99999999999999999999999999975432211 1
Q ss_pred cceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHh-----------c-CC
Q 005803 515 TNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWN-----------E-GK 581 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~-----------~-~~ 581 (676)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||........ +.. ..+... . ..
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFR-IFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCChHHhhhhhhchh
Confidence 1223568899999988654 578999999999999999999999975432110 000 000000 0 00
Q ss_pred ----ccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 582 ----ALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 582 ----~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
......... ..........+.+++.+||+.+|++||+++|+++
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0111222346788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=274.99 Aligned_cols=244 Identities=22% Similarity=0.278 Sum_probs=176.8
Q ss_pred HHHHHHHhcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccccc------
Q 005803 375 FQTIAAATDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDSS------ 445 (676)
Q Consensus 375 ~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~------ 445 (676)
..++..++++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++.+++|+||++..
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 456777889999999999999999999985 468899999986532 22345678899999999999987311
Q ss_pred ------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccC
Q 005803 446 ------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFG 501 (676)
Q Consensus 446 ------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFG 501 (676)
....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||
T Consensus 89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg 165 (345)
T cd07877 89 RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 165 (345)
T ss_pred ccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccc
Confidence 1134778888999999999999999998 9999999999999999999999999
Q ss_pred cceeccccccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH--------
Q 005803 502 MARTYAMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY-------- 572 (676)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~-------- 572 (676)
++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..
T Consensus 166 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T cd07877 166 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240 (345)
T ss_pred cccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 98754321 223567889999998876 5688999999999999999999999965332111000000
Q ss_pred HHHHHhcCC---ccccCCcccCCC---CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 573 AWQLWNEGK---ALELMDPTLDES---CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 573 ~~~~~~~~~---~~~~~d~~l~~~---~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
....+.... ....++...... ........+.+++.+|++.||.+||++.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000 000000000000 000123357789999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=261.10 Aligned_cols=231 Identities=21% Similarity=0.305 Sum_probs=180.8
Q ss_pred cCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLT---------------- 442 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv---------------- 442 (676)
++|+++++||+|.-|+||++++.+ +..+|+|++.+.. .....+.+.|.+||+.++||-+.
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 356668899999999999999875 6889999998753 33455678899999999999976
Q ss_pred ------------cccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc--
Q 005803 443 ------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM-- 508 (676)
Q Consensus 443 ------------~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~-- 508 (676)
+....+.+++..+.-++.+++.||+|||-.| ||.|||||+||||.++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 2345567888888888889999999999998 99999999999999999999999998743210
Q ss_pred ---------------------------c-----c--------------------cccccceeeccCCccChhhhccCCCC
Q 005803 509 ---------------------------N-----E--------------------LEANTNRIVGTHGYMSPEYVMNGIVS 536 (676)
Q Consensus 509 ---------------------------~-----~--------------------~~~~~~~~~gt~~Y~APE~~~~~~~s 536 (676)
. . ........+||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 00122346899999999999999999
Q ss_pred chhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCC
Q 005803 537 MKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAAD 616 (676)
Q Consensus 537 ~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~ 616 (676)
.++|.|+|||++||||.|..||......+... .++...+.....++....+.+|+.+.|..||.+
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~---------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR---------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHH---------------HHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 99999999999999999999999876544221 122222222222344556788999999999999
Q ss_pred CCC----HHHHHHH--HhcCc
Q 005803 617 RRT----MSDVVSM--LTNDT 631 (676)
Q Consensus 617 RPs----~~eVl~~--Le~~~ 631 (676)
|.- +.||-+. ++++.
T Consensus 379 Rlg~~rGA~eIK~HpFF~gVn 399 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRHPFFEGVN 399 (459)
T ss_pred hhccccchHHhhcCccccCCC
Confidence 998 8888764 56654
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=253.14 Aligned_cols=225 Identities=23% Similarity=0.354 Sum_probs=176.2
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--hhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++|+||+..
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999876 689999999876432 456788999999999999998720
Q ss_pred ------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 445 ------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 445 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
.....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 11125778888999999999999999988 999999999999999999999999999876544321
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.......++..|+|||.+....++.++||||||+++++|++|+.||..... .......... .....
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~---------~~~~~ 223 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGS---------SGEPP 223 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccc---------cCCCc
Confidence 112335678899999999888899999999999999999999999976541 1111111110 01111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
..+......+.+++.+|++.+|++||++.++++
T Consensus 224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 122233456888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=263.79 Aligned_cols=231 Identities=19% Similarity=0.263 Sum_probs=172.8
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|++.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.++||||+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47889999999999999999865 47899999987543 233457889999999999999872
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc-
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL- 511 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~- 511 (676)
......+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 112244677888889999999999999988 99999999999999999999999999864211000
Q ss_pred ------------ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhc
Q 005803 512 ------------EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNE 579 (676)
Q Consensus 512 ------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 579 (676)
........++..|+|||.+.+..++.++|+|||||++|||++|+.||......+ .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-------~~~~~~~ 230 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-------LFGQVIS 230 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHh
Confidence 001112457889999999988889999999999999999999999996432211 1111111
Q ss_pred CCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 580 GKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 580 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
+.. ..+.... .....+.+++.+||+.+|++||++.++.+.|+..
T Consensus 231 ~~~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 231 DDI---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred ccc---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 111 1111111 2233477899999999999999988788777664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=261.08 Aligned_cols=234 Identities=22% Similarity=0.341 Sum_probs=171.1
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
+|++.++||+|++|.||+|+.. +++.||||.+..... .....+.+|+.++++++|+|+++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999975 588999999875432 234567889999999999998720
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 155 (284)
T cd07836 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-- 155 (284)
T ss_pred CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--
Confidence 11235788899999999999999999998 99999999999999999999999999975433211
Q ss_pred ccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH--------HHHHHhcCCccc
Q 005803 514 NTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY--------AWQLWNEGKALE 584 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~--------~~~~~~~~~~~~ 584 (676)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||......+....... .++.+.. ..
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 232 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ---LP 232 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc---Cc
Confidence 11224578899999988654 578999999999999999999999976543221110000 0000000 00
Q ss_pred cCCcccC-------CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 585 LMDPTLD-------ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 585 ~~d~~l~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
....... ....+.....+.+++.+|++.||.+||++.+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0011122346778999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=250.89 Aligned_cols=223 Identities=26% Similarity=0.416 Sum_probs=175.0
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|+.++++++|+|++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999875 68899999997755556778999999999999999862
Q ss_pred --------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 444 --------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 444 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
......+++..+..++.|+++||.+||+.+ ++|+||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 011146788899999999999999999988 99999999999999999999999999886544321 2
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCS 595 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 595 (676)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ............ .. .
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~-----~~--~ 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-------LFKIATNGPPGL-----RN--P 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-------HHHHHhcCCCCc-----Cc--c
Confidence 346788999999999888899999999999999999999999875432110 011111111111 11 1
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 596 SDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 596 ~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
......+.+++.+||+.||++|||+.++++.
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1113457888999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=259.22 Aligned_cols=223 Identities=25% Similarity=0.447 Sum_probs=171.2
Q ss_pred CCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccC-CchhhHHHHHHHHHHHHcc---CCcccc---------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQ---HTNLTD--------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~---H~niv~--------------- 443 (676)
.|++.+.||+|+||.||+|.. .+++.||+|.+... ......++.+|+.++++++ |+|+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999986 46899999998654 3344567889999999997 999862
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++.....++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-- 156 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--
Confidence 111235788888999999999999999998 99999999999999999999999999987654331
Q ss_pred ccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
......|+..|+|||.+.++ .++.++|+|||||++|+|++|+.||......... ... .....+.+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------~~~-----~~~~~~~~~~ 224 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------MLI-----PKSKPPRLED 224 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------hcc-----ccCCCCCCCc
Confidence 12234688899999988754 5789999999999999999999999754321110 000 0001111111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
. .....+.+++.+||+.||++||++.++++.
T Consensus 225 ~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 225 N---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred c---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1 133457788999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=274.75 Aligned_cols=226 Identities=25% Similarity=0.379 Sum_probs=179.4
Q ss_pred CCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-------------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------------- 444 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------------- 444 (676)
....++||-|.||.||.|.++. .-.||||.++. ..-..++|+.|+.+|+.++|||+|+.
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 3456899999999999999865 67799999965 45678899999999999999999831
Q ss_pred ---------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 445 ---------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 445 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
..+..++.-..++++.||+.|++||..++ +|||||..+|+|+.++..+||+|||+++++..+......
T Consensus 348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence 11223334455789999999999999998 999999999999999999999999999988755433221
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
. ..-...|.|||.+....++.|+|||+|||+|||+.| |-.||...+.. .++.++..+- +.+-
T Consensus 425 G-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-------qVY~LLEkgy---------RM~~ 487 (1157)
T KOG4278|consen 425 G-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYGLLEKGY---------RMDG 487 (1157)
T ss_pred C-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-------HHHHHHhccc---------cccC
Confidence 1 222457999999999999999999999999999998 77888754322 2333433332 2233
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+..++..+.+|+..||+.+|.+||++.|+-+.+|.+.
T Consensus 488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 488 PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 4455667889999999999999999999999987543
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=263.36 Aligned_cols=218 Identities=24% Similarity=0.320 Sum_probs=171.1
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47889999999999999999865 58999999986532 234567889999999999999872
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 112345788888999999999999999988 999999999999999999999999999865433
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...... ........+.. .+..
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~------~~~~ 219 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKILEGKV------RFPS 219 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCc------cCCc
Confidence 22346889999999998888899999999999999999999998754311 11111111111 1111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRR-----TMSDVVS 625 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~ 625 (676)
.....+.+++.+||+.||.+|| +++|+++
T Consensus 220 ----~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 220 ----FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1234577888999999999999 6777664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=260.34 Aligned_cols=222 Identities=25% Similarity=0.414 Sum_probs=171.9
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
-|++.++||+|+||.||+|... +++.||||.+.... ......+.+|+.++.+++|+||++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667889999999999999864 58899999986432 234467889999999999999872
Q ss_pred -------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccc
Q 005803 444 -------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516 (676)
Q Consensus 444 -------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 516 (676)
......+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........ ...
T Consensus 85 ~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~ 159 (277)
T cd06641 85 GGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRN 159 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--hhc
Confidence 112345788889999999999999999988 99999999999999999999999999876543221 122
Q ss_pred eeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCCh
Q 005803 517 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSS 596 (676)
Q Consensus 517 ~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 596 (676)
...++..|+|||.+.+..++.++|+|||||++|+|++|..||....... .......+. .+.+. .
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~-----~~~~~----~ 223 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLFLIPKNN-----PPTLE----G 223 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-------HHHHHhcCC-----CCCCC----c
Confidence 2467889999999988888999999999999999999999986432211 011111111 11111 2
Q ss_pred HHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 597 DEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 597 ~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.....+.+++.+||+.+|.+||++.++++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 233457788999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=270.90 Aligned_cols=228 Identities=21% Similarity=0.279 Sum_probs=164.5
Q ss_pred cCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|++.++||+|+||.||+++... ++.||+|++.+. .......+.+|+.++..++|+||+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478999999999999999998764 788999998642 2223445788999999999999862
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 011245777888899999999999999998 99999999999999999999999999875432221
Q ss_pred ccccceeeccCCccChhhhc-----cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 512 EANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...... .............. +
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~-~ 229 (332)
T cd05623 158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERFQ-F 229 (332)
T ss_pred -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCcccc-C
Confidence 1122357899999999986 346889999999999999999999999743211 11111111110000 0
Q ss_pred CcccCCCCChHHHHHHHHHHHHhccc--CcCCCCCHHHHHHH
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCVQD--RAADRRTMSDVVSM 626 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl~~--dP~~RPs~~eVl~~ 626 (676)
+.. .......+.+++.+|+.. ++..|+++.|+++.
T Consensus 230 -p~~----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 -PAQ----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -CCc----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000 111223456666676644 44447899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=261.92 Aligned_cols=224 Identities=21% Similarity=0.300 Sum_probs=171.5
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc------------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------------ 444 (676)
+|...+.||+|++|.||++... +++.||+|++........+.+.+|+.+++.+.|+|++..
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3444679999999999999864 688999999876555556678999999999999998731
Q ss_pred -------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccce
Q 005803 445 -------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 445 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
.....+++.++..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++........ ....
T Consensus 100 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~ 174 (285)
T cd06648 100 GGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKS 174 (285)
T ss_pred CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cccc
Confidence 11134677888999999999999999998 99999999999999999999999998875432211 1122
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChH
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 597 (676)
..|+..|+|||.+.+..++.++|||||||++|||++|+.||...... . ......... .+.+.. ...
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~-~~~~~~~~~-----~~~~~~--~~~ 240 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------Q-AMKRIRDNL-----PPKLKN--LHK 240 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------H-HHHHHHhcC-----CCCCcc--ccc
Confidence 46889999999998888999999999999999999999998643211 1 111111111 111111 111
Q ss_pred HHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 598 EVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 598 ~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
....+.+++.+||+.+|++||++.++++.
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 23468889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=262.94 Aligned_cols=238 Identities=24% Similarity=0.314 Sum_probs=172.5
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccccc-----------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDSS----------- 445 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~----------- 445 (676)
...++|++.+.||+|+||.||+|... +++.||||+++... ......+.+|+.++++++|||++...
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 48899999986542 22335678899999999999987410
Q ss_pred -------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEecc
Q 005803 446 -------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDF 500 (676)
Q Consensus 446 -------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DF 500 (676)
....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcc
Confidence 0124788889999999999999999998 999999999999999999999999
Q ss_pred CcceeccccccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhc
Q 005803 501 GMARTYAMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNE 579 (676)
Q Consensus 501 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 579 (676)
|++......... ......++..|+|||.+.+ ..++.++|||||||++|||++|++||........ ..........
T Consensus 161 g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~---~~~~~~~~~~ 236 (302)
T cd07864 161 GLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ---LELISRLCGS 236 (302)
T ss_pred cccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCC
Confidence 999865433211 1122345778999998865 4578999999999999999999999974332111 1111111000
Q ss_pred CC---cccc--------CCc------ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 580 GK---ALEL--------MDP------TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 580 ~~---~~~~--------~d~------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.. ...+ .++ .+... .......+.+++.+||+.+|++||++.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0000 000 00000 0012346788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=255.29 Aligned_cols=222 Identities=24% Similarity=0.338 Sum_probs=170.3
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
+|++.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++|+|++.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999875 48899999986531 234567889999999999999872
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC-CeEEeccCcceecccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM-NPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~-~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.|++.||.|||+.+ ++|+||||+||++++++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 011224688889999999999999999988 99999999999999875 469999999876543221
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
......|++.|+|||.+.+..++.++|+||||++++||++|+.||..... ....... ..+....
T Consensus 158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~-~~~~~~~------- 221 (257)
T cd08225 158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKI-CQGYFAP------- 221 (257)
T ss_pred --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHH-hcccCCC-------
Confidence 11224688899999999888899999999999999999999999864321 1111111 1111111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
..+.....+.+++.+|++.+|++|||+.+|++.
T Consensus 222 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 --ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111223457888999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=270.93 Aligned_cols=228 Identities=21% Similarity=0.272 Sum_probs=166.4
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|.+.+.||+|+||.||+++.. +++.||+|.+.+. .......+.+|..++..++|+||+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999865 5788999998642 2223445788999999999999862
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 011345778888899999999999999998 99999999999999999999999999986543322
Q ss_pred ccccceeeccCCccChhhhcc-----CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMN-----GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
. ......||+.|+|||++.+ +.++.++|||||||++|||++|+.||...... .............. +
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~-~ 229 (331)
T cd05624 158 V-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERFQ-F 229 (331)
T ss_pred e-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCccc-C
Confidence 1 1223568999999999875 46789999999999999999999999743221 11111111110000 1
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCcCC--CCCHHHHHHH
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAAD--RRTMSDVVSM 626 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~eVl~~ 626 (676)
.+. .....+.+.+++.+|+..++.+ |++++++++.
T Consensus 230 p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 230 PSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111 1112345677788888765544 5688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=257.39 Aligned_cols=221 Identities=26% Similarity=0.309 Sum_probs=172.2
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
+|++.+.||.|+||.||+|+.. +++.||+|.+.+.. ....+.+.+|++++++++||||+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999875 58999999997542 234678899999999999999872
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++.....++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--- 154 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--- 154 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc---
Confidence 011236788889999999999999999998 9999999999999999999999999987654332
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 593 (676)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....... .......... ..+ .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~------~~~----~ 220 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET------ADV----L 220 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc------ccc----c
Confidence 1223567889999999988889999999999999999999999997654321 1111111110 001 1
Q ss_pred CChHHHHHHHHHHHHhcccCcCCCCCH--HHHH
Q 005803 594 CSSDEVMRCIHVGLLCVQDRAADRRTM--SDVV 624 (676)
Q Consensus 594 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~--~eVl 624 (676)
.+......+.+++.+||+.||.+||++ +|++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 122233568889999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=266.97 Aligned_cols=242 Identities=19% Similarity=0.230 Sum_probs=171.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSS--------------- 445 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~~--------------- 445 (676)
..+|.+.+.||.|+||.||+|... +++.||+|++........+.+.+|++++++++||||+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999864 5899999998766556667789999999999999987321
Q ss_pred -----------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc-CCCCeEEeccC
Q 005803 446 -----------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD-EQMNPKISDFG 501 (676)
Q Consensus 446 -----------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~-~~~~vkL~DFG 501 (676)
....+++.....++.||+.||.|||+.+ |+||||||+||+++ +++.+||+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcc
Confidence 0124677888899999999999999998 99999999999997 45678999999
Q ss_pred cceecccccccc-ccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH-------
Q 005803 502 MARTYAMNELEA-NTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY------- 572 (676)
Q Consensus 502 la~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~------- 572 (676)
++.......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 997653321111 1122357889999998764 5688999999999999999999999965432111000000
Q ss_pred -HHHHHhcCCccccCCcccCCC-----CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 573 -AWQLWNEGKALELMDPTLDES-----CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 573 -~~~~~~~~~~~~~~d~~l~~~-----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
..................... ..+.....+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000000000000000000000 011123457789999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=269.64 Aligned_cols=239 Identities=23% Similarity=0.288 Sum_probs=169.6
Q ss_pred CCCcceeeccCCCccEEEEEEc-C--CcEEEEEEeccCC--chhhHHHHHHHHHHHHc-cCCcccccc------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-D--GQEIAIKRLSKSS--GQGIVEFKNEAKLIAKL-QHTNLTDSS------------ 445 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~--~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~~~------------ 445 (676)
+|++.+.||+|+||.||+++.. . ++.||||++.... ....+.+.+|+.+++++ +|+||++..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999864 3 7789999986432 22345678899999999 599987311
Q ss_pred -----------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 446 -----------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 446 -----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 2245677888899999999999999998 99999999999999999999999999986543
Q ss_pred cccc--cccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH--------HHHHH
Q 005803 509 NELE--ANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY--------AWQLW 577 (676)
Q Consensus 509 ~~~~--~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~--------~~~~~ 577 (676)
.... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.............. ....+
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 2211 11223578999999998765 5689999999999999999999999875432110000000 00000
Q ss_pred hcCCcc-------ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 578 NEGKAL-------ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 578 ~~~~~~-------~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
...... ......+. ...+.....+.+++.+||+.||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 00000000 0011123457889999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=262.78 Aligned_cols=235 Identities=21% Similarity=0.289 Sum_probs=167.9
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--hhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
++|++.+.||+|++|.||+|+.. +++.||+|.+..... .....+.+|++++++++|+|+++.
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999865 588999999865322 234568899999999999998731
Q ss_pred ------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC-CCCeEEeccCcceecccccc
Q 005803 445 ------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE-QMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 445 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~-~~~vkL~DFGla~~~~~~~~ 511 (676)
.....+++.....++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~- 157 (294)
T PLN00009 82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV- 157 (294)
T ss_pred cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc-
Confidence 01122456677789999999999999998 999999999999985 5579999999997543221
Q ss_pred ccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccC----
Q 005803 512 EANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM---- 586 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~---- 586 (676)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......+. ........... .....
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~ 232 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE---LFKIFRILGTP-NEETWPGVT 232 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCC-Chhhccccc
Confidence 11122456889999998876 4578999999999999999999999975432211 11011100000 00000
Q ss_pred ---C-----cccCC----CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 587 ---D-----PTLDE----SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 587 ---d-----~~l~~----~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+ +.... ...+.....+.+++.+|++.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00000 0111223457889999999999999999999863
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=268.39 Aligned_cols=245 Identities=25% Similarity=0.317 Sum_probs=177.9
Q ss_pred CCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
+|++.+.||+|+||.||+|+... ++.||||++.... ....+.+.+|+.+++.++|+||+..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58889999999999999998754 8999999987643 3445678999999999999998621
Q ss_pred --------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 445 --------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.....+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 11225677888899999999999999998 9999999999999999999999999998765432
Q ss_pred cc-cccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHH--------HHHHhcC
Q 005803 511 LE-ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYA--------WQLWNEG 580 (676)
Q Consensus 511 ~~-~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~--------~~~~~~~ 580 (676)
.. .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....+... +......
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 10 112235678899999999887 7899999999999999999999999765432111100000 0000000
Q ss_pred CccccCC---cccC---CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcCc
Q 005803 581 KALELMD---PTLD---ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTNDT 631 (676)
Q Consensus 581 ~~~~~~d---~~l~---~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~~ 631 (676)
.....+. .... ....+.....+.+++.+||+.+|++||++.++++. +++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0000000 0000 00011134467889999999999999999999985 65543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=253.42 Aligned_cols=220 Identities=26% Similarity=0.351 Sum_probs=173.2
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
+|++.++||+|+||.||+++.. +++.+|+|.+.... .....++.+|+.++++++|+||+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5888999999999999999754 58899999986532 3345677899999999999998720
Q ss_pred --------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 445 --------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.....+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 01245777888999999999999999998 999999999999999999999999999876543
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||....... .......+...
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------- 219 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGKYP------- 219 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCCC-------
Confidence 1122457889999999999899999999999999999999999997543211 11111111111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
..+......+.+++.+|++.+|++||++.++++.
T Consensus 220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 --PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred --CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1122344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=264.44 Aligned_cols=222 Identities=29% Similarity=0.427 Sum_probs=170.4
Q ss_pred CCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|+|++..
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667889999999999999864 58899999986432 2334568899999999999998720
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------ 177 (317)
T cd06635 107 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP------ 177 (317)
T ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence 12345788888999999999999999998 99999999999999999999999999875432
Q ss_pred cceeeccCCccChhhhc---cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 515 TNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.....++..|+|||++. .+.++.++|||||||++|||++|+.||....... . .. ....... +..
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~---~~-~~~~~~~-----~~~- 244 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---A---LY-HIAQNES-----PTL- 244 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---H---HH-HHHhccC-----CCC-
Confidence 12246788999999874 4568899999999999999999999986432111 0 11 1111111 011
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
........+.+++.+||+.+|.+||++.+|++.+--.
T Consensus 245 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 245 --QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred --CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 1112334578899999999999999999999876554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=275.21 Aligned_cols=225 Identities=23% Similarity=0.356 Sum_probs=176.2
Q ss_pred cCCCcceeeccCCCccEEEEEEcCC-cEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDG-QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~-~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
+.|.++..||.|+||+||+|..++. -..|.|++........+.++-|++||....||+||+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 3456678899999999999987653 345788888777888899999999999999999983
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
...+..|.+.++..++.|++.||.|||++. |||||||..|||++-+|.++|+|||.+..... ....
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQK 186 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HHhh
Confidence 234567889999999999999999999998 99999999999999999999999999754321 1222
Q ss_pred cceeeccCCccChhhhc-----cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 515 TNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
...+.||++|||||+.. ..+|+.++||||||++|.||.-+.+|-....+.... -.+.... .|.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl-------lKiaKSe-----PPT 254 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL-------LKIAKSE-----PPT 254 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH-------HHHhhcC-----CCc
Confidence 34589999999999875 468999999999999999999999997644332211 1111111 122
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
|.. +..-...+.+++.+||..||..||+++++++.
T Consensus 255 Llq--PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 255 LLQ--PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ccC--cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 221 22334457788889999999999999998864
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=258.48 Aligned_cols=232 Identities=20% Similarity=0.264 Sum_probs=167.2
Q ss_pred CCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHcc-CCccccc-----------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQ-HTNLTDS----------------- 444 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~~----------------- 444 (676)
|++.++||+|+||.||+|+.. +++.||+|+++... ........+|+.++.++. |+|+++.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 667899999999999999865 58899999987542 222234457888899885 9998720
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++..+..++.|++.||.|||+.+ ++||||||+||+++. +.+||+|||++........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 11245788899999999999999999998 999999999999999 9999999999986543221
Q ss_pred ccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHH-----------HHhcCC
Q 005803 514 NTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQ-----------LWNEGK 581 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~-----------~~~~~~ 581 (676)
.....++..|+|||.+.. ..++.++|||||||++|||++|..||......+ ....... ......
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcccc
Confidence 122457889999997654 557899999999999999999999997543211 1111110 000000
Q ss_pred ccccCCcccCC----CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 582 ALELMDPTLDE----SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 582 ~~~~~d~~l~~----~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
......+.... .........+.+++.+||+.+|++||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000 0011235678899999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=273.57 Aligned_cols=222 Identities=26% Similarity=0.316 Sum_probs=173.3
Q ss_pred cceeeccCCCccEEEEEEc--CCc--EEEEEEeccCCch-hhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 387 PANRLGQGGFGPVYNGKLL--DGQ--EIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 387 ~~~~LG~G~fG~Vy~~~~~--~~~--~VAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
..++||+|.||.|++|.+. +|+ .||||.+...... ....|++|+.+|.+|+|+|+++.
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELap 193 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAP 193 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhcc
Confidence 3689999999999999865 355 4799999765443 67889999999999999998731
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc-
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA- 513 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~- 513 (676)
.....|-......++.|||.|+.||.+++ +|||||..+|+|+...-.+||+|||+.+.+...+...
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 12233444455678999999999999998 9999999999999999999999999998776543222
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
......-.+.|+|||.+....++.++|||+|||+||||++ |+.||....... +.+.+|..-.-
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD~~erL 334 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNIDAGERL 334 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhccccccC
Confidence 1122223567999999999999999999999999999999 778887653322 11223322222
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~L 627 (676)
.-+..+.+.+.+++..||..+|++|||+..|.+.+
T Consensus 335 pRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 33567788899999999999999999999998543
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=258.91 Aligned_cols=226 Identities=21% Similarity=0.316 Sum_probs=167.5
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCC-chhhHHHHHHHHHHHHcc-CCcccccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQ-HTNLTDSS------------- 445 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~~~------------- 445 (676)
.++|++.+.||+|+||.||+|+..+ ++.||||.++... .....++..|+.++.+.. |+||+...
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3578889999999999999999765 8999999997543 234456677887777775 99987311
Q ss_pred -------------ccCcCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 446 -------------RKSLLDWKKRFYIIEGIVQGLLYLHKY-SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 446 -------------~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
....+++..+..++.||+.||+|||+. + |+||||+|+||++++++.+||+|||++..+.....
T Consensus 94 e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 94 ELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 123578888899999999999999974 6 99999999999999999999999999876543221
Q ss_pred ccccceeeccCCccChhhhccCC----CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGI----VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~----~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
.....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .. ...........
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~-~~~~~~~~~~~---- 237 (296)
T cd06618 171 ---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FE-VLTKILQEEPP---- 237 (296)
T ss_pred ---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HH-HHHHHhcCCCC----
Confidence 11235678899999987543 789999999999999999999998643211 00 11111111111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+.. .......+.+++.+||+.||++||++.++++.
T Consensus 238 -~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 -SLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -CCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 01123457889999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=256.64 Aligned_cols=232 Identities=20% Similarity=0.299 Sum_probs=168.2
Q ss_pred CCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCc--hhhHHHHHHHHHHHHc---cCCccccc--------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSG--QGIVEFKNEAKLIAKL---QHTNLTDS-------------- 444 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~~-------------- 444 (676)
|++.+.||+|+||.||+|+... ++.||+|++..... .....+.+|+.++.++ .|+|+++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6678999999999999999764 89999999974322 2234566788877766 59998620
Q ss_pred ------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceec
Q 005803 445 ------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTY 506 (676)
Q Consensus 445 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~ 506 (676)
.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 01124788888999999999999999998 999999999999999999999999999875
Q ss_pred cccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCc----
Q 005803 507 AMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKA---- 582 (676)
Q Consensus 507 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~---- 582 (676)
..... .....++..|+|||.+.+..++.++|||||||++|||++|++||......+. .............
T Consensus 158 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 158 SFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDKIFDVIGLPSEEEWP 231 (287)
T ss_pred cCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHHHHHHcCCCChHhcC
Confidence 43321 1223578899999999998999999999999999999999999875432211 1111110000000
Q ss_pred ------cccCCcccC---CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 583 ------LELMDPTLD---ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 583 ------~~~~d~~l~---~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
......... ....++....+.+++.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 1111233456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=267.34 Aligned_cols=225 Identities=22% Similarity=0.346 Sum_probs=179.3
Q ss_pred CcceeeccCCCccEEEEEEcC---Cc--EEEEEEeccC-CchhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 386 SPANRLGQGGFGPVYNGKLLD---GQ--EIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 386 ~~~~~LG~G~fG~Vy~~~~~~---~~--~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
...+.||+|.||.||+|...+ |+ .||||..+.. ..+..+.|..|+.+|+.++||||++
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmEL 471 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVMEL 471 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEec
Confidence 345689999999999998432 33 4899998764 4455778999999999999999983
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......|+......++.||+.||+|||++. +|||||..+|||+.....+||+|||+++.+.......
T Consensus 472 ~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 472 APLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred ccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 122345666677788999999999999998 9999999999999999999999999999877655433
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.. ...-..-|||||.+.-..++.++|||-|||.+||+++ |..||..-...+.. -.+...-+.
T Consensus 549 aS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI----------------~~iEnGeRl 611 (974)
T KOG4257|consen 549 AS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI----------------GHIENGERL 611 (974)
T ss_pred cc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE----------------EEecCCCCC
Confidence 32 2233567999999999999999999999999999987 99999865443322 222222233
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.+++.++..+..|+.+||.++|.+||.+.|+...|+.+
T Consensus 612 P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 612 PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 45666777889999999999999999999998887644
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=266.32 Aligned_cols=245 Identities=23% Similarity=0.305 Sum_probs=175.2
Q ss_pred HHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccccc---------
Q 005803 378 IAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDSS--------- 445 (676)
Q Consensus 378 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~--------- 445 (676)
+....++|++.+.||+|+||.||++... +++.||||++.... ......+.+|+.++++++|+||+...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 4446788999999999999999999854 68999999986432 22345688999999999999987311
Q ss_pred ---------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcce
Q 005803 446 ---------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR 504 (676)
Q Consensus 446 ---------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~ 504 (676)
....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 90 DRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred cccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 0135778888999999999999999988 9999999999999999999999999987
Q ss_pred eccccccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchH-H-------HHHH
Q 005803 505 TYAMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLV-G-------YAWQ 575 (676)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~-~-------~~~~ 575 (676)
..... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||............ . ....
T Consensus 167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 167 QTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred ccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 64321 122467889999999876 45889999999999999999999999754321100000 0 0000
Q ss_pred HHhcCCccccCC--cccC----CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcC
Q 005803 576 LWNEGKALELMD--PTLD----ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTND 630 (676)
Q Consensus 576 ~~~~~~~~~~~d--~~l~----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~ 630 (676)
.+.......... +... ..........+.+++.+|++.||++|||+.++++. ++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 000000000000 0000 00011223357789999999999999999999943 5444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=265.63 Aligned_cols=241 Identities=24% Similarity=0.338 Sum_probs=174.3
Q ss_pred HHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccc----------
Q 005803 378 IAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDS---------- 444 (676)
Q Consensus 378 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~---------- 444 (676)
+..++++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++.+++|||+++.
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 4557889999999999999999999855 6899999988543 22345678899999999999998731
Q ss_pred ---------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 445 ---------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 445 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
.....+++.....++.|+++||.|||+.+ |+|+||+|+||++++++.+||+|||++......
T Consensus 85 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 85 IYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred EEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 11234566777889999999999999998 999999999999999999999999998754321
Q ss_pred ccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHH--------HHHHHHhcC
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVG--------YAWQLWNEG 580 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~--------~~~~~~~~~ 580 (676)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............. ........+
T Consensus 162 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 162 -----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred -----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence 122457888999998765 568999999999999999999999997543211100000 000000000
Q ss_pred CccccCCc-ccCCCCC-----hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 581 KALELMDP-TLDESCS-----SDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 581 ~~~~~~d~-~l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
...+.+.. ......+ +.....+.+++.+||+.+|++||++++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 0000011 1123567889999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=260.91 Aligned_cols=228 Identities=23% Similarity=0.373 Sum_probs=175.9
Q ss_pred HHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 379 AAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 379 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
...++.|++.+.||+|++|.||+|... +++.||+|++..... ....+.+|++++++++|+|++..
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 346778999999999999999999876 588999999976443 56778999999999999998620
Q ss_pred -------------ccc-CcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 445 -------------SRK-SLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 -------------~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 011 26888899999999999999999988 9999999999999999999999999987543322
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... . .. ..........
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~---~---~~-~~~~~~~~~~----- 236 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---A---LF-LITTKGIPPL----- 236 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---H---HH-HHHhcCCCCC-----
Confidence 1 1122457789999999988889999999999999999999999986432211 0 01 1111111110
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.. .......+.+++.+||+.+|.+||++.+|++.
T Consensus 237 ~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 237 KN--PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred cc--hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00 11123457889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=251.48 Aligned_cols=222 Identities=23% Similarity=0.331 Sum_probs=174.8
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--hhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
+|.+.+.||+|+||.||++... +++.||+|++..... ....++.+|+++++.++|+|++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788999999999999999865 588999999875432 456678999999999999998620
Q ss_pred --------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 445 --------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.....+++.....++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 01256788889999999999999999998 9999999999999999999999999998654432
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
.......|++.|+|||.+.+..++.++|+||+|+++++|++|+.||...... . ........... .+
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~-----~~ 223 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------E-LALKILKGQYP-----PI 223 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------H-HHHHHhcCCCC-----CC
Confidence 1223356888999999998888999999999999999999999998644311 1 11111111111 11
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+......+.+++.+||..+|++||++.++++.
T Consensus 224 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 ----PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11233457888999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=244.83 Aligned_cols=222 Identities=22% Similarity=0.313 Sum_probs=168.7
Q ss_pred cceeeccCCCccEEEEEEcC-CcEEEEEEeccC-CchhhHHHHHHHHHHHHcc-CCcccc--------------------
Q 005803 387 PANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQ-HTNLTD-------------------- 443 (676)
Q Consensus 387 ~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~-H~niv~-------------------- 443 (676)
.+..||.|..|.|++.+... |..+|||.+.+. .....++++..+.++.+-+ .|.||+
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 35789999999999998764 888999999765 3455677888888877765 788873
Q ss_pred ------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccce
Q 005803 444 ------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 444 ------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
.....++++...-++...++.||.||.+++ +|||||+||+|||+|+.|++||||||++..+..... ...
T Consensus 176 C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---htr 250 (391)
T KOG0983|consen 176 CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---HTR 250 (391)
T ss_pred HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc---ccc
Confidence 123445677777788888999999999876 699999999999999999999999999987654332 233
Q ss_pred eeccCCccChhhhc---cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 518 IVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 518 ~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
..|.+.|||||.+. ...|+.++||||||+.|+||.||+.||.....+-. ......+. ..|.|....
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe------~ltkvln~-----ePP~L~~~~ 319 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE------VLTKVLNE-----EPPLLPGHM 319 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH------HHHHHHhc-----CCCCCCccc
Confidence 57899999999885 34689999999999999999999999986433211 11111111 112332211
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.....+++++..||+.|+.+||...++++.
T Consensus 320 --gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 320 --GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 123457788889999999999999999875
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=251.09 Aligned_cols=221 Identities=26% Similarity=0.400 Sum_probs=173.3
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--hhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
+|++.+.||+|++|.||+++.. +++.||+|.+..... .....+.+|++++.+++|+|++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5788999999999999999865 578999999976543 456789999999999999997620
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 155 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-- 155 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc--
Confidence 11245788889999999999999999998 999999999999999999999999999876543221
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
.....++..|+|||...+..++.++||||||+++|+|++|+.||...... ...+... .... +.+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~~~-----~~~---- 219 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFRIV-QDDH-----PPL---- 219 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHh-ccCC-----CCC----
Confidence 22356788999999998888899999999999999999999998743311 0011111 1111 111
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
+......+.+++.+||+.+|++||++.+++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1122345778899999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=293.90 Aligned_cols=232 Identities=26% Similarity=0.377 Sum_probs=176.0
Q ss_pred HHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc-----------
Q 005803 378 IAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD----------- 443 (676)
Q Consensus 378 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~----------- 443 (676)
+...+-++.-..+||.|.||.||.|... +|...|+|-++.. .....+...+|..++..++|||+|.
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 4446678888999999999999999854 5888899987643 3344567889999999999999983
Q ss_pred ---------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 444 ---------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
...+...++.....+..|++.|++|||++| ||||||||+||+++.+|.+|++|||.|..+..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 122233444455567789999999999999 99999999999999999999999999987765
Q ss_pred cc--cccccceeeccCCccChhhhccCC---CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 509 NE--LEANTNRIVGTHGYMSPEYVMNGI---VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 509 ~~--~~~~~~~~~gt~~Y~APE~~~~~~---~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
.. .........||+.|||||++.+.. -..++||||+|||+.||+||++||...+.+-.. . -....|..
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI--M----y~V~~gh~- 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI--M----YHVAAGHK- 1459 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH--H----hHHhccCC-
Confidence 42 223334578999999999998643 567899999999999999999999876543211 0 01111221
Q ss_pred ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 005803 584 ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627 (676)
Q Consensus 584 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~L 627 (676)
|.+ +.....+-.+++..||+.||++|.++.|+++.=
T Consensus 1460 ----Pq~----P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1460 ----PQI----PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred ----CCC----chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 222 222333456788899999999999998887763
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=273.83 Aligned_cols=218 Identities=24% Similarity=0.369 Sum_probs=167.8
Q ss_pred ceeeccCCCccEEEEEEc-CCcEEE---EEEecc-CCchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 388 ANRLGQGGFGPVYNGKLL-DGQEIA---IKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~-~~~~VA---vK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
..+||+|+|-+||+|.+. +|.+|| ||.-+. ......++|..|+.+|+.|+|+||++
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 468999999999999864 477775 332211 13445688999999999999999983
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC-CCCeEEeccCcceecccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE-QMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~-~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.......+.+....+++||++||.|||++. ++|||||||.+||+|+. .|.|||+|+|+|.......
T Consensus 125 ~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~--- 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH--- 200 (632)
T ss_pred ccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc---
Confidence 122344666777889999999999999986 68999999999999985 5889999999999765433
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 593 (676)
....+|||.|||||++. ..|++.+||||||+.++||+|+..||...... ...++....|.-.+.+..-
T Consensus 201 -aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~------AQIYKKV~SGiKP~sl~kV---- 268 (632)
T KOG0584|consen 201 -AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP------AQIYKKVTSGIKPAALSKV---- 268 (632)
T ss_pred -cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH------HHHHHHHHcCCCHHHhhcc----
Confidence 23479999999999887 78999999999999999999999999865432 2234444444433322221
Q ss_pred CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 594 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
. -.++.+++.+||.. .++|||+.|+|+.
T Consensus 269 -~---dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 269 -K---DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -C---CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1 12366788899999 9999999999964
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=254.75 Aligned_cols=222 Identities=23% Similarity=0.381 Sum_probs=182.0
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
-|.+.++||+|+||.||++.++ .|+.||||.+.. +...+++..|+.++++...+.+|+
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4667889999999999999765 599999999865 456789999999999999999873
Q ss_pred --------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 444 --------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 444 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
....+.|.+.++..+++..+.||+|||... -||||||..|||++-+|.+||+|||.|..+... ....
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKR 186 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--HHhh
Confidence 245678899999999999999999999886 899999999999999999999999999866532 2234
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCS 595 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 595 (676)
+++.||+.|||||++..-.|+.++||||||+...||.-|++||....+......+ .-.|......+
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI--------------PT~PPPTF~KP 252 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI--------------PTKPPPTFKKP 252 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec--------------cCCCCCCCCCh
Confidence 4589999999999999999999999999999999999999999866544322111 01111122234
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 596 SDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 596 ~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+-...+-+++..||-.+|++|-|+-++++.
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 4455678889999999999999999988875
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=253.75 Aligned_cols=224 Identities=24% Similarity=0.333 Sum_probs=169.2
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC-----CchhhHHHHHHHHHHHHccCCccccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS-----SGQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
.+|++.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|++++++++|+||+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999864 5899999987532 22344678899999999999998720
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
.....+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 11234667778889999999999999998 99999999999999999999999999976432
Q ss_pred ccc-ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 509 NEL-EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 509 ~~~-~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
... ........++..|+|||.+.+..++.++|+|||||++|||++|+.||...... .........
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-------- 224 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIFKIATQ-------- 224 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHHHHHcC--------
Confidence 111 11112346888999999998888999999999999999999999999643211 111111100
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
......+......+.+++.+|++ +|..||++.+++.
T Consensus 225 -~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 -PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 01111233334557888889998 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=258.65 Aligned_cols=239 Identities=24% Similarity=0.374 Sum_probs=177.7
Q ss_pred CCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHH--ccCCcccc------------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAK--LQHTNLTD------------------ 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~------------------ 443 (676)
.....+.||+|.||.||+|.+ +++.||||++.. +....|++|-+|.+. ++|+||++
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 334568899999999999998 569999999954 566778888887664 58999972
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcC------CCceEeeccccCceEEcCCCCeEEeccCcceec
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYS------RLRAIHRDLKVSNILLDEQMNPKISDFGMARTY 506 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~ 506 (676)
......++|....+|+..+++||+|||+.- +++|+|||||.+||||..++...|+|||+|..+
T Consensus 287 t~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred eeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 233456889999999999999999999743 467999999999999999999999999999988
Q ss_pred cccccccccceeeccCCccChhhhccCC-CC-----chhHHHHHHHHHHHHHhCCcCCCCCCCCCccch-----------
Q 005803 507 AMNELEANTNRIVGTHGYMSPEYVMNGI-VS-----MKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNL----------- 569 (676)
Q Consensus 507 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s-----~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l----------- 569 (676)
............+||.+|||||++.+.. +. .+.||||+|.|||||++.-..+... +...+.+
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~-~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPG-PVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCC-CCCcccCchhHHhcCCCC
Confidence 7665555555589999999999997642 22 3679999999999999977655321 1111110
Q ss_pred HHHHHHHHhcCCccccCCcccCCCCCh-HHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 570 VGYAWQLWNEGKALELMDPTLDESCSS-DEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 570 ~~~~~~~~~~~~~~~~~d~~l~~~~~~-~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.+..+... +.+-.+|.+...+.. ..+.-+++.+..||..||+.|.|+.=|.+++.++.
T Consensus 446 ~e~mq~~V----V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 446 LEEMQELV----VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred HHHHHHHH----HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 11111111 122222333222111 34556788889999999999999999999998876
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=261.80 Aligned_cols=221 Identities=26% Similarity=0.335 Sum_probs=170.2
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
..+.|+.-+.||+||||.||-+... +|+.+|.|.+.+. ...+.....+|-.+|.+++.+.||.
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3467888899999999999998754 5999999988653 2334455789999999999998871
Q ss_pred ---------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 444 ---------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
......+++....-.+.+|+.||++||... ||.|||||+|||+|+.|+++|+|.|+|..+..
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 223357889999999999999999999988 99999999999999999999999999998765
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
.... ...+||.+|||||++.++.|+...|.|||||+||||+.|+.||..........-+ .+...+ +
T Consensus 340 g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv---drr~~~-------~- 405 (591)
T KOG0986|consen 340 GKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV---DRRTLE-------D- 405 (591)
T ss_pred CCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH---HHHHhc-------c-
Confidence 4432 2358999999999999999999999999999999999999999865432211000 000000 1
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCH
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTM 620 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~ 620 (676)
...++....+++..|....|+.||.+|.-.
T Consensus 406 --~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 406 --PEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred --hhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 112233333445566667889999999643
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=250.39 Aligned_cols=177 Identities=27% Similarity=0.372 Sum_probs=144.0
Q ss_pred hcCCCcceeeccCCCccEEEEEEc---C--CcEEEEEEeccCCch--hhHHHHHHHHHHHHccCCcccc-----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL---D--GQEIAIKRLSKSSGQ--GIVEFKNEAKLIAKLQHTNLTD----------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~---~--~~~VAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~----------- 443 (676)
...|+.+.+||+|.||.||+|... + .+.+|||+++..... -.....+|+.+++.++|+|++.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 356888999999999999999532 2 337899999765321 2345789999999999999871
Q ss_pred --------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC----CCeEEec
Q 005803 444 --------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ----MNPKISD 499 (676)
Q Consensus 444 --------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~----~~vkL~D 499 (676)
......++......|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+|
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 122346677777889999999999999987 9999999999999877 8999999
Q ss_pred cCcceeccccc-cccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCC
Q 005803 500 FGMARTYAMNE-LEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSY 561 (676)
Q Consensus 500 FGla~~~~~~~-~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~ 561 (676)
||+++.+...- .......++-|..|+|||.+.+. .|+.+.||||.|||+.||++-++.|...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999876532 12233446779999999999875 6999999999999999999999988764
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=253.90 Aligned_cols=223 Identities=27% Similarity=0.353 Sum_probs=173.4
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHcc-CCcccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQ-HTNLTD-------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~-------------- 443 (676)
++|.+.+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.++.+++ |+||++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47899999999999999999865 6899999998653 2233467889999999999 999872
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 112235888999999999999999999998 99999999999999999999999999986543321
Q ss_pred c------------------cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHH
Q 005803 512 E------------------ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYA 573 (676)
Q Consensus 512 ~------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~ 573 (676)
. .......++..|+|||......++.++||||||++++++++|+.||....... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~---- 230 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---T---- 230 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---H----
Confidence 1 12233467889999999988889999999999999999999999997543111 0
Q ss_pred HHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCH----HHHHH
Q 005803 574 WQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTM----SDVVS 625 (676)
Q Consensus 574 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~----~eVl~ 625 (676)
...... .....+......+.+++.+||+.+|++||++ +++++
T Consensus 231 ~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQKILK----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHh----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 011111 0111122224567889999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=252.31 Aligned_cols=221 Identities=25% Similarity=0.324 Sum_probs=168.0
Q ss_pred eccCCCccEEEEEEcC-CcEEEEEEeccCCc---hhhHHHHHHHHHHHHccCCccccc----------------------
Q 005803 391 LGQGGFGPVYNGKLLD-GQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNLTDS---------------------- 444 (676)
Q Consensus 391 LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~~---------------------- 444 (676)
||.|+||.||+++... ++.+|+|.+..... .....+.+|+.++++++|+|+++.
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 89999999865433 355678999999999999998720
Q ss_pred ----cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc------ccc
Q 005803 445 ----SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL------EAN 514 (676)
Q Consensus 445 ----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~------~~~ 514 (676)
.....+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 11235788889999999999999999998 99999999999999999999999999875432211 012
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
.....++..|+|||...+...+.++||||||+++|||++|+.||....... .......+... . ..
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~----~--~~-- 222 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-------IFQNILNGKIE----W--PE-- 222 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCcC----C--Cc--
Confidence 223567889999999988889999999999999999999999997543211 11111111110 0 00
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
.......+.+++.+||+.+|++|||+.+|.+.|+.
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00113567889999999999999999777776653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=253.20 Aligned_cols=216 Identities=25% Similarity=0.329 Sum_probs=157.9
Q ss_pred eeccCCCccEEEEEEc-CCcEEEEEEeccCCc---hhhHHHHHHHHHHH---HccCCcccc-------------------
Q 005803 390 RLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG---QGIVEFKNEAKLIA---KLQHTNLTD------------------- 443 (676)
Q Consensus 390 ~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~---~~~~~~~~E~~~l~---~l~H~niv~------------------- 443 (676)
.||+|+||.||++... +++.||+|.+.+... .....+.+|..++. ...|+|++.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999865 588999998865321 12233445544443 346888762
Q ss_pred -------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccc
Q 005803 444 -------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516 (676)
Q Consensus 444 -------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 516 (676)
......+++.....++.|++.||.|||+.+ |+|+||||+|||+++++.+||+|||++....... ..
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~ 153 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH 153 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----cc
Confidence 112345788889999999999999999998 9999999999999999999999999987543221 12
Q ss_pred eeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCC
Q 005803 517 RIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCS 595 (676)
Q Consensus 517 ~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 595 (676)
...|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ..... . .....+ +
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~----~--~~~~~~----~ 219 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMT----L--TVNVEL----P 219 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHh----h--cCCcCC----c
Confidence 2468999999998864 568999999999999999999999997543322111 01100 0 011112 2
Q ss_pred hHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 005803 596 SDEVMRCIHVGLLCVQDRAADRR-----TMSDVVSM 626 (676)
Q Consensus 596 ~~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~ 626 (676)
......+.+++.+||+.||++|| +++|+++.
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 22334577888999999999999 69999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=257.38 Aligned_cols=220 Identities=21% Similarity=0.298 Sum_probs=168.6
Q ss_pred ceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc----------------------
Q 005803 388 ANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS---------------------- 444 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~---------------------- 444 (676)
..+||+|+||.||++... +++.||||++..........+.+|+.++++++|+|++..
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 367999999999999874 689999999865555556678999999999999998721
Q ss_pred ---cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeecc
Q 005803 445 ---SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGT 521 (676)
Q Consensus 445 ---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt 521 (676)
.....+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......++
T Consensus 105 ~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~ 179 (292)
T cd06657 105 TDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGT 179 (292)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccC
Confidence 11235678888999999999999999998 99999999999999999999999999875543221 12235688
Q ss_pred CCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHH
Q 005803 522 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMR 601 (676)
Q Consensus 522 ~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 601 (676)
..|+|||.+.+..++.++|+||||+++|||++|..||....... . ....... ..+.+.. .......
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~----~~~~~~~-----~~~~~~~--~~~~~~~ 245 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---A----MKMIRDN-----LPPKLKN--LHKVSPS 245 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H----HHHHHhh-----CCcccCC--cccCCHH
Confidence 99999999988889999999999999999999999986432211 1 1111111 1111110 1112334
Q ss_pred HHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 602 CIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 602 l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+.+++.+||+.+|.+||++.++++.
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhcC
Confidence 6788889999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=262.40 Aligned_cols=239 Identities=22% Similarity=0.313 Sum_probs=169.3
Q ss_pred hcCCCc-ceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchh--------------hHHHHHHHHHHHHccCCccccc-
Q 005803 382 TDNFSP-ANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQG--------------IVEFKNEAKLIAKLQHTNLTDS- 444 (676)
Q Consensus 382 t~~y~~-~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~~- 444 (676)
.++|.. .+.||+|+||.||+|... +++.||||.+....... ...+.+|++++++++|+||+..
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456754 467999999999999865 58999999986532211 1247789999999999998731
Q ss_pred ------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEecc
Q 005803 445 ------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDF 500 (676)
Q Consensus 445 ------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DF 500 (676)
.....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCc
Confidence 12235677888999999999999999998 999999999999999999999999
Q ss_pred Ccceecccccc------------ccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCcc
Q 005803 501 GMARTYAMNEL------------EANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPL 567 (676)
Q Consensus 501 Gla~~~~~~~~------------~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~ 567 (676)
|++........ ........++..|+|||.+.+. .++.++|||||||++|||++|+.||......+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-- 241 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID-- 241 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 99976541110 1111123467889999998764 47899999999999999999999997554321
Q ss_pred chHHHHHHHHhcCC---cccc--------CCcccCC---CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 568 NLVGYAWQLWNEGK---ALEL--------MDPTLDE---SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 568 ~l~~~~~~~~~~~~---~~~~--------~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
............. ..+. ....... .........+.+++.+||+.+|++||+++|++..
T Consensus 242 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 242 -QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred -HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1111111111000 0000 0000000 0011223457889999999999999999999974
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=258.29 Aligned_cols=223 Identities=30% Similarity=0.407 Sum_probs=169.5
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
+.|+..+.||+|+||.||+|+.. +++.||+|.+... ......++.+|+++++.++|+|++..
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34667789999999999999865 5788999998642 22334568899999999999998620
Q ss_pred ------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 445 ------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 445 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 12334788888999999999999999998 999999999999999999999999998764321
Q ss_pred cccceeeccCCccChhhhc---cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 513 ANTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
....++..|+|||.+. ...++.++|||||||++|||++|+.||........ . .....+.. +.
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~-~~~~~~~~-----~~ 233 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------L-YHIAQNES-----PA 233 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------H-HHHhhcCC-----CC
Confidence 2246788999999975 35678899999999999999999999864321110 0 11111111 11
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
.. .......+.+++.+||+.+|++||++.+|++..--
T Consensus 234 ~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 234 LQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred cC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 11 11233457788999999999999999999977433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=267.62 Aligned_cols=239 Identities=24% Similarity=0.316 Sum_probs=172.9
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccc------------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
...++|++.+.||+|++|.||+|+.. +++.||||++... .......+.+|+.+++++.|+|++..
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45678999999999999999999875 5889999998643 22344567889999999999998621
Q ss_pred ------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceec
Q 005803 445 ------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTY 506 (676)
Q Consensus 445 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~ 506 (676)
.....+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||++...
T Consensus 92 ~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 92 FQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 01135788889999999999999999998 999999999999999999999999999765
Q ss_pred cccccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH--------HHHHH
Q 005803 507 AMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY--------AWQLW 577 (676)
Q Consensus 507 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~--------~~~~~ 577 (676)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.. ....+
T Consensus 169 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 169 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred ccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 322 223467889999999865 4678999999999999999999999975432111000000 00000
Q ss_pred hcCCcccc---CCcccCCC---CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 578 NEGKALEL---MDPTLDES---CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 578 ~~~~~~~~---~d~~l~~~---~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
........ +....... ........+.+++.+||+.+|++|||+.+|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000 00000000 001124568899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=257.62 Aligned_cols=218 Identities=28% Similarity=0.424 Sum_probs=166.7
Q ss_pred CCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc---hhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
|...++||+|+||.||+|+.. +++.||+|++..... .....+.+|+++++.++|+|++..
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999864 588999999864322 334568899999999999998720
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++.++..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------ 173 (313)
T cd06633 103 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ 173 (313)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC------
Confidence 12345788889999999999999999998 99999999999999999999999999864321
Q ss_pred cceeeccCCccChhhhc---cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 515 TNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.....|+..|+|||++. ...++.++|||||||++|||++|..||....... . ..... ..... ...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~---~---~~~~~-~~~~~-----~~~ 241 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---A---LYHIA-QNDSP-----TLQ 241 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---H---HHHHH-hcCCC-----CCC
Confidence 12356888999999984 4568899999999999999999999986543211 1 11111 11111 111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.......+.+++.+||+.+|.+||++.+++..
T Consensus 242 ---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 ---SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122347788999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=251.01 Aligned_cols=216 Identities=24% Similarity=0.341 Sum_probs=166.1
Q ss_pred eccCCCccEEEEEEcC-CcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc-----------------------
Q 005803 391 LGQGGFGPVYNGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD----------------------- 443 (676)
Q Consensus 391 LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~----------------------- 443 (676)
||.|+||.||+++... ++.||+|.+.... ....+.+.+|+.++++++|+||++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999754 8899999986532 234567899999999999999872
Q ss_pred ---ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeec
Q 005803 444 ---SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVG 520 (676)
Q Consensus 444 ---~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~g 520 (676)
......+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++....... ......+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~ 154 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCG 154 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccC
Confidence 112235778888899999999999999988 9999999999999999999999999998764432 1223467
Q ss_pred cCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHH
Q 005803 521 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVM 600 (676)
Q Consensus 521 t~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 600 (676)
+..|+|||.+.+..++.++|+||||+++|+|++|..||....... . .. ......+. .....+.....
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~---~~-~~~~~~~~--------~~~~~~~~~~~ 221 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-M---EI-YNDILKGN--------GKLEFPNYIDK 221 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-H---HH-HHHHhccC--------CCCCCCcccCH
Confidence 889999999988889999999999999999999999997654311 1 11 11111100 01111222245
Q ss_pred HHHHHHHHhcccCcCCCCC-----HHHHHH
Q 005803 601 RCIHVGLLCVQDRAADRRT-----MSDVVS 625 (676)
Q Consensus 601 ~l~~L~~~Cl~~dP~~RPs-----~~eVl~ 625 (676)
.+.+++.+||+.+|++||+ ++|+++
T Consensus 222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 6889999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=259.38 Aligned_cols=233 Identities=20% Similarity=0.248 Sum_probs=161.8
Q ss_pred eeeccC--CCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc-------------------
Q 005803 389 NRLGQG--GFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS------------------- 444 (676)
Q Consensus 389 ~~LG~G--~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~------------------- 444 (676)
..||+| +||.||++++. +++.||||++.... ....+.+.+|+.+++.++||||++.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 88999999864 69999999986432 2335678899999999999999731
Q ss_pred ---------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc---
Q 005803 445 ---------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE--- 512 (676)
Q Consensus 445 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~--- 512 (676)
.....+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 01123667777889999999999999988 999999999999999999999999865432211100
Q ss_pred --cccceeeccCCccChhhhccC--CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHH---------------
Q 005803 513 --ANTNRIVGTHGYMSPEYVMNG--IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYA--------------- 573 (676)
Q Consensus 513 --~~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~--------------- 573 (676)
.......++..|+|||++.+. .++.++|||||||++|||++|+.||......... ....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccccch
Confidence 001112345679999999763 4789999999999999999999999754321100 0000
Q ss_pred -HHHH----------------hcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 574 -WQLW----------------NEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 574 -~~~~----------------~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.... ..+......+..+...........+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000 0000001111112222223445678899999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=252.27 Aligned_cols=236 Identities=23% Similarity=0.247 Sum_probs=168.2
Q ss_pred CCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc-hhhHHHHHHHHHHHHcc-CCcccc------------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQ-HTNLTD------------------ 443 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~------------------ 443 (676)
|++.+.||+|+||.||+|+.. +++.||||++..... .......+|+..+.++. |+|++.
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 667899999999999999976 478899999865432 22234567999999999 999862
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC---
Confidence 011236788899999999999999999998 99999999999999999999999999986543221
Q ss_pred cceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHH----------HHHHHHhcCCcc
Q 005803 515 TNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVG----------YAWQLWNEGKAL 583 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~----------~~~~~~~~~~~~ 583 (676)
.....++..|+|||.+.+ ..++.++|+||||++++||++|+.||............. +...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 122467889999998754 457899999999999999999999986543221110000 000000000000
Q ss_pred ccCCcccC---CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 584 ELMDPTLD---ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 584 ~~~d~~l~---~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
..+..... ....+.....+.+++.+||+.+|++||+++|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 00011123568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-28 Score=252.54 Aligned_cols=230 Identities=21% Similarity=0.307 Sum_probs=170.6
Q ss_pred CCCcceeeccCCCccEEEEEE----cCCcEEEEEEeccCC----chhhHHHHHHHHHHHHc-cCCccccc----------
Q 005803 384 NFSPANRLGQGGFGPVYNGKL----LDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKL-QHTNLTDS---------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~----~~~~~VAvK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~~---------- 444 (676)
+|++.+.||+|++|.||+++. .+++.||||.+.+.. ....+.+.+|+.++.++ +|+|++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478889999999999999974 247889999986432 22345688999999999 58987621
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
.....+++.....++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 11245677888889999999999999988 99999999999999999999999999876543
Q ss_pred cccccccceeeccCCccChhhhccCC--CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGI--VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
.... ......|+..|+|||.+.+.. .+.++||||||+++|||++|..||........ ......... ..
T Consensus 158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~-~~------ 227 (288)
T cd05583 158 EEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRIL-KS------ 227 (288)
T ss_pred cccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHH-cc------
Confidence 3211 122246788999999987655 78899999999999999999999864322111 111111111 10
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.+.... .....+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 228 ~~~~~~----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 KPPFPK----TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred CCCCCc----ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 111111 1223467888999999999999999998887654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=252.13 Aligned_cols=236 Identities=22% Similarity=0.275 Sum_probs=170.1
Q ss_pred CCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
|+..+.||+|++|.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++|+|++..
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566789999999999999876 48999999987653 3344678899999999999998720
Q ss_pred --------cc-cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 445 --------SR-KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 445 --------~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++........ ..
T Consensus 81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~ 155 (282)
T cd07829 81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TY 155 (282)
T ss_pred CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--cc
Confidence 01 136788899999999999999999998 99999999999999999999999999976543221 11
Q ss_pred ceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHH--------HHHHHHhcCC-cccc
Q 005803 516 NRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVG--------YAWQLWNEGK-ALEL 585 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~--------~~~~~~~~~~-~~~~ 585 (676)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+. ..+..+..-. ....
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 223456789999998776 78999999999999999999999986543211100000 0000000000 0000
Q ss_pred CCc---ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 586 MDP---TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 586 ~d~---~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
... .......+.....+.+++.+||+.+|++||++.+|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000 0000001112446889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=269.87 Aligned_cols=226 Identities=24% Similarity=0.339 Sum_probs=169.6
Q ss_pred CCcceeeccCCCccEEEEEE-cCCcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 385 FSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
|...+.||+|+||.||+|+. .+|+.||||.++.. .....+...+|+++|++++|+|||+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44467899999999999995 46999999999764 3445667889999999999999982
Q ss_pred ----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc--CCCC--eEEeccCcc
Q 005803 444 ----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD--EQMN--PKISDFGMA 503 (676)
Q Consensus 444 ----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~--~~~~--vkL~DFGla 503 (676)
......|++.+.+.++.+++.||.|||+++ |+||||||.||++- ++|+ .||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 233456888999999999999999999998 99999999999984 3343 799999999
Q ss_pred eeccccccccccceeeccCCccChhhhc-cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcC--
Q 005803 504 RTYAMNELEANTNRIVGTHGYMSPEYVM-NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG-- 580 (676)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~-- 580 (676)
+.+.... ...+.+||..|++||.+. ++.|+..+|.|||||++|++.||..||..........-+ .+......
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~--~~~~~tkkp~ 246 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEI--MWHIITKKPS 246 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchh--hhhhhccCCC
Confidence 9876544 455689999999999998 488999999999999999999999999876544322111 22222111
Q ss_pred CccccCCccc------------CCCCChHHHHHHHHHHHHhcccCcCCCC
Q 005803 581 KALELMDPTL------------DESCSSDEVMRCIHVGLLCVQDRAADRR 618 (676)
Q Consensus 581 ~~~~~~d~~l------------~~~~~~~~~~~l~~L~~~Cl~~dP~~RP 618 (676)
.+.-..++.. ..........++-+.+..+|..+|.+|-
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1111111111 1112233445666777778888888887
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=255.83 Aligned_cols=229 Identities=19% Similarity=0.211 Sum_probs=161.6
Q ss_pred cceeeccCCCccEEEEEEcCCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccc--------------------
Q 005803 387 PANRLGQGGFGPVYNGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDS-------------------- 444 (676)
Q Consensus 387 ~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~-------------------- 444 (676)
+.+.+|.|+++.||+++. +++.||||++... .......+.+|+.++++++|+||+..
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344455555555555544 6899999998754 34456789999999999999998720
Q ss_pred --------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc-----
Q 005803 445 --------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL----- 511 (676)
Q Consensus 445 --------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~----- 511 (676)
.....+++.....++.|++.||.|||+++ |+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 11234677888899999999999999998 99999999999999999999999998875432211
Q ss_pred ccccceeeccCCccChhhhcc--CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcccc----
Q 005803 512 EANTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALEL---- 585 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~---- 585 (676)
........++..|+|||++.. ..++.++|||||||++|||++|+.||....... ... ... .+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~----~~~-~~~~~~~~~~~ 234 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLL----EKV-RGTVPCLLDKS 234 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHH-hccCccccccC
Confidence 111223456778999999876 358899999999999999999999997543211 000 000 0000000
Q ss_pred ----------------CCccc----CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 586 ----------------MDPTL----DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 586 ----------------~d~~l----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.++.. ...........+.+++.+||+.||++|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 001112233467889999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=251.31 Aligned_cols=216 Identities=23% Similarity=0.313 Sum_probs=162.2
Q ss_pred eccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCccccc----------------------
Q 005803 391 LGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTDS---------------------- 444 (676)
Q Consensus 391 LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~~---------------------- 444 (676)
||+|+||.||++... +++.||+|.+.... ......+.+|++++++++|||++..
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999754 58899999986532 2234456789999999999998720
Q ss_pred ------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccccee
Q 005803 445 ------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRI 518 (676)
Q Consensus 445 ------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 518 (676)
.....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||.+...... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence 11125788888999999999999999998 999999999999999999999999998764331 112234
Q ss_pred eccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHH
Q 005803 519 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDE 598 (676)
Q Consensus 519 ~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 598 (676)
.++..|+|||.+.+..++.++||||||+++|+|++|+.||.......... ......... ... .+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~~--~~~----~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-------ELKRRTLEM--AVE----YPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-------HHHhccccc--ccc----CCccC
Confidence 67889999999988889999999999999999999999997544321111 011110100 111 11222
Q ss_pred HHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q 005803 599 VMRCIHVGLLCVQDRAADRR-----TMSDVVS 625 (676)
Q Consensus 599 ~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~ 625 (676)
...+.+++.+||+.+|++|| ++.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 34577889999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=251.69 Aligned_cols=226 Identities=23% Similarity=0.334 Sum_probs=166.5
Q ss_pred CCCcceeeccCCCccEEEEEE----cCCcEEEEEEeccCC----chhhHHHHHHHHHHHHc-cCCccccc----------
Q 005803 384 NFSPANRLGQGGFGPVYNGKL----LDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKL-QHTNLTDS---------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~----~~~~~VAvK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~~---------- 444 (676)
+|++.+.||+|+||.||+++. .+|+.||+|++.... ....+++.+|+.++.++ +|+||+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999985 368899999986532 22346688999999999 58988721
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
.....+++.....++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 12234677778888999999999999988 99999999999999999999999999986543
Q ss_pred cccccccceeeccCCccChhhhccC--CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNG--IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
.... ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ............
T Consensus 158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~------- 227 (290)
T cd05613 158 DEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS------- 227 (290)
T ss_pred cccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhcc-------
Confidence 3221 12235688999999998753 46889999999999999999999986432211 111111111110
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAADRR-----TMSDVVSM 626 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~ 626 (676)
.+. .+......+.+++.+||+.||++|| ++.++++.
T Consensus 228 ~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 EPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 011 1222334577889999999999997 66666653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-29 Score=247.51 Aligned_cols=216 Identities=25% Similarity=0.327 Sum_probs=168.5
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLT-------------- 442 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv-------------- 442 (676)
..++|..+++||+|.||+|-+++-+ +++.+|+|++++.. ......-..|-++|+..+||.+.
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467888999999999999999854 68999999998763 33344457899999999999864
Q ss_pred ------------cccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 443 ------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 443 ------------~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.......+++......-.+|+.||.|||+++ ||.||||.+|+|+|.+|++||+|||+++.-..
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-- 320 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-- 320 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc--
Confidence 1334455666666677788999999999998 99999999999999999999999999985332
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
....+.+.+||+.|+|||++....|+.++|.|.+||++|||++|+.||-..+.+....++. -+ |-+
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-------~e------d~k- 386 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-------ME------DLK- 386 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-------hh------hcc-
Confidence 2334556899999999999999999999999999999999999999998665443322221 10 111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCC
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRR 618 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RP 618 (676)
++.....+...|+...|..||.+|.
T Consensus 387 ---FPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 387 ---FPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ---CCccCCHHHHHHHHHHhhcChHhhc
Confidence 1222223456677788999999995
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=244.76 Aligned_cols=220 Identities=25% Similarity=0.327 Sum_probs=164.6
Q ss_pred CCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccC-----CchhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKS-----SGQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
+|.+.++||+|+||.||+++... +..+++|.++.. ......++..|+.++++++|||+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58889999999999999998653 445666655431 1223445778999999999999872
Q ss_pred ----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 444 ----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 444 ----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
......+++..++.++.|++.||.|||+.+ ++|+||||+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 012345788888999999999999999988 999999999999976 569999999987654
Q ss_pred ccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 508 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 508 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
.... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ..... ....+. .
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~-~~~~~~-----~ 222 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVL-RIVEGP-----T 222 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHH-HHHcCC-----C
Confidence 3221 12234578899999999888899999999999999999999999863221 11111 111111 1
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
+. .+......+.+++.+||+.+|++||++.|+++
T Consensus 223 ~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 PS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11 12233456788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=264.34 Aligned_cols=223 Identities=22% Similarity=0.321 Sum_probs=175.5
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCch--hhHHHHHHHHHHHHccCCcccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQ--GIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
-...|.+.+.||+|.|++|.+|++. ++..||||.+.+.... ....+.+|+++|..++|||||+
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4568999999999999999999864 5999999999876332 3355889999999999999973
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
........+.++..++.|+.+|++|||+++ |||||||++||||+.+.++||+|||++.++....
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~- 209 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGL- 209 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccc-
Confidence 112233445777889999999999999999 9999999999999999999999999999876433
Q ss_pred ccccceeeccCCccChhhhccCCC-CchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
...+.+|++.|.|||++.+..| ++.+|+||+|++||.|+.|..||+...-.... + ..+...+
T Consensus 210 --~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------~----rvl~gk~ 272 (596)
T KOG0586|consen 210 --MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------P----RVLRGKY 272 (596)
T ss_pred --cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------c----hheeeee
Confidence 3445799999999999998776 68999999999999999999999854322110 0 0011111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+ ++.-....+-+++.++|-.+|.+|++++++.+.
T Consensus 273 r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 273 R--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred c--ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1 111122346678888999999999999999865
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=247.11 Aligned_cols=219 Identities=21% Similarity=0.257 Sum_probs=161.0
Q ss_pred eeeccCCCccEEEEEEc-CCcEEEEEEeccCCc---hhhHHHHHHHHH-HHHccCCccccc-------------------
Q 005803 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG---QGIVEFKNEAKL-IAKLQHTNLTDS------------------- 444 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~---~~~~~~~~E~~~-l~~l~H~niv~~------------------- 444 (676)
+.||+|+||.||+|+.. +++.||||.+.+... .....+..|..+ ....+|+|++..
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999864 589999999865422 122334455444 445589998731
Q ss_pred -------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccce
Q 005803 445 -------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 445 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
.....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..... ...
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~ 152 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKK 152 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------ccc
Confidence 11245788888999999999999999988 99999999999999999999999999875432 122
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChH
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 597 (676)
..++..|+|||.+.+..++.++||||||+++|||++|..||....... .......+... .... ....
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~--~~~~----~~~~ 219 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRIN--WPEE----VKEF 219 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcccC--CCCc----cccc
Confidence 467889999999988889999999999999999999999996433211 11111111111 0111 1112
Q ss_pred HHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 598 EVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 598 ~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
....+.+++.+||+.+|++||++.++.+.|+.
T Consensus 220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred CCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 23457889999999999999988777666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-29 Score=261.02 Aligned_cols=216 Identities=26% Similarity=0.400 Sum_probs=169.8
Q ss_pred ceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc---------------------
Q 005803 388 ANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD--------------------- 443 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~--------------------- 443 (676)
.+.||.|.||.||-|++. +|+.||||++.+. ...+..++++|+.||+++.||.||.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999864 6999999999764 3345578999999999999999882
Q ss_pred ------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC---CCeEEeccCcceeccccccccc
Q 005803 444 ------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ---MNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~---~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......|++.....++.||+.||.|||.++ |+|+||||+|||+... -++||||||+|+.++....
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--- 722 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--- 722 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh---
Confidence 233456777777788999999999999998 9999999999999643 3689999999999876543
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
....+||+.|+|||++.+..|...-|+||.|||+|.-++|..||....+.. ..++ +..+ +..+..
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQ-------NAaF--MyPp~P---- 787 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQ-------NAAF--MYPPNP---- 787 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHhh-------cccc--ccCCCc----
Confidence 334799999999999999999999999999999999999999997543221 1111 1111 111211
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVV 624 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl 624 (676)
-.+.....++++...||..-.+|-|...-+
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 123344577888889999999998887654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=247.32 Aligned_cols=241 Identities=22% Similarity=0.338 Sum_probs=179.6
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHH--HccCCcccc---------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIA--KLQHTNLTD--------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~--~l~H~niv~--------------- 443 (676)
..++-.+.+.||+|.||+||+|++ .|+.||||++.. .....+.+|.+|.+ .|+|+||..
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 446677889999999999999988 689999999954 34456777877776 469999872
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHh-----cCCCceEeeccccCceEEcCCCCeEEeccCcce
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHK-----YSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR 504 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~-----~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~ 504 (676)
......++-+..++++..+|.||+|||. +|++.|.|||||..|||+..++...|+|+|+|.
T Consensus 285 wLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred EEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 2334557778889999999999999995 577889999999999999999999999999998
Q ss_pred ecccc--ccccccceeeccCCccChhhhccCC----C--CchhHHHHHHHHHHHHHhCC----------cCCCCCCCCCc
Q 005803 505 TYAMN--ELEANTNRIVGTHGYMSPEYVMNGI----V--SMKSDVYSFGVLVLEIVSSK----------KNNGSYDTERP 566 (676)
Q Consensus 505 ~~~~~--~~~~~~~~~~gt~~Y~APE~~~~~~----~--s~ksDVwSlGvvl~elltG~----------~pf~~~~~~~~ 566 (676)
..... ......+..+||.+|||||++.... + -..+||||||.|+||+...- .||....+.+.
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 75543 3334456689999999999986432 1 13689999999999997522 34443322221
Q ss_pred cchHHHHHHHHhcCCccccCCcccCCCC-ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 567 LNLVGYAWQLWNEGKALELMDPTLDESC-SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 567 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
. .+.+.+---.+-+.|.+...+ ..+.+..+.+|+..||..||.-|-|+-.|-+.|.++.
T Consensus 445 s------~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 445 S------FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred C------HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 1 011111111222333333222 3467788999999999999999999999999998876
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=244.09 Aligned_cols=223 Identities=21% Similarity=0.250 Sum_probs=163.1
Q ss_pred HHHHHHhcCCCcceee--ccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCcccc--------
Q 005803 376 QTIAAATDNFSPANRL--GQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTD-------- 443 (676)
Q Consensus 376 ~~l~~~t~~y~~~~~L--G~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~-------- 443 (676)
.++....++|++.+.+ |+|+||.||+++.. +++.+|+|.+........ |+.....+ +|+|+++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 4455556788887777 99999999999864 588899999865322111 22222222 6999872
Q ss_pred ------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC-CeEEeccCcce
Q 005803 444 ------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM-NPKISDFGMAR 504 (676)
Q Consensus 444 ------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~-~vkL~DFGla~ 504 (676)
......+++..+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||++.
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 112237889999999999999999999998 99999999999999988 99999999987
Q ss_pred eccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccc
Q 005803 505 TYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584 (676)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (676)
..... ....++..|+|||.+.+..++.++||||||+++|||++|+.||....... ......... . ..
T Consensus 159 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-----~-~~ 225 (267)
T PHA03390 159 IIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKR-----Q-QK 225 (267)
T ss_pred ecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHh-----h-cc
Confidence 65422 12467889999999998899999999999999999999999997443221 111111110 0 00
Q ss_pred cCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCC-HHHHHH
Q 005803 585 LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRT-MSDVVS 625 (676)
Q Consensus 585 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-~~eVl~ 625 (676)
.. .........+.+++.+||+.+|.+||+ ++|+++
T Consensus 226 ----~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 ----KL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----cC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 011123345788889999999999996 688874
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=246.79 Aligned_cols=216 Identities=26% Similarity=0.338 Sum_probs=158.4
Q ss_pred eeccCCCccEEEEEEc-CCcEEEEEEeccCCc---hhhHHHHHHHH---HHHHccCCcccc-------------------
Q 005803 390 RLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG---QGIVEFKNEAK---LIAKLQHTNLTD------------------- 443 (676)
Q Consensus 390 ~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~---~~~~~~~~E~~---~l~~l~H~niv~------------------- 443 (676)
.||+|+||.||+++.. +++.||+|.+.+... .....+..|.. ++....||+++.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 588999999865321 12223444443 444457898862
Q ss_pred -------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccc
Q 005803 444 -------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516 (676)
Q Consensus 444 -------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 516 (676)
......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~ 153 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH 153 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----Cc
Confidence 112345788999999999999999999988 9999999999999999999999999987543221 12
Q ss_pred eeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCC
Q 005803 517 RIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCS 595 (676)
Q Consensus 517 ~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 595 (676)
...|+..|+|||.+.++ .++.++||||+||++|||++|+.||........... ..... ..+..+..
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~------~~~~~~~~--- 220 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTL------TMAVELPD--- 220 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhh------ccCCCCCC---
Confidence 34689999999998754 689999999999999999999999976432221110 11100 01111211
Q ss_pred hHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 005803 596 SDEVMRCIHVGLLCVQDRAADRR-----TMSDVVSM 626 (676)
Q Consensus 596 ~~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~ 626 (676)
.....+.+++.+||+.+|.+|| ++.++++.
T Consensus 221 -~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 221 -SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred -cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 2234577888899999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=242.69 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=183.2
Q ss_pred HHHHHHHhcCCCcceeeccCCCccEEEEE-EcCCcEEEEEEeccCCchhhHHHHHHHHHHHHcc-CCcccc---------
Q 005803 375 FQTIAAATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLTD--------- 443 (676)
Q Consensus 375 ~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~-~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~--------- 443 (676)
|+++.+.| .+.||+|+++.|-.++ +.++.++|||++.+.......++.+|++++.+.+ |+||+.
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 56666665 4689999999999886 6689999999999887778889999999999996 999872
Q ss_pred -----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC---eEEeccCcc
Q 005803 444 -----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN---PKISDFGMA 503 (676)
Q Consensus 444 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~---vkL~DFGla 503 (676)
......+++.++-.+..+|+.||.|||.+| |.||||||+|||-..... +|||||.+.
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred eEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccc
Confidence 234456888999999999999999999999 999999999999976544 799999887
Q ss_pred eecccc-----ccccccceeeccCCccChhhhc-----cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCcc------
Q 005803 504 RTYAMN-----ELEANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPL------ 567 (676)
Q Consensus 504 ~~~~~~-----~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~------ 567 (676)
.-+... .......+.+|+..|||||+.. ...|+.++|.||||||||-||+|.+||......+--
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~ 306 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV 306 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence 543221 1122234578999999999763 245899999999999999999999999876543311
Q ss_pred c--hHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH-----HHhcCcCCCCCCCC
Q 005803 568 N--LVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS-----MLTNDTMALPKPKQ 639 (676)
Q Consensus 568 ~--l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~-----~Le~~~~~l~~p~~ 639 (676)
. --....+.+.+|... ..|.. -.....+..+++...+..|+.+|.++.+++. +.... +++|+|+.
T Consensus 307 Cr~CQ~~LFesIQEGkYe-FPdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e-kalptp~v 378 (463)
T KOG0607|consen 307 CRVCQNKLFESIQEGKYE-FPDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE-KALPTPQV 378 (463)
T ss_pred cHHHHHHHHHHHhccCCc-CChhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh-ccCCCCcc
Confidence 0 000111222333322 11111 1123334566777788899999999999987 22222 46777754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=252.45 Aligned_cols=237 Identities=19% Similarity=0.233 Sum_probs=176.6
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccC--Cc-----------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH--TN----------------- 440 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H--~n----------------- 440 (676)
.+++|.+..++|+|.||.|-++... .+..||||+++. ...-.+..+-|+++|.++.+ |+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3789999999999999999999754 378899999965 34445666789999999943 22
Q ss_pred --cc------------cccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC---------------
Q 005803 441 --LT------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE--------------- 491 (676)
Q Consensus 441 --iv------------~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~--------------- 491 (676)
|| +......++...+..|+.|+++++++||+.+ ++|-||||+|||+-.
T Consensus 166 iCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 166 ICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred eEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccce
Confidence 11 2334556788889999999999999999998 999999999999831
Q ss_pred -----CCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCc
Q 005803 492 -----QMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERP 566 (676)
Q Consensus 492 -----~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~ 566 (676)
+..+||+|||.|....... ...+.|+.|+|||++.+-.++..+||||+||||+|+.+|...|...++.+.
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 3458999999998743322 457899999999999999999999999999999999999999988765443
Q ss_pred cchHHHH--------------HHHHhcCCcc-----------ccCCccc----CCCCChHHHHHHHHHHHHhcccCcCCC
Q 005803 567 LNLVGYA--------------WQLWNEGKAL-----------ELMDPTL----DESCSSDEVMRCIHVGLLCVQDRAADR 617 (676)
Q Consensus 567 ~~l~~~~--------------~~~~~~~~~~-----------~~~d~~l----~~~~~~~~~~~l~~L~~~Cl~~dP~~R 617 (676)
+.+.+.. .+.+..+.+. ...++.. .......+..++++|+.++|..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 2222111 1111111110 0111100 011234566689999999999999999
Q ss_pred CCHHHHHHH
Q 005803 618 RTMSDVVSM 626 (676)
Q Consensus 618 Ps~~eVl~~ 626 (676)
+|+.|++..
T Consensus 398 iTl~EAL~H 406 (415)
T KOG0671|consen 398 ITLREALSH 406 (415)
T ss_pred ccHHHHhcC
Confidence 999998753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=262.70 Aligned_cols=216 Identities=22% Similarity=0.220 Sum_probs=166.5
Q ss_pred HhcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCccccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTDS-------------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~~-------------- 444 (676)
.++.|.+...+|.|+|+.|-.+.. .+++..+||++.+.. .+..+|+.++.+. +|+|++..
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 467888889999999999988875 458899999997652 2335677665555 69998731
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE-cCCCCeEEeccCcceeccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL-DEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl-~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
.........++..|+.+|+.|+.|||++| +|||||||+|||+ +..++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred hhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 11112222566679999999999999998 9999999999999 58999999999999876544
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
....+-|..|.|||++....|++++|+||||++||+||+|+.||....... . ....+..++.
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--e----i~~~i~~~~~---------- 531 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--E----IHTRIQMPKF---------- 531 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--H----HHHhhcCCcc----------
Confidence 223456889999999999999999999999999999999999998765441 1 1122222222
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.........+|+.+||+.||.+||+|.++...
T Consensus 532 --s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 532 --SECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 13334457788889999999999999998764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=261.93 Aligned_cols=225 Identities=27% Similarity=0.360 Sum_probs=179.3
Q ss_pred ceeeccCCCccEEEEEE-cCC----cEEEEEEeccC-CchhhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 388 ANRLGQGGFGPVYNGKL-LDG----QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~-~~~----~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
.++||+|+||.||+|.+ +.+ -+||||++... ..+...++.+|+-+|.++.|||+++.
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~mP 780 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLMP 780 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhcc
Confidence 67999999999999974 343 46899998654 34456789999999999999998741
Q ss_pred ---------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 445 ---------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 445 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
..+..+-.+..+.+..|||+|+.|||++. ++||||-.+|||+.....+||.|||+++.+.........
T Consensus 781 ~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~ 857 (1177)
T KOG1025|consen 781 LGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSA 857 (1177)
T ss_pred cchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccccc
Confidence 23445666777889999999999999987 999999999999999999999999999988766544333
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
....-.+.|||-|.+....|+.++|||||||++||++| |..|+.....++..++ ++.|. +-..
T Consensus 858 ~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-------le~ge---------RLsq 921 (1177)
T KOG1025|consen 858 PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-------LEKGE---------RLSQ 921 (1177)
T ss_pred cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-------Hhccc---------cCCC
Confidence 32333567999999999999999999999999999998 8899887654443222 22221 2234
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
++-....+..++.+||..|++.||+++++...+.+..
T Consensus 922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 922 PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 5556667888899999999999999999999887654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=240.38 Aligned_cols=235 Identities=23% Similarity=0.292 Sum_probs=168.8
Q ss_pred CccccHHHHHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc-hhhHHHHHHHHHHHH-ccCCccccc--
Q 005803 370 LKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAK-LQHTNLTDS-- 444 (676)
Q Consensus 370 ~~~f~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~-l~H~niv~~-- 444 (676)
+..|+...|+. +..||.|+||+|++-.++ .|+..|||+++.... ...+++..|.+...+ -+.||||+.
T Consensus 58 ~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 34455555544 568999999999998764 599999999976533 556778888876544 468999841
Q ss_pred ----------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeE
Q 005803 445 ----------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPK 496 (676)
Q Consensus 445 ----------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vk 496 (676)
.....+++...-.|..-.+.||.||.+.- .|||||+||+|||++..|.+|
T Consensus 131 a~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEe
Confidence 12233444444555556689999998754 599999999999999999999
Q ss_pred EeccCcceeccccccccccceeeccCCccChhhhcc--CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHH
Q 005803 497 ISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAW 574 (676)
Q Consensus 497 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~ 574 (676)
|||||.+..+...-. .+...|.+.|||||.+.. ..|+.++||||||++|||+.||+.|+..... ..+ ..
T Consensus 209 LCDFGIcGqLv~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfe-ql 279 (361)
T KOG1006|consen 209 LCDFGICGQLVDSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFE-QL 279 (361)
T ss_pred eecccchHhHHHHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHH-HH
Confidence 999999876543321 223578999999998863 3589999999999999999999999875432 111 11
Q ss_pred HHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 575 QLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 575 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.....|....+..+. ...+....+++++.-|+..|..+||...++.++
T Consensus 280 ~~Vv~gdpp~l~~~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 280 CQVVIGDPPILLFDK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHcCCCCeecCcc----cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 222233332222211 123345568888999999999999999988764
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=238.06 Aligned_cols=210 Identities=25% Similarity=0.336 Sum_probs=162.7
Q ss_pred eccCCCccEEEEEEc-CCcEEEEEEeccCCc---hhhHHHHHHHHHHHHccCCcccc-----------------------
Q 005803 391 LGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNLTD----------------------- 443 (676)
Q Consensus 391 LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~----------------------- 443 (676)
||+|+||.||++... +++.+|+|.+..... .....+.+|+.++++++|+|++.
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 488999999875432 24567899999999999999862
Q ss_pred ---ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeec
Q 005803 444 ---SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVG 520 (676)
Q Consensus 444 ---~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~g 520 (676)
......+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCG 155 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcC
Confidence 011235788889999999999999999988 9999999999999999999999999997654322 11233567
Q ss_pred cCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHH
Q 005803 521 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVM 600 (676)
Q Consensus 521 t~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 600 (676)
+..|+|||...+...+.++|+||||+++|+|++|+.||...... .. ....... ... .+.....
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~----~~~~~~~------~~~----~~~~~~~ 218 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EI----YEKILKD------PLR----FPEFLSP 218 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HH----HHHHhcC------CCC----CCCCCCH
Confidence 88999999998888899999999999999999999999654321 01 1111111 011 1112244
Q ss_pred HHHHHHHHhcccCcCCCCCHHH
Q 005803 601 RCIHVGLLCVQDRAADRRTMSD 622 (676)
Q Consensus 601 ~l~~L~~~Cl~~dP~~RPs~~e 622 (676)
.+.+++.+||..||++||++.+
T Consensus 219 ~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 219 EARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHhcCCHhhCCCccc
Confidence 5788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-28 Score=237.90 Aligned_cols=241 Identities=20% Similarity=0.365 Sum_probs=172.7
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
+.|.-..+||+|.||.||+|+.. .++.||+|++-.. .+.--....+|+++|..+.|+|++.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34555789999999999999865 4888999876432 2223345689999999999999761
Q ss_pred ------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 444 ------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 444 ------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
......++..++.+++.++.+||.|+|... |+|||+||+|+||+.++.+||+|||+++.
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 112245777888999999999999999887 99999999999999999999999999976
Q ss_pred ccccc--cccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHH-----H
Q 005803 506 YAMNE--LEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQL-----W 577 (676)
Q Consensus 506 ~~~~~--~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~-----~ 577 (676)
+.... .....+..+-|..|++||.+.+ ..|+++.|||..|||+.||.+|.+.+....+.....++...... |
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 54332 2223334566899999999986 46999999999999999999999988776555444333221111 1
Q ss_pred hc---CCccccCC-cccCCC---CChHHH------HHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 578 NE---GKALELMD-PTLDES---CSSDEV------MRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 578 ~~---~~~~~~~d-~~l~~~---~~~~~~------~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+ -.+.+.+. +.+... ...+.. ...++|+..++..||.+|+.+++++..
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11 01111110 001100 011111 156778888999999999999998865
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-28 Score=252.36 Aligned_cols=224 Identities=21% Similarity=0.311 Sum_probs=178.0
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCc-EEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQ-EIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~-~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
..+++.+..||-||||.|=+++..... .+|+|.+++. ...+.+.+..|-.+|...+.|.||+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 345566788999999999999875543 4788888754 3455667889999999999999883
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
...+..++......++..+++|++|||.++ ||.|||||+|.+++.+|-+||.|||+|+.+...
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-- 573 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-- 573 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC--
Confidence 234455777777778888999999999999 999999999999999999999999999987643
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
..+.+++||+.|.|||++.+...+.++|.||||+++|||++|.+||...++...++++-.....+
T Consensus 574 -~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i-------------- 638 (732)
T KOG0614|consen 574 -RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI-------------- 638 (732)
T ss_pred -CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--------------
Confidence 34566899999999999999999999999999999999999999999877666555443322222
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRT-----MSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~eVl~~ 626 (676)
.++........+|+.+....+|.+|.- +.+|-+.
T Consensus 639 -~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 639 -EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred -hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 123334445677777888899999976 5666544
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=235.21 Aligned_cols=227 Identities=20% Similarity=0.209 Sum_probs=171.4
Q ss_pred HHhcCCCcc-eeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCcccc-------------
Q 005803 380 AATDNFSPA-NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTD------------- 443 (676)
Q Consensus 380 ~~t~~y~~~-~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~------------- 443 (676)
.++++|++. ++||-|-.|+|-.+..+ +++.+|+|++... ...++|+++.-+. .|||||.
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 367778764 67999999999999765 5889999998542 3457788876655 5999872
Q ss_pred -------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc---CCCCeEEeccC
Q 005803 444 -------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD---EQMNPKISDFG 501 (676)
Q Consensus 444 -------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~---~~~~vkL~DFG 501 (676)
......+++.++-.|+.||+.|+.|||+.+ |.||||||+|+|.. .|..+||+|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 233456889999999999999999999998 99999999999996 45569999999
Q ss_pred cceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC
Q 005803 502 MARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK 581 (676)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 581 (676)
+|+..... ....+.+.|+.|.|||++....|+..+|+||+||++|-|++|.+||-...... +..-....+..|.
T Consensus 210 FAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gq 283 (400)
T KOG0604|consen 210 FAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQ 283 (400)
T ss_pred cccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccC
Confidence 99975432 22344678999999999999999999999999999999999999997543311 1111122222222
Q ss_pred ccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 582 ALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 582 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.. ..++ .-.+..+...+++...|..+|.+|.|+.+++..
T Consensus 284 y~-FP~p-----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 YE-FPEP-----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cc-CCCh-----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 21 1111 112344566778888999999999999999875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-27 Score=216.80 Aligned_cols=237 Identities=20% Similarity=0.264 Sum_probs=171.0
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
+|...++||+|.||+||+|+.. +++.||+|+++... +.......+|+-+++.+.|.|||+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566789999999999999865 47889999986542 2234567899999999999999831
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....++.+....++.|+++||.++|+++ +.||||||.|.||+.+|++||+|||+++.++-.- ..
T Consensus 83 cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv--rc 157 (292)
T KOG0662|consen 83 CDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RC 157 (292)
T ss_pred hhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce--Ee
Confidence 22345777888899999999999999998 9999999999999999999999999998765332 12
Q ss_pred cceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCC---ccccCCcc
Q 005803 515 TNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGK---ALELMDPT 589 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d~~ 589 (676)
....+-|..|++|.++.+. -|+...|+||.|||+.|+.. |++.|+..+..++...+.+......+.. +..+.|-.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 2334568899999999875 58999999999999999986 6777776554443332222221111211 12222222
Q ss_pred cCCCCCh-----HHH----HHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 590 LDESCSS-----DEV----MRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 590 l~~~~~~-----~~~----~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.-..++. ..+ ..=.++++..+.-+|.+|.++++.++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 2222221 111 12235667788889999999988765
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=268.90 Aligned_cols=120 Identities=25% Similarity=0.413 Sum_probs=102.1
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
.++|.+.++||+|+||.||+|... +++.||||++.... ......+.+|+.++..++|+||+..
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 368999999999999999999876 58999999986532 2234678899999999999998731
Q ss_pred -------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcce
Q 005803 445 -------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR 504 (676)
Q Consensus 445 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~ 504 (676)
.....+++...+.++.||+.||.|||.++ |+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 11234677788999999999999999988 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=264.24 Aligned_cols=229 Identities=24% Similarity=0.388 Sum_probs=175.1
Q ss_pred cCCCcceeeccCCCccEEEEEEc----C----CcEEEEEEeccCCc-hhhHHHHHHHHHHHHcc-CCcccc---------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL----D----GQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQ-HTNLTD--------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~----~----~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~--------- 443 (676)
++..+.+.||+|.||.|++|... . ...||||.++.... ...+.+..|+++|+.+. |+|++.
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34455679999999999999743 1 35689999976533 45677999999999995 999871
Q ss_pred ----------------cc--cc---------------CcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc
Q 005803 444 ----------------SS--RK---------------SLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD 490 (676)
Q Consensus 444 ----------------~~--~~---------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~ 490 (676)
.. .+ ..+.....+.++.|||.|++||++.. +|||||..+|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 00 01 23788889999999999999999988 99999999999999
Q ss_pred CCCCeEEeccCcceeccccccccccceee--ccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCcc
Q 005803 491 EQMNPKISDFGMARTYAMNELEANTNRIV--GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPL 567 (676)
Q Consensus 491 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~--gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~ 567 (676)
++..+||+|||+|+............ -. -...|||||.+....|+.|+|||||||+||||++ |..|+.....
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~---- 527 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP---- 527 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc----
Confidence 99999999999998644332221111 11 1345999999999999999999999999999999 8888875221
Q ss_pred chHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 568 NLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 568 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.....+.+.+|...+ .+..+..++.+++..||+.+|++||++.++++.|+..
T Consensus 528 --~~~l~~~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 --TEELLEFLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred --HHHHHHHHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 111233444554432 2333455678999999999999999999999999884
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=261.94 Aligned_cols=233 Identities=21% Similarity=0.267 Sum_probs=143.3
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-C----CcEEEEEEeccCCchhhHHHHHHH----------HHHHHccCCc-----
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-D----GQEIAIKRLSKSSGQGIVEFKNEA----------KLIAKLQHTN----- 440 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~----~~~VAvK~l~~~~~~~~~~~~~E~----------~~l~~l~H~n----- 440 (676)
..++|++.++||+|+||.||+|++. + +..||||++...... +...+|. ..+..+.++.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNERVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHHHHHhhchhhHHHHHHhhhcccccccC
Confidence 5678999999999999999999865 4 689999998643211 1111110 0011100000
Q ss_pred ----cc----------cccc---------------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccC
Q 005803 441 ----LT----------DSSR---------------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVS 485 (676)
Q Consensus 441 ----iv----------~~~~---------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~ 485 (676)
++ +... ........+..++.||+.||.|||+++ |+||||||+
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~ 284 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQ 284 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHH
Confidence 01 0000 000112234578999999999999998 999999999
Q ss_pred ceEEcC-CCCeEEeccCcceeccccccccccceeeccCCccChhhhccC----------------------CCCchhHHH
Q 005803 486 NILLDE-QMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG----------------------IVSMKSDVY 542 (676)
Q Consensus 486 NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----------------------~~s~ksDVw 542 (676)
|||++. ++.+||+|||+|+.+.... ........+++.|+|||.+... .++.++|||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 999985 5789999999998653322 1122346789999999966422 234567999
Q ss_pred HHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC----ccccCCcc----cCCC--CChHHHHHHHHHHHHhccc
Q 005803 543 SFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK----ALELMDPT----LDES--CSSDEVMRCIHVGLLCVQD 612 (676)
Q Consensus 543 SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~----~~~~~d~~----l~~~--~~~~~~~~l~~L~~~Cl~~ 612 (676)
||||+||||+++..+++.. +..........+. ....+.+. +... ..........+|+.+||+.
T Consensus 364 SlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 9999999999976654321 1111000000000 00001111 0000 0001122345789999999
Q ss_pred CcCCCCCHHHHHHH
Q 005803 613 RAADRRTMSDVVSM 626 (676)
Q Consensus 613 dP~~RPs~~eVl~~ 626 (676)
||++|||+.|+++.
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=231.79 Aligned_cols=236 Identities=22% Similarity=0.313 Sum_probs=174.8
Q ss_pred ceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc---------------------
Q 005803 388 ANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD--------------------- 443 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~--------------------- 443 (676)
.+.||-|+||.||.++++ +|+.||+|++... .....+.+.+|+++|..++|.|+..
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 578999999999999865 6999999998643 2334577899999999999999751
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......++.....-++.||++||.|||+.+ |.||||||.|.|++.+..+||||||+|+....++....
T Consensus 138 LmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 138 LMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence 122345666667778999999999999998 99999999999999999999999999998665554443
Q ss_pred cceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH--------HHHHHhcCCcccc
Q 005803 515 TNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY--------AWQLWNEGKALEL 585 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~--------~~~~~~~~~~~~~ 585 (676)
+. .+-|..|+|||++++. .|+.+.||||.|||+.||+..+..|....+.++..++.. +.+..-+|....+
T Consensus 215 Tq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 215 TH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred HH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 33 4568899999999974 699999999999999999999988876655544433321 1112223322222
Q ss_pred CCcccCCC---------CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 005803 586 MDPTLDES---------CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627 (676)
Q Consensus 586 ~d~~l~~~---------~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~L 627 (676)
+....... .+...-.+.+.+.+.++..||++|.+..+.+..+
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 22222111 1112223455667778999999999998888765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=241.37 Aligned_cols=214 Identities=24% Similarity=0.333 Sum_probs=161.5
Q ss_pred cCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCc-cc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTN-LT--------------- 442 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~n-iv--------------- 442 (676)
.+|..+..||+|+||+|.+|..+. .+.+|||++++.. .+..+--+.|-++|.....|- ++
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 367789999999999999997654 6678999998752 233344456666666554333 22
Q ss_pred -----------cccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 443 -----------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 443 -----------~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
...+...+.+..+.-.+.+||-||-+||++| ||.||||.+|||+|.+|++||+|||+++.-.-.
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-- 503 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-- 503 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC--
Confidence 1223345666677778999999999999999 999999999999999999999999999853222
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
...+.+.+||+.|+|||++...+|+..+|.|||||+||||+.|++||+..++++.. +.+.+. .
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF-------~aI~eh----------n 566 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF-------QAIMEH----------N 566 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHHHc----------c
Confidence 23455689999999999999999999999999999999999999999876554321 111111 1
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCC
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRR 618 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP 618 (676)
..++.....+...+....|...|.+|.
T Consensus 567 vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 123444455566777778889999885
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=224.97 Aligned_cols=212 Identities=26% Similarity=0.333 Sum_probs=163.1
Q ss_pred CCccEEEEEEcC-CcEEEEEEeccCCchh-hHHHHHHHHHHHHccCCccccc--------------------------cc
Q 005803 395 GFGPVYNGKLLD-GQEIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLTDS--------------------------SR 446 (676)
Q Consensus 395 ~fG~Vy~~~~~~-~~~VAvK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~~--------------------------~~ 446 (676)
+||.||+|+... ++.+|+|++....... .+.+.+|++.+++++|+|++.. ..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 8999999997654444 6789999999999999998620 01
Q ss_pred cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccC
Q 005803 447 KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMS 526 (676)
Q Consensus 447 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~A 526 (676)
...+++..+..++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|++
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMA 154 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCC
Confidence 112678888999999999999999998 9999999999999999999999999998765432 2223567889999
Q ss_pred hhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHH
Q 005803 527 PEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVG 606 (676)
Q Consensus 527 PE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~ 606 (676)
||.+.+..++.++||||||+++++|++|..||....... ........+..... .........+.+++
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~i 221 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL------ELFKKIGKPKPPFP-------PPEWKISPEAKDLI 221 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH------HHHHHHhccCCCCc-------cccccCCHHHHHHH
Confidence 999988889999999999999999999999986532111 11111111111100 00000334688899
Q ss_pred HHhcccCcCCCCCHHHHHH
Q 005803 607 LLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 607 ~~Cl~~dP~~RPs~~eVl~ 625 (676)
.+|+..+|++||++.++++
T Consensus 222 ~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 222 RKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHccCCchhccCHHHHhh
Confidence 9999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=237.44 Aligned_cols=237 Identities=22% Similarity=0.275 Sum_probs=181.9
Q ss_pred HHHHHHHhcCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCcccc----
Q 005803 375 FQTIAAATDNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTD---- 443 (676)
Q Consensus 375 ~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~---- 443 (676)
.++|.....+++....+-+|.||.||.|.+. +.+.|-+|.++.. +.-+...+..|..++..+.|||+..
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4566667788999999999999999999543 3456778877543 3345567889999999999999851
Q ss_pred -------------------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC
Q 005803 444 -------------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ 492 (676)
Q Consensus 444 -------------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~ 492 (676)
......+...+...++.|++.|++|||.++ +||.||..+|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 111223444556678999999999999998 9999999999999999
Q ss_pred CCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHH
Q 005803 493 MNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVG 571 (676)
Q Consensus 493 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~ 571 (676)
.++||+|=.+++.+-+.+........-....||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm----- 507 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM----- 507 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-----
Confidence 9999999999886554443322222233567999999999999999999999999999998 8889876554331
Q ss_pred HHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 572 YAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 572 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
...+++|... . .+..++.++..++.-||...|++||+++|++.-|.+-
T Consensus 508 --~~ylkdGyRl-------a--QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 508 --EHYLKDGYRL-------A--QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred --HHHHhcccee-------c--CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 2223333221 1 2445666788999999999999999999999998764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=227.96 Aligned_cols=194 Identities=19% Similarity=0.089 Sum_probs=145.8
Q ss_pred CCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc--------------------------cc
Q 005803 394 GGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS--------------------------SR 446 (676)
Q Consensus 394 G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~--------------------------~~ 446 (676)
|.+|.||+++.. +++.||+|++.... .+.+|...+....|||++.. ..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999865 58999999986542 23445555666678998720 11
Q ss_pred cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccC
Q 005803 447 KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMS 526 (676)
Q Consensus 447 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~A 526 (676)
...+++.....++.|+++||.|||+.+ |+||||||+||+++.++.++++|||.+...... .....++..|+|
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~a 150 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCA 150 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccC
Confidence 234778888999999999999999998 999999999999999999999999987654321 112345678999
Q ss_pred hhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHH
Q 005803 527 PEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVG 606 (676)
Q Consensus 527 PE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~ 606 (676)
||.+.+..++.++||||+|+++|||++|+.|+....... ....... .+......+.+++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~~~----~~~~~~~~~~~li 209 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTTLN----IPEWVSEEARSLL 209 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------ccccccC----CcccCCHHHHHHH
Confidence 999988889999999999999999999998875321100 0000001 1122234577889
Q ss_pred HHhcccCcCCCCCHH
Q 005803 607 LLCVQDRAADRRTMS 621 (676)
Q Consensus 607 ~~Cl~~dP~~RPs~~ 621 (676)
.+||+.||++||++.
T Consensus 210 ~~~l~~dp~~R~~~~ 224 (237)
T cd05576 210 QQLLQFNPTERLGAG 224 (237)
T ss_pred HHHccCCHHHhcCCC
Confidence 999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-25 Score=243.59 Aligned_cols=234 Identities=20% Similarity=0.242 Sum_probs=153.2
Q ss_pred HhcCCCcceeeccCCCccEEEEEE-----------------cCCcEEEEEEeccCCchhhHH--------------HHHH
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKL-----------------LDGQEIAIKRLSKSSGQGIVE--------------FKNE 429 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~-----------------~~~~~VAvK~l~~~~~~~~~~--------------~~~E 429 (676)
..++|++.++||+|+||.||+|.+ ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 235679999986543322223 3346
Q ss_pred HHHHHHccCCcccc-----------------------------c----------------------------------cc
Q 005803 430 AKLIAKLQHTNLTD-----------------------------S----------------------------------SR 446 (676)
Q Consensus 430 ~~~l~~l~H~niv~-----------------------------~----------------------------------~~ 446 (676)
+.++.+++|.+++. . ..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 67777777765410 0 00
Q ss_pred cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccC
Q 005803 447 KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMS 526 (676)
Q Consensus 447 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~A 526 (676)
...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........ .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 112355677889999999999999998 99999999999999999999999999975432211 11111234789999
Q ss_pred hhhhccCC--------------------C--CchhHHHHHHHHHHHHHhCCc-CCCCCCCCCc----cchHHHHHHHHhc
Q 005803 527 PEYVMNGI--------------------V--SMKSDVYSFGVLVLEIVSSKK-NNGSYDTERP----LNLVGYAWQLWNE 579 (676)
Q Consensus 527 PE~~~~~~--------------------~--s~ksDVwSlGvvl~elltG~~-pf~~~~~~~~----~~l~~~~~~~~~~ 579 (676)
||.+.... + ..+.||||+||++|||++|.. |+........ .......|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875422 1 234799999999999999875 6643211110 0000011111111
Q ss_pred CCccccCCcccCCCCChHHHHHHHHHHHHhcccCc---CCCCCHHHHHHH
Q 005803 580 GKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRA---ADRRTMSDVVSM 626 (676)
Q Consensus 580 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP---~~RPs~~eVl~~ 626 (676)
... +-. ..........+++.++|..+| .+|+|++|+++.
T Consensus 459 ~~~----~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QKY----DFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cCC----Ccc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111 111 111223456778888888765 689999999864
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-26 Score=256.57 Aligned_cols=233 Identities=22% Similarity=0.276 Sum_probs=169.6
Q ss_pred HHHHHHhcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEecc---CCchhhHHHHHHHHHHHHccCCcccc--------
Q 005803 376 QTIAAATDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNLTD-------- 443 (676)
Q Consensus 376 ~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~-------- 443 (676)
.++.-..++|.+++.||+|+||.|..++... ++.+|.|++++ ........|..|-.+|..-+.+-|+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 4555567899999999999999999999764 78889999976 23445567888888887766555441
Q ss_pred ------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 444 ------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 444 ------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
......+++.-+..++.+|+.||.-||+.| +|||||||+|||||..|++||+|||.+-.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHh
Confidence 112225677766667777999999999998 99999999999999999999999999987
Q ss_pred ccccccccccceeeccCCccChhhhcc-----CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcC
Q 005803 506 YAMNELEANTNRIVGTHGYMSPEYVMN-----GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG 580 (676)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 580 (676)
+..+.. ......+|||.|++||++.. +.|+..+|.||+||++|||+.|..||-.. +++.-..+.+...
T Consensus 225 m~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~KIm~hk 297 (1317)
T KOG0612|consen 225 MDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGKIMNHK 297 (1317)
T ss_pred cCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHHHhchh
Confidence 765443 23344799999999999963 56999999999999999999999999632 2332222222222
Q ss_pred CccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCC---HHHHHHH
Q 005803 581 KALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRT---MSDVVSM 626 (676)
Q Consensus 581 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs---~~eVl~~ 626 (676)
....+.+ ..+..+...+|+.+.+ .+|+.|.. ++++-..
T Consensus 298 ~~l~FP~-------~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 298 ESLSFPD-------ETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hhcCCCc-------ccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 2222211 1112333445555544 57888887 8887654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=214.68 Aligned_cols=247 Identities=19% Similarity=0.317 Sum_probs=177.2
Q ss_pred cCcCccccHHHHHH---HhcCCCcceeeccCCCccEEEEE-EcCCcEEEEEEeccCCchhhHHHHHHHHHHHHcc-CCcc
Q 005803 367 KRDLKIFDFQTIAA---ATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNL 441 (676)
Q Consensus 367 ~~~~~~f~~~~l~~---~t~~y~~~~~LG~G~fG~Vy~~~-~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~ni 441 (676)
.++-..++++.... ..++|++.+++|+|.++.||.|. ..+++.++||+++.. ..+.+.+|++||..|. ||||
T Consensus 19 ~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NI 95 (338)
T KOG0668|consen 19 ERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNI 95 (338)
T ss_pred cCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCe
Confidence 33444566654432 56799999999999999999997 456889999999653 4567899999999997 9998
Q ss_pred ccc-------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC-CCe
Q 005803 442 TDS-------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ-MNP 495 (676)
Q Consensus 442 v~~-------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~-~~v 495 (676)
+.. .....+....+...+.+++.||.|+|+.| |+|||+||.|++||.. -.+
T Consensus 96 i~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkL 172 (338)
T KOG0668|consen 96 IKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKL 172 (338)
T ss_pred eehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhcee
Confidence 731 11223445566778899999999999999 9999999999999954 569
Q ss_pred EEeccCcceeccccccccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHH
Q 005803 496 KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAW 574 (676)
Q Consensus 496 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~ 574 (676)
+|+|+|+|.++.... ..+..+.++.|--||.+... .|+..-|+|||||+|..|+..+.||-..... ...++..+.
T Consensus 173 rlIDWGLAEFYHp~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIak 248 (338)
T KOG0668|consen 173 RLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAK 248 (338)
T ss_pred eeeecchHhhcCCCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHH
Confidence 999999998876443 23446778899999999864 5888999999999999999999998654321 122222221
Q ss_pred H--------HHhcCCccccCCcccCC--------CC-------ChH-HHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 575 Q--------LWNEGKALELMDPTLDE--------SC-------SSD-EVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 575 ~--------~~~~~~~~~~~d~~l~~--------~~-------~~~-~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
- .+.. ..-.+|+...+ .+ ... ...+.++++-+.|..|-.+|||++|.+.
T Consensus 249 VLGt~el~~Yl~K--Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 249 VLGTDELYAYLNK--YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HhChHHHHHHHHH--HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1 0000 00012222211 00 000 1245778888999999999999998764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=223.31 Aligned_cols=222 Identities=22% Similarity=0.319 Sum_probs=167.3
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHc-cCCccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLT-------------- 442 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv-------------- 442 (676)
.++|.++..||+|+|++|.++++. +.+.+|+|++++. ....++=.+.|-.+..+. +||.+|
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467888999999999999999875 4788999999764 233444466777777665 578776
Q ss_pred ------------cccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 443 ------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 443 ------------~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.......++++.+.....+|..||.|||+.| ||.||||.+|+|+|.+|++||.|+|+++.--.
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~-- 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG-- 403 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC--
Confidence 1345567888888888889999999999999 99999999999999999999999999985322
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCC-ccchHHHHHHHHhcCCccccCCcc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTER-PLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
....+.+.+||+.|+|||++.+..|+..+|.|+|||+++||+.|+.||+.-.-.+ ..+-..+..+.+.+..+.
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir------ 477 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR------ 477 (593)
T ss_pred CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc------
Confidence 2234556899999999999999999999999999999999999999998643221 122223333333332221
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCC
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRR 618 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP 618 (676)
++....-+...++..-|..||.+|.
T Consensus 478 ----iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 ----IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ----ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1111222345566678889999884
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-26 Score=207.81 Aligned_cols=105 Identities=42% Similarity=0.623 Sum_probs=76.6
Q ss_pred CccEEEccCCCCCCCC-CCceEEEEcCCCcEEEEcCCCceEEEe-eeccCC-cceEEEEeeCCCEEEEEecCCCCccccc
Q 005803 113 KQPVWIANRETPVLRN-ESASLIIDSTDGNLKILRNGKNPIGIS-SVRRAG-NTTSATLLKNGNLVLYEMNSDGLSIRRG 189 (676)
Q Consensus 113 ~~~vW~anr~~p~~~~-~~~~l~~~~~~G~L~l~~~~~~~vw~s-~~~~~~-~~~~a~l~d~GNlVl~~~~~~~~~~~~~ 189 (676)
+||||+|||+.|+... ...+|.+.. ||+|+|++.++..+|++ ++.+.. .+..|+|+|+|||||++. .. .+
T Consensus 2 ~tvvW~an~~~p~~~~s~~~~L~l~~-dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~---~~---~~ 74 (114)
T PF01453_consen 2 RTVVWVANRNSPLTSSSGNYTLILQS-DGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS---SG---NV 74 (114)
T ss_dssp --------TTEEEEECETTEEEEEET-TSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET---TS---EE
T ss_pred cccccccccccccccccccccceECC-CCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee---cc---eE
Confidence 7899999999999532 247899998 99999999999999999 444433 468899999999999982 22 69
Q ss_pred cccccCCCcccccCCCcccccccCCceeEEEecCC
Q 005803 190 LWQSFDYPTHALLPGMKLGINLQTGHQWFLQSSES 224 (676)
Q Consensus 190 lWqSFd~PtDtlLpg~~l~~~~~t~~~~~l~s~~~ 224 (676)
+||||||||||+||||+|+.+..++....++||+.
T Consensus 75 lW~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s 109 (114)
T PF01453_consen 75 LWQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSS 109 (114)
T ss_dssp EEESTTSSS-EEEEEET--TSEEEEESTSSEEEES
T ss_pred EEeecCCCccEEEeccCcccCCCccccceEEeECC
Confidence 99999999999999999998877766667889874
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-26 Score=235.73 Aligned_cols=232 Identities=25% Similarity=0.328 Sum_probs=170.3
Q ss_pred HhcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccC-------CchhhHHHHHHHHHHHHccCCcccc---------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKS-------SGQGIVEFKNEAKLIAKLQHTNLTD--------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~-------~~~~~~~~~~E~~~l~~l~H~niv~--------- 443 (676)
..++|-++++||+|||+.||+|.+ ...+.||||+-... ...-.+...+|..|.+.|.||.||+
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 346788899999999999999974 45788999975321 1112344678999999999999983
Q ss_pred ------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc---CCCCeEEeccCc
Q 005803 444 ------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD---EQMNPKISDFGM 502 (676)
Q Consensus 444 ------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~---~~~~vkL~DFGl 502 (676)
....+.++++++..|+.||+.||.||.+.. ++|||-||||.|||+- .-|.+||.|||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecch
Confidence 233456788899999999999999999985 7799999999999995 457899999999
Q ss_pred ceeccccccc-----cccceeeccCCccChhhhccC----CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHH
Q 005803 503 ARTYAMNELE-----ANTNRIVGTHGYMSPEYVMNG----IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYA 573 (676)
Q Consensus 503 a~~~~~~~~~-----~~~~~~~gt~~Y~APE~~~~~----~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~ 573 (676)
++.+..+... ..+....||..|++||.+.-+ .++.|+||||.|||+|..+.|+.||.......
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-------- 691 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-------- 691 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--------
Confidence 9988765432 223456899999999988643 47899999999999999999999998543221
Q ss_pred HHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q 005803 574 WQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVV 624 (676)
Q Consensus 574 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl 624 (676)
..+.+..+...-. ......+....+...++.+||++.-++|....++.
T Consensus 692 -dILqeNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 692 -DILQENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -HHHhhhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1111221111100 00011112223456788899999999998766654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-25 Score=246.13 Aligned_cols=233 Identities=25% Similarity=0.400 Sum_probs=185.4
Q ss_pred cHHHHHHHhcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCccc---------
Q 005803 374 DFQTIAAATDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLT--------- 442 (676)
Q Consensus 374 ~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv--------- 442 (676)
++..+...++-|++.+.||.|.+|.||+++. ++++.+|||++.. ..+..+++..|.++++.+ .|||++
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 4445556778899999999999999999984 4688999999865 445567788899998887 589976
Q ss_pred ------------------------cccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEe
Q 005803 443 ------------------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKIS 498 (676)
Q Consensus 443 ------------------------~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~ 498 (676)
+...+..+.|..+.+|+++++.||.+||... ++|||||-.|||++.++.+||.
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 1233667889999999999999999999987 9999999999999999999999
Q ss_pred ccCcceeccccccccccceeeccCCccChhhhcc-----CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHH
Q 005803 499 DFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN-----GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYA 573 (676)
Q Consensus 499 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~ 573 (676)
|||++..+... .....+.+||+.|||||++.. ..|+..+|+||||++..||--|.+|+..+.+...+.++
T Consensus 166 DFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I--- 240 (953)
T KOG0587|consen 166 DFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--- 240 (953)
T ss_pred eeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---
Confidence 99998765432 233445789999999999863 34788999999999999999999999877654322111
Q ss_pred HHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 574 WQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 574 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
..-..|.+ .-+..-.+++.+++..||..|-.+||++.++++.
T Consensus 241 ---------pRNPPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 ---------PRNPPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---------CCCCCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111222 2244556788999999999999999999988754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=248.78 Aligned_cols=217 Identities=25% Similarity=0.379 Sum_probs=157.5
Q ss_pred CcceeeccCCCcc-EEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCccccc-------------------
Q 005803 386 SPANRLGQGGFGP-VYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTDS------------------- 444 (676)
Q Consensus 386 ~~~~~LG~G~fG~-Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~~------------------- 444 (676)
.-.+.+|.|..|+ ||+|.. ++++||||++-. .......+|+..|+.- +||||++.
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred ccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 3345689998875 599988 788999999844 3344568899999888 59999830
Q ss_pred -----ccc--CcC---CHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC---C--CCeEEeccCcceecccc
Q 005803 445 -----SRK--SLL---DWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE---Q--MNPKISDFGMARTYAMN 509 (676)
Q Consensus 445 -----~~~--~~l---~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~---~--~~vkL~DFGla~~~~~~ 509 (676)
... ... .......+..|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++.+...
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 000 001 11234678899999999999987 999999999999975 2 46899999999987654
Q ss_pred ccc-cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhC-CcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 510 ELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSS-KKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 510 ~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG-~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
... .......||-+|+|||++....-+.++||||+|||+|..++| .+||+.....+. + .+....-...+.
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-N-------Il~~~~~L~~L~ 736 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-N-------ILTGNYTLVHLE 736 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-h-------hhcCccceeeec
Confidence 322 224456799999999999988888899999999999999986 899985432211 1 111111111111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
+ ..++ +..+|+.+|+..+|..||++.+|+.
T Consensus 737 ~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 737 P------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred c------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1 1111 5678889999999999999999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-25 Score=209.84 Aligned_cols=174 Identities=26% Similarity=0.362 Sum_probs=139.5
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC-CchhhHHHHHHHHHHHHc-cCCcccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNLTD---------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~---------------- 443 (676)
++...+..||+|++|.|-+-++. +|+..|+|++... ..+..++..+|+.+..+. .+|.+|.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 33444678999999999888754 6899999999754 345566778888876655 4676662
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
...+..+++...-+|+..+.+||.|||++- .+||||+||+||||+.+|++|+||||.+..+...-
T Consensus 126 ~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 126 LMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred HhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 234556777778899999999999999964 69999999999999999999999999998765432
Q ss_pred cccccceeeccCCccChhhhcc----CCCCchhHHHHHHHHHHHHHhCCcCCCCC
Q 005803 511 LEANTNRIVGTHGYMSPEYVMN----GIVSMKSDVYSFGVLVLEIVSSKKNNGSY 561 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~----~~~s~ksDVwSlGvvl~elltG~~pf~~~ 561 (676)
... -..|...|||||.+.. ..|+.|+||||||+.+.||.+++.||+..
T Consensus 204 Akt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 204 AKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred HHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 211 1457889999998853 46999999999999999999999999754
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=192.67 Aligned_cols=115 Identities=40% Similarity=0.641 Sum_probs=97.3
Q ss_pred CcccCCCeEEecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCCCCCCCCCccEEE
Q 005803 39 QVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPYSPAIKKQPVWI 118 (676)
Q Consensus 39 ~~l~~~~~l~S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~ 118 (676)
+.|.+|++|+|++|.|++|||.+......+++|||.+.+ .++||.
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-----------------------------------~~~vW~ 46 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-----------------------------------RTVVWV 46 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-----------------------------------CeEEEE
Confidence 578899999999999999999987654599999998741 467999
Q ss_pred ccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccccccCCC
Q 005803 119 ANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYP 197 (676)
Q Consensus 119 anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~P 197 (676)
|||+.|.. . .+.|.+.+ ||+|+|+|.+|.+||+|++.......+|+|+|+|||||++.++ .++|||||||
T Consensus 47 snt~~~~~-~-~~~l~l~~-dGnLvl~~~~g~~vW~S~~~~~~~~~~~~L~ddGnlvl~~~~~------~~~W~Sf~~P 116 (116)
T cd00028 47 ANRDNPSG-S-SCTLTLQS-DGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDG------NFLWQSFDYP 116 (116)
T ss_pred CCCCCCCC-C-CEEEEEec-CCCeEEEcCCCcEEEEecccCCCCceEEEEeCCCCEEEECCCC------CEEEcCCCCC
Confidence 99999842 2 57899987 9999999999999999997653345789999999999998432 6899999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-25 Score=232.52 Aligned_cols=245 Identities=21% Similarity=0.232 Sum_probs=173.4
Q ss_pred ccHHHHHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHcc--------------
Q 005803 373 FDFQTIAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-------------- 437 (676)
Q Consensus 373 f~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~-------------- 437 (676)
+.+..-...-.+|.+....|+|-|+.|-.|... .|+.||||+|... +.-.+.=+.|+++|++|+
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 333333445678999999999999999999865 4889999999753 223334467777777763
Q ss_pred ----CCc---cc-------------cccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC-CeE
Q 005803 438 ----HTN---LT-------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM-NPK 496 (676)
Q Consensus 438 ----H~n---iv-------------~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~-~vk 496 (676)
|.| +| +....-.|.......++.|+.-||..|...+ |+|.||||+|||+++.- .+|
T Consensus 501 r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceee
Confidence 222 22 1233344666677789999999999999988 99999999999998654 589
Q ss_pred EeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH----
Q 005803 497 ISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY---- 572 (676)
Q Consensus 497 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~---- 572 (676)
|||||.|......+. +.+.-+..|.|||++.+.+|+...|+||.||.||||.||+..|++....+.+.+...
T Consensus 578 LCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 578 LCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred eccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 999999987654433 224557789999999999999999999999999999999999987665432222111
Q ss_pred -HHHHHhcCCc---------------------------cccCCc------ccC--CCC---ChHHHHHHHHHHHHhcccC
Q 005803 573 -AWQLWNEGKA---------------------------LELMDP------TLD--ESC---SSDEVMRCIHVGLLCVQDR 613 (676)
Q Consensus 573 -~~~~~~~~~~---------------------------~~~~d~------~l~--~~~---~~~~~~~l~~L~~~Cl~~d 613 (676)
..+++..+.+ ...+.| .|. +.. .+..+..+..|+-.||..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 1111111111 111111 000 011 2344556778899999999
Q ss_pred cCCCCCHHHHHH
Q 005803 614 AADRRTMSDVVS 625 (676)
Q Consensus 614 P~~RPs~~eVl~ 625 (676)
|++|.|..+.|+
T Consensus 734 P~KRit~nqAL~ 745 (752)
T KOG0670|consen 734 PEKRITVNQALK 745 (752)
T ss_pred hhhcCCHHHHhc
Confidence 999999998775
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=218.33 Aligned_cols=237 Identities=19% Similarity=0.224 Sum_probs=168.6
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHcc-----CCc---cc----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-----HTN---LT---------- 442 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~-----H~n---iv---------- 442 (676)
.++|.+.++||-|.|++||++.+. ..+.||+|+.+. ...-.+..+.|+++|++++ |++ ||
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 368999999999999999999754 477899999854 4445566789999999984 322 22
Q ss_pred ---------------------cccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC---------
Q 005803 443 ---------------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ--------- 492 (676)
Q Consensus 443 ---------------------~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~--------- 492 (676)
.......++...+..|++||+.||.|||.++ +|||-||||+|||+..+
T Consensus 156 pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhh
Confidence 1344566778888999999999999999987 79999999999997110
Q ss_pred --------------------------------------------------------------------------------
Q 005803 493 -------------------------------------------------------------------------------- 492 (676)
Q Consensus 493 -------------------------------------------------------------------------------- 492 (676)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred -----------------------------------------------------------------------------CCe
Q 005803 493 -----------------------------------------------------------------------------MNP 495 (676)
Q Consensus 493 -----------------------------------------------------------------------------~~v 495 (676)
..+
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 002
Q ss_pred EEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCcc----chH-
Q 005803 496 KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPL----NLV- 570 (676)
Q Consensus 496 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~----~l~- 570 (676)
||+|||-|+..... .+.-..|+.|+|||++.+..|++.+||||++|++|||.||...|+........ .+.
T Consensus 394 KIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 394 KIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred EEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 33333333322111 11135688999999999999999999999999999999999999876543311 111
Q ss_pred ------HHHHHHHhcCCcc-ccCCcc-----------------c--CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q 005803 571 ------GYAWQLWNEGKAL-ELMDPT-----------------L--DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVV 624 (676)
Q Consensus 571 ------~~~~~~~~~~~~~-~~~d~~-----------------l--~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl 624 (676)
...+.....|+.. +.+..+ | .=.++.+++..+.+++.-||+.+|++|||+.+.+
T Consensus 469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl 548 (590)
T KOG1290|consen 469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL 548 (590)
T ss_pred HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence 1112222223221 111110 0 0135678888999999999999999999999998
Q ss_pred HH
Q 005803 625 SM 626 (676)
Q Consensus 625 ~~ 626 (676)
+.
T Consensus 549 ~h 550 (590)
T KOG1290|consen 549 KH 550 (590)
T ss_pred cC
Confidence 65
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-24 Score=213.78 Aligned_cols=250 Identities=22% Similarity=0.227 Sum_probs=176.0
Q ss_pred cCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDSS-------------- 445 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~-------------- 445 (676)
.+|..++.+|.|.- .|-.+-+ -.++.||+|++... .....++..+|..++..++|+|++...
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46767788888887 4544432 35899999987543 344567788999999999999998311
Q ss_pred ---------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 446 ---------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 446 ---------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
....++.+...+|..|++.|+.|||+.+ |+||||||+||++..++.+||.|||+|......
T Consensus 96 ~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred HHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc-
Confidence 1123555667789999999999999998 999999999999999999999999999864322
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH----------------HH
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY----------------AW 574 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~----------------~~ 574 (676)
...+.++.|+.|+|||++.+..|.+.+||||.||++.||++|+..|.+.+.-++...+.. +.
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 234457889999999999998899999999999999999999998886443322211111 11
Q ss_pred HHHhc------CCccccCCccc-C--CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--Hh---cCcCCCCCCCCC
Q 005803 575 QLWNE------GKALELMDPTL-D--ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LT---NDTMALPKPKQP 640 (676)
Q Consensus 575 ~~~~~------~~~~~~~d~~l-~--~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le---~~~~~l~~p~~P 640 (676)
..... -...+.+...+ . .+.+.-....+-.++.+||-.||++|.+++++++. ++ .. .+.+.|++|
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~-~ev~ap~pe 328 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDP-DEVEAPPPE 328 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccc-ccccCCCCc
Confidence 11100 01111111111 0 01112233345678889999999999999999976 43 22 245556555
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-24 Score=228.06 Aligned_cols=180 Identities=23% Similarity=0.348 Sum_probs=142.8
Q ss_pred cCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
.-|..++.||-|+||+|.+++. ++...+|.|.+.+.. ..+....+.|-.||.....+-+|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4577789999999999999974 446778999987642 334456788999999998888773
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc---
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN--- 509 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~--- 509 (676)
......+.+..+...+.++..|+++.|..| +|||||||+|||||.+|++||+|||++.-+...
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccc
Confidence 122344566665556667999999999998 999999999999999999999999998633110
Q ss_pred ------c-c------------------------------ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHH
Q 005803 510 ------E-L------------------------------EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIV 552 (676)
Q Consensus 510 ------~-~------------------------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ell 552 (676)
. . .......+||+.|+|||++....|+..+|.||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 0 0 00011258999999999999999999999999999999999
Q ss_pred hCCcCCCCCCCCC
Q 005803 553 SSKKNNGSYDTER 565 (676)
Q Consensus 553 tG~~pf~~~~~~~ 565 (676)
.|+.||......+
T Consensus 866 ~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 866 VGQPPFLADTPGE 878 (1034)
T ss_pred hCCCCccCCCCCc
Confidence 9999998765544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=199.24 Aligned_cols=184 Identities=33% Similarity=0.536 Sum_probs=153.4
Q ss_pred eccCCCccEEEEEEcC-CcEEEEEEeccCCch-hhHHHHHHHHHHHHccCCccccc------------------------
Q 005803 391 LGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLTDS------------------------ 444 (676)
Q Consensus 391 LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~~------------------------ 444 (676)
||+|.+|.||++.... ++.+++|++...... ....+.+|+..++.+.|++++..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 899999998764332 35678999999999999987620
Q ss_pred -ccc--CcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC-CCCeEEeccCcceeccccccccccceeec
Q 005803 445 -SRK--SLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE-QMNPKISDFGMARTYAMNELEANTNRIVG 520 (676)
Q Consensus 445 -~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~g 520 (676)
... ..+++..+..++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 011 25788888999999999999999998 999999999999999 89999999999986543321 1222457
Q ss_pred cCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHH
Q 005803 521 THGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEV 599 (676)
Q Consensus 521 t~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 599 (676)
...|++||.+... .++.+.|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7889999999877 788999999999999999
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 005803 600 MRCIHVGLLCVQDRAADRRTMSDVVSML 627 (676)
Q Consensus 600 ~~l~~L~~~Cl~~dP~~RPs~~eVl~~L 627 (676)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4577889999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-24 Score=226.97 Aligned_cols=171 Identities=25% Similarity=0.387 Sum_probs=143.2
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCC--------chhhHHHHHHHHHHHHcc---CCcccc------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSS--------GQGIVEFKNEAKLIAKLQ---HTNLTD------ 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~--------~~~~~~~~~E~~~l~~l~---H~niv~------ 443 (676)
..+|..++.+|+|+||.|+++.++. ..+|+||.+.++. ....-.+-.|+.||..++ |+||++
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3468899999999999999998764 6789999987642 111223457999999998 999983
Q ss_pred ---------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCc
Q 005803 444 ---------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGM 502 (676)
Q Consensus 444 ---------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGl 502 (676)
......+++.+...|+.|++.|+++||+++ |||||||-+||.++.+|-+||+|||.
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccc
Confidence 233456788899999999999999999999 99999999999999999999999999
Q ss_pred ceeccccccccccceeeccCCccChhhhccCCC-CchhHHHHHHHHHHHHHhCCcCCC
Q 005803 503 ARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIVSSKKNNG 559 (676)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~elltG~~pf~ 559 (676)
|....... ....+||..|.|||++.+.+| +..-|||++|++||.++....||-
T Consensus 717 aa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98755433 334899999999999999887 456799999999999999888874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=196.54 Aligned_cols=156 Identities=17% Similarity=0.165 Sum_probs=116.9
Q ss_pred CcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccCh
Q 005803 448 SLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSP 527 (676)
Q Consensus 448 ~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~AP 527 (676)
..+++..+..++.||+.||.|||+++ ||+|||++.++.+|+ ||++....... ..|++.|+||
T Consensus 12 ~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~~g~~~y~aP 73 (176)
T smart00750 12 RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-------SRVDPYFMAP 73 (176)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-------CCCcccccCh
Confidence 46899999999999999999999875 999999999999999 99998654321 2688999999
Q ss_pred hhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHH--HHHHH
Q 005803 528 EYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVM--RCIHV 605 (676)
Q Consensus 528 E~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~--~l~~L 605 (676)
|++.+..++.++|||||||++|||++|+.||....... .... .+....... ++.. ......... .+.++
T Consensus 74 E~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~----~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 74 EVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILE----ILLNGMPAD--DPRD-RSNLESVSAARSFADF 144 (176)
T ss_pred HHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHH----HHHHHhccC--Cccc-cccHHHHHhhhhHHHH
Confidence 99999999999999999999999999999986432211 1111 111110000 0000 001112222 58899
Q ss_pred HHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 606 GLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 606 ~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
+.+||+.+|++||++.|+++.+...
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=182.33 Aligned_cols=113 Identities=40% Similarity=0.656 Sum_probs=95.5
Q ss_pred CcccCCCeEEecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCCCCCCCCCccEEE
Q 005803 39 QVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPYSPAIKKQPVWI 118 (676)
Q Consensus 39 ~~l~~~~~l~S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vW~ 118 (676)
+.|..|++|+|++|.|++|||.+... ..+++|||++.+ .++||.
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-----------------------------------~~~vW~ 45 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-----------------------------------RTVVWV 45 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-----------------------------------CcEEEE
Confidence 56889999999999999999998644 689999998741 467999
Q ss_pred ccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccccccCC
Q 005803 119 ANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDY 196 (676)
Q Consensus 119 anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~ 196 (676)
|||+.|+.. ...|.+.+ ||+|+|++.+|.+||+|++.......+|+|+|+|||||++..+ .++||||||
T Consensus 46 snt~~~~~~--~~~l~l~~-dGnLvl~~~~g~~vW~S~t~~~~~~~~~~L~ddGnlvl~~~~~------~~~W~Sf~~ 114 (114)
T smart00108 46 ANRDNPVSD--SCTLTLQS-DGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDG------NFLWQSFDY 114 (114)
T ss_pred CCCCCCCCC--CEEEEEeC-CCCEEEEeCCCCEEEEecccCCCCceEEEEeCCCCEEEECCCC------CEEeCCCCC
Confidence 999999854 37899987 9999999999999999987633455789999999999997322 589999997
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=194.67 Aligned_cols=172 Identities=30% Similarity=0.465 Sum_probs=143.5
Q ss_pred CCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCch-hhHHHHHHHHHHHHccCCccccc------------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLTDS------------------ 444 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~~------------------ 444 (676)
|.+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++..
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999765 889999999765444 67789999999999999997620
Q ss_pred --------cccCc-CCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 445 --------SRKSL-LDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 445 --------~~~~~-l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
..... +++.....++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence 01122 778888899999999999999997 999999999999999999999999999876543211 22
Q ss_pred ceeeccCCccChhhh-ccCCCCchhHHHHHHHHHHHHHhCCcCCCC
Q 005803 516 NRIVGTHGYMSPEYV-MNGIVSMKSDVYSFGVLVLEIVSSKKNNGS 560 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~-~~~~~s~ksDVwSlGvvl~elltG~~pf~~ 560 (676)
....++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 335678889999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-22 Score=197.96 Aligned_cols=226 Identities=19% Similarity=0.324 Sum_probs=163.7
Q ss_pred cCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCcccc-----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTD----------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~----------------- 443 (676)
+.|.+.+.||+|.||.+.+++++. ++.+++|.+.+. .....+|.+|...--.| .|.||+.
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 568889999999999999998764 788999998764 44567899998766555 4778862
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc--CCCCeEEeccCcceeccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD--EQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~--~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+-+....+++.|++.||.|+|+++ +||||||.+||||- +...+||||||.....+..
T Consensus 103 ~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t--- 176 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT--- 176 (378)
T ss_pred cCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCce---
Confidence 122344666777899999999999999998 99999999999994 3347999999998753321
Q ss_pred cccceeeccCCccChhhhcc---C--CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMN---G--IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~---~--~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
.....-+..|.+||.... + ...+.+|||.||+++|.+++|..||...... ....+.+..|..+....+.+
T Consensus 177 --V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~---d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 177 --VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM---DKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred --ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc---CchHHHHHHHhcccCccCch
Confidence 111233557899997753 2 2467889999999999999999999844333 23345566666655543322
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.- .. ..+++.++..+-+..+|++|--+.++.++
T Consensus 252 ~F--~~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 252 KF--NP----FSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred hh--cc----cCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 11 11 12345666678899999999666665554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-22 Score=238.16 Aligned_cols=158 Identities=16% Similarity=0.193 Sum_probs=111.8
Q ss_pred CcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC-------------------CCCeEEeccCcceeccc
Q 005803 448 SLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE-------------------QMNPKISDFGMARTYAM 508 (676)
Q Consensus 448 ~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~-------------------~~~vkL~DFGla~~~~~ 508 (676)
..+++.+++.++.||++||.|||+++ |+||||||+||||+. ++.+||+|||+++....
T Consensus 75 ~~~~~~~~~~i~~qi~~al~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~ 151 (793)
T PLN00181 75 RSVDAFECFHVFRQIVEIVNAAHSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEI 151 (793)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHhCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccccc
Confidence 45889999999999999999999998 999999999999954 44566667776653211
Q ss_pred ccc--------------ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHH
Q 005803 509 NEL--------------EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAW 574 (676)
Q Consensus 509 ~~~--------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~ 574 (676)
... ........||+.|+|||++.+..++.++|||||||+||||++|..|+.... .. .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~----~ 222 (793)
T PLN00181 152 LSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RT----M 222 (793)
T ss_pred ccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HH----H
Confidence 000 000112457889999999999999999999999999999999888764211 00 0
Q ss_pred HHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 575 QLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 575 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
..+... .+.+.. .........++.+||+.+|.+||+|.||++.
T Consensus 223 ~~~~~~----~~~~~~-----~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 223 SSLRHR----VLPPQI-----LLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHh----hcChhh-----hhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 011000 111111 1112335677889999999999999999863
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.3e-22 Score=204.80 Aligned_cols=182 Identities=23% Similarity=0.402 Sum_probs=141.1
Q ss_pred HHHHHHhcCCCcceeeccCCCccEEEEEEc----CCcEEEEEEeccCCchhhHHHHHHHHHHHHcc-CCcccc-------
Q 005803 376 QTIAAATDNFSPANRLGQGGFGPVYNGKLL----DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLTD------- 443 (676)
Q Consensus 376 ~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~----~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~------- 443 (676)
+.+....+.|...++||+|.|++||++.+. ..+.||+|.+... ....++.+|+++|..+. +.||+.
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 445556788999999999999999999743 3678999998653 34567899999999985 666552
Q ss_pred ----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC-CCCeEEeccCcceec
Q 005803 444 ----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE-QMNPKISDFGMARTY 506 (676)
Q Consensus 444 ----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~-~~~vkL~DFGla~~~ 506 (676)
..-...++..++...++.++.||.++|.+| ||||||||+|+|.+. .+.-.|.|||+|...
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred CCeeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHH
Confidence 111234667778889999999999999999 999999999999984 456799999999721
Q ss_pred cccc------c------------------------------------ccccceeeccCCccChhhhccC-CCCchhHHHH
Q 005803 507 AMNE------L------------------------------------EANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYS 543 (676)
Q Consensus 507 ~~~~------~------------------------------------~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS 543 (676)
.... . ........||++|+|||++... ..++++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 1000 0 0000125799999999999864 5789999999
Q ss_pred HHHHHHHHHhCCcCCCCCC
Q 005803 544 FGVLVLEIVSSKKNNGSYD 562 (676)
Q Consensus 544 lGvvl~elltG~~pf~~~~ 562 (676)
.|||++-+++++.||-...
T Consensus 264 ~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred ccceeehhhccccccccCc
Confidence 9999999999999987543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-22 Score=216.61 Aligned_cols=227 Identities=23% Similarity=0.367 Sum_probs=175.4
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
..++|....++|.|.+|.||+++.. .++..|||+++........-+++|+-+++..+|+||+.
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3468889999999999999999865 58899999998877777788899999999999999982
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+.+.++-+++++.+.||+|||+++ -+|||||-.|||+++.|.+|++|||.+..+... -.
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat--i~ 167 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IA 167 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--hh
Confidence 122356788888999999999999999998 899999999999999999999999998765432 22
Q ss_pred ccceeeccCCccChhhhc---cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC-cc
Q 005803 514 NTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD-PT 589 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-~~ 589 (676)
......||+.|||||+.. .+.|..++|||++|+...|+---++|.....+.+ +..+... ..++ +.
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~l~LmTk----S~~qpp~ 236 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------ALFLMTK----SGFQPPT 236 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------HHHHhhc----cCCCCCc
Confidence 234578999999999874 5679999999999999999987777754332221 1111111 1122 22
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
+.+. ..-.+.+-+++..|+..+|++||+++.+++
T Consensus 237 lkDk--~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 237 LKDK--TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccCC--ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2221 122334667778899999999999987664
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-18 Score=185.96 Aligned_cols=233 Identities=20% Similarity=0.216 Sum_probs=167.0
Q ss_pred CCCcceeeccCCCccEEEEEEcCC--cEEEEEEeccCCchhhHHHHHHHHHHHHccC----Cc---ccc-----------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLLDG--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH----TN---LTD----------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~~~--~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H----~n---iv~----------- 443 (676)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ ++ +..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999986553 4788888765433333378889999888873 11 110
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC-----CCeEEeccCcce
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ-----MNPKISDFGMAR 504 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~-----~~vkL~DFGla~ 504 (676)
......++..+.+.|+.|++.+|++||+.| ++||||||+|+++... ..+.|.|||+++
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 112367888999999999999999999999 9999999999999865 358999999998
Q ss_pred --ecccccc----c--cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHH
Q 005803 505 --TYAMNEL----E--ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQL 576 (676)
Q Consensus 505 --~~~~~~~----~--~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~ 576 (676)
.+..... . .......||..|+++....+...+.+.|+||++.++.|++.|..||...............
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~--- 252 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD--- 252 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH---
Confidence 3222211 1 1122356999999999999999999999999999999999999999655433221111100
Q ss_pred HhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 577 WNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 577 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
........ .....+. .+.++...+-..+..++|....+...|+...
T Consensus 253 ----~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 253 ----PRKLLTDR--FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred ----hhhhcccc--ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 00111111 1112223 3444444555689999999999999987765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.5e-19 Score=190.09 Aligned_cols=151 Identities=16% Similarity=0.174 Sum_probs=114.7
Q ss_pred HHHhcCCCcceeeccCCCccEEEEEEc--CCcEEEEEEeccC-----CchhhHHHHHHHHHHHHccCCcccc--------
Q 005803 379 AAATDNFSPANRLGQGGFGPVYNGKLL--DGQEIAIKRLSKS-----SGQGIVEFKNEAKLIAKLQHTNLTD-------- 443 (676)
Q Consensus 379 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~--~~~~VAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~-------- 443 (676)
....++|.+.+.||+|+||.||+|.+. +++.||||++... .......+.+|+++|++++|+|++.
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~ 93 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKD 93 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCc
Confidence 345678999999999999999999764 5777899987532 1223556899999999999999872
Q ss_pred -----ccccCcCCH---HHHHHHHHHHHHHHHHHHhcCCCceEeecc-ccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 -----SSRKSLLDW---KKRFYIIEGIVQGLLYLHKYSRLRAIHRDL-KVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 -----~~~~~~l~~---~~~~~i~~qia~gL~yLH~~~~~~iiH~DL-Kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
...+..|.. .....++.++++||.|||+++ |+|||| ||+|||++.++.+||+|||+|+.+........
T Consensus 94 ~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~ 170 (365)
T PRK09188 94 GLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYR 170 (365)
T ss_pred EEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhh
Confidence 111111211 112568899999999999998 999999 99999999999999999999997654321111
Q ss_pred ------cceeeccCCccChhhhcc
Q 005803 515 ------TNRIVGTHGYMSPEYVMN 532 (676)
Q Consensus 515 ------~~~~~gt~~Y~APE~~~~ 532 (676)
.....+++.|+|||.+..
T Consensus 171 ~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 171 IAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred hhhhhhhhhhhccCccCCcccCCh
Confidence 124578889999998864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-17 Score=172.13 Aligned_cols=233 Identities=25% Similarity=0.360 Sum_probs=170.4
Q ss_pred CCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCch---hhHHHHHHHHHHHHccCC-cccc-----------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQ---GIVEFKNEAKLIAKLQHT-NLTD----------------- 443 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~----------------- 443 (676)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667889999999999999876 88999998765332 367799999999999988 5651
Q ss_pred --------c-ccc---CcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC-CeEEeccCcceeccccc
Q 005803 444 --------S-SRK---SLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM-NPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 --------~-~~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~-~vkL~DFGla~~~~~~~ 510 (676)
. ... ..+.......++.|++.++.|+|+.+ ++|||+||+||+++... .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 0 011 25777888899999999999999998 99999999999999988 79999999998654433
Q ss_pred ccc----ccceeeccCCccChhhhcc---CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 511 LEA----NTNRIVGTHGYMSPEYVMN---GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 511 ~~~----~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
... ......|+..|+|||.+.+ ..+....|+||+|++++++++|..||...... ................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 221 2345789999999999987 57889999999999999999999996654331 0011111221111111
Q ss_pred ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 584 ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 584 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000111111112223457788889999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.1e-19 Score=199.86 Aligned_cols=230 Identities=20% Similarity=0.213 Sum_probs=161.0
Q ss_pred CcceeeccCCCccEEEEEEc-CCcEEEEEEec----c-CCchh-hHHHHHHHHHHHHccCCcccc---------------
Q 005803 386 SPANRLGQGGFGPVYNGKLL-DGQEIAIKRLS----K-SSGQG-IVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 386 ~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~----~-~~~~~-~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
.....+|.|.+|.|+..... .....+.|... . ..... ...+..|..+-..+.|+|+++
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999988877633 34444444332 1 11111 112566777788889999762
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc-
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE- 512 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~- 512 (676)
......+...++..++.|++.|+.|||+.| |.|||||++|+++..++.+||+|||.+..+......
T Consensus 401 E~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 011124566677789999999999999999 999999999999999999999999999876544333
Q ss_pred -cccceeeccCCccChhhhccCCCCc-hhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 513 -ANTNRIVGTHGYMSPEYVMNGIVSM-KSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 513 -~~~~~~~gt~~Y~APE~~~~~~~s~-ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
......+|+..|+|||.+.+..|.+ ..||||.|+++..|++|+.||......+... ........... ..-
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~---~~~ 549 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNI---FEG 549 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccccccc---ccC
Confidence 3445578999999999999988876 5699999999999999999998654443321 00000000000 000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
..........+...++.++|+.||.+|.||++|++.
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 011122344566788899999999999999999864
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.4e-18 Score=193.84 Aligned_cols=227 Identities=18% Similarity=0.210 Sum_probs=156.5
Q ss_pred CCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCC-chhh---HHHHHHHHHHHHccCCcccc----------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSS-GQGI---VEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~-~~~~---~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
+|...+.||++.|=+|.+++++.|. |+||++-+.. .-.. .+...|++ ...++|||.+.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5666789999999999999988887 9999986543 2223 33344555 66778999751
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc--ccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA--MNELE 512 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~--~~~~~ 512 (676)
...+..+...+..-|+-|++.||.-+|..| |+|||||.+||||+.=.-+.|+||..-+..- .+...
T Consensus 102 yvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 102 YVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 333445666777889999999999999998 9999999999999998899999998766421 11111
Q ss_pred cc---cceeeccCCccChhhhccC----------C-CCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHH
Q 005803 513 AN---TNRIVGTHGYMSPEYVMNG----------I-VSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLW 577 (676)
Q Consensus 513 ~~---~~~~~gt~~Y~APE~~~~~----------~-~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~ 577 (676)
.. ..+...-..|+|||.+... . .+++.||||+||++.||++ |+++|.... +.. +
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~a-----Y 247 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLA-----Y 247 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHh-----H
Confidence 10 0111122369999988541 1 5788999999999999998 678775321 110 1
Q ss_pred hcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 578 NEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 578 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+.+. .......++. +.. ..+.++++.|++.||++|.++++.++.-.+..
T Consensus 248 r~~~-~~~~e~~Le~-Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 248 RSGN-ADDPEQLLEK-IED---VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred hccC-ccCHHHHHHh-CcC---ccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 1111 0000000111 000 14668889999999999999999999877664
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=171.48 Aligned_cols=204 Identities=20% Similarity=0.262 Sum_probs=135.3
Q ss_pred CCcceeeccCCCccEEEEEEcC-CcEEEEEEeccC---CchhhHHHHHHHHHHHHccC-Cc---------c-c-----c-
Q 005803 385 FSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH-TN---------L-T-----D- 443 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H-~n---------i-v-----~- 443 (676)
+...+.||.|+++.||.+++.. ++++|||++... .....+++++|.-.+..+.+ .| + + .
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3446889999999999999765 899999987533 23345667777655555333 11 0 0 0
Q ss_pred ------------------------------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeec
Q 005803 444 ------------------------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRD 481 (676)
Q Consensus 444 ------------------------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~D 481 (676)
......+....++.+..|+++.+++||+.| ++|+|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd 170 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD 170 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence 001122334456777899999999999999 99999
Q ss_pred cccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhcc--------CCCCchhHHHHHHHHHHHHHh
Q 005803 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN--------GIVSMKSDVYSFGVLVLEIVS 553 (676)
Q Consensus 482 LKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--------~~~s~ksDVwSlGvvl~ellt 553 (676)
|||+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|+||+++|.|.+
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999887654332211 233467999997744 247899999999999999999
Q ss_pred CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCC
Q 005803 554 SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADR 617 (676)
Q Consensus 554 G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R 617 (676)
|+.||+.......... . -..+. +.++.+..|+..+|+.||.+|
T Consensus 246 ~~lPf~~~~~~~~~~~-------------------~-f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW-------------------D-FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG-------------------G-GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc-------------------c-chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999986533221110 1 12334 666778889999999999988
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.8e-17 Score=165.39 Aligned_cols=178 Identities=21% Similarity=0.344 Sum_probs=143.9
Q ss_pred cCCCcceeeccCCCccEEEEE-EcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccC-Cccc----------------c-
Q 005803 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH-TNLT----------------D- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~-~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv----------------~- 443 (676)
-+|.+.++||+|.||+++.|+ +-+++.||||.-.. .....++..|....+.|.+ +.|- +
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 368999999999999999998 55799999997543 3445677888888888853 2321 1
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC-----CeEEeccCcceecccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM-----NPKISDFGMARTYAMN 509 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~-----~vkL~DFGla~~~~~~ 509 (676)
..-+..++.++..-||.|++.-++|+|++. +|.|||||+|+||...+ .+.|+|||+|+.+...
T Consensus 106 LGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 106 LGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 122345777888999999999999999999 99999999999997543 4899999999987654
Q ss_pred ccc-----cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCC
Q 005803 510 ELE-----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTER 565 (676)
Q Consensus 510 ~~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~ 565 (676)
... .......||..||+--...+...+.+-|+=|||-+++..|-|..||.......
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 332 22344679999999999999999999999999999999999999998765443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=161.64 Aligned_cols=233 Identities=19% Similarity=0.248 Sum_probs=162.1
Q ss_pred hcCCCcceeeccCCCccEEEEE-EcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccC----Cccc-------------c
Q 005803 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH----TNLT-------------D 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~-~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv-------------~ 443 (676)
.+.|.++++||.|+||.+|.|. ..+|.+||||.-+. .....++..|.++...|+| |.|- +
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4689999999999999999997 45799999998543 3344577889999988875 2222 1
Q ss_pred c----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC---CCeEEeccCcceeccccc
Q 005803 444 S----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ---MNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 ~----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~---~~vkL~DFGla~~~~~~~ 510 (676)
. .-...++.++.+-++.|++.-++|+|.++ +|||||||+|+|+.-+ ..+.|+|||+|+.+....
T Consensus 92 LLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 92 LLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred ccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 1 11234667788889999999999999999 9999999999999633 458999999998764322
Q ss_pred cc-----cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcccc
Q 005803 511 LE-----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALEL 585 (676)
Q Consensus 511 ~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (676)
.. .......||..|.+--...+...+.+.|+=|+|.+|....-|..||........... .+.+.+.+..-.
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK----yEkI~EkK~s~~ 244 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK----YEKISEKKMSTP 244 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH----HHHHHHhhcCCC
Confidence 11 122346799999998888777788999999999999999999999987654332222 122222222111
Q ss_pred CCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 586 MDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 586 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
+ ..+-..+|. ++.-.+.-|-..--++-|.-.-+.+.+.
T Consensus 245 i-e~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 245 I-EVLCKGFPA----EFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred H-HHHhCCCcH----HHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 1 111122232 2344444566666677776655555443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.9e-18 Score=167.92 Aligned_cols=217 Identities=17% Similarity=0.253 Sum_probs=160.0
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc----------------------
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD---------------------- 443 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~---------------------- 443 (676)
..+|.+...|..|+|++. |..+++|++... .....+.|..|...|+.+.||||..
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 567899999999999984 556666776532 3334467999999999999999862
Q ss_pred ------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEe--ccCcceecccccccccc
Q 005803 444 ------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKIS--DFGMARTYAMNELEANT 515 (676)
Q Consensus 444 ------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~--DFGla~~~~~~~~~~~~ 515 (676)
....-..+..+..+++.+|++|++|||+..+. |.---|....+++|++..++|+ |--++.. .
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfsfq---------e 343 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFSFQ---------E 343 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceeeee---------c
Confidence 12223456677889999999999999998632 4444688999999999988874 3222111 1
Q ss_pred ceeeccCCccChhhhccCCC---CchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIV---SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~---s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
....-.+.||+||.++..+- -.++|+|||.+++|||.|...||....+.+..-.+ .-..++.
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---------------aleglrv 408 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---------------ALEGLRV 408 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh---------------hhccccc
Confidence 11234678999999987654 35789999999999999999999876554422111 1123334
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.+++.....+.+|+.-|+.+||.+||.+..|+-.||+.
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 45566666788999999999999999999999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.7e-17 Score=177.99 Aligned_cols=145 Identities=26% Similarity=0.345 Sum_probs=102.5
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc----cccccceeeccCCccChhh
Q 005803 454 KRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE----LEANTNRIVGTHGYMSPEY 529 (676)
Q Consensus 454 ~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~~~~~gt~~Y~APE~ 529 (676)
..+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+........ .....+...||..||+||.
T Consensus 360 ~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQ 433 (516)
T KOG1033|consen 360 LMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQ 433 (516)
T ss_pred HHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHH
Confidence 346678889999999 66 9999999999999999999999999987655433 2233445789999999999
Q ss_pred hccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHH
Q 005803 530 VMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLL 608 (676)
Q Consensus 530 ~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~ 608 (676)
+.+..|+.|+||||||++|+|++. -...+... .+...+..+.+ ++....+.+. -..++++
T Consensus 434 i~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~t~~d~r~g~i----p~~~~~d~p~-----e~~ll~~ 494 (516)
T KOG1033|consen 434 IRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------ATLTDIRDGII----PPEFLQDYPE-----EYTLLQQ 494 (516)
T ss_pred HhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------HhhhhhhcCCC----ChHHhhcCcH-----HHHHHHH
Confidence 999999999999999999999997 22222110 01111111111 1111122222 2457778
Q ss_pred hcccCcCCCCCHHHH
Q 005803 609 CVQDRAADRRTMSDV 623 (676)
Q Consensus 609 Cl~~dP~~RPs~~eV 623 (676)
++...|.+||++.++
T Consensus 495 lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 495 LLSPSPEERPSAIEV 509 (516)
T ss_pred hcCCCcccCchHHHH
Confidence 999999999954443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.3e-16 Score=155.31 Aligned_cols=115 Identities=19% Similarity=0.174 Sum_probs=90.2
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEeccCCch--h-------hHH-----------------HHHHHHHHHHccCCcc
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQ--G-------IVE-----------------FKNEAKLIAKLQHTNL 441 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~ni 441 (676)
...||+|+||.||+|...+|+.||||+++..... . ... ...|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999999754211 0 111 2359999999976553
Q ss_pred cc------------------------ccccCcCCHHHHHHHHHHHHHHHHHH-HhcCCCceEeeccccCceEEcCCCCeE
Q 005803 442 TD------------------------SSRKSLLDWKKRFYIIEGIVQGLLYL-HKYSRLRAIHRDLKVSNILLDEQMNPK 496 (676)
Q Consensus 442 v~------------------------~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~iiH~DLKp~NILl~~~~~vk 496 (676)
.. ......++..+...++.|++.+|.+| |+.+ |+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcEE
Confidence 20 01234567778899999999999999 6887 99999999999998 47899
Q ss_pred EeccCcceec
Q 005803 497 ISDFGMARTY 506 (676)
Q Consensus 497 L~DFGla~~~ 506 (676)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=2e-16 Score=158.51 Aligned_cols=153 Identities=12% Similarity=0.072 Sum_probs=112.5
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhH---H------HHHHHHHHHHccCCcccccccc----
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIV---E------FKNEAKLIAKLQHTNLTDSSRK---- 447 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~---~------~~~E~~~l~~l~H~niv~~~~~---- 447 (676)
..++|.+.+.||.|+||.||++.. ++..+|||.+......... . +.+|+..+.++.|++|......
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 578999999999999999999765 5778999999754322222 2 6789999999999997621100
Q ss_pred ------------------CcCCHHHH----HHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 448 ------------------SLLDWKKR----FYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 448 ------------------~~l~~~~~----~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
...+..+. .....+++.+|..||..+ ++|||+||+||+++.++ ++|+|||....
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~ 183 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRC 183 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCccc
Confidence 00011111 235679999999999998 99999999999999988 99999998865
Q ss_pred ccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHH
Q 005803 506 YAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIV 552 (676)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ell 552 (676)
...... ...+.....|..++|+||||+.+....
T Consensus 184 ~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 184 TAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 422111 111344556778999999999987665
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-16 Score=182.06 Aligned_cols=206 Identities=20% Similarity=0.288 Sum_probs=141.1
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccccccCcCCHHHHHH--
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFY-- 457 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~l~~~~~~~-- 457 (676)
...+|..++.|..|++|.||.++++. .+.+|+|+ ++... -+++ ++.....|.+|.. ....++
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----ilRn---ilt~a~npfvvgD-------c~tllk~~ 145 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----ILRN---ILTFAGNPFVVGD-------CATLLKNI 145 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----hhhc---cccccCCcceech-------hhhhcccC
Confidence 45688899999999999999998764 77889843 33211 1111 4444455555410 011111
Q ss_pred --HHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc-------------ccccccceeeccC
Q 005803 458 --IIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN-------------ELEANTNRIVGTH 522 (676)
Q Consensus 458 --i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~-------------~~~~~~~~~~gt~ 522 (676)
.-.+++.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+.+..-.. .........+||+
T Consensus 146 g~lPvdmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTP 222 (1205)
T KOG0606|consen 146 GPLPVDMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTP 222 (1205)
T ss_pred CCCcchhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCc
Confidence 0112378999999998 999999999999999999999999998743211 0111223468999
Q ss_pred CccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHH
Q 005803 523 GYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRC 602 (676)
Q Consensus 523 ~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 602 (676)
.|+|||++....|+..+|.|++|+|+||.+.|..||....+++....+......| .+- +.....++
T Consensus 223 eyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w-----pE~---------dea~p~Ea 288 (1205)
T KOG0606|consen 223 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW-----PEE---------DEALPPEA 288 (1205)
T ss_pred cccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc-----ccc---------CcCCCHHH
Confidence 9999999999999999999999999999999999998765554322111111111 111 11122245
Q ss_pred HHHHHHhcccCcCCCC
Q 005803 603 IHVGLLCVQDRAADRR 618 (676)
Q Consensus 603 ~~L~~~Cl~~dP~~RP 618 (676)
..++...|+.+|.+|-
T Consensus 289 ~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 289 QDLIEQLLRQNPLCRL 304 (1205)
T ss_pred HHHHHHHHHhChHhhc
Confidence 6677788999999995
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.8e-16 Score=150.85 Aligned_cols=116 Identities=22% Similarity=0.254 Sum_probs=92.7
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEeccCCch---------------------h-----hHHHHHHHHHHHHccCCcc
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQ---------------------G-----IVEFKNEAKLIAKLQHTNL 441 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~ni 441 (676)
...||+|+||.||+|+..+|+.||||+++..... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5789999999999999878999999998754211 0 1123578999999988875
Q ss_pred c--------------cc----------cccCcCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeeccccCceEEcCCCCeE
Q 005803 442 T--------------DS----------SRKSLLDWKKRFYIIEGIVQGLLYLHK-YSRLRAIHRDLKVSNILLDEQMNPK 496 (676)
Q Consensus 442 v--------------~~----------~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLKp~NILl~~~~~vk 496 (676)
. +. .....++......++.|++.+|.+||+ .+ |+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEE
Confidence 2 00 112235566788999999999999999 88 99999999999999 78999
Q ss_pred EeccCcceecc
Q 005803 497 ISDFGMARTYA 507 (676)
Q Consensus 497 L~DFGla~~~~ 507 (676)
|+|||++....
T Consensus 158 liDFG~a~~~~ 168 (190)
T cd05145 158 IIDVSQAVELD 168 (190)
T ss_pred EEEcccceecC
Confidence 99999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-15 Score=156.03 Aligned_cols=160 Identities=21% Similarity=0.243 Sum_probs=108.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc--CCCC--eEEeccCcceeccccccc----cccceeecc
Q 005803 450 LDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD--EQMN--PKISDFGMARTYAMNELE----ANTNRIVGT 521 (676)
Q Consensus 450 l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~--~~~~--vkL~DFGla~~~~~~~~~----~~~~~~~gt 521 (676)
.+...+.-|+.|+++|+.|||.+| |.|||+|.+|||+. +++. +.|+|||++--....... ...-...|.
T Consensus 338 ~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGN 414 (598)
T KOG4158|consen 338 RSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGN 414 (598)
T ss_pred CchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCc
Confidence 344455668899999999999999 99999999999994 4443 688999998543321111 111124567
Q ss_pred CCccChhhhccCC------CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCC
Q 005803 522 HGYMSPEYVMNGI------VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCS 595 (676)
Q Consensus 522 ~~Y~APE~~~~~~------~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 595 (676)
..-||||+....+ --.|+|.|+.|.+.||++....||-...+.. .+. ....+.--|.+...++
T Consensus 415 a~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~----------r~Yqe~qLPalp~~vp 483 (598)
T KOG4158|consen 415 AKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDT----------RTYQESQLPALPSRVP 483 (598)
T ss_pred ceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-ech----------hhhhhhhCCCCcccCC
Confidence 7889999886432 1258999999999999999999986522211 111 1112222233444444
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 005803 596 SDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627 (676)
Q Consensus 596 ~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~L 627 (676)
+ .+.+++...|+.||++|++..-....|
T Consensus 484 p----~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 484 P----VARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred h----HHHHHHHHHhcCCccccCCccHHHhHH
Confidence 4 366778889999999999876555544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.9e-16 Score=171.61 Aligned_cols=207 Identities=22% Similarity=0.283 Sum_probs=147.7
Q ss_pred eeccCCCccEEEEE----EcCCcEEEEEEeccCCchh--hHHHHHHHHHHHHcc-CCcccc-------------------
Q 005803 390 RLGQGGFGPVYNGK----LLDGQEIAIKRLSKSSGQG--IVEFKNEAKLIAKLQ-HTNLTD------------------- 443 (676)
Q Consensus 390 ~LG~G~fG~Vy~~~----~~~~~~VAvK~l~~~~~~~--~~~~~~E~~~l~~l~-H~niv~------------------- 443 (676)
.+|+|.||.|++++ .+.++.+|.|.+++..... ......|..++...+ ||.++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999875 2347778999886542211 124566888888887 887762
Q ss_pred -------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccc
Q 005803 444 -------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516 (676)
Q Consensus 444 -------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 516 (676)
......+++.........++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+++.......
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----- 152 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh-----
Confidence 122233444444556667899999999998 99999999999999999999999999986543322
Q ss_pred eeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCCh
Q 005803 517 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSS 596 (676)
Q Consensus 517 ~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 596 (676)
.+||..|||||++. ....++|.||||++.+||++|..||.. +. ..... .. ....+.
T Consensus 153 -~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~------~~~Il---------~~--~~~~p~ 208 (612)
T KOG0603|consen 153 -ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DT------MKRIL---------KA--ELEMPR 208 (612)
T ss_pred -cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HH------HHHHh---------hh--ccCCch
Confidence 28999999999998 567889999999999999999999975 10 11111 10 112234
Q ss_pred HHHHHHHHHHHHhcccCcCCCCCH--HHHHHHHh
Q 005803 597 DEVMRCIHVGLLCVQDRAADRRTM--SDVVSMLT 628 (676)
Q Consensus 597 ~~~~~l~~L~~~Cl~~dP~~RPs~--~eVl~~Le 628 (676)
+....+..++..++..+|..|--. ..+.+.++
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 444455666777888888888755 44555444
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.6e-14 Score=141.95 Aligned_cols=171 Identities=16% Similarity=0.111 Sum_probs=120.8
Q ss_pred CcceeeccCCCccEEEEEEcCCcEEEEEEeccCCch----hhHHHHHHHHHHHHccC-Cccccc------------cccC
Q 005803 386 SPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQ----GIVEFKNEAKLIAKLQH-TNLTDS------------SRKS 448 (676)
Q Consensus 386 ~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~----~~~~~~~E~~~l~~l~H-~niv~~------------~~~~ 448 (676)
.+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|++|+| +++... ..+.
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~ 83 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGA 83 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCc
Confidence 3467899999999998765 6788888887654221 12257899999999954 433311 1111
Q ss_pred cCCH---HHHHHHHHHHHHHHHHHHhcCCCceEeecc-ccCceEEcCCCCeEEeccCcceeccccccc----c-------
Q 005803 449 LLDW---KKRFYIIEGIVQGLLYLHKYSRLRAIHRDL-KVSNILLDEQMNPKISDFGMARTYAMNELE----A------- 513 (676)
Q Consensus 449 ~l~~---~~~~~i~~qia~gL~yLH~~~~~~iiH~DL-Kp~NILl~~~~~vkL~DFGla~~~~~~~~~----~------- 513 (676)
.+.. .....++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||+|......... .
T Consensus 84 ~L~~~~~~~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~l 160 (218)
T PRK12274 84 AMYQRPPRGDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHL 160 (218)
T ss_pred cHHhhhhhhhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHH
Confidence 1211 122457889999999999998 999999 799999999999999999999865433210 0
Q ss_pred ccceeeccCCccChhhhccC-CCC-chhHHHHHHHHHHHHHhCCcCCCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNG-IVS-MKSDVYSFGVLVLEIVSSKKNNGS 560 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~-~~s-~ksDVwSlGvvl~elltG~~pf~~ 560 (676)
.......++.|++|+...-. ..+ ...+.++-|+-+|.++|++.+.-.
T Consensus 161 lk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 161 LKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 00112357788888855422 233 567899999999999999887543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-14 Score=168.08 Aligned_cols=174 Identities=18% Similarity=0.273 Sum_probs=130.9
Q ss_pred HHHHhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCc-------hhhHHHHHHHHHHHHccC---------Cc-
Q 005803 378 IAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSG-------QGIVEFKNEAKLIAKLQH---------TN- 440 (676)
Q Consensus 378 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~-------~~~~~~~~E~~~l~~l~H---------~n- 440 (676)
+..-.+.|.|.+.||+|+||.||+|...+|+.||+|+-+.... +-..++. ..++..+-| -.
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk--~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLK--PQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhc--hhhhcchHHHHHHHccCCcce
Confidence 3345678999999999999999999988899999998654321 1111222 111111111 01
Q ss_pred cc----------c-ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc-------CCCCeEEeccCc
Q 005803 441 LT----------D-SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD-------EQMNPKISDFGM 502 (676)
Q Consensus 441 iv----------~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~-------~~~~vkL~DFGl 502 (676)
++ + ....+.++|...+.++.|++.-+++||..+ |||+||||+|.||. ++..++|+|||.
T Consensus 771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 11 1 234567889999999999999999999999 99999999999994 234589999999
Q ss_pred ceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCc
Q 005803 503 ARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKK 556 (676)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~ 556 (676)
+--+..-.........++|-.+-.+|+..+.+++..+|.|.|..+++-||.|+.
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 975543322334455778889999999999999999999999999999999975
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.1e-14 Score=157.10 Aligned_cols=176 Identities=20% Similarity=0.292 Sum_probs=125.9
Q ss_pred cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccC
Q 005803 447 KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMS 526 (676)
Q Consensus 447 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~A 526 (676)
...+++.-...++++|+.||.|||... -..|+.|++.|+++|....+||+|||+.................-...|.|
T Consensus 42 ~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~a 119 (484)
T KOG1023|consen 42 DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTA 119 (484)
T ss_pred ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccC
Confidence 345788888899999999999999875 129999999999999999999999999876542111111111223456999
Q ss_pred hhhhccCC-------CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCcc-chHHHHHHHHhcCCccccCCcccCCCCChHH
Q 005803 527 PEYVMNGI-------VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPL-NLVGYAWQLWNEGKALELMDPTLDESCSSDE 598 (676)
Q Consensus 527 PE~~~~~~-------~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 598 (676)
||.+.... .+.+.||||||++++|+++.+.||+........ .++. . ... .....+.|.+.... +.
T Consensus 120 Pellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~---~-~~~-~~~~~~rP~i~~~~--e~ 192 (484)
T KOG1023|consen 120 PELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIIL---R-VKK-GGSNPFRPSIELLN--EL 192 (484)
T ss_pred HHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHH---H-HHh-cCCCCcCcchhhhh--hc
Confidence 99987631 467799999999999999999999875433322 1222 1 111 12222333332111 33
Q ss_pred HHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 599 VMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 599 ~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
...++.++..||..+|.+||++++|-..++...
T Consensus 193 ~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 193 PPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred chHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 336888999999999999999999999988775
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-13 Score=136.89 Aligned_cols=130 Identities=19% Similarity=0.179 Sum_probs=97.8
Q ss_pred HHHHHHHhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCch----------------------hhHHHHHHHHH
Q 005803 375 FQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQ----------------------GIVEFKNEAKL 432 (676)
Q Consensus 375 ~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~----------------------~~~~~~~E~~~ 432 (676)
++++......|.+.+.||+|+||.||++...+|+.||||++...... ....+..|..+
T Consensus 7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 86 (198)
T cd05144 7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA 86 (198)
T ss_pred HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence 34565555568889999999999999999888999999987542200 11235778899
Q ss_pred HHHccCCccc--------------cccccCc---CCH-HHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC
Q 005803 433 IAKLQHTNLT--------------DSSRKSL---LDW-KKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN 494 (676)
Q Consensus 433 l~~l~H~niv--------------~~~~~~~---l~~-~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~ 494 (676)
+.++.|+++. +...+.. +.. .....++.+++.++.++|+.+ |+|+||||+||++++++.
T Consensus 87 l~~l~~~~i~v~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 87 LKALYEEGFPVPKPIDWNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEK 163 (198)
T ss_pred HHHHHHcCCCCCceeecCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCc
Confidence 9999887531 0011111 111 345678899999999999988 999999999999999999
Q ss_pred eEEeccCcceecc
Q 005803 495 PKISDFGMARTYA 507 (676)
Q Consensus 495 vkL~DFGla~~~~ 507 (676)
++|+|||++....
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.3e-13 Score=140.49 Aligned_cols=121 Identities=17% Similarity=0.154 Sum_probs=92.7
Q ss_pred cCCCcceeeccCCCccEEEEE--EcCCcEEEEEEeccCCch------------------------hhHHHHHHHHHHHHc
Q 005803 383 DNFSPANRLGQGGFGPVYNGK--LLDGQEIAIKRLSKSSGQ------------------------GIVEFKNEAKLIAKL 436 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~--~~~~~~VAvK~l~~~~~~------------------------~~~~~~~E~~~l~~l 436 (676)
..|.+.+.||+|+||.||+|. ..+|+.||||++...... ....+..|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358889999999999999998 567999999998653210 012356899999999
Q ss_pred cCCccc--------------c----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC
Q 005803 437 QHTNLT--------------D----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ 492 (676)
Q Consensus 437 ~H~niv--------------~----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~ 492 (676)
.+..+. + ......+...+...++.||+.+|.+||+.+ .|+||||||+||+++ +
T Consensus 108 ~~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~-~ 184 (237)
T smart00090 108 YEAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH-D 184 (237)
T ss_pred HhcCCCCCeeeEecCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE-C
Confidence 764321 0 011223344456789999999999999886 499999999999999 8
Q ss_pred CCeEEeccCcceec
Q 005803 493 MNPKISDFGMARTY 506 (676)
Q Consensus 493 ~~vkL~DFGla~~~ 506 (676)
+.++|+|||.+...
T Consensus 185 ~~i~LiDFg~a~~~ 198 (237)
T smart00090 185 GKVVIIDVSQSVEL 198 (237)
T ss_pred CCEEEEEChhhhcc
Confidence 89999999998753
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.7e-13 Score=132.80 Aligned_cols=111 Identities=23% Similarity=0.261 Sum_probs=80.3
Q ss_pred CcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHc-----cCCcccccc---------------
Q 005803 386 SPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-----QHTNLTDSS--------------- 445 (676)
Q Consensus 386 ~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~~~--------------- 445 (676)
.-.+.||+|+||.||. ...++.. +||++........+.+.+|+.+++++ .||||++..
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3467899999999996 3223444 79988765445567899999999999 579987310
Q ss_pred --c--c------------CcCCHHHHHHHHHHHHHHH-HHHHhcCCCceEeeccccCceEEcC----CCCeEEeccCcc
Q 005803 446 --R--K------------SLLDWKKRFYIIEGIVQGL-LYLHKYSRLRAIHRDLKVSNILLDE----QMNPKISDFGMA 503 (676)
Q Consensus 446 --~--~------------~~l~~~~~~~i~~qia~gL-~yLH~~~~~~iiH~DLKp~NILl~~----~~~vkL~DFGla 503 (676)
. + ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||+.+
T Consensus 83 I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 0 0 011222 34567788777 9999998 999999999999974 347999995444
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.3e-12 Score=126.06 Aligned_cols=115 Identities=20% Similarity=0.191 Sum_probs=83.4
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEeccCCch--hhHH----------------------HHHHHHHHHHccCCcc--
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQ--GIVE----------------------FKNEAKLIAKLQHTNL-- 441 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~H~ni-- 441 (676)
.+.||+|+||.||+|...+++.||||++...... .... ...|...+.++.+..+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5689999999999999878999999998653211 1111 1356666666654421
Q ss_pred -----------c-ccccc-----CcCC---H-HHHHHHHHHHHHHHHHHHh-cCCCceEeeccccCceEEcCCCCeEEec
Q 005803 442 -----------T-DSSRK-----SLLD---W-KKRFYIIEGIVQGLLYLHK-YSRLRAIHRDLKVSNILLDEQMNPKISD 499 (676)
Q Consensus 442 -----------v-~~~~~-----~~l~---~-~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLKp~NILl~~~~~vkL~D 499 (676)
+ +...+ ..+. . .+...++.+++.++.++|. .+ |+|+||||+||+++ ++.++|+|
T Consensus 82 ~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liD 157 (187)
T cd05119 82 PKPIDLNRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIID 157 (187)
T ss_pred CceEecCCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEE
Confidence 1 11111 1111 1 5567899999999999999 77 99999999999999 88999999
Q ss_pred cCcceec
Q 005803 500 FGMARTY 506 (676)
Q Consensus 500 FGla~~~ 506 (676)
||.+...
T Consensus 158 fg~a~~~ 164 (187)
T cd05119 158 VPQAVEI 164 (187)
T ss_pred Ccccccc
Confidence 9999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.4e-12 Score=126.21 Aligned_cols=111 Identities=23% Similarity=0.259 Sum_probs=84.1
Q ss_pred eeccCCCccEEEEEEcCCcEEEEEEeccCCc--------hhhHHHHHHHHHHHHccCCcccc----------------cc
Q 005803 390 RLGQGGFGPVYNGKLLDGQEIAIKRLSKSSG--------QGIVEFKNEAKLIAKLQHTNLTD----------------SS 445 (676)
Q Consensus 390 ~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~----------------~~ 445 (676)
.||+|+||.||+|.. ++..|++|....... ....++.+|++++..+.|+++.. ..
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 678899998643211 11356778999999999877531 11
Q ss_pred ccCcCCHHHHH---HHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 446 RKSLLDWKKRF---YIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 446 ~~~~l~~~~~~---~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
.+..+...... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGNDELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 11122111111 78999999999999998 99999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.6e-12 Score=126.38 Aligned_cols=112 Identities=21% Similarity=0.234 Sum_probs=86.3
Q ss_pred eeeccCCCccEEEEEEcCCcEEEEEEeccCCch--------hhHHHHHHHHHHHHccCCcccc----------------c
Q 005803 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQ--------GIVEFKNEAKLIAKLQHTNLTD----------------S 444 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~----------------~ 444 (676)
+.||+|++|.||+|.. .+..|+||+....... ....+.+|+.++..+.|+++.. .
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999986532211 1245788999999999887641 0
Q ss_pred cccCcCCH------HHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 445 SRKSLLDW------KKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 445 ~~~~~l~~------~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
..+..+.. ..+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNGMEELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 11111110 145689999999999999998 99999999999999 78899999999864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.32 E-value=3e-12 Score=146.10 Aligned_cols=120 Identities=19% Similarity=0.277 Sum_probs=88.2
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcCCcEEEEEE-eccCC-------chhhHHHHHHHHHHHHccCCccccc--------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKR-LSKSS-------GQGIVEFKNEAKLIAKLQHTNLTDS-------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~-l~~~~-------~~~~~~~~~E~~~l~~l~H~niv~~-------- 444 (676)
....|...++||+|+||.||+|...... +++|+ +.+.. ....+++.+|++++.+++|+++...
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 3455667899999999999999875443 33333 22211 1123568899999999999987521
Q ss_pred --------cccCcCCH--HHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 445 --------SRKSLLDW--KKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 445 --------~~~~~l~~--~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
..+..+.. .....++.+++++|.+||+.+ ++||||||+|||+ .++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 11112221 135678999999999999998 9999999999999 677999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.9e-13 Score=153.49 Aligned_cols=229 Identities=21% Similarity=0.263 Sum_probs=162.0
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC--CcEEEEEEeccCC--chhhHHHHHHHHHHHHcc-CCcccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD--GQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQ-HTNLTD------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~--~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~------------- 443 (676)
...|.+.+.||+|.|+.|-...... ...+|+|.+.... .........|..+-..+. |.|++.
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3457778889999999998886533 4556777775442 333445556888877887 999872
Q ss_pred -------------c-cccC-cCCHHHHHHHHHHHHHHHHHHH-hcCCCceEeeccccCceEEcCCC-CeEEeccCcceec
Q 005803 444 -------------S-SRKS-LLDWKKRFYIIEGIVQGLLYLH-KYSRLRAIHRDLKVSNILLDEQM-NPKISDFGMARTY 506 (676)
Q Consensus 444 -------------~-~~~~-~l~~~~~~~i~~qia~gL~yLH-~~~~~~iiH~DLKp~NILl~~~~-~vkL~DFGla~~~ 506 (676)
. .... ..+....-..+.|+..++.|+| ..+ +.|+||||+|.+++..+ ..|++|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 1 1111 3444556678899999999999 887 99999999999999999 9999999999987
Q ss_pred cc-cccccccceeec-cCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 507 AM-NELEANTNRIVG-THGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 507 ~~-~~~~~~~~~~~g-t~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........... .+.+...
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~------~~~~~~~- 248 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS------SWKSNKG- 248 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce------eeccccc-
Confidence 66 444555555778 9999999999884 456788999999999999999999986554432110 0111110
Q ss_pred ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 584 ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 584 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
..... ..........++..+++..+|..|.+.+++..
T Consensus 249 -~~~~~----~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 -RFTQL----PWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -ccccC----ccccCChhhhhcccccccCCchhccccccccc
Confidence 00000 11112223556667788899999999888754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.4e-10 Score=107.75 Aligned_cols=116 Identities=22% Similarity=0.171 Sum_probs=91.1
Q ss_pred cceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCC--cccc----------------ccccC
Q 005803 387 PANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT--NLTD----------------SSRKS 448 (676)
Q Consensus 387 ~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~----------------~~~~~ 448 (676)
+.+.||+|.++.||+++..+ ..++||....... ...+.+|+.++..++|. ++.+ ...+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 46789999999999999754 7899999865432 56788999999999774 3321 11111
Q ss_pred cC---CHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 449 LL---DWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 449 ~l---~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
.+ +......++.+++++|++||.....+++|+|++|+||+++..+.++++|||.+..
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 12 3466778899999999999986545699999999999999988999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.2e-10 Score=116.88 Aligned_cols=113 Identities=22% Similarity=0.225 Sum_probs=83.8
Q ss_pred ceeec-cCCCccEEEEEEcCCcEEEEEEeccCC-------------chhhHHHHHHHHHHHHccCCccc--c---c----
Q 005803 388 ANRLG-QGGFGPVYNGKLLDGQEIAIKRLSKSS-------------GQGIVEFKNEAKLIAKLQHTNLT--D---S---- 444 (676)
Q Consensus 388 ~~~LG-~G~fG~Vy~~~~~~~~~VAvK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~niv--~---~---- 444 (676)
...|| .||.|+||.+... +..++||++.... ......+.+|+.++.++.|+++. . .
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999874 7789999875311 12335678899999999988752 0 0
Q ss_pred -------------cccCcCCHHH-------HHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcce
Q 005803 445 -------------SRKSLLDWKK-------RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR 504 (676)
Q Consensus 445 -------------~~~~~l~~~~-------~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~ 504 (676)
..+ ..+... ....+.+|+.+|.+||+.| |+|+||||+|||++.++.++|+|||.+.
T Consensus 115 ~~~~~~~~lV~e~l~G-~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 115 HGLFYRADILIERIEG-ARDLVALLQEAPLSEEQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred cCcceeeeEEEEecCC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 000 011111 1234678999999999999 9999999999999998899999999886
Q ss_pred e
Q 005803 505 T 505 (676)
Q Consensus 505 ~ 505 (676)
.
T Consensus 191 ~ 191 (239)
T PRK01723 191 L 191 (239)
T ss_pred c
Confidence 4
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.92 E-value=4.5e-09 Score=116.54 Aligned_cols=117 Identities=21% Similarity=0.278 Sum_probs=80.9
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhh----------------------------------------HHHH
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGI----------------------------------------VEFK 427 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~----------------------------------------~~~~ 427 (676)
.+.||.|++|.||+|++.+|+.||||+.+....... -.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999865321110 0244
Q ss_pred HHHHHHHHcc-----CCccc----------------cccccCcCC-HH-------HHHHHHHHHHH-HHHHHHhcCCCce
Q 005803 428 NEAKLIAKLQ-----HTNLT----------------DSSRKSLLD-WK-------KRFYIIEGIVQ-GLLYLHKYSRLRA 477 (676)
Q Consensus 428 ~E~~~l~~l~-----H~niv----------------~~~~~~~l~-~~-------~~~~i~~qia~-gL~yLH~~~~~~i 477 (676)
+|+..+.++. ++++. +...+..+. .. .+..++..++. .+..+|..| +
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g---~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDG---F 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCC---c
Confidence 5555555553 23321 111111121 11 23457777766 478889888 9
Q ss_pred EeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 478 IHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 478 iH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
+|+|++|.||+++.++.++|+|||++..+.
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.1e-09 Score=118.27 Aligned_cols=222 Identities=19% Similarity=0.273 Sum_probs=147.7
Q ss_pred CCCcceeecc--CCCccEEEEEE---cCCcEEEEEEeccC--CchhhHHHHHHHHHHHHc-cCCcccc------------
Q 005803 384 NFSPANRLGQ--GGFGPVYNGKL---LDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKL-QHTNLTD------------ 443 (676)
Q Consensus 384 ~y~~~~~LG~--G~fG~Vy~~~~---~~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~------------ 443 (676)
.|.+.+.+|. |.+|.||.+.. .++..+|+|+-+.. .......=.+|+....++ .|+|.+.
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556788999 99999999986 35788999984322 122222334555555555 3667652
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHH----HHHHHHhcCCCceEeeccccCceEEcCC-CCeEEeccCcce
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQ----GLLYLHKYSRLRAIHRDLKVSNILLDEQ-MNPKISDFGMAR 504 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~----gL~yLH~~~~~~iiH~DLKp~NILl~~~-~~vkL~DFGla~ 504 (676)
......++....+....+... ||.++|+.. ++|-|+||.||++..+ ...+++|||+..
T Consensus 195 iqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 195 IQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeE
Confidence 111223555566777777777 999999988 9999999999999998 889999999998
Q ss_pred eccccccccc---cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC
Q 005803 505 TYAMNELEAN---TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK 581 (676)
Q Consensus 505 ~~~~~~~~~~---~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 581 (676)
.+........ .....|...|++||.. ++.++.+.|+|++|.++.+..++........... |.....+.
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~~~r~~~ 342 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WSQLRQGY 342 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC--------cccccccc
Confidence 8766543222 1223577789999966 4577899999999999999999887654331111 11111111
Q ss_pred ccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 582 ALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 582 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
+..++...-..++...+..+++.+|-.|++.+.+..
T Consensus 343 --------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 343 --------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111111111112333667789999999998877654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.87 E-value=7.5e-09 Score=99.25 Aligned_cols=115 Identities=20% Similarity=0.120 Sum_probs=83.6
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc---------------ccccCcCCH
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD---------------SSRKSLLDW 452 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~---------------~~~~~~l~~ 452 (676)
.+.|+.|.++.||+++.. ++.|++|....... ....+.+|+.++..+.+.+++. ...+..+..
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLT 80 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccc
Confidence 467899999999999864 77899999755322 2335688999999987655431 111112221
Q ss_pred --HHHHHHHHHHHHHHHHHHhcC--CCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 453 --KKRFYIIEGIVQGLLYLHKYS--RLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 453 --~~~~~i~~qia~gL~yLH~~~--~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
.....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 81 ~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 EDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 122356789999999999986 23469999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.7e-07 Score=99.03 Aligned_cols=179 Identities=13% Similarity=0.094 Sum_probs=117.6
Q ss_pred ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCcc
Q 005803 446 RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYM 525 (676)
Q Consensus 446 ~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~ 525 (676)
.....+|.-.+++++.++.+.+.||..| .+-+|+.++|+|+.+++.+.|.|=..-..... .......+|...|.
T Consensus 110 s~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n---g~~~~cpVg~~eft 183 (637)
T COG4248 110 SYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN---GTLHLCPVGVSEFT 183 (637)
T ss_pred cCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeeccC---CceEecccCccccC
Confidence 3456788999999999999999999999 89999999999999999999988544332211 11223357889999
Q ss_pred Chhhhc-----cCCCCchhHHHHHHHHHHHHHhC-CcCCCCCCCCCcc-chHHHHHHHHhcCCccccCCccc-----CCC
Q 005803 526 SPEYVM-----NGIVSMKSDVYSFGVLVLEIVSS-KKNNGSYDTERPL-NLVGYAWQLWNEGKALELMDPTL-----DES 593 (676)
Q Consensus 526 APE~~~-----~~~~s~ksDVwSlGvvl~elltG-~~pf~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l-----~~~ 593 (676)
+||... +-.-+...|.|.||+++++++.| ++||......... .-.+ ..+..+.+...-+... ...
T Consensus 184 PPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia~g~f~ya~~~~~g~~p~P~~ 260 (637)
T COG4248 184 PPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIAHGRFAYASDQRRGLKPPPRS 260 (637)
T ss_pred CHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhhcceeeechhccCCCCCCCCC
Confidence 999664 22346788999999999999987 9999864322110 0000 0111122211111111 111
Q ss_pred CChHH-HHHHHHHHHHhcccC--cCCCCCHHHHHHHHhcCcCC
Q 005803 594 CSSDE-VMRCIHVGLLCVQDR--AADRRTMSDVVSMLTNDTMA 633 (676)
Q Consensus 594 ~~~~~-~~~l~~L~~~Cl~~d--P~~RPs~~eVl~~Le~~~~~ 633 (676)
++.+. ...+..+..+|+..- +.-|||++..+..|..+..+
T Consensus 261 ~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 261 IPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred CChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 22221 224556667788543 56899999999888766433
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.1e-08 Score=101.27 Aligned_cols=106 Identities=24% Similarity=0.249 Sum_probs=77.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcce--eccccccccccceeeccCCccCh
Q 005803 450 LDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR--TYAMNELEANTNRIVGTHGYMSP 527 (676)
Q Consensus 450 l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~--~~~~~~~~~~~~~~~gt~~Y~AP 527 (676)
+....-.+++.||+.||.|||+.. ++|+|+++..+.|++..++-+|+.--.-.. ...............+-++|.+|
T Consensus 173 ~~~~~wkkw~tqIlsal~yLhs~~-PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~ 251 (458)
T KOG1266|consen 173 LFQKAWKKWCTQILSALSYLHSCD-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAP 251 (458)
T ss_pred hhHHHHHHHHHHHHhhhhhhhccC-CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccC
Confidence 344445679999999999999985 679999999999999999988885321111 00001111122234567899999
Q ss_pred hhhccCCCCchhHHHHHHHHHHHHHhCCc
Q 005803 528 EYVMNGIVSMKSDVYSFGVLVLEIVSSKK 556 (676)
Q Consensus 528 E~~~~~~~s~ksDVwSlGvvl~elltG~~ 556 (676)
|+=.....+.++|||+||+..+||-.+..
T Consensus 252 ~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 252 ESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred CcCcccccccchhhhhhhHHHHHHHHhee
Confidence 98776677889999999999999988765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.6e-07 Score=90.93 Aligned_cols=115 Identities=14% Similarity=0.091 Sum_probs=81.3
Q ss_pred ceeeccCCCccEEEEEEcC-------CcEEEEEEeccCC------------c----------hhhHHHH----HHHHHHH
Q 005803 388 ANRLGQGGFGPVYNGKLLD-------GQEIAIKRLSKSS------------G----------QGIVEFK----NEAKLIA 434 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~-------~~~VAvK~l~~~~------------~----------~~~~~~~----~E~~~l~ 434 (676)
...||.|.-+.||.|...+ +..+|||+.+... . .....+. +|...|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999997543 4789999874320 0 0122233 7999999
Q ss_pred HccCCcc-----c---------cccc----------cCcCCHHHHHHHHHHHHHHHHHH-HhcCCCceEeeccccCceEE
Q 005803 435 KLQHTNL-----T---------DSSR----------KSLLDWKKRFYIIEGIVQGLLYL-HKYSRLRAIHRDLKVSNILL 489 (676)
Q Consensus 435 ~l~H~ni-----v---------~~~~----------~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~iiH~DLKp~NILl 489 (676)
++....+ + +... ...++..+...+..+++.+|..| |..+ +||+||++.|||+
T Consensus 82 rl~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NIL~ 158 (197)
T cd05146 82 RMQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNMLW 158 (197)
T ss_pred HHHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9864332 1 1111 11233345567789999999999 7877 9999999999999
Q ss_pred cCCCCeEEeccCcceec
Q 005803 490 DEQMNPKISDFGMARTY 506 (676)
Q Consensus 490 ~~~~~vkL~DFGla~~~ 506 (676)
++ +.+.|+|||.+...
T Consensus 159 ~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 159 HD-GKVWFIDVSQSVEP 174 (197)
T ss_pred EC-CcEEEEECCCceeC
Confidence 74 68999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.3e-08 Score=110.15 Aligned_cols=226 Identities=19% Similarity=0.182 Sum_probs=145.8
Q ss_pred HHHHhcCCCcceeeccCCCccEEEEEE--cCCcEEEEEEeccCCchhhHHH--HHHHHHHHHc-cCCcccc---------
Q 005803 378 IAAATDNFSPANRLGQGGFGPVYNGKL--LDGQEIAIKRLSKSSGQGIVEF--KNEAKLIAKL-QHTNLTD--------- 443 (676)
Q Consensus 378 l~~~t~~y~~~~~LG~G~fG~Vy~~~~--~~~~~VAvK~l~~~~~~~~~~~--~~E~~~l~~l-~H~niv~--------- 443 (676)
..+-+.+|..+..||.|.|+.|+.... .++..+++|.+.+.......++ ..|+.+...+ .|.+.+.
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 445567888999999999999998864 3578899998865433222221 2344333333 2333331
Q ss_pred -----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC-CCeEEeccCccee
Q 005803 444 -----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ-MNPKISDFGMART 505 (676)
Q Consensus 444 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~-~~vkL~DFGla~~ 505 (676)
......++...++++..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||++..
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 111223556677889999999999999988 9999999999999886 7889999999864
Q ss_pred ccccccccccceeeccCCc-cChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccc
Q 005803 506 YAMNELEANTNRIVGTHGY-MSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584 (676)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~Y-~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (676)
+.-.... .......| .+|+......+..+.|++|||.-+.|.+++...-...... .....+..
T Consensus 417 ~~~~~~~----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~----------~~i~~~~~-- 480 (524)
T KOG0601|consen 417 LAFSSGV----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS----------LTIRSGDT-- 480 (524)
T ss_pred cceeccc----ccccccccccchhhccccccccccccccccccccccccCcccCcccccc----------eeeecccc--
Confidence 2211110 01223344 3566666778889999999999999999987643322110 00011111
Q ss_pred cCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 585 LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 585 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
+.+. ...+.+..++..++..++..||.+.++..+.+-.
T Consensus 481 ---p~~~-----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 481 ---PNLP-----GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ---cCCC-----chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1111 1113445555668889999999998877665443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=7.3e-07 Score=99.54 Aligned_cols=145 Identities=15% Similarity=0.211 Sum_probs=101.5
Q ss_pred EcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccccc------------cc--CcCC-------HHHHHHHHHHH
Q 005803 404 LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSS------------RK--SLLD-------WKKRFYIIEGI 462 (676)
Q Consensus 404 ~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~~------------~~--~~l~-------~~~~~~i~~qi 462 (676)
..++.+|.|...+...........+-++.|+.++||||+... .. .++. .......+.||
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~~~~v~~Gl~qI 113 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELGKEEVCLGLFQI 113 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhHHHHHHHHHHHH
Confidence 446889999988776654455678889999999999997311 11 1111 22334567899
Q ss_pred HHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHH
Q 005803 463 VQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542 (676)
Q Consensus 463 a~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVw 542 (676)
+.||.|||..+ .++|++|.-+.|++++.|+-||++|.++.....-.. ......--..|..|+.+.... -..|.|
T Consensus 114 l~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~ 187 (690)
T KOG1243|consen 114 LAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSW 187 (690)
T ss_pred HHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhh
Confidence 99999999766 599999999999999999999999988754322111 011111122456666443221 356999
Q ss_pred HHHHHHHHHHhC
Q 005803 543 SFGVLVLEIVSS 554 (676)
Q Consensus 543 SlGvvl~elltG 554 (676)
-|||+++|++.|
T Consensus 188 ~Lg~li~el~ng 199 (690)
T KOG1243|consen 188 GLGCLIEELFNG 199 (690)
T ss_pred hHHHHHHHHhCc
Confidence 999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.5e-07 Score=103.13 Aligned_cols=123 Identities=18% Similarity=0.200 Sum_probs=76.9
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCchh----------------------------------h---
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQG----------------------------------I--- 423 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~~----------------------------------~--- 423 (676)
-..|+. +.||.|++|.||+|++.+ |+.||||+++...... .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345765 789999999999999987 9999999997532110 0
Q ss_pred ---HHHHHHHHHHHHcc----CCccc-----------------cccccCcCCHHH--------HHHHHHHHHHH-HHHHH
Q 005803 424 ---VEFKNEAKLIAKLQ----HTNLT-----------------DSSRKSLLDWKK--------RFYIIEGIVQG-LLYLH 470 (676)
Q Consensus 424 ---~~~~~E~~~l~~l~----H~niv-----------------~~~~~~~l~~~~--------~~~i~~qia~g-L~yLH 470 (676)
-.+.+|+..+.++. +.+.+ +...+..++... +..++...++. +..++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 12344555555543 22211 111122221111 11233333322 33445
Q ss_pred hcCCCceEeeccccCceEEcCCC----CeEEeccCcceeccc
Q 005803 471 KYSRLRAIHRDLKVSNILLDEQM----NPKISDFGMARTYAM 508 (676)
Q Consensus 471 ~~~~~~iiH~DLKp~NILl~~~~----~vkL~DFGla~~~~~ 508 (676)
..| ++|+|+||.||+++.++ .++++|||++..+..
T Consensus 278 ~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 556 99999999999999888 899999999987654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.4e-08 Score=110.31 Aligned_cols=157 Identities=17% Similarity=0.219 Sum_probs=101.8
Q ss_pred HHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc-------cccceeeccCCccCh
Q 005803 455 RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE-------ANTNRIVGTHGYMSP 527 (676)
Q Consensus 455 ~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~-------~~~~~~~gt~~Y~AP 527 (676)
.+.=+.+++.||.|+|... .+||++|.|++|.++.++..||+.|+++......... ....-..-...|.||
T Consensus 101 ~f~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap 178 (700)
T KOG2137|consen 101 GFANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP 178 (700)
T ss_pred hhhhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc
Confidence 3344455679999999865 6999999999999999999999999988643331100 000112234579999
Q ss_pred hhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHH
Q 005803 528 EYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVG 606 (676)
Q Consensus 528 E~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~ 606 (676)
|++.+...+.++|+||+||++|.+.. |+..+.......... ... . .+..-...+..+.+.++.+-+
T Consensus 179 E~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-----~~~----~----~~~~~~~~~s~~~p~el~~~l 245 (700)
T KOG2137|consen 179 EYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-----FSR----N----LLNAGAFGYSNNLPSELRESL 245 (700)
T ss_pred hhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhh-----hhh----c----ccccccccccccCcHHHHHHH
Confidence 99999888999999999999999995 444443221111110 000 0 000001111223334455666
Q ss_pred HHhcccCcCCCCCHHHHHHH
Q 005803 607 LLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 607 ~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+.+..++.-||++.++...
T Consensus 246 ~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 246 KKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred HHHhcCCcccCcchhhhhcc
Confidence 67899999999988776543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.30 E-value=6.3e-06 Score=82.26 Aligned_cols=118 Identities=17% Similarity=0.220 Sum_probs=87.5
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCcc-----ccc----------------c
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL-----TDS----------------S 445 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~ni-----v~~----------------~ 445 (676)
.+.|+.|..+.||+++..+|+.+++|....... .....+..|++++..+.+.++ +.. .
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 367899999999999887678999999754322 135678999999999876332 210 0
Q ss_pred cc---------CcCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 005803 446 RK---------SLLDWKKRFYIIEGIVQGLLYLHKYS------------------------------------------- 473 (676)
Q Consensus 446 ~~---------~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------------- 473 (676)
.+ ..++...+..++.++++.|..||+..
T Consensus 83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (223)
T cd05154 83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR 162 (223)
T ss_pred CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence 00 12455667788999999999999531
Q ss_pred ----------CCceEeeccccCceEEcC--CCCeEEeccCccee
Q 005803 474 ----------RLRAIHRDLKVSNILLDE--QMNPKISDFGMART 505 (676)
Q Consensus 474 ----------~~~iiH~DLKp~NILl~~--~~~vkL~DFGla~~ 505 (676)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=5.9e-07 Score=104.27 Aligned_cols=224 Identities=16% Similarity=0.197 Sum_probs=134.1
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCccccc------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
..+.+.+.+-+-+|.++.++.++-.. +...++|..... .....+....+-.++-...||-++..
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 45677778888889999998775332 433344433211 11112222222222222223333210
Q ss_pred ----c----------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc-
Q 005803 445 ----S----------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN- 509 (676)
Q Consensus 445 ----~----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~- 509 (676)
. .-...+.+-....+..+..+++|||... +.|+|++|.|+++..+++.++.|||........
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccccc
Confidence 0 0011222223334555788999999876 899999999999999999999999843321100
Q ss_pred ------------------------ccc----cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCC
Q 005803 510 ------------------------ELE----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSY 561 (676)
Q Consensus 510 ------------------------~~~----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~ 561 (676)
... .......||+.|.+||.+.+......+|.|++|++++|.++|.+||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 000 1122357899999999999999999999999999999999999999765
Q ss_pred CCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHH
Q 005803 562 DTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMS 621 (676)
Q Consensus 562 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 621 (676)
...... +.+..+.+ +. ...+.+.......++...+..+|.+|-.|.
T Consensus 1039 tpq~~f-------~ni~~~~~-----~~--p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQIF-------ENILNRDI-----PW--PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred chhhhh-------hccccCCC-----CC--CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 443221 11111111 00 011222233455566677788999997776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.7e-05 Score=77.76 Aligned_cols=105 Identities=27% Similarity=0.298 Sum_probs=69.7
Q ss_pred cEEEEEEcCCcEEEEEEeccCC-------------ch-------------hhHHHHHHHHHHHHccCCccc---------
Q 005803 398 PVYNGKLLDGQEIAIKRLSKSS-------------GQ-------------GIVEFKNEAKLIAKLQHTNLT--------- 442 (676)
Q Consensus 398 ~Vy~~~~~~~~~VAvK~l~~~~-------------~~-------------~~~~~~~E~~~l~~l~H~niv--------- 442 (676)
.||.|...++..+|||...... .. ......+|.+.|.++..-++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 3899998899999999874320 00 112357899999999765431
Q ss_pred -----cccc--cCc--------CCHHHHHHHHHHHHHHHHH-HHhcCCCceEeeccccCceEEcCCCCeEEeccCcceec
Q 005803 443 -----DSSR--KSL--------LDWKKRFYIIEGIVQGLLY-LHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTY 506 (676)
Q Consensus 443 -----~~~~--~~~--------l~~~~~~~i~~qia~gL~y-LH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~ 506 (676)
+... +.. ++..+...++.+++..+.. +|..| |+|+||.+.|||++++ .+.|+|||.+...
T Consensus 81 ~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp TEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred CEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEecCcceec
Confidence 1111 111 1123456788888886666 56777 9999999999999988 9999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.12 E-value=5e-05 Score=82.73 Aligned_cols=140 Identities=21% Similarity=0.301 Sum_probs=106.7
Q ss_pred CccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------------------------
Q 005803 396 FGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------------------- 443 (676)
Q Consensus 396 fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------------------- 443 (676)
-...|++.. .||..|++|+++....+.......-++..+++.|+|+|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356788874 479999999996654444444566788999999999871
Q ss_pred ---------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 444 ---------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
...+...++...+.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 223445677888999999999999999999 88899999999999999999988887665433
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcC
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKN 557 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~p 557 (676)
+.. +| +.. -.+-|.=.||.+++.|.+|...
T Consensus 446 d~~--------------~~--le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT--------------EP--LES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC--------------cc--hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 220 11 111 1356888999999999999654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.5e-05 Score=76.55 Aligned_cols=112 Identities=25% Similarity=0.314 Sum_probs=76.3
Q ss_pred eeeccCCCccEEEEEEcCCcEEEEEE-eccCCc-------hhhHHHHHHHHHHHHccCCcc-----cc-----------c
Q 005803 389 NRLGQGGFGPVYNGKLLDGQEIAIKR-LSKSSG-------QGIVEFKNEAKLIAKLQHTNL-----TD-----------S 444 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~~~~VAvK~-l~~~~~-------~~~~~~~~E~~~l~~l~H~ni-----v~-----------~ 444 (676)
..+++|+-+.+|.+.+. |..+++|. +++... -...+..+|+.++.++.--.+ .. .
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999999663 33456664 333211 123456789999998864322 11 1
Q ss_pred cccCcCC---HHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 445 SRKSLLD---WKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 445 ~~~~~l~---~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
..+..+. +..+..++..+-.-+.-||..+ |+|+||.++||++.... +.++|||++..
T Consensus 81 I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhcchHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 1111111 1113468888889999999999 99999999999998764 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=2.1e-05 Score=75.27 Aligned_cols=115 Identities=29% Similarity=0.306 Sum_probs=79.8
Q ss_pred cceeeccCCCccEEEEEEcCCcEEEEEE-eccCC-------chhhHHHHHHHHHHHHccCCcc-----cc----------
Q 005803 387 PANRLGQGGFGPVYNGKLLDGQEIAIKR-LSKSS-------GQGIVEFKNEAKLIAKLQHTNL-----TD---------- 443 (676)
Q Consensus 387 ~~~~LG~G~fG~Vy~~~~~~~~~VAvK~-l~~~~-------~~~~~~~~~E~~~l~~l~H~ni-----v~---------- 443 (676)
....|-+|+-+.|+++.. .|+...||. +.+.. .-...+..+|+++|.++.--.| ..
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467899999999999987 566666664 33321 1134567889999998853332 10
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC---eEEeccCccee
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN---PKISDFGMART 505 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~---vkL~DFGla~~ 505 (676)
..............++..|-+.+.-||..+ |||+||..+||++..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 000111112222578889999999999998 999999999999975553 58999999864
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.6e-06 Score=61.51 Aligned_cols=45 Identities=42% Similarity=0.711 Sum_probs=37.4
Q ss_pred CCCCCCCCCccceeccCCCCCCcccccccccccccceeeeccccC
Q 005803 632 MALPKPKQPAFFINISSDYEEPDVTEIKLEVCSVNDVTISRMEGR 676 (676)
Q Consensus 632 ~~l~~p~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (676)
.+||.|+.|+|+.+|...+..++++...++.+++|+||+|.|+||
T Consensus 4 ~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 4 ATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred ccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 479999999999999988877662221148999999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.7e-05 Score=71.25 Aligned_cols=85 Identities=29% Similarity=0.521 Sum_probs=58.1
Q ss_pred EEEcCCCcEEEEcCC-CceEEEeeeccCCc-ceEEEEeeCCCEEEEEecCCCCccccccccccCCCcccccCCCcccccc
Q 005803 134 IIDSTDGNLKILRNG-KNPIGISSVRRAGN-TTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYPTHALLPGMKLGINL 211 (676)
Q Consensus 134 ~~~~~~G~L~l~~~~-~~~vw~s~~~~~~~-~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~ 211 (676)
.... ||+||+++.. +.+||++++..+.. ...+.|.++|||||++.+ + .++|+| +|- +
T Consensus 25 ~~q~-dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~--g----~~vW~S-----~t~-~-------- 83 (114)
T smart00108 25 IMQN-DYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD--G----RVVWSS-----NTT-G-------- 83 (114)
T ss_pred CCCC-CEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC--C----CEEEEe-----ccc-C--------
Confidence 3344 8999999765 58999998764432 367899999999999732 2 589998 111 1
Q ss_pred cCCceeEEEecCCCCcceEEEeeeCCCCCeEEEEEe-CCeEEEEec
Q 005803 212 QTGHQWFLQSSESAEGSYRLGLGTDPNMTSKLVIWK-NDKVVWTSA 256 (676)
Q Consensus 212 ~t~~~~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~w~sg 256 (676)
..|.+.+.| +.+|+. ++++ .+.+.|.|.
T Consensus 84 -------------~~~~~~~~L--~ddGnl--vl~~~~~~~~W~Sf 112 (114)
T smart00108 84 -------------ANGNYVLVL--LDDGNL--VIYDSDGNFLWQSF 112 (114)
T ss_pred -------------CCCceEEEE--eCCCCE--EEECCCCCEEeCCC
Confidence 235567777 777774 4554 346788764
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.98 E-value=3e-05 Score=69.90 Aligned_cols=82 Identities=26% Similarity=0.464 Sum_probs=57.4
Q ss_pred CCcEEEEcCC-CceEEEeeeccC-CcceEEEEeeCCCEEEEEecCCCCccccccccccCCCcccccCCCcccccccCCce
Q 005803 139 DGNLKILRNG-KNPIGISSVRRA-GNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYPTHALLPGMKLGINLQTGHQ 216 (676)
Q Consensus 139 ~G~L~l~~~~-~~~vw~s~~~~~-~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~t~~~ 216 (676)
||+||+++.. +.+||++++..+ .....+.|.++|||||.+.+. .++|+|=-. +
T Consensus 30 dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g------~~vW~S~~~-------~------------ 84 (116)
T cd00028 30 DYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSG------TVVWSSNTT-------R------------ 84 (116)
T ss_pred eEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCC------cEEEEeccc-------C------------
Confidence 8999999764 589999997653 334678999999999987322 579997211 0
Q ss_pred eEEEecCCCCcceEEEeeeCCCCCeEEEEEe-CCeEEEEecc
Q 005803 217 WFLQSSESAEGSYRLGLGTDPNMTSKLVIWK-NDKVVWTSAI 257 (676)
Q Consensus 217 ~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~w~sg~ 257 (676)
..+.+.+.| +.+|+ +++++ .+.+.|.|..
T Consensus 85 --------~~~~~~~~L--~ddGn--lvl~~~~~~~~W~Sf~ 114 (116)
T cd00028 85 --------VNGNYVLVL--LDDGN--LVLYDSDGNFLWQSFD 114 (116)
T ss_pred --------CCCceEEEE--eCCCC--EEEECCCCCEEEcCCC
Confidence 135567777 77777 45564 3567898754
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.91 E-value=8e-05 Score=75.64 Aligned_cols=127 Identities=17% Similarity=0.166 Sum_probs=85.0
Q ss_pred HHHHHHHhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCC----------------------chhhHHHHHHHHH
Q 005803 375 FQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSS----------------------GQGIVEFKNEAKL 432 (676)
Q Consensus 375 ~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~----------------------~~~~~~~~~E~~~ 432 (676)
+..+.....=..+.++||-|.-+.||.|..+.|.++|||.=+... .-.....++|.++
T Consensus 83 L~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 83 LHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 334443333345678999999999999999999999999532110 0112346789999
Q ss_pred HHHccCC--cc----------c--cc-----cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC
Q 005803 433 IAKLQHT--NL----------T--DS-----SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM 493 (676)
Q Consensus 433 l~~l~H~--ni----------v--~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~ 493 (676)
|.+|... .+ + .. ...-.++.+..-.|+..|++-+.-+-..| |||+|+.+-||+++++|
T Consensus 163 L~~L~~~G~~VP~P~~~nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg 239 (304)
T COG0478 163 LQRLYPEGVKVPKPIAWNRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDG 239 (304)
T ss_pred HHHhhhcCCCCCCccccccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCC
Confidence 9998644 11 1 11 11111234444555666666555555666 99999999999999999
Q ss_pred CeEEeccCcce
Q 005803 494 NPKISDFGMAR 504 (676)
Q Consensus 494 ~vkL~DFGla~ 504 (676)
.+.++||=-+.
T Consensus 240 ~~~vIDwPQ~v 250 (304)
T COG0478 240 DIVVIDWPQAV 250 (304)
T ss_pred CEEEEeCcccc
Confidence 99999996554
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00011 Score=72.84 Aligned_cols=123 Identities=15% Similarity=0.194 Sum_probs=87.9
Q ss_pred HHHHhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccC------CchhhHHHHHHHHHHHHccCCccc---------
Q 005803 378 IAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKS------SGQGIVEFKNEAKLIAKLQHTNLT--------- 442 (676)
Q Consensus 378 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~------~~~~~~~~~~E~~~l~~l~H~niv--------- 442 (676)
+-.....+-..---|+||.+.|+.... +|+.+-+|+-... ...+...|.+|...|.+|...++.
T Consensus 13 ~w~~~~~wve~pN~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~ 91 (216)
T PRK09902 13 WWATEGDWVEEPNYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEA 91 (216)
T ss_pred HHhCCCceecCCCcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeee
Confidence 333333333333357799999999876 4457888976421 133567899999999999765542
Q ss_pred -------------c-cc------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC--
Q 005803 443 -------------D-SS------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN-- 494 (676)
Q Consensus 443 -------------~-~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~-- 494 (676)
+ .. .....+...+..++.+++..++-||..| +.|+|+-+.||+++.++.
T Consensus 92 ~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~ 168 (216)
T PRK09902 92 VKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAE 168 (216)
T ss_pred eccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCee
Confidence 0 00 0112345556789999999999999999 999999999999986666
Q ss_pred eEEeccCcce
Q 005803 495 PKISDFGMAR 504 (676)
Q Consensus 495 vkL~DFGla~ 504 (676)
++++||.-++
T Consensus 169 v~lIDlEk~r 178 (216)
T PRK09902 169 AGFLDLEKSR 178 (216)
T ss_pred EEEEEhhccc
Confidence 9999997665
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00011 Score=76.15 Aligned_cols=113 Identities=14% Similarity=0.127 Sum_probs=76.1
Q ss_pred eeeccCCCccEEEEEEcCCcEEEEEEeccCCch-----------hhHHHHHHHHHHHHccCCccc-----c---------
Q 005803 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQ-----------GIVEFKNEAKLIAKLQHTNLT-----D--------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv-----~--------- 443 (676)
+.+-+-....|++... +|+.|.||+....... ....+.+|...+.++...+|. .
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3344334445667655 6788999977432211 111377899888888543331 0
Q ss_pred ---------ccc-------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC-------CCC
Q 005803 444 ---------SSR-------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE-------QMN 494 (676)
Q Consensus 444 ---------~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~-------~~~ 494 (676)
... ....+...+..++.+++..+.-||..| |+|+|+++.|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 000 111233456688999999999999999 999999999999975 467
Q ss_pred eEEeccCccee
Q 005803 495 PKISDFGMART 505 (676)
Q Consensus 495 vkL~DFGla~~ 505 (676)
+.|+||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998753
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0017 Score=65.52 Aligned_cols=131 Identities=21% Similarity=0.226 Sum_probs=88.1
Q ss_pred ccHHHHHHHhcCCCcceeec---cCCCccEEEEEEcCCcEEEEEEeccCCch-------------------hhHH-----
Q 005803 373 FDFQTIAAATDNFSPANRLG---QGGFGPVYNGKLLDGQEIAIKRLSKSSGQ-------------------GIVE----- 425 (676)
Q Consensus 373 f~~~~l~~~t~~y~~~~~LG---~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~-------------------~~~~----- 425 (676)
.+...|.....+..+....| .|.-+.||+|...++..+|||+++..... ...+
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 44566666666666666555 56677899998888999999998643111 1111
Q ss_pred HHHHHHHHHHccCCc------------cc-------c-----ccccCcCCHHHHHHHHHHHHHHHHHHHh-cCCCceEee
Q 005803 426 FKNEAKLIAKLQHTN------------LT-------D-----SSRKSLLDWKKRFYIIEGIVQGLLYLHK-YSRLRAIHR 480 (676)
Q Consensus 426 ~~~E~~~l~~l~H~n------------iv-------~-----~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~ 480 (676)
..+|..-|.++..-. +. . ....-.+...+...+..++++.+.-|-. .+ +||+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHg 191 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHG 191 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeecCCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccc
Confidence 245777777774322 21 0 1111122333567778888888888876 44 9999
Q ss_pred ccccCceEEcCCCCeEEeccCcceecc
Q 005803 481 DLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 481 DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
||..-|||+. ++.+.|+|||-|....
T Consensus 192 DLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 192 DLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cchhhheEEE-CCeEEEEECccccccC
Confidence 9999999999 7899999999887543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0003 Score=70.15 Aligned_cols=52 Identities=27% Similarity=0.298 Sum_probs=46.1
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC---CeEEeccCccee
Q 005803 451 DWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM---NPKISDFGMART 505 (676)
Q Consensus 451 ~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~---~vkL~DFGla~~ 505 (676)
+...+..++.++++.++-||..| |+|+|+++.|||++.+. .+.|+||+-++.
T Consensus 116 ~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 116 DPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred chhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 34556789999999999999999 99999999999999887 799999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0017 Score=58.26 Aligned_cols=74 Identities=22% Similarity=0.250 Sum_probs=46.6
Q ss_pred CccEEEc-cCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEee--CCCEEEEEecCCCCccccc
Q 005803 113 KQPVWIA-NRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLK--NGNLVLYEMNSDGLSIRRG 189 (676)
Q Consensus 113 ~~~vW~a-nr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d--~GNlVl~~~~~~~~~~~~~ 189 (676)
.++||.. +...... ....+.+.+ +|||||+|..+.++|+|... ...+....++ .||++ .. ... .+
T Consensus 38 ~~~iWss~~t~~~~~--~~~~~~L~~-~GNlvl~d~~~~~lW~Sf~~--ptdt~L~~q~l~~~~~~-~~---~~~---~~ 105 (114)
T PF01453_consen 38 GSVIWSSNNTSGRGN--SGCYLVLQD-DGNLVLYDSSGNVLWQSFDY--PTDTLLPGQKLGDGNVT-GK---NDS---LT 105 (114)
T ss_dssp TEEEEE--S-TTSS---SSEEEEEET-TSEEEEEETTSEEEEESTTS--SS-EEEEEET--TSEEE-EE---STS---SE
T ss_pred CCEEEEecccCCccc--cCeEEEEeC-CCCEEEEeecceEEEeecCC--CccEEEeccCcccCCCc-cc---cce---EE
Confidence 3569999 3333321 146888888 99999999999999998422 3446666666 88888 54 111 47
Q ss_pred cccccCCCc
Q 005803 190 LWQSFDYPT 198 (676)
Q Consensus 190 lWqSFd~Pt 198 (676)
.|.|=+.|+
T Consensus 106 sw~s~~dps 114 (114)
T PF01453_consen 106 SWSSNTDPS 114 (114)
T ss_dssp EEESS----
T ss_pred eECCCCCCC
Confidence 898876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.002 Score=61.61 Aligned_cols=113 Identities=20% Similarity=0.204 Sum_probs=77.1
Q ss_pred cceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------cccc-CcCCH
Q 005803 387 PANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD-------------SSRK-SLLDW 452 (676)
Q Consensus 387 ~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~-------------~~~~-~~l~~ 452 (676)
..+.|++|.+|.||+|.+ .|..+|+|+-.. +.....+..|+++|..++--++.. ...+ .+..+
T Consensus 26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~~ 102 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGKL 102 (201)
T ss_pred hhhhhhcccccEEEEeec-cCceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhhh
Confidence 357899999999999987 455899998644 345667899999999997655431 1112 22222
Q ss_pred HHH--HHHHHHHHHHHHHHHhcCCCceEeeccc-cCceEEcCCCCeEEeccCccee
Q 005803 453 KKR--FYIIEGIVQGLLYLHKYSRLRAIHRDLK-VSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 453 ~~~--~~i~~qia~gL~yLH~~~~~~iiH~DLK-p~NILl~~~~~vkL~DFGla~~ 505 (676)
... .+-+..+++.---|...| |-|+.|. |...+|-.+..+.|+||..|+.
T Consensus 103 ~~~~~rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 103 EIGGDRKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhcccHHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 221 334445666655566666 9999984 5555555555999999998874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0023 Score=63.02 Aligned_cols=124 Identities=24% Similarity=0.327 Sum_probs=84.5
Q ss_pred ccCcCccccHHHHHHHhcCCCcceeeccCCC-ccEEEEEEcCCcEEEEEEecc---C---------C--c-------hhh
Q 005803 366 VKRDLKIFDFQTIAAATDNFSPANRLGQGGF-GPVYNGKLLDGQEIAIKRLSK---S---------S--G-------QGI 423 (676)
Q Consensus 366 ~~~~~~~f~~~~l~~~t~~y~~~~~LG~G~f-G~Vy~~~~~~~~~VAvK~l~~---~---------~--~-------~~~ 423 (676)
....+..|++. +.+++.++.||.|.- |.||++++ +|+.+|+|.+.. . . . ...
T Consensus 25 ~gPKL~~F~~h-----~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 98 (207)
T PF13095_consen 25 PGPKLEPFTHH-----GDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYA 98 (207)
T ss_pred CCCCcCCcCCC-----CCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhc
Confidence 44456667762 278888999999999 99999998 677999999321 0 0 0 112
Q ss_pred HHHHHHHHHHHHccCC---cc--ccccccCcCCH-------------------------------HHHHHHHHHHHHHHH
Q 005803 424 VEFKNEAKLIAKLQHT---NL--TDSSRKSLLDW-------------------------------KKRFYIIEGIVQGLL 467 (676)
Q Consensus 424 ~~~~~E~~~l~~l~H~---ni--v~~~~~~~l~~-------------------------------~~~~~i~~qia~gL~ 467 (676)
..|..|.+...+|++- ++ |+....-.|+. .....-+.+|.+-+.
T Consensus 99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~ 178 (207)
T PF13095_consen 99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLK 178 (207)
T ss_pred ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHH
Confidence 3578899888888643 33 22111112221 112334567888889
Q ss_pred HHHhcCCCceEeeccccCceEEcCCCCeEEeccCcc
Q 005803 468 YLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMA 503 (676)
Q Consensus 468 yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla 503 (676)
.+|..| |+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 999888 999999999986 3489999864
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0013 Score=74.07 Aligned_cols=49 Identities=24% Similarity=0.270 Sum_probs=36.8
Q ss_pred HHHHHHHHH-HHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 457 YIIEGIVQG-LLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 457 ~i~~qia~g-L~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
.++..++++ +..+-..| +.|+|..|.||+++.++.+.+.|||+...+..
T Consensus 268 ~ia~~~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 268 ELAELLVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 444444443 23333345 99999999999999999999999999876654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0032 Score=62.97 Aligned_cols=49 Identities=18% Similarity=0.193 Sum_probs=39.1
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCC
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 439 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ 439 (676)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+...
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~ 50 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEH 50 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHT
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhc
Confidence 4689999999999999876 69999997553 4566788899988888643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.00011 Score=82.00 Aligned_cols=162 Identities=18% Similarity=0.191 Sum_probs=112.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccc-c-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT-D----------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~----------------- 443 (676)
++-+...+.+++|++++++|.+..-.+....+.+... ....-++++|.+++|||.+ .
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3334445668899999999987543444445555332 4556789999999999932 1
Q ss_pred -ccc----------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -SSR----------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -~~~----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
... ...+...+..++.+.-.++|++||+.. -+|+| ||+..+ +..|..||+.+..+....
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--
Confidence 000 001112223345556678899999864 58998 777665 578999999987655432
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNG 559 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~ 559 (676)
......+++.++|||......+..+.|+|++|+-..+|--|-+|-.
T Consensus 386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 2344678999999999999999999999999998777777776644
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.006 Score=60.86 Aligned_cols=120 Identities=18% Similarity=0.160 Sum_probs=76.9
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHH---------HHHHHHHHHccC-----Cc---cc-
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEF---------KNEAKLIAKLQH-----TN---LT- 442 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~---------~~E~~~l~~l~H-----~n---iv- 442 (676)
..++|.+.+.+-......|.+... +|+.+++|..........+.| .+++..+.++.. ++ ++
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 567888888888888888888776 678899998765433222222 223333333321 11 11
Q ss_pred ---------------cccccCcCCH-HHH-HHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 443 ---------------DSSRKSLLDW-KKR-FYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 443 ---------------~~~~~~~l~~-~~~-~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
....+..+.. ... -.++..+++++.-||+.| +.|+|..|.|++++++ .++++||+..+.
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECccccc
Confidence 1111222221 111 135677888999999999 9999999999999965 599999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.013 Score=59.37 Aligned_cols=111 Identities=16% Similarity=0.118 Sum_probs=71.7
Q ss_pred eeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcc-----cc-------------ccccC--
Q 005803 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----TD-------------SSRKS-- 448 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-----v~-------------~~~~~-- 448 (676)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-.+ +. ...+.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 67999999999984 35567788875422 34456889999988764333 21 11111
Q ss_pred -----cCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------CCCceEeeccc
Q 005803 449 -----LLDWKKRFYIIEGIVQGLLYLHKY----------------------------------------SRLRAIHRDLK 483 (676)
Q Consensus 449 -----~l~~~~~~~i~~qia~gL~yLH~~----------------------------------------~~~~iiH~DLK 483 (676)
..+......++..+++.+.-||+. ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 112222334555555555555531 12346899999
Q ss_pred cCceEEcCCCCeEEeccCccee
Q 005803 484 VSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 484 p~NILl~~~~~vkL~DFGla~~ 505 (676)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.025 Score=57.21 Aligned_cols=50 Identities=10% Similarity=0.122 Sum_probs=33.9
Q ss_pred ceeeccCCCccEEEEEEcC--CcEEEEEEeccCCchhhHHHHHHHHHHHHccC
Q 005803 388 ANRLGQGGFGPVYNGKLLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH 438 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~--~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H 438 (676)
.+.|..|-...+|+....+ ++.|++|+...... ......+|+.++..+..
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~ 54 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSK 54 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHh
Confidence 4678888888999988664 67888997654322 22233578888887754
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.017 Score=60.73 Aligned_cols=48 Identities=13% Similarity=0.019 Sum_probs=34.1
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCC
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 439 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ 439 (676)
.+.|..|....+|+....+ ..+++|+... .....+..|+.++..+.+.
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~ 66 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAER 66 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHC
Confidence 5677888888999987644 4688898754 2345567788888887543
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.037 Score=58.83 Aligned_cols=30 Identities=30% Similarity=0.326 Sum_probs=25.8
Q ss_pred CceEeeccccCceEEcCCCCeEEeccCcce
Q 005803 475 LRAIHRDLKVSNILLDEQMNPKISDFGMAR 504 (676)
Q Consensus 475 ~~iiH~DLKp~NILl~~~~~vkL~DFGla~ 504 (676)
.++||+|+.|.||+++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 359999999999999976556899999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.029 Score=67.27 Aligned_cols=171 Identities=18% Similarity=0.240 Sum_probs=111.0
Q ss_pred HHHHHHHHHHHccCCcccc------------------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCC
Q 005803 425 EFKNEAKLIAKLQHTNLTD------------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSR 474 (676)
Q Consensus 425 ~~~~E~~~l~~l~H~niv~------------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~ 474 (676)
...-|...+.++.|+|++. ...-...+....+.+..++.+||+|+|+..
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~- 306 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS- 306 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence 3455778888999999872 112233455666678889999999999986
Q ss_pred CceEeeccccC---ceEEcCCCCeEEe--ccCcceeccccccccccceeeccCCccChhhhccCCCCc--hhHHHHHHHH
Q 005803 475 LRAIHRDLKVS---NILLDEQMNPKIS--DFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSM--KSDVYSFGVL 547 (676)
Q Consensus 475 ~~iiH~DLKp~---NILl~~~~~vkL~--DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~--ksDVwSlGvv 547 (676)
..|.-+..+ +-..+..+.+.++ ||+..+.+........ ...+..+.+||......+.. ..|+|.+|..
T Consensus 307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred --cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHHHHH
Confidence 556555554 4445566667766 8888876544322111 23345677888777665544 4699999999
Q ss_pred HHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 005803 548 VLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627 (676)
Q Consensus 548 l~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~L 627 (676)
+..+..|..+-..... ...+++. .... .+......|+..++++|+++.+++...
T Consensus 382 ~~~~~~~~~i~~~~~~------------------~~~~l~~----~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV------------------PVSLLDV----LSTS----ELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HhhhhhcCcccccccc------------------hhhhhcc----ccch----hhhhhhhhhcchhhhhccchhhhhhch
Confidence 9999998765321100 0011111 1111 244556679999999999999999875
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.028 Score=57.75 Aligned_cols=29 Identities=24% Similarity=0.374 Sum_probs=25.5
Q ss_pred ceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 476 RAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 476 ~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
.++|+|+.|.||++++++ +.|+||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 489999999999999876 78999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.0057 Score=54.48 Aligned_cols=38 Identities=24% Similarity=0.485 Sum_probs=28.9
Q ss_pred EEecccCCC---CCCc---------eeecCCCce-eee-------eceEEEccCCCCc
Q 005803 253 WTSAIWLNN---SLPS---------YTRSSDDEI-NNS-------LPSYTRSSDDGIN 290 (676)
Q Consensus 253 w~sg~w~~~---~~~~---------~~~~~~~~~-~~~-------~~~~~l~~~G~~~ 290 (676)
||+|+|+|. +.|+ .|+.++++. ++| ++|++||.+|.++
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~ 58 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQ 58 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEE
Confidence 899999993 6664 456666665 444 7899999999877
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.066 Score=54.28 Aligned_cols=30 Identities=27% Similarity=0.380 Sum_probs=25.4
Q ss_pred ceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 476 RAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 476 ~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
.++|+|+.+.|||++++...-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 379999999999998765567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.069 Score=52.86 Aligned_cols=111 Identities=17% Similarity=0.233 Sum_probs=67.3
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEeccCC----------------chhhHHHHHHHHHHHHcc-CCccc--------
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSS----------------GQGIVEFKNEAKLIAKLQ-HTNLT-------- 442 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~----------------~~~~~~~~~E~~~l~~l~-H~niv-------- 442 (676)
...||+|+.-.||. +++.....||++.... ....++..+|+.....+. +.++.
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 56899999999995 4556677888876544 223567788888877777 44432
Q ss_pred -----------------cccccCcCCHHHHH-------HHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC--C--C
Q 005803 443 -----------------DSSRKSLLDWKKRF-------YIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ--M--N 494 (676)
Q Consensus 443 -----------------~~~~~~~l~~~~~~-------~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~--~--~ 494 (676)
+.......+....+ .+...+-+-..||-+.+ |+.+|++|.||++... + .
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~ 160 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDHH---IVIRDLNPHNIVVQRRDSGEFR 160 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHcC---CeecCCCcccEEEEecCCCceE
Confidence 01111011111111 23333334456666666 9999999999999632 2 4
Q ss_pred eEEec-cCcc
Q 005803 495 PKISD-FGMA 503 (676)
Q Consensus 495 vkL~D-FGla 503 (676)
+.|+| ||..
T Consensus 161 lvlIDG~G~~ 170 (199)
T PF10707_consen 161 LVLIDGLGEK 170 (199)
T ss_pred EEEEeCCCCc
Confidence 67777 4433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.089 Score=53.53 Aligned_cols=30 Identities=27% Similarity=0.317 Sum_probs=26.3
Q ss_pred CceEeeccccCceEEcCCCCeEEeccCcce
Q 005803 475 LRAIHRDLKVSNILLDEQMNPKISDFGMAR 504 (676)
Q Consensus 475 ~~iiH~DLKp~NILl~~~~~vkL~DFGla~ 504 (676)
..++|+|+.|.|||++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 347999999999999998778899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.17 Score=53.50 Aligned_cols=30 Identities=33% Similarity=0.375 Sum_probs=26.6
Q ss_pred CceEeeccccCceEEcCCCCeEEeccCcce
Q 005803 475 LRAIHRDLKVSNILLDEQMNPKISDFGMAR 504 (676)
Q Consensus 475 ~~iiH~DLKp~NILl~~~~~vkL~DFGla~ 504 (676)
.+++|+|+.+.||+++.++...|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 459999999999999988777899998875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.16 Score=53.55 Aligned_cols=31 Identities=32% Similarity=0.349 Sum_probs=27.2
Q ss_pred CCceEeeccccCceEEcCC----CCeEEeccCcce
Q 005803 474 RLRAIHRDLKVSNILLDEQ----MNPKISDFGMAR 504 (676)
Q Consensus 474 ~~~iiH~DLKp~NILl~~~----~~vkL~DFGla~ 504 (676)
...++|+|+.+.|||++++ +.++|+||..|.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 4568999999999999975 789999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.13 Score=55.40 Aligned_cols=31 Identities=32% Similarity=0.460 Sum_probs=26.5
Q ss_pred CceEeeccccCceEEcC-CCCeEEeccCccee
Q 005803 475 LRAIHRDLKVSNILLDE-QMNPKISDFGMART 505 (676)
Q Consensus 475 ~~iiH~DLKp~NILl~~-~~~vkL~DFGla~~ 505 (676)
..++|+|+++.|||+++ ++.++|+||..+..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 45899999999999986 46799999988753
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.041 Score=54.03 Aligned_cols=57 Identities=16% Similarity=0.060 Sum_probs=51.0
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 449 LLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 449 ~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
..+|..|.+||.++++.+.+|+......+.-+|++++|+-+++++++|++|...+..
T Consensus 55 ~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 55 QSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred ccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 468999999999999999999986555689999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.099 Score=59.10 Aligned_cols=30 Identities=17% Similarity=0.374 Sum_probs=26.7
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEecc
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSK 417 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~ 417 (676)
.+.||.-+.|.||+|++++|+.||||+-+.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P 195 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHP 195 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCc
Confidence 367899999999999999999999998754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.072 Score=55.91 Aligned_cols=128 Identities=15% Similarity=0.189 Sum_probs=82.0
Q ss_pred ccHHHHHHHhc---CCCcceeeccCCCccEEEEEEcCCcEEEEEEeccC---------C--------c-----hhhHHHH
Q 005803 373 FDFQTIAAATD---NFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKS---------S--------G-----QGIVEFK 427 (676)
Q Consensus 373 f~~~~l~~~t~---~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~---------~--------~-----~~~~~~~ 427 (676)
+++-.|+...+ =+.+.+.||-|.-+-||.+....|++.++|.-... . . -..-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 44555554333 46778999999999999999988999998843110 0 0 0122346
Q ss_pred HHHHHHHHccCCc------------cc--cccccCcC----CHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE
Q 005803 428 NEAKLIAKLQHTN------------LT--DSSRKSLL----DWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL 489 (676)
Q Consensus 428 ~E~~~l~~l~H~n------------iv--~~~~~~~l----~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl 489 (676)
+|...|+.|.... +| ....+.++ .....-.+...+..-+.-|-.+| +||+|..-=||++
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv 235 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDHNRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMV 235 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccccceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHcC---ceecccchheeEE
Confidence 7888888885321 11 11111111 11122234444555556666677 9999999999999
Q ss_pred cCCCCeEEeccCcc
Q 005803 490 DEQMNPKISDFGMA 503 (676)
Q Consensus 490 ~~~~~vkL~DFGla 503 (676)
++++.++++||=-.
T Consensus 236 ~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQM 249 (465)
T ss_pred ecCCCEEEeechHh
Confidence 99999999999543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=94.59 E-value=0.35 Score=58.50 Aligned_cols=54 Identities=17% Similarity=0.343 Sum_probs=38.7
Q ss_pred ceeeccCCCccEEEEEEcCC---cEEEEEEeccCC-chhhHHHHHHHHHHHHcc-CCcc
Q 005803 388 ANRLGQGGFGPVYNGKLLDG---QEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQ-HTNL 441 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~---~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~ni 441 (676)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~v 101 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDV 101 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCC
Confidence 57789999999999876553 467788764322 223456889999999985 6554
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.23 E-value=0.022 Score=69.82 Aligned_cols=81 Identities=10% Similarity=0.019 Sum_probs=67.1
Q ss_pred ceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCC
Q 005803 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555 (676)
Q Consensus 476 ~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~ 555 (676)
.-+|++||+-|.+|..+..+|++++|+.+...+ .........+++.|+.|++...-.++.++|+|..|+-+|+.--|.
T Consensus 1360 T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1360 TNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred cchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhccc
Confidence 368999999999999999999999999983322 122233467788999999998888999999999999999998887
Q ss_pred cCC
Q 005803 556 KNN 558 (676)
Q Consensus 556 ~pf 558 (676)
.+|
T Consensus 1438 ~~f 1440 (2724)
T KOG1826|consen 1438 AYF 1440 (2724)
T ss_pred HHH
Confidence 765
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.22 E-value=0.33 Score=50.72 Aligned_cols=30 Identities=30% Similarity=0.489 Sum_probs=25.2
Q ss_pred ceEeeccccCceEEcCCCC-eEEeccCccee
Q 005803 476 RAIHRDLKVSNILLDEQMN-PKISDFGMART 505 (676)
Q Consensus 476 ~iiH~DLKp~NILl~~~~~-vkL~DFGla~~ 505 (676)
.++|+|+.|.|||+++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4799999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.50 E-value=0.7 Score=49.55 Aligned_cols=116 Identities=22% Similarity=0.238 Sum_probs=82.1
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEeccCC------------------------chhhHH--HHHHHHHHHHccCCcc
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSS------------------------GQGIVE--FKNEAKLIAKLQHTNL 441 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~------------------------~~~~~~--~~~E~~~l~~l~H~ni 441 (676)
..-|..|.-+.||.+.-.+|..+|||+++.+. ...... ...|+.-|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34577888999999998899999999885320 011111 2457788888865333
Q ss_pred c------------------------cccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEE
Q 005803 442 T------------------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKI 497 (676)
Q Consensus 442 v------------------------~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL 497 (676)
. .......+...++..+-.+++.-+.-|-+.+ ++||.||.--|+|+.+ |.+.|
T Consensus 229 P~PePIlLk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-G~lyi 305 (520)
T KOG2270|consen 229 PCPEPILLKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-GKLYI 305 (520)
T ss_pred CCCCceeeecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-CEEEE
Confidence 1 1222334556677778888888888887776 5999999999999865 58999
Q ss_pred eccCcceec
Q 005803 498 SDFGMARTY 506 (676)
Q Consensus 498 ~DFGla~~~ 506 (676)
+|-+-+...
T Consensus 306 IDVSQSVE~ 314 (520)
T KOG2270|consen 306 IDVSQSVEH 314 (520)
T ss_pred EEccccccC
Confidence 998877543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=92.37 E-value=0.81 Score=49.05 Aligned_cols=30 Identities=27% Similarity=0.327 Sum_probs=25.7
Q ss_pred ceEeeccccCceEEcC-CCCeEEeccCccee
Q 005803 476 RAIHRDLKVSNILLDE-QMNPKISDFGMART 505 (676)
Q Consensus 476 ~iiH~DLKp~NILl~~-~~~vkL~DFGla~~ 505 (676)
.++|.|+.+.|||+++ ++.++++||..|..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 4799999999999974 56899999988753
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.10 E-value=1.3 Score=47.45 Aligned_cols=28 Identities=36% Similarity=0.569 Sum_probs=25.5
Q ss_pred eEeeccccCceEEcCCCC-eEEeccCcce
Q 005803 477 AIHRDLKVSNILLDEQMN-PKISDFGMAR 504 (676)
Q Consensus 477 iiH~DLKp~NILl~~~~~-vkL~DFGla~ 504 (676)
+||+|+.|.||+++.+.. ..++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999998875 8899999875
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.95 E-value=1.8 Score=45.60 Aligned_cols=47 Identities=9% Similarity=-0.069 Sum_probs=33.0
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHcc
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ 437 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~ 437 (676)
.+.||.|..+.||+....+++ +.+|..+. ......+..|...|+.+.
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~ 65 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLA 65 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHc
Confidence 567999999999998765554 66676432 113357788888887774
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=91.59 E-value=1.8 Score=47.65 Aligned_cols=49 Identities=18% Similarity=0.251 Sum_probs=36.1
Q ss_pred ceeeccCCCccEEEEEEcCC-cEEEEEEeccC------C-chhhHHHHHHHHHHHHc
Q 005803 388 ANRLGQGGFGPVYNGKLLDG-QEIAIKRLSKS------S-GQGIVEFKNEAKLIAKL 436 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~-~~VAvK~l~~~------~-~~~~~~~~~E~~~l~~l 436 (676)
.+.||.|.+..||++...+| +.|+||.-... . ....+++..|.+.|..+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l 87 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQ 87 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHH
Confidence 46799999999999998776 58999984311 0 12345677788888775
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.69 E-value=2.6 Score=45.08 Aligned_cols=43 Identities=16% Similarity=0.062 Sum_probs=30.5
Q ss_pred CCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHcc
Q 005803 394 GGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ 437 (676)
Q Consensus 394 G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~ 437 (676)
+.-..||+....+++.+++|+.+.. .....++..|++.+..|.
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~ 78 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELA 78 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHH
Confidence 3456799998878888999987532 234556677888777764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=89.09 E-value=0.98 Score=45.20 Aligned_cols=76 Identities=20% Similarity=0.236 Sum_probs=51.2
Q ss_pred HHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHH
Q 005803 463 VQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542 (676)
Q Consensus 463 a~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVw 542 (676)
+.+|.-.|+.. ...+|+|-.|+|||-|..|.+||.|-+.-.. . +..|.--| ....+.++.+-
T Consensus 151 i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------~------~V~~vN~~---Y~~lT~~aE~~ 212 (308)
T PF07387_consen 151 IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------N------QVNMVNIE---YESLTQEAEVK 212 (308)
T ss_pred HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--------h------eeeEEeee---ccccChHHHHH
Confidence 46677788553 3599999999999999999999999775421 0 01111111 12346677777
Q ss_pred HHHHHHHHHHhCCc
Q 005803 543 SFGVLVLEIVSSKK 556 (676)
Q Consensus 543 SlGvvl~elltG~~ 556 (676)
+|=.-++++....+
T Consensus 213 ~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 213 VFVKSCLKLVEKQR 226 (308)
T ss_pred HHHHHHHHHHHHHh
Confidence 77777777776443
|
The function of this family is unknown. |
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=88.38 E-value=0.27 Score=44.37 Aligned_cols=46 Identities=20% Similarity=0.373 Sum_probs=34.8
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHc
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 436 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l 436 (676)
.+.||.|+.|.||+|++.+|+.||||+.+... .+.+..++.+|+.+
T Consensus 16 ~~PlasASiaQVh~a~l~~g~~VaVKV~rP~i---~~~i~~Dl~~l~~~ 61 (119)
T PF03109_consen 16 PEPLASASIAQVHRARLKDGEEVAVKVQRPGI---EEQIEADLRILRRL 61 (119)
T ss_pred cchhhheehhhheeeeecccchhhhhhcchHH---HHHHHHHHHHHHHH
Confidence 46899999999999999999999999986532 33445555555443
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=87.48 E-value=3.8 Score=50.76 Aligned_cols=31 Identities=35% Similarity=0.438 Sum_probs=25.9
Q ss_pred CceEeeccccCceEEcCCC--CeE-EeccCccee
Q 005803 475 LRAIHRDLKVSNILLDEQM--NPK-ISDFGMART 505 (676)
Q Consensus 475 ~~iiH~DLKp~NILl~~~~--~vk-L~DFGla~~ 505 (676)
..+||+|+.+.|||++.+. .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4599999999999999775 554 999998764
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.32 E-value=0.59 Score=49.34 Aligned_cols=37 Identities=24% Similarity=0.177 Sum_probs=24.9
Q ss_pred HHHHHHHHHHHHHHH-HhcCCCceEeeccccCceEEcC
Q 005803 455 RFYIIEGIVQGLLYL-HKYSRLRAIHRDLKVSNILLDE 491 (676)
Q Consensus 455 ~~~i~~qia~gL~yL-H~~~~~~iiH~DLKp~NILl~~ 491 (676)
...+..||+.-.-.+ .-.+....+|-||||+|||+-+
T Consensus 281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd 318 (444)
T PHA03111 281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD 318 (444)
T ss_pred HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence 344677776554334 3333456999999999999943
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=86.79 E-value=2.4 Score=45.92 Aligned_cols=29 Identities=28% Similarity=0.387 Sum_probs=24.7
Q ss_pred ceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 476 RAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 476 ~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
.++|||+.+.||+++++ .++++|+.++..
T Consensus 193 ~llHGDl~~gNi~~~~~-~~~~iD~e~~~~ 221 (370)
T TIGR01767 193 TLLHGDLHSGSIFVSEH-ETKVIDPEFAFY 221 (370)
T ss_pred eeeeccCCcccEEEcCC-CCEEEcCccccc
Confidence 48999999999999775 488999987754
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=86.22 E-value=7.4 Score=42.73 Aligned_cols=49 Identities=10% Similarity=0.155 Sum_probs=33.7
Q ss_pred ceeeccCCCccEEEEEEcC-CcEEEEEEeccC------CchhhHHHHHHHHHHHHc
Q 005803 388 ANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKS------SGQGIVEFKNEAKLIAKL 436 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~------~~~~~~~~~~E~~~l~~l 436 (676)
.+.||.|.-.-||++...+ ++.|+||.-... -.-..++..-|.+.|+..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~ 89 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLE 89 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHH
Confidence 4689999999999998743 678999964311 122345566677777665
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=85.44 E-value=5 Score=43.99 Aligned_cols=29 Identities=34% Similarity=0.301 Sum_probs=24.0
Q ss_pred CceEeeccccCceEEcCCCCeEEeccCcce
Q 005803 475 LRAIHRDLKVSNILLDEQMNPKISDFGMAR 504 (676)
Q Consensus 475 ~~iiH~DLKp~NILl~~~~~vkL~DFGla~ 504 (676)
...+|.|+-+.||+.+++ .++++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC-CEEEEEecccc
Confidence 357999999999997654 69999997764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 676 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-40 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-39 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-29 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-29 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-25 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 329 bits (846), Expect = e-108
Identities = 92/306 (30%), Positives = 139/306 (45%), Gaps = 50/306 (16%)
Query: 369 DLKIFDFQTIAAATDNFSP------ANRLGQGGFGPVYNGKLLDGQEIAIKRLSK----S 418
F F + T+NF N++G+GGFG VY G ++ +A+K+L+ +
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDIT 69
Query: 419 SGQGIVEFKNEAKLIAKLQHTNL--------TDSSR---------KSL------------ 449
+ + +F E K++AK QH NL SL
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 450 LDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509
L W R I +G G+ +LH+ IHRD+K +NILLDE KISDFG+AR
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERP-LN 568
T+RIVGT YM+PE + G ++ KSD+YSFGV++LEI++ D R
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPA---VDEHREPQL 242
Query: 569 LVGYAWQLWNEGKALE-LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
L+ ++ +E K +E +D + S V V C+ ++ R + V +L
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
Query: 628 TNDTMA 633
T +
Sbjct: 302 QEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = e-105
Identities = 104/300 (34%), Positives = 155/300 (51%), Gaps = 40/300 (13%)
Query: 370 LKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGI-VEFKN 428
LK F + + A+DNFS N LG+GGFG VY G+L DG +A+KRL + QG ++F+
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 429 EAKLIAKLQHTNL--------TDSSR----------------------KSLLDWKKRFYI 458
E ++I+ H NL T + R + LDW KR I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 459 IEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRI 518
G +GL YLH + + IHRD+K +NILLDE+ + DFG+A+ + T +
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AV 195
Query: 519 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPL-----NLVGYA 573
GT G+++PEY+ G S K+DV+ +GV++LE+++ ++ +D R L+ +
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA---FDLARLANDDDVMLLDWV 252
Query: 574 WQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMA 633
L E K L+D L + +EV + I V LLC Q +R MS+VV ML D +A
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 9e-92
Identities = 86/296 (29%), Positives = 140/296 (47%), Gaps = 33/296 (11%)
Query: 362 NDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQ 421
+ V + + AT+NF +G G FG VY G L DG ++A+KR + S Q
Sbjct: 18 SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ 77
Query: 422 GIVEFKNEAKLIAKLQHTNLT------------------------------DSSRKSLLD 451
GI EF+ E + ++ +H +L +
Sbjct: 78 GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137
Query: 452 WKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511
W++R I G +GL YLH + IHRD+K NILLDE PKI+DFG+++ +
Sbjct: 138 WEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVG 571
+ + GT GY+ PEY + G ++ KSDVYSFGV++ E++ ++ +NL
Sbjct: 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254
Query: 572 YAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
+A + N G+ +++DP L + + + + + C+ + DR +M DV+ L
Sbjct: 255 WAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 9e-67
Identities = 56/307 (18%), Positives = 110/307 (35%), Gaps = 55/307 (17%)
Query: 373 FDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKL 432
+ + + +G FG V+ +L + +A+K Q + + E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 433 IAKLQHTN-----------------------------LTDSSRKSLLDWKKRFYIIEGIV 463
+ ++H N L+D + +++ W + +I E +
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMA 131
Query: 464 QGLLYLH-------KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516
+GL YLH + HRD+K N+LL + I+DFG+A + + +T+
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191
Query: 517 RIVGTHGYMSPEYVMNGI-----VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVG 571
VGT YM+PE + I ++ D+Y+ G+++ E+ S D ++
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA---ADGPVDEYMLP 248
Query: 572 YAWQLWNEGKALEL--------MDPTLDESCSSDEVMRCI-HVGLLCVQDRAADRRTMSD 622
+ ++ ++ P L + M + C A R +
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 623 VVSMLTN 629
V +T
Sbjct: 309 VGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 6e-60
Identities = 61/334 (18%), Positives = 108/334 (32%), Gaps = 66/334 (19%)
Query: 373 FDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAK- 431
+ DN +G+G +G VY G L D + +A+K S ++ Q F NE
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 432 -LIAKLQHTN------------------------------LTDSSRKSLLDWKKRFYIIE 460
+ ++H N L DW +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH 118
Query: 461 GIVQGLLYLH------KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN----- 509
+ +GL YLH + + HRDL N+L+ ISDFG++ N
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 510 -ELEANTNRIVGTHGYMSPEYVMNGI-------VSMKSDVYSFGVLVLEIVSSKKNNGSY 561
E + VGT YM+PE + + + D+Y+ G++ EI +
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 562 DTERPLNLVGYAWQLWNEGKALELMD--------PTLDESCSSDEVMRCIHVGLL--CVQ 611
++ + + ++ N ++ P E+ + + + C
Sbjct: 239 ESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297
Query: 612 DRAADRRTMSDVVSMLTNDTMALPKPKQPAFFIN 645
A R T + M + K + +
Sbjct: 298 QDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-41
Identities = 63/291 (21%), Positives = 121/291 (41%), Gaps = 61/291 (20%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN------ 440
++G G FG V+ + G ++A+K L + + + EF E ++ +L+H N
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 441 -----------------------LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRA 477
L S + LD ++R + + +G+ YLH
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSM 537
+HR+LK N+L+D++ K+ DFG++R A L + + GT +M+PE + + +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSNE 218
Query: 538 KSDVYSFGVLVLEIVSSKKNNGSYDTERP---LNLVGYAWQLWNEGKALELMDPTLDESC 594
KSDVYSFGV++ E+ + ++P LN + + K + +
Sbjct: 219 KSDVYSFGVILWELATL---------QQPWGNLNPAQVVAAVGFKCKR-----LEIPRNL 264
Query: 595 SSD--EVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN-DTMALPKPKQPAF 642
+ ++ C + R + + ++ +L A+P P +
Sbjct: 265 NPQVAAIIE------GCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-40
Identities = 61/290 (21%), Positives = 109/290 (37%), Gaps = 54/290 (18%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN-------- 440
+G+G FG V K +++AIK++ S F E + ++++ H N
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 441 -------------------LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRD 481
L + QG+ YLH IHRD
Sbjct: 71 LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 482 LKVSNILLDEQMN-PKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSD 540
LK N+LL KI DFG A +++ + G+ +M+PE S K D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 541 VYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD--E 598
V+S+G+++ E+++ +K +D + G A+++ P L ++
Sbjct: 186 VFSWGIILWEVITRRK---PFD-----EIGGPAFRI--MWAVHNGTRPPLIKNLPKPIES 235
Query: 599 VMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQPAFFINISS 648
+M C + R +M ++V ++T+ P +P + S
Sbjct: 236 LMTR------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHS 279
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 59/284 (20%), Positives = 111/284 (39%), Gaps = 65/284 (22%)
Query: 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQG-------IVEFKNEAKLIAKLQHTN 440
++G+GGFG V+ G+L+ D +AIK L +G EF+ E +++ L H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 441 LTD-------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRL 475
+ + + W + ++ I G+ Y+
Sbjct: 85 IVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNP 143
Query: 476 RAIHRDLKVSNILLDEQ-----MNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYV 530
+HRDL+ NI L + K++DFG+++ + + + ++G +M+PE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPE-T 197
Query: 531 MNG---IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587
+ + K+D YSF +++ I++ + +D + + + EG
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEG---PFDEYSYGK-IKFINMIREEGLR----- 248
Query: 588 PTLDESCSSD--EVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629
PT+ E C V+ LC R S +V L+
Sbjct: 249 PTIPEDCPPRLRNVIE------LCWSGDPKKRPHFSYIVKELSE 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 42/204 (20%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKS----SGQGIVEFKNEAKLIAKLQHTNL--- 441
+G GGFG VY G E+A+K Q I + EAKL A L+H N+
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 442 ----TDS----------SRKSL--------LDWKKRFYIIEGIVQGLLYLHKYSRLRAIH 479
L + I +G+ YLH + + IH
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 480 RDLKVSNILLDEQMNP--------KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM 531
RDLK SNIL+ +++ KI+DFG+AR + + G + +M+PE +
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPEVIR 187
Query: 532 NGIVSMKSDVYSFGVLVLEIVSSK 555
+ S SDV+S+GVL+ E+++ +
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 36/198 (18%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL----- 441
R+G G FG VY GK ++A+K L+ + + Q + FKNE ++ K +H N+
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 442 --TDS-------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHR 480
T + ++ + KK I +G+ YLH IHR
Sbjct: 88 YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 481 DLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN---GIVSM 537
DLK +NI L E KI DFG+A + ++ G+ +M+PE + S
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 538 KSDVYSFGVLVLEIVSSK 555
+SDVY+FG+++ E+++ +
Sbjct: 205 QSDVYAFGIVLYELMTGQ 222
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 51/208 (24%), Positives = 81/208 (38%), Gaps = 43/208 (20%)
Query: 389 NRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 441
LG+G FG + G+ + +K L + + F E K++ L+H N+
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 442 -TDS--------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHR 480
S S W +R + I G+ YLH + IHR
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 481 DLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR------------IVGTHGYMSPE 528
DL N L+ E N ++DFG+AR + + R +VG +M+PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 529 YVMNGIVSMKSDVYSFGVLVLEIVSSKK 556
+ K DV+SFG+++ EI+
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 48/280 (17%), Positives = 98/280 (35%), Gaps = 71/280 (25%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL----- 441
+L + G ++ G+ G +I +K L S + +F E + H N+
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 442 --TDS------------SRKSL-----------LDWKKRFYIIEGIVQGLLYLHKYSRLR 476
SL +D + + +G+ +LH L
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL- 133
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG--- 533
L ++++DE M +IS + ++ + +++PE +
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQSPG-------RMYAPAWVAPE-ALQKKPE 185
Query: 534 -IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERP---LNLVGYAWQLWNEGKALELMDPT 589
+D++SF VL+ E+V+ E P L+ + ++ EG + PT
Sbjct: 186 DTNRRSADMWSFAVLLWELVTR---------EVPFADLSNMEIGMKVALEG-----LRPT 231
Query: 590 LDESCSSD--EVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
+ S ++M+ +C+ + A R +V +L
Sbjct: 232 IPPGISPHVSKLMK------ICMNEDPAKRPKFDMIVPIL 265
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 69/293 (23%), Positives = 114/293 (38%), Gaps = 59/293 (20%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAK--LIAKLQHTN------ 440
++G+G +G V+ GK G+++A+K + E + ++H N
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 441 -----------------------LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRA 477
L D + + LD K + V GL +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 478 -----IHRDLKVSNILLDEQMNPKISDFGMARTYA--MNELEANTNRIVGTHGYMSPEYV 530
HRDLK NIL+ + I+D G+A + NE++ N VGT YM PE V
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-V 217
Query: 531 MNGIVSM-------KSDVYSFGVLVL-EIVSSKKNNGSYDTERP----LNLVGYAWQLWN 578
++ ++ +D+YSFG L+L E+ + G + + L +++
Sbjct: 218 LDESLNRNHFQSYIMADMYSFG-LILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 579 EGKALELMDPTLDESCSSDEVMRCIHVGLL--CVQDRAADRRTMSDVVSMLTN 629
E ++ + P+ SSDE +R + L+ C A R T V L
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQM-GKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 65/298 (21%), Positives = 112/298 (37%), Gaps = 69/298 (23%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKL--IAKLQHTN------ 440
+G+G +G V+ G G+ +A+K S + + E +L L+H N
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 441 -----------------------LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRA 477
L D + + LD I+ I GL +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 478 -----IHRDLKVSNILLDEQMNPKISDFGMARTYA--MNELEANTNRIVGTHGYMSPEYV 530
HRDLK NIL+ + I+D G+A ++ N+L+ N VGT YM+PE V
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-V 188
Query: 531 MNGIVSM-------KSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK-A 582
++ + + + D+++FG+++ E+ +NG + +P + +
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP------PFYDVVPNDPS 242
Query: 583 LELMD---------PTLDESCSSDEVMRCIHVGLL--CVQDRAADRRTMSDVVSMLTN 629
E M P + SD + + L+ C + R T + LT
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSL-AKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 45/208 (21%), Positives = 81/208 (38%), Gaps = 47/208 (22%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL----- 441
+G+G FG VY+G+ E+AI+ + + + FK E + +H N+
Sbjct: 39 ELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 442 --TDS--------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIH 479
K +LD K I + IV+G+ YLH +H
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRI---VGTHGYMSPEYVMNGIV- 535
+DLK N+ D I+DFG+ + + +++ G +++PE +
Sbjct: 154 KDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 536 --------SMKSDVYSFGVLVLEIVSSK 555
S SDV++ G + E+ + +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 7e-32
Identities = 62/298 (20%), Positives = 109/298 (36%), Gaps = 69/298 (23%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAK--LIAKLQHTN------ 440
+G+G FG V+ GK G+E+A+K S + + EA+ L+H N
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 441 -----------------------LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRA 477
L D + + + + GL +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 478 -----IHRDLKVSNILLDEQMNPKISDFGMARTYA--MNELEANTNRIVGTHGYMSPEYV 530
HRDLK NIL+ + I+D G+A + + ++ N VGT YM+PE V
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-V 222
Query: 531 MNGIVSM-------KSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWN-EGKA 582
++ ++M ++D+Y+ G++ EI G ++ + + +
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL------PYYDLVPSDPS 276
Query: 583 LELMD---------PTLDESCSSDEVMRCIHVGLL--CVQDRAADRRTMSDVVSMLTN 629
+E M P + S E +R + ++ C A R T + L+
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVM-AKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 55/219 (25%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN- 440
+F +G GGFG V+ K +DG+ IKR+ ++ + + E K +AKL H N
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 441 -------------LTDSSRKSLLDWKKRFYII----EG---------------------- 461
SS+ S K +I +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 462 ----IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517
I +G+ Y+H + I+RDLK SNI L + KI DFG+ + N+ +
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTS-LKNDGKRTR-- 180
Query: 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKK 556
GT YMSPE + + + D+Y+ G+++ E++
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 56/222 (25%), Positives = 83/222 (37%), Gaps = 56/222 (25%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTN 440
+F P LG+GGFG V+ K +D AIKR+ + E K +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 441 --------LTDSS---------------------RKSLLDWKKR------------FYII 459
L ++ +++L DW +I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 460 EGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR----------TYAMN 509
I + + +LH +HRDLK SNI K+ DFG+
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEI 551
A VGT YMSPE + S K D++S G+++ E+
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 55/224 (24%), Positives = 85/224 (37%), Gaps = 60/224 (26%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 440
+F LGQG FG V + LD + AIK++ + + + +E L+A L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 441 LT-----------DSSRKSLLDWKKRFYII----EG------------------------ 461
+ + + K +I E
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 462 -IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR------------TYAM 508
I++ L Y+H IHRDLK NI +DE N KI DFG+A+ + +
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 509 NELEANTNRIVGTHGYMSPEYVMNGIVS--MKSDVYSFGVLVLE 550
N +GT Y++ E V++G K D+YS G++ E
Sbjct: 181 PGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFE 223
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 53/200 (26%), Positives = 82/200 (41%), Gaps = 40/200 (20%)
Query: 390 RLGQGGFGPVYNGK-LLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNLTD--S 444
+G+G F VY G E+A + K + FK EA+++ LQH N+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 445 SRKSLLDWKKRFYII----EG------------------------IVQGLLYLHKYSRLR 476
S +S + KK ++ I++GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPP 151
Query: 477 AIHRDLKVSNILLD-EQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
IHRDLK NI + + KI D G+A A ++GT +M+PE
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKA--VIGTPEFMAPEMYEEK-Y 206
Query: 536 SMKSDVYSFGVLVLEIVSSK 555
DVY+FG+ +LE+ +S+
Sbjct: 207 DESVDVYAFGMCMLEMATSE 226
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 44/228 (19%)
Query: 361 HNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIK--RLSK 417
H+ V + FQ++ + + ++G+G FG K DG++ IK +S+
Sbjct: 6 HHSSGVDLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR 61
Query: 418 SSGQGIVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYII----EG------------ 461
S + E + E ++A ++H N+ R+S + YI+ EG
Sbjct: 62 MSSKEREESRREVAVLANMKHPNIV-QYRESFEE-NGSLYIVMDYCEGGDLFKRINAQKG 119
Query: 462 --------------IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507
I L ++H + +HRD+K NI L + ++ DFG+AR
Sbjct: 120 VLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 508 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
A +GT Y+SPE N + KSD+++ G ++ E+ + K
Sbjct: 177 STVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 52/197 (26%), Positives = 81/197 (41%), Gaps = 40/197 (20%)
Query: 390 RLGQGGFGPVYNGKL-LDGQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL------ 441
++G+G FG V++G+L D +A+K +F EA+++ + H N+
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 442 -TDS--------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHR 480
T + + L K ++ G+ YL IHR
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHR 237
Query: 481 DLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGY----MSPEYVMNGIVS 536
DL N L+ E+ KISDFGM+R E + G +PE + G S
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 537 MKSDVYSFGVLVLEIVS 553
+SDV+SFG+L+ E S
Sbjct: 294 SESDVWSFGILLWETFS 310
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 52/238 (21%), Positives = 95/238 (39%), Gaps = 46/238 (19%)
Query: 359 QVHNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKS 418
H+ V + FQ+++ +S ++G GG V+ Q AIK ++
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE 63
Query: 419 --SGQGIVEFKNEAKLIAKLQHTN-----LTDS-----------------------SRKS 448
Q + ++NE + KLQ + L D +KS
Sbjct: 64 EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKS 123
Query: 449 LLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508
+ W+++ Y +++ + +H++ +H DLK +N L+ + K+ DFG+A
Sbjct: 124 IDPWERKSYWKN-MLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQP 178
Query: 509 NELEANTNRIVGTHGYMSPEYVMN-----------GIVSMKSDVYSFGVLVLEIVSSK 555
+ + VGT YM PE + + +S KSDV+S G ++ + K
Sbjct: 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 48/209 (22%), Positives = 87/209 (41%), Gaps = 43/209 (20%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQH 438
NF ++G+G F VY LLDG +A+K++ + + E L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 439 TNLTDSSRKSLLDWKKRFYII----EG----------------------------IVQGL 466
N+ S ++ I+ + + L
Sbjct: 92 PNVI-KYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 467 LYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMS 526
++H R +HRD+K +N+ + K+ D G+ R ++ A++ +VGT YMS
Sbjct: 150 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 204
Query: 527 PEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
PE + + KSD++S G L+ E+ + +
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 47/208 (22%), Positives = 84/208 (40%), Gaps = 46/208 (22%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN-----L 441
++G GG V+ Q AIK ++ Q + ++NE + KLQ + L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 442 TDS-----------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAI 478
D +KS+ W+++ Y +++ + +H++ +
Sbjct: 75 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKN-MLEAVHTIHQH---GIV 130
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN------ 532
H DLK +N L+ + K+ DFG+A + + VGT YM PE + +
Sbjct: 131 HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 189
Query: 533 -----GIVSMKSDVYSFGVLVLEIVSSK 555
+S KSDV+S G ++ + K
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 45/208 (21%), Positives = 82/208 (39%), Gaps = 46/208 (22%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN------ 440
++G GG V+ Q AIK ++ Q + ++NE + KLQ +
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 441 --------------------LTD--SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAI 478
L +KS+ W+++ Y +++ + +H++ +
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKN-MLEAVHTIHQH---GIV 177
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN------ 532
H DLK +N L+ + K+ DFG+A + + VG YM PE + +
Sbjct: 178 HSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236
Query: 533 -----GIVSMKSDVYSFGVLVLEIVSSK 555
+S KSDV+S G ++ + K
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 44/205 (21%), Positives = 74/205 (36%), Gaps = 39/205 (19%)
Query: 383 DNFSPANRLGQGGFGPVYNG-KLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKL-QH 438
+F +RLG G +G V+ DG+ A+KR + E K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 439 TNLTD--------------------SSRKSLLDWKKRF-------YIIEGIVQGLLYLHK 471
S ++ W Y+ + + L +LH
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRD-TLLALAHLHS 175
Query: 472 YSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM 531
+H D+K +NI L + K+ DFG+ G YM+PE ++
Sbjct: 176 ---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEV--QEGDPRYMAPE-LL 228
Query: 532 NGIVSMKSDVYSFGVLVLEIVSSKK 556
G +DV+S G+ +LE+ + +
Sbjct: 229 QGSYGTAADVFSLGLTILEVACNME 253
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 52/208 (25%), Positives = 85/208 (40%), Gaps = 39/208 (18%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHT 439
+++ +G G +G + DG+ + K L + +E L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 440 NL-------TDSSRKSLL-----------------DWKKRFYIIEG--------IVQGLL 467
N+ D + +L K+R Y+ E + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 468 YLH--KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYM 525
H +HRDLK +N+ LD + N K+ DFG+AR + A T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 526 SPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
SPE + + KSD++S G L+ E+ +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCA 211
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 47/193 (24%), Positives = 80/193 (41%), Gaps = 34/193 (17%)
Query: 390 RLGQGGFGPVYNGK-LLDGQEIAIK--RLSKSSGQGIVE-FKNEAKLIAKLQHTNL---- 441
+LG GG VY + + ++AIK + + ++ F+ E ++L H N+
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 442 ---TDSS-------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIH 479
+ L I+ G+ + H +R +H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIVH 134
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 539
RD+K NIL+D KI DFG+A+ + L TN ++GT Y SPE +
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECT 193
Query: 540 DVYSFGVLVLEIV 552
D+YS G+++ E++
Sbjct: 194 DIYSIGIVLYEML 206
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 45/202 (22%)
Query: 389 NRLGQGGFGPVYNGKLLDGQE-----IAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL- 441
LG G FG VY G + E +AIK L + +S + E +EA ++A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 442 ------TDSSRK---------SLLDW----KKRFYIIE------GIVQGLLYLHKYSRLR 476
S+ + LLD+ K I +G+ YL R
Sbjct: 81 RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRR 137
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG-----YMSPEYVM 531
+HRDL N+L+ + KI+DFG+A+ E E + G +M+ E ++
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWMALESIL 192
Query: 532 NGIVSMKSDVYSFGVLVLEIVS 553
+ I + +SDV+S+GV V E+++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMT 214
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 46/217 (21%), Positives = 79/217 (36%), Gaps = 48/217 (22%)
Query: 376 QTIAAATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIA 434
+ ++ +LG+GGF V + L DG A+KR+ Q E + EA +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 435 KLQHTN---LTDS------------------SRKSLLD-------WKKRF------YIIE 460
H N L R +L + +++
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 461 GIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIV- 519
GI +GL +H HRDLK +NILL ++ P + D G ++ + +
Sbjct: 142 GICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 520 ------GTHGYMSPEYV---MNGIVSMKSDVYSFGVL 547
T Y +PE + ++ ++DV+S G +
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 3e-25
Identities = 52/197 (26%), Positives = 83/197 (42%), Gaps = 42/197 (21%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 441
+G G FG V+ G L+ ++AIK + + +F EA+++ KL H L
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 442 TDS--------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRD 481
+ +++ L + + + +G+ YL IHRD
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRD 129
Query: 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTN-----RIVGTHGYMSPEYVMNGIVS 536
L N L+ E K+SDFGM R ++ ++T + + SPE S
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK------WASPEVFSFSRYS 183
Query: 537 MKSDVYSFGVLVLEIVS 553
KSDV+SFGVL+ E+ S
Sbjct: 184 SKSDVWSFGVLMWEVFS 200
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 64/289 (22%), Positives = 114/289 (39%), Gaps = 64/289 (22%)
Query: 389 NRLGQGGFGPVYNGKLL-----DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-- 441
+LG+G FG V + G+ +A+K+L S+ + + +F+ E +++ LQH N+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 442 -----TDSSRK------------SLLDW----KKRF------YIIEGIVQGLLYLHKYSR 474
+ R+ SL D+ K+R I +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 132
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG-----YMSPEY 529
R IHRDL NIL++ + KI DFG+ + ++ V G + +PE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYAPES 188
Query: 530 VMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD-- 587
+ S+ SDV+SFGV++ E+ + + + S E + +EL+
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248
Query: 588 -----PTLDESCSSD--EVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629
P + C + +M C + R + D+ +
Sbjct: 249 GRLPRP---DGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQ 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 64/289 (22%), Positives = 114/289 (39%), Gaps = 64/289 (22%)
Query: 389 NRLGQGGFGPVYNGKLL-----DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-- 441
+LG+G FG V + G+ +A+K+L S+ + + +F+ E +++ LQH N+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 442 -----TDSSRK------------SLLDW----KKRF------YIIEGIVQGLLYLHKYSR 474
+ R+ SL D+ K+R I +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 163
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG-----YMSPEY 529
R IHRDL NIL++ + KI DFG+ + ++ V G + +PE
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAPES 219
Query: 530 VMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD-- 587
+ S+ SDV+SFGV++ E+ + + + S E + +EL+
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279
Query: 588 -----PTLDESCSSD--EVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629
P + C + +M C + R + D+ +
Sbjct: 280 GRLPRP---DGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQ 319
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 46/203 (22%)
Query: 389 NRLGQGGFGPVYNGKLL--DGQEI--AIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL-- 441
+G G G V G+L +++ AIK L + + + +F +EA ++ + H N+
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 442 -----TDS----------SRKSLLDW----KKRF------YIIEGIVQGLLYLHKYSRLR 476
T SL + +F ++ G+ G+ YL S L
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG------YMSPEYV 530
+HRDL N+L+D + K+SDFG++R LE + + T G + +PE +
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSR-----VLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 531 MNGIVSMKSDVYSFGVLVLEIVS 553
S SDV+SFGV++ E+++
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLA 249
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 6e-25
Identities = 40/195 (20%), Positives = 74/195 (37%), Gaps = 43/195 (22%)
Query: 390 RLGQGGFGPVYNGK--LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLT---D 443
+ GG G +Y ++G+ + +K L S E + +A++ H ++ +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 444 SSRKSLLDWKKRFYI----IEG----------------------IVQGLLYLHKYSRLRA 477
+ YI + G I+ L YLH +
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH---SIGL 203
Query: 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSM 537
++ DLK NI+L E+ K+ D G +N + GT G+ +PE V G ++
Sbjct: 204 VYNDLKPENIMLTEE-QLKLIDLGAVS--RINS----FGYLYGTPGFQAPEIVRTG-PTV 255
Query: 538 KSDVYSFGVLVLEIV 552
+D+Y+ G + +
Sbjct: 256 ATDIYTVGRTLAALT 270
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 390 RLGQGGFGPVYNGK-LLDGQEIAIK--RLSKSSGQGIVE-FKNEAKLIAKLQHTNL---- 441
LG GG V+ + L D +++A+K R + F+ EA+ A L H +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 442 ----TDSSRKSL----------------------LDWKKRFYIIEGIVQGLLYLHKYSRL 475
++ L + K+ +I Q L + H +
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QN 135
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA---NTNRIVGTHGYMSPEYVMN 532
IHRD+K +NI++ K+ DFG+AR A+ + T ++GT Y+SPE
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 533 GIVSMKSDVYSFGVLVLEIV 552
V +SDVYS G ++ E++
Sbjct: 194 DSVDARSDVYSLGCVLYEVL 213
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 44/200 (22%), Positives = 78/200 (39%), Gaps = 44/200 (22%)
Query: 390 RLGQGGFGPVYNGKLLDGQE---IAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL---- 441
LG G FG V G ++ +AIK L + + E EA+++ +L + +
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 442 ---TDS-------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIH 479
++ + ++ + G+ YL +H
Sbjct: 77 GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVH 133
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG------YMSPEYVMNG 533
RDL N+LL + KISDFG+++ L A+ + + +PE +
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSK-----ALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 534 IVSMKSDVYSFGVLVLEIVS 553
S +SDV+S+GV + E +S
Sbjct: 189 KFSSRSDVWSYGVTMWEALS 208
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 47/203 (23%)
Query: 390 RLGQGGFGPVYNGKLLDGQE-----IAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL-- 441
+G G FG VY G L +AIK L + + V+F EA ++ + H N+
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 442 -----TDS--------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLR 476
+ + + ++ GI G+ YL + +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMN 167
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG------YMSPEYV 530
+HRDL NIL++ + K+SDFG++R LE + T G + +PE +
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSR-----VLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 531 MNGIVSMKSDVYSFGVLVLEIVS 553
+ SDV+SFG+++ E+++
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMT 245
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 64/290 (22%), Positives = 103/290 (35%), Gaps = 68/290 (23%)
Query: 389 NRLGQGGFGPVYNGKLL---DGQEI--AIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL- 441
LG+G FG V DG A+K L +G Q +K E ++ L H ++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 442 ------TDSSRK------------SLLDW--KKRF------YIIEGIVQGLLYLHKYSRL 475
D+ SL D+ + + I +G+ YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQ 153
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG-----YMSPEYV 530
IHRDL N+LLD KI DFG+A+ V G + +PE +
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAPECL 209
Query: 531 MNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWN--------EGK 581
SDV+SFGV + E+++ + L + Q+ G+
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-GQMTVLRLTELLERGE 268
Query: 582 ALELMDPTLDESCSSD--EVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629
L + C ++ +M C + A+ R T +++ +L
Sbjct: 269 RLPRP-----DKCPAEVYHLM------KNCWETEASFRPTFENLIPILKT 307
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 53/194 (27%), Positives = 82/194 (42%), Gaps = 40/194 (20%)
Query: 391 LGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN--------L 441
LG+G +G VY G+ L IAIK + + + E L L+H N
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 442 TDS------------SRKSLLDWKK----------RFYIIEGIVQGLLYLHKYSRLRAIH 479
+ S +LL K FY + I++GL YLH + +H
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-ILEGLKYLH---DNQIVH 145
Query: 480 RDLKVSNILLDEQM-NPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV--S 536
RD+K N+L++ KISDFG ++ + + T GT YM+PE + G
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 537 MKSDVYSFGVLVLE 550
+D++S G ++E
Sbjct: 204 KAADIWSLGCTIIE 217
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 52/197 (26%), Positives = 82/197 (41%), Gaps = 42/197 (21%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 441
LG G FG V GK ++AIK + K EF EAK++ L H L
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 442 TDS--------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRD 481
T + ++ + + + + + YL + +HRD
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRD 145
Query: 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTN-----RIVGTHGYMSPEYVMNGIVS 536
L N L+++Q K+SDFG++R +E ++ R + PE +M S
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLMYSKFS 199
Query: 537 MKSDVYSFGVLVLEIVS 553
KSD+++FGVL+ EI S
Sbjct: 200 SKSDIWAFGVLMWEIYS 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 51/197 (25%), Positives = 80/197 (40%), Gaps = 44/197 (22%)
Query: 390 RLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------T 442
LG G FG V GK ++A+K + K EF EA+ + KL H L +
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 443 DS--------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDL 482
S L+ + + + +G+ +L + IHRDL
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDL 130
Query: 483 KVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG------YMSPEYVMNGIVS 536
N L+D + K+SDFGM R ++ + + G + +PE S
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVS-------SVGTKFPVKWSAPEVFHYFKYS 183
Query: 537 MKSDVYSFGVLVLEIVS 553
KSDV++FG+L+ E+ S
Sbjct: 184 SKSDVWAFGILMWEVFS 200
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 61/218 (27%)
Query: 389 NRLGQGGFGPVYNGKLLDG------QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 441
LG+G FG V+ + + +A+K L + +F+ EA+L+ LQH ++
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 442 -----------------------------------------TDSSRKSLLDWKKRFYIIE 460
K L + +I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 461 GIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVG 520
I G++YL + +HRDL N L+ + KI DFGM+R + + R VG
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYR-VG 192
Query: 521 THG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
H +M PE +M + +SDV+SFGV++ EI +
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 55/190 (28%), Positives = 82/190 (43%), Gaps = 41/190 (21%)
Query: 391 LGQGGFGPVYNGKLLD-GQEIAIKRLSKSS--GQGIVE-FKNEAKLIAKLQHTNL----- 441
LG+GGF + D + A K + KS E E + L H ++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 442 ---TDS---------SRKSLLDW---KKRF------YIIEGIVQGLLYLHKYSRLRAIHR 480
+ R+SLL+ +K Y + IV G YLH R R IHR
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 139
Query: 481 DLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR---IVGTHGYMSPEYVMNGIVSM 537
DLK+ N+ L+E + KI DFG+A ++E + R + GT Y++PE + S
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 538 KSDVYSFGVL 547
+ DV+S G +
Sbjct: 195 EVDVWSIGCI 204
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 46/204 (22%)
Query: 389 NRLGQGGFGPVYNGKLLDG----QEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL-- 441
+G+G FG VY+G LLD A+K L++ + + +F E ++ H N+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 442 -----TDS---------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRL 475
S + K + +G+ YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 147
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG------YMSPEY 529
+ +HRDL N +LDE+ K++DFG+AR + + + G +M+ E
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 530 VMNGIVSMKSDVYSFGVLVLEIVS 553
+ + KSDV+SFGVL+ E+++
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 46/203 (22%)
Query: 389 NRLGQGGFGPVYNGKLL--DGQEI--AIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL-- 441
+G G FG V +G+L +EI AIK L + + +F EA ++ + H N+
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 442 -----TDS--------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLR 476
T S + + ++ GI G+ YL S +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG------YMSPEYV 530
+HRDL NIL++ + K+SDFG+ R LE + T G + SPE +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGR-----VLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 531 MNGIVSMKSDVYSFGVLVLEIVS 553
+ SDV+S+G+++ E++S
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS 245
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 50/217 (23%), Positives = 87/217 (40%), Gaps = 60/217 (27%)
Query: 389 NRLGQGGFGPVYNGKLLDGQE------IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 441
LG+G FG V+ + + +A+K L ++S +F+ EA+L+ LQH ++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 442 ----------------------------------------TDSSRKSLLDWKKRFYIIEG 461
+ L + +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGT 521
+ G++YL + L +HRDL N L+ + + KI DFGM+R + + R VG
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VGG 218
Query: 522 HG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+M PE ++ + +SDV+SFGV++ EI +
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-24
Identities = 55/195 (28%), Positives = 85/195 (43%), Gaps = 38/195 (19%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 441
+LG G FG V+ ++A+K + K + F EA ++ LQH L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 442 TD--------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRD 481
T S S K I +G+ ++ + IHRD
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRD 309
Query: 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG---YMSPEYVMNGIVSMK 538
L+ +NIL+ + KI+DFG+AR NE A G + +PE + G ++K
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFTIK 365
Query: 539 SDVYSFGVLVLEIVS 553
SDV+SFG+L++EIV+
Sbjct: 366 SDVWSFGILLMEIVT 380
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 56/190 (29%), Positives = 82/190 (43%), Gaps = 41/190 (21%)
Query: 391 LGQGGFGPVYNGKLLD-GQEIAIKRLSKSS--GQGIVE-FKNEAKLIAKLQHTN------ 440
LG+GGF + D + A K + KS E E + L H +
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 441 -LTDS----------SRKSLLDW---KKRF------YIIEGIVQGLLYLHKYSRLRAIHR 480
D+ R+SLL+ +K Y + IV G YLH R R IHR
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 165
Query: 481 DLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR---IVGTHGYMSPEYVMNGIVSM 537
DLK+ N+ L+E + KI DFG+A ++E + R + GT Y++PE + S
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 538 KSDVYSFGVL 547
+ DV+S G +
Sbjct: 221 EVDVWSIGCI 230
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 49/200 (24%), Positives = 75/200 (37%), Gaps = 44/200 (22%)
Query: 390 RLGQGGFGPVYNGKLLDG---QEIAIKRLSK--SSGQGIVEFKNEAKLIAKLQHTNL--- 441
LG G FG V G + +A+K L + E EA ++ +L + +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 442 ----TDS---------SRKSLLDW---KKRF------YIIEGIVQGLLYLHKYSRLRAIH 479
L + + ++ + G+ YL +H
Sbjct: 84 IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL---EESNFVH 140
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG------YMSPEYVMNG 533
RDL N+LL Q KISDFG+++ L A+ N + +PE +
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSK-----ALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 534 IVSMKSDVYSFGVLVLEIVS 553
S KSDV+SFGVL+ E S
Sbjct: 196 KFSSKSDVWSFGVLMWEAFS 215
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 50/199 (25%), Positives = 82/199 (41%), Gaps = 44/199 (22%)
Query: 389 NRLGQGGFGPVYNGKLLDG-QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 441
++LG G +G VY G +A+K L K + EF EA ++ +++H NL
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 442 -TD---------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIH 479
T + + Y+ I + YL + IH
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 134
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN-----RIVGTHGYMSPEYVMNGI 534
RDL N L+ E K++DFG++R + A+ + + +PE +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAYNK 188
Query: 535 VSMKSDVYSFGVLVLEIVS 553
S+KSDV++FGVL+ EI +
Sbjct: 189 FSIKSDVWAFGVLLWEIAT 207
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 45/194 (23%), Positives = 77/194 (39%), Gaps = 36/194 (18%)
Query: 390 RLGQGGFGPVYNGK--LLDGQEIAIKRLSK--SSGQGIVE-FKNEAKLIAKLQHTNL--- 441
+G+GG G VY + + + + +A+K +S+ SS + EA+ +LQ ++
Sbjct: 41 LVGRGGMGDVYEAEDTVRE-RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 442 -----TDS------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAI 478
D R+ L + I+ I L H A
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH---AAGAT 156
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 538
HRD+K NIL+ + DFG+A +L VGT YM+PE + +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHATYR 215
Query: 539 SDVYSFGVLVLEIV 552
+D+Y+ ++ E +
Sbjct: 216 ADIYALTCVLYECL 229
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 54/203 (26%), Positives = 79/203 (38%), Gaps = 47/203 (23%)
Query: 390 RLGQGGFGPVYNGKLL--DGQEI--AIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNL- 441
+LG G FG V G+ G+ + A+K L S + + +F E + L H NL
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 442 ------TDSSRK---------SLLDW----KKRFYIIE------GIVQGLLYLHKYSRLR 476
K SLLD + F + + +G+ YL R
Sbjct: 85 RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ESKR 141
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG------YMSPEYV 530
IHRDL N+LL + KI DFG+ R L N + V + +PE +
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMR-----ALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 531 MNGIVSMKSDVYSFGVLVLEIVS 553
S SD + FGV + E+ +
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 59/290 (20%), Positives = 112/290 (38%), Gaps = 70/290 (24%)
Query: 389 NRLGQGGFGPVYNGKLL-----DGQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL- 441
LG+G FG V + G+++A+K L +S G I + K E +++ L H N+
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 442 ------TDSSRK------------SLLDW----KKRF------YIIEGIVQGLLYLHKYS 473
T+ SL ++ K + I +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---G 143
Query: 474 RLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG------YMSP 527
+ +HRDL N+L++ + KI DFG+ + +E + + +P
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTK-----AIETDKEYYTVKDDRDSPVFWYAP 198
Query: 528 EYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWN--------E 579
E +M + SDV+SFGV + E+++ ++ S + Q+ E
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258
Query: 580 GKALELMDPTLDESCSSD--EVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
GK L +C + ++M C + + ++R + +++
Sbjct: 259 GKRLPCP-----PNCPDEVYQLM------RKCWEFQPSNRTSFQNLIEGF 297
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 44/192 (22%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKSS--GQGIVE-FKNEAKLIAKLQHTN------ 440
LG+G F VY + + G E+AIK + K + G+V+ +NE K+ +L+H +
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 441 -LTDSSR---------------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAI 478
DS+ K + + R ++ + I+ G+LYLH +
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ-IITGMLYLH---SHGIL 134
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR---IVGTHGYMSPEYVMNGIV 535
HRDL +SN+LL MN KI+DFG+A +L+ + + GT Y+SPE
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATRSAH 189
Query: 536 SMKSDVYSFGVL 547
++SDV+S G +
Sbjct: 190 GLESDVWSLGCM 201
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 44/202 (21%), Positives = 77/202 (38%), Gaps = 45/202 (22%)
Query: 389 NRLGQGGFGPVYNGKLLDGQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL- 441
LG G FG V+ G + E + IK + SG Q + I L H ++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 442 ------TDS-------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLR 476
S + L + I +G+ YL
Sbjct: 79 RLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL---EEHG 135
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG-----YMSPEYVM 531
+HR+L N+LL +++DFG+A L + +++ + +M+ E +
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVAD-----LLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 532 NGIVSMKSDVYSFGVLVLEIVS 553
G + +SDV+S+GV V E+++
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMT 212
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 57/197 (28%), Positives = 87/197 (44%), Gaps = 42/197 (21%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 441
RLG G FG V+ G ++A+K L K F EA L+ +LQH L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 442 TD--------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRD 481
T + L K + I +G+ ++ IHRD
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRD 134
Query: 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTN-----RIVGTHGYMSPEYVMNGIVS 536
L+ +NIL+ + ++ KI+DFG+AR NE A + + +PE + G +
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK------WTAPEAINYGTFT 188
Query: 537 MKSDVYSFGVLVLEIVS 553
+KSDV+SFG+L+ EIV+
Sbjct: 189 IKSDVWSFGILLTEIVT 205
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 9e-24
Identities = 54/192 (28%), Positives = 84/192 (43%), Gaps = 32/192 (16%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----- 443
+LGQG FG V+ G +AIK L K F EA+++ KL+H L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 444 ----------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRD 481
L + + I G+ Y+ R+ +HRD
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRD 305
Query: 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 541
L+ +NIL+ E + K++DFG+AR NE A + +PE + G ++KSDV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDV 364
Query: 542 YSFGVLVLEIVS 553
+SFG+L+ E+ +
Sbjct: 365 WSFGILLTELTT 376
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 44/203 (21%)
Query: 389 NRLGQGGFGPVYNGKLLDGQE----IAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL-- 441
+G+G FG VY+G+ +D + AIK LS+ + Q + F E L+ L H N+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 442 -----TDS---------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRL 475
S + K + +G+ YL +
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AEQ 143
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG-----YMSPEYV 530
+ +HRDL N +LDE K++DFG+AR + + E + + H + + E +
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQ-QHRHARLPVKWTALESL 200
Query: 531 MNGIVSMKSDVYSFGVLVLEIVS 553
+ KSDV+SFGVL+ E+++
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT 223
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 62/219 (28%)
Query: 389 NRLGQGGFGPVYNGKLLDG------QEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL 441
LG+ FG VY G L Q +AIK L + G EF++EA L A+LQH N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 442 ------------------------------------------TDSSRKSLLDWKKRFYII 459
D + KS L+ +++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 460 EGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIV 519
I G+ YL S +H+DL N+L+ +++N KISD G+ R E+ A +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAADYYKL 186
Query: 520 GTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+ +M+PE +M G S+ SD++S+GV++ E+ S
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 54/192 (28%), Positives = 84/192 (43%), Gaps = 32/192 (16%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----- 443
+LGQG FG V+ G +AIK L K F EA+++ KL+H L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 444 ----------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRD 481
L + + I G+ Y+ R+ +HRD
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRD 388
Query: 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 541
L+ +NIL+ E + K++DFG+AR NE A + +PE + G ++KSDV
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDV 447
Query: 542 YSFGVLVLEIVS 553
+SFG+L+ E+ +
Sbjct: 448 WSFGILLTELTT 459
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 56/256 (21%), Positives = 98/256 (38%), Gaps = 56/256 (21%)
Query: 346 NVSLPIIFGNRKTQVHNDQTVKRDLKIFDFQTIAAATDNFSPANR--------LGQGGFG 397
+ SL G+ TV DL + + + A + +G+G FG
Sbjct: 44 STSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFG 103
Query: 398 PVYNGKLLDG----QEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL-------TDS- 444
VY+G LLD A+K L++ + + +F E ++ H N+ S
Sbjct: 104 CVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163
Query: 445 --------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKV 484
+ K + +G+ +L + + +HRDL
Sbjct: 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAA 220
Query: 485 SNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG-------YMSPEYVMNGIVSM 537
N +LDE+ K++DFG+AR ++ V +M+ E + +
Sbjct: 221 RNCMLDEKFTVKVADFGLAR-----DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 275
Query: 538 KSDVYSFGVLVLEIVS 553
KSDV+SFGVL+ E+++
Sbjct: 276 KSDVWSFGVLLWELMT 291
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 47/200 (23%), Positives = 78/200 (39%), Gaps = 45/200 (22%)
Query: 390 RLGQGGFGPVYNGKLL--DGQEI--AIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL--- 441
LG+G FG VY G G++I A+K K + +F +EA ++ L H ++
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 442 ----TDS---------SRKSLLDW----KKRF------YIIEGIVQGLLYLHKYSRLRAI 478
+ L + K I + + YL + +
Sbjct: 79 IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESINCV 135
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG-----YMSPEYVMNG 533
HRD+ V NIL+ K+ DFG++R + + + +MSPE +
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSR------YIEDEDYYKASVTRLPIKWMSPESINFR 189
Query: 534 IVSMKSDVYSFGVLVLEIVS 553
+ SDV+ F V + EI+S
Sbjct: 190 RFTTASDVWMFAVCMWEILS 209
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 45/200 (22%), Positives = 77/200 (38%), Gaps = 45/200 (22%)
Query: 390 RLGQGGFGPVYNGKLL--DGQEI--AIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL--- 441
+G+G FG V+ G + + + AIK +S +F EA + + H ++
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 442 ----TDS-------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAI 478
T++ RK LD + L YL R +
Sbjct: 82 IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKRFV 138
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG-----YMSPEYVMNG 533
HRD+ N+L+ K+ DFG++R ++ + G +M+PE +
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKASKGKLPIKWMAPESINFR 192
Query: 534 IVSMKSDVYSFGVLVLEIVS 553
+ SDV+ FGV + EI+
Sbjct: 193 RFTSASDVWMFGVCMWEILM 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 45/202 (22%)
Query: 389 NRLGQGGFGPVYNGKLLDGQE-----IAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL- 441
LG G FG VY G + E +AIK L +S + E +EA ++A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 442 ------TDS-------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLR 476
S K + + I +G+ YL R
Sbjct: 81 RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRR 137
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG-----YMSPEYVM 531
+HRDL N+L+ + KI+DFG+A+ E E + G +M+ E ++
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWMALESIL 192
Query: 532 NGIVSMKSDVYSFGVLVLEIVS 553
+ I + +SDV+S+GV V E+++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMT 214
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 46/204 (22%)
Query: 389 NRLGQGGFGPVYNGKLL-----DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-- 441
++LG+G FG V + G +A+K+L S +F+ E +++ L +
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 442 -----TDSSRK------------SLLDW----KKRF------YIIEGIVQGLLYLHKYSR 474
R+ L D+ + R I +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL---GS 145
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG-----YMSPEY 529
R +HRDL NIL++ + + KI+DFG+A+ +++ +V G + +PE
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAPES 201
Query: 530 VMNGIVSMKSDVYSFGVLVLEIVS 553
+ + I S +SDV+SFGV++ E+ +
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFT 225
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 47/193 (24%), Positives = 75/193 (38%), Gaps = 39/193 (20%)
Query: 389 NRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT---DS 444
R+G+G FG V+ K G + A+K++ + E A L + +
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 445 SRK--------------SLLDWKKRF---------YIIEGIVQGLLYLHKYSRLRAIHRD 481
R+ SL K+ Y + ++GL YLH R +H D
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGD 175
Query: 482 LKVSNILLDEQMNP-KISDFGMARTYAMNELEANTNR---IVGTHGYMSPEYVMNGIVSM 537
+K N+LL + + DFG A + L + I GT +M+PE VM
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235
Query: 538 KSDVYSFGVLVLE 550
K D++S ++L
Sbjct: 236 KVDIWSSCCMMLH 248
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 47/206 (22%), Positives = 90/206 (43%), Gaps = 42/206 (20%)
Query: 384 NFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL- 441
+F P + LG G G + + D +++A+KR+ E +L+ + +H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVI 81
Query: 442 ----TDSSRK-----------SLLDW--KKRF--------YIIEGIVQGLLYLHKYSRLR 476
T+ R+ +L ++ +K F +++ GL +LH L
Sbjct: 82 RYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LN 138
Query: 477 AIHRDLKVSNILLDEQ-----MNPKISDFGMARTYAMNELE-ANTNRIVGTHGYMSPEYV 530
+HRDLK NIL+ + ISDFG+ + A+ + + + GT G+++PE +
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 531 ---MNGIVSMKSDVYSFGVLVLEIVS 553
+ D++S G + ++S
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 49/194 (25%), Positives = 81/194 (41%), Gaps = 34/194 (17%)
Query: 389 NRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 441
++LG G +G VY G +A+K L K + EF EA ++ +++H NL
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 442 -TD---------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIH 479
T + + Y+ I + YL + IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 341
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 539
R+L N L+ E K++DFG++R + A+ + +PE + S+KS
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKS 400
Query: 540 DVYSFGVLVLEIVS 553
DV++FGVL+ EI +
Sbjct: 401 DVWAFGVLLWEIAT 414
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 49/197 (24%), Positives = 86/197 (43%), Gaps = 31/197 (15%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 440
++ ++GQG G VY + GQE+AI++++ NE ++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 441 LT---DSSRK--------------SLLD--WKKRF------YIIEGIVQGLLYLHKYSRL 475
+ DS SL D + + +Q L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV- 137
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
IHRD+K NILL + K++DFG + + +T +VGT +M+PE V
Sbjct: 138 --IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAY 193
Query: 536 SMKSDVYSFGVLVLEIV 552
K D++S G++ +E++
Sbjct: 194 GPKVDIWSLGIMAIEMI 210
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 52/213 (24%), Positives = 85/213 (39%), Gaps = 56/213 (26%)
Query: 389 NRLGQGGFGPVYNGKLLDGQE------IAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL 441
LGQG FG VY G + +AIK +++ +S + +EF NEA ++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 442 ------------------------------------TDSSRKSLLDWKKRFYIIEGIVQG 465
++ + K + I G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 466 LLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGY- 524
+ YL + + +HRDL N ++ E KI DFGM R ++ G G
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLL 202
Query: 525 ----MSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
MSPE + +G+ + SDV+SFGV++ EI +
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 40/214 (18%), Positives = 74/214 (34%), Gaps = 65/214 (30%)
Query: 390 RLGQGGFGPVYNGKL--------LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 441
LGQG F ++ G L E+ +K L K+ F A +++KL H +L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 442 -------TDS--------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSR 474
K+ ++ + + + + + +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL---EE 131
Query: 475 LRAIHRDLKVSNILLDEQMNP--------KISDFGMARTYAMNELEANTNRIVGTHGY-- 524
IH ++ NILL + + K+SD G++ T ++
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDILQE 179
Query: 525 ----MSPEYVMNGIV-SMKSDVYSFGVLVLEIVS 553
+ PE + N ++ +D +SFG + EI S
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 47/201 (23%), Positives = 77/201 (38%), Gaps = 54/201 (26%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 441
+G+G FG V G G ++A+K + + F EA ++ +L+H+NL
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVI 83
Query: 442 TD----------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIH 479
+ S +S+L + + + YL +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVH 140
Query: 480 RDLKVSNILLDEQMNPKISDFGMAR-TYAMNELEANTNRIVGTHG------YMSPEYVMN 532
RDL N+L+ E K+SDFG+ + + +PE +
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEAS------------STQDTGKLPVKWTAPEALRE 188
Query: 533 GIVSMKSDVYSFGVLVLEIVS 553
S KSDV+SFG+L+ EI S
Sbjct: 189 KKFSTKSDVWSFGILLWEIYS 209
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 48/215 (22%), Positives = 80/215 (37%), Gaps = 59/215 (27%)
Query: 389 NRLGQGGFGPVYNGKLLDG----QEIAIKRLSK--SSGQGIVEFKNEAKLIAKLQHTNLT 442
LG+G FG V +L ++A+K L + I EF EA + + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 443 D----SSRKSLLDWKKRFYII----------------------------------EGIVQ 464
S R +I I
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 465 GLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR-TYAMNELEANTNRIVGTHG 523
G+ YL S IHRDL N +L E M ++DFG++R Y+ + G
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ------GCAS 199
Query: 524 -----YMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+++ E + + + ++ SDV++FGV + EI++
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 45/200 (22%), Positives = 77/200 (38%), Gaps = 45/200 (22%)
Query: 390 RLGQGGFGPVYNG--KLLDGQEI--AIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL--- 441
+G+G FG V+ G + + AIK + +S +F EA + + H ++
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 442 ----TDS-------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAI 478
T++ RK LD + L YL R +
Sbjct: 457 IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL---ESKRFV 513
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG-----YMSPEYVMNG 533
HRD+ N+L+ K+ DFG++R ++ + G +M+PE +
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 534 IVSMKSDVYSFGVLVLEIVS 553
+ SDV+ FGV + EI+
Sbjct: 568 RFTSASDVWMFGVCMWEILM 587
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 44/200 (22%), Positives = 78/200 (39%), Gaps = 44/200 (22%)
Query: 390 RLGQGGFGPVYNGKL-LDGQEI--AIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL---- 441
LG G FG V G + ++I AIK L + E EA+++ +L + +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 442 ---TDS-------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIH 479
++ + ++ + G+ YL +H
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVH 459
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG------YMSPEYVMNG 533
R+L N+LL + KISDFG+++ L A+ + + +PE +
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSK-----ALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 534 IVSMKSDVYSFGVLVLEIVS 553
S +SDV+S+GV + E +S
Sbjct: 515 KFSSRSDVWSYGVTMWEALS 534
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 59/213 (27%), Positives = 81/213 (38%), Gaps = 56/213 (26%)
Query: 389 NRLGQGGFGPVYNGKLLDG------QEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL 441
LG G FG VY G++ ++A+K L + S Q ++F EA +I+K H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 442 ---------------------------------TDSSRKSLLDWKKRFYIIEGIVQGLLY 468
S+ S L ++ I G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 469 LHKYSRLRAIHRDLKVSNILLD---EQMNPKISDFGMARTYAMNELEANTNRIVGTHGY- 524
L IHRD+ N LL KI DFGMAR ++ + G
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAML 207
Query: 525 ----MSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
M PE M GI + K+D +SFGVL+ EI S
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 32/197 (16%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHT 439
+ F+ ++G+G FG V+ G + +AIK + + + I + + E ++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 440 NLT---DSSRK--------------SLLDW--KKRF------YIIEGIVQGLLYLHKYSR 474
+T S K S LD I+ I++GL YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHS--- 137
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGI 534
+ IHRD+K +N+LL E K++DFG+A +++ NT VGT +M+PE +
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSA 195
Query: 535 VSMKSDVYSFGVLVLEI 551
K+D++S G+ +E+
Sbjct: 196 YDSKADIWSLGITAIEL 212
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 39/201 (19%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKS--SGQGIVE-FKNEAKLIAKLQH 438
++F LG+G FG VY + +A+K L K+ G+ + E ++ + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 439 TNLT-------DSSR--------------------KSLLDWKKRFYIIEGIVQGLLYLHK 471
N+ D++R + + YI E + L Y H
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-LANALSYCHS 127
Query: 472 YSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM 531
R IHRD+K N+LL KI+DFG + +A + + GT Y+ PE +
Sbjct: 128 ---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSR---RTDLCGTLDYLPPEMIE 180
Query: 532 NGIVSMKSDVYSFGVLVLEIV 552
+ K D++S GVL E +
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFL 201
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 49/214 (22%), Positives = 81/214 (37%), Gaps = 54/214 (25%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTN-------- 440
L +GGF VY + + G+E A+KRL + + E + KL H N
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 441 ----------------LTDSSRKSLLDW------KKRF------YIIEGIVQGLLYLHKY 472
LT+ + L+++ + I + + ++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-R 154
Query: 473 SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA-----------MNELEANTNRIVGT 521
+ IHRDLKV N+LL Q K+ DFG A T + +E R T
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR-NTT 213
Query: 522 HGYMSPEYV---MNGIVSMKSDVYSFGVLVLEIV 552
Y +PE + N + K D+++ G ++ +
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 46/214 (21%), Positives = 80/214 (37%), Gaps = 58/214 (27%)
Query: 389 NRLGQGGFGPVYNGKLLDGQE----IAIKRLSK--SSGQGIVEFKNEAKLIAKLQHTNL- 441
LG+G FG V G L +A+K + SS + I EF +EA + H N+
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 442 ------------------------------------TDSSRKSLLDWKKRFYIIEGIVQG 465
+ + + + I G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 466 LLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR-TYAMNELEANTNRIVGTHG- 523
+ YL S +HRDL N +L + M ++DFG+++ Y+ + G
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ------GRIAK 210
Query: 524 ----YMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+++ E + + + + KSDV++FGV + EI +
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 47/197 (23%), Positives = 84/197 (42%), Gaps = 31/197 (15%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 440
++G+G G V + G+++A+K + Q NE ++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 441 LT---DSSRK--------------SLLDWKKRFYIIEG--------IVQGLLYLHKYSRL 475
+ S +L D + + E ++Q L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGV- 162
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
IHRD+K +ILL K+SDFG + + + + +VGT +M+PE + +
Sbjct: 163 --IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLY 218
Query: 536 SMKSDVYSFGVLVLEIV 552
+ + D++S G++V+E+V
Sbjct: 219 ATEVDIWSLGIMVIEMV 235
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 41/202 (20%), Positives = 83/202 (41%), Gaps = 38/202 (18%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 440
+ + LG G FG VY K G A K + S + + ++ E +++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 441 LT---DSSRK--------------SLLD----WKKRF------YIIEGIVQGLLYLHKYS 473
+ + ++ + + +++ L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 474 RLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG 533
IHRDLK N+L+ + + +++DFG++ + ++ +GT +M+PE VM
Sbjct: 138 I---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCE 192
Query: 534 IVS-----MKSDVYSFGVLVLE 550
+ K+D++S G+ ++E
Sbjct: 193 TMKDTPYDYKADIWSLGITLIE 214
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 5e-22
Identities = 53/232 (22%), Positives = 96/232 (41%), Gaps = 43/232 (18%)
Query: 354 GNRKTQVHNDQTVKRDLKIFDFQ---TIAAATDNFSPANRLGQGGFGPVYNGKLL-DGQE 409
G + ++ D+ ++ L+ F Q D+F + LG G G V+ G
Sbjct: 1 GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 410 IAIKRLSKSSGQGIVEF-KNEAKLIAKLQHTNLTDS-----------------SRKSLLD 451
+A K + I E +++ + + SL
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 452 WKKRF---------YIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGM 502
K+ + +++GL YL + + +HRD+K SNIL++ + K+ DFG+
Sbjct: 121 VLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV 178
Query: 503 ARTYAMNELE---ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEI 551
+ +L AN+ VGT YMSPE + S++SD++S G+ ++E+
Sbjct: 179 SG-----QLIDSMANSF--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-22
Identities = 47/200 (23%), Positives = 77/200 (38%), Gaps = 52/200 (26%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 441
+G+G FG V G G ++A+K + + F EA ++ +L+H+NL
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVI 255
Query: 442 TD----------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIH 479
+ S +S+L + + + YL +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVH 312
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG------YMSPEYVMNG 533
RDL N+L+ E K+SDFG+ + + +PE +
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEALREK 361
Query: 534 IVSMKSDVYSFGVLVLEIVS 553
S KSDV+SFG+L+ EI S
Sbjct: 362 KFSTKSDVWSFGILLWEIYS 381
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 7e-22
Identities = 59/213 (27%), Positives = 80/213 (37%), Gaps = 56/213 (26%)
Query: 389 NRLGQGGFGPVYNGKLLDG------QEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL 441
LG G FG VY G++ ++A+K L + S Q ++F EA +I+K H N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 442 ---------------------------------TDSSRKSLLDWKKRFYIIEGIVQGLLY 468
S+ S L ++ I G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 469 LHKYSRLRAIHRDLKVSNILLD---EQMNPKISDFGMARTYAMNELEANTNRIVGTHGY- 524
L IHRD+ N LL KI DFGMAR ++ G
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAML 248
Query: 525 ----MSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
M PE M GI + K+D +SFGVL+ EI S
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 35/197 (17%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 440
+ F +LG+G +G VY GQ +AIK++ + E E ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 441 LT---DSSRK--------------SLLDWKKRF----------YIIEGIVQGLLYLHKYS 473
+ S K S+ D + I++ ++GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF-- 143
Query: 474 RLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG 533
+R IHRD+K NILL+ + + K++DFG+A + NT ++GT +M+PE +
Sbjct: 144 -MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEI 200
Query: 534 IVSMKSDVYSFGVLVLE 550
+ +D++S G+ +E
Sbjct: 201 GYNCVADIWSLGITAIE 217
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 61/231 (26%), Positives = 88/231 (38%), Gaps = 51/231 (22%)
Query: 354 GNRKTQVHNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEI-AI 412
G Q R + DF+ LG+G F V + L AI
Sbjct: 11 GAGSLQHAQPPPQPRKKRPEDFKFGKI----------LGEGSFSTVVLARELATSREYAI 60
Query: 413 KRLSKSSGQGIVEFK------NEAKLIAKLQHTNLT-------DSSR------------- 446
K L K I++ E ++++L H D +
Sbjct: 61 KILEKRH---IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL 117
Query: 447 -------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISD 499
S + RFY E IV L YLH IHRDLK NILL+E M+ +I+D
Sbjct: 118 LKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITD 173
Query: 500 FGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 550
FG A+ + +A N VGT Y+SPE + SD+++ G ++ +
Sbjct: 174 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 224
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 2e-21
Identities = 35/128 (27%), Positives = 51/128 (39%), Gaps = 25/128 (19%)
Query: 445 SRKSLLDWKKR------------FYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ 492
+++L DW R +I I + + +LH +HRDLK SNI
Sbjct: 144 RKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMD 200
Query: 493 MNPKISDFGMAR----------TYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY 542
K+ DFG+ A VGT YMSPE + S K D++
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIF 260
Query: 543 SFGVLVLE 550
S G+++ E
Sbjct: 261 SLGLILFE 268
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 25/127 (19%), Positives = 43/127 (33%), Gaps = 3/127 (2%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN 440
+F P +G+GGFG V+ K +D AIKR+ + + E E K +AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 441 -LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISD 499
+ + +K ++ I + V +D
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 500 FGMARTY 506
+
Sbjct: 126 QLQPSSP 132
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 51/210 (24%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKR--------------------LSKSSGQ 421
D+ P LG+G +G V + + GQ +A+KR +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 422 GIVEFKNEAKLIAKLQHTNL----------TDSSRKSLLDWKKRF------YIIEGIVQG 465
V F A + ++ D K ++D + I IV+
Sbjct: 67 FTVTFYG-----ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 466 LLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYM 525
L +LH S+L IHRD+K SN+L++ K+ DFG++ Y ++++ + + G YM
Sbjct: 122 LEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDID--AGCKPYM 176
Query: 526 SPEYVMNGIV----SMKSDVYSFGVLVLEI 551
+PE + + S+KSD++S G+ ++E+
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 49/227 (21%), Positives = 84/227 (37%), Gaps = 70/227 (30%)
Query: 389 NRLGQGGFGPVYNGKLLDG------QEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL 441
+G+G FG V+ + +A+K L ++S +F+ EA L+A+ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 442 --------------------------------------------------TDSSRKSLLD 451
S L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 452 WKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511
++ I + G+ YL S + +HRDL N L+ E M KI+DFG++R N
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NIY 225
Query: 512 EANTNRIVGTHGY-----MSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
A+ + + M PE + + +SDV+++GV++ EI S
Sbjct: 226 SADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 51/218 (23%), Positives = 80/218 (36%), Gaps = 57/218 (26%)
Query: 389 NRLGQGGFGPVYNGKLLDGQE------IAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTN 440
LG G FG V + +A+K L S +E K+++ L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 441 L-------TD---------------------SSRKSLLDWKKRFYIIEG----------- 461
+ T R S + K I+E
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 462 -----IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR-TYAMNELEANT 515
+ +G+ +L + IHRDL NILL KI DFG+AR +
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
N + +M+PE + N + + +SDV+S+G+ + E+ S
Sbjct: 206 NARLPVK-WMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 47/222 (21%), Positives = 91/222 (40%), Gaps = 65/222 (29%)
Query: 389 NRLGQGGFGPVYNGKLLD--------GQEIAIKRL-SKSSGQGIVEFKNEAKLIAKL-QH 438
LG+G FG V + + +A+K L ++ + + + +E +++ + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 439 TNL-------TD---------------------SSRKSLLDWKKRFYIIEG--------- 461
N+ T + R +++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 462 -----IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516
+ +G+ YL + + IHRDL N+L+ E KI+DFG+AR ++
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 212
Query: 517 RIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
T+G +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 45/216 (20%), Positives = 79/216 (36%), Gaps = 51/216 (23%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN 440
+ ++ LGQG V+ G+ G AIK + S V+ E +++ KL H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 441 -------------------------------LTDSSRKSLLDWKKRFYIIEGIVQGLLYL 469
L + S L + ++ +V G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 470 HKYSRLRAIHRDLKVSNILL----DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYM 525
+ +HR++K NI+ D Q K++DFG AR +E + + GT Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS--LYGTEEYL 182
Query: 526 SPEYVMNGIVSM--------KSDVYSFGVLVLEIVS 553
P+ ++ D++S GV +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 69/340 (20%), Positives = 129/340 (37%), Gaps = 100/340 (29%)
Query: 389 NRLGQGGFGPVYNGKLLD--------GQEIAIKRL-SKSSGQGIVEFKNEAKLIAKL-QH 438
LG+G FG V + + ++A+K L S ++ + + + +E +++ + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 439 TNL-------TD---------------------SSRKSLLDWKKRFYIIEG--------- 461
N+ T + R L++
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 462 -----IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516
+ +G+ YL + + IHRDL N+L+ E KI+DFG+AR ++
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 246
Query: 517 RIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGS-----YDTERP 566
T+G +M+PE + + I + +SDV+SFGVL+ EI + G E
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL----GGSPYPGVPVEEL 302
Query: 567 LNLV--GYAWQLWNEGKALELMDPTLDESCSSD--EVMRCIHVGLLCVQDRAADRRTMSD 622
L+ G+ MD +C+++ +MR C + R T
Sbjct: 303 FKLLKEGH------------RMDKP--SNCTNELYMMMR------DCWHAVPSQRPTFKQ 342
Query: 623 VVSMLTNDTMALPKPKQPAFFINIS-SDYEEPDVTEIKLE 661
+V L + +AL ++ ++ + DY+ P +
Sbjct: 343 LVEDL-DRIVALTSNQEMGYYHHHHHHDYDIPTTENLYFN 381
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 50/223 (22%), Positives = 85/223 (38%), Gaps = 62/223 (27%)
Query: 389 NRLGQGGFGPVYNGKLLDG------QEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL 441
LG+G FG V +A+K L +S + + +E ++ ++ H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 442 -------TD---------------------SSRKSLLDWKKRFYIIEG------------ 461
+ SRK +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 462 ----------IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR-TYAMNE 510
I QG+ YL + ++ +HRDL NIL+ E KISDFG++R Y +
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+ + +M+ E + + I + +SDV+SFGVL+ EIV+
Sbjct: 206 YVKRSQGRIPVK-WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 42/217 (19%)
Query: 368 RDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLS---KSSGQGI 423
+D + + FS +G G FG VY + + + + +AIK++S K S +
Sbjct: 39 KDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 98
Query: 424 VEFKNEAKLIAKLQHTNLT---DSSRK-------------SLLD----WKKRF------Y 457
+ E + + KL+H N + S D KK
Sbjct: 99 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 158
Query: 458 IIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517
+ G +QGL YLH ++ IHRD+K NILL E K+ DFG A A AN+
Sbjct: 159 VTHGALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMA----PANS-- 209
Query: 518 IVGTHGYMSPEYVMNGIVS---MKSDVYSFGVLVLEI 551
VGT +M+PE ++ K DV+S G+ +E+
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 47/193 (24%), Positives = 79/193 (40%), Gaps = 39/193 (20%)
Query: 391 LGQGGFGPVYNGKLLD-GQEIAIKRLSKS--SGQGIVE-FKNEAKLIAKLQHTNLT---- 442
LG+G FG VY + +A+K L KS +G+ + E ++ + L+H N+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 443 ---DSSR--------------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIH 479
D R + + ++ E + L Y H + IH
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-LADALHYCH---ERKVIH 137
Query: 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 539
RD+K N+L+ + KI+DFG + +A + + GT Y+ PE + K
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWS-VHAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKV 193
Query: 540 DVYSFGVLVLEIV 552
D++ GVL E +
Sbjct: 194 DLWCAGVLCYEFL 206
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 49/218 (22%), Positives = 85/218 (38%), Gaps = 61/218 (27%)
Query: 389 NRLGQGGFGPVYNGKLLDGQE------IAIKRL-SKSSGQGIVEFKNEAKLIAKL-QHTN 440
LG G FG V + +A+K L S + +E K+++ L QH N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 441 L----------------------------------------TDSSRKSLLDWKKRFYIIE 460
+ + S + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 461 GIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVG 520
+ QG+ +L + IHRD+ N+LL KI DFG+AR ++ ++N IV
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVK 223
Query: 521 THG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+ +M+PE + + + +++SDV+S+G+L+ EI S
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 49/221 (22%), Positives = 85/221 (38%), Gaps = 64/221 (28%)
Query: 389 NRLGQGGFGPVYNGKL--LDGQE----IAIKRL-SKSSGQGIVEFKNEAKLIAKL-QHTN 440
LG+G FG V +D +A+K L ++ +E K++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 441 L-------------------------------------------TDSSRKSLLDWKKRFY 457
+ + K L +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 458 IIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR 517
+ +G+ +L + + IHRDL NILL E+ KI DFG+AR ++ + +
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDY 204
Query: 518 IVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+ +M+PE + + + +++SDV+SFGVL+ EI S
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 47/222 (21%), Positives = 91/222 (40%), Gaps = 65/222 (29%)
Query: 389 NRLGQGGFGPVYNGKLLD--------GQEIAIKRL-SKSSGQGIVEFKNEAKLIAKL-QH 438
LG+G FG V + + +A+K L ++ + + + +E +++ + +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 439 TNL-------TD---------------------SSRKSLLDWKKRFYIIEG--------- 461
N+ T + R +++ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 462 -----IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516
+ +G+ YL + + IHRDL N+L+ E KI+DFG+AR ++
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 258
Query: 517 RIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
T+G +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 54/220 (24%), Positives = 88/220 (40%), Gaps = 69/220 (31%)
Query: 389 NRLGQGGFGPVYNGKLLDGQE---IAIKRL-SKSSGQGIVEFKNEAKLIAKL-QHTNL-- 441
+ +G+G FG V ++ AIKR+ +S +F E +++ KL H N+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 442 ----------------------------------------TDSSRKSLLDWKKRFYIIEG 461
+S S L ++ +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR---TYAMNELEANTNRI 518
+ +G+ YL S+ + IHRDL NIL+ E KI+DFG++R Y +
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----------V 196
Query: 519 VGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
T G +M+ E + + + SDV+S+GVL+ EIVS
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 94.0 bits (233), Expect = 4e-20
Identities = 55/204 (26%), Positives = 81/204 (39%), Gaps = 46/204 (22%)
Query: 390 RLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL-----T 442
RLG GGFG V G+++AIK+ + E + E +++ KL H N+
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 443 DSSRKSLLDWKKRFYIIE----G--------------------------IVQGLLYLHKY 472
+ L +E G I L YLH+
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139
Query: 473 SRLRAIHRDLKVSNILLD---EQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEY 529
R IHRDLK NI+L +++ KI D G A+ EL VGT Y++PE
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTE--FVGTLQYLAPEL 194
Query: 530 VMNGIVSMKSDVYSFGVLVLEIVS 553
+ ++ D +SFG L E ++
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECIT 218
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 41/219 (18%)
Query: 360 VHNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKS 418
+H+ + FQ + ++ LG+G FG V K + QE A+K ++K+
Sbjct: 1 MHHHHHHSSGRENLYFQ--GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA 58
Query: 419 --SGQGIVEFKNEAKLIAKLQHTN---LTDS--SRKS------------LLDW--KKRFY 457
+ E +L+ KL H N L + S L D K++ +
Sbjct: 59 SAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF 118
Query: 458 -------IIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL---DEQMNPKISDFGMARTYA 507
II+ + G+ Y+HK +HRDLK NILL ++ + KI DFG++ +
Sbjct: 119 SEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 508 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGV 546
N +GT Y++PE V+ G K DV+S GV
Sbjct: 176 QNTK---MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGV 210
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 5e-20
Identities = 46/216 (21%), Positives = 81/216 (37%), Gaps = 51/216 (23%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN 440
+ ++ LGQG V+ G+ G AIK + S V+ E +++ KL H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 441 L--------TDSSRK-----------SLLDW---KKRFY---------IIEGIVQGLLYL 469
+ ++R SL Y ++ +V G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 470 HKYSRLRAIHRDLKVSNILL----DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYM 525
+ +HR++K NI+ D Q K++DFG AR +E + + GT Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS--LYGTEEYL 182
Query: 526 SPEYVMNGIVSM--------KSDVYSFGVLVLEIVS 553
P+ ++ D++S GV +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 54/230 (23%), Positives = 82/230 (35%), Gaps = 58/230 (25%)
Query: 367 KRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKR----------- 414
LKI Q ++ +G+G +G V GQ +A+KR
Sbjct: 6 SGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK 65
Query: 415 ---------LSKSSGQGIVEFK----NEAKLIAKLQH--TNLTDSSRKSLLDWKKRF--- 456
+ S IV+F E ++ T+ +
Sbjct: 66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEE 125
Query: 457 ---YIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFG--------MART 505
I V+ L +L L+ IHRD+K SNILLD N K+ DFG +A+T
Sbjct: 126 ILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT 183
Query: 506 YAMNELEANTNRIVGTHGYMSPEYVMNGIV----SMKSDVYSFGVLVLEI 551
R G YM+PE + ++SDV+S G+ + E+
Sbjct: 184 -----------RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 58/226 (25%), Positives = 89/226 (39%), Gaps = 47/226 (20%)
Query: 367 KRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVE 425
R L D + F +G G +G VY G+ + GQ AIK + +G E
Sbjct: 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEE 66
Query: 426 FKNEAKLIAKL-QHTNLT---DSSRK--------------------SLLD-----WKKRF 456
K E ++ K H N+ + K S+ D
Sbjct: 67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 457 ------YIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510
YI I++GL +LH+ + IHRD+K N+LL E K+ DFG++
Sbjct: 127 KEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183
Query: 511 LEANTNRIVGTHGYMSPEYVMNGIVS-----MKSDVYSFGVLVLEI 551
NT +GT +M+PE + KSD++S G+ +E+
Sbjct: 184 GRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 39/198 (19%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 438
++ + +LG G +G V + + E AIK + K+ S + E ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 439 TN---LTDS--SRKS------------LLDW--KKRFY-------IIEGIVQGLLYLHKY 472
N L D +++ L D + + II+ ++ G+ YLHK
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK- 154
Query: 473 SRLRAIHRDLKVSNILL---DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEY 529
+HRDLK N+LL ++ KI DFG++ + + +GT Y++PE
Sbjct: 155 --HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPE- 208
Query: 530 VMNGIVSMKSDVYSFGVL 547
V+ K DV+S GV+
Sbjct: 209 VLRKKYDEKCDVWSIGVI 226
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 43/218 (19%)
Query: 361 HNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKS- 418
H+ + R + + ++ LG+G FG V K + QE A+K ++K+
Sbjct: 4 HHHHSSGR----ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS 59
Query: 419 -SGQGIVEFKNEAKLIAKLQHTN---LTDS--SRKS------------LLDW---KKRF- 456
+ E +L+ KL H N L + S L D +KRF
Sbjct: 60 AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS 119
Query: 457 -----YIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL---DEQMNPKISDFGMARTYAM 508
II+ + G+ Y+HK +HRDLK NILL ++ + KI DFG++ +
Sbjct: 120 EHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGV 546
N +GT Y++PE V+ G K DV+S GV
Sbjct: 177 NT---KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGV 210
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 1e-19
Identities = 37/210 (17%), Positives = 70/210 (33%), Gaps = 43/210 (20%)
Query: 382 TDNFSPANRLGQG--GFGPVYNGK-LLDGQEIAIKR--LSKSSGQGIVEFKNEAKLIAKL 436
+ +G+G V + G+ + ++R L S + + + E +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 437 QHTNLT---DSSRK--------------SLLDWKKRF-----------YIIEGIVQGLLY 468
H N+ + S D YI++G+++ L Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 469 LHKYSRLRAIHRDLKVSNILLDEQMNPKISDFG----MARTYAM-NELEANTNRIVGTHG 523
+H +HR +K S+IL+ +S M + V
Sbjct: 144 IHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 524 YMSPEYVMNGIV--SMKSDVYSFGVLVLEI 551
++SPE + + KSD+YS G+ E+
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACEL 230
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 46/214 (21%), Positives = 81/214 (37%), Gaps = 47/214 (21%)
Query: 376 QTIAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVE-FKNEAKLI 433
Q A ++ +G G G V+ + G IA+K++ +S + + + ++
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 434 AKL-QHTNLTD--------------------SSRKSLLDWKKRF------YIIEGIVQGL 466
K + + K + + IV+ L
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKAL 137
Query: 467 LYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFG----MARTYAMNELEANTNRIVGTH 522
YL + IHRD+K SNILLDE+ K+ DFG + A +R G
Sbjct: 138 YYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-------DRSAGCA 188
Query: 523 GYMSPEYVMNGIV-----SMKSDVYSFGVLVLEI 551
YM+PE + +++DV+S G+ ++E+
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 40/199 (20%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQ 437
+D + LG+G FG V K + GQE A+K +SK E +L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 438 HTN---LTDS--SRKS------------LLDW--KKRFY-------IIEGIVQGLLYLHK 471
H N L + + L D ++ + II ++ G+ Y+HK
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 472 YSRLRAIHRDLKVSNILL---DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPE 528
+ +HRDLK N+LL + N +I DFG++ + ++ +GT Y++PE
Sbjct: 145 ---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPE 198
Query: 529 YVMNGIVSMKSDVYSFGVL 547
V++G K DV+S GV+
Sbjct: 199 -VLHGTYDEKCDVWSTGVI 216
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 51/196 (26%), Positives = 76/196 (38%), Gaps = 52/196 (26%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLTDSSRKS 448
LG G FG V+ + G E IK ++K Q +E + E +++ L H N+
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII-----K 84
Query: 449 LLDW---KKRFYII----EG----------------------------IVQGLLYLHKYS 473
+ + YI+ EG ++ L Y H
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-- 142
Query: 474 RLRAIHRDLKVSNILL---DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYV 530
+H+DLK NIL KI DFG+A + +E + GT YM+PE V
Sbjct: 143 -QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPE-V 197
Query: 531 MNGIVSMKSDVYSFGV 546
V+ K D++S GV
Sbjct: 198 FKRDVTFKCDIWSAGV 213
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 46/186 (24%), Positives = 76/186 (40%), Gaps = 37/186 (19%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN---LTDS-- 444
+G+G +G V A K++ K + + FK E +++ L H N L ++
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 445 SRKS------------LLDW---KKRFY------IIEGIVQGLLYLHKYSRLRAIHRDLK 483
L + K+ F I++ ++ + Y HK L HRDLK
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLK 133
Query: 484 VSNILL---DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSD 540
N L K+ DFG+A + ++ VGT Y+SP+ V+ G+ + D
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQ-VLEGLYGPECD 189
Query: 541 VYSFGV 546
+S GV
Sbjct: 190 EWSAGV 195
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 51/211 (24%), Positives = 86/211 (40%), Gaps = 47/211 (22%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTN 440
D++ +G G V +++AIKR++ + + E E + +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 441 LT---DSSRK--------------SLLDWKKRF-----------------YIIEGIVQGL 466
+ S S+LD K I+ +++GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 467 LYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMA-----RTYAMNELEANTNRIVGT 521
YLHK IHRD+K NILL E + +I+DFG++ T VGT
Sbjct: 135 EYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT--FVGT 189
Query: 522 HGYMSPEYVMNGIV-SMKSDVYSFGVLVLEI 551
+M+PE + K+D++SFG+ +E+
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-19
Identities = 52/203 (25%), Positives = 83/203 (40%), Gaps = 41/203 (20%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQH 438
D F LG+GGFG V+ ++ ++ A K+L+K +G E K++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 439 ---TNLT---------------------------DSSRKSLLDWKK-RFYIIEGIVQGLL 467
+L + FY + IV GL
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLE 303
Query: 468 YLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSP 527
+LH+ I+RDLK N+LLD+ N +ISD G+A + + GT G+M+P
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMAP 358
Query: 528 EYVMNGIVSMKSDVYSFGVLVLE 550
E ++ D ++ GV + E
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYE 381
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 54/281 (19%), Positives = 88/281 (31%), Gaps = 81/281 (28%)
Query: 382 TDNFSPANRLGQGGFGPVYNG-KLLDGQEIAIKR--LSKSSGQGIVEFKNEAKLIAKL-Q 437
T F ++G G FG V+ K LDG AIKR + E A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 438 HTNLT---DSSRK--------------SLLDWKKRFYIIEG-------------IVQGLL 467
H+++ + + SL D Y I + +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 468 YLHKYSRLRAIHRDLKVSNILLDEQMNP-------------------KISDFGMARTYAM 508
Y+H + +H D+K SNI + P KI D G
Sbjct: 130 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 509 NELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPL 567
++ G +++ E + K+D+++ + V+ PL
Sbjct: 185 ----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA----------GAEPL 230
Query: 568 NLVGYAWQLWNEGKALELMDPTLDESCSS---DEVMRCIHV 605
G W +G+ P + + S + + IH
Sbjct: 231 PRNGDQWHEIRQGRL-----PRIPQVLSQEFTELLKVMIHP 266
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 7e-19
Identities = 42/211 (19%), Positives = 75/211 (35%), Gaps = 62/211 (29%)
Query: 391 LGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEF-----------------KNEAKLI 433
L QG F + + D + A+K+ KS + +F KNE ++I
Sbjct: 39 LNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 434 AKLQHTN-----------------------------------LTDSSRKSLLDWKKRFYI 458
+++ L + + + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 459 IEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRI 518
++ Y+H + HRD+K SNIL+D+ K+SDFG + +++
Sbjct: 158 KS-VLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--G--S 210
Query: 519 VGTHGYMSPEYVMN--GIVSMKSDVYSFGVL 547
GT+ +M PE+ N K D++S G+
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 7e-19
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 49/206 (23%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVEFKNEAKLIAK---LQH 438
++FS +G+GGFG VY + D ++ A+K L K I + E + + L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALNERIMLSL 245
Query: 439 TNLTDS-----------SRKSL---LDW-------------------KKRFYIIEGIVQG 465
+ D + L LD RFY E I+ G
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-IILG 304
Query: 466 LLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYM 525
L ++H ++RDLK +NILLDE + +ISD G+A ++ + + VGTHGYM
Sbjct: 305 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYM 357
Query: 526 SPEYVMNGIVSMKS-DVYSFGVLVLE 550
+PE + G+ S D +S G ++ +
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFK 383
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 8e-19
Identities = 46/224 (20%), Positives = 77/224 (34%), Gaps = 50/224 (22%)
Query: 363 DQTVKRDLKIFDFQTIAAATDNFSP----ANRLGQGGFGPVYNGK-LLDGQEIAIKRLSK 417
D+ + K + Q + + LG G FG V+ G+ K ++
Sbjct: 27 DKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 86
Query: 418 SSGQGIVEFKNEAKLIAKLQHTNLTDSSRKSLLDW---KKRFYII----EG--------- 461
KNE ++ +L H L +L D K +I G
Sbjct: 87 PYPLDKYTVKNEISIMNQLHHPKLI-----NLHDAFEDKYEMVLILEFLSGGELFDRIAA 141
Query: 462 ----------------IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNP--KISDFGMA 503
+GL ++H+ +H D+K NI+ + + KI DFG+A
Sbjct: 142 EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLA 198
Query: 504 RTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVL 547
+E T + +PE V V +D+++ GVL
Sbjct: 199 TKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 239
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 1e-18
Identities = 54/201 (26%), Positives = 84/201 (41%), Gaps = 40/201 (19%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQH 438
+ F LG+GGFG V ++ ++ A K+L K +G NE +++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 439 ---TNLTDS--------------------------SRKSLLDWKKRFYIIEGIVQGLLYL 469
+L + + + + FY E I GL L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDL 302
Query: 470 HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEY 529
H+ R ++RDLK NILLD+ + +ISD G+A + VGT GYM+PE
Sbjct: 303 HR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEV 356
Query: 530 VMNGIVSMKSDVYSFGVLVLE 550
V N + D ++ G L+ E
Sbjct: 357 VKNERYTFSPDWWALGCLLYE 377
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 49/223 (21%), Positives = 83/223 (37%), Gaps = 62/223 (27%)
Query: 389 NRLGQGGFGPVYNGKLLDGQE------IAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTN 440
LG G FG V N + +A+K L + +E K++ +L H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 441 L-------TD---------------------SSRKSLLDWKKRFYIIEG----------- 461
+ T S R+ + + + +
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 462 ----------IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR-TYAMNE 510
+ +G+ +L +HRDL N+L+ KI DFG+AR + +
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
N + +M+PE + GI ++KSDV+S+G+L+ EI S
Sbjct: 228 YVVRGNARLPVK-WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 60/242 (24%), Positives = 93/242 (38%), Gaps = 62/242 (25%)
Query: 354 GNRKTQVHNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAI 412
R+ + ++ + +++ +LG G +G V K E AI
Sbjct: 9 SGRENLYFQGIAINPG--MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAI 66
Query: 413 KRLSKSSGQGIV-------------EFKNEAKLIAKLQHTNLTDSSRKSLLDW---KKRF 456
K + KS E NE L+ L H N+ L D KK F
Sbjct: 67 KVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII-----KLFDVFEDKKYF 121
Query: 457 YII----EG------------------------IVQGLLYLHKYSRLRAIHRDLKVSNIL 488
Y++ EG I+ G+ YLHK +HRD+K NIL
Sbjct: 122 YLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENIL 178
Query: 489 L---DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFG 545
L + +N KI DFG++ ++ + +GT Y++PE V+ + K DV+S G
Sbjct: 179 LENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCG 234
Query: 546 VL 547
V+
Sbjct: 235 VI 236
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 37/186 (19%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN---LTDS-- 444
LG G F V+ K L G+ A+K + KS +NE ++ K++H N L D
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 445 SRKS------------LLDW--KKRFY-------IIEGIVQGLLYLHKYSRLRAIHRDLK 483
S L D ++ Y +I+ ++ + YLH+ +HRDLK
Sbjct: 77 STTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLK 133
Query: 484 VSNILL---DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSD 540
N+L +E I+DFG+++ + + GT GY++PE + S D
Sbjct: 134 PENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGTPGYVAPEVLAQKPYSKAVD 189
Query: 541 VYSFGV 546
+S GV
Sbjct: 190 CWSIGV 195
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 47/195 (24%), Positives = 72/195 (36%), Gaps = 45/195 (23%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKL---IAKLQHTNLTDSSR 446
LG GGFG VY+G + D +AIK + K E N ++ + L+ + S
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 447 KSLLDW---KKRFYII----EG-------------------------IVQGLLYLHKYSR 474
LLDW F +I E +++ + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---N 167
Query: 475 LRAIHRDLKVSNILLD-EQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG 533
+HRD+K NIL+D + K+ DFG GT Y PE++
Sbjct: 168 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT----DFDGTRVYSPPEWIRYH 223
Query: 534 I-VSMKSDVYSFGVL 547
+ V+S G+L
Sbjct: 224 RYHGRSAAVWSLGIL 238
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 2e-18
Identities = 39/197 (19%), Positives = 70/197 (35%), Gaps = 36/197 (18%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 440
D++ LG G FG V+ G A K + + E + ++ L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 441 ---LTDS--SRKS------------LLDW--KKRFY--------IIEGIVQGLLYLHKYS 473
L D+ L + + + + +GL ++H+
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE-- 273
Query: 474 RLRAIHRDLKVSNILLDEQMNP--KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM 531
+H DLK NI+ + + K+ DFG+ + + GT + +PE
Sbjct: 274 -NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAE 329
Query: 532 NGIVSMKSDVYSFGVLV 548
V +D++S GVL
Sbjct: 330 GKPVGYYTDMWSVGVLS 346
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 54/223 (24%), Positives = 86/223 (38%), Gaps = 52/223 (23%)
Query: 366 VKRDLKIFDFQTIAAATDNFS------PANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKS 418
+ FD + + A + LG G FG V+ + G ++A K +
Sbjct: 66 IPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR 125
Query: 419 SGQGIVEFKNEAKLIAKLQHTNLTDSSRKSLLDW---KKRFYII----EG---------- 461
+ E KNE ++ +L H NL L D K ++ +G
Sbjct: 126 GMKDKEEVKNEISVMNQLDHANLI-----QLYDAFESKNDIVLVMEYVDGGELFDRIIDE 180
Query: 462 ---------------IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNP--KISDFGMAR 504
I +G+ ++H+ + +H DLK NIL + KI DFG+AR
Sbjct: 181 SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLAR 237
Query: 505 TYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVL 547
Y E GT +++PE V VS +D++S GV+
Sbjct: 238 RYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 4e-18
Identities = 49/227 (21%), Positives = 80/227 (35%), Gaps = 61/227 (26%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL 441
+ LG G G V G+ +A+KR+ E KL+ + H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNV 71
Query: 442 -----TDSSRK-----------SLLDW--KKRFY--------------IIEGIVQGLLYL 469
++++ + +L D K ++ I G+ +L
Sbjct: 72 IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 470 HKYSRLRAIHRDLKVSNILLD-------------EQMNPKISDFGMARTYAMNE--LEAN 514
H L+ IHRDLK NIL+ E + ISDFG+ + + N
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 515 TNRIVGTHGYMSPEYVMNGIVSM-------KSDVYSFGVLVLEIVSS 554
N GT G+ +PE + D++S G + I+S
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 44/197 (22%), Positives = 74/197 (37%), Gaps = 47/197 (23%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSSRK-- 447
LG+GGFG V+ G L D ++AIK + ++ G + ++ +
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 448 ---SLLDW---KKRFYII---------------------EG--------IVQGLLYLHKY 472
LLDW ++ F ++ EG +V + + H
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH-- 156
Query: 473 SRLRAIHRDLKVSNILLDEQMNP-KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM 531
+HRD+K NIL+D + K+ DFG GT Y PE++
Sbjct: 157 -SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT----DFDGTRVYSPPEWIS 211
Query: 532 NGI-VSMKSDVYSFGVL 547
++ + V+S G+L
Sbjct: 212 RHQYHALPATVWSLGIL 228
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 17/227 (7%), Positives = 48/227 (21%), Gaps = 72/227 (31%)
Query: 390 RLGQGGFGPVYNGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTDSS 445
L G V+ + ++ ++ A+K + S + A+L + ++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 446 RKSLL------------------------DWKKRFYIIEGIVQGLL-------------- 467
+ L + ++ L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 468 --------------------YLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507
L +H N+ + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 508 MNELEANTNRIVGTHGYMSPEYVM--NGIVSMKSDVYSFGVLVLEIV 552
++ Y E++ + + + G+ + +
Sbjct: 243 --KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 48/193 (24%), Positives = 77/193 (39%), Gaps = 41/193 (21%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTN----- 440
LG+G +G V A+K L K G K E +L+ +L+H N
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 441 --LTDSSRKS--------------LLDW--KKRFYIIEG------IVQGLLYLHKYSRLR 476
L + ++ +LD +KRF + + ++ GL YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQG 129
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVS 536
+H+D+K N+LL KIS G+A + G+ + PE + NG+ +
Sbjct: 130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE-IANGLDT 188
Query: 537 ---MKSDVYSFGV 546
K D++S GV
Sbjct: 189 FSGFKVDIWSAGV 201
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 17/113 (15%), Positives = 39/113 (34%), Gaps = 19/113 (16%)
Query: 450 LDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509
L R + +++ L LH +H L+ +I+LD++ ++ F
Sbjct: 208 LVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV----- 259
Query: 510 ELEANTNRIVGTHGYMSPEYVM----------NGIVSMKSDVYSFGVLVLEIV 552
+ + G+ PE +++ D ++ G+ + I
Sbjct: 260 -RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 38/301 (12%), Positives = 78/301 (25%), Gaps = 68/301 (22%)
Query: 335 VNEDLLRELGHNVSLPIIFGNRKTQVHNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQG 394
++ L+ +L +S P+ + + +FQ + + LG+G
Sbjct: 22 WDDKLIFKLLSGLSKPV--SSYPNTFEWQCKLPAIKPKTEFQLG---SKLVYVHHLLGEG 76
Query: 395 GFGPVY------NGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----- 443
F VY + Q+ +K ++ + +
Sbjct: 77 AFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136
Query: 444 ------------SSRKSLLD---------WKK------RFYIIEGIVQGLLYLHKYSRLR 476
S +LL+ K + + ++ + +H
Sbjct: 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR-MLYMIEQVHDCEI-- 193
Query: 477 AIHRDLKVSNILLDEQMNP-----------KISDFGMARTYAMNELEANTNRIVGTHGYM 525
IH D+K N +L + D G + + T G+
Sbjct: 194 -IHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQ 252
Query: 526 SPEYVMNGIVSMKSDVYSFGVLVLEIVSSK-----KNNGSYDTERPLNLVGYAWQ--LWN 578
E + N + + D + V ++ G E +WN
Sbjct: 253 CVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR---RLPHLDMWN 309
Query: 579 E 579
E
Sbjct: 310 E 310
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 50/221 (22%), Positives = 88/221 (39%), Gaps = 56/221 (25%)
Query: 364 QTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQG 422
+ ++ F I LG G FG V K + A+K L K
Sbjct: 32 TPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKILDKQK--- 78
Query: 423 IVEFK------NEAKLIAKLQH---TNLTDSSRKS-----LLDWKK-------------- 454
+V+ K NE +++ + L S + + ++++
Sbjct: 79 VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 455 -----RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509
RFY + IV YLH I+RDLK N+L+D+Q +++DFG A+
Sbjct: 139 SEPHARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 550
++ T + GT ++PE +++ + D ++ GVL+ E
Sbjct: 190 RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 19/121 (15%), Positives = 42/121 (34%), Gaps = 20/121 (16%)
Query: 444 SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMA 503
SS L R + +++ L LH +H L+ +I+LD++ ++ F
Sbjct: 197 SSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 504 RTYAMNELEANTNRIVGTHGYMSPEYVM-----------NGIVSMKSDVYSFGVLVLEIV 552
+ + G+ PE +++ D ++ G+++ I
Sbjct: 254 V------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 553 S 553
Sbjct: 308 C 308
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 38/197 (19%)
Query: 382 TDNFSPANRLGQGGFGPVYNG-KLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 438
+DN+ LG+G F V G E A K ++ S + + + EA++ KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 439 TN---LTDS--SRKS------------LLDW--KKRFY-------IIEGIVQGLLYLHKY 472
N L DS L + + FY I+ I++ + Y H
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS- 123
Query: 473 SRLRAIHRDLKVSNILL---DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEY 529
+HR+LK N+LL + K++DFG+A +E + GT GY+SPE
Sbjct: 124 --NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEV 178
Query: 530 VMNGIVSMKSDVYSFGV 546
+ S D+++ GV
Sbjct: 179 LKKDPYSKPVDIWACGV 195
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 40/196 (20%), Positives = 71/196 (36%), Gaps = 37/196 (18%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 440
+ + A LG+G FG V+ + K + G V K E ++ +H N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRN 62
Query: 441 ---LTDS--SRKS------------LLDW---KKRFY-------IIEGIVQGLLYLHKYS 473
L +S S + + + + + + L +LH
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS-- 120
Query: 474 RLRAIHRDLKVSNILLDEQMNP--KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM 531
H D++ NI+ + + KI +FG AR + N + Y +PE
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQ 176
Query: 532 NGIVSMKSDVYSFGVL 547
+ +VS +D++S G L
Sbjct: 177 HDVVSTATDMWSLGTL 192
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 49/234 (20%), Positives = 94/234 (40%), Gaps = 50/234 (21%)
Query: 356 RKTQVHNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKR 414
+ T+ Q++ + ++ D+ + P + +G+G V G E A+K
Sbjct: 67 KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 415 LSKSSGQGIVE--------FKNEAKLIAKL-QHTN---LTDS--SRKS------------ 448
+ ++ + E + E ++ ++ H + L DS S
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186
Query: 449 LLDW---KKRF------YIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISD 499
L D+ K I+ +++ + +LH +HRDLK NILLD+ M ++SD
Sbjct: 187 LFDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSD 243
Query: 500 FGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV-------SMKSDVYSFGV 546
FG + E + GT GY++PE ++ + + D+++ GV
Sbjct: 244 FGFSCHLEPGEK---LRELCGTPGYLAPE-ILKCSMDETHPGYGKEVDLWACGV 293
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 38/197 (19%)
Query: 382 TDNFSPANRLGQGGFGPVYNG-KLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 438
+DN+ LG+G F V G E A K ++ S + + + EA++ KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 439 TN---LTDS--SRKS------------LLDW--KKRFY-------IIEGIVQGLLYLHKY 472
N L DS L + + FY I+ I++ + Y H
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS- 146
Query: 473 SRLRAIHRDLKVSNILL---DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEY 529
+HR+LK N+LL + K++DFG+A +E + GT GY+SPE
Sbjct: 147 --NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEV 201
Query: 530 VMNGIVSMKSDVYSFGV 546
+ S D+++ GV
Sbjct: 202 LKKDPYSKPVDIWACGV 218
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 55/221 (24%), Positives = 85/221 (38%), Gaps = 57/221 (25%)
Query: 367 KRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVE 425
D+ F+ + A +G+G FG V + D +++ A+K ++K VE
Sbjct: 9 NEDVNFDHFEILRA----------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQK---CVE 55
Query: 426 FK------NEAKLIAKLQH---TNLTDS--SRKSL---LDWKK----------------- 454
E +++ L+H NL S + + +D
Sbjct: 56 RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE 115
Query: 455 --RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512
+ +I E +V L YL R IHRD+K NILLDE + I+DF +A
Sbjct: 116 TVKLFICE-LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ- 170
Query: 513 ANTNRIVGTHGYMSPEYVMNGIV---SMKSDVYSFGVLVLE 550
+ GT YM+PE + S D +S GV E
Sbjct: 171 --ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYE 209
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 51/203 (25%), Positives = 81/203 (39%), Gaps = 43/203 (21%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSS------GQGIVEFKNEAKLIA 434
D + LG G F V + G E A K + K G E + E ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 435 KLQHTN---LTDS--SRKS------------LLDW--KKRFY-------IIEGIVQGLLY 468
++ H N L D +R L D+ +K I+ I+ G+ Y
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 469 LHKYSRLRAIHRDLKVSNILLDEQMNP----KISDFGMARTYAMNELEANTNRIVGTHGY 524
LH + H DLK NI+L ++ P K+ DFG+A I GT +
Sbjct: 131 LHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEF 184
Query: 525 MSPEYVMNGIVSMKSDVYSFGVL 547
++PE V + +++D++S GV+
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVI 207
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 44/199 (22%), Positives = 74/199 (37%), Gaps = 53/199 (26%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKL------IAKLQHTNL 441
LG G FG V+ +E+ +K + K +E K+ +++++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 442 TDSSRKSLLDW---KKRFYII-----EG------------------------IVQGLLYL 469
+LD + F ++ G +V + YL
Sbjct: 92 I-----KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146
Query: 470 HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEY 529
IHRD+K NI++ E K+ DFG A +L GT Y +PE
Sbjct: 147 R---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEV 200
Query: 530 VM-NGIVSMKSDVYSFGVL 547
+M N + +++S GV
Sbjct: 201 LMGNPYRGPELEMWSLGVT 219
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 52/222 (23%), Positives = 84/222 (37%), Gaps = 49/222 (22%)
Query: 368 RDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVE- 425
RD + + +N+ P LG+G V +E A+K + + G
Sbjct: 2 RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 426 --------FKNEAKLIAKL-QHTN---LTDS--SRKS------------LLDW---KKRF 456
E ++ K+ H N L D+ + L D+ K
Sbjct: 62 EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 457 ------YIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510
I+ +++ + LHK L +HRDLK NILLD+ MN K++DFG + E
Sbjct: 122 SEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
Query: 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKS------DVYSFGV 546
+ GT Y++PE + + D++S GV
Sbjct: 179 K---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 46/186 (24%), Positives = 79/186 (42%), Gaps = 34/186 (18%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 441
LG+G +G V + + +A+K + E K E + L H N+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 442 -TDS-------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRD 481
+ + + + + + ++ G++YLH + HRD
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ-LMAGVVYLH---GIGITHRD 130
Query: 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSD 540
+K N+LLDE+ N KISDFG+A + N E N++ GT Y++PE + + D
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 541 VYSFGV 546
V+S G+
Sbjct: 191 VWSCGI 196
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 45/180 (25%), Positives = 79/180 (43%), Gaps = 43/180 (23%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLS-KSSGQGIVEFKN-----EAKLIAK 435
+NF ++G+G +G VY + L G+ +A+K++ + +G+ E L+ +
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV----PSTAIREISLLKE 58
Query: 436 LQHTN-------------LT------DSSRKSLLDWKKRFYIIEGIV--------QGLLY 468
L H N L K +D I ++ QGL +
Sbjct: 59 LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 469 LHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPE 528
H + R +HRDLK N+L++ + K++DFG+AR + + T+ +V T Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPE 173
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 49/203 (24%), Positives = 80/203 (39%), Gaps = 43/203 (21%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKS------SGQGIVEFKNEAKLIA 434
D + LG G F V + G E A K + K G E + E ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 435 KLQHTNLTD-----SSRKS------------LLDW--KKRFY-------IIEGIVQGLLY 468
++ H N+ +R L D+ +K I+ I+ G+ Y
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 469 LHKYSRLRAIHRDLKVSNILLDEQMNP----KISDFGMARTYAMNELEANTNRIVGTHGY 524
LH + H DLK NI+L ++ P K+ DFG+A I GT +
Sbjct: 131 LHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEF 184
Query: 525 MSPEYVMNGIVSMKSDVYSFGVL 547
++PE V + +++D++S GV+
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVI 207
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 46/213 (21%), Positives = 82/213 (38%), Gaps = 62/213 (29%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKS-------------------SGQGIVEFKNEA 430
+G+G +G V D A+K LSK + G ++ +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 431 KLIA-------KLQHTN-------LTDSSRKS------------LLD--WKKRFYIIEG- 461
+ + KL H N L D + +++ K +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 462 -----IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516
+++G+ YLH + IHRD+K SN+L+ E + KI+DFG++ + ++ +
Sbjct: 141 FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT 197
Query: 517 RIVGTHGYMSPEYVMN---GIVSMKSDVYSFGV 546
VGT +M+PE + DV++ GV
Sbjct: 198 --VGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 49/205 (23%), Positives = 74/205 (36%), Gaps = 44/205 (21%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIK-----RLSKSSGQGIVEFKNEAKLIAK 435
D + +G+G F V GQ+ A+K + + S G + K EA +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 436 LQHTN---LTD--SSRKS------------LLD------WKKRFY-------IIEGIVQG 465
L+H + L + SS L Y + I++
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 466 LLYLHKYSRLRAIHRDLKVSNILL---DEQMNPKISDFGMARTYAMNELEANTNRIVGTH 522
L Y H IHRD+K +LL + K+ FG+A + L A VGT
Sbjct: 143 LRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTP 197
Query: 523 GYMSPEYVMNGIVSMKSDVYSFGVL 547
+M+PE V DV+ GV+
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 50/193 (25%), Positives = 83/193 (43%), Gaps = 48/193 (24%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL------ 441
+G+G F V + +L G+E+AIK + K+ + + + E +++ L H N+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 442 --TDS---------SRKSLLDWKKRFYIIEG--------------IVQGLLYLHKYSRLR 476
T+ S + D Y++ IV + Y H + R
Sbjct: 83 IETEKTLYLIMEYASGGEVFD-----YLVAHGRMKEKEARSKFRQIVSAVQYCH---QKR 134
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGI-- 534
+HRDLK N+LLD MN KI+DFG + + + + G Y +PE + G
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPE-LFQGKKY 190
Query: 535 VSMKSDVYSFGVL 547
+ DV+S GV+
Sbjct: 191 DGPEVDVWSLGVI 203
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 43/203 (21%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKS------SGQGIVEFKNEAKLIA 434
D++ LG G F V + G+E A K + K G E + E ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 435 KLQHTN---LTDS--SRKS------------LLDW--KKRFY-------IIEGIVQGLLY 468
+++H N L D ++ L D+ +K ++ I+ G+ Y
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 469 LHKYSRLRAIHRDLKVSNILLDEQMNP----KISDFGMARTYAMNELEANTNRIVGTHGY 524
LH R H DLK NI+L ++ P K+ DFG+A I GT +
Sbjct: 124 LHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEF 177
Query: 525 MSPEYVMNGIVSMKSDVYSFGVL 547
++PE V + +++D++S GV+
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVI 200
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 49/198 (24%), Positives = 84/198 (42%), Gaps = 39/198 (19%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 438
T+ + LG+G F V +L GQE A ++ S + + + EA++ L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 439 TN---LTDS--SRKS------------LLDW--KKRFY-------IIEGIVQGLLYLHKY 472
N L DS L + + +Y I+ I++ +L+ H+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ- 128
Query: 473 SRLRAIHRDLKVSNILL---DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEY 529
+ +HR+LK N+LL + K++DFG+A + GT GY+SPE
Sbjct: 129 --MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPE- 183
Query: 530 VMNGIV-SMKSDVYSFGV 546
V+ D+++ GV
Sbjct: 184 VLRKDPYGKPVDLWACGV 201
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 48/194 (24%), Positives = 81/194 (41%), Gaps = 43/194 (22%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKS------SGQGIVEFKNEAKLIAKLQHTN--- 440
LG G F V + G + A K + K G + + E ++ ++QH N
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 441 LTDS--SRKS------------LLDW--KKRFY-------IIEGIVQGLLYLHKYSRLRA 477
L + ++ L D+ +K ++ I+ G+ YLH L+
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQI 135
Query: 478 IHRDLKVSNILLDEQMNP----KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG 533
H DLK NI+L ++ P KI DFG+A I GT +++PE V
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE 192
Query: 534 IVSMKSDVYSFGVL 547
+ +++D++S GV+
Sbjct: 193 PLGLEADMWSIGVI 206
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 3e-16
Identities = 43/178 (24%), Positives = 79/178 (44%), Gaps = 41/178 (23%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLS-KSSGQGIVEFKN-----EAKLIAKL 436
+ + ++G+G +G VY K G+ +A+KR+ + +GI E L+ +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI----PSTAIREISLLKEL 76
Query: 437 QHTN-------LTDSSR------------KSLLDWKKRFYIIEGI-------VQGLLYLH 470
H N + K +LD K I ++G+ + H
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 471 KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPE 528
++ R +HRDLK N+L++ K++DFG+AR + + + T+ +V T Y +P+
Sbjct: 137 QH---RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV-TLWYRAPD 189
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 50/218 (22%), Positives = 81/218 (37%), Gaps = 53/218 (24%)
Query: 380 AATDNFSP---------ANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNE 429
+TD+FS + LG+G V L+ QE A+K + K G E
Sbjct: 1 GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE 60
Query: 430 AKLIAKLQ-HTN---LTDS--------------SRKSLLD--WKKRFY-------IIEGI 462
+++ + Q H N L + S+L K+R + +++ +
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDV 120
Query: 463 VQGLLYLHKYSRLRAIHRDLKVSNILL---DEQMNPKISDFGMARTYAMNELEANTNR-- 517
L +LH HRDLK NIL ++ KI DF + +N + +
Sbjct: 121 ASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 518 ---IVGTHGYMSPEYVMNGIVSMKS-----DVYSFGVL 547
G+ YM+PE V D++S GV+
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 7e-16
Identities = 46/238 (19%), Positives = 86/238 (36%), Gaps = 62/238 (26%)
Query: 356 RKTQVHNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEI-AIKR 414
+ + + + L+ DF+ + +G+G F V K+ ++ A+K
Sbjct: 44 QWAEPIVVRLKEVRLQRDDFEILKV----------IGRGAFSEVAVVKMKQTGQVYAMKI 93
Query: 415 LSKSSGQGIVE------FKNEAKLIAKLQH-----------------------------T 439
++K +++ F+ E ++ T
Sbjct: 94 MNKWD---MLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLT 150
Query: 440 NLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISD 499
L+ + + RFY+ E IV + +H+ L +HRD+K NILLD + +++D
Sbjct: 151 LLSKFGERIPAEMA-RFYLAE-IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLAD 205
Query: 500 FGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY-------SFGVLVLE 550
FG + + VGT Y+SPE + + Y + GV E
Sbjct: 206 FGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-16
Identities = 44/186 (23%), Positives = 79/186 (42%), Gaps = 46/186 (24%)
Query: 380 AATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN-----EAKLI 433
+++ F +LG G + VY G G +A+K + S +G E L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLM 57
Query: 434 AKLQHTN-------------LT------DSSRKSLLDWKKRFYIIEG------------I 462
+L+H N LT D+ K +D + G +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 463 VQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTH 522
+QGL + H+ + +HRDLK N+L++++ K+ DFG+AR + + ++ +V T
Sbjct: 118 LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVV-TL 172
Query: 523 GYMSPE 528
Y +P+
Sbjct: 173 WYRAPD 178
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 49/181 (27%), Positives = 81/181 (44%), Gaps = 43/181 (23%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN--------EAKLI 433
+ + LG+G F VY + Q +AIK++ E K+ E KL+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS---EAKDGINRTALREIKLL 66
Query: 434 AKLQHTN---LTD--SSRKSL--------LDWKK-----RFYIIEGIV--------QGLL 467
+L H N L D + ++ D + + + QGL
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 468 YLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSP 527
YLH++ +HRDLK +N+LLDE K++DFG+A+++ + A T+++V T Y +P
Sbjct: 127 YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV-TRWYRAP 181
Query: 528 E 528
E
Sbjct: 182 E 182
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 51/194 (26%), Positives = 82/194 (42%), Gaps = 46/194 (23%)
Query: 391 LGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVEFK------NEAKLIAKLQH---TN 440
LG G FG V+ + A+K L K +V K +E +++ + H
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEI---VVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 441 LTDS--SRKSL---LDWKK-------------------RFYIIEGIVQGLLYLHKYSRLR 476
+ + + + +D+ + +FY E + L YLH
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE-VCLALEYLHSKD--- 126
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVS 536
I+RDLK NILLD+ + KI+DFG A+ + T + GT Y++PE V +
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYN 181
Query: 537 MKSDVYSFGVLVLE 550
D +SFG+L+ E
Sbjct: 182 KSIDWWSFGILIYE 195
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 46/186 (24%), Positives = 79/186 (42%), Gaps = 34/186 (18%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 441
LG+G +G V + + +A+K + E K E + L H N+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 442 -TDS-------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRD 481
+ + + + + + ++ G++YLH + HRD
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ-LMAGVVYLH---GIGITHRD 130
Query: 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSD 540
+K N+LLDE+ N KISDFG+A + N E N++ GT Y++PE + + D
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 541 VYSFGV 546
V+S G+
Sbjct: 191 VWSCGI 196
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 42/197 (21%), Positives = 77/197 (39%), Gaps = 48/197 (24%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLS-KSSGQGIVEFKN-----EAKLIAK 435
+ ++G+G +G V+ K + +A+KR+ +G+ E L+ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSALREICLLKE 57
Query: 436 LQHTN-------------LT------DSSRKSLLDWKKRFYIIEGI-------VQGLLYL 469
L+H N LT D K D E + ++GL +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 470 HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEY 529
H +HRDLK N+L++ K+++FG+AR + + + +V T Y P+
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV-TLWYRPPD- 171
Query: 530 VMNGIVSMKSDVYSFGV 546
V + +YS +
Sbjct: 172 -----VLFGAKLYSTSI 183
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 45/174 (25%), Positives = 75/174 (43%), Gaps = 33/174 (18%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTN 440
+ + ++LG+G + VY GK L +A+K + +G E L+ L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 441 -------------LT------DSSRKSLLDWKKRFYIIEGI-------VQGLLYLHKYSR 474
LT D K LD + + ++GL Y H+
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ-- 119
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPE 528
+ +HRDLK N+L++E+ K++DFG+AR + + N +V T Y P+
Sbjct: 120 -KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV-TLWYRPPD 170
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 52/210 (24%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVE------FKNEAKLIAK 435
++F +G+G FG V KL + ++ A+K L+K +++ F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE---MLKRAETACFREERDVLVN 130
Query: 436 LQH-----------------------------TNLTDSSRKSLLDWKKRFYIIEGIVQGL 466
T L+ + + RFY+ E +V +
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLAE-MVIAI 188
Query: 467 LYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMS 526
+H+ L +HRD+K NIL+D + +++DFG M + ++ VGT Y+S
Sbjct: 189 DSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCL-KLMEDGTVQSSVAVGTPDYIS 244
Query: 527 PEYVMNGIVSMKS------DVYSFGVLVLE 550
PE ++ + K D +S GV + E
Sbjct: 245 PE-ILQAMEGGKGRYGPECDWWSLGVCMYE 273
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 48/206 (23%), Positives = 76/206 (36%), Gaps = 48/206 (23%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVE--------FKNEAKL 432
D + + LG G G V +++AIK +SK + E ++
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 433 IAKLQHTN---LTDS--SRKS-----------LLDW---KKRFY------IIEGIVQGLL 467
+ KL H + + + L D KR ++ +
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 468 YLHKYSRLRAIHRDLKVSNILL---DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGY 524
YLH IHRDLK N+LL +E KI+DFG ++ L + GT Y
Sbjct: 129 YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTY 182
Query: 525 MSPEYVMNGIV----SMKSDVYSFGV 546
++PE V+ + + D +S GV
Sbjct: 183 LAPE-VLVSVGTAGYNRAVDCWSLGV 207
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 50/232 (21%), Positives = 88/232 (37%), Gaps = 55/232 (23%)
Query: 356 RKTQVHNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEI-AIKR 414
+ + ++ +K D++ + +G+G FG V + +++ A+K
Sbjct: 52 SRYKDTINKIRDLRMKAEDYEVVKV----------IGRGAFGEVQLVRHKSTRKVYAMKL 101
Query: 415 LSKSSGQGIVE------FKNEAKLIAKLQH---TNL-----TDS---------------- 444
LSK +++ F E ++A L D
Sbjct: 102 LSKFE---MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN 158
Query: 445 --SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGM 502
S + + RFY E +V L +H + IHRD+K N+LLD+ + K++DFG
Sbjct: 159 LMSNYDVPEKWARFYTAE-VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT 214
Query: 503 ARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMK----SDVYSFGVLVLE 550
+ + VGT Y+SPE + + D +S GV + E
Sbjct: 215 CMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 53/247 (21%), Positives = 88/247 (35%), Gaps = 59/247 (23%)
Query: 354 GNRKTQVHND--QTVKRDLKIFDFQTIAAATDNFSPAN---------RLGQGGFGPVYNG 402
G R+ +N K+F F + + P LG G G V
Sbjct: 95 GKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA 154
Query: 403 K-LLDGQEIAIKRLSKS--------SGQGIVEFKNEAKLIAKLQHTN---LTDSSRKS-- 448
+++AI+ +SK + + E +++ KL H + +
Sbjct: 155 FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY 214
Query: 449 -----------LLDW---KKRF------YIIEGIVQGLLYLHKYSRLRAIHRDLKVSNIL 488
L D KR ++ + YLH+ IHRDLK N+L
Sbjct: 215 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVL 271
Query: 489 L---DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV----SMKSDV 541
L +E KI+DFG ++ L + GT Y++PE V+ + + D
Sbjct: 272 LSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPE-VLVSVGTAGYNRAVDC 327
Query: 542 YSFGVLV 548
+S GV++
Sbjct: 328 WSLGVIL 334
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 45/192 (23%), Positives = 74/192 (38%), Gaps = 41/192 (21%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHT----NLTD 443
LG+G F V GQE A K L K E +E ++ + NL +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 444 S--SRKS------------LLDW----KKRFY-------IIEGIVQGLLYLHKYSRLRAI 478
+ + +I+ I++G+ YLH+ +
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIV 153
Query: 479 HRDLKVSNILL---DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
H DLK NILL + KI DFGM+R I+GT Y++PE + +
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPI 210
Query: 536 SMKSDVYSFGVL 547
+ +D+++ G++
Sbjct: 211 TTATDMWNIGII 222
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 46/210 (21%), Positives = 85/210 (40%), Gaps = 49/210 (23%)
Query: 374 DFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKN-EAKL 432
D +T ++ +G G FG V+ KL++ E+AIK++ + FKN E ++
Sbjct: 31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQI 85
Query: 433 IAKLQHTN--------LTDSSRKSLLD-------------------WKKRFYIIEGIVQ- 464
+ ++H N ++ +K + K + + +++
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL 145
Query: 465 -------GLLYLHKYSRLRAIHRDLKVSNILLDEQMNP-KISDFGMARTYAMNELEANTN 516
L Y+H + HRD+K N+LLD K+ DFG A+ + E N +
Sbjct: 146 YMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK--ILIAGEPNVS 200
Query: 517 RIVGTHGYMSPEYVMNGIV-SMKSDVYSFG 545
I + Y +PE + + D++S G
Sbjct: 201 YIC-SRYYRAPELIFGATNYTTNIDIWSTG 229
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 33/97 (34%), Positives = 56/97 (57%), Gaps = 13/97 (13%)
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGT 521
+ +G+ +L + + IHRDL NILL E+ KI DFG+AR ++ + + +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRKG 253
Query: 522 HG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
+M+PE + + + +++SDV+SFGVL+ EI S
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 38/186 (20%)
Query: 391 LGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN---LTDS-- 444
LG+G VY K + A+K L K+ + IV + E ++ +L H N L +
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV--RTEIGVLLRLSHPNIIKLKEIFE 118
Query: 445 SRKS------------LLDW--KKRFY-------IIEGIVQGLLYLHKYSRLRAIHRDLK 483
+ L D +K +Y ++ I++ + YLH+ +HRDLK
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLK 175
Query: 484 VSNILL---DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSD 540
N+L KI+DFG+++ L + GT GY +PE + + D
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVD 232
Query: 541 VYSFGV 546
++S G+
Sbjct: 233 MWSVGI 238
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 75.2 bits (186), Expect = 4e-15
Identities = 44/178 (24%), Positives = 77/178 (43%), Gaps = 41/178 (23%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLS-KSSGQGIVEFKN-----EAKLIAKL 436
+ + ++G+G +G VY + G+ A+K++ + +GI E ++ +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTIREISILKEL 57
Query: 437 QHTN-------------LT------DSSRKSLLDWKKRFYIIEGI-------VQGLLYLH 470
+H+N L D K LLD + + G+ Y H
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 471 KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPE 528
R +HRDLK N+L++ + KI+DFG+AR + + T+ IV T Y +P+
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV-TLWYRAPD 170
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 7e-15
Identities = 50/188 (26%), Positives = 81/188 (43%), Gaps = 37/188 (19%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKSS--GQGIVE-FKNEAKLIAKLQHTNLT---- 442
LG G FG V G+ L G ++A+K L++ +V K E + + +H ++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 443 --DSSRK-----------SLLDW---KKRFYIIEG------IVQGLLYLHKYSRLRAIHR 480
+ L D+ R +E I+ + Y H R +HR
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH---RHMVVHR 135
Query: 481 DLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKS 539
DLK N+LLD MN KI+DFG++ + E T+ G+ Y +PE + +
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPEVISGRLYAGPEV 192
Query: 540 DVYSFGVL 547
D++S GV+
Sbjct: 193 DIWSCGVI 200
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 43/185 (23%), Positives = 71/185 (38%), Gaps = 45/185 (24%)
Query: 383 DNFSPANRLGQGGFGPVYNGK--LLDGQEIAIKR-----------------------LSK 417
+ +G+G +G V+ + G+ +A+KR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 418 SSGQGIVEFKNEAKLIAKLQHTNLT------DSSRKSLLDWKKRFYIIEGIV-------- 463
+V + + + T LT D + LD + +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 464 QGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG 523
+GL +LH + R +HRDLK NIL+ K++DFG+AR Y+ A T+ +V T
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVV-TLW 184
Query: 524 YMSPE 528
Y +PE
Sbjct: 185 YRAPE 189
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 27/96 (28%), Positives = 41/96 (42%), Gaps = 11/96 (11%)
Query: 458 IIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL--DEQMNPKISDFGMARTYAMNELEANT 515
I+ I L YLH HRD+K N L ++ K+ DFG+++ +
Sbjct: 173 IMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY 229
Query: 516 --NRIVGTHGYMSPEYVMNGIV---SMKSDVYSFGV 546
GT +++PE V+N K D +S GV
Sbjct: 230 GMTTKAGTPYFVAPE-VLNTTNESYGPKCDAWSAGV 264
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 44/195 (22%), Positives = 78/195 (40%), Gaps = 62/195 (31%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEA----------- 430
+ ++GQG FG V+ + GQ++A+K+ V +NE
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKK---------VLMENEKEGFPITALREI 67
Query: 431 KLIAKLQHTN---LTD---SSRKSLLDWKKRFYII--------------------EGIV- 463
K++ L+H N L + + K Y++ +
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 127
Query: 464 -------QGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN-- 514
GL Y+H+ + +HRD+K +N+L+ K++DFG+AR +++ +
Sbjct: 128 RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 515 -TNRIVGTHGYMSPE 528
TNR+V T Y PE
Sbjct: 185 YTNRVV-TLWYRPPE 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 36/187 (19%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKS--SGQGIVE-FKNEAKLIAKLQHTNLT---- 442
LG+G FG V Q++A+K +S+ + + E + L+H ++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 443 --DSSRK----------SLLDW---KKRFYIIEG------IVQGLLYLHKYSRLRAIHRD 481
+ L D+ KKR EG I+ + Y H R + +HRD
Sbjct: 77 VITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRD 133
Query: 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSD 540
LK N+LLD+ +N KI+DFG++ T+ G+ Y +PE + + D
Sbjct: 134 LKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTS--CGSPNYAAPEVINGKLYAGPEVD 190
Query: 541 VYSFGVL 547
V+S G++
Sbjct: 191 VWSCGIV 197
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 54/202 (26%), Positives = 83/202 (41%), Gaps = 42/202 (20%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVE------FKNEAKLIAK 435
+ F LG+G FG V K A+K L K IV E +++
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEV---IVAKDEVAHTLTENRVLQN 204
Query: 436 LQH---TNL-----TDS------------------SRKSLLDWKK-RFYIIEGIVQGLLY 468
+H T L T SR+ + + RFY E IV L Y
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE-IVSALDY 263
Query: 469 LHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPE 528
LH S ++RDLK+ N++LD+ + KI+DFG+ + + + A GT Y++PE
Sbjct: 264 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKTFCGTPEYLAPE 319
Query: 529 YVMNGIVSMKSDVYSFGVLVLE 550
+ + D + GV++ E
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYE 341
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 45/198 (22%), Positives = 83/198 (41%), Gaps = 50/198 (25%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQHT 439
+ + ++G+G +G V+ + GQ +AIK+ +S +++ E +++ +L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 440 NLTDSSRKSLLD---WKKRFYII--------------------EGIV--------QGLLY 468
NL +LL+ K+R +++ E +V Q + +
Sbjct: 63 NLV-----NLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 469 LHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPE 528
HK+ IHRD+K NIL+ + K+ DFG AR + + + T Y SPE
Sbjct: 118 CHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWYRSPE 172
Query: 529 YVMNGIVSMKSDVYSFGV 546
+ + Y V
Sbjct: 173 ------LLVGDTQYGPPV 184
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 45/183 (24%), Positives = 74/183 (40%), Gaps = 46/183 (25%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLS-KSSGQGIVEFKN-----EAKLIAK 435
D + +LG+G +G VY + + +AIKR+ + +G+ E L+ +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV----PGTAIREVSLLKE 89
Query: 436 LQHTN-------LTDSSR------------KSLLDWKKRF------YIIEGIVQGLLYLH 470
LQH N + + R K +D + ++ G+ + H
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 471 KYSRLRAIHRDLKVSNILLDEQMNP-----KISDFGMARTYAMNELEANTNRIVGTHGYM 525
R +HRDLK N+LL KI DFG+AR + + + T+ I+ T Y
Sbjct: 150 SR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEII-TLWYR 204
Query: 526 SPE 528
PE
Sbjct: 205 PPE 207
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 47/189 (24%), Positives = 73/189 (38%), Gaps = 47/189 (24%)
Query: 381 ATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLS-KSSGQGIVEFKN----EAKLIA 434
AT + P +G G +G VY + G +A+K + + G G E L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 435 KLQ--------------HTNLTDSSR-------------KSLLDWKKRFYIIEGIV---- 463
+L+ T+ TD ++ LD + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 464 ----QGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIV 519
+GL +LH +HRDLK NIL+ K++DFG+AR Y+ A T +V
Sbjct: 127 RQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPVVV 181
Query: 520 GTHGYMSPE 528
T Y +PE
Sbjct: 182 -TLWYRAPE 189
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 42/188 (22%), Positives = 70/188 (37%), Gaps = 39/188 (20%)
Query: 391 LGQGGFGPVYNG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTN---LTDS- 444
LG+G F Q A+K +SK + E + + H N L +
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEITALKLCEGHPNIVKLHEVF 75
Query: 445 -SRKS------------LLD--WKKRFY-------IIEGIVQGLLYLHKYSRLRAIHRDL 482
+ L + KK+ + I+ +V + ++H + +HRDL
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDL 132
Query: 483 KVSNILL---DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 539
K N+L ++ + KI DFG AR + T T Y +PE +
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQNGYDESC 190
Query: 540 DVYSFGVL 547
D++S GV+
Sbjct: 191 DLWSLGVI 198
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 54/230 (23%), Positives = 86/230 (37%), Gaps = 56/230 (24%)
Query: 357 KTQVHNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEI-AIKRL 415
Q++ + K DF + +G+G FG V + + A+K L
Sbjct: 22 SQQINLGPSSNPHAKPSDFHFLKV----------IGKGSFGKVLLARHKAEEVFYAVKVL 71
Query: 416 SKSSGQGIVEFKNEAK--------LIAKLQH---TNL-----TDS--------------- 444
K + I++ K E K L+ ++H L T
Sbjct: 72 QKKA---ILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELF 127
Query: 445 ---SRKSLLDWKK-RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDF 500
R+ + RFY E I L YLH L ++RDLK NILLD Q + ++DF
Sbjct: 128 YHLQRERCFLEPRARFYAAE-IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDF 183
Query: 501 GMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 550
G+ + + +T GT Y++PE + D + G ++ E
Sbjct: 184 GLCKENIEHNSTTST--FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 48/205 (23%), Positives = 94/205 (45%), Gaps = 40/205 (19%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HT 439
D++ +LG+G + V+ + + +++ +K L + + K E K++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91
Query: 440 N---LTD-----SSRKSLL--------DWKK----------RFYIIEGIVQGLLYLHKYS 473
N L D SR L D+K+ RFY+ E I++ L Y H S
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE-ILKALDYCH--S 148
Query: 474 RLRAIHRDLKVSNILLD-EQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN 532
+HRD+K N+++D E ++ D+G+A Y + + R V + + PE +++
Sbjct: 149 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVR-VASRYFKGPELLVD 204
Query: 533 GIVSMKS-DVYSFGVLVLEIVSSKK 556
+ S D++S G ++ ++ K+
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 6e-14
Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 44/180 (24%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQHT 439
+ + +G+G +G V + G+ +AIK+ +S +V+ E KL+ +L+H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 440 NLTDSSRKSLLD---WKKRFYII--------------------EGIV--------QGLLY 468
NL +LL+ KKR+Y++ +V G+ +
Sbjct: 85 NLV-----NLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 469 LHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPE 528
H + IHRD+K NIL+ + K+ DFG ART A E + + T Y +PE
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVA-TRWYRAPE 194
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 9e-14
Identities = 51/198 (25%), Positives = 78/198 (39%), Gaps = 41/198 (20%)
Query: 382 TDNFSPANRLGQGGFGPVYNG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHT 439
TD + +G G + E A+K + KS + E +++ + QH
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHP 76
Query: 440 N---LTDS--SRKS------------LLDW--KKRFY-------IIEGIVQGLLYLHKYS 473
N L D K LLD +++F+ ++ I + + YLH
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA-- 134
Query: 474 RLRAIHRDLKVSNILL-DEQMNP---KISDFGMARTYAMNELEANTNRIVGTHGYMSPEY 529
+HRDLK SNIL DE NP +I DFG A+ T T +++PE
Sbjct: 135 -QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPEV 191
Query: 530 VMNGIVSMKSDVYSFGVL 547
+ D++S GVL
Sbjct: 192 LERQGYDAACDIWSLGVL 209
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 9e-14
Identities = 49/194 (25%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 391 LGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVE------FKNEAKLIAKLQH---TN 440
LG+G FG V + A+K L K I+ E++++ +H T
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEV---IIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 441 L-----TDS------------------SRKSLLDWKK-RFYIIEGIVQGLLYLHKYSRLR 476
L T SR+ + ++ RFY E IV L YLH
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE-IVSALEYLHS---RD 125
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVS 536
++RD+K+ N++LD+ + KI+DFG+ + +++ A GT Y++PE + +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 537 MKSDVYSFGVLVLE 550
D + GV++ E
Sbjct: 184 RAVDWWGLGVVMYE 197
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 39/201 (19%)
Query: 383 DNFSPANRLGQGGFGPVY---NGKLLDGQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKL 436
F LGQG FG V+ D +++ A+K L K++ + V K E ++ ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 437 QH---TNL-----TDS------------------SRKSLLDWKK-RFYIIEGIVQGLLYL 469
H L T+ S++ + + +FY+ E + L +L
Sbjct: 84 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHL 142
Query: 470 HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEY 529
H L I+RDLK NILLDE+ + K++DFG+++ +E +A + GT YM+PE
Sbjct: 143 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEV 197
Query: 530 VMNGIVSMKSDVYSFGVLVLE 550
V + +D +SFGVL+ E
Sbjct: 198 VNRRGHTQSADWWSFGVLMFE 218
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 37/188 (19%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLT---- 442
LG G FG V GK L G ++A+K L++ S + + + E + + +H ++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 443 --DSSRK-----------SLLDW---KKRFYIIEG------IVQGLLYLHKYSRLRAIHR 480
+ L D+ R E I+ G+ Y H R +HR
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH---RHMVVHR 140
Query: 481 DLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKS 539
DLK N+LLD MN KI+DFG++ + E T+ G+ Y +PE + +
Sbjct: 141 DLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPEVISGRLYAGPEV 197
Query: 540 DVYSFGVL 547
D++S GV+
Sbjct: 198 DIWSSGVI 205
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 455 RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514
+ Y+ E IV L +LHK L I+RD+K+ NILLD + ++DFG+++ + +
Sbjct: 162 QIYVGE-IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETER 216
Query: 515 TNRIVGTHGYMSPEYVMNGIVSMKSDV--YSFGVLVLE 550
GT YM+P+ V G V +S GVL+ E
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 45/186 (24%), Positives = 76/186 (40%), Gaps = 51/186 (27%)
Query: 382 TDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHT 439
+++ +G G FG VY KL D G+ +AIK++ + FKN E +++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHC 107
Query: 440 NL---------------------------TD---------SSRKSLLDWKKRFYIIEGIV 463
N+ ++++L + Y+ + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LF 166
Query: 464 QGLLYLHKYSRLRAIHRDLKVSNILLDEQMNP-KISDFGMARTYAMNELEANTNRIVGTH 522
+ L Y+H HRD+K N+LLD K+ DFG A+ + E N + I +
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SR 220
Query: 523 GYMSPE 528
Y +PE
Sbjct: 221 YYRAPE 226
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 50/187 (26%), Positives = 79/187 (42%), Gaps = 39/187 (20%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN-------- 440
+G G FG + L + +A+K + + G I E + E L+H N
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 441 LTDS---------SRKSLLDW---KKRFYIIEG------IVQGLLYLHKYSRLRAIHRDL 482
LT + S L + RF E ++ G+ Y H ++ HRDL
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDL 142
Query: 483 KVSNILLDEQ--MNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKS 539
K+ N LLD KI DFG +++ ++ +T VGT Y++PE ++ +
Sbjct: 143 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRQEYDGKIA 199
Query: 540 DVYSFGV 546
DV+S GV
Sbjct: 200 DVWSCGV 206
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 6e-13
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 51/208 (24%)
Query: 383 DNFSPANRLGQGGFGPVY-----NGKLLDGQEI-AIKRLSKSSGQGIVEFKNEA------ 430
+ F LG+GG+G V+ G + +I A+K L K+ IV +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGA--NTGKIFAMKVLKKAM---IVRNAKDTAHTKAE 71
Query: 431 -KLIAKLQH---TNL-----TDS------------------SRKSLLDWKK-RFYIIEGI 462
++ +++H +L T R+ + FY+ E I
Sbjct: 72 RNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE-I 130
Query: 463 VQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTH 522
L +LH+ I+RDLK NI+L+ Q + K++DFG+ + + +T GT
Sbjct: 131 SMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTI 185
Query: 523 GYMSPEYVMNGIVSMKSDVYSFGVLVLE 550
YM+PE +M + D +S G L+ +
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYD 213
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 71.2 bits (174), Expect = 6e-13
Identities = 51/207 (24%), Positives = 79/207 (38%), Gaps = 52/207 (25%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQEI-AIKRLSK------------------------ 417
+F+ LG+G FG V + E+ A+K L K
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 418 --------SSGQG------IVEFKNEAKLIAKLQHTNLTDSSRKSLLDWKKRFYIIEGIV 463
S Q ++E+ N L+ +Q FY E I
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAE-IA 452
Query: 464 QGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHG 523
GL +L I+RDLK+ N++LD + + KI+DFGM + + + T GT
Sbjct: 453 IGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPD 507
Query: 524 YMSPEYVMNGIVSMKSDVYSFGVLVLE 550
Y++PE + D ++FGVL+ E
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYE 534
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 9e-13
Identities = 43/190 (22%), Positives = 66/190 (34%), Gaps = 53/190 (27%)
Query: 382 TDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKR-LSKSSGQGIVEFKN----EAKLIAK 435
D F GQG FG V GK G +AIK+ + F+N + +A
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQIMQDLAV 75
Query: 436 LQHTN---LTDSSRKSLLDWKKRFY--------------IIEG----------------- 461
L H N L ++ Y
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 462 --IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNP-KISDFGMARTYAMNELEANTNRI 518
+++ + LH S + HRD+K N+L++E K+ DFG A+ ++ E N I
Sbjct: 136 FQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAK--KLSPSEPNVAYI 192
Query: 519 VGTHGYMSPE 528
+ Y +PE
Sbjct: 193 C-SRYYRAPE 201
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 42/195 (21%), Positives = 68/195 (34%), Gaps = 51/195 (26%)
Query: 391 LGQGGFGPVYNG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTN---LTDSS 445
LG G G V GQ+ A+K L S + + E + + + D
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVY 91
Query: 446 RKSLLDWKKRFYII----EG--------------------------IVQGLLYLHKYSRL 475
+++ K+ II EG I + +LH
Sbjct: 92 -ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---H 147
Query: 476 RAIHRDLKVSNILL---DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN 532
HRD+K N+L ++ K++DFG A+ N L T Y++PE +
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYTPYYVAPEVLGP 203
Query: 533 GIVSMKSDVYSFGVL 547
D++S GV+
Sbjct: 204 EKYDKSCDMWSLGVI 218
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 49/220 (22%), Positives = 80/220 (36%), Gaps = 55/220 (25%)
Query: 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVE--FKN---------EA 430
++ + G +G V G +G +AIKR+ + G + E
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 431 KLIAKLQHTNL--------------------------TD------SSRKSLLDWKKRFYI 458
+L+ H N+ TD R + ++++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 459 IEGIVQGLLYLHKYSRLRA--IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516
I+ GL LH+ A +HRDL NILL + + I DF +AR + N
Sbjct: 141 YH-ILLGLHVLHE-----AGVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKT 191
Query: 517 RIVGTHGYMSPEYVMNGIVSMKS-DVYSFGVLVLEIVSSK 555
V Y +PE VM K D++S G ++ E+ + K
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 48/196 (24%), Positives = 77/196 (39%), Gaps = 46/196 (23%)
Query: 391 LGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVEFKNEAK--------LIAKLQH--- 438
LG+G FG V + E+ A+K L K +++ ++ + L +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDV---VIQ-DDDVECTMVEKRVLALPGKPPFL 83
Query: 439 TNL-----TDS------------------SRKSLLDWKK-RFYIIEGIVQGLLYLHKYSR 474
T L T + FY E I GL +L
Sbjct: 84 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQS--- 139
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGI 534
I+RDLK+ N++LD + + KI+DFGM + + + T GT Y++PE +
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEIIAYQP 197
Query: 535 VSMKSDVYSFGVLVLE 550
D ++FGVL+ E
Sbjct: 198 YGKSVDWWAFGVLLYE 213
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 46/196 (23%)
Query: 391 LGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVEFKNEAK--------LIAKLQH--- 438
LG+G FG V ++ + ++ A+K L K I++ ++ + L H
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDV---ILQ-DDDVECTMTEKRILSLARNHPFL 86
Query: 439 TNL-----TDS------------------SRKSLLDWKK-RFYIIEGIVQGLLYLHKYSR 474
T L T + D + RFY E I+ L++LH
Sbjct: 87 TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE-IISALMFLHD--- 142
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGI 534
I+RDLK+ N+LLD + + K++DFGM + N + T GT Y++PE + +
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEILQEML 200
Query: 535 VSMKSDVYSFGVLVLE 550
D ++ GVL+ E
Sbjct: 201 YGPAVDWWAMGVLLYE 216
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 45/188 (23%), Positives = 74/188 (39%), Gaps = 59/188 (31%)
Query: 390 RLGQGGFGPVYNGKLLD---GQEIAIKRLSK----SSGQGIVEFKNEAKLIAKLQHTN-- 440
++G+G +G VY K D ++ A+K++ S E L+ +L+H N
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVI 81
Query: 441 ------LTDSSR-------------KSLLDW-------KKRFYIIEGIV--------QGL 466
L+ + R ++ + KK + G+V G+
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 467 LYLHKYSRLRAIHRDLKVSNILLDEQMNP----KISDFGMARTYA--MNELEANTNRIVG 520
YLH +HRDLK +NIL+ + KI+D G AR + + L +V
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV- 197
Query: 521 THGYMSPE 528
T Y +PE
Sbjct: 198 TFWYRAPE 205
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 56/226 (24%)
Query: 361 HNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEI-AIKRLSKSS 419
+++ LKI DF LG+G FG V+ + + AIK L K
Sbjct: 5 KERPSLQIKLKIEDFILHKM----------LGKGSFGKVFLAEFKKTNQFFAIKALKKDV 54
Query: 420 GQGIVEFKNEAK--------LIAKLQH---TNL-----TDS------------------S 445
++ ++ + L +H T++ T
Sbjct: 55 ---VLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ 110
Query: 446 RKSLLDWKK-RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR 504
D + FY E I+ GL +LH ++RDLK+ NILLD+ + KI+DFGM +
Sbjct: 111 SCHKFDLSRATFYAAE-IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166
Query: 505 TYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 550
+ + + NT GT Y++PE ++ + D +SFGVL+ E
Sbjct: 167 ENMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 50/216 (23%), Positives = 77/216 (35%), Gaps = 58/216 (26%)
Query: 382 TDNFSPANRLGQGGFGPVYNGKLLD---GQEIAIKRLSKSSGQGIVEFKN---------E 429
+ +G G G V D + +AIK+LS+ F+N E
Sbjct: 24 LKRYQNLKPIGSGAQGIVC--AAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRE 74
Query: 430 AKLIAKLQHTNLT--------DSSRKSLLDWKKRFYIIEG---------IVQGLLYLHK- 471
L+ + H N+ S + D YI+ I L +
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQD----VYIVMELMDANLCQVIQMELDHERMS 130
Query: 472 ---YSRLRA---------IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIV 519
Y L IHRDLK SNI++ KI DFG+ART + + V
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---V 187
Query: 520 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
T Y +PE ++ D++S G ++ E++
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 50/220 (22%), Positives = 81/220 (36%), Gaps = 56/220 (25%)
Query: 367 KRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEI-AIKRLSKSSGQGIVE 425
L + DF + +G+G + V +L I A+K + K + +
Sbjct: 3 MDPLGLQDFDLLRV----------IGRGSYAKVLLVRLKKTDRIYAMKVVKKEL---VND 49
Query: 426 FKNEAK--------LIAKLQH---TNL-----TDS------------------SRKSLLD 451
+ H L T+S R+ L
Sbjct: 50 -DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP 108
Query: 452 WKK-RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510
+ RFY E I L YLH+ I+RDLK+ N+LLD + + K++D+GM +
Sbjct: 109 EEHARFYSAE-ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164
Query: 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 550
+T GT Y++PE + D ++ GVL+ E
Sbjct: 165 DTTST--FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 202
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 49/232 (21%), Positives = 81/232 (34%), Gaps = 56/232 (24%)
Query: 355 NRKTQVHNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEI-AIK 413
L + DF + +G+G + V +L I A++
Sbjct: 34 KEAMNTRESGKASSSLGLQDFDLLRV----------IGRGSYAKVLLVRLKKTDRIYAMR 83
Query: 414 RLSKSSGQGIVEFKNEAK--------LIAKLQH---TNL-----TDS------------- 444
+ K + + + H L T+S
Sbjct: 84 VVKKEL---VND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD 139
Query: 445 -----SRKSLLDWKK-RFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKIS 498
R+ L + RFY E I L YLH+ I+RDLK+ N+LLD + + K++
Sbjct: 140 LMFHMQRQRKLPEEHARFYSAE-ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLT 195
Query: 499 DFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 550
D+GM + +T GT Y++PE + D ++ GVL+ E
Sbjct: 196 DYGMCKEGLRPGDTTST--FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 245
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 38/194 (19%), Positives = 67/194 (34%), Gaps = 48/194 (24%)
Query: 391 LGQGGFGPVYNG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNL------- 441
LG G G V ++ A+K L + + E +L + ++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVY 124
Query: 442 --TDSSRKS------------LLD-----WKKRF------YIIEGIVQGLLYLHKYSRLR 476
+ RK L + F I++ I + + YLH +
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---IN 181
Query: 477 AIHRDLKVSNILL---DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG 533
HRD+K N+L K++DFG A+ + + T Y++PE +
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPE 238
Query: 534 IVSMKSDVYSFGVL 547
D++S GV+
Sbjct: 239 KYDKSCDMWSLGVI 252
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 49/214 (22%), Positives = 80/214 (37%), Gaps = 54/214 (25%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 431
+ +G G G V + + +AIK+LS+ F+N E
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113
Query: 432 LIAKLQH------------------------------TNLTDSSRKSLLDWKKRFYIIEG 461
L+ + H NL + L + + + +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ- 172
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGT 521
++ G+ +LH IHRDLK SNI++ KI DFG+ART + T V T
Sbjct: 173 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPY-VVT 226
Query: 522 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
Y +PE ++ D++S G ++ E+V K
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 36/192 (18%), Positives = 73/192 (38%), Gaps = 52/192 (27%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 431
D + + +G G +G V L+ + +AIK++ + F++ E
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 432 LIAKLQHTNL--------------------------TD-----SSRKSLLDWKKRFYIIE 460
++ +L H ++ +D + L + + +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYN 164
Query: 461 GIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVG 520
++ G+ Y+H S +HRDLK +N L+++ + K+ DFG+ART E + I
Sbjct: 165 -LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 521 THGYMSPEYVMN 532
M+ +
Sbjct: 221 REDDMNLVTFPH 232
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 48/213 (22%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 431
++ + +G+G +G V + L+ +AIK++S F++ E K
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 432 LIAKLQHTN---LTDSSRKSLLDWKKRFYIIEGIV----------QGLLYLHK----YSR 474
++ + +H N + D R ++ K YI++ ++ Q L H Y
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI 137
Query: 475 LRA---------IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN--TNRIVGTHG 523
LR +HRDLK SN+LL+ + KI DFG+AR + T V T
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-VATRW 196
Query: 524 YMSPEYVMNGIVSMKS-DVYSFGVLVLEIVSSK 555
Y +PE ++N KS D++S G ++ E++S++
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 39/224 (17%), Positives = 80/224 (35%), Gaps = 65/224 (29%)
Query: 359 QVHNDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSK 417
H+ + R+ F DN+ + +G+G +G VY + +AIK++++
Sbjct: 2 HHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR 61
Query: 418 SSGQGIVEFKN---------EAKLIAKLQHTNL--------------------------T 442
F++ E ++ +L+ + +
Sbjct: 62 M-------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS 114
Query: 443 D-----SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRA--IHRDLKVSNILLDEQMNP 495
D + L + + I+ ++ G ++H+ + IHRDLK +N LL++ +
Sbjct: 115 DLKKLFKTPIFLTEEHIK-TILYNLLLGENFIHE-----SGIIHRDLKPANCLLNQDCSV 168
Query: 496 KISDFGMARTYAMNELEANTNRIVGTHGYMSP---------EYV 530
K+ DFG+ART + N + +V
Sbjct: 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHV 212
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 9e-11
Identities = 46/185 (24%), Positives = 75/185 (40%), Gaps = 47/185 (25%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 431
+ +F + LG+G +G V + G+ +AIK++ F E K
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 432 LIAKLQHTN---LTDSSRKSLLDWKKRFYIIEGIV----------QGLLYLHK----YSR 474
++ +H N + + R + YII+ ++ Q L H Y
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 475 LRA---------IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYM 525
LRA IHRDLK SN+L++ + K+ DFG+AR + A+ + G M
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES--AADNSEPTGQQSGM 179
Query: 526 SPEYV 530
E+V
Sbjct: 180 V-EFV 183
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 47/215 (21%), Positives = 89/215 (41%), Gaps = 57/215 (26%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 431
+ +G G +G V + G+++AIK+LS+ F++ E
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75
Query: 432 LIAKLQHTNL---------------------------TDSS---RKSLLDWKKRFYIIEG 461
L+ +QH N+ TD + K ++ + +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQ- 134
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGT 521
+++GL Y+H +HRDLK N+ ++E KI DFG+AR V T
Sbjct: 135 MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YVVT 186
Query: 522 HGYMSPEYVMNGIVSMKS-DVYSFGVLVLEIVSSK 555
Y +PE +++ + ++ D++S G ++ E+++ K
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 60/217 (27%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 431
+ +G G +G V + G ++AIK+L + F++ E +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76
Query: 432 LIAKLQHTNLT--------DSSRKSL----------------------LDWKKRFYIIEG 461
L+ ++H N+ D + L + +++
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 136
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA--MNELEANTNRIV 519
+++GL Y+H IHRDLK N+ ++E KI DFG+AR M V
Sbjct: 137 MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY-------V 186
Query: 520 GTHGYMSPEYVMNGIVSMKS-DVYSFGVLVLEIVSSK 555
T Y +PE ++N + ++ D++S G ++ E+++ K
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 47/223 (21%), Positives = 83/223 (37%), Gaps = 59/223 (26%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 431
+ LG GG G V++ + +AIK++ + E K
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 432 LIAKLQHTNLT------------DSSRKSLLDWKKRFYIIEGIV----------QGLLYL 469
+I +L H N+ + L YI++ + LL
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 470 HK----YSRLRA---------IHRDLKVSNILLD-EQMNPKISDFGMARTYAMNELEAN- 514
H Y LR +HRDLK +N+ ++ E + KI DFG+AR +
Sbjct: 121 HARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 515 -TNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIVSSK 555
+ +V T Y SP +++ + D+++ G + E+++ K
Sbjct: 181 LSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 58/216 (26%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 431
+ + + +G G +G V G +A+K+LS+ F++ E +
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 432 LIAKLQHTNL---------------------------TDSSR----KSLLDWKKRFYIIE 460
L+ ++H N+ D + + L D +F I +
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 461 GIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVG 520
I++GL Y+H IHRDLK SN+ ++E KI DFG+AR A V
Sbjct: 141 -ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY-----VA 191
Query: 521 THGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSK 555
T Y +PE ++N + D++S G ++ E+++ +
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 46/242 (19%), Positives = 80/242 (33%), Gaps = 76/242 (31%)
Query: 382 TDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHT 439
+ +S LG G FG V ++ G+ A+K++ + +KN E ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHV 60
Query: 440 NL--------TDSSRKSLLDWKKRFYIIEGIVQGL-----------------LY------ 468
N+ T + + G L
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 469 ---LHKYSR---------------------LRA---------IHRDLKVSNILLDEQMNP 495
LHK + RA HRD+K N+L++ + N
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 496 -KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIVS 553
K+ DFG A+ E + I + Y +PE ++ + D++S G + E++
Sbjct: 181 LKLCDFGSAKKL--IPSEPSVAYIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237
Query: 554 SK 555
K
Sbjct: 238 GK 239
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 39/197 (19%), Positives = 76/197 (38%), Gaps = 61/197 (30%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 431
+ +LG+G +G V+ G+ +A+K++ + F+N E
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 432 LIAKLQ-HTNL-----------------------TDSSR----KSLLDWKKRFYIIEGIV 463
++ +L H N+ TD L K+ Y++ ++
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQ-YVVYQLI 119
Query: 464 QGLLYLHKYSRLRA--IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGT 521
+ + YLH +HRD+K SNILL+ + + K++DFG++R++ N +
Sbjct: 120 KVIKYLHS-----GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 522 HGYMSP--------EYV 530
+ +YV
Sbjct: 175 ENTENFDDDQPILTDYV 191
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 30/150 (20%), Positives = 51/150 (34%), Gaps = 45/150 (30%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL------- 441
LG G G V ++ A+K L + + E +L + Q ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVY 80
Query: 442 --TDSSRKS------------LLD----WKKRFY-------IIEGIVQGLLYLHKYSRLR 476
+ RK L + + I++ I + + YLH +
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---IN 137
Query: 477 AIHRDLKVSNILL---DEQMNPKISDFGMA 503
HRD+K N+L K++DFG A
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 45/218 (20%), Positives = 82/218 (37%), Gaps = 69/218 (31%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLTDSSR 446
LG G F V+ K +++ +A+K + + E I LQ N D+++
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE-------IKLLQRVNDADNTK 79
Query: 447 K----------------------------------SLLDWKKRF-----------YIIEG 461
+ +LL K++ I +
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNP------KISDFGMARTYAMNELEANT 515
++ GL Y+H+ + IH D+K N+L++ +P KI+D G A + T
Sbjct: 140 LLLGLDYMHRRCGI--IHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHY---T 193
Query: 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS 553
N I Y SPE ++ +D++S L+ E+++
Sbjct: 194 NSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 15/192 (7%), Positives = 41/192 (21%), Gaps = 62/192 (32%)
Query: 390 RLGQGGFGPVYNGK--LLDGQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNL--- 441
G + LD +++A+ + + E + ++++ +
Sbjct: 38 FHGGVPPLQFWQALDTALD-RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 442 ----TDSSR----------KSL-------LDWKKRFYIIEGIVQGLLYLHKYSRLRAIHR 480
+ SL ++ + H R
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAH---RAGVALS 153
Query: 481 DLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSD 540
S + +S G + M + + D
Sbjct: 154 IDHPSRVR--------VSIDGDVV--------------LAYPATMPD-------ANPQDD 184
Query: 541 VYSFGVLVLEIV 552
+ G + ++
Sbjct: 185 IRGIGASLYALL 196
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 2e-06
Identities = 59/444 (13%), Positives = 122/444 (27%), Gaps = 120/444 (27%)
Query: 26 GLCYCQTDKLQQGQVL-----KDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRA 80
C L+ Q L + N +L S R L KP +
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK---SKPYENC 246
Query: 81 ----ADV-------SFDSYSRCR--------PVCYAIGNRPRKYPYSPAIKKQPVWIANR 121
+V +F+ C+ V + + + + +
Sbjct: 247 LLVLLNVQNAKAWNAFNL--SCKILLTTRFKQVTDFLSAATTTH----------ISLDHH 294
Query: 122 ETPVLRNESASL---IIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYE 178
+ +E SL +D +L NP +S + A +++G
Sbjct: 295 SMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII--------AESIRDG------ 340
Query: 179 MNSDGLSIRRGLWQSFDYPTH-ALLPGMKLGINLQTGHQWFLQSSESAEGSYRLG-LGTD 236
W ++ + L ++ +N L+ +E + RL
Sbjct: 341 ---------LATWDNWKHVNCDKLTTIIESSLN-------VLEPAEYRKMFDRLSVFPPS 384
Query: 237 PNMTSKL--VIWKN----------DKVVWTSAIWLNNSLPSYTRSSDDEINNSLPSYTRS 284
++ + L +IW + +K+ S + + + I +
Sbjct: 385 AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS------IPSIYLELKVK 438
Query: 285 SDDGI---NNCLPSYRGSRDDDSNYCCNPAIFDYGFYNF-SY---TSNEQER-------Y 330
++ + + Y + DS+ P + Y FY+ + ER +
Sbjct: 439 LENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY-FYSHIGHHLKNIEHPERMTLFRMVF 497
Query: 331 LTYSVNEDLLRELGHNVSLPIIFGN-----RKTQVH---NDQTVKRDLK-IFDFQTIAAA 381
L + E +R + N + + + ND +R + I DF
Sbjct: 498 LDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEE 557
Query: 382 TDNFSPANRLGQGGF----GPVYN 401
S L + ++
Sbjct: 558 NLICSKYTDLLRIALMAEDEAIFE 581
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 6e-05
Identities = 87/565 (15%), Positives = 160/565 (28%), Gaps = 173/565 (30%)
Query: 40 VLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKK-PRDRAADVSFDSYSRCRPVCYAI 98
+L EE+V F L Y +L K R + Y R Y
Sbjct: 71 LLSKQEEMVQKFVEEVLR--INYK----FLMSPIKTEQRQPSMMT--RMYIEQRDRLY-- 120
Query: 99 GNRPRKYPYSPAIKKQPVWIANRETPV--LRNESASLIIDSTDGNLKILRNGKNPIGISS 156
N + + K V R P LR L LR KN + I
Sbjct: 121 -NDNQVFA------KYNVS---RLQPYLKLRQ------------ALLELRPAKN-VLIDG 157
Query: 157 VRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRG---LWQSF-DYPTHALLPGMKLGINLQ 212
V +G T + L S + + W + + + + M + Q
Sbjct: 158 VLGSGKTW---------VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ 208
Query: 213 TGHQWFLQSSESAEGSYRLG--------LGTDPNMTSKLVIWKNDKVVWTSAIW------ 258
W +S S+ R+ L + L++ N V + W
Sbjct: 209 IDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN---VQNAKAWNAFNLS 265
Query: 259 -----------LNNSLPSYTRSSDDEINNSLPSYTRSSDDGINNCLPSYRGSRDDD--SN 305
+ + L + T + +++ + T + L Y R D
Sbjct: 266 CKILLTTRFKQVTDFLSAATTT-HISLDHHSMTLTPDEVKSL---LLKYLDCRPQDLPRE 321
Query: 306 YC-CNP--------------AIFDY--------------GFYNFSYTSNEQERY------ 330
NP A +D N + ++ +
Sbjct: 322 VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF 381
Query: 331 -----------------LTYSVNEDLLRELGHNVSLPIIFGNRKT---QVHNDQTVKRDL 370
+ S ++ +L H SL + K + ++ +
Sbjct: 382 PPSAHIPTILLSLIWFDVIKSDVMVVVNKL-HKYSL--VEKQPKESTISIP-SIYLELKV 437
Query: 371 KIFDFQTI-AAATDNFSPANRLGQGGFGPVYNGKLLDG---QEIA--IKRLSKSSGQGIV 424
K+ + + + D+++ P Y LD I +K + + +
Sbjct: 438 KLENEYALHRSIVDHYNIPKTFDSDDLIPPY----LDQYFYSHIGHHLKNIEH--PERMT 491
Query: 425 EFK----NEAKLIAKLQHTNLTDSSRKS----LLDWKK-RFYII------EGIVQGLL-Y 468
F+ + L K++H + ++ S L K + YI E +V +L +
Sbjct: 492 LFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF 551
Query: 469 LHKYSR--LRAIHRDLKVSNILLDE 491
L K + + + DL + L+ E
Sbjct: 552 LPKIEENLICSKYTDL-LRIALMAE 575
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 39/177 (22%), Positives = 69/177 (38%), Gaps = 49/177 (27%)
Query: 390 RLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT--------- 439
++G G FG +Y G + G+E+AIK + + E+K+ +Q
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWC 73
Query: 440 -----------NLTDSSRKSLLDWKKRFY-------IIEGIVQGLLYLHKYSRLRAIHRD 481
L S + L ++ R + + + ++ + Y+H + IHRD
Sbjct: 74 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 130
Query: 482 LKVSNILLDEQMNPK---ISDFGMARTYAMNELEANTNR---------IVGTHGYMS 526
+K N L+ I DFG+A+ Y +A T++ + GT Y S
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAKKY----RDARTHQHIPYRENKNLTGTARYAS 183
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 39/179 (21%), Positives = 64/179 (35%), Gaps = 51/179 (28%)
Query: 390 RLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN-------- 440
++G G FG + GK L + +AIK S + E + +L +
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYF 73
Query: 441 ------------LTDSSRKSLLDWKKRFY-------IIEGIVQGLLYLHKYSRLRAIHRD 481
L S + L D R + I ++ + Y+H + I+RD
Sbjct: 74 GPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL---IYRD 130
Query: 482 LKVSNILLDEQMNPK-----ISDFGMARTYAMNELEANTNR---------IVGTHGYMS 526
+K N L+ N I DF +A+ Y ++ T + + GT YMS
Sbjct: 131 VKPENFLIGRPGNKTQQVIHIIDFALAKEY----IDPETKKHIPYREHKSLTGTARYMS 185
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 26/91 (28%), Positives = 41/91 (45%), Gaps = 8/91 (8%)
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNP--KISDFGMARTYAMNELEANTNRIV 519
+ LL+L L IH DLK NILL KI DFG + + + +
Sbjct: 166 MCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRI----YQYI 219
Query: 520 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 550
+ Y SPE ++ + D++S G +++E
Sbjct: 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 33/170 (19%), Positives = 55/170 (32%), Gaps = 67/170 (39%)
Query: 446 RKSLLDWKKRFY-----------IIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL----- 489
LL W + II+ ++QGL YLH ++ R IH D+K NILL
Sbjct: 128 GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQ 185
Query: 490 --------------------------------------------DEQMNPKISDFGMART 505
E++ KI+D G A
Sbjct: 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW 245
Query: 506 YAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
+ + + T Y S E ++ + +D++S + E+ +
Sbjct: 246 -----VHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 49/205 (23%), Positives = 74/205 (36%), Gaps = 61/205 (29%)
Query: 391 LGQGGFGPVYNGKLLD---GQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLTDS 444
+G+G FG V K D Q +A+K + + Q E I L+H D
Sbjct: 105 IGKGSFGQVV--KAYDHKVHQHVALKMVRNEKRFHRQAAEE-------IRILEHLRKQDK 155
Query: 445 SRKS----LLDW----------------------KKRFY----------IIEGIVQGLLY 468
+L+ KK + I+Q L
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215
Query: 469 LHKYSRLRAIHRDLKVSNILLDEQMNP--KISDFGMARTYAMNELEANTNRIVGTHGYMS 526
LHK R IH DLK NILL +Q K+ DFG + Y + + + Y +
Sbjct: 216 LHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRV----YTYIQSRFYRA 267
Query: 527 PEYVMNGIVSMKSDVYSFGVLVLEI 551
PE ++ M D++S G ++ E+
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAEL 292
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 6e-06
Identities = 15/87 (17%), Positives = 25/87 (28%), Gaps = 13/87 (14%)
Query: 438 HTNLTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKI 497
+ R L I+ + L LR HRDL N+LL + K+
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKL 203
Query: 498 SDFGMARTYAMNELEANTNRIVGTHGY 524
++ + + G
Sbjct: 204 HYTLNGKSST-----------IPSCGL 219
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 37/177 (20%), Positives = 69/177 (38%), Gaps = 49/177 (27%)
Query: 390 RLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN-------- 440
++G G FG +Y G + +E+AIK + + + + E+K+ LQ
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWF 71
Query: 441 ------------LTDSSRKSLLDWKKRFY-------IIEGIVQGLLYLHKYSRLRAIHRD 481
L S + L ++ R + + ++ + ++H S +HRD
Sbjct: 72 GVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF---LHRD 128
Query: 482 LKVSNILLDEQMNPK---ISDFGMARTYAMNELEANTNR---------IVGTHGYMS 526
+K N L+ I DFG+A+ Y + +T++ + GT Y S
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAKKY----RDTSTHQHIPYRENKNLTGTARYAS 181
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 39/179 (21%), Positives = 67/179 (37%), Gaps = 51/179 (28%)
Query: 390 RLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN-------- 440
R+G+G FG ++ G LL+ Q++AIK + S + E + L
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYYF 74
Query: 441 ------------LTDSSRKSLLDWKKRFY-------IIEGIVQGLLYLHKYSRLRAIHRD 481
L S + LLD R + + ++ + +H+ S ++RD
Sbjct: 75 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL---VYRD 131
Query: 482 LKVSNILLDEQMNPK-----ISDFGMARTYAMNELEANTNR---------IVGTHGYMS 526
+K N L+ + + DFGM + Y + T + + GT YMS
Sbjct: 132 IKPDNFLIGRPNSKNANMIYVVDFGMVKFY----RDPVTKQHIPYREKKNLSGTARYMS 186
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 31/189 (16%), Positives = 61/189 (32%), Gaps = 56/189 (29%)
Query: 390 RLGQGGFGPVYNGK-LLDGQEIA---IKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSS 445
++G GGFG +Y ++ A +K + +G E K + +AK
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFY-QRVAKKDCIKKWIER 102
Query: 446 RK-----------------------------------SLLDWKKRF------YIIEGIVQ 464
++ + F + ++
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLD 162
Query: 465 GLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKI--SDFGMARTYAMNEL-----EANTNR 517
L Y+H+ +H D+K +N+LL + ++ +D+G++ Y N E
Sbjct: 163 VLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKG 219
Query: 518 IVGTHGYMS 526
GT + S
Sbjct: 220 HNGTIEFTS 228
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 32/166 (19%), Positives = 57/166 (34%), Gaps = 52/166 (31%)
Query: 390 RLGQGGFGPVYNGKLLDGQEI------AIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD 443
+GQGGFG +Y + + + +K +G E K + Q
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 444 SSRKSLL--------------DWKKRFYIIE--G-------------------------I 462
+ + L RF I++ G I
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRI 161
Query: 463 VQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKI--SDFGMARTY 506
+ L Y+H++ +H D+K SN+LL+ + ++ D+G+A Y
Sbjct: 162 LDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 39.1 bits (91), Expect = 6e-04
Identities = 17/85 (20%), Positives = 28/85 (32%), Gaps = 12/85 (14%)
Query: 112 KKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKN 171
VW +N + A L +DGN + + S R L ++
Sbjct: 36 HSTSVWASNTGILGKKGCKAVL---QSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQED 92
Query: 172 GNLVLYEMNSDGLSIRRGLWQSFDY 196
GN+V+Y +W + Y
Sbjct: 93 GNVVIY---------GSDIWSTGTY 108
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 38.8 bits (90), Expect = 8e-04
Identities = 26/162 (16%), Positives = 49/162 (30%), Gaps = 56/162 (34%)
Query: 32 TDKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRC 91
+D+L G L G L G + + + L +Y
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQN-----DCNLVLYDNN---------------- 37
Query: 92 RPVCYAIGNRPRKYPYSPAIKKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNP 151
+ VW + + L + + DGNL ++ +G
Sbjct: 38 ----------------------RAVWASGTNG---KASGCVLKMQN-DGNL-VIYSGSRA 70
Query: 152 IGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQS 193
I S+ R L ++ N+V+Y ++ +I W +
Sbjct: 71 IWASNTNRQNGNYYLILQRDRNVVIY--DNSNNAI----WAT 106
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 9e-04
Identities = 28/193 (14%), Positives = 56/193 (29%), Gaps = 59/193 (30%)
Query: 389 NRLGQGGFGPVYNGK---------LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 439
+ + G +Y Q+ ++K L G+ E + LQ
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 440 NLTDSSRKSLL-----------DWKKRFYIIE--G------------------------- 461
LL K RF ++ G
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVAC 166
Query: 462 -IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKI--SDFGMARTYAMNEL-----EA 513
++ L +LH+ +H ++ NI +D + ++ + +G A Y + E
Sbjct: 167 RLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223
Query: 514 NTNRIVGTHGYMS 526
+ + G ++S
Sbjct: 224 SRSPHEGDLEFIS 236
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 676 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.98 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.98 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.98 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.98 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.98 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.98 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.98 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.98 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.85 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.83 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.82 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.81 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.8 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.78 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.77 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.75 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.71 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.62 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.62 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.61 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.57 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.53 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.48 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.47 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.43 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.42 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.39 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.16 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.08 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.08 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.89 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.89 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.84 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.56 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.53 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.53 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.28 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.26 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.15 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.4 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 96.98 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.94 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.84 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.52 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.44 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.3 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.27 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.74 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.39 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 95.14 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.0 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.85 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.39 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 94.37 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 93.72 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 93.24 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.3 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 90.32 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 89.84 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 87.34 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.51 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=390.26 Aligned_cols=238 Identities=26% Similarity=0.409 Sum_probs=181.9
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
+++.+.++||+|+||.||+|++. ..||||+++.. .....++|.+|+.++++++|||||.
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~ 113 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWC 113 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcC
Confidence 56788999999999999999864 36999998643 3345678999999999999999982
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......+++.+++.|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+..........
T Consensus 114 ~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 114 EGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp SSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 123356899999999999999999999998 99999999999999999999999999987654333333
Q ss_pred cceeeccCCccChhhhcc---CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 515 TNRIVGTHGYMSPEYVMN---GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
....+||+.|||||++.+ +.|+.++|||||||+||||+||+.||....... ........+.. .+.+.
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~----~p~~~ 260 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYA----SPDLS 260 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCC----CCCST
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCC----CCCcc
Confidence 445789999999999964 469999999999999999999999997543211 11122222211 11111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCCC
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPK 636 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~~ 636 (676)
..+......+.+|+.+||+.||++||||.||++.|+.+...+|.
T Consensus 261 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 261 -KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp -TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred -cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 12223345688899999999999999999999999988755554
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=393.43 Aligned_cols=231 Identities=26% Similarity=0.388 Sum_probs=186.9
Q ss_pred cCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
++|.+.++||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46888999999999999999863 477899999987766777889999999999999999820
Q ss_pred ---------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEE
Q 005803 445 ---------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKI 497 (676)
Q Consensus 445 ---------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL 497 (676)
.....++|.+++.|+.||++||.|||+++ ||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 11246899999999999999999999998 999999999999999999999
Q ss_pred eccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHH
Q 005803 498 SDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQL 576 (676)
Q Consensus 498 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~ 576 (676)
+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...... .....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-------~~~~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------EVIEC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHH
Confidence 99999987654443333444679999999999999999999999999999999999 89999754321 11222
Q ss_pred HhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcC
Q 005803 577 WNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTM 632 (676)
Q Consensus 577 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 632 (676)
...+.... .+......+.+|+.+||+.||++||||+||++.|+++.+
T Consensus 243 i~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 243 ITQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 33333221 122233457889999999999999999999999998753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=395.10 Aligned_cols=230 Identities=25% Similarity=0.368 Sum_probs=178.9
Q ss_pred cCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
++|.+.++||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46778899999999999999864 478899999987777777889999999999999999820
Q ss_pred -----------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCe
Q 005803 445 -----------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNP 495 (676)
Q Consensus 445 -----------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~v 495 (676)
.....++|.+++.|+.||++||+|||+++ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 01235899999999999999999999998 9999999999999999999
Q ss_pred EEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHH
Q 005803 496 KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAW 574 (676)
Q Consensus 496 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~ 574 (676)
||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||......+ ..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~ 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------AI 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-------HH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence 9999999987654443334445689999999999999999999999999999999999 899997543211 12
Q ss_pred HHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 575 QLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 575 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
..+..+... .. +......+.+|+.+||+.||++||||+||+++|+.+.
T Consensus 271 ~~i~~g~~~-----~~----p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 271 DCITQGREL-----ER----PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHHHHTCCC-----CC----CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHcCCCC-----CC----cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 222233211 11 2223345788999999999999999999999999876
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=387.31 Aligned_cols=228 Identities=29% Similarity=0.433 Sum_probs=183.3
Q ss_pred CCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
++++.++||+|+||.||+|++. +++.||||+++... ....++|.+|+.++++++|||||+.
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4566899999999999999862 46789999997543 3345789999999999999999820
Q ss_pred ------------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC
Q 005803 445 ------------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN 494 (676)
Q Consensus 445 ------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~ 494 (676)
.....++|.+++.|+.|||+||+|||+++ ||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 01245889999999999999999999998 999999999999999999
Q ss_pred eEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHH
Q 005803 495 PKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYA 573 (676)
Q Consensus 495 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~ 573 (676)
+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||......+ .
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~-------~ 256 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------V 256 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-------H
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999987655444444455789999999999999999999999999999999998 899997543211 1
Q ss_pred HHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 574 WQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 574 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
......+.... .+.+.+..+.+|+.+||+.||++||||+||++.|+..
T Consensus 257 ~~~i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMIRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22233333221 1223345688899999999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=380.49 Aligned_cols=225 Identities=21% Similarity=0.285 Sum_probs=182.6
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
+.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999875 59999999998766666778999999999999999983
Q ss_pred -------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccc
Q 005803 444 -------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516 (676)
Q Consensus 444 -------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 516 (676)
......+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+..... ...
T Consensus 154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~ 228 (346)
T 4fih_A 154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRK 228 (346)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBC
T ss_pred CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC--ccc
Confidence 112356899999999999999999999998 99999999999999999999999999987654322 234
Q ss_pred eeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCCh
Q 005803 517 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSS 596 (676)
Q Consensus 517 ~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 596 (676)
..+||+.|||||++.+..|+.++|||||||++|||++|+.||...... . ....+..+. .+.+. ...
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~----~~~~i~~~~-----~~~~~--~~~ 294 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---K----AMKMIRDNL-----PPRLK--NLH 294 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---H----HHHHHHHSS-----CCCCS--CGG
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---H----HHHHHHcCC-----CCCCC--ccc
Confidence 478999999999999999999999999999999999999999753221 1 111222211 11111 112
Q ss_pred HHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 597 DEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 597 ~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.....+.+|+.+||+.||++|||++|+++.
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 233457889999999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=380.31 Aligned_cols=223 Identities=22% Similarity=0.317 Sum_probs=173.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
.++|+++++||+|+||.||+|+.. +|+.||||++.+. .....+.+.+|+.+|++++|||||+
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999865 5999999999754 2344577999999999999999983
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 122345688889999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||..... ... ......+... .+
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~-~~~i~~~~~~-----~~ 245 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNL-VLKIISGSFP-----PV 245 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHH-HHHHHHTCCC-----CC
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHH-HHHHHcCCCC-----CC
Confidence 122346899999999999999999999999999999999999999975321 111 1122222221 11
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.. .....+.+|+.+||+.||++|||++|+++
T Consensus 246 ~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SL----HYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Cc----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12 22345788999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=374.78 Aligned_cols=222 Identities=25% Similarity=0.348 Sum_probs=181.3
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+.+|+++|++++|||||+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999865 5999999999753 2344567899999999999999983
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+......
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 123356889999999999999999999998 999999999999999999999999999987654444
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||...... . .......+.. .+..
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~----~~~~i~~~~~------~~p~ 255 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---L----IFAKIIKLEY------DFPE 255 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHTCC------CCCT
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---H----HHHHHHcCCC------CCCc
Confidence 4455679999999999999999999999999999999999999999753211 1 1122222221 1112
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVV 624 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl 624 (676)
.. ...+.+|+.+||+.||++|||++|++
T Consensus 256 ~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 256 KF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp TC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred cc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 22 33577899999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=375.29 Aligned_cols=228 Identities=20% Similarity=0.229 Sum_probs=177.6
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
.+.|++.++||+|+||.||+|+.. +|+.||||+++.... ..+|+.++++++|||||+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888999999999999999875 599999999975422 257999999999999983
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC-CeEEeccCcceecccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM-NPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~-~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++.++..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+.......
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 122356899999999999999999999998 99999999999999987 69999999999765432211
Q ss_pred ---ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 514 ---NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 514 ---~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||........... .. .+... +
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------i~-~~~~~------~ 275 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK------IA-SEPPP------I 275 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH------HH-HSCCG------G
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH------HH-cCCCC------c
Confidence 22336799999999999999999999999999999999999999986544332211 11 11110 0
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
...++.....+.+++.+||+.||++|||+.||++.|....
T Consensus 276 -~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 276 -REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp -GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 0112233345788899999999999999999998876553
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=369.35 Aligned_cols=243 Identities=23% Similarity=0.281 Sum_probs=178.2
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
++|.+.++||+|+||.||+|++ +|+.||||+++... .....+..|+..+.+++|||||+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 5688899999999999999987 68999999996532 22223345666677899999983
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcC-----CCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYS-----RLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
......+++..+.+++.|+++||+|||+++ ..+||||||||+||||+.++.+||+|||+|+....
T Consensus 81 Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 112345788999999999999999999871 23599999999999999999999999999987654
Q ss_pred ccc--ccccceeeccCCccChhhhccC------CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCcc--------chHHH
Q 005803 509 NEL--EANTNRIVGTHGYMSPEYVMNG------IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPL--------NLVGY 572 (676)
Q Consensus 509 ~~~--~~~~~~~~gt~~Y~APE~~~~~------~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~--------~l~~~ 572 (676)
... .......+||+.|||||++.+. .++.++|||||||+||||+||++|+......... .....
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 322 1223346899999999999764 4678999999999999999999887644322211 01111
Q ss_pred HHHHHhcCCccccCCcccCCC-CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 573 AWQLWNEGKALELMDPTLDES-CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 573 ~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
....... +.+++.+... ...+....+.+|+.+||+.||++||||.||+++|+++.
T Consensus 241 ~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 241 MRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111111 2223333222 12356678899999999999999999999999998764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=362.75 Aligned_cols=221 Identities=21% Similarity=0.328 Sum_probs=165.5
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|++.+.||+|+||.||+|+.. +++.||||++++.. ......+.+|+.++++++||||++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999864 69999999997542 234567899999999999999983
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 93 Ey~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--- 166 (275)
T 3hyh_A 93 EYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--- 166 (275)
T ss_dssp ECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC---
Confidence 123456899999999999999999999998 9999999999999999999999999998654322
Q ss_pred ccceeeccCCccChhhhccCCC-CchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.....+||+.|||||++.+..| +.++||||+||++|||++|+.||..... . ........+.. .+..
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~-~~~~~i~~~~~------~~p~ 233 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------P-VLFKNISNGVY------TLPK 233 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------H-HHHHHHHHTCC------CCCT
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------H-HHHHHHHcCCC------CCCC
Confidence 2234789999999999998876 5899999999999999999999974321 1 11222222221 1112
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.. ...+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 234 FL----SPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp TS----CHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CC----CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 22 2357788999999999999999999873
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=381.21 Aligned_cols=225 Identities=21% Similarity=0.292 Sum_probs=182.7
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
+.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 57999999999999999999875 59999999998766666778999999999999999983
Q ss_pred -------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccc
Q 005803 444 -------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516 (676)
Q Consensus 444 -------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 516 (676)
......+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+..... ...
T Consensus 231 ~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~ 305 (423)
T 4fie_A 231 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRK 305 (423)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBC
T ss_pred CCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc--ccc
Confidence 122346889999999999999999999998 99999999999999999999999999987654322 234
Q ss_pred eeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCCh
Q 005803 517 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSS 596 (676)
Q Consensus 517 ~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 596 (676)
..+||+.|||||++.+..|+.++|||||||++|||++|+.||......+ ....+..+. .+.+.. ..
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~-----~~~~~~--~~ 371 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNL-----PPRLKN--LH 371 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSC-----CCCCSC--TT
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCC-----CCCCcc--cc
Confidence 5789999999999999999999999999999999999999997532211 112222211 111111 11
Q ss_pred HHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 597 DEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 597 ~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.....+.+|+.+||+.||++|||+.|+++.
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 223457788999999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=378.11 Aligned_cols=236 Identities=25% Similarity=0.360 Sum_probs=187.2
Q ss_pred HHHHhcCCCcceeeccCCCccEEEEEEcC------CcEEEEEEeccCCc-hhhHHHHHHHHHHHHccC-Cccccc-----
Q 005803 378 IAAATDNFSPANRLGQGGFGPVYNGKLLD------GQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQH-TNLTDS----- 444 (676)
Q Consensus 378 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~------~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H-~niv~~----- 444 (676)
..-..++|++.++||+|+||.||+|++.. ++.||||++..... ...++|.+|+++|.++.| ||||+.
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 33345789999999999999999998543 36799999976533 345679999999999976 898720
Q ss_pred --------------------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCc
Q 005803 445 --------------------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSN 486 (676)
Q Consensus 445 --------------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~N 486 (676)
.....+++.+++.++.|||+||+|||+++ ||||||||+|
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~N 215 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN 215 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccc
Confidence 01234789999999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCC
Q 005803 487 ILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTER 565 (676)
Q Consensus 487 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~ 565 (676)
||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.......
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987655443334445789999999999999999999999999999999998 999997654322
Q ss_pred ccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 566 PLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 566 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.....+.++... .... .....+.+++.+||+.||++|||+.||++.|+++.
T Consensus 296 ------~~~~~i~~g~~~-----~~p~----~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 296 ------EFCRRLKEGTRM-----RAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp ------HHHHHHHHTCCC-----CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHHHHHHcCCCC-----CCCc----cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 122233333222 1122 22345788999999999999999999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=364.51 Aligned_cols=220 Identities=25% Similarity=0.383 Sum_probs=171.2
Q ss_pred CcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccc------------------
Q 005803 386 SPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 444 (676)
Q Consensus 386 ~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~------------------ 444 (676)
++.++||+|+||.||+|+.. +++.||||++... .....+.|.+|++++++++|||||+.
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56778999999999999875 5899999999653 33445679999999999999999831
Q ss_pred ------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc-CCCCeEEeccCcceecccccc
Q 005803 445 ------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD-EQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 445 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~-~~~~vkL~DFGla~~~~~~~~ 511 (676)
.....+++..+..++.||+.||+|||+++ .+||||||||+||||+ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---
Confidence 12345788889999999999999999875 3599999999999998 478999999999985432
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
......+||+.|||||++.+ .|+.++|||||||++|||++|+.||...... .........+... +.+.
T Consensus 185 -~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~~i~~~~~~----~~~~ 252 (290)
T 3fpq_A 185 -SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKP----ASFD 252 (290)
T ss_dssp -TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCC----GGGG
T ss_pred -CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HHHHHHHHcCCCC----CCCC
Confidence 22345789999999998864 6999999999999999999999999743221 1112222222111 1111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
...+ ..+.+|+.+||+.||++|||++|+++
T Consensus 253 ~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2222 34778899999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=363.93 Aligned_cols=221 Identities=25% Similarity=0.347 Sum_probs=168.3
Q ss_pred cCCCcceeeccCCCccEEEEEEc----CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL----DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~----~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
++|++.+.||+|+||.||+|+.. .++.||||++++.. .....++.+|+++|++++|||||+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 47899999997542 233456889999999999999983
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 122356889999999999999999999998 9999999999999999999999999998654322
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||......+ .......+.. .+
T Consensus 181 --~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~------~~ 245 (304)
T 3ubd_A 181 --KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-------TMTMILKAKL------GM 245 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC------CC
T ss_pred --ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-------HHHHHHcCCC------CC
Confidence 22334789999999999999999999999999999999999999997543211 1112222211 11
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRT-----MSDVVS 625 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~eVl~ 625 (676)
... ....+.+|+.+||+.||++||| ++|+++
T Consensus 246 p~~----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 246 PQF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CTT----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCc----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 122 2345778999999999999998 467764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=349.85 Aligned_cols=257 Identities=33% Similarity=0.553 Sum_probs=220.6
Q ss_pred cccHHHHHHHhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-------
Q 005803 372 IFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------- 444 (676)
Q Consensus 372 ~f~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------- 444 (676)
.+.+.++..++++|++.+.||+|+||.||+|+..+++.||||++........+.+.+|+.++++++||||++.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 3445566678899999999999999999999988899999999987666677889999999999999998720
Q ss_pred -----------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccC
Q 005803 445 -----------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFG 501 (676)
Q Consensus 445 -----------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFG 501 (676)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 01124788999999999999999999998 9999999999999999999999999
Q ss_pred cceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC
Q 005803 502 MARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK 581 (676)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 581 (676)
+++...............||+.|+|||.+.+..++.++|||||||++|||++|+.||.............+.......+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 99865433322233445789999999999999999999999999999999999999988776666667776666667777
Q ss_pred ccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 582 ALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 582 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
....+++.+......+....+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 78888888888888899999999999999999999999999999998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=353.76 Aligned_cols=222 Identities=26% Similarity=0.337 Sum_probs=159.9
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCccccccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTDSSR-------------- 446 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~-------------- 446 (676)
++|++++.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+.+|++++|||||+...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999865 689999999975433 34567899999999999999983110
Q ss_pred ---------------------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEec
Q 005803 447 ---------------------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISD 499 (676)
Q Consensus 447 ---------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~D 499 (676)
....++..++.++.||++||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 011334457789999999999999998 99999999999999999999999
Q ss_pred cCcceeccccccc----------cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccch
Q 005803 500 FGMARTYAMNELE----------ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNL 569 (676)
Q Consensus 500 FGla~~~~~~~~~----------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l 569 (676)
||+|+.+...... ......+||+.|||||++.+..|+.++|||||||++|||++ ||... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHH
Confidence 9999876543221 11233679999999999999999999999999999999996 66421 011
Q ss_pred HHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 570 VGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 570 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.. ........... . ........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~-~~~~~~~~~~p-----~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VR-TLTDVRNLKFP-----P----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-HHHHHHTTCCC-----H----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HHHHHhcCCCC-----C----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 10 11111111111 0 01122334667899999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=361.88 Aligned_cols=241 Identities=22% Similarity=0.339 Sum_probs=179.9
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
.++|+++++||+|+||.||+|+.. +|+.||||++++.. ....+.+.+|+++|++++|||||+.
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999875 69999999997542 2345678899999999999999831
Q ss_pred -----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 445 -----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 445 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
.....+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.+.
T Consensus 133 ~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 12356889999999999999999999998 9999999999999999999999999998764
Q ss_pred ccc--cccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc-
Q 005803 508 MNE--LEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL- 583 (676)
Q Consensus 508 ~~~--~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~- 583 (676)
... ........+||+.|+|||++.+. .++.++||||+||++|||++|++||......+....+ ..........
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I---~~~~g~p~~~~ 286 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI---MMVLGTPSPAV 286 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH---HHHHCCCCGGG
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhcCCCChHH
Confidence 322 12233457899999999998875 5699999999999999999999999764332211111 1111000000
Q ss_pred -------------ccCCcccCCCCC-----hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcC
Q 005803 584 -------------ELMDPTLDESCS-----SDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTND 630 (676)
Q Consensus 584 -------------~~~d~~l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~ 630 (676)
..+.+. ...+ +.....+.+|+.+||+.||++|||+.|+++. |++.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPR--QPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp TC-----CHHHHHHSSCCC--CCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhhhhhcCCCc--CCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 000000 0001 1112457889999999999999999999874 5443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.76 Aligned_cols=263 Identities=37% Similarity=0.631 Sum_probs=215.9
Q ss_pred CcCccccHHHHHHHhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCcccc---
Q 005803 368 RDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTD--- 443 (676)
Q Consensus 368 ~~~~~f~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~--- 443 (676)
..++.|++.++..++++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|+.++++++||||++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 45678999999999999999999999999999999987899999999976432 23346899999999999999872
Q ss_pred ---------------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeE
Q 005803 444 ---------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPK 496 (676)
Q Consensus 444 ---------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vk 496 (676)
......+++..+..++.|++.||.|||++...+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 01223488999999999999999999999222399999999999999999999
Q ss_pred EeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCC--CCCCccchHHHHH
Q 005803 497 ISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSY--DTERPLNLVGYAW 574 (676)
Q Consensus 497 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~--~~~~~~~l~~~~~ 574 (676)
|+|||++......... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||... ..........+..
T Consensus 175 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp ECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred eccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 9999999876533222 223356899999999999999999999999999999999999999632 1222333444444
Q ss_pred HHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 575 QLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 575 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
............+..+......+....+.+++.+||+.||.+|||+.||+++|++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 444556667777888888888999999999999999999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.58 Aligned_cols=180 Identities=22% Similarity=0.356 Sum_probs=146.3
Q ss_pred HHHHHhcCCCcceeeccCCCccEEEEEEc----CCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCccccc-------
Q 005803 377 TIAAATDNFSPANRLGQGGFGPVYNGKLL----DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTDS------- 444 (676)
Q Consensus 377 ~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~----~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~~------- 444 (676)
.+....++|++.++||+|+||.||+|+.+ .++.||||++.... ...++.+|+++|.++ +||||+..
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 34456789999999999999999999753 46789999986543 345688999999998 69999831
Q ss_pred ---------c-------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC-CCeEEeccCcceecc
Q 005803 445 ---------S-------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ-MNPKISDFGMARTYA 507 (676)
Q Consensus 445 ---------~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~-~~vkL~DFGla~~~~ 507 (676)
. .-..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+...
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred CEEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 0 0135788999999999999999999998 9999999999999876 789999999998654
Q ss_pred ccccc--------------------------cccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCC
Q 005803 508 MNELE--------------------------ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGS 560 (676)
Q Consensus 508 ~~~~~--------------------------~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~ 560 (676)
..... ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 32110 112335799999999999875 589999999999999999999999964
Q ss_pred C
Q 005803 561 Y 561 (676)
Q Consensus 561 ~ 561 (676)
.
T Consensus 250 ~ 250 (361)
T 4f9c_A 250 A 250 (361)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=359.36 Aligned_cols=226 Identities=19% Similarity=0.255 Sum_probs=181.3
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++||||++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999875 59999999998766666778999999999999999983
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC--CCeEEeccCcceecccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ--MNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~--~~vkL~DFGla~~~~~~~~ 511 (676)
......+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 012346788899999999999999999998 9999999999999854 899999999999865432
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+ ........... +.+...
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-------~~~~i~~~~~~--~~~~~~ 380 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWN--MDDSAF 380 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCCC--CCSGGG
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHhCCCC--CCcccc
Confidence 2334689999999999999999999999999999999999999997543211 11122222111 111111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
. .....+.+|+.+||+.||++|||+.|+++.
T Consensus 381 ~----~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 381 S----GISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 123457788999999999999999999873
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.64 Aligned_cols=256 Identities=33% Similarity=0.552 Sum_probs=203.0
Q ss_pred CcCccccHHHHHHHhcCCCcc------eeeccCCCccEEEEEEcCCcEEEEEEeccC----CchhhHHHHHHHHHHHHcc
Q 005803 368 RDLKIFDFQTIAAATDNFSPA------NRLGQGGFGPVYNGKLLDGQEIAIKRLSKS----SGQGIVEFKNEAKLIAKLQ 437 (676)
Q Consensus 368 ~~~~~f~~~~l~~~t~~y~~~------~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~----~~~~~~~~~~E~~~l~~l~ 437 (676)
.+...|++.++..++++|... +.||+|+||.||+|+. +++.||||++... .....+.+.+|+.++++++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 356789999999999999887 8999999999999986 6889999998653 2334567899999999999
Q ss_pred CCcccc-----------------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceE
Q 005803 438 HTNLTD-----------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNIL 488 (676)
Q Consensus 438 H~niv~-----------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NIL 488 (676)
||||++ ......+++..+..++.||+.||.|||+++ |+||||||+||+
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 999872 112345889999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccc
Q 005803 489 LDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLN 568 (676)
Q Consensus 489 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~ 568 (676)
++.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|||++|+.||..........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 99999999999999987654332222334578999999998765 58999999999999999999999998655443222
Q ss_pred hHHHHHHHHh-cCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 569 LVGYAWQLWN-EGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 569 l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.+ ...... ...+.+.+++.+ ...+......+.+++.+||+.||.+|||+.+|++.|+++.
T Consensus 245 ~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 245 DI--KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HH--HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HH--HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11 111111 122333444443 2346677788999999999999999999999999998864
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=326.00 Aligned_cols=174 Identities=21% Similarity=0.264 Sum_probs=145.2
Q ss_pred cceeccccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCC
Q 005803 27 LCYCQTDKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYP 106 (676)
Q Consensus 27 ~~~~~~~~l~~g~~l~~~~~l~S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (676)
.|+++.|+|++|++|++|++|+|++|.|+||||.++ ++|| |+ . .
T Consensus 9 ~~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~-~--------------------------~--- 52 (276)
T 3m7h_A 9 FNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD-N--------------------------G--- 52 (276)
T ss_dssp CCCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE-T--------------------------T---
T ss_pred eccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC-C--------------------------C---
Confidence 455788999999999999999999999999999543 6787 65 2 1
Q ss_pred CCCCCCCccEEEccCCCCCCCC---CCceEEEEcCCCcEEE--EcCCCceEEEeeeccC-----CcceEEEEeeCCCEEE
Q 005803 107 YSPAIKKQPVWIANRETPVLRN---ESASLIIDSTDGNLKI--LRNGKNPIGISSVRRA-----GNTTSATLLKNGNLVL 176 (676)
Q Consensus 107 ~~~~~~~~~vW~anr~~p~~~~---~~~~l~~~~~~G~L~l--~~~~~~~vw~s~~~~~-----~~~~~a~l~d~GNlVl 176 (676)
+ |||+||||+|+.+. .+++|.|+. ||+|+| .|++|.+||+++++.+ ..++.|+|+|+|||||
T Consensus 53 ------~-vvW~Anr~~p~~~~~~~~~~~l~l~~-~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl 124 (276)
T 3m7h_A 53 ------A-TVWVANEQQPFSSTIPLRNKKAPLAF-YVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVL 124 (276)
T ss_dssp ------E-EEEECSTTSTTEEEEECCCTTCCSEE-EESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEE
T ss_pred ------C-eEEECCCCCCcCCcccccceEEEEeC-CCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEe
Confidence 5 79999999999652 157899988 999999 7888999999997542 2357899999999999
Q ss_pred EEecCCCCccccccccccCCCcccccCCCcccccccCCceeEEEecC-CCCcceEEEeeeCCCCCeEEEEEeC-CeEEEE
Q 005803 177 YEMNSDGLSIRRGLWQSFDYPTHALLPGMKLGINLQTGHQWFLQSSE-SAEGSYRLGLGTDPNMTSKLVIWKN-DKVVWT 254 (676)
Q Consensus 177 ~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~t~~~~~l~s~~-~~~g~~~~~~~~~~~~~~~~~~~~~-~~~~w~ 254 (676)
++ + .+|||| |||||+|||||||.++++|. .|.|.. |++|.|++.| ++++. +++|++ ..+||+
T Consensus 125 ~~--~------~~lWqS--~ptdtlLpg~~~~~~l~~g~--~L~S~~dps~G~fsl~l--~~dGn--lvLy~~~~~~yW~ 188 (276)
T 3m7h_A 125 VD--S------LALWNG--TPAIPLVPGAIDSLLLAPGS--ELVQGVVYGAGASKLVF--QGDGN--LVAYGPNGAATWN 188 (276)
T ss_dssp EE--E------EEEEES--CTTSCCCCSCTTCEEECSSE--EECTTCEEEETTEEEEE--CTTSC--EEEECTTSSEEEE
T ss_pred cC--C------ceeeCc--ccccccccccccccccccCc--ccccCCCCCCceEEEee--cCCce--EEEEeCCCeEEEE
Confidence 97 2 589999 99999999999999998884 475544 7889999999 78775 566764 589999
Q ss_pred ecccCC
Q 005803 255 SAIWLN 260 (676)
Q Consensus 255 sg~w~~ 260 (676)
+|+|+.
T Consensus 189 Sgt~~~ 194 (276)
T 3m7h_A 189 AGTQGK 194 (276)
T ss_dssp CCCTTT
T ss_pred CCCCCC
Confidence 999976
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=353.99 Aligned_cols=223 Identities=25% Similarity=0.319 Sum_probs=171.9
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHH---HHHHHHHccCCcccc-----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKN---EAKLIAKLQHTNLTD----------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~---E~~~l~~l~H~niv~----------- 443 (676)
.++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ......+.+ ++.+++.++|||||.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 478999999999999999999875 59999999996531 122223334 466677789999983
Q ss_pred ---------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 444 ---------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
......+++..+..++.||+.||.|||+++ ||||||||+||||+.+|++||+|||+|+.+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 122356889999999999999999999998 99999999999999999999999999987654
Q ss_pred cccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
.. ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||..........+ ........
T Consensus 345 ~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i----~~~i~~~~------ 410 (689)
T 3v5w_A 345 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMA------ 410 (689)
T ss_dssp CC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH----HHHHHHCC------
T ss_pred CC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhhcCCC------
Confidence 32 334789999999999975 5799999999999999999999999975433322111 11111111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRT-----MSDVVS 625 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~eVl~ 625 (676)
..+.. .....+.+|+.+||+.||.+|++ ++||++
T Consensus 411 ~~~p~----~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 VELPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CCCCT----TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCCc----cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11112 22345788999999999999998 688775
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.77 Aligned_cols=241 Identities=22% Similarity=0.330 Sum_probs=184.7
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
.++|++.++||+|+||.||+|+.. ++.||||++... ......+..|+.++.+++||||++.
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999874 799999999653 3344556779999999999999831
Q ss_pred ------------cccCcCCHHHHHHHHHHHHHHHHHHHhc----------CCCceEeeccccCceEEcCCCCeEEeccCc
Q 005803 445 ------------SRKSLLDWKKRFYIIEGIVQGLLYLHKY----------SRLRAIHRDLKVSNILLDEQMNPKISDFGM 502 (676)
Q Consensus 445 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~----------~~~~iiH~DLKp~NILl~~~~~vkL~DFGl 502 (676)
.....+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 101 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCc
Confidence 1123478889999999999999999988 6 99999999999999999999999999
Q ss_pred ceeccccccccccceeeccCCccChhhhccC-----CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHH------
Q 005803 503 ARTYAMNELEANTNRIVGTHGYMSPEYVMNG-----IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVG------ 571 (676)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~------ 571 (676)
++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||.............
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 9876554433334446799999999999863 56678999999999999999999998654433222111
Q ss_pred ---HHHHHHhcCCccccCCcccCCC-CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 572 ---YAWQLWNEGKALELMDPTLDES-CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 572 ---~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
........... .+.+... ........+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 258 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 258 SLEDMQEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhhhhhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01111111111 1111111 12245667899999999999999999999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.33 Aligned_cols=230 Identities=23% Similarity=0.378 Sum_probs=175.0
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCc----EEEEEEeccC-CchhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQ----EIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~----~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
++|++.+.||+|+||.||+|++. +++ .||+|.+... .....+++.+|+.++++++||||+.
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 57889999999999999999854 344 3688887543 2345678999999999999999973
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 112345888999999999999999999998 9999999999999999999999999998765443
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
.........+|..|+|||.+.+..++.++|||||||++|||++ |+.||....... + ......+..
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~----~~~~~~~~~------- 237 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGER------- 237 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H----HHHHHTTCC-------
T ss_pred ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---H----HHHHHcCCC-------
Confidence 3333333566889999999999999999999999999999999 999997543322 1 111111111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
...+......+.+++.+||+.||++||++.||++.|+.+.
T Consensus 238 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 238 --LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp --CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1112233446888999999999999999999999997654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=323.53 Aligned_cols=238 Identities=24% Similarity=0.414 Sum_probs=174.0
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
..++|++.+.||+|+||.||+|+. +++.||||++.... ....+++.+|+.++++++||||+..
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356899999999999999999987 68899999987543 3345678999999999999999730
Q ss_pred ------------cc---cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 445 ------------SR---KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 445 ------------~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
.. ...+++..++.++.||+.||+|||+++ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 00 113888899999999999999999875 34999999999999999999999999999754332
Q ss_pred ccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ........... ..
T Consensus 193 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~~~~~~~~~~-----~~ 259 (309)
T 3p86_A 193 FL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VVAAVGFKCKR-----LE 259 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHHSCCC-----CC
T ss_pred cc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcCCC-----CC
Confidence 21 2233679999999999999999999999999999999999999997543211 11111111111 11
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCCCC
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKP 637 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~~p 637 (676)
+ +......+.+++.+||+.||++|||+.+|++.|+.+.+....|
T Consensus 260 ~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 260 I----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred C----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 1 1222345788999999999999999999999999986443333
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=321.64 Aligned_cols=235 Identities=24% Similarity=0.393 Sum_probs=184.5
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
.++|++.++||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 357889999999999999999875 58999999987766677788999999999999999973
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 011356889999999999999999999998 9999999999999999999999999998764332211
Q ss_pred ------------ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC
Q 005803 514 ------------NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK 581 (676)
Q Consensus 514 ------------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 581 (676)
......||+.|+|||.+.+..++.++||||||+++|||++|..|+............. ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~~----- 239 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRGF----- 239 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HHHH-----
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hhcc-----
Confidence 1113579999999999999999999999999999999999999987643322111000 0000
Q ss_pred ccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCC
Q 005803 582 ALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMA 633 (676)
Q Consensus 582 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 633 (676)
.+......+ ...+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 240 ----~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 240 ----LDRYCPPNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ----HHHTCCTTC----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----ccccCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 001111112 23477899999999999999999999999987643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=317.11 Aligned_cols=227 Identities=22% Similarity=0.347 Sum_probs=181.0
Q ss_pred HhcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
..++|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||++.
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346899999999999999999985 4689999999976666667789999999999999999831
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........ .
T Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 172 (297)
T 3fxz_A 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 172 (297)
T ss_dssp CCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred CCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--c
Confidence 11234788889999999999999999998 99999999999999999999999999987654332 2
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ........+.. .. ..
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~~-~~-------~~ 238 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP-EL-------QN 238 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSC-CC-------SC
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCC-CC-------CC
Confidence 233679999999999999999999999999999999999999997532211 11111111111 11 11
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+......+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 22233457889999999999999999999874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=325.67 Aligned_cols=231 Identities=24% Similarity=0.387 Sum_probs=182.3
Q ss_pred hcCCCcceeeccCCCccEEEEEEc--------CCcEEEEEEeccCC-chhhHHHHHHHHHHHHc-cCCccccc-------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL--------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLTDS------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~--------~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~------- 444 (676)
.++|++.+.||+|+||.||+|+.. ++..||||+++... ....+++.+|+.+++++ +||||++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999852 34579999997643 33456799999999999 89999720
Q ss_pred ---------c--------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE
Q 005803 445 ---------S--------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL 489 (676)
Q Consensus 445 ---------~--------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl 489 (676)
. ....+++.+++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 0 0124788889999999999999999998 9999999999999
Q ss_pred cCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccc
Q 005803 490 DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLN 568 (676)
Q Consensus 490 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~ 568 (676)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999987654333233333467789999999999999999999999999999999 999997643221
Q ss_pred hHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 569 LVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 569 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+ ......+... . .+......+.+++.+||+.||++||++.||++.|+.+.
T Consensus 314 ~----~~~~~~~~~~-----~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 314 L----FKLLKEGHRM-----D----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp H----HHHHHTTCCC-----C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----HHHHhcCCCC-----C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 1122222211 1 12223345888999999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=318.75 Aligned_cols=237 Identities=23% Similarity=0.324 Sum_probs=188.2
Q ss_pred ccccHHHHHHHhcC----------CCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCC
Q 005803 371 KIFDFQTIAAATDN----------FSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 439 (676)
Q Consensus 371 ~~f~~~~l~~~t~~----------y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ 439 (676)
..|++++++.+++. |...++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788888888764 777889999999999999976 6999999999876666778899999999999999
Q ss_pred cccc-------------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC
Q 005803 440 NLTD-------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN 494 (676)
Q Consensus 440 niv~-------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~ 494 (676)
||+. ......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 179 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGR 179 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCc
Confidence 9973 112345889999999999999999999998 999999999999999999
Q ss_pred eEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHH
Q 005803 495 PKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAW 574 (676)
Q Consensus 495 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~ 574 (676)
+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ..
T Consensus 180 ~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------~-~~ 250 (321)
T 2c30_A 180 VKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------Q-AM 250 (321)
T ss_dssp EEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------H-HH
T ss_pred EEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HH
Confidence 99999999987654322 123467999999999999999999999999999999999999999753211 1 11
Q ss_pred HHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 575 QLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 575 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
........ +.+.. .......+.+++.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~-----~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 251 KRLRDSPP-----PKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHSSC-----CCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhcCCC-----CCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11212111 11111 11223457788999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=317.60 Aligned_cols=237 Identities=20% Similarity=0.294 Sum_probs=177.8
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
..++|++.++||+|+||.||+|+..+++.||||++.... ......+.+|+.++++++||||++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 347899999999999999999999889999999986542 223467889999999999999983
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 99 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 99 EFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp ECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 112345888999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc--------
Q 005803 513 ANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL-------- 583 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~-------- 583 (676)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.... ...........
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK---IFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH---HHHHHCCCCTTTSGGGTTS
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHHCCCChHHhhhhhcc
Confidence 1223578999999999876 5689999999999999999999999986654432211 11111110000
Q ss_pred --------ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 584 --------ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 584 --------~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
...+........+.....+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000000001112345788999999999999999999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.21 Aligned_cols=241 Identities=22% Similarity=0.325 Sum_probs=180.3
Q ss_pred hcCCCcceeeccCCCccEEEEEE-----cCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL-----LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~-----~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
.++|++.++||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36789999999999999999984 2588999999987666667889999999999999999731
Q ss_pred -----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 445 -----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 445 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
.....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 11234888899999999999999999998 9999999999999999999999999998764
Q ss_pred ccccc-cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCC--------C-CccchHHHHHHHH
Q 005803 508 MNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDT--------E-RPLNLVGYAWQLW 577 (676)
Q Consensus 508 ~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~--------~-~~~~l~~~~~~~~ 577 (676)
..... .......++..|+|||.+.+..++.++||||||+++|||++|..|+..... . .............
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 43211 112223467789999999999999999999999999999999998864210 0 0000001111111
Q ss_pred hcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCC
Q 005803 578 NEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMAL 634 (676)
Q Consensus 578 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l 634 (676)
..+. ....+......+.+++.+||+.||++|||+.||++.|+.+...+
T Consensus 246 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 246 KNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 1111 11112233456888999999999999999999999998875443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=312.69 Aligned_cols=237 Identities=24% Similarity=0.319 Sum_probs=179.3
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHH--ccCCccccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAK--LQHTNLTDS-------------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~~-------------- 444 (676)
..++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||++.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 357899999999999999999987 7899999998643 34556677777777 799998731
Q ss_pred ---------------cccCcCCHHHHHHHHHHHHHHHHHHH--------hcCCCceEeeccccCceEEcCCCCeEEeccC
Q 005803 445 ---------------SRKSLLDWKKRFYIIEGIVQGLLYLH--------KYSRLRAIHRDLKVSNILLDEQMNPKISDFG 501 (676)
Q Consensus 445 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~iiH~DLKp~NILl~~~~~vkL~DFG 501 (676)
.....+++..++.++.||+.||.||| +.+ |+||||||+|||++.++.+||+|||
T Consensus 82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCC
Confidence 12345788999999999999999999 666 9999999999999999999999999
Q ss_pred cceeccccccc--cccceeeccCCccChhhhccC------CCCchhHHHHHHHHHHHHHhC----------CcCCCCCCC
Q 005803 502 MARTYAMNELE--ANTNRIVGTHGYMSPEYVMNG------IVSMKSDVYSFGVLVLEIVSS----------KKNNGSYDT 563 (676)
Q Consensus 502 la~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~------~~s~ksDVwSlGvvl~elltG----------~~pf~~~~~ 563 (676)
+++........ .......||+.|+|||.+.+. .++.++|||||||++|||++| +.||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 99865443221 112235799999999999876 456799999999999999999 777765433
Q ss_pred CCccchHHHHHHHHhcCCccccCCcccCC-CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 564 ERPLNLVGYAWQLWNEGKALELMDPTLDE-SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 564 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
..... ........... ..+.+.. .........+.+++.+||+.||++|||+.||++.|+++
T Consensus 239 ~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 NDPSF--EDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SSCCH--HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcch--hhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 32211 11111111111 1111111 12234667899999999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=317.68 Aligned_cols=235 Identities=18% Similarity=0.189 Sum_probs=182.0
Q ss_pred hcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCccccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTDS--------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~~--------------- 444 (676)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+|+.+++++ +||||+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999986 468999999986542 345689999999999 99998720
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC-----eEEeccCcceeccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN-----PKISDFGMARTYAM 508 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~-----vkL~DFGla~~~~~ 508 (676)
.....+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 86 LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred eCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 11356889999999999999999999998 999999999999998887 99999999987644
Q ss_pred ccccc-----ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 509 NELEA-----NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 509 ~~~~~-----~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~- 241 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI- 241 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH-
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH-
Confidence 32211 123468999999999999999999999999999999999999999876544322222111111000000
Q ss_pred ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 584 ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 584 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
..+... .+ .+.+++..||+.||.+||++++|++.|+.+.
T Consensus 242 ----~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 242 ----EVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp ----HHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ----HHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 000111 12 6888999999999999999999999997654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=310.34 Aligned_cols=228 Identities=26% Similarity=0.361 Sum_probs=181.6
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
++|++.+.||+|+||.||+|+..+++.||||++... ....+++.+|+.++++++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 578899999999999999999888999999999764 334567999999999999999872
Q ss_pred --------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 444 --------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 444 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
......+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... ..
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SS 164 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-ST
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc-cc
Confidence 112345888999999999999999999998 999999999999999999999999999865433221 12
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+. ....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-------~~~~~~~~~-----~~~~---- 228 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGF-----RLYK---- 228 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTC-----CCCC----
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhcCc-----cCCC----
Confidence 22456778999999999999999999999999999999 999997533211 111121211 1111
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+......+.+++.+||+.||++||++.|+++.|+++.
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 1112345788899999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=308.34 Aligned_cols=229 Identities=25% Similarity=0.331 Sum_probs=182.0
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
.++|++.+.||+|+||.||+|+..++..||||++.... ...+++.+|+.++.+++||||++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46799999999999999999998888899999997643 345679999999999999998730
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..........
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~- 161 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS- 161 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE-
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhc-
Confidence 11234888999999999999999999998 9999999999999999999999999998765433222
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 593 (676)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+... ..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~--~~------ 226 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-------VVLKVSQGHRL--YR------ 226 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTCCC--CC------
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-------HHHHHHcCCCC--CC------
Confidence 122456678999999999899999999999999999999 999997543211 11111111111 11
Q ss_pred CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 594 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+......+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 227 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 227 -PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp -CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred -CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1112235788999999999999999999999999885
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=318.83 Aligned_cols=231 Identities=24% Similarity=0.345 Sum_probs=179.7
Q ss_pred hcCCCcceeeccCCCccEEEEEEc----CCcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL----DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~----~~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
.++|++.+.||+|+||.||+|++. .+..||||+++.. .....+.+.+|+.++++++||||+.
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 357889999999999999999874 3456999999764 3344567999999999999999972
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 012346888999999999999999999998 999999999999999999999999999876543
Q ss_pred cccc-ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 510 ELEA-NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 510 ~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
.... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... .......+..
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~~----- 272 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------VISSVEEGYR----- 272 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCC-----
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCCC-----
Confidence 2111 1222345778999999999999999999999999999999 999996543211 1112222211
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.. .+......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 273 ~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 273 LP----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 12223346888999999999999999999999999876
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=333.90 Aligned_cols=232 Identities=25% Similarity=0.402 Sum_probs=184.5
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
..++|.+.+.||+|+||.||+|+..+++.||||+++.. ....++|.+|+.++++++||||++.
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEeec
Confidence 45678899999999999999999988899999999764 3457789999999999999999831
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 11125677888899999999999999998 9999999999999999999999999998754332211
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.....++..|+|||.+....++.++|||||||++|||++ |+.||......+ .......+...
T Consensus 342 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~~--------- 404 (454)
T 1qcf_A 342 -REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYRM--------- 404 (454)
T ss_dssp -TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHHTCCC---------
T ss_pred -cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC---------
Confidence 122346778999999999999999999999999999999 999997543211 11122222111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCC
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMA 633 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 633 (676)
..+......+.+++.+||+.||++|||+.+|++.|+....+
T Consensus 405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 11222344678899999999999999999999999998643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.08 Aligned_cols=231 Identities=25% Similarity=0.371 Sum_probs=181.4
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
.++|.+.+.||+|+||.||+|+.. +++.||||+++... .....++.+|+.++++++||||++.
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 357888999999999999999986 68999999987543 2344578999999999999999830
Q ss_pred ------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 445 ------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 445 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
.....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 11235788889999999999999999998 999999999999999999999999999865433222
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ........+... .
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~-----~-- 335 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEKGGRL-----P-- 335 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHTTCCC-----C--
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCC-----C--
Confidence 22222346778999999999999999999999999999998 99999754321 112222222111 1
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.+......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 336 --~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 336 --CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 11222345778999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=325.84 Aligned_cols=241 Identities=25% Similarity=0.375 Sum_probs=187.7
Q ss_pred ccHHHHHHHhcCCCcceeeccCCCccEEEEEE------cCCcEEEEEEeccCC-chhhHHHHHHHHHHHHc-cCCccccc
Q 005803 373 FDFQTIAAATDNFSPANRLGQGGFGPVYNGKL------LDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLTDS 444 (676)
Q Consensus 373 f~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~------~~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~ 444 (676)
++..+.....++|++.+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|++++.++ +||||++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44555566778999999999999999999973 236789999997643 33456799999999999 78998720
Q ss_pred -----------------------------cc-------------------------------------------------
Q 005803 445 -----------------------------SR------------------------------------------------- 446 (676)
Q Consensus 445 -----------------------------~~------------------------------------------------- 446 (676)
..
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 00
Q ss_pred ---------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 447 ---------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 447 ---------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 111888899999999999999999998 99999999999999999999999999987644333
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||........ .......+.... .
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~~~-----~ 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMR-----A 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCCCC-----C
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCCCCC-----C
Confidence 333444678999999999999999999999999999999998 9999976443221 112222222111 1
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+......+.+++.+||+.||++|||+.||+++|+.+.
T Consensus 318 ----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 318 ----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1122345788899999999999999999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.91 Aligned_cols=240 Identities=16% Similarity=0.176 Sum_probs=184.8
Q ss_pred hcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCcccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTD---------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~---------------- 443 (676)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+|+.++.++ +|+|++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999986 46899999998653 2345688999999999 7888752
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC-----eEEeccCcceeccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN-----PKISDFGMARTYAM 508 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~-----vkL~DFGla~~~~~ 508 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++.....
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 87 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred ecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 011345889999999999999999999998 999999999999987766 99999999987654
Q ss_pred cccc-----cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 509 NELE-----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 509 ~~~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........................
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence 3221 12234679999999999999999999999999999999999999998755443322222111111111111
Q ss_pred ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCC
Q 005803 584 ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALP 635 (676)
Q Consensus 584 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~ 635 (676)
+ +... ....+.+++.+||+.||++||++++|++.|+++...+.
T Consensus 244 ~-----~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 244 E-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp H-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred H-----HHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 1 1111 23457889999999999999999999999998764443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=318.24 Aligned_cols=223 Identities=24% Similarity=0.369 Sum_probs=177.7
Q ss_pred HhcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
..++|++.+.||+|+||.||+|++ .+++.||||++... .....+++.+|++++++++||||++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356899999999999999999987 46999999999654 2344567889999999999999973
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 112345788899999999999999999998 9999999999999999999999999997654332
Q ss_pred ccccceeeccCCccChhhhccCCCC-chhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVS-MKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s-~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
......||+.|+|||++.+..+. .++|||||||++|||++|+.||...... . .......+.. .+
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~-~~~~i~~~~~------~~ 233 (328)
T 3fe3_A 169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------E-LRERVLRGKY------RI 233 (328)
T ss_dssp --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCC------CC
T ss_pred --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCC------CC
Confidence 22346799999999999988765 8999999999999999999999754211 1 1122222221 11
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+......+.+++.+||+.||.+|||++|+++.
T Consensus 234 ----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 ----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11223457788999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=315.65 Aligned_cols=228 Identities=22% Similarity=0.321 Sum_probs=177.2
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999876 68999999986543 233467899999999999999972
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+.......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 122345889999999999999999999998 9999999999999999999999999998765433333
Q ss_pred ccceeeccCCccChhhhccCCC-CchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ...+...... ..
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~~~~~~~~~--~~----- 229 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTY--LN----- 229 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH------HHHHHTTCTT--ST-----
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHHhccccc--CC-----
Confidence 3345689999999999988775 78999999999999999999999765432211 1111111110 00
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
........+.+++.+||+.||++|||+.|+++.
T Consensus 230 -~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 -PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 011223456789999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=310.41 Aligned_cols=234 Identities=26% Similarity=0.437 Sum_probs=172.2
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
.++|++.++||+|+||.||+|+.. ..||||+++... ....+.+.+|+.++++++||||+.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~ 100 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 100 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEe
Confidence 468999999999999999999853 469999986543 344567899999999999999872
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 123456888999999999999999999998 9999999999999999999999999998654333233
Q ss_pred ccceeeccCCccChhhhc---cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 514 NTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
......||+.|+|||.+. +..++.++||||||+++|||++|+.||....... ........+.....+.
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~--- 248 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLSPDLS--- 248 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCCCCTT---
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccCcchh---
Confidence 334467899999999986 5678999999999999999999999997543221 1122222222221111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.........+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 249 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 249 --KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp --SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 112223356888999999999999999999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=315.09 Aligned_cols=233 Identities=21% Similarity=0.329 Sum_probs=170.1
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcC-C---cEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccccc---------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLD-G---QEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDSS--------- 445 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-~---~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~--------- 445 (676)
..++|++.+.||+|+||.||+|+... + ..||||++... .....+++.+|+.++++++||||++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45689999999999999999998654 3 27999999754 344567899999999999999987310
Q ss_pred -----------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeE
Q 005803 446 -----------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPK 496 (676)
Q Consensus 446 -----------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vk 496 (676)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 0014788889999999999999999998 99999999999999999999
Q ss_pred EeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHH
Q 005803 497 ISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQ 575 (676)
Q Consensus 497 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~ 575 (676)
|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||........ ..
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~ 250 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-------YN 250 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HH
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-------HH
Confidence 999999987654433333333556788999999999999999999999999999999 9999975443221 11
Q ss_pred HHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcC
Q 005803 576 LWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTM 632 (676)
Q Consensus 576 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 632 (676)
....+... ..+......+.+++.+||+.||++|||+.++++.|+++..
T Consensus 251 ~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 251 YLIGGNRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HHHTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCC---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11121111 1122233468889999999999999999999999998763
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=320.85 Aligned_cols=227 Identities=22% Similarity=0.300 Sum_probs=170.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccC--CchhhHHHHHHHHHHHHccC--Ccccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH--TNLTD-------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H--~niv~-------------- 443 (676)
.++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| +||+.
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4679999999999999999999888999999998654 23345778999999999987 88873
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++.++..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++........
T Consensus 88 ~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 88 MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp ECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 112346788899999999999999999998 99999999999997 578999999999876544333
Q ss_pred cccceeeccCCccChhhhcc-----------CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMN-----------GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK 581 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~-----------~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 581 (676)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .........
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~---- 234 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII---- 234 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHH----
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHh----
Confidence 33344679999999999865 6789999999999999999999999974321 111111111
Q ss_pred ccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 582 ALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 582 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
++......+......+.+++.+||+.||.+|||+.|+++.
T Consensus 235 -----~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 -----DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -----CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111111222223457789999999999999999999865
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=324.13 Aligned_cols=238 Identities=24% Similarity=0.356 Sum_probs=186.4
Q ss_pred hcCCCcceeeccCCCccEEEEEEc--------CCcEEEEEEeccCC-chhhHHHHHHHHHHHHc-cCCccccc-------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL--------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLTDS------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~--------~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~------- 444 (676)
.++|.+.++||+|+||.||+|+.. .++.||||++.... .....++.+|+++++++ +||||++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 468999999999999999999852 23579999997643 33457789999999999 99999720
Q ss_pred ---------------------c--------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE
Q 005803 445 ---------------------S--------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL 489 (676)
Q Consensus 445 ---------------------~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl 489 (676)
. ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 0 0134889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccc
Q 005803 490 DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLN 568 (676)
Q Consensus 490 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~ 568 (676)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---- 300 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 300 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999999987654433333344567889999999999999999999999999999999 99999754321
Q ss_pred hHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCCCCC
Q 005803 569 LVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPK 638 (676)
Q Consensus 569 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~~p~ 638 (676)
.....+..+.... . +......+.+++.+||+.||++|||+.||++.|+.+........
T Consensus 301 ---~~~~~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 301 ---ELFKLLKEGHRMD-----K----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp ---HHHHHHHTTCCCC-----C----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred ---HHHHHHHcCCCCC-----C----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 1222222222111 1 11223457889999999999999999999999999874444333
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=331.02 Aligned_cols=233 Identities=24% Similarity=0.396 Sum_probs=180.5
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
.++|++.++||+|+||.||+|+..++..||||+++... ...++|.+|+.++++++||||++.
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhc
Confidence 46788899999999999999999888889999997643 345789999999999999998730
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ .
T Consensus 262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~ 337 (452)
T 1fmk_A 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-A 337 (452)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee-c
Confidence 11234788899999999999999999998 999999999999999999999999999875433211 1
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 593 (676)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ .......+... .
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~~---------~ 401 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM---------P 401 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCC---------C
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC---------C
Confidence 222456788999999999999999999999999999999 999997543211 11222222111 1
Q ss_pred CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCC
Q 005803 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALP 635 (676)
Q Consensus 594 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~ 635 (676)
.+......+.+++.+||+.||++|||+++|++.|+......+
T Consensus 402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 122334567889999999999999999999999999864443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=323.07 Aligned_cols=231 Identities=29% Similarity=0.393 Sum_probs=180.3
Q ss_pred hcCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCccccc----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTDS---------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~~---------- 444 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++... ......++.+|+.++++++||||+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367899999999999999999843 3678999999654 33445678999999999999999720
Q ss_pred -----------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC---CeEEe
Q 005803 445 -----------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM---NPKIS 498 (676)
Q Consensus 445 -----------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~---~vkL~ 498 (676)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 11234888899999999999999999998 99999999999999555 59999
Q ss_pred ccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHH
Q 005803 499 DFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLW 577 (676)
Q Consensus 499 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~ 577 (676)
|||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |+.||....... .....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-------~~~~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH
Confidence 9999986543333333334567899999999999999999999999999999998 999997543211 11222
Q ss_pred hcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 578 NEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 578 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
..+... .. +......+.+++.+||+.||++|||+.+|++.|+...
T Consensus 300 ~~~~~~-----~~----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 300 TSGGRM-----DP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HTTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCCC-----CC----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 222211 11 1222345788999999999999999999999998765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=320.07 Aligned_cols=231 Identities=24% Similarity=0.372 Sum_probs=174.1
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcE----EEEEEeccC-CchhhHHHHHHHHHHHHccCCccccc-----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQE----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTDS----------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~----VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~~----------- 444 (676)
.++|++.+.||+|+||.||+|+.. +++. ||+|.+... ......++.+|+.++++++||||+..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence 367999999999999999999864 3443 577877543 34456789999999999999999731
Q ss_pred ---------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 445 ---------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 445 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 12345888899999999999999999998 999999999999999999999999999876544
Q ss_pred ccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
..........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........ ......+...
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~~~~~~~~~----- 238 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGERL----- 238 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTCCC-----
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCCCC-----
Confidence 33333333556788999999999999999999999999999999 9999976433221 1111111111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
..+......+.+++.+||+.||.+||++.|+++.|+.+.
T Consensus 239 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 239 ----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 112223345788999999999999999999999999876
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=308.88 Aligned_cols=229 Identities=25% Similarity=0.351 Sum_probs=178.9
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
.++|++.+.||+|+||.||+++..+++.||||++.... ...+++.+|++++.+++|+||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 46889999999999999999999888899999997643 34577999999999999999872
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~- 177 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS- 177 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS-
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccccc-
Confidence 011345888999999999999999999998 9999999999999999999999999998654432211
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 593 (676)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+. ....
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~-----~~~~--- 242 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGL-----RLYR--- 242 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTC-----CCCC---
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-------HHHHHhccc-----CCCC---
Confidence 222456778999999999999999999999999999998 999997543211 111121211 1111
Q ss_pred CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 594 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 243 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 243 -PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp -CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 1112245788999999999999999999999998753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=309.91 Aligned_cols=240 Identities=23% Similarity=0.371 Sum_probs=179.9
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------------ 444 (676)
++|++.+.||+|+||.||+|+. .++.||||++.. ....+.+.+|+.++++++||||++.
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~ 84 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGG 84 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTC
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCC
Confidence 5788899999999999999987 478899999864 3456789999999999999999731
Q ss_pred ---------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC-eEEeccCcceeccccccccc
Q 005803 445 ---------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN-PKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~-vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----- 159 (307)
T 2eva_A 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----- 159 (307)
T ss_dssp BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----
Confidence 01123677888999999999999999943234999999999999998887 799999999754322
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+. ...+.. +.+....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~-~~~~~~-----~~~~~~~ 229 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWA-VHNGTR-----PPLIKNL 229 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHH-HHTTCC-----CCCBTTC
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHH-HhcCCC-----CCccccc
Confidence 223468999999999999999999999999999999999999997543221 111111 111111 1111222
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCCCCCCCccce
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQPAFFI 644 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~~p~~P~~~~ 644 (676)
...+.+++.+||+.||++|||+.+|++.|+.+...++.+..|..+.
T Consensus 230 ----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~~ 275 (307)
T 2eva_A 230 ----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275 (307)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCCCE
T ss_pred ----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccccc
Confidence 3357789999999999999999999999999876676666665543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=305.65 Aligned_cols=239 Identities=18% Similarity=0.208 Sum_probs=182.5
Q ss_pred HHhcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
...++|++.+.||+|+||.||+|+. .+++.||||++.... ...++.+|+.++.+++|++++.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3567899999999999999999986 468999999875432 3346889999999999988651
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE---cCCCCeEEeccCcceeccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL---DEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl---~~~~~vkL~DFGla~~~~~ 508 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 84 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 012346889999999999999999999998 9999999999999 7889999999999987654
Q ss_pred cccc-----cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 509 NELE-----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 509 ~~~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 3221 12234678999999999999999999999999999999999999998765544433332222211111110
Q ss_pred ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcC
Q 005803 584 ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTM 632 (676)
Q Consensus 584 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 632 (676)
.+...+ ...+.+++.+||+.||++|||+++|++.|+++..
T Consensus 241 -----~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 241 -----VLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp -----HHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred -----hhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 011111 2457889999999999999999999999988753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=308.67 Aligned_cols=231 Identities=29% Similarity=0.413 Sum_probs=183.0
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
.++|++.+.||+|+||.||+|+..+++.||||.+... ....+.+.+|++++++++||||++.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCC
Confidence 4678999999999999999999888889999999754 3356789999999999999998730
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~- 166 (279)
T 1qpc_A 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA- 166 (279)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC-
T ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccccc-
Confidence 01125788899999999999999999998 9999999999999999999999999998765432221
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 593 (676)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+.. ...
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~-----~~~--- 231 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------VIQNLERGYR-----MVR--- 231 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC-----CCC---
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-------HHHHHhcccC-----CCC---
Confidence 122456788999999998899999999999999999999 899987543211 1112222211 111
Q ss_pred CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCC
Q 005803 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMA 633 (676)
Q Consensus 594 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 633 (676)
+......+.+++.+||+.||++|||+.+|++.|+....+
T Consensus 232 -~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 112234578899999999999999999999999887533
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=304.04 Aligned_cols=230 Identities=25% Similarity=0.462 Sum_probs=178.5
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchh-------hHHHHHHHHHHHHccCCcccc----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQG-------IVEFKNEAKLIAKLQHTNLTD---------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~-------~~~~~~E~~~l~~l~H~niv~---------- 443 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++....... .+.+.+|+.++++++||||++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR 97 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence 468999999999999999999874 68999999986532221 267899999999999999973
Q ss_pred ---------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC-----eEEeccCcc
Q 005803 444 ---------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN-----PKISDFGMA 503 (676)
Q Consensus 444 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~-----vkL~DFGla 503 (676)
......+++..+..++.|++.||+|||+++ .+|+||||||+|||++.++. +||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~ 176 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176 (287)
T ss_dssp EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence 112346889999999999999999999875 34999999999999987776 999999999
Q ss_pred eeccccccccccceeeccCCccChhhhc--cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC
Q 005803 504 RTYAMNELEANTNRIVGTHGYMSPEYVM--NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK 581 (676)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~--~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 581 (676)
+.... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||........ ..... .....
T Consensus 177 ~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~-~~~~~ 246 (287)
T 4f0f_A 177 QQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINM-IREEG 246 (287)
T ss_dssp BCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHH-HHHSC
T ss_pred ccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHH-HhccC
Confidence 75432 223367899999999984 45688999999999999999999999976543221 11111 11111
Q ss_pred ccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 582 ALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 582 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
. .+.+ +......+.+++.+||+.||++|||+.||++.|+++
T Consensus 247 ~----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 L----RPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp C----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred C----CCCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1 1112 222334578899999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.80 Aligned_cols=229 Identities=28% Similarity=0.378 Sum_probs=172.1
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCC----chhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
.++|++.+.||+|+||.||+|+. .++.||||++.... ....+.+.+|+++++.++||||++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 36899999999999999999987 48899999986542 233567899999999999999873
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC--------CCCeEEeccCcce
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE--------QMNPKISDFGMAR 504 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~--------~~~vkL~DFGla~ 504 (676)
......+++..+..++.|++.||.|||+++..+|+||||||+|||++. ++.+||+|||++.
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp EECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 122456888999999999999999999998666899999999999986 6789999999998
Q ss_pred eccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccc
Q 005803 505 TYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584 (676)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (676)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ....... ....
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~~~-- 231 (271)
T 3dtc_A 165 EWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVA-MNKL-- 231 (271)
T ss_dssp ---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHH-TSCC--
T ss_pred cccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhh-cCCC--
Confidence 654322 22357899999999999999999999999999999999999999754311 1111111 1111
Q ss_pred cCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 585 LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 585 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
... .+......+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 232 --~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 --ALP----IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --CCC----CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111 1222334588899999999999999999999999863
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=304.20 Aligned_cols=237 Identities=19% Similarity=0.248 Sum_probs=176.8
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
++|++.++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999875 58999999997543 233467889999999999999983
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 156 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-- 156 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCccc--
Confidence 112356889999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccceeeccCCccChhhhccCC-CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCc------cccC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKA------LELM 586 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~------~~~~ 586 (676)
......||+.|+|||.+.+.. ++.++|||||||++|||++|..|+..... ................. ....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 223357899999999998765 89999999999999999999888643221 11111111111111000 0000
Q ss_pred C---------cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 587 D---------PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 587 d---------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+ ........+.....+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 000011112334567889999999999999999999863
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=305.52 Aligned_cols=236 Identities=20% Similarity=0.299 Sum_probs=173.9
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCc--hhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|+.++++++||||++.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999987899999999865432 234678899999999999999830
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........ .
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 156 (288)
T 1ob3_A 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--K 156 (288)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc--c
Confidence 12346888899999999999999999998 99999999999999999999999999976542211 1
Q ss_pred cceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC------cc--cc
Q 005803 515 TNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK------AL--EL 585 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~------~~--~~ 585 (676)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+ ............. .. ..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhcccc
Confidence 223578999999999976 458999999999999999999999997543211 1111111111100 00 00
Q ss_pred CCcccC-------CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 586 MDPTLD-------ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 586 ~d~~l~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.++... ..........+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111110 01111233457889999999999999999999863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=316.22 Aligned_cols=230 Identities=21% Similarity=0.315 Sum_probs=178.0
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcE----EEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQE----IAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~----VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
++|++.+.||+|+||.||+|+.. +++. ||+|.+.... ......+.+|+.++++++||||+..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence 57889999999999999999864 3443 7888875432 3344677899999999999999730
Q ss_pred --------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 445 --------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 11346888899999999999999999998 9999999999999999999999999998765544
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
.........++..|+|||.+.+..++.++|||||||++|||++ |+.||........ ......+.....
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~~~---- 238 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-------PDLLEKGERLAQ---- 238 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-------HHHHHTTCBCCC----
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-------HHHHHcCCCCCC----
Confidence 3333444678889999999999999999999999999999999 9999986443221 112222211111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+......+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus 239 -----~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 239 -----PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -----CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -----CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111223677888999999999999999999998875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.66 Aligned_cols=234 Identities=24% Similarity=0.364 Sum_probs=178.1
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++.+++||||+.
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999865 5899999998543 2334567899999999999999973
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 111245788999999999999999999998 99999999999999999999999999986543321
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .......... ... ...
T Consensus 167 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~-~~~-----~~~ 233 (294)
T 4eqm_A 167 -TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQD-SVP-----NVT 233 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSS-CCC-----CHH
T ss_pred -cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhc-cCC-----Ccc
Confidence 222336799999999999999999999999999999999999999975321 1111111111 111 011
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCC-CHHHHHHHHhcCc
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRR-TMSDVVSMLTNDT 631 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP-s~~eVl~~Le~~~ 631 (676)
..........+.+++.+||+.||++|| +++++.+.|+...
T Consensus 234 ~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 234 TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 111222334578899999999999998 9999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.69 Aligned_cols=235 Identities=23% Similarity=0.358 Sum_probs=184.6
Q ss_pred HHHhcCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc-------
Q 005803 379 AAATDNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS------- 444 (676)
Q Consensus 379 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~------- 444 (676)
....++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 335688999999999999999999874 34789999997643 3345678999999999999998720
Q ss_pred ---------c----------------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeec
Q 005803 445 ---------S----------------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRD 481 (676)
Q Consensus 445 ---------~----------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~D 481 (676)
. ....+++.+++.++.||++||.|||+++ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 0 0146888999999999999999999998 99999
Q ss_pred cccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCC
Q 005803 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGS 560 (676)
Q Consensus 482 LKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~ 560 (676)
|||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999986544333233334567889999999999999999999999999999999 9999975
Q ss_pred CCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcC
Q 005803 561 YDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTM 632 (676)
Q Consensus 561 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 632 (676)
.... ........+.... . +......+.+++.+||+.||++||++.+|++.|+++..
T Consensus 280 ~~~~-------~~~~~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 280 MAHE-------EVIYYVRDGNILA-----C----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SCHH-------HHHHHHHTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CChH-------HHHHHHhCCCcCC-----C----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 3221 1122222222211 1 12223457889999999999999999999999998863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.62 Aligned_cols=232 Identities=25% Similarity=0.373 Sum_probs=182.9
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc---------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS--------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~--------- 444 (676)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3568999999999999999999852 35789999997543 3445778999999999999999830
Q ss_pred -------c----------------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccc
Q 005803 445 -------S----------------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLK 483 (676)
Q Consensus 445 -------~----------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLK 483 (676)
. ....+++..++.++.||+.||.|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 0 0123788899999999999999999998 9999999
Q ss_pred cCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCC
Q 005803 484 VSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYD 562 (676)
Q Consensus 484 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~ 562 (676)
|+|||++.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987654433333333567888999999999999999999999999999999 999997544
Q ss_pred CCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 563 TERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 563 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
... + ......+... . .+......+.+++.+||+.||++||++.||++.|+++.
T Consensus 258 ~~~---~----~~~~~~~~~~-----~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 258 PER---L----FNLLKTGHRM-----E----RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GGG---H----HHHHHTTCCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH---H----HHHhhcCCcC-----C----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 322 1 1122222111 1 11223345788999999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.42 Aligned_cols=242 Identities=20% Similarity=0.236 Sum_probs=185.7
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
.++|++.+.||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||++.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3679999999999999999998764 8999999997543 3345678899999999999998731
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE----cCCCCeEEeccCcce
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL----DEQMNPKISDFGMAR 504 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl----~~~~~vkL~DFGla~ 504 (676)
.....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 01122889999999999999999999998 9999999999999 778889999999998
Q ss_pred eccccccccccceeeccCCccChhhhc--------cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHH
Q 005803 505 TYAMNELEANTNRIVGTHGYMSPEYVM--------NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQL 576 (676)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~Y~APE~~~--------~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~ 576 (676)
....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||.......... ......
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~ 239 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMYKI 239 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH--HHHHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH--HHHHHH
Confidence 7654322 22357899999999986 5778999999999999999999999997554332221 111222
Q ss_pred HhcCC---cccc---C--------CcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 577 WNEGK---ALEL---M--------DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 577 ~~~~~---~~~~---~--------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
..... .... . +..............+.+++.+||+.||++|||++|+++..+...
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11110 0000 0 011122345567778889999999999999999999999987654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=332.42 Aligned_cols=229 Identities=24% Similarity=0.372 Sum_probs=183.2
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
.++|++.++||+|+||.||+|++.. ++.||||+++.. ....++|.+|+.++++++||||++
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4568889999999999999999765 889999999764 345678999999999999999972
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 012345788899999999999999999998 999999999999999999999999999876433221
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
. .....++..|+|||.+.+..++.++|||||||++|||++ |+.||....... . ......+..
T Consensus 375 ~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~--------- 437 (495)
T 1opk_A 375 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---V----YELLEKDYR--------- 437 (495)
T ss_dssp C-CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H----HHHHHTTCC---------
T ss_pred e-cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCC---------
Confidence 1 122446778999999999999999999999999999999 999997654221 1 112222111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
...+......+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1112233356788999999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=304.06 Aligned_cols=240 Identities=18% Similarity=0.208 Sum_probs=186.3
Q ss_pred HhcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ...++.+|+.++++++|++++.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999986 568999999986543 3356899999999999988541
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE---cCCCCeEEeccCcceecccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL---DEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl---~~~~~vkL~DFGla~~~~~~ 509 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 85 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 012346889999999999999999999998 9999999999999 48889999999999876543
Q ss_pred cccc-----ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccc
Q 005803 510 ELEA-----NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584 (676)
Q Consensus 510 ~~~~-----~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (676)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 239 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-- 239 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH--
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch--
Confidence 2211 123467999999999999999999999999999999999999999876544433332222211111110
Q ss_pred cCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCC
Q 005803 585 LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMAL 634 (676)
Q Consensus 585 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l 634 (676)
+.+...+ ...+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 240 ---~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 240 ---EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ---HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ---HHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 0111112 245788999999999999999999999999875433
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=323.42 Aligned_cols=231 Identities=25% Similarity=0.379 Sum_probs=169.9
Q ss_pred hcCCCcceeeccCCCccEEEEEEc----CCcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL----DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~----~~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
.++|++.+.||+|+||.||+|+.. ++..||||+++.. .....+++.+|+.++++++||||++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 358999999999999999999864 4778999999754 3344567999999999999999972
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 012235888999999999999999999998 999999999999999999999999999876543
Q ss_pred cccc-ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 510 ELEA-NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 510 ~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
.... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||....... .......+.
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------~~~~i~~~~------ 267 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------VIKAVDEGY------ 267 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-------HHHHHHTTE------
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC------
Confidence 2111 1112345678999999999999999999999999999998 999997543211 111121111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
....+......+.+++.+||+.||++||++.+|+++|+.+.
T Consensus 268 ---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 268 ---RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp ---ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 11112233456888999999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=303.63 Aligned_cols=224 Identities=21% Similarity=0.273 Sum_probs=170.5
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--------------------------hhhHHHHHHHHHHH
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--------------------------QGIVEFKNEAKLIA 434 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--------------------------~~~~~~~~E~~~l~ 434 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999865 588999999865421 12356899999999
Q ss_pred HccCCcccc---------------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCce
Q 005803 435 KLQHTNLTD---------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNI 487 (676)
Q Consensus 435 ~l~H~niv~---------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NI 487 (676)
+++||||++ ......+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Ni 168 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNL 168 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHE
Confidence 999999872 112345789999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCC---CCchhHHHHHHHHHHHHHhCCcCCCCCCCC
Q 005803 488 LLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGI---VSMKSDVYSFGVLVLEIVSSKKNNGSYDTE 564 (676)
Q Consensus 488 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---~s~ksDVwSlGvvl~elltG~~pf~~~~~~ 564 (676)
|++.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.....
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~- 245 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI- 245 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred EECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH-
Confidence 999999999999999987653321 123357899999999987654 47899999999999999999999964321
Q ss_pred CccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 565 RPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 565 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.. ........... ..... .....+.+++.+||+.||++|||+.|+++
T Consensus 246 -----~~-~~~~~~~~~~~----~~~~~----~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 -----MC-LHSKIKSQALE----FPDQP----DIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -----HH-HHHHHHHCCCC----CCSSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----HH-HHHHHhcccCC----CCCcc----ccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 11 11111111111 00111 22345788999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.05 Aligned_cols=226 Identities=22% Similarity=0.299 Sum_probs=170.5
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccC--CchhhHHHHHHHHHHHHcc--CCccccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQ--HTNLTDS-------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~--H~niv~~-------------- 444 (676)
++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ ||||+..
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999999888999999998654 2345577899999999997 4898731
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++.+.......
T Consensus 136 E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 136 ECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp ECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 12245778889999999999999999998 99999999999996 5789999999998765433322
Q ss_pred ccceeeccCCccChhhhcc-----------CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCc
Q 005803 514 NTNRIVGTHGYMSPEYVMN-----------GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKA 582 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~-----------~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~ 582 (676)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .........
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~----- 281 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII----- 281 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHH-----
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHh-----
Confidence 3344679999999999875 4689999999999999999999999964321 111111111
Q ss_pred cccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 583 LELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 583 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
++......+......+.+++.+||+.||++|||+.||++.
T Consensus 282 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 ----DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ----CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111111111123457788999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=310.13 Aligned_cols=237 Identities=22% Similarity=0.333 Sum_probs=175.1
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc----CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccc---------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL----DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDS--------- 444 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~----~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~--------- 444 (676)
...++|.+.+.||+|+||.||+|+.. .++.||||++... .....+.+.+|+.++++++||||++.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 35578999999999999999999754 2458999998754 23345678999999999999998731
Q ss_pred ----------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeE
Q 005803 445 ----------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPK 496 (676)
Q Consensus 445 ----------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vk 496 (676)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 12245788999999999999999999998 99999999999999999999
Q ss_pred EeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHH
Q 005803 497 ISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQ 575 (676)
Q Consensus 497 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~ 575 (676)
|+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||....... . ..
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----~~ 260 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---M----YD 260 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H----HH
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---H----HH
Confidence 999999987654332222333567889999999999999999999999999999999 888987543221 1 11
Q ss_pred HHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCC
Q 005803 576 LWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALP 635 (676)
Q Consensus 576 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~ 635 (676)
....+.. +.. +......+.+++.+||+.||++|||+.+|++.|+.+...+|
T Consensus 261 ~~~~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 261 YLLHGHR-----LKQ----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHTTCC-----CCC----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHcCCC-----CCC----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1112211 111 12223457889999999999999999999999998765444
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=315.36 Aligned_cols=236 Identities=23% Similarity=0.351 Sum_probs=181.3
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccC-CchhhHHHHHHHHHHHHc-cCCccccc--------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNLTDS-------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~-------- 444 (676)
..++|.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++.++ +||||+..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4578999999999999999999852 3568999999754 234457799999999999 89998720
Q ss_pred --------------------cc---------------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccc
Q 005803 445 --------------------SR---------------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLK 483 (676)
Q Consensus 445 --------------------~~---------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLK 483 (676)
.. ...+++..++.++.||+.||.|||+++ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 00 123788899999999999999999998 9999999
Q ss_pred cCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCC
Q 005803 484 VSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYD 562 (676)
Q Consensus 484 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~ 562 (676)
|+|||++.++.+||+|||++................||+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654433333344667889999999999999999999999999999998 999997654
Q ss_pred CCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCC
Q 005803 563 TERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMAL 634 (676)
Q Consensus 563 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l 634 (676)
.... .......+.. .. .+......+.+++.+||+.||.+|||+.+|++.|+......
T Consensus 280 ~~~~------~~~~~~~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 280 VDAN------FYKLIQNGFK-----MD----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CSHH------HHHHHHTTCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cHHH------HHHHHhcCCC-----CC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 3221 1122222211 11 11222345788999999999999999999999999876433
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=306.20 Aligned_cols=230 Identities=23% Similarity=0.364 Sum_probs=183.8
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
..++|++.+.||+|+||.||+|.... ++.||||++.. .....+.+.+|+.++++++||||+.
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS-CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45789999999999999999999764 88999999975 3445678999999999999999872
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 112345888999999999999999999998 99999999999999999999999999986554322
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
. ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ ........ ...
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~-------~~~~~~~~-----~~~- 232 (288)
T 3kfa_A 167 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKDY-----RME- 232 (288)
T ss_dssp E-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------HHHHHTTC-----CCC-
T ss_pred c-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhccC-----CCC-
Confidence 1 2223567889999999999999999999999999999999 9999975432221 11111111 111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.+......+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 233 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 233 ---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 12223345788999999999999999999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=314.86 Aligned_cols=223 Identities=22% Similarity=0.327 Sum_probs=177.1
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++++. .......+.+|+.+++.++||||+.
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 368999999999999999999875 5899999999753 2344567899999999999999973
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence 112345788889999999999999999998 9999999999999999999999999998643222
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .......+.. .+
T Consensus 160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~-~~~~i~~~~~------~~- 224 (337)
T 1o6l_A 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------R-LFELILMEEI------RF- 224 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCC------CC-
T ss_pred -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCC------CC-
Confidence 1233468999999999999999999999999999999999999999743211 1 1111111111 11
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRR-----TMSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~ 626 (676)
+......+.+++.+||+.||++|| +++||++.
T Consensus 225 ---p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 ---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 112234577889999999999999 89999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.87 Aligned_cols=237 Identities=22% Similarity=0.300 Sum_probs=173.5
Q ss_pred HhcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCC-----chhhHHHHHHHHHHHHcc---CCccccc-------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSS-----GQGIVEFKNEAKLIAKLQ---HTNLTDS------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~~------- 444 (676)
.+++|++.++||+|+||.||+|+. .+++.||||++.... ......+.+|+.+++++. ||||++.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999986 468999999986432 122346778888877775 9998731
Q ss_pred -------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEec
Q 005803 445 -------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISD 499 (676)
Q Consensus 445 -------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~D 499 (676)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEee
Confidence 11123889999999999999999999998 99999999999999999999999
Q ss_pred cCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhc
Q 005803 500 FGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNE 579 (676)
Q Consensus 500 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 579 (676)
||++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ...........
T Consensus 164 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~ 237 (308)
T 3g33_A 164 FGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGL 237 (308)
T ss_dssp CSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHHCC
T ss_pred CccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCC
Confidence 99998654322 2233678999999999999999999999999999999999999997543221 11111111110
Q ss_pred CC---cccc---CCcccCC-------CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 580 GK---ALEL---MDPTLDE-------SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 580 ~~---~~~~---~d~~l~~-------~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.. .... ....... ...++....+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00 0000 0000000 0011233467889999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=305.05 Aligned_cols=230 Identities=20% Similarity=0.293 Sum_probs=170.3
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC----CcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD----GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~----~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
.++|++.+.||+|+||.||+|+... +..||||++.... ....+.+.+|+.++++++||||++.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv 93 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 93 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEE
Confidence 4689999999999999999998643 4579999987543 3345678999999999999998730
Q ss_pred --------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 445 --------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCccc
Confidence 11235888999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
.. ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ .. .....+... .
T Consensus 171 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~----~~i~~~~~~-----~ 237 (281)
T 1mp8_A 171 YY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI----GRIENGERL-----P 237 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTCCC-----C
T ss_pred cc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HH----HHHHcCCCC-----C
Confidence 21 1222456788999999999999999999999999999997 999997543322 11 111122111 1
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+ +......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 238 ~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 238 M----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 1223345788999999999999999999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=315.56 Aligned_cols=186 Identities=25% Similarity=0.345 Sum_probs=157.8
Q ss_pred CcCccccHHHHHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHcc-----CCcc
Q 005803 368 RDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-----HTNL 441 (676)
Q Consensus 368 ~~~~~f~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~-----H~ni 441 (676)
.+...|++++.....++|++.++||+|+||.||+|+.. +++.||||++.. .......+..|+.+++++. ||||
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 45566777777778899999999999999999999874 589999999965 3345567788999999997 9998
Q ss_pred ccc---------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC---
Q 005803 442 TDS---------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE--- 491 (676)
Q Consensus 442 v~~---------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~--- 491 (676)
+.. .....+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp CCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred ecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 731 11234888999999999999999999998 999999999999975
Q ss_pred ----------------------CCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHH
Q 005803 492 ----------------------QMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVL 549 (676)
Q Consensus 492 ----------------------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ 549 (676)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 788999999999864322 23367899999999999999999999999999999
Q ss_pred HHHhCCcCCCCCC
Q 005803 550 EIVSSKKNNGSYD 562 (676)
Q Consensus 550 elltG~~pf~~~~ 562 (676)
||++|+.||....
T Consensus 251 ell~g~~pf~~~~ 263 (360)
T 3llt_A 251 ELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHSSCSCCCSS
T ss_pred HHHHCCCCCCCCc
Confidence 9999999997543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=312.88 Aligned_cols=237 Identities=23% Similarity=0.260 Sum_probs=167.9
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHcc-CCccccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLTDS-------------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~~-------------- 444 (676)
...+|++.++||+|+||.||+|+.. +++.||||++..........+.+|+.++.++. ||||++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3457999999999999999999865 68999999987766666778999999999996 9998731
Q ss_pred ----------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCc
Q 005803 445 ----------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGM 502 (676)
Q Consensus 445 ----------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGl 502 (676)
.....+++..++.++.||+.||.|||+++ .+|+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 11245888999999999999999999875 3499999999999999999999999999
Q ss_pred ceeccccccc----------cccceeeccCCccChhhh---ccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccch
Q 005803 503 ARTYAMNELE----------ANTNRIVGTHGYMSPEYV---MNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNL 569 (676)
Q Consensus 503 a~~~~~~~~~----------~~~~~~~gt~~Y~APE~~---~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l 569 (676)
+......... .......||+.|+|||.+ .+..++.++|||||||++|||++|+.||........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--- 261 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI--- 261 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh---
Confidence 9875432211 111135689999999998 566789999999999999999999999964322110
Q ss_pred HHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCCCC
Q 005803 570 VGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKP 637 (676)
Q Consensus 570 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~~p 637 (676)
..+.. ...... .....+.+++.+||+.||++|||+.|+++.|+.+....+.+
T Consensus 262 --------~~~~~----~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 262 --------VNGKY----SIPPHD----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp ------------C----CCCTTC----CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred --------hcCcc----cCCccc----ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 00001 001111 11223678889999999999999999999998876444333
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=308.62 Aligned_cols=233 Identities=20% Similarity=0.236 Sum_probs=178.7
Q ss_pred hcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~---------------- 444 (676)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||++.
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999987 4689999999877666677889999999999999998731
Q ss_pred ------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceec
Q 005803 445 ------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTY 506 (676)
Q Consensus 445 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~ 506 (676)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 01345888999999999999999999998 999999999999999999999999998764
Q ss_pred cccccc-------cccceeeccCCccChhhhccCC---CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHH
Q 005803 507 AMNELE-------ANTNRIVGTHGYMSPEYVMNGI---VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQL 576 (676)
Q Consensus 507 ~~~~~~-------~~~~~~~gt~~Y~APE~~~~~~---~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~ 576 (676)
...... .......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||......... .. ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~----~~ 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VA----LA 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HH----HH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hh----HH
Confidence 322111 0112245799999999987554 789999999999999999999998532111100 00 01
Q ss_pred HhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 577 WNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 577 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
... .. ...........+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 260 ~~~-~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 260 VQN-QL--------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHC-C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hhc-cC--------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 111 00 00111222345888999999999999999999999999886
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=323.61 Aligned_cols=223 Identities=24% Similarity=0.332 Sum_probs=178.5
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
.++|++.+.||+|+||.||+|+.. ++.||||+++... ..+.|.+|+.++++++||||++.
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467889999999999999999874 7899999997643 56789999999999999999730
Q ss_pred ------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 445 ------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 445 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
.....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 11123688889999999999999999998 999999999999999999999999999854321
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+. ......+... .
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-------~~~i~~~~~~-----~-- 406 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGYKM-----D-- 406 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH-------HHHHHTTCCC-----C--
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCCC-----C--
Confidence 112356889999999999999999999999999999998 9999986544321 1122222111 1
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.+......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 407 --~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 407 --APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 12223346788999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.09 Aligned_cols=232 Identities=23% Similarity=0.362 Sum_probs=182.9
Q ss_pred hcCCCcceeeccCCCccEEEEEE------cCCcEEEEEEeccCCc-hhhHHHHHHHHHHHHc-cCCccccc---------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL------LDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKL-QHTNLTDS--------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~------~~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~--------- 444 (676)
.++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++.++ +||||++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999984 2467899999976433 3457789999999999 99998720
Q ss_pred -------------------cc----------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE
Q 005803 445 -------------------SR----------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL 489 (676)
Q Consensus 445 -------------------~~----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl 489 (676)
.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 00 114889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccc
Q 005803 490 DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLN 568 (676)
Q Consensus 490 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~ 568 (676)
+.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence 9999999999999987654433333334567889999999999999999999999999999999 9999976543211
Q ss_pred hHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 569 LVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 569 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.......+. .... +......+.+++.+||+.||.+|||+.||++.|++..
T Consensus 257 ----~~~~~~~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 257 ----FYKMIKEGF-----RMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp ----HHHHHHHTC-----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHhccCC-----CCCC----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111121111 1111 1222345788999999999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=309.11 Aligned_cols=237 Identities=21% Similarity=0.309 Sum_probs=162.2
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999865 58999999997543 2344678899999999999999830
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 84 FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred ecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 01134788889999999999999999998 99999999999999999999999999987543
Q ss_pred cccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC--c---
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK--A--- 582 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~--~--- 582 (676)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ............ .
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 161 PVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp CCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCGG
T ss_pred Ccc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhhh
Confidence 221 1223578999999999976 4689999999999999999999999975432211 111111110000 0
Q ss_pred -cc--cCCcccC------------CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 583 -LE--LMDPTLD------------ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 583 -~~--~~d~~l~------------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.. ...+.+. ..........+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00 0000000 00011123457889999999999999999998763
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=314.06 Aligned_cols=248 Identities=17% Similarity=0.170 Sum_probs=182.1
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcC------CcEEEEEEeccCCchh-----------hHHHHHHHHHHHHccCCcccc
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLD------GQEIAIKRLSKSSGQG-----------IVEFKNEAKLIAKLQHTNLTD 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~------~~~VAvK~l~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~ 443 (676)
..++|++.++||+|+||.||+|++.. ++.||||++....... ...+..|+..+..++|+||+.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998754 4789999986543211 112344556677778999873
Q ss_pred c------------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc--C
Q 005803 444 S------------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD--E 491 (676)
Q Consensus 444 ~------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~--~ 491 (676)
. .....+++..++.++.||+.||.|||+++ |+||||||+|||++ .
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSC
T ss_pred EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCC
Confidence 1 11256899999999999999999999998 99999999999999 8
Q ss_pred CCCeEEeccCcceecccccccc-----ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCc
Q 005803 492 QMNPKISDFGMARTYAMNELEA-----NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERP 566 (676)
Q Consensus 492 ~~~vkL~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~ 566 (676)
++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~- 268 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP- 268 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH-
Confidence 8999999999998765432211 1123459999999999999999999999999999999999999998533221
Q ss_pred cchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCCCC
Q 005803 567 LNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKP 637 (676)
Q Consensus 567 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~~p 637 (676)
.......... ...+.+++++.+... .....+.+++..||+.||.+||++.+|++.|+.....+..+
T Consensus 269 -~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 269 -KYVRDSKIRY-RENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp -HHHHHHHHHH-HHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred -HHHHHHHHHh-hhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 1111111111 122333333333211 12235778888999999999999999999998876444433
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=324.74 Aligned_cols=239 Identities=23% Similarity=0.233 Sum_probs=174.2
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDSS------------- 445 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~------------- 445 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+++.+|+.+++.++||||++..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 568999999999999999999865 5899999999754 334466788999999999999998411
Q ss_pred ----------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 446 ----------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 446 ----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 0123778889999999999999999998 999999999999999999999999999865432
Q ss_pred ccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH----------------H
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY----------------A 573 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~----------------~ 573 (676)
. .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......+....+.. .
T Consensus 218 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 218 F---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp C---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred c---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 1 23346899999999999999999999999999999999999999976432211111000 0
Q ss_pred HHHHhcCC-c-----cccCCcccCCC---CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 574 WQLWNEGK-A-----LELMDPTLDES---CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 574 ~~~~~~~~-~-----~~~~d~~l~~~---~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
........ . ...+...+... ........+.+|+.+||+.||++|||++|+++.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 0 00000000000 001124568899999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=313.48 Aligned_cols=222 Identities=19% Similarity=0.257 Sum_probs=176.4
Q ss_pred hcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.+++.++||||++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999996 468999999986531 223457899999999999999983
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 88 ~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 88 IEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred EECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence 112345888999999999999999999998 9999999999999999999999999998654332
Q ss_pred cccceeeccCCccChhhhccCCC-CchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||........... +... .
T Consensus 163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~---------------i~~~--~ 224 (336)
T 3h4j_B 163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK---------------VNSC--V 224 (336)
T ss_dssp -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC---------------CCSS--C
T ss_pred -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH---------------HHcC--C
Confidence 2233579999999999988776 7899999999999999999999975433221110 0000 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
...+......+.+++.+||+.||.+|||++|+++.
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 01122223457789999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=301.02 Aligned_cols=228 Identities=26% Similarity=0.360 Sum_probs=180.7
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
++|++.+.||+|+||.||+|+..+++.||||++.... ...+.+.+|+.++++++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 5788999999999999999998888999999997643 34568999999999999999872
Q ss_pred --------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 444 --------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 444 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
......+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... ..
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SS 162 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-ST
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc-cc
Confidence 011245788899999999999999999998 999999999999999999999999999865432211 11
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... . .......+.. ...
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~-~~~~i~~~~~-----~~~---- 226 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------E-VVEDISTGFR-----LYK---- 226 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHHHTTCC-----CCC----
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------H-HHHHHhcCCc-----CCC----
Confidence 22456778999999998999999999999999999999 89998753211 1 1112222211 111
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+......+.+++.+||+.||++||++.++++.|+++.
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1122345778999999999999999999999998764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=320.64 Aligned_cols=241 Identities=20% Similarity=0.314 Sum_probs=168.8
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHcc-CCccccc-----------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQ-HTNLTDS----------- 444 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~-H~niv~~----------- 444 (676)
...++|++.+.||+|+||.||+|... +++.||||++... ......++.+|+.++.++. ||||+..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45679999999999999999999864 5899999998643 3344567889999999997 9999731
Q ss_pred ---------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 445 ---------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 445 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
.....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 86 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 86 VYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 11245778888999999999999999998 999999999999999999999999999865321
Q ss_pred c-------------------cccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccch
Q 005803 510 E-------------------LEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNL 569 (676)
Q Consensus 510 ~-------------------~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l 569 (676)
. ........+||+.|+|||++.+ ..++.++|||||||++|||++|++||...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0 1112234689999999999986 6799999999999999999999999976432221111
Q ss_pred HHHHHHHHhcCCccc---cC------------------CcccCCC------------CChHHHHHHHHHHHHhcccCcCC
Q 005803 570 VGYAWQLWNEGKALE---LM------------------DPTLDES------------CSSDEVMRCIHVGLLCVQDRAAD 616 (676)
Q Consensus 570 ~~~~~~~~~~~~~~~---~~------------------d~~l~~~------------~~~~~~~~l~~L~~~Cl~~dP~~ 616 (676)
............ +. ....... ........+.+|+.+||+.||++
T Consensus 243 ---i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 243 ---IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp ---HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred ---HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 111000000000 00 0000000 00012345788999999999999
Q ss_pred CCCHHHHHHH
Q 005803 617 RRTMSDVVSM 626 (676)
Q Consensus 617 RPs~~eVl~~ 626 (676)
|||++|+++.
T Consensus 320 R~t~~e~l~H 329 (388)
T 3oz6_A 320 RISANDALKH 329 (388)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhCC
Confidence 9999999876
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=309.62 Aligned_cols=237 Identities=24% Similarity=0.391 Sum_probs=185.1
Q ss_pred HHHHHHhcCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCccccc----
Q 005803 376 QTIAAATDNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTDS---- 444 (676)
Q Consensus 376 ~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~~---- 444 (676)
++.....++|++.+.||+|+||.||+|+.. +++.||||.+..... ....++.+|+.++++++||||+..
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344456688999999999999999999754 367899999975432 345578999999999999998720
Q ss_pred ------------c--------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC
Q 005803 445 ------------S--------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ 492 (676)
Q Consensus 445 ------------~--------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~ 492 (676)
. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence 0 0134578888999999999999999998 9999999999999999
Q ss_pred CCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHH
Q 005803 493 MNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVG 571 (676)
Q Consensus 493 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~ 571 (676)
+.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------- 247 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------- 247 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-------
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-------
Confidence 9999999999986554433333334567889999999999999999999999999999999 88998754221
Q ss_pred HHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 572 YAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 572 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
........+.... .+......+.+++.+||+.||.+|||+.|+++.|++..
T Consensus 248 ~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 248 QVLRFVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 1112222222211 11222345788999999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=302.06 Aligned_cols=231 Identities=23% Similarity=0.318 Sum_probs=177.7
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcC----CcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCccccc-----------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLD----GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTDS----------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~----~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~~----------- 444 (676)
..++|.+.+.||+|+||.||+|+... +..||||.+... .....+.+.+|+.++++++||||++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI 89 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEE
Confidence 34689999999999999999998543 346999998764 23456779999999999999999731
Q ss_pred ---------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 445 ---------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 445 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 11234788889999999999999999998 999999999999999999999999999865443
Q ss_pred ccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .. .....+...
T Consensus 167 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~----~~~~~~~~~----- 233 (281)
T 3cc6_A 167 DYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VI----GVLEKGDRL----- 233 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HH----HHHHHTCCC-----
T ss_pred ccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HH----HHHhcCCCC-----
Confidence 221 1222456788999999999999999999999999999998 999997543322 11 111111111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.. +......+.+++.+||+.||++||++.||++.|+.+.
T Consensus 234 ~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 234 PK----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 11 1112345788999999999999999999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=308.71 Aligned_cols=225 Identities=20% Similarity=0.252 Sum_probs=177.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
.++|++.+.||+|+||.||+|+.. +++.||+|.+... ......+.+|+.++++++||||++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 578999999999999999999875 5889999998653 345567899999999999999972
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC--CCCeEEeccCcceecccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE--QMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~--~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 112235889999999999999999999998 999999999999987 7899999999998765332
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+... .+....
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~--~~~~~~ 227 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYT--FDEEAF 227 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCC--CCHHHH
T ss_pred --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-------HHHHHHcCCCC--CChhhh
Confidence 2234678999999999999889999999999999999999999997533211 11111121111 011000
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
. .....+.+++.+||+.||.+|||+.|+++.
T Consensus 228 ~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 228 K----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 123457889999999999999999999974
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=309.92 Aligned_cols=240 Identities=25% Similarity=0.352 Sum_probs=173.7
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHH--HHHccCCcccccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKL--IAKLQHTNLTDSS-------------- 445 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~--l~~l~H~niv~~~-------------- 445 (676)
.++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.++ +..++|+||++..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46899999999999999999976 7899999999653 23344444444 5568999987311
Q ss_pred ----------------ccCcCCHHHHHHHHHHHHHHHHHHHhc---------CCCceEeeccccCceEEcCCCCeEEecc
Q 005803 446 ----------------RKSLLDWKKRFYIIEGIVQGLLYLHKY---------SRLRAIHRDLKVSNILLDEQMNPKISDF 500 (676)
Q Consensus 446 ----------------~~~~l~~~~~~~i~~qia~gL~yLH~~---------~~~~iiH~DLKp~NILl~~~~~vkL~DF 500 (676)
.....++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeec
Confidence 112356778889999999999999998 7 999999999999999999999999
Q ss_pred Ccceecccccc------ccccceeeccCCccChhhhcc-------CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCcc
Q 005803 501 GMARTYAMNEL------EANTNRIVGTHGYMSPEYVMN-------GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPL 567 (676)
Q Consensus 501 Gla~~~~~~~~------~~~~~~~~gt~~Y~APE~~~~-------~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~ 567 (676)
|+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 99987643221 111223468999999999986 45678999999999999999998776543322211
Q ss_pred c-hH----------HHHHHHHhcCCccccCCcccCCC--CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcC
Q 005803 568 N-LV----------GYAWQLWNEGKALELMDPTLDES--CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTM 632 (676)
Q Consensus 568 ~-l~----------~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 632 (676)
. .. ............ .+.+... ........+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 1 00 000111111111 1111111 123456679999999999999999999999999998763
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=316.98 Aligned_cols=246 Identities=24% Similarity=0.307 Sum_probs=180.1
Q ss_pred CCcceeeccCCCccEEEEEEc-----CCcEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 385 FSPANRLGQGGFGPVYNGKLL-----DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~-----~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
|++.++||+|+||.||++... +++.||||++..... ...+.+.+|++++++++||||+.
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999988642 588999999976532 44567899999999999999873
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp EECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 112234788999999999999999999998 99999999999999999999999999987654322
Q ss_pred c-cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 512 E-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 512 ~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
. .......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ................+.++...
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELLERGE 268 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHHHTTC
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHHhccc
Confidence 1 122335678889999999999999999999999999999999999864211000 00000000000000011111111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCC
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMAL 634 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l 634 (676)
....+......+.+++.+||+.||++|||+.||++.|+.+.+.+
T Consensus 269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 11122233456888999999999999999999999999876443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=308.94 Aligned_cols=226 Identities=21% Similarity=0.300 Sum_probs=176.6
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCch------hhHHHHHHHHHHHHccCCcccc-----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQ------GIVEFKNEAKLIAKLQHTNLTD----------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~----------- 443 (676)
.++|.+.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++||||+.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457999999999999999999875 5899999998754321 3567899999999999999972
Q ss_pred ---------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC----CeEEeccCcce
Q 005803 444 ---------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM----NPKISDFGMAR 504 (676)
Q Consensus 444 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~----~vkL~DFGla~ 504 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++.
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 122345888999999999999999999998 99999999999999887 79999999998
Q ss_pred eccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccc
Q 005803 505 TYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584 (676)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (676)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...........
T Consensus 167 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~~~~~~~~- 235 (326)
T 2y0a_A 167 KIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNYE- 235 (326)
T ss_dssp ECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHTCCC-
T ss_pred ECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-------HHHHHHhcCCC-
Confidence 764322 1233579999999999999999999999999999999999999996432111 11111111110
Q ss_pred cCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 585 LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 585 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
....... .....+.+++.+||+.||++|||+.|+++.
T Consensus 236 -~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 -FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -CCHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -cCccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0011111 122457788999999999999999999974
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=309.53 Aligned_cols=241 Identities=25% Similarity=0.369 Sum_probs=187.0
Q ss_pred ccHHHHHHHhcCCCcceeeccCCCccEEEEEE------cCCcEEEEEEeccCCc-hhhHHHHHHHHHHHHc-cCCccccc
Q 005803 373 FDFQTIAAATDNFSPANRLGQGGFGPVYNGKL------LDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKL-QHTNLTDS 444 (676)
Q Consensus 373 f~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~------~~~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~ 444 (676)
++..+.....++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.++.++ +||||+..
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455555678999999999999999999974 2468899999976433 3456789999999999 78998720
Q ss_pred ---------------------------cc----------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeec
Q 005803 445 ---------------------------SR----------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRD 481 (676)
Q Consensus 445 ---------------------------~~----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~D 481 (676)
.. ...+++..+..++.||+.||.|||+++ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 00 112778889999999999999999998 99999
Q ss_pred cccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCC
Q 005803 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGS 560 (676)
Q Consensus 482 LKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~ 560 (676)
|||+||+++.++.+||+|||++................||+.|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654333333334678899999999999999999999999999999998 9999975
Q ss_pred CCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 561 YDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 561 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
...... .......+... .... .....+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus 254 ~~~~~~------~~~~~~~~~~~-----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 254 VKIDEE------FCRRLKEGTRM-----RAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCCSHH------HHHHHHHTCCC-----CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchhHH------HHHHhccCccC-----CCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 433221 11222222211 1111 12345788899999999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=303.19 Aligned_cols=234 Identities=23% Similarity=0.340 Sum_probs=183.1
Q ss_pred cCCCcce-eeccCCCccEEEEEEc---CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 383 DNFSPAN-RLGQGGFGPVYNGKLL---DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 383 ~~y~~~~-~LG~G~fG~Vy~~~~~---~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
++|.+.+ .||+|+||.||+|... +++.||||+++... ....+++.+|+.++++++||||++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 88 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 88 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEE
Confidence 4566666 9999999999999753 57889999997643 345677999999999999999872
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 112345889999999999999999999998 99999999999999999999999999987643322
Q ss_pred c-cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 512 E-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 512 ~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+... .
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~i~~~~~~-----~ 233 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM-----E 233 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCC-----C
T ss_pred eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHhcCCcC-----C
Confidence 1 11222456889999999998899999999999999999998 999997543211 11222222211 1
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCC
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALP 635 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~ 635 (676)
.+......+.+++.+||+.||++||++.+|++.|+.+..+..
T Consensus 234 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 234 ----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp ----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 122333468889999999999999999999999988764433
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=306.31 Aligned_cols=241 Identities=15% Similarity=0.136 Sum_probs=173.6
Q ss_pred hcCCCcceeeccCCCccEEEEEEc----CCcEEEEEEeccCCch-----------hhHHHHHHHHHHHHccCCccccc--
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL----DGQEIAIKRLSKSSGQ-----------GIVEFKNEAKLIAKLQHTNLTDS-- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~----~~~~VAvK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~~-- 444 (676)
.++|.+.+.||+|+||.||+|+.. ++..||||++...... ....+.+|+..+..++||||+..
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999875 5788999998764322 12346678889999999998731
Q ss_pred ---------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC--Ce
Q 005803 445 ---------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM--NP 495 (676)
Q Consensus 445 ---------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~--~v 495 (676)
.....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++ .+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSE
T ss_pred ccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcE
Confidence 11236889999999999999999999998 99999999999999877 99
Q ss_pred EEeccCcceeccccccc-----cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchH
Q 005803 496 KISDFGMARTYAMNELE-----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLV 570 (676)
Q Consensus 496 kL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~ 570 (676)
||+|||+++.+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ..
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~ 270 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV--AV 270 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH--HH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH--HH
Confidence 99999999876533211 111345799999999999999999999999999999999999999964322111 11
Q ss_pred HHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 571 GYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 571 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
......... .....+...... ......+.+++.+||+.||++||++.+|++.|+...
T Consensus 271 ~~~~~~~~~-~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 271 QTAKTNLLD-ELPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHH-TTTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHhhcc-cccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111111111 111100000000 022335788899999999999999999999998875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=331.68 Aligned_cols=232 Identities=25% Similarity=0.402 Sum_probs=184.2
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
.++|++.++||+|+||.||+|++.++..||||+++... ...++|.+|+.+|++++|+||++.
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~~ 344 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 344 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehhc
Confidence 46788899999999999999999888889999997643 345789999999999999999731
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
.....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~- 420 (535)
T 2h8h_A 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA- 420 (535)
T ss_dssp TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT-
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec-
Confidence 11234788899999999999999999998 9999999999999999999999999998654322111
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 593 (676)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ .......+... .
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~~---------~ 484 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM---------P 484 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------HHHHHHTTCCC---------C
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC---------C
Confidence 122346778999999999999999999999999999999 999997543211 11222222111 1
Q ss_pred CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCC
Q 005803 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMAL 634 (676)
Q Consensus 594 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l 634 (676)
.+......+.+|+.+||+.||++|||+.+|++.|+......
T Consensus 485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 12233446788999999999999999999999999986433
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.25 Aligned_cols=219 Identities=22% Similarity=0.307 Sum_probs=166.9
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--hhhHHHHHHHHHHHHc-cCCccccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKL-QHTNLTDS-------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l-~H~niv~~-------------- 444 (676)
++|++.++||+|+||.||+|+.. +++.||||++..... ....++..|+..+.++ +|+||+..
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999976 699999999865322 2334455666666555 89999731
Q ss_pred ------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 445 ------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 445 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 137 e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-- 211 (311)
T 3p1a_A 137 ELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-- 211 (311)
T ss_dssp ECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred eccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCC--
Confidence 11245899999999999999999999998 9999999999999999999999999998754332
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
......||+.|+|||++.+ .++.++|||||||++|||++|..|+... ..+..+..+.. .+.+..
T Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~----~~~~~~ 275 (311)
T 3p1a_A 212 -AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYL----PPEFTA 275 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCC----CHHHHT
T ss_pred -CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCC----Cccccc
Confidence 2233568999999998875 7899999999999999999997766421 11222222211 111111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.....+.+++.+||+.||++|||++|+++.
T Consensus 276 ----~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 276 ----GLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----CCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 123457889999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=309.67 Aligned_cols=225 Identities=26% Similarity=0.323 Sum_probs=170.1
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccccc------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDSSR------------ 446 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~------------ 446 (676)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||++...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467999999999999999999976 69999999997543 335577999999999999999985211
Q ss_pred --------------------------------------------------------------------------cCcCCH
Q 005803 447 --------------------------------------------------------------------------KSLLDW 452 (676)
Q Consensus 447 --------------------------------------------------------------------------~~~l~~ 452 (676)
....++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 011233
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc----------cccceeeccC
Q 005803 453 KKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE----------ANTNRIVGTH 522 (676)
Q Consensus 453 ~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~----------~~~~~~~gt~ 522 (676)
..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 457889999999999999998 999999999999999999999999999876543211 1123357999
Q ss_pred CccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHH
Q 005803 523 GYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRC 602 (676)
Q Consensus 523 ~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 602 (676)
.|+|||.+.+..++.++|||||||++|||++|..|+.. ... ........... .........+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~-~~~~~~~~~~~---------~~~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVR-IITDVRNLKFP---------LLFTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHH-HHHHHHTTCCC---------HHHHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHH-HHHHhhccCCC---------cccccCChhH
Confidence 99999999999999999999999999999998765421 000 11111111110 0112333456
Q ss_pred HHHHHHhcccCcCCCCCHHHHHHH
Q 005803 603 IHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 603 ~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+++.+||+.||++|||+.|+++.
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 889999999999999999999873
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=314.18 Aligned_cols=226 Identities=22% Similarity=0.277 Sum_probs=177.6
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCch------hhHHHHHHHHHHHHccCCcccc----------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQ------GIVEFKNEAKLIAKLQHTNLTD---------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~---------- 443 (676)
..++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++||||+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4568999999999999999999875 5899999999764322 3467899999999999999972
Q ss_pred ----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC----CeEEeccCcc
Q 005803 444 ----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM----NPKISDFGMA 503 (676)
Q Consensus 444 ----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~----~vkL~DFGla 503 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 122346889999999999999999999998 99999999999998777 7999999999
Q ss_pred eeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 504 RTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+..+...
T Consensus 167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-------~~~~i~~~~~~ 236 (361)
T 2yab_A 167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANITAVSYD 236 (361)
T ss_dssp EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCCC
T ss_pred eEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhcCCC
Confidence 8765422 2234679999999999999999999999999999999999999997532111 11112121111
Q ss_pred ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 584 ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 584 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
+++.... .....+.+++.+||+.||++|||+.|+++
T Consensus 237 --~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 --FDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --CCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111111 12235778999999999999999999985
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=316.26 Aligned_cols=223 Identities=22% Similarity=0.340 Sum_probs=171.7
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHc-cCCcccc------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLTD------------ 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~------------ 443 (676)
..++|++.+.||+|+||.||+|+.. +++.||||++++. .......+.+|..++..+ +||||+.
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999875 5899999999753 233456688999999998 7999973
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 112345888899999999999999999998 999999999999999999999999999854322
Q ss_pred ccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......+...
T Consensus 178 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~~------ 242 (353)
T 3txo_A 178 G--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEVV------ 242 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC------
T ss_pred C--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC------
Confidence 2 22334689999999999999899999999999999999999999997543211 11222222111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCH------HHHHH
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTM------SDVVS 625 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~------~eVl~ 625 (676)
++......+.+++.+||+.||.+||++ .||++
T Consensus 243 ----~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 ----YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ----CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111223457788999999999999998 77765
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.66 Aligned_cols=223 Identities=23% Similarity=0.329 Sum_probs=175.8
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|++.+.||+|+||.||+++.. +++.||||++.+. .......+.+|+.++++++||||+.
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67999999999999999999875 4889999998653 2334567889999999999999983
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-- 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-- 169 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC--
Confidence 122346889999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccceeeccCCccChhhhcc---CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 513 ANTNRIVGTHGYMSPEYVMN---GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ ........
T Consensus 170 -~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~----~~~~~~~~------- 237 (384)
T 4fr4_A 170 -QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV----HTFETTVV------- 237 (384)
T ss_dssp -CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH----HHHHHCCC-------
T ss_pred -ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH----HHHhhccc-------
Confidence 2334689999999999874 45899999999999999999999999755433221111 11111111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCC-HHHHHH
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRT-MSDVVS 625 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-~~eVl~ 625 (676)
..+......+.+++.+||+.||.+||+ +++|++
T Consensus 238 ---~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ---TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 112222345788999999999999998 777765
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=309.41 Aligned_cols=252 Identities=19% Similarity=0.296 Sum_probs=176.5
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCch-hhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
++|++.++||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++||||+.
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999876 6899999998654322 2234568999999999999983
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........ .
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~ 156 (324)
T 3mtl_A 82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--T 156 (324)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--c
Confidence 112345888999999999999999999998 99999999999999999999999999986543221 2
Q ss_pred cceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc----
Q 005803 515 TNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT---- 589 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~---- 589 (676)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+ ........... ...+.....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~-~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGT-PTEETWPGILSNE 232 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC-CCTTTSTTGGGCH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCC-CChHhchhhhcch
Confidence 223578999999999876 568999999999999999999999997643222 11111111110 000000000
Q ss_pred ---------cCC----CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcCcCCCCCCCCCccc
Q 005803 590 ---------LDE----SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTNDTMALPKPKQPAFF 643 (676)
Q Consensus 590 ---------l~~----~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~~~~l~~p~~P~~~ 643 (676)
... ...+.....+.+++.+||+.||++|||++|+++. +.+........+.+..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~ 301 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSI 301 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCG
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcH
Confidence 000 0011123457789999999999999999999984 66655444443344333
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=309.05 Aligned_cols=231 Identities=24% Similarity=0.378 Sum_probs=180.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEc--------CCcEEEEEEeccCC-chhhHHHHHHHHHHHHc-cCCccccc-------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL--------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLTDS------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~--------~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~------- 444 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++++ +||||++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468999999999999999999863 46789999997543 33456789999999999 89998720
Q ss_pred ---------------------c--------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE
Q 005803 445 ---------------------S--------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL 489 (676)
Q Consensus 445 ---------------------~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl 489 (676)
. ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 0 0123788899999999999999999998 9999999999999
Q ss_pred cCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccc
Q 005803 490 DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLN 568 (676)
Q Consensus 490 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~ 568 (676)
+.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---- 266 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 266 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH----
Confidence 9999999999999987654433223333567788999999999999999999999999999999 99999754211
Q ss_pred hHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 569 LVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 569 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
........+... .. +......+.+++.+||+.||.+||++.||++.|+++.
T Consensus 267 ---~~~~~~~~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 267 ---ELFKLLKEGHRM-----DK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp ---HHHHHHHHTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHhcCCCC-----CC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111222222211 11 1222345788999999999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=313.38 Aligned_cols=229 Identities=21% Similarity=0.320 Sum_probs=174.4
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHc-cCCcccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL-QHTNLTD------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~------------- 443 (676)
.++|++.++||+|+||.||+|+.. +++.||||++++.. ......+.+|..++.++ +||||+.
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999976 47889999997642 23345688999999887 8999983
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 112346888999999999999999999998 9999999999999999999999999998532221
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCc--cchHHHHHHHHhcCCccccCCc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERP--LNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ................
T Consensus 208 --~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 279 (396)
T 4dc2_A 208 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 279 (396)
T ss_dssp --CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred --CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence 223447899999999999999999999999999999999999999975432211 1111112222222211
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCH------HHHHH
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTM------SDVVS 625 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~------~eVl~ 625 (676)
.+ +......+.+++.+||+.||++||++ +||++
T Consensus 280 ~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 280 RI----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred CC----CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 11 12223457789999999999999995 56654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=310.16 Aligned_cols=238 Identities=24% Similarity=0.349 Sum_probs=183.9
Q ss_pred cCCCcceeeccCCCccEEEEEE-----cCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKL-----LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~-----~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
++|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|++++++++||||+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788999999999999999984 3588999999987666667789999999999999998731
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
.....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 01234788899999999999999999998 99999999999999999999999999987653
Q ss_pred cccc-cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCC--------CccchHHHHHHHHhc
Q 005803 509 NELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTE--------RPLNLVGYAWQLWNE 579 (676)
Q Consensus 509 ~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~--------~~~~l~~~~~~~~~~ 579 (676)
.... .......||..|+|||.+.+..++.++|||||||++|||++|+.||...... ...............
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 3221 1223356788899999999999999999999999999999999998642110 000011111111111
Q ss_pred CCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcC
Q 005803 580 GKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTM 632 (676)
Q Consensus 580 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 632 (676)
+. ....+......+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 260 ~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 260 GQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred cc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11 111223334568889999999999999999999999998863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=320.13 Aligned_cols=169 Identities=24% Similarity=0.383 Sum_probs=130.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+++.+|+.+|++++||||+..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999865 5899999998653 23345678999999999999999831
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 11235888899999999999999999998 99999999999999999999999999987542
Q ss_pred cccc-------------------------cccceeeccCCccChhhhc-cCCCCchhHHHHHHHHHHHHHh
Q 005803 509 NELE-------------------------ANTNRIVGTHGYMSPEYVM-NGIVSMKSDVYSFGVLVLEIVS 553 (676)
Q Consensus 509 ~~~~-------------------------~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwSlGvvl~ellt 553 (676)
.... ......+||+.|+|||++. +..++.++|||||||++|||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 2110 1223467899999999864 5679999999999999999999
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=298.15 Aligned_cols=240 Identities=22% Similarity=0.286 Sum_probs=172.4
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--hhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
.++|++.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 368999999999999999999975 489999999865432 23466889999999999999973
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence 112345889999999999999999999998 99999999999999999999999999987553221
Q ss_pred cccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHH--------HHHHhcCCcc
Q 005803 513 ANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYA--------WQLWNEGKAL 583 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~--------~~~~~~~~~~ 583 (676)
......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+... ...+......
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 1233578999999999976 67899999999999999999999999765432211111000 0011111110
Q ss_pred c---cCCcccCCC---CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 584 E---LMDPTLDES---CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 584 ~---~~d~~l~~~---~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
. ..++..... ..+.....+.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 001100000 001223457889999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=311.11 Aligned_cols=228 Identities=21% Similarity=0.293 Sum_probs=167.0
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
..++|++.+.||+|+||.||+++.. +++.||||++... ....+.+.+|+.++++++||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3568999999999999999999976 6899999999753 334467889999999999999983
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC--eEEeccCcceecccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN--PKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~--vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 112345888999999999999999999998 999999999999987765 999999999743222
Q ss_pred ccccceeeccCCccChhhhccCCCCch-hHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMK-SDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~k-sDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||.......... ... ......... +
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~~~-~~~~~~~~~------~ 241 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR--KTI-QRILSVKYS------I 241 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH--HHH-HHHHTTCCC------C
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH--HHH-HHHhcCCCC------C
Confidence 12233579999999999988887665 899999999999999999998654433221 111 111111110 0
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.. .......+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 PD--DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00 11122457889999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=304.24 Aligned_cols=225 Identities=20% Similarity=0.301 Sum_probs=174.6
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC-C-------cEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD-G-------QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD---------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~-~-------~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~---------- 443 (676)
.++|++.+.||+|+||.||+|+... + +.||+|++........+.+.+|+.++++++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3578999999999999999998543 3 479999997766667788999999999999999973
Q ss_pred -----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC--------eEEe
Q 005803 444 -----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN--------PKIS 498 (676)
Q Consensus 444 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~--------vkL~ 498 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeec
Confidence 011223888889999999999999999998 999999999999998877 9999
Q ss_pred ccCcceeccccccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHH
Q 005803 499 DFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLW 577 (676)
Q Consensus 499 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~ 577 (676)
|||++...... ....|++.|+|||.+.+ ..++.++|||||||++|||++|..|+...... .. .....
T Consensus 164 Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~~-~~~~~ 231 (289)
T 4fvq_A 164 DPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-----QR-KLQFY 231 (289)
T ss_dssp CCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HH-HHHHH
T ss_pred cCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-----HH-HHHHh
Confidence 99998754322 22467899999999987 77999999999999999999965544322111 00 11111
Q ss_pred hcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcC
Q 005803 578 NEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTM 632 (676)
Q Consensus 578 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 632 (676)
... ..+.... ...+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 232 ~~~-------~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 EDR-------HQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HTT-------CCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hcc-------CCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 0111111 2246788899999999999999999999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=320.41 Aligned_cols=229 Identities=21% Similarity=0.263 Sum_probs=177.0
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
...++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 35678999999999999999999864 68999999987543 234567899999999999999983
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc---CCCCeEEeccCcceecc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD---EQMNPKISDFGMARTYA 507 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~---~~~~vkL~DFGla~~~~ 507 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 112345788999999999999999999998 99999999999998 56789999999998655
Q ss_pred ccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 508 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 508 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........+.... ..
T Consensus 165 ~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~~-~~ 234 (444)
T 3soa_A 165 GEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-------RLYQQIKAGAYDF-PS 234 (444)
T ss_dssp TTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTCCCC-CT
T ss_pred CCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHhCCCCC-Cc
Confidence 4322 123367999999999999999999999999999999999999999653211 1122222222211 11
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+. .......+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~-----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 235 PE-----WDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11 11223457788999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=308.39 Aligned_cols=237 Identities=20% Similarity=0.313 Sum_probs=176.3
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
.++|++.++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 368999999999999999999874 68999999986543 2334578899999999999998731
Q ss_pred --------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcce
Q 005803 445 --------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR 504 (676)
Q Consensus 445 --------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~ 504 (676)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 11245788999999999999999999998 9999999999999999999999999998
Q ss_pred ecccccc--ccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC
Q 005803 505 TYAMNEL--EANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK 581 (676)
Q Consensus 505 ~~~~~~~--~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 581 (676)
....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ....... +.
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~--~~ 247 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLC--GS 247 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHH--CC
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHh--CC
Confidence 7643221 122234578999999999876 56899999999999999999999999754322111 1111111 11
Q ss_pred ccc-c------------CCcccCCCCC-hHH------HHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 582 ALE-L------------MDPTLDESCS-SDE------VMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 582 ~~~-~------------~d~~l~~~~~-~~~------~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
... . +......... .+. ...+.+|+.+||+.||++|||++|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 100 0 0000000000 111 2347789999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=300.12 Aligned_cols=235 Identities=26% Similarity=0.324 Sum_probs=178.1
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcC----CcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc-----------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLD----GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS----------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~----~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~----------- 444 (676)
...+|++.+.||+|+||.||+|+..+ ...||+|.+.... ....+.+.+|+.++++++||||++.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34568889999999999999998643 2358999987543 3345678999999999999998731
Q ss_pred -----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 445 -----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 445 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 12345788889999999999999999998 9999999999999999999999999998664
Q ss_pred ccccc--cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccc
Q 005803 508 MNELE--ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584 (676)
Q Consensus 508 ~~~~~--~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (676)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||........ . .....+...
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~----~~~~~~~~~- 251 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---T----VYLLQGRRL- 251 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---H----HHHHTTCCC-
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---H----HHHhcCCCC-
Confidence 43221 12233567789999999999999999999999999999999 5556654433221 1 111111111
Q ss_pred cCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCC
Q 005803 585 LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMAL 634 (676)
Q Consensus 585 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l 634 (676)
.. +......+.+++.+||+.||++|||+.|+++.|+.+...+
T Consensus 252 ----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 252 ----LQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ----CC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11 1112245788999999999999999999999999876443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=313.10 Aligned_cols=226 Identities=22% Similarity=0.247 Sum_probs=178.9
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999875 58999999997765556678899999999999999972
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC--CCCeEEeccCcceecccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE--QMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~--~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++.......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 112235889999999999999999999998 999999999999974 5779999999998765432
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. .......... .++..
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~----~~~i~~~~~~--~~~~~- 273 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ET----LQNVKRCDWE--FDEDA- 273 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH----HHHHHHCCCC--CCSST-
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HH----HHHHHhCCCC--CCccc-
Confidence 123357999999999999999999999999999999999999999753211 11 1111111111 11111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 274 ---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 ---FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ---TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11223457889999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=295.55 Aligned_cols=229 Identities=22% Similarity=0.316 Sum_probs=178.9
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3468999999999999999999875 68999999986432 344577899999999999999872
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 122345788999999999999999999998 999999999999999999999999999876443322
Q ss_pred cccceeeccCCccChhhhccCCC-CchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||......... ...+...... ..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~--~~---- 229 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTY--LN---- 229 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH------HHHHHTTCTT--ST----
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHhhhcccc--cC----
Confidence 33344678999999999987665 78999999999999999999999765432211 1111111110 00
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
........+.+++.+||+.||++|||+.|+++.
T Consensus 230 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 230 --PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 011223457789999999999999999999863
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.58 Aligned_cols=227 Identities=22% Similarity=0.308 Sum_probs=177.3
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4578999999999999999999875 58999999997542 334567899999999999999973
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC---CCeEEeccCcceeccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ---MNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~---~~vkL~DFGla~~~~~ 508 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 122345788999999999999999999998 9999999999999865 4599999999986553
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+.... ..+
T Consensus 184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------~~~~~i~~~~~~~-~~~ 252 (362)
T 2bdw_A 184 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKAGAYDY-PSP 252 (362)
T ss_dssp CC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCC-CTT
T ss_pred Cc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCCCC-Ccc
Confidence 22 123367999999999999999999999999999999999999999753211 1112222222111 000
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
. .......+.+++.+||+.||++||++.|+++.
T Consensus 253 ~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 253 E-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp G-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred c-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 11223457889999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.46 Aligned_cols=236 Identities=23% Similarity=0.360 Sum_probs=178.6
Q ss_pred cCCCcceeeccCCCccEEEEEE-----cCCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKL-----LDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~-----~~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
++|++.++||+|+||.||+|++ .+++.||||++.... ......+.+|+.++++++||||+..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588899999999999999983 358899999997542 3445778999999999999998730
Q ss_pred -----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 445 -----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 445 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
.....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccccc
Confidence 12235788889999999999999999998 9999999999999999999999999998765
Q ss_pred ccccc-cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCC--------CCCccchHHHHHHHHh
Q 005803 508 MNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYD--------TERPLNLVGYAWQLWN 578 (676)
Q Consensus 508 ~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~--------~~~~~~l~~~~~~~~~ 578 (676)
..... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+.... ................
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 43221 22233567888999999999999999999999999999999998864311 0000011111111111
Q ss_pred cCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 579 EGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 579 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.+. ....+......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 258 ~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 258 EGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 111 1112223345688899999999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=312.12 Aligned_cols=247 Identities=16% Similarity=0.206 Sum_probs=178.3
Q ss_pred HhcCCCcceeeccC--CCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc------------
Q 005803 381 ATDNFSPANRLGQG--GFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD------------ 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G--~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~------------ 443 (676)
..++|++.++||+| +||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||++
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35689999999999 99999999976 59999999997543 334567889999999999999983
Q ss_pred ----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 444 ----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 444 ----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 011255888999999999999999999998 9999999999999999999999999987543
Q ss_pred cccc-----ccccceeeccCCccChhhhcc--CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHH-HHHHHHh-
Q 005803 508 MNEL-----EANTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVG-YAWQLWN- 578 (676)
Q Consensus 508 ~~~~-----~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~-~~~~~~~- 578 (676)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. .......
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 2211 111223478899999999987 579999999999999999999999997654332111000 0000000
Q ss_pred ------------------cCCccccCC---c------ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--Hhc
Q 005803 579 ------------------EGKALELMD---P------TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTN 629 (676)
Q Consensus 579 ------------------~~~~~~~~d---~------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~ 629 (676)
.....+.+. + .............+.+|+.+||+.||++|||+.|+++. +++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 000000000 0 00000112223458889999999999999999999865 554
Q ss_pred C
Q 005803 630 D 630 (676)
Q Consensus 630 ~ 630 (676)
.
T Consensus 340 ~ 340 (389)
T 3gni_B 340 I 340 (389)
T ss_dssp C
T ss_pred H
Confidence 4
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=307.08 Aligned_cols=225 Identities=23% Similarity=0.273 Sum_probs=174.5
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC-----CchhhHHHHHHHHHHHHccCCccccc-----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS-----SGQGIVEFKNEAKLIAKLQHTNLTDS----------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~~----------- 444 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||++.
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457999999999999999999865 5899999998642 12245779999999999999999830
Q ss_pred -------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC---eEEeccCc
Q 005803 445 -------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN---PKISDFGM 502 (676)
Q Consensus 445 -------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~---vkL~DFGl 502 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 01224788889999999999999999998 999999999999986554 99999999
Q ss_pred ceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCc
Q 005803 503 ARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKA 582 (676)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~ 582 (676)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .........+..
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~i~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--------ERLFEGIIKGKY 249 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--------HHHHHHHHHTCC
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--------HHHHHHHHcCCC
Confidence 987654322 1233579999999999999999999999999999999999999997531 111112222221
Q ss_pred cccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 583 LELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 583 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
. ..+.... .....+.+++.+||+.||++|||+.|+++
T Consensus 250 ~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 K--MNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 0111101 12345788999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=304.33 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=175.8
Q ss_pred HHHHhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHc--cCCccccc-----------
Q 005803 378 IAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL--QHTNLTDS----------- 444 (676)
Q Consensus 378 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l--~H~niv~~----------- 444 (676)
-....++|++.++||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||++.
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3445678999999999999999999874 899999998543 233445566665554 89998731
Q ss_pred ------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcC-----CCceEeeccccCceEEcCCCCeEEeccC
Q 005803 445 ------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYS-----RLRAIHRDLKVSNILLDEQMNPKISDFG 501 (676)
Q Consensus 445 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~iiH~DLKp~NILl~~~~~vkL~DFG 501 (676)
.....+++..++.++.|++.||.|||+++ ..+|+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 11234778889999999999999999881 1129999999999999999999999999
Q ss_pred cceecccccccc--ccceeeccCCccChhhhccCCCCch------hHHHHHHHHHHHHHhC----------CcCCCCCCC
Q 005803 502 MARTYAMNELEA--NTNRIVGTHGYMSPEYVMNGIVSMK------SDVYSFGVLVLEIVSS----------KKNNGSYDT 563 (676)
Q Consensus 502 la~~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~s~k------sDVwSlGvvl~elltG----------~~pf~~~~~ 563 (676)
++.......... ......||+.|+|||++.+.....+ +|||||||++|||++| +.||.....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 998654432211 1223579999999999987766554 9999999999999999 555554332
Q ss_pred CCccchHHHHHHHHhcCCccccCCcccCCC-CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcC
Q 005803 564 ERPLNLVGYAWQLWNEGKALELMDPTLDES-CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTM 632 (676)
Q Consensus 564 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 632 (676)
..... ........... ..+.+... ...+....+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 268 ~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 268 SDPSY--EDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp SSCCH--HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCch--hhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 22211 11111111111 11211111 122567789999999999999999999999999998753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=309.60 Aligned_cols=245 Identities=20% Similarity=0.262 Sum_probs=177.2
Q ss_pred ccHHHHHHHhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCch-----------hhHHHHHHHHHHHHccCCcc
Q 005803 373 FDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQ-----------GIVEFKNEAKLIAKLQHTNL 441 (676)
Q Consensus 373 f~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~ni 441 (676)
....++....++|++.+.||+|+||.||+|...+++.||||++...... ..+.+.+|+.++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 3456788899999999999999999999999888999999998643221 23678999999999999998
Q ss_pred ccc-------------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc
Q 005803 442 TDS-------------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD 490 (676)
Q Consensus 442 v~~-------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~ 490 (676)
++. .....+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLA 168 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred cceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEc
Confidence 731 12235888999999999999999999998 99999999999999
Q ss_pred CCCCeEEeccCcceeccccccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccch
Q 005803 491 EQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNL 569 (676)
Q Consensus 491 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l 569 (676)
.++.+||+|||++....... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~ 242 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN---Q 242 (362)
T ss_dssp TTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H
T ss_pred CCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH---H
Confidence 99999999999997543322 2233578999999999887 678999999999999999999999997543211 1
Q ss_pred HHHHHHHHhcCCc-----------cccCCcccC-------CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 570 VGYAWQLWNEGKA-----------LELMDPTLD-------ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 570 ~~~~~~~~~~~~~-----------~~~~d~~l~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
............. .+.+...+. ....+.....+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1111111000000 000000000 00111223457889999999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=299.97 Aligned_cols=234 Identities=26% Similarity=0.324 Sum_probs=177.5
Q ss_pred CCCcceeeccCCCccEEEEEEcC-C---cEEEEEEeccCCc-hhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLLD-G---QEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~~-~---~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
.|.+.++||+|+||.||+|+..+ + ..||+|.+..... ...+.+.+|+.++++++||||+.
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45567899999999999998543 2 3799999975433 44577899999999999999873
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 011345778889999999999999999998 9999999999999999999999999998654332
Q ss_pred c--ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 511 L--EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 511 ~--~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
. ........+++.|+|||.+.+..++.++||||||+++|||++|..|+....... ... .....+...
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~----~~~~~~~~~----- 247 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLT----HFLAQGRRL----- 247 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHH----HHHHTTCCC-----
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHH----HHhhcCCCC-----
Confidence 1 122233567889999999999999999999999999999999665543322111 111 111111111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCC
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALP 635 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~ 635 (676)
. .+......+.+++.+||+.||.+|||+.++++.|+++..++.
T Consensus 248 ~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 248 P----QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred C----CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1 111223457889999999999999999999999998764443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.90 Aligned_cols=235 Identities=20% Similarity=0.207 Sum_probs=179.9
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHcc--------CCccccc--------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ--------HTNLTDS-------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~--------H~niv~~-------- 444 (676)
.++|++.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++ |+||++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999864 5889999999653 445677899999999996 6667620
Q ss_pred -----------------------cccCcCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeeccccCceEEcCCC-------
Q 005803 445 -----------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKY-SRLRAIHRDLKVSNILLDEQM------- 493 (676)
Q Consensus 445 -----------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLKp~NILl~~~~------- 493 (676)
.....+++..+..++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhh
Confidence 1124588999999999999999999998 7 99999999999999775
Q ss_pred ------------------------------------------CeEEeccCcceeccccccccccceeeccCCccChhhhc
Q 005803 494 ------------------------------------------NPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM 531 (676)
Q Consensus 494 ------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 531 (676)
.+||+|||++...... .....||+.|+|||++.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhc
Confidence 7999999999875432 23357899999999999
Q ss_pred cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHH---H--------hcCCcc-ccCCcc-----c----
Q 005803 532 NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQL---W--------NEGKAL-ELMDPT-----L---- 590 (676)
Q Consensus 532 ~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~---~--------~~~~~~-~~~d~~-----l---- 590 (676)
+..++.++|||||||++|||++|+.||.................. . ..+... +..... +
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 999999999999999999999999999876544322211111111 0 001100 000000 0
Q ss_pred ----------CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 591 ----------DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 591 ----------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
....+.+....+.+|+.+||+.||++|||++|+++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01234566778999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=300.15 Aligned_cols=238 Identities=21% Similarity=0.343 Sum_probs=171.6
Q ss_pred hcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
.++|++.+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++++++||||++.
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999986 46899999998753 23445678999999999999998720
Q ss_pred -----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 445 -----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 445 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
.....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 11345788889999999999999999998 9999999999999999999999999998654
Q ss_pred ccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 508 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 508 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .... .............
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~~~~~~~~~~~- 259 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-CKKIEQCDYPPLP- 259 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHH-HHHHHTTCSCCCC-
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHH-HHHhhcccCCCCc-
Confidence 3221 122357899999999999999999999999999999999999999643211 1111 1122222211111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCCCC
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKP 637 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~~p 637 (676)
.. .....+.+++.+||+.||++|||+.+|++.|+++......|
T Consensus 260 ---~~----~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 260 ---SD----HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp ---TT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred ---cc----ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 11 22335778899999999999999999999999886433333
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=304.15 Aligned_cols=245 Identities=25% Similarity=0.341 Sum_probs=175.1
Q ss_pred hcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++.+++||||++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999986 468999999997642 2334578899999999999999731
Q ss_pred -----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 445 -----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 445 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 11245788889999999999999999998 9999999999999999999999999998654
Q ss_pred ccccc-cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 508 MNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 508 ~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...............
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~~-- 239 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPP-- 239 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCH--
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCCc--
Confidence 43211 222345789999999999999999999999999999999999999975322 111122222111110
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHH-HHHHHhcCcCCCCCCCCCccc
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSD-VVSMLTNDTMALPKPKQPAFF 643 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~e-Vl~~Le~~~~~l~~p~~P~~~ 643 (676)
..... .....+.+++.+||+.||++||++.+ +.+.|.... ....|..|...
T Consensus 240 -~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~-~~~~~~~~~~~ 291 (311)
T 3ork_A 240 -SARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH-NGEPPEAPKVL 291 (311)
T ss_dssp -HHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH-TTCCCSSCCCC
T ss_pred -ccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh-cCCCCCCCccc
Confidence 00011 12345778899999999999996555 445566554 33334444443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=306.78 Aligned_cols=229 Identities=22% Similarity=0.320 Sum_probs=174.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHc-cCCcccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL-QHTNLTD------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~------------- 443 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++.+.. ......+.+|..++.++ +||||++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357999999999999999999975 48899999997542 23456688999999988 8999973
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 112245788899999999999999999998 9999999999999999999999999998533221
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCcc--chHHHHHHHHhcCCccccCCc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPL--NLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d~ 588 (676)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...............
T Consensus 165 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 236 (345)
T 3a8x_A 165 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 236 (345)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------
T ss_pred --CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------
Confidence 1233468999999999999999999999999999999999999999753222111 111112222222211
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCH------HHHHH
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTM------SDVVS 625 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~------~eVl~ 625 (676)
.+ +......+.+++.+||+.||.+||++ .|+++
T Consensus 237 ~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 237 RI----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred CC----CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 11 12223457788999999999999995 56664
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=299.59 Aligned_cols=223 Identities=24% Similarity=0.321 Sum_probs=171.1
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSS---------------- 445 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~~---------------- 445 (676)
.++|++.+.||+|+||.||+|+. .++.||||+++.. ...+.+.+|+.++++++||||+...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46799999999999999999987 5889999998653 3567789999999999999987310
Q ss_pred -------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 446 -------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 446 -------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 0112677788899999999999999998 999999999999999999999999999754322
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... . ......+. ....
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~----~~~~~~~~-----~~~~- 235 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPRVEKGY-----KMDA- 235 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---H----HHHHTTTC-----CCCC-
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHhcCC-----CCCC-
Confidence 122457889999999999999999999999999999998 999997543221 1 11111111 1111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+......+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 236 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 236 ---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 2223345788999999999999999999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=304.95 Aligned_cols=220 Identities=23% Similarity=0.280 Sum_probs=175.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
.++|++.+.||+|+||.||+++.. +++.||+|++++.. ....+.+.+|+.+++.++||||++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999875 58999999997532 234567889999999999999973
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 112345788889999999999999999998 999999999999999999999999999865432
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .......+.. .+
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~-~~~~i~~~~~------~~- 222 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MK-TYEKILNAEL------RF- 222 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HH-HHHHHHHCCC------CC-
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HH-HHHHHHhCCC------CC-
Confidence 2346799999999999999999999999999999999999999975321 11 1111212211 11
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRR-----TMSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~ 626 (676)
+......+.+++.+||+.||++|| +++||++.
T Consensus 223 ---p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 223 ---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ---CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 112234577888999999999999 89998853
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=307.85 Aligned_cols=217 Identities=22% Similarity=0.324 Sum_probs=174.9
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--------hhhHHHHHHHHHHHHccCCcccc--------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--------QGIVEFKNEAKLIAKLQHTNLTD-------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~-------- 443 (676)
..++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999864 588999999976421 13446788999999999999973
Q ss_pred -------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcce
Q 005803 444 -------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR 504 (676)
Q Consensus 444 -------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~ 504 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccce
Confidence 112235888999999999999999999998 9999999999999999999999999998
Q ss_pred eccccccccccceeeccCCccChhhhccCCC-CchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 505 TYAMNELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 179 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------------- 235 (335)
T 3dls_A 179 YLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------------- 235 (335)
T ss_dssp ECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------------
T ss_pred ECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------------
Confidence 765432 2234679999999999988776 8899999999999999999999964211
Q ss_pred ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 584 ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 584 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
........ +......+.+++.+||+.||++|||+.|+++.
T Consensus 236 -~~~~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 -TVEAAIHP--PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -GTTTCCCC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -HHhhccCC--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000100 11123357888999999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.58 Aligned_cols=233 Identities=23% Similarity=0.360 Sum_probs=181.3
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcC-C-----cEEEEEEeccCCc-hhhHHHHHHHHHHHHc-cCCcccccc-------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLD-G-----QEIAIKRLSKSSG-QGIVEFKNEAKLIAKL-QHTNLTDSS------- 445 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-~-----~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~------- 445 (676)
..++|++.+.||+|+||.||+|+... + +.||||.+..... ...+.+.+|+.+++++ +||||++..
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 45789999999999999999998643 2 4799999976432 3456789999999999 899987300
Q ss_pred ---------------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC
Q 005803 446 ---------------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ 492 (676)
Q Consensus 446 ---------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~ 492 (676)
....+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 0234688889999999999999999998 9999999999999999
Q ss_pred CCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHH
Q 005803 493 MNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVG 571 (676)
Q Consensus 493 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~ 571 (676)
+.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~----- 275 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK----- 275 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-----
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-----
Confidence 9999999999986654333223334567889999999999999999999999999999998 9999975433211
Q ss_pred HHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 572 YAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 572 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.......+.. ... +......+.+++.+||+.||.+|||+.||++.|+...
T Consensus 276 -~~~~~~~~~~-----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 276 -FYKLVKDGYQ-----MAQ----PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp -HHHHHHHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHhcCCC-----CCC----CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 1112212111 111 1112345788999999999999999999999998753
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.46 Aligned_cols=240 Identities=14% Similarity=0.112 Sum_probs=181.5
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC---------CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc--------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD---------GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS-------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~---------~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~-------- 444 (676)
.++|++.+.||+|+||.||+|+... ++.||||++... ..+.+|+.++++++||||++.
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999998763 789999998653 468899999999999987620
Q ss_pred -----------------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE
Q 005803 445 -----------------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL 489 (676)
Q Consensus 445 -----------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl 489 (676)
.....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~ 192 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFV 192 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEE
T ss_pred ccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEE
Confidence 01256889999999999999999999998 9999999999999
Q ss_pred cCCC--CeEEeccCcceecccccccc-----ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCC
Q 005803 490 DEQM--NPKISDFGMARTYAMNELEA-----NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYD 562 (676)
Q Consensus 490 ~~~~--~vkL~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~ 562 (676)
+.++ .+||+|||+++.+....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 89999999998765432111 1123478999999999999999999999999999999999999998653
Q ss_pred CCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCC
Q 005803 563 TERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALP 635 (676)
Q Consensus 563 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~ 635 (676)
... .........+. .....+.+..... ......+.+++.+||+.||++||++++|++.|+++.....
T Consensus 273 ~~~--~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 273 PNT--EDIMKQKQKFV-DKPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TCH--HHHHHHHHHHH-HSCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCH--HHHHHHHHhcc-CChhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 221 11111111111 1111122111110 1112457888899999999999999999999988764443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=310.57 Aligned_cols=228 Identities=8% Similarity=0.028 Sum_probs=162.3
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc---hhhHHHHHHHHHHHHc--cCCccccccc---------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG---QGIVEFKNEAKLIAKL--QHTNLTDSSR--------- 446 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~---~~~~~~~~E~~~l~~l--~H~niv~~~~--------- 446 (676)
..+|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++.+ +||||++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888999999999999999965 689999999976532 3445678886666666 5999653110
Q ss_pred -----------------------------------------cCcCCHHHH------HHHHHHHHHHHHHHHhcCCCceEe
Q 005803 447 -----------------------------------------KSLLDWKKR------FYIIEGIVQGLLYLHKYSRLRAIH 479 (676)
Q Consensus 447 -----------------------------------------~~~l~~~~~------~~i~~qia~gL~yLH~~~~~~iiH 479 (676)
...+.+..+ +.++.||+.||+|||+++ |+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivH 217 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVH 217 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 112344445 678899999999999998 999
Q ss_pred eccccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhcc--CCCCchhHHHHHHHHHHHHHhCCcC
Q 005803 480 RDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIVSSKKN 557 (676)
Q Consensus 480 ~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~elltG~~p 557 (676)
|||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998654321 12456799999999987 6799999999999999999999999
Q ss_pred CCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 558 NGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 558 f~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
|........... ............+...........+.+++.+||+.||++|||+.|+++
T Consensus 293 f~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 986543221100 000001111111111111233456788999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=293.01 Aligned_cols=224 Identities=27% Similarity=0.387 Sum_probs=177.9
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+|++++++++||||+..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999976 69999999996543 457899999999999998731
Q ss_pred -----------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCe
Q 005803 445 -----------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNP 495 (676)
Q Consensus 445 -----------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~v 495 (676)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 01235778888999999999999999998 9999999999999999999
Q ss_pred EEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHH
Q 005803 496 KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQ 575 (676)
Q Consensus 496 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~ 575 (676)
||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+... .....
T Consensus 162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~~ 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFFT 229 (284)
T ss_dssp EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHHH
T ss_pred EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHHH
Confidence 9999999987654321 22356899999999999999999999999999999999999876311 11111
Q ss_pred HHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCC
Q 005803 576 LWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALP 635 (676)
Q Consensus 576 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~ 635 (676)
....+. +...++ ..+.+++.+||+.||.+|||+.|+++.|+...+...
T Consensus 230 ~~~~~~--------~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 230 DLRDGI--------ISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHHTTC--------CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred Hhhccc--------ccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 222211 111222 346788899999999999999999999988764433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=311.39 Aligned_cols=224 Identities=26% Similarity=0.377 Sum_probs=175.0
Q ss_pred HHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHc-cCCcccc----------
Q 005803 379 AAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL-QHTNLTD---------- 443 (676)
Q Consensus 379 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~---------- 443 (676)
....++|.+.+.||+|+||.||+|+.. +++.||||++++.. ......+..|..++.++ +||||++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345679999999999999999999975 58999999997532 33456688899999987 9999973
Q ss_pred ----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 444 ----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 444 ----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 111245788899999999999999999998 9999999999999999999999999998543
Q ss_pred ccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 508 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 508 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+.
T Consensus 170 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~------ 234 (345)
T 1xjd_A 170 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDN------ 234 (345)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC------
T ss_pred cCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHhCC------
Confidence 222 12344689999999999999999999999999999999999999997543211 111121211
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHH-HHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMS-DVV 624 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~-eVl 624 (676)
+.+. ......+.+++.+||+.||++||++. +|+
T Consensus 235 ~~~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 PFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCC----cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1111 12234577889999999999999997 665
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=306.15 Aligned_cols=223 Identities=23% Similarity=0.331 Sum_probs=165.9
Q ss_pred hcCCCcceeeccCCCccEEEEEE----cCCcEEEEEEeccCC----chhhHHHHHHHHHHHHccCCccccc---------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL----LDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLTDS--------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~----~~~~~VAvK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~~--------- 444 (676)
.++|++.+.||+|+||.||+++. .+++.||||++++.. ......+.+|+.++++++||||++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999986 468999999997642 2334567899999999999999831
Q ss_pred -----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 445 -----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 445 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 11345778888999999999999999998 9999999999999999999999999997543
Q ss_pred ccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 508 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 508 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ..........
T Consensus 173 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~-~~~~i~~~~~----- 238 (327)
T 3a62_A 173 HDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------K-TIDKILKCKL----- 238 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------H-HHHHHHHTCC-----
T ss_pred cCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------H-HHHHHHhCCC-----
Confidence 2221 123357899999999999999999999999999999999999999753221 1 1111111111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRR-----TMSDVVSM 626 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~ 626 (676)
.+ +......+.+++.+||+.||++|| ++.|+++.
T Consensus 239 -~~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 -NL----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -CC----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -CC----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 11 122234578889999999999999 78888764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=318.47 Aligned_cols=235 Identities=20% Similarity=0.242 Sum_probs=179.7
Q ss_pred HHHHHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc-------
Q 005803 375 FQTIAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD------- 443 (676)
Q Consensus 375 ~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~------- 443 (676)
+.++....++|++.+.||+|+||.||+|+.. +++.||+|++.+. .......+.+|+.+++.++||||++
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455557789999999999999999999976 4889999999652 1223456889999999999999983
Q ss_pred ------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 444 ------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 444 ------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 111235788889999999999999999998 99999999999999999999999999987
Q ss_pred ccccccccccceeeccCCccChhhhccCC----CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC
Q 005803 506 YAMNELEANTNRIVGTHGYMSPEYVMNGI----VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK 581 (676)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~----~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 581 (676)
....... .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... . ...+..+.
T Consensus 218 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~----~~~i~~~~ 289 (410)
T 3v8s_A 218 MNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---T----YSKIMNHK 289 (410)
T ss_dssp CCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H----HHHHHTHH
T ss_pred eccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh---H----HHHHHhcc
Confidence 6543221 223468999999999998755 8899999999999999999999997532211 1 11111110
Q ss_pred ccccCCcccCCCCChHHHHHHHHHHHHhcccCcCC--CCCHHHHHHH
Q 005803 582 ALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAAD--RRTMSDVVSM 626 (676)
Q Consensus 582 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~eVl~~ 626 (676)
.. +. .. ........+.+|+.+||+.+|.+ ||+++||++.
T Consensus 290 ~~--~~--~p--~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 290 NS--LT--FP--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HH--CC--CC--TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cc--cc--CC--CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00 00 00 00112245778888999999988 9999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=317.93 Aligned_cols=235 Identities=19% Similarity=0.224 Sum_probs=182.6
Q ss_pred hcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
.++|++.++||+|+||.||+|+. .+++.||||++.... ...++.+|++++..++|++.+.
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999986 468999999886533 2346889999999999865431
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE---cCCCCeEEeccCcceeccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL---DEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl---~~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++..++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.+....
T Consensus 84 ~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 011456899999999999999999999998 9999999999999 688999999999998765432
Q ss_pred cc-----cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcccc
Q 005803 511 LE-----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALEL 585 (676)
Q Consensus 511 ~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (676)
.. .......||..|+|||.+.+..++.++|||||||+||||++|+.||..........................
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~- 239 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA- 239 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH-
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH-
Confidence 21 112246799999999999999999999999999999999999999987655433322222211111111111
Q ss_pred CCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 586 MDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 586 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
+...+ ...+.+++..||+.+|++||++.+|++.|+.+
T Consensus 240 ----l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 240 ----LCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp ----HHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ----HhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11112 24578899999999999999999999998765
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.52 Aligned_cols=233 Identities=26% Similarity=0.342 Sum_probs=169.7
Q ss_pred cCCCcceeeccCCCccEEEEEEc--CC--cEEEEEEeccC-CchhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL--DG--QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~--~~--~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
..|.+.+.||+|+||.||+|+.. ++ ..||||.++.. .....+++.+|+.++++++||||++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 34677899999999999999854 22 36899998654 33456789999999999999999731
Q ss_pred ---------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 445 ---------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 445 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 11234677888999999999999999998 999999999999999999999999999865433
Q ss_pred cccc--ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 510 ELEA--NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 510 ~~~~--~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
.... ......+++.|+|||.+.+..++.++|||||||++|||++ |.+||......+. . .....+...
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~----~~~~~~~~~--- 315 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---T----VYLLQGRRL--- 315 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---H----HHHHTTCCC---
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---H----HHHHcCCCC---
Confidence 2111 1223456788999999999999999999999999999999 6777765443321 1 111122111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCC
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMAL 634 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l 634 (676)
.. +......+.+++.+||+.||++|||+.||++.|+.+...+
T Consensus 316 --~~----p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 316 --LQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp --CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred --CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11 1122345788999999999999999999999999876443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.89 Aligned_cols=221 Identities=29% Similarity=0.427 Sum_probs=174.1
Q ss_pred hcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
.+.|++.+.||+|+||.||+|+. .+++.||||++.... ....+++.+|++++++++||||+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35689999999999999999986 468999999997542 2234578999999999999999731
Q ss_pred -------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 445 -------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 445 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 133 ~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 133 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred EecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 12356888999999999999999999998 999999999999999999999999999765422
Q ss_pred ccccceeeccCCccChhhhc---cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 512 EANTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ........ .+.. +
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~-~~~~-----~ 271 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIA-QNES-----P 271 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHH-HSCC-----C
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHH-hcCC-----C
Confidence 2357899999999985 56789999999999999999999999965421 11111111 1111 1
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+.. ......+.+++.+||+.||++|||++++++.
T Consensus 272 ~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 272 ALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1111 1122347788899999999999999999865
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=305.11 Aligned_cols=240 Identities=21% Similarity=0.289 Sum_probs=178.3
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++.+++||||+..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999999999999865 58889999997543 3334678999999999999999731
Q ss_pred ---------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 445 ---------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 445 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 105 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 11234788889999999999999999998 999999999999999999999999999876543
Q ss_pred cccc-ccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCc-----
Q 005803 510 ELEA-NTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKA----- 582 (676)
Q Consensus 510 ~~~~-~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~----- 582 (676)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.... ..........
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH---ILGILGSPSQEDLNC 258 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH---HHHHHCSCCHHHHHT
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH---HHHHhCCCCHHHHHH
Confidence 2221 1234689999999998764 4589999999999999999999999976543322111 1111000000
Q ss_pred ----------cccCCcccC--CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 583 ----------LELMDPTLD--ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 583 ----------~~~~d~~l~--~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.....+... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 00001123457889999999999999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=317.36 Aligned_cols=215 Identities=13% Similarity=0.149 Sum_probs=164.9
Q ss_pred HhcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccC---CchhhHHHHHHH---HHHHHccCCcccccc--------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKS---SGQGIVEFKNEA---KLIAKLQHTNLTDSS-------- 445 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~---~~~~~~~~~~E~---~~l~~l~H~niv~~~-------- 445 (676)
..++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+ .++++++||||++..
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 356899999999999999999996 46999999999743 334567789999 556666899986321
Q ss_pred --------------------------------cc---------CcCC-------HHHHHHHHHHHHHHHHHHHhcCCCce
Q 005803 446 --------------------------------RK---------SLLD-------WKKRFYIIEGIVQGLLYLHKYSRLRA 477 (676)
Q Consensus 446 --------------------------------~~---------~~l~-------~~~~~~i~~qia~gL~yLH~~~~~~i 477 (676)
.+ ..++ +..++.++.||+.||+|||+++ |
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 00 0111 3667789999999999999998 9
Q ss_pred EeeccccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccC-----------CCCchhHHHHHHH
Q 005803 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG-----------IVSMKSDVYSFGV 546 (676)
Q Consensus 478 iH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----------~~s~ksDVwSlGv 546 (676)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986332 2233567 999999999887 8999999999999
Q ss_pred HHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 547 LVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 547 vl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
++|||++|+.||........... +... .... ...+.+++.+||+.||++|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~---------------~~~~--~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEW---------------IFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSGG---------------GGSS--CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchhh---------------hhhh--ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999975433222111 1110 0122 245778899999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.62 Aligned_cols=238 Identities=23% Similarity=0.334 Sum_probs=182.2
Q ss_pred hcCCCcceeeccCCCccEEEEEE-----cCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL-----LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~-----~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688899999999999999984 3588999999987666677889999999999999998730
Q ss_pred -----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 445 -----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 445 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
.....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 11234788889999999999999999998 9999999999999999999999999998765
Q ss_pred ccccc-cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCC--------CCCc-cchHHHHHHHH
Q 005803 508 MNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYD--------TERP-LNLVGYAWQLW 577 (676)
Q Consensus 508 ~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~--------~~~~-~~l~~~~~~~~ 577 (676)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.... .... ...........
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 43221 11222456778999999999899999999999999999999999876321 0000 00000111111
Q ss_pred hcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 578 NEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 578 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
..+.. ...+......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 277 ~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 277 KNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 1112223356888999999999999999999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=297.85 Aligned_cols=222 Identities=23% Similarity=0.336 Sum_probs=172.5
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
+.++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4578999999999999999999865 47899999986432 223467889999999999999973
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 111245788889999999999999999988 9999999999999999999999999986543221
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ......... ...
T Consensus 164 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~------~~~ 226 (279)
T 3fdn_A 164 ----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVE------FTF 226 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTC------CCC
T ss_pred ----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-------HHHHHHhCC------CCC
Confidence 233578999999999999999999999999999999999999997432111 111111111 111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+......+.+++.+||+.||++|||+.||++.
T Consensus 227 ----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 ----PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11223457788999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=307.27 Aligned_cols=241 Identities=22% Similarity=0.259 Sum_probs=171.0
Q ss_pred HHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCch-----hhHHHHHHHHHHHHccCCcccc--------
Q 005803 378 IAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQ-----GIVEFKNEAKLIAKLQHTNLTD-------- 443 (676)
Q Consensus 378 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~-------- 443 (676)
+....++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++||||+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 3445678999999999999999999875 5899999998653221 2346889999999999999973
Q ss_pred ------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 444 ------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 444 ------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 85 SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 112235788899999999999999999998 99999999999999999999999999986
Q ss_pred ccccccccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCc--
Q 005803 506 YAMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKA-- 582 (676)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~-- 582 (676)
...... ......||+.|+|||.+.+. .++.++|||||||++|||++|.+||....... ..............
T Consensus 162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 162 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTT
T ss_pred ccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHcCCCChhh
Confidence 543221 22335789999999999764 58999999999999999999999987543211 11111111111000
Q ss_pred -cc---cCCc---ccCCCCC-----hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 583 -LE---LMDP---TLDESCS-----SDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 583 -~~---~~d~---~l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+ ..+. ......+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 0000 0000011 1223568889999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=308.71 Aligned_cols=220 Identities=24% Similarity=0.279 Sum_probs=176.7
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++.+.. ....+.+.+|+.++++++||||+.
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 368999999999999999999875 58999999996532 234567889999999999999973
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 111245788889999999999999999998 999999999999999999999999999875432
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+.. .+.
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~~------~~p 258 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------QIYEKIVSGKV------RFP 258 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC------CCC
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-------HHHHHHHcCCC------CCC
Confidence 23468999999999999999999999999999999999999999753211 11222222221 111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRT-----MSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~eVl~~ 626 (676)
. .....+.+++.+||+.||.+||+ ++||++.
T Consensus 259 ~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 259 S----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp T----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred C----CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1 22345788999999999999998 8888753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=310.69 Aligned_cols=238 Identities=22% Similarity=0.300 Sum_probs=173.2
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDSS------------- 445 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~------------- 445 (676)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .....+++.+|+.++++++||||+...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999874 5999999998653 233456789999999999999997311
Q ss_pred -----------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 446 -----------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 446 -----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 1134778888999999999999999998 99999999999999999999999999987542
Q ss_pred cccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcC-------
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG------- 580 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~------- 580 (676)
. .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.... ........
T Consensus 181 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~---i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 181 E-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE---IMKVTGTPPAEFVQR 252 (367)
T ss_dssp S-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCHHHHHT
T ss_pred c-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCCHHHHHH
Confidence 2 233578999999999887 6799999999999999999999999975432211111 10000000
Q ss_pred -----------CccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcCc
Q 005803 581 -----------KALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTNDT 631 (676)
Q Consensus 581 -----------~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~~ 631 (676)
.........+. .........+.+|+.+||+.||++|||+.|+++. ++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 00000000110 1112223457889999999999999999999984 65543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=310.01 Aligned_cols=241 Identities=21% Similarity=0.256 Sum_probs=185.3
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
.++|.+.++||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||++.
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3679999999999999999998764 8999999997543 2345678899999999999999720
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE----cCCCCeEEeccCcce
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL----DEQMNPKISDFGMAR 504 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl----~~~~~vkL~DFGla~ 504 (676)
.....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 01112889999999999999999999998 9999999999999 777889999999998
Q ss_pred eccccccccccceeeccCCccChhhhcc--------CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHH
Q 005803 505 TYAMNELEANTNRIVGTHGYMSPEYVMN--------GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQL 576 (676)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~--------~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~ 576 (676)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ......
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~~~~~ 239 (396)
T 4eut_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMYKI 239 (396)
T ss_dssp ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--HHHHHH
T ss_pred EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--HHHHHH
Confidence 7654322 223578999999999875 567889999999999999999999997654333221 111222
Q ss_pred HhcCCccccC---------------CcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 577 WNEGKALELM---------------DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 577 ~~~~~~~~~~---------------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
. .+.....+ +..............+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 240 ~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 240 I-TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp H-HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred h-cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 2 12111100 011122344667778889999999999999999999999987764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=315.23 Aligned_cols=226 Identities=23% Similarity=0.364 Sum_probs=179.2
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+++.++||||++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 368999999999999999999875 69999999996532 233567899999999999999972
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~- 170 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 170 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence 123456889999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccceeeccCCccChhhhccCCC-CchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... . .......+... .
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~----~~~~i~~~~~~------~ 235 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---T----LFKKICDGIFY------T 235 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---H----HHHHHHTTCCC------C
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---H----HHHHHhcCCcC------C
Confidence 2234679999999999988765 78999999999999999999999753321 1 11222222111 1
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH--HHhcC
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS--MLTND 630 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~--~Le~~ 630 (676)
+......+.+++.+||+.||++|||+.||++ .+...
T Consensus 236 ----p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 236 ----PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ----CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 1112235778899999999999999999997 35543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=306.84 Aligned_cols=227 Identities=20% Similarity=0.291 Sum_probs=163.1
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+.
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 35678999999999999999999976 48899999997542 3467889999999999999972
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC---CCCeEEeccCcceecccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE---QMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~---~~~vkL~DFGla~~~~~~ 509 (676)
......+++.++..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 128 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 112345788999999999999999999998 999999999999975 889999999999865432
Q ss_pred ccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............ ...
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~~-~~~-- 272 (349)
T 2w4o_A 205 V---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEYY-FIS-- 272 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCCC-CCT--
T ss_pred c---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCCc-cCC--
Confidence 2 1233678999999999999999999999999999999999999996543211 111222222111 111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.........+.+++.+||+.||++|||+.|+++.
T Consensus 273 ---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 ---PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112233457889999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.70 Aligned_cols=240 Identities=24% Similarity=0.308 Sum_probs=173.6
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCc--hhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
.++|++.+.||+|+||.||+|+... ++.||||++..... ...+.+.+|+.++++++||||++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3579999999999999999998764 89999999865432 23456789999999999999973
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 179 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 179 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-
Confidence 122356889999999999999999999998 99999999999999999999999999976543221
Q ss_pred cccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHH--------HHHHHHhcCC-c
Q 005803 513 ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVG--------YAWQLWNEGK-A 582 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~--------~~~~~~~~~~-~ 582 (676)
......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+. .....+.... .
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 12235789999999999875 78999999999999999999999997643221111000 0001111111 1
Q ss_pred cccCCcccCCCCC-----hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 583 LELMDPTLDESCS-----SDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 583 ~~~~d~~l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.....+.+....+ +.....+.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111111111111 1234568899999999999999999998863
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=297.49 Aligned_cols=230 Identities=20% Similarity=0.239 Sum_probs=178.8
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC----chhhHHHHHHHHHHHHccCCcccc------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLTD------------ 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~------------ 443 (676)
..++|.+.+.||+|+||.||++... +++.||||++.... ......+.+|+.++++++||||++
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999875 58899999996532 234577999999999999999872
Q ss_pred -----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceec
Q 005803 444 -----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTY 506 (676)
Q Consensus 444 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~ 506 (676)
......+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 112345788899999999999999999998 999999999999999999999999999876
Q ss_pred cccccccccceeeccCCccChhhhccCC--CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccc
Q 005803 507 AMNELEANTNRIVGTHGYMSPEYVMNGI--VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584 (676)
Q Consensus 507 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (676)
.............|++.|+|||.+.+.. ++.++||||||+++|||++|+.||..... .. .......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~-~~~~i~~~~~-- 230 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YK-LFENIGKGSY-- 230 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HH-HHHHHHHCCC--
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HH-HHHHHhcCCC--
Confidence 5433223333457899999999997644 47899999999999999999999975321 11 1122222211
Q ss_pred cCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcC
Q 005803 585 LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTND 630 (676)
Q Consensus 585 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~ 630 (676)
.+.. .....+.+++.+||+.||++|||+.|+++. +.+.
T Consensus 231 ----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 231 ----AIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp ----CCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred ----CCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 1112 223457788999999999999999999964 5443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.91 Aligned_cols=241 Identities=24% Similarity=0.317 Sum_probs=182.4
Q ss_pred HHHHhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHH--ccCCccccc-----------
Q 005803 378 IAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAK--LQHTNLTDS----------- 444 (676)
Q Consensus 378 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~~----------- 444 (676)
-....++|.+.+.||+|+||.||+|+. +++.||||++... ....+.+|++++.. ++||||++.
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 345667899999999999999999987 5899999998642 34667889999988 789998731
Q ss_pred ------------------cccCcCCHHHHHHHHHHHHHHHHHHH--------hcCCCceEeeccccCceEEcCCCCeEEe
Q 005803 445 ------------------SRKSLLDWKKRFYIIEGIVQGLLYLH--------KYSRLRAIHRDLKVSNILLDEQMNPKIS 498 (676)
Q Consensus 445 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~iiH~DLKp~NILl~~~~~vkL~ 498 (676)
.....+++..++.++.||+.||.||| +.+ |+||||||+|||++.++.+||+
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEEC
T ss_pred ceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEE
Confidence 11234778889999999999999999 666 9999999999999999999999
Q ss_pred ccCcceeccccccc--cccceeeccCCccChhhhccC------CCCchhHHHHHHHHHHHHHhC----------CcCCCC
Q 005803 499 DFGMARTYAMNELE--ANTNRIVGTHGYMSPEYVMNG------IVSMKSDVYSFGVLVLEIVSS----------KKNNGS 560 (676)
Q Consensus 499 DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~------~~s~ksDVwSlGvvl~elltG----------~~pf~~ 560 (676)
|||++......... .......||+.|+|||.+.+. .++.++|||||||++|||++| +.||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 99999876543211 122345789999999999865 234789999999999999999 667765
Q ss_pred CCCCCccchHHHHHHHHhcCCccccCCcccCCC-CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 561 YDTERPLNLVGYAWQLWNEGKALELMDPTLDES-CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 561 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
....... . ........... ..+.+... ...+....+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 270 ~~~~~~~-~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 270 LVPSDPS-V-EEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp TSCSSCC-H-HHHHHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCcCccc-H-HHHHHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 4332211 1 11122221211 12222211 12356778999999999999999999999999998864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=294.69 Aligned_cols=223 Identities=28% Similarity=0.452 Sum_probs=155.7
Q ss_pred HhcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346799999999999999999987 468999999986432 223467899999999999999872
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
......+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 112256889999999999999999999998 999999999999999999999999999875432
Q ss_pred ccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .... .+..
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------~~~~---~~~~ 230 (278)
T 3cok_A 166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----------KVVL---ADYE 230 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CCS---SCCC
T ss_pred CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH----------HHhh---cccC
Confidence 21 1223578999999999998889999999999999999999999997644322110 0000 0111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
+ +......+.+++.+||+.||++|||++++++
T Consensus 231 ~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 M----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp C----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred C----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1 1222345778999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.59 Aligned_cols=226 Identities=17% Similarity=0.301 Sum_probs=176.0
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
.++|++.+.||+|+||.||+|+. +++.||||++.... ....+++.+|+.++++++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 35789999999999999999998 48899999997542 344567999999999999999872
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
......+++..+..++.||+.||.|||+++ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 011124789999999999999999999875 3499999999999999999999999888754221
Q ss_pred ccccccceeeccCCccChhhhccCCCCc---hhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVSM---KSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~---ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
....||+.|+|||.+.+..++. ++|||||||++|||++|+.||...... .........+.
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~----- 228 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGL----- 228 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSCC-----
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcCC-----
Confidence 2256899999999998765444 899999999999999999999754321 11111211111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.+.+.. .....+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 229 ~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 229 RPTIPP----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 112222 22345788999999999999999999999998764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=311.37 Aligned_cols=176 Identities=23% Similarity=0.358 Sum_probs=143.0
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+++.+|+.++++++|+||+..
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3578999999999999999999865 4889999999753 23345678999999999999999731
Q ss_pred -----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 445 -----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 445 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 104 ELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred eEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 11234889999999999999999999998 9999999999999999999999999998764
Q ss_pred ccccc--------------------cccceeeccCCccChhhh-ccCCCCchhHHHHHHHHHHHHHhCCcCCC
Q 005803 508 MNELE--------------------ANTNRIVGTHGYMSPEYV-MNGIVSMKSDVYSFGVLVLEIVSSKKNNG 559 (676)
Q Consensus 508 ~~~~~--------------------~~~~~~~gt~~Y~APE~~-~~~~~s~ksDVwSlGvvl~elltG~~pf~ 559 (676)
..... ......+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 33211 123457899999999986 45679999999999999999998655543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=295.26 Aligned_cols=227 Identities=23% Similarity=0.317 Sum_probs=176.4
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999875 58999999986542 334567889999999999999873
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC---eEEeccCcceeccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN---PKISDFGMARTYAM 508 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~---vkL~DFGla~~~~~ 508 (676)
......+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 111234788899999999999999999998 999999999999986655 99999999986543
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... .......+.... ..+
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~-~~~ 229 (284)
T 3kk8_A 161 SEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAYDY-PSP 229 (284)
T ss_dssp SCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC-CTT
T ss_pred Ccc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-------HHHHHHhccccC-Cch
Confidence 322 223578999999999999999999999999999999999999996532111 111222222111 011
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
. .......+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 230 E-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp T-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred h-----hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 11223457789999999999999999999873
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=308.10 Aligned_cols=233 Identities=24% Similarity=0.333 Sum_probs=162.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDSS------------- 445 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~------------- 445 (676)
.++|++.+.||+|+||.||+|... +++.||||++... .....+++.+|+.++++++||||+...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999864 5899999998653 233456788999999999999997311
Q ss_pred -----------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 446 -----------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 446 -----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 108 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---------
T ss_pred eEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 1235788899999999999999999998 99999999999999999999999999986432
Q ss_pred cccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ........ ...+.+.
T Consensus 185 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~---~i~~~~g~-p~~~~~~ 255 (367)
T 2fst_X 185 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK---LILRLVGT-PGAELLK 255 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCS-CCHHHHT
T ss_pred c-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCC-CCHHHHH
Confidence 2 233678999999999987 679999999999999999999999997643221111 11111000 0000000
Q ss_pred c-----------ccC--CCCC-----hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 588 P-----------TLD--ESCS-----SDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 588 ~-----------~l~--~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
. .+. .... ......+.+|+.+||+.||++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 000 0000 1112457889999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=305.75 Aligned_cols=237 Identities=22% Similarity=0.308 Sum_probs=173.6
Q ss_pred cccHHHHHHHhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccC--CchhhHHHHHHHHHHHHccC--Ccccc----
Q 005803 372 IFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH--TNLTD---- 443 (676)
Q Consensus 372 ~f~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H--~niv~---- 443 (676)
.+.++.+....++|++.+.||+|+||.||+++..+++.||||++... .....+.+.+|+.++.+++| +||+.
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 34445555567789999999999999999999888999999998653 23455778999999999984 88873
Q ss_pred ---------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCc
Q 005803 444 ---------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGM 502 (676)
Q Consensus 444 ---------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGl 502 (676)
......+++..+..++.||++||.|||+++ |+||||||+|||+++ +.+||+|||+
T Consensus 97 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 97 EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp EECSSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred eecCCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccc
Confidence 112345788899999999999999999998 999999999999975 7899999999
Q ss_pred ceeccccccccccceeeccCCccChhhhcc-----------CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHH
Q 005803 503 ARTYAMNELEANTNRIVGTHGYMSPEYVMN-----------GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVG 571 (676)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----------~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~ 571 (676)
+................|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~ 247 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----IS 247 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HH
Confidence 987654333223334578999999999875 47889999999999999999999999643211 11
Q ss_pred HHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 572 YAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 572 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
...... . +......+......+.+++.+||+.||++||++.|+++.
T Consensus 248 ~~~~~~-~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 248 KLHAII-D--------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHH-C--------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHH-h--------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111 1 111111111123457788999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=296.11 Aligned_cols=236 Identities=21% Similarity=0.249 Sum_probs=171.3
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc---hhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
..++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999875 588999999975422 23467899999999999999873
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 111245888999999999999999999998 9999999999999999999999999997654332
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .......... ... ....
T Consensus 189 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~-~~~--~~~~ 257 (309)
T 2h34_A 189 LT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQA-IPR--PSTV 257 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSC-CCC--GGGT
T ss_pred cc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccC-CCC--cccc
Confidence 21 22335789999999999999999999999999999999999999974321 1111111111 100 0011
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCC-CHHHHHHHHhcCcCCC
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRR-TMSDVVSMLTNDTMAL 634 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-s~~eVl~~Le~~~~~l 634 (676)
.......+.+++.+||+.||++|| +++++++.|+......
T Consensus 258 ----~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 258 ----RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp ----STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ----CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 112223577889999999999999 9999999999886433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=318.05 Aligned_cols=237 Identities=20% Similarity=0.260 Sum_probs=180.1
Q ss_pred cHHHHHHHhcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc------
Q 005803 374 DFQTIAAATDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD------ 443 (676)
Q Consensus 374 ~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~------ 443 (676)
.+.++....++|++.++||+|+||.||+|+... ++.||||++.+.. ......+.+|+.++..++||||+.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 345566678999999999999999999999765 7889999996531 223345899999999999999972
Q ss_pred --------------------c-cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCc
Q 005803 444 --------------------S-SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGM 502 (676)
Q Consensus 444 --------------------~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGl 502 (676)
. .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhh
Confidence 0 11356889999999999999999999998 99999999999999999999999999
Q ss_pred ceeccccccccccceeeccCCccChhhhc-----cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHH
Q 005803 503 ARTYAMNELEANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLW 577 (676)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~ 577 (676)
++........ .....+||+.|+|||++. ...++.++|||||||++|||++|+.||......+. .....
T Consensus 222 a~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~------~~~i~ 294 (437)
T 4aw2_A 222 CLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIM 294 (437)
T ss_dssp CEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH
T ss_pred hhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH------HHhhh
Confidence 9865443221 223368999999999997 46789999999999999999999999975432111 11111
Q ss_pred hcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCC--CCCHHHHHHH
Q 005803 578 NEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAAD--RRTMSDVVSM 626 (676)
Q Consensus 578 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~eVl~~ 626 (676)
.... ...-+.... .....+.+++.+||..+|++ ||+++|+++.
T Consensus 295 ~~~~--~~~~p~~~~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 295 NHKE--RFQFPTQVT----DVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp THHH--HCCCCSSCC----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hccc--cccCCcccc----cCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1000 000011111 12334778888999888888 9999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.57 Aligned_cols=239 Identities=20% Similarity=0.269 Sum_probs=166.7
Q ss_pred HHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--hhhHHHHHHHHHHHHccCCcccc------------
Q 005803 379 AAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLTD------------ 443 (676)
Q Consensus 379 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~------------ 443 (676)
....++|++.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||++
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345678999999999999999999865 689999999965432 23456789999999999999983
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc-----CCCCeEEeccCccee
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD-----EQMNPKISDFGMART 505 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~-----~~~~vkL~DFGla~~ 505 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 110 lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 110 LIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 112345888999999999999999999998 99999999999994 455599999999986
Q ss_pred ccccccccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc-
Q 005803 506 YAMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL- 583 (676)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~- 583 (676)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ...............
T Consensus 187 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 187 FGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTT
T ss_pred cCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHHHHHHhCCCchhh
Confidence 543221 22335789999999999874 58999999999999999999999997543211 111111111000000
Q ss_pred -----cc--CC---cccCCC-----CChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 584 -----EL--MD---PTLDES-----CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 584 -----~~--~d---~~l~~~-----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.. .. +..... ........+.+++.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 00 000000 00012346788999999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=302.53 Aligned_cols=231 Identities=29% Similarity=0.391 Sum_probs=174.7
Q ss_pred hcCCCcceeeccCCCccEEEEEE------cCCcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCccccc----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL------LDGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTDS---------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~------~~~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~~---------- 444 (676)
.++|++.+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++++++||||++.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999983 24778999999654 33455678999999999999998720
Q ss_pred -----------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC---CCCeEEe
Q 005803 445 -----------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE---QMNPKIS 498 (676)
Q Consensus 445 -----------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~---~~~vkL~ 498 (676)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 01134788899999999999999999998 999999999999984 4469999
Q ss_pred ccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHH
Q 005803 499 DFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLW 577 (676)
Q Consensus 499 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~ 577 (676)
|||++................|++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ......
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFV 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-------HHHHHH
Confidence 9999976543332222333567889999999999999999999999999999998 99998754211 111222
Q ss_pred hcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 578 NEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 578 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
..+... .. +......+.+++.+||+.||.+||++.+|++.|+...
T Consensus 259 ~~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 259 TSGGRM-----DP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HTTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCC-----CC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 222111 11 1122345788999999999999999999999998764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.87 Aligned_cols=236 Identities=21% Similarity=0.232 Sum_probs=171.6
Q ss_pred hcCCCcc-eeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCcccc---------------
Q 005803 382 TDNFSPA-NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTD--------------- 443 (676)
Q Consensus 382 t~~y~~~-~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~--------------- 443 (676)
.+.|.+. +.||+|+||.||+|+.. +++.||||++..........+.+|+.++.++ +||||++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3578774 78999999999999854 6899999999876666677899999999995 7999973
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC---eEEeccCcceecccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN---PKISDFGMARTYAMN 509 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~---vkL~DFGla~~~~~~ 509 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 112245788899999999999999999998 999999999999998776 999999999765322
Q ss_pred cc-----ccccceeeccCCccChhhhcc-----CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccch--------HH
Q 005803 510 EL-----EANTNRIVGTHGYMSPEYVMN-----GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNL--------VG 571 (676)
Q Consensus 510 ~~-----~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l--------~~ 571 (676)
.. ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........... ..
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 11 111223568999999999875 5688999999999999999999999986543321100 01
Q ss_pred HHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 572 YAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 572 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
........+... . ...... .....+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~i~~~~~~-~-~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 248 MLFESIQEGKYE-F-PDKDWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHCCCC-C-CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhccCcc-c-Cchhcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111122222111 0 000001 123457889999999999999999999984
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=299.06 Aligned_cols=232 Identities=23% Similarity=0.327 Sum_probs=171.1
Q ss_pred hcCCCcceeeccCCCccEEEEEEc--CCc--EEEEEEeccC---CchhhHHHHHHHHHHHHccCCccccc----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL--DGQ--EIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTDS---------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~--~~~--~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~~---------- 444 (676)
.++|++.+.||+|+||.||+|++. +++ .||||+++.. .....+.+.+|+.++++++||||++.
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 96 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence 357999999999999999999853 233 6899998654 23456788999999999999999731
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
.....+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccc
Confidence 11245788899999999999999999998 99999999999999999999999999987654
Q ss_pred cccc-cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 509 NELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 509 ~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ............
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~---- 243 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGER---- 243 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCC----
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCCC----
Confidence 3221 12233467788999999999889999999999999999999 99999754321 111111111111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.. .+......+.+++.+||+.||++|||+.++++.|++..
T Consensus 244 -~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 244 -LP----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp -CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -CC----CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 11 11223346888999999999999999999999998875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=298.27 Aligned_cols=231 Identities=24% Similarity=0.321 Sum_probs=178.1
Q ss_pred hcCCCcce-eeccCCCccEEEEEEc---CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc------------
Q 005803 382 TDNFSPAN-RLGQGGFGPVYNGKLL---DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD------------ 443 (676)
Q Consensus 382 t~~y~~~~-~LG~G~fG~Vy~~~~~---~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~------------ 443 (676)
.++|.+.+ .||+|+||.||+|... +++.||||++.... ....+++.+|+.++++++||||++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~l 94 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWML 94 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEE
Confidence 45788877 9999999999999642 36889999997542 233577999999999999999873
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 112345888999999999999999999998 9999999999999999999999999998764432
Q ss_pred cc-cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 511 LE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 511 ~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
.. .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+...
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~----- 239 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERM----- 239 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCC-----
T ss_pred CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC-----
Confidence 21 11222346788999999998899999999999999999999 999997543211 12222222211
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
. .+......+.+++.+||+.||++||++.+|++.|++..
T Consensus 240 ~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 240 G----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp C----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 12223345888999999999999999999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=302.81 Aligned_cols=230 Identities=25% Similarity=0.394 Sum_probs=172.8
Q ss_pred cCCCcceeeccCCCccEEEEEEcC-----CcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD-----GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~-----~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
++|.+.+.||+|+||.||+|+... +..||||++.... ......+.+|+.++++++||||++.
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 567888999999999999998643 2359999997543 3345678999999999999999730
Q ss_pred ---------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 445 ---------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 445 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 12245888999999999999999999998 999999999999999999999999999875433
Q ss_pred cccc-ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 510 ELEA-NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 510 ~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
.... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ........+...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~~~~~~~~~~---- 269 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-------EVMKAINDGFRL---- 269 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTCCC----
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHCCCcC----
Confidence 2111 1122345778999999999999999999999999999999 99999654221 111222222111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
. .+......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 270 -~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 270 -P----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp -C----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -C----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 11223345788999999999999999999999998875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=308.34 Aligned_cols=219 Identities=24% Similarity=0.277 Sum_probs=167.7
Q ss_pred ceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc----------------------
Q 005803 388 ANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS---------------------- 444 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~---------------------- 444 (676)
.+.||+|+||.||+|+.. +++.||||+++.......+++.+|+.++++++||||++.
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 578999999999999864 589999999987665667789999999999999999730
Q ss_pred -----cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE--cCCCCeEEeccCcceeccccccccccce
Q 005803 445 -----SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL--DEQMNPKISDFGMARTYAMNELEANTNR 517 (676)
Q Consensus 445 -----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl--~~~~~vkL~DFGla~~~~~~~~~~~~~~ 517 (676)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++....... ...
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~ 247 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKV 247 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---ccc
Confidence 11235788889999999999999999998 9999999999999 5678899999999987654322 223
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChH
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 597 (676)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ...+...... +...... .
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~-~~~i~~~~~~--~~~~~~~----~ 314 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------T-LNNILACRWD--LEDEEFQ----D 314 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------H-HHHHHHTCCC--SCSGGGT----T
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------H-HHHHHhccCC--CChhhhc----c
Confidence 569999999999999999999999999999999999999997543211 1 1111111110 0111111 1
Q ss_pred HHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 598 EVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 598 ~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
....+.+++.+||+.||.+|||+.|+++
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2345788999999999999999999997
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=314.87 Aligned_cols=237 Identities=21% Similarity=0.265 Sum_probs=179.0
Q ss_pred ccHHHHHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCccccc----
Q 005803 373 FDFQTIAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTDS---- 444 (676)
Q Consensus 373 f~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~~---- 444 (676)
+.++++....++|++.+.||+|+||.||+++.. +++.||||++++.. ......+.+|..++.+++||||+..
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345556667899999999999999999999975 59999999996532 2234568899999999999998720
Q ss_pred -----------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccC
Q 005803 445 -----------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFG 501 (676)
Q Consensus 445 -----------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFG 501 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 11246888899999999999999999998 9999999999999999999999999
Q ss_pred cceeccccccccccceeeccCCccChhhhc-------cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHH
Q 005803 502 MARTYAMNELEANTNRIVGTHGYMSPEYVM-------NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAW 574 (676)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~-------~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~ 574 (676)
+++........ .....+||+.|+|||++. ...++.++|||||||++|||++|+.||......+. ..
T Consensus 208 la~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~ 280 (412)
T 2vd5_A 208 SCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET------YG 280 (412)
T ss_dssp TCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HH
T ss_pred hheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH------HH
Confidence 99876543221 122368999999999997 35789999999999999999999999975432111 11
Q ss_pred HHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCC---CCHHHHHHH
Q 005803 575 QLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADR---RTMSDVVSM 626 (676)
Q Consensus 575 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R---Ps~~eVl~~ 626 (676)
... .... ...-+...... ...+.+++.+||+ +|.+| |+++||++.
T Consensus 281 ~i~-~~~~-~~~~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 281 KIV-HYKE-HLSLPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHH-THHH-HCCCC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHH-hccc-CcCCCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 111 1000 00011111122 2357788899999 99998 689999865
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=293.64 Aligned_cols=225 Identities=20% Similarity=0.257 Sum_probs=176.9
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
..++|++.+.||+|+||.||+|+... ++.||+|++........+.+.+|++++++++||||++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 45689999999999999999998764 7799999998766666788999999999999999873
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE---cCCCCeEEeccCcceeccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL---DEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl---~~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 112345788899999999999999999998 9999999999999 788999999999998765332
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
......||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... .......+.... ....
T Consensus 164 ---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~--~~~~ 230 (277)
T 3f3z_A 164 ---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIREGTFTF--PEKD 230 (277)
T ss_dssp ---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC--CHHH
T ss_pred ---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCCC--Cchh
Confidence 2233578999999998865 48999999999999999999999997543211 111122221110 0000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.. .....+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 WL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 12345788999999999999999999985
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=308.53 Aligned_cols=224 Identities=22% Similarity=0.313 Sum_probs=174.9
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccC---CchhhHHHHHHHHHHHHc-cCCcccc------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLTD------------ 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~------------ 443 (676)
..++|++.+.||+|+||.||+|+... ++.||||++++. .....+.+..|..++..+ +||||+.
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 35789999999999999999999764 789999999754 223456788999999988 7999872
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 111245788899999999999999999998 999999999999999999999999999854322
Q ss_pred ccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ....+..+.. .
T Consensus 175 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~-~~~~i~~~~~------~ 239 (353)
T 2i0e_A 175 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------E-LFQSIMEHNV------A 239 (353)
T ss_dssp T--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCC------C
T ss_pred C--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------H-HHHHHHhCCC------C
Confidence 2 1233468999999999999999999999999999999999999999753211 1 1112222211 1
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHH
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRT-----MSDVVSM 626 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~eVl~~ 626 (676)
+ +......+.+++.+||+.||.+||+ +++|++.
T Consensus 240 ~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 240 Y----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp C----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred C----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 1222345788899999999999995 5777653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=302.39 Aligned_cols=237 Identities=20% Similarity=0.241 Sum_probs=175.6
Q ss_pred HHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC-----CchhhHHHHHHHHHHHHccCCccccc-------
Q 005803 378 IAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS-----SGQGIVEFKNEAKLIAKLQHTNLTDS------- 444 (676)
Q Consensus 378 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~~------- 444 (676)
+....++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||++.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 5667789999999999999999999875 5889999998643 23456789999999999999999831
Q ss_pred ---------c-c-------------------------------------------------cCcCCHHHHHHHHHHHHHH
Q 005803 445 ---------S-R-------------------------------------------------KSLLDWKKRFYIIEGIVQG 465 (676)
Q Consensus 445 ---------~-~-------------------------------------------------~~~l~~~~~~~i~~qia~g 465 (676)
. . ...+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 0 0 1112456677899999999
Q ss_pred HHHHHhcCCCceEeeccccCceEEcCCC--CeEEeccCcceeccccccc--cccceeeccCCccChhhhcc--CCCCchh
Q 005803 466 LLYLHKYSRLRAIHRDLKVSNILLDEQM--NPKISDFGMARTYAMNELE--ANTNRIVGTHGYMSPEYVMN--GIVSMKS 539 (676)
Q Consensus 466 L~yLH~~~~~~iiH~DLKp~NILl~~~~--~vkL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~--~~~s~ks 539 (676)
|+|||+++ |+||||||+|||++.++ .+||+|||++..+...... .......||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 8999999999865432211 12234679999999999975 6789999
Q ss_pred HHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCC
Q 005803 540 DVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRT 619 (676)
Q Consensus 540 DVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs 619 (676)
|||||||++|||++|+.||...... ......... ... ...+. .......+.+++.+||+.||.+||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~-~~~-~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNK-KLC-FENPN-----YNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC-CCC-TTSGG-----GGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhc-ccc-cCCcc-----cccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999999754321 111112111 110 00111 1112345788999999999999999
Q ss_pred HHHHHHH--HhcC
Q 005803 620 MSDVVSM--LTND 630 (676)
Q Consensus 620 ~~eVl~~--Le~~ 630 (676)
+.|+++. +++.
T Consensus 325 ~~~~l~hp~~~~~ 337 (345)
T 3hko_A 325 AMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHSHHHHTT
T ss_pred HHHHhcChhhccC
Confidence 9999874 5444
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.05 Aligned_cols=224 Identities=25% Similarity=0.414 Sum_probs=178.6
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
.+.|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356899999999999999999864 58999999997543 345678999999999999999872
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++........ .
T Consensus 101 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 175 (303)
T 3a7i_A 101 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--K 175 (303)
T ss_dssp CCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--C
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc--c
Confidence 122346889999999999999999999998 99999999999999999999999999987654322 1
Q ss_pred cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 515 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .......+. .+.+....
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~-----~~~~~~~~ 243 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-------VLFLIPKNN-----PPTLEGNY 243 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSC-----CCCCCSSC
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-------HHHHhhcCC-----CCCCcccc
Confidence 233578999999999999999999999999999999999999997532111 111111111 11222222
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
...+.+++.+||+.||++|||+.|+++.
T Consensus 244 ----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 244 ----SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 2357889999999999999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=305.21 Aligned_cols=225 Identities=20% Similarity=0.233 Sum_probs=153.0
Q ss_pred ceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHcc-CCcccc----------------------
Q 005803 388 ANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLTD---------------------- 443 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~---------------------- 443 (676)
.+.||+|+||.||+|+.. +++.||||++... ....+.+|+.++.++. ||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999875 5899999999642 4567789999999997 999983
Q ss_pred ----ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC---CeEEeccCcceeccccccccccc
Q 005803 444 ----SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM---NPKISDFGMARTYAMNELEANTN 516 (676)
Q Consensus 444 ----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~---~vkL~DFGla~~~~~~~~~~~~~ 516 (676)
......+++.++..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++....... ...
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~ 167 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLK 167 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--ccc
Confidence 112345889999999999999999999998 99999999999997665 799999999986543322 223
Q ss_pred eeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCCh
Q 005803 517 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSS 596 (676)
Q Consensus 517 ~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 596 (676)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||.....................+... .......
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~~~ 241 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGEAWK 241 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSHHHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCccccc
Confidence 3578999999999999999999999999999999999999998654332222222222233222221 0000001
Q ss_pred HHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 597 DEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 597 ~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.....+.+++.+||+.||++|||++|+++.
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 223467889999999999999999999854
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=311.40 Aligned_cols=231 Identities=22% Similarity=0.296 Sum_probs=171.5
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc-----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~----------------- 444 (676)
.+|++.+.||+|+||.||+|++. +++.||||++.... ....+|++++++++|+||+..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999975 58999999986532 223579999999999999831
Q ss_pred ------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC-CCeEEeccCccee
Q 005803 445 ------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ-MNPKISDFGMART 505 (676)
Q Consensus 445 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~-~~vkL~DFGla~~ 505 (676)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 11245777888999999999999999998 9999999999999965 5689999999987
Q ss_pred ccccccccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHH--------
Q 005803 506 YAMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQL-------- 576 (676)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~-------- 576 (676)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.. ......
T Consensus 207 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l---~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 207 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL---VEIIKVLGTPTREQ 280 (420)
T ss_dssp CCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCSCCHHH
T ss_pred cccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHH
Confidence 543321 2235789999999999765 7999999999999999999999999764322111 111111
Q ss_pred Hh--cCCccccCCcccCCC-----CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 577 WN--EGKALELMDPTLDES-----CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 577 ~~--~~~~~~~~d~~l~~~-----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+. .....+..-+.+... +.......+.+|+.+||+.||++||++.|+++.
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00 111111111111110 112223568899999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=320.86 Aligned_cols=224 Identities=23% Similarity=0.321 Sum_probs=166.7
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
..++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+.
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3468999999999999999999865 5899999999753 3334566789999999999999873
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHK-YSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
......+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 1123457888999999999999999998 77 999999999999999999999999999754322
Q ss_pred ccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......... .
T Consensus 303 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~------~ 367 (446)
T 4ejn_A 303 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEI------R 367 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC------C
T ss_pred C--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHHhCCC------C
Confidence 2 12234689999999999999999999999999999999999999997543211 1111111111 1
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRR-----TMSDVVSM 626 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~ 626 (676)
+ +......+.+++.+||+.||.+|| +++|+++.
T Consensus 368 ~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 368 F----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C----CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1 112234578899999999999999 99999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=312.11 Aligned_cols=229 Identities=22% Similarity=0.282 Sum_probs=168.8
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--------chhhHHHHHHHHHHHHccCCcccc-------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--------GQGIVEFKNEAKLIAKLQHTNLTD------- 443 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~------- 443 (676)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 35679999999999999999999865 58999999986532 122335889999999999999973
Q ss_pred ------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC---CCeEEeccCc
Q 005803 444 ------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ---MNPKISDFGM 502 (676)
Q Consensus 444 ------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~---~~vkL~DFGl 502 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeeccc
Confidence 122356889999999999999999999998 9999999999999754 4599999999
Q ss_pred ceeccccccccccceeeccCCccChhhhcc---CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhc
Q 005803 503 ARTYAMNELEANTNRIVGTHGYMSPEYVMN---GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNE 579 (676)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 579 (676)
++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +. .....
T Consensus 289 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~----~~i~~ 359 (419)
T 3i6u_A 289 SKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK----DQITS 359 (419)
T ss_dssp TTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HH----HHHHT
T ss_pred ceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HH----HHHhc
Confidence 98754322 2234679999999999863 6788999999999999999999999976433221 11 11112
Q ss_pred CCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 580 GKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 580 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+.... .+.... .....+.+++.+||+.||++|||++|+++.
T Consensus 360 ~~~~~--~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 360 GKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp TCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCC--Cchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 21110 011111 123457889999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=311.31 Aligned_cols=173 Identities=23% Similarity=0.286 Sum_probs=146.0
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHcc------CCcccc----------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ------HTNLTD---------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~---------- 443 (676)
...+|++.++||+|+||.||+|+.. +++.||||++... .....++.+|+.++..+. |+||+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 4568999999999999999999865 4889999999653 344567888999999884 557762
Q ss_pred -----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC--eEEeccCcce
Q 005803 444 -----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN--PKISDFGMAR 504 (676)
Q Consensus 444 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~--vkL~DFGla~ 504 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++.
T Consensus 174 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 174 ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 111234888999999999999999999998 999999999999999887 9999999997
Q ss_pred eccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCC
Q 005803 505 TYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYD 562 (676)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~ 562 (676)
..... .....||+.|+|||++.+..++.++|||||||++|||++|++||....
T Consensus 251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 64322 233678999999999999999999999999999999999999997653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=327.12 Aligned_cols=230 Identities=23% Similarity=0.335 Sum_probs=176.6
Q ss_pred cCCCcce-eeccCCCccEEEEEEc---CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 383 DNFSPAN-RLGQGGFGPVYNGKLL---DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 383 ~~y~~~~-~LG~G~fG~Vy~~~~~---~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
+++.+.+ +||+|+||.||+|.+. ++..||||+++... ....+++.+|+++|++++||||++
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~ 414 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 414 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEE
Confidence 3444455 7999999999999764 46679999997643 345678999999999999999983
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 112345889999999999999999999998 99999999999999999999999999986543221
Q ss_pred c-cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 512 E-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 512 ~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
. .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ ....+..+...
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~------ 558 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM------ 558 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCCC------
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCC------
Confidence 1 11122345688999999999999999999999999999998 999998654321 12222233211
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
..+......+.+|+..||+.||++||++.+|++.|+...
T Consensus 559 ---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 559 ---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 112233456888999999999999999999999998764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=310.22 Aligned_cols=237 Identities=19% Similarity=0.270 Sum_probs=174.3
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------------ 444 (676)
.+|++.+.||+|+||.||+|+...+..||+|++..... ...+|+.++++++||||++.
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 46899999999999999999987777799998865322 22479999999999999831
Q ss_pred -----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc-CCCCeEEeccCcceec
Q 005803 445 -----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD-EQMNPKISDFGMARTY 506 (676)
Q Consensus 445 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~-~~~~vkL~DFGla~~~ 506 (676)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 01345778888999999999999999998 99999999999999 7899999999999876
Q ss_pred cccccccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHH--------HHHH
Q 005803 507 AMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYA--------WQLW 577 (676)
Q Consensus 507 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~--------~~~~ 577 (676)
..... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+... ....
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 43322 2235789999999998765 5899999999999999999999999764322111110000 0000
Q ss_pred hcCCccccCCccc-----CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcC
Q 005803 578 NEGKALELMDPTL-----DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTND 630 (676)
Q Consensus 578 ~~~~~~~~~d~~l-----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~ 630 (676)
.....+..-+.. ...+.......+.+|+.+||+.||.+|||+.|+++. ++++
T Consensus 270 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 270 -NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp -CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred -ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 000000000000 011112233468899999999999999999999975 5544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.65 Aligned_cols=227 Identities=22% Similarity=0.274 Sum_probs=176.8
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCch------hhHHHHHHHHHHHHccCCcccc----------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQ------GIVEFKNEAKLIAKLQHTNLTD---------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~---------- 443 (676)
..++|++.+.||+|+||.||+|+.. +++.||||.+...... ..+++.+|+.++++++||||+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467999999999999999999875 5899999998754321 3567999999999999999872
Q ss_pred ----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC----CeEEeccCcc
Q 005803 444 ----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM----NPKISDFGMA 503 (676)
Q Consensus 444 ----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~----~vkL~DFGla 503 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 112345788899999999999999999998 99999999999999887 7999999999
Q ss_pred eeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 504 RTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~- 235 (321)
T 2a2a_A 167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANITSVSY- 235 (321)
T ss_dssp EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCC-
T ss_pred eecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhccc-
Confidence 8765422 1233578999999999999999999999999999999999999997532111 1111111111
Q ss_pred ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 584 ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 584 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
..++..... ....+.+++.+||+.||++|||+.|+++.
T Consensus 236 -~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 236 -DFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp -CCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred -ccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011111111 22357789999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=301.52 Aligned_cols=227 Identities=23% Similarity=0.345 Sum_probs=178.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
.++|.+.+.||+|+||.||+++..+ ++.||+|++... .....+.+.+|+.++++++|+||++.
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4689999999999999999998764 889999998654 22345678999999999999999730
Q ss_pred -------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 445 -------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 445 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 11245788899999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... . .......... .+.
T Consensus 197 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~-~~~~~~~~~~------~~~ 261 (335)
T 2owb_A 197 --RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------E-TYLRIKKNEY------SIP 261 (335)
T ss_dssp --CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHHTCC------CCC
T ss_pred --cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------H-HHHHHhcCCC------CCC
Confidence 123357899999999999999999999999999999999999999753211 1 1111111111 111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcC
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTND 630 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~ 630 (676)
... ...+.+++.+||+.||++|||+.|+++. +.+.
T Consensus 262 ~~~----~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 262 KHI----NPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp TTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ccC----CHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 122 2357788999999999999999999973 5544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=305.08 Aligned_cols=229 Identities=22% Similarity=0.330 Sum_probs=174.9
Q ss_pred hcCCCcceeeccCCCccEEEEEE----cCCcEEEEEEeccCC----chhhHHHHHHHHHHHHc-cCCcccc---------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL----LDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKL-QHTNLTD--------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~----~~~~~VAvK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~--------- 443 (676)
.++|++.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|+.++.++ +||||+.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999987 368999999986532 23445678899999999 6999872
Q ss_pred -----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceec
Q 005803 444 -----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTY 506 (676)
Q Consensus 444 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~ 506 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 011245788889999999999999999998 999999999999999999999999999875
Q ss_pred cccccccccceeeccCCccChhhhcc--CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccc
Q 005803 507 AMNELEANTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584 (676)
Q Consensus 507 ~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (676)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ........ .
T Consensus 210 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~-~---- 281 (355)
T 1vzo_A 210 VADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILK-S---- 281 (355)
T ss_dssp CGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHH-C----
T ss_pred ccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHHHHhc-c----
Confidence 433222 2233579999999999985 357899999999999999999999997554332211 11111111 1
Q ss_pred cCCcccCCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHHH
Q 005803 585 LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRR-----TMSDVVSML 627 (676)
Q Consensus 585 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~L 627 (676)
.+. .+......+.+++.+||+.||.+|| ++.|+++..
T Consensus 282 --~~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 --EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --CCC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 111 1222334577899999999999999 999998764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.91 Aligned_cols=239 Identities=22% Similarity=0.232 Sum_probs=169.1
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccccc------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDSSR------------ 446 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~------------ 446 (676)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999865 5889999999753 2334567889999999999999983110
Q ss_pred -----------------cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 447 -----------------KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 447 -----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 124678888999999999999999998 999999999999999999999999999865432
Q ss_pred ccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchH----------------HHH
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLV----------------GYA 573 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~----------------~~~ 573 (676)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ...
T Consensus 181 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 181 F---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred c---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 1 123367899999999999999999999999999999999999999754321100000 000
Q ss_pred HHHHhcCC------ccccCCcccCCC---CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 574 WQLWNEGK------ALELMDPTLDES---CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 574 ~~~~~~~~------~~~~~d~~l~~~---~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
........ ............ ........+.+|+.+||+.||++|||++|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000 000000000000 011235578899999999999999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=295.45 Aligned_cols=231 Identities=23% Similarity=0.295 Sum_probs=177.5
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 568999999999999999999875 58999999997542 3445678999999999999998731
Q ss_pred ------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcC--CCceEeeccccCceEEcCCCCeEEeccCcce
Q 005803 445 ------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYS--RLRAIHRDLKVSNILLDEQMNPKISDFGMAR 504 (676)
Q Consensus 445 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~iiH~DLKp~NILl~~~~~vkL~DFGla~ 504 (676)
.....+++..++.++.||+.||.|||+.+ ..+|+||||||+||+++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 01123888899999999999999999976 2349999999999999999999999999997
Q ss_pred eccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccc
Q 005803 505 TYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584 (676)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (676)
....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ........+....
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~i~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGKIREGKFRR 235 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCC
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-------HHHHHHhhccccc
Confidence 6543221 112356899999999999999999999999999999999999999754311 1112222332211
Q ss_pred cCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 585 LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 585 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
+. ......+.+++.+||+.||++||++.||++.+...
T Consensus 236 -----~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 236 -----IP----YRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp -----CC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred -----CC----cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 11 12234578899999999999999999999877554
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=308.56 Aligned_cols=236 Identities=19% Similarity=0.237 Sum_probs=171.6
Q ss_pred HHHHhcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccccc-----------
Q 005803 378 IAAATDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSS----------- 445 (676)
Q Consensus 378 l~~~t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~~----------- 445 (676)
+....++|++.+.||+|+||.||+|+. .+++.||||++..... ...+|+.+++.++||||++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345678999999999999999999986 4689999999865322 234799999999999987411
Q ss_pred --------------------------------------------------------ccCcCCHHHHHHHHHHHHHHHHHH
Q 005803 446 --------------------------------------------------------RKSLLDWKKRFYIIEGIVQGLLYL 469 (676)
Q Consensus 446 --------------------------------------------------------~~~~l~~~~~~~i~~qia~gL~yL 469 (676)
....+++..+..++.||++||.||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp --------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 123467778889999999999999
Q ss_pred HhcCCCceEeeccccCceEEc-CCCCeEEeccCcceeccccccccccceeeccCCccChhhhccC-CCCchhHHHHHHHH
Q 005803 470 HKYSRLRAIHRDLKVSNILLD-EQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVL 547 (676)
Q Consensus 470 H~~~~~~iiH~DLKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvv 547 (676)
|+++ |+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++|||||||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9998 99999999999998 688999999999987643322 2335789999999998875 48999999999999
Q ss_pred HHHHHhCCcCCCCCCCCCccchHHHHHHHHh----------cCCccccCCccc-----CCCCChHHHHHHHHHHHHhccc
Q 005803 548 VLEIVSSKKNNGSYDTERPLNLVGYAWQLWN----------EGKALELMDPTL-----DESCSSDEVMRCIHVGLLCVQD 612 (676)
Q Consensus 548 l~elltG~~pf~~~~~~~~~~l~~~~~~~~~----------~~~~~~~~d~~l-----~~~~~~~~~~~l~~L~~~Cl~~ 612 (676)
+|||++|+.||......+.. ........ .....+..-+.+ ....+......+.+|+.+||+.
T Consensus 232 l~ell~g~~pf~~~~~~~~~---~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQL---VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHHHH---HHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 99999999999764322211 11111000 000111100111 1111222334578999999999
Q ss_pred CcCCCCCHHHHHHH
Q 005803 613 RAADRRTMSDVVSM 626 (676)
Q Consensus 613 dP~~RPs~~eVl~~ 626 (676)
||.+|||+.|+++.
T Consensus 309 dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 309 EPDLRINPYEAMAH 322 (383)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999853
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=292.40 Aligned_cols=225 Identities=22% Similarity=0.289 Sum_probs=176.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+.
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999876 47889999986432 223467899999999999999873
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 011235788899999999999999999998 9999999999999999999999999997654321
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... . ......... ..+
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~-~~~~~~~~~------~~~- 231 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------E-THRRIVNVD------LKF- 231 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHTTC------CCC-
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------H-HHHHHhccc------cCC-
Confidence 22357899999999999999999999999999999999999999753211 1 111111111 111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH--HHhcC
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS--MLTND 630 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~--~Le~~ 630 (676)
+......+.+++.+||+.||.+||++.++++ .+...
T Consensus 232 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 232 ---PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ---CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 1222345778999999999999999999986 34443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=295.52 Aligned_cols=223 Identities=22% Similarity=0.331 Sum_probs=176.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
.++|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++|+||++.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467899999999999999999976 48899999986542 2345678899999999999999731
Q ss_pred -------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 445 -------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 445 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
.....+++.++..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 11245788999999999999999999998 99999999999999999999999999987543221
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... . .......... .+.
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~------~~~ 235 (294)
T 2rku_A 171 --RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------E-TYLRIKKNEY------SIP 235 (294)
T ss_dssp --CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHTTCC------CCC
T ss_pred --ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHhhccC------CCc
Confidence 123357899999999999988999999999999999999999999753211 1 1111111111 111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
. .....+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 236 K----HINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp T----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred c----ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 222357788999999999999999999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=296.75 Aligned_cols=224 Identities=23% Similarity=0.320 Sum_probs=160.4
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--hhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.++...++.++||||+.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 468999999999999999999874 689999999975422 22233455566688899999872
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKY-SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
......+++..+..++.||+.||.|||++ + |+||||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 01235688999999999999999999998 8 99999999999999999999999999986543
Q ss_pred cccccccceeeccCCccChhhh----ccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccc
Q 005803 509 NELEANTNRIVGTHGYMSPEYV----MNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~----~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (676)
... .....||+.|+|||.+ .+..++.++|||||||++|||++|+.||...... ........... ...
T Consensus 163 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~ 233 (290)
T 3fme_A 163 DVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEP-SPQ 233 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSC-CCC
T ss_pred ccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccC-CCC
Confidence 321 2224689999999996 4567899999999999999999999999743221 11111111111 111
Q ss_pred cCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 585 LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 585 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.. .......+.+++.+||+.||++|||+.|+++
T Consensus 234 -----~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 -----LP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----cc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11 1122345788999999999999999999987
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=290.30 Aligned_cols=223 Identities=23% Similarity=0.315 Sum_probs=168.2
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
.++|.+.++||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467999999999999999999875 58999999987643 3346788999999999999999730
Q ss_pred ---------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE---cCCCCeEEeccCcceec
Q 005803 445 ---------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL---DEQMNPKISDFGMARTY 506 (676)
Q Consensus 445 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl---~~~~~vkL~DFGla~~~ 506 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 11245888899999999999999999998 9999999999999 45678999999999865
Q ss_pred cccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 507 AMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 507 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
.... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||...... . ..............
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~-~~~~~~~~~~~~~~ 246 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------E-VQQKATYKEPNYAV 246 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCCCCC
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------H-HHhhhccCCccccc
Confidence 4322 123357899999999875 56899999999999999999999999754311 1 11111111111000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
. ... ....+.+++.+||+.||++|||+.||++
T Consensus 247 ~---~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 E---CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c---cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 011 1235778899999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=304.91 Aligned_cols=239 Identities=22% Similarity=0.309 Sum_probs=159.2
Q ss_pred cCCCc-ceeeccCCCccEEEEEEc---CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccccc-------------
Q 005803 383 DNFSP-ANRLGQGGFGPVYNGKLL---DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSS------------- 445 (676)
Q Consensus 383 ~~y~~-~~~LG~G~fG~Vy~~~~~---~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~~------------- 445 (676)
+.|.+ .++||+|+||.||+|+.. +++.||||++.... ....+.+|+.++++++||||+...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44655 558999999999999865 47889999996532 345788999999999999998310
Q ss_pred -----------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE----cCCCCeEEe
Q 005803 446 -----------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL----DEQMNPKIS 498 (676)
Q Consensus 446 -----------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl----~~~~~vkL~ 498 (676)
....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+
T Consensus 98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 0113788889999999999999999998 9999999999999 678899999
Q ss_pred ccCcceecccccc-ccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCc------cchH
Q 005803 499 DFGMARTYAMNEL-EANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERP------LNLV 570 (676)
Q Consensus 499 DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~------~~l~ 570 (676)
|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987643211 1223346889999999999874 589999999999999999999999975433210 0111
Q ss_pred HHHHHHHhcCC---cccc------------CCcccCCCCCh---------HHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 571 GYAWQLWNEGK---ALEL------------MDPTLDESCSS---------DEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 571 ~~~~~~~~~~~---~~~~------------~d~~l~~~~~~---------~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
......+.... ...+ +.......... .....+.+|+.+||+.||.+|||++|+++.
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11111110000 0000 00000000000 012357789999999999999999999985
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.60 Aligned_cols=227 Identities=21% Similarity=0.261 Sum_probs=173.8
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCcccc---------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTD--------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~--------------- 443 (676)
..++|++.+.||+|+||.||+++.. +++.||||++.+... ...+|++++.++ +||||+.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4568999999999999999999875 588999999976432 345788888888 7999972
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC----CCeEEeccCcceeccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ----MNPKISDFGMARTYAM 508 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~----~~vkL~DFGla~~~~~ 508 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||+.++ +.+||+|||+++....
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 112345888999999999999999999998 9999999999998543 3499999999987644
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .......+...
T Consensus 173 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~~~~i~~~~~~----- 241 (342)
T 2qr7_A 173 ENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE----ILARIGSGKFS----- 241 (342)
T ss_dssp TTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH----HHHHHHHCCCC-----
T ss_pred CCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH----HHHHHccCCcc-----
Confidence 322 2234678999999999998889999999999999999999999997543222111 12222222221
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+...........+.+++.+||+.||++||++.|+++.
T Consensus 242 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 -LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp -CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111112233457789999999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=296.96 Aligned_cols=243 Identities=21% Similarity=0.276 Sum_probs=176.9
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccccc-------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDSS------------- 445 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~------------- 445 (676)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999875 58999999996533 33456788999999999999998311
Q ss_pred ----------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 446 ----------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 446 ----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 89 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 1234788889999999999999999998 999999999999999999999999999876432
Q ss_pred cccc--------ccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcC
Q 005803 510 ELEA--------NTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG 580 (676)
Q Consensus 510 ~~~~--------~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 580 (676)
.... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~ 242 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFGIIGTP 242 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCC
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCC
Confidence 2111 1123578999999998765 6789999999999999999999999975432111 00001110000
Q ss_pred Ccccc-------------------CCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcC
Q 005803 581 KALEL-------------------MDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTND 630 (676)
Q Consensus 581 ~~~~~-------------------~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~ 630 (676)
..... ....+. ...+.....+.+++.+||+.||++|||+.|+++. ++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred chhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 00000 000000 0001223457889999999999999999999974 5443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=296.40 Aligned_cols=240 Identities=20% Similarity=0.251 Sum_probs=175.9
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHcc-----------CCcccc------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-----------HTNLTD------ 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~------ 443 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++.. .......+.+|+.+++++. |+||+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 368999999999999999999864 689999999965 3345567889999999887 778762
Q ss_pred -------------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeeccccCceEEc------C
Q 005803 444 -------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKY-SRLRAIHRDLKVSNILLD------E 491 (676)
Q Consensus 444 -------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLKp~NILl~------~ 491 (676)
......+++..+..++.||+.||.|||++ + |+||||||+|||++ .
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcC
Confidence 01123488889999999999999999998 8 99999999999994 4
Q ss_pred CCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHH
Q 005803 492 QMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVG 571 (676)
Q Consensus 492 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~ 571 (676)
.+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 174 ~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 447999999999875432 223578999999999999999999999999999999999999998654322111111
Q ss_pred HHHHHHh-----------cCC----------ccccCCc-c---------cCCCCChHHHHHHHHHHHHhcccCcCCCCCH
Q 005803 572 YAWQLWN-----------EGK----------ALELMDP-T---------LDESCSSDEVMRCIHVGLLCVQDRAADRRTM 620 (676)
Q Consensus 572 ~~~~~~~-----------~~~----------~~~~~d~-~---------l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~ 620 (676)
....... .+. ....+.. . -....+......+.+|+.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 1111100 000 0000000 0 0112445677789999999999999999999
Q ss_pred HHHHHH--HhcC
Q 005803 621 SDVVSM--LTND 630 (676)
Q Consensus 621 ~eVl~~--Le~~ 630 (676)
+||++. +.+.
T Consensus 329 ~ell~hp~f~~~ 340 (373)
T 1q8y_A 329 GGLVNHPWLKDT 340 (373)
T ss_dssp HHHHTCGGGTTC
T ss_pred HHHhhChhhhcc
Confidence 999984 5544
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=301.78 Aligned_cols=225 Identities=12% Similarity=0.113 Sum_probs=175.5
Q ss_pred HHhcCCCcceeeccCCCccEEEEE------EcCCcEEEEEEeccCCchhhHHHHHHHHHHHHcc---CCcccc-------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGK------LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ---HTNLTD------- 443 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~------~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~------- 443 (676)
...++|.+.++||+|+||.||+|. ..+++.||||++... ...++..|+.++.+++ |+|++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 446889999999653 3456788888888887 888762
Q ss_pred ------------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC--------
Q 005803 444 ------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE-------- 491 (676)
Q Consensus 444 ------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~-------- 491 (676)
......+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 013456899999999999999999999998 999999999999998
Q ss_pred ---CCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccc
Q 005803 492 ---QMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLN 568 (676)
Q Consensus 492 ---~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~ 568 (676)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-- 293 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-- 293 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence 899999999999865433223333446799999999999999999999999999999999999999864322110
Q ss_pred hHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCC-CCHHHHHHHHhcCc
Q 005803 569 LVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADR-RTMSDVVSMLTNDT 631 (676)
Q Consensus 569 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R-Ps~~eVl~~Le~~~ 631 (676)
.+...+..... .+.+.+++..|++.+|.+| |+++++.+.|+...
T Consensus 294 ----------------~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 294 ----------------KPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp ----------------EECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ----------------eechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 01111111112 3345677788999999999 68888888888764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=295.79 Aligned_cols=235 Identities=17% Similarity=0.260 Sum_probs=173.8
Q ss_pred hcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHcc-CCccccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLTDS--------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~~--------------- 444 (676)
.++|++.++||+|+||.||+|+. .+++.||||+++.. ..+.+.+|+.+++++. ||||+..
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36899999999999999999986 46899999998643 3567899999999997 9998731
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC-CeEEeccCcceecccccccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM-NPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~-~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++.......
T Consensus 112 ~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-- 186 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-- 186 (330)
T ss_dssp EECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--
T ss_pred EeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--
Confidence 00123678889999999999999999998 99999999999999776 899999999987543322
Q ss_pred ccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHH--------HHHHhcCCc--
Q 005803 514 NTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYA--------WQLWNEGKA-- 582 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~--------~~~~~~~~~-- 582 (676)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .+.... .........
T Consensus 187 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 187 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHHHhcccc
Confidence 233578999999999987 6789999999999999999999999954322110 000000 000000000
Q ss_pred ------------cccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 583 ------------LELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 583 ------------~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
...................+.+++.+||+.||++|||++|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000011111111234568889999999999999999999873
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=318.00 Aligned_cols=227 Identities=25% Similarity=0.323 Sum_probs=178.7
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
..++|++.+.||+|+||.||+|+.. +++.||||++.+. .......+.+|+.+|++++||||+.
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4578999999999999999999875 6999999999653 2234566889999999999999972
Q ss_pred ---------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 444 ---------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 111234889999999999999999999998 99999999999999999999999999987643
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........... ......... .
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~---i~~~i~~~~------~ 406 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKEVP------E 406 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH---HHHHHHHCC------C
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH---HHHHhhccc------c
Confidence 32 12335899999999999999999999999999999999999999986543221111 111111111 1
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRR-----TMSDVVSM 626 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~ 626 (676)
. ++......+.+|+.+||+.||.+|| +++||++.
T Consensus 407 ~----~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 E----YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred c----CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1 1122234578889999999999999 78888754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.43 Aligned_cols=225 Identities=21% Similarity=0.288 Sum_probs=173.1
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc------hhhHHHHHHHHHHHHccCCcccc-----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG------QGIVEFKNEAKLIAKLQHTNLTD----------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~----------- 443 (676)
.++|++.+.||+|+||.||+|+.. +++.||||.+..... ...+.+.+|+.++++++||||+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999976 589999999875421 13577999999999999999973
Q ss_pred ---------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC----CeEEeccCcce
Q 005803 444 ---------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM----NPKISDFGMAR 504 (676)
Q Consensus 444 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~----~vkL~DFGla~ 504 (676)
......+++..+..++.||+.||.|||+++ |+||||||+||+++.++ .+||+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 012245788999999999999999999998 99999999999998877 79999999998
Q ss_pred eccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccc
Q 005803 505 TYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584 (676)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (676)
...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ...........
T Consensus 161 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~- 229 (283)
T 3bhy_A 161 KIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-------TLTNISAVNYD- 229 (283)
T ss_dssp ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCCC-
T ss_pred eccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-------HHHHhHhcccC-
Confidence 754322 1223568999999999999999999999999999999999999997532111 11111111110
Q ss_pred cCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 585 LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 585 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.++.... .....+.+++.+||+.||++|||+.|+++
T Consensus 230 -~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 -FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 1111111 12345788999999999999999999997
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=295.13 Aligned_cols=243 Identities=23% Similarity=0.332 Sum_probs=171.8
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
..++|++.+.||+|+||.||+|+... .||+|++... .....+.+.+|+.++++++|+||+.
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 45789999999999999999998743 5999998653 2334466889999999999999872
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc-
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE- 510 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~- 510 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++.......
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 111235888999999999999999999998 99999999999998 6799999999987543211
Q ss_pred --cccccceeeccCCccChhhhcc---------CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhc
Q 005803 511 --LEANTNRIVGTHGYMSPEYVMN---------GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNE 579 (676)
Q Consensus 511 --~~~~~~~~~gt~~Y~APE~~~~---------~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 579 (676)
.........|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...... . .......
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~-~~~~~~~ 257 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------A-IIWQMGT 257 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------H-HHHHHHT
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHhcc
Confidence 1122233568999999999874 45789999999999999999999999753321 1 1111222
Q ss_pred CCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCCCCCCCccce
Q 005803 580 GKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQPAFFI 644 (676)
Q Consensus 580 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~~p~~P~~~~ 644 (676)
+........ ..+ ..+.+++.+||+.||++|||+.+|+++|+.+.........|..+.
T Consensus 258 ~~~~~~~~~----~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~ 314 (319)
T 2y4i_B 258 GMKPNLSQI----GMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW 314 (319)
T ss_dssp TCCCCCCCS----SCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred CCCCCCCcC----CCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence 211111111 112 247788999999999999999999999999876655555555544
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=298.83 Aligned_cols=244 Identities=20% Similarity=0.271 Sum_probs=171.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSS--------------- 445 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~~--------------- 445 (676)
.++|++.+.||+|+||.||+|+... ++.||||++........+++.+|+.++++++||||++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999764 899999999876666678899999999999999997421
Q ss_pred -----------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc-CCCCeEEeccC
Q 005803 446 -----------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD-EQMNPKISDFG 501 (676)
Q Consensus 446 -----------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~-~~~~vkL~DFG 501 (676)
....+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||
T Consensus 90 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 90 SLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp -CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred cccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCc
Confidence 1234778889999999999999999998 99999999999997 56789999999
Q ss_pred cceecccccc-ccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH-------
Q 005803 502 MARTYAMNEL-EANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY------- 572 (676)
Q Consensus 502 la~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~------- 572 (676)
++........ ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCH
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence 9986543211 112223467889999998875 6789999999999999999999999975432111100000
Q ss_pred -HHHHHhcCCccccCCcccC-CC-----CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--Hhc
Q 005803 573 -AWQLWNEGKALELMDPTLD-ES-----CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTN 629 (676)
Q Consensus 573 -~~~~~~~~~~~~~~d~~l~-~~-----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~ 629 (676)
.+..... .....+..... .. ........+.+++.+||+.||++|||++|+++. ++.
T Consensus 247 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 247 EDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp HHHHHHHT-TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred hhhhhhhh-cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 0000000 00000000000 00 011223467889999999999999999999873 543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=296.34 Aligned_cols=235 Identities=24% Similarity=0.369 Sum_probs=158.0
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.++++++||||+..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 4578999999999999999999854 68999999986542 3345678899999999999998720
Q ss_pred --------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcce
Q 005803 445 --------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR 504 (676)
Q Consensus 445 --------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~ 504 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 01344889999999999999999999998 9999999999999999999999999987
Q ss_pred ecccccc---ccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcC
Q 005803 505 TYAMNEL---EANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG 580 (676)
Q Consensus 505 ~~~~~~~---~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 580 (676)
....... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ . .... ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~---~~~~-~~ 242 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---L---MLTL-QN 242 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---H---HHHH-TS
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---H---HHHh-cc
Confidence 6543211 111233578999999999876 5689999999999999999999999976433221 1 1111 11
Q ss_pred CccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 581 KALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 581 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.....................+.+++.+||+.||.+||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111111100001111122345788999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=314.18 Aligned_cols=226 Identities=25% Similarity=0.332 Sum_probs=177.0
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
.++|.+.+.||+|+||.||+|+.. +++.||||++.+.. ......+.+|+.++++++||||+..
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 478999999999999999999975 59999999996532 2345678899999999999998720
Q ss_pred -----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 445 -----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 445 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 01235888999999999999999999998 9999999999999999999999999998765
Q ss_pred ccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 508 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 508 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. ..........
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~-~~~~i~~~~~----- 410 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KE-LKQRVLEQAV----- 410 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HH-HHHHHHHCCC-----
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HH-HHHHHhhccc-----
Confidence 4322 123358999999999999999999999999999999999999999865332211 11 1111111111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCH-----HHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTM-----SDVVS 625 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~-----~eVl~ 625 (676)
. .+......+.+++.+||+.||++||++ ++|++
T Consensus 411 -~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 -T----YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -C----CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -C----CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1 112223457788999999999999975 66664
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=289.43 Aligned_cols=224 Identities=24% Similarity=0.347 Sum_probs=168.7
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
+|.....||+|+||.||+|+.. +++.||||.+........+.+.+|+.++++++||||+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3445669999999999999864 58899999998766666778999999999999999873
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC-CCCeEEeccCcceeccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE-QMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~-~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.||+.||.|||+++ |+|+||||+||+++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 011224567788889999999999999998 999999999999987 89999999999987543221
Q ss_pred cccceeeccCCccChhhhccCC--CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGI--VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||....... . ........ ...+.+
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~--~~~~~~~~-----~~~~~~ 247 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---A--AMFKVGMF-----KVHPEI 247 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---H--HHHHHHHH-----CCCCCC
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---H--HHHhhccc-----cccccc
Confidence 123357899999999997654 8899999999999999999999996432111 0 00111000 111122
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
. ......+.+++.+||+.||++||++.|+++.
T Consensus 248 ~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 248 P----ESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp C----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred c----ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2 2223457788999999999999999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-33 Score=302.04 Aligned_cols=225 Identities=19% Similarity=0.190 Sum_probs=165.6
Q ss_pred hcCCCcc-eeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHH-HccCCccccc--------------
Q 005803 382 TDNFSPA-NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIA-KLQHTNLTDS-------------- 444 (676)
Q Consensus 382 t~~y~~~-~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~-~l~H~niv~~-------------- 444 (676)
.++|.+. +.||+|+||.||+++.. +++.||||++.. ...+.+|+.++. ..+||||+..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567766 68999999999999875 589999999863 245678888874 4589998720
Q ss_pred ------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC---CCCeEEeccCcc
Q 005803 445 ------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE---QMNPKISDFGMA 503 (676)
Q Consensus 445 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~---~~~vkL~DFGla 503 (676)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 11234888999999999999999999998 999999999999997 788999999999
Q ss_pred eeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 504 RTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............ ......+...
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~i~~~~~~ 285 (400)
T 1nxk_A 212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQYE 285 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH---HHHHHHTCCC
T ss_pred cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH---HHHHHcCccc
Confidence 8654322 223467899999999999999999999999999999999999999765433321111 1111122211
Q ss_pred ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 584 ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 584 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
...+ ........+.+|+.+||+.||++|||+.||++.
T Consensus 286 -~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 -FPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -CCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CCCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 011223457889999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=327.83 Aligned_cols=223 Identities=25% Similarity=0.336 Sum_probs=172.5
Q ss_pred eeeccCCCccEEEEEEc---CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc--------------------
Q 005803 389 NRLGQGGFGPVYNGKLL---DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD-------------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~---~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~-------------------- 443 (676)
++||+|+||.||+|.+. .++.||||+++... ....+++.+|+.++++++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 47999999999999653 36789999997543 234578999999999999999983
Q ss_pred -----ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc-cccce
Q 005803 444 -----SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE-ANTNR 517 (676)
Q Consensus 444 -----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~ 517 (676)
......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...... .....
T Consensus 455 ~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 455 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 112345888999999999999999999998 999999999999999999999999999876443221 12223
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCCh
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSS 596 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 596 (676)
..+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ .......+.... .+.
T Consensus 532 ~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~---------~p~ 595 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG---------CPA 595 (635)
T ss_dssp ---CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC---------CCT
T ss_pred CCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC---------CCC
Confidence 456788999999999999999999999999999998 999997543211 222222222111 122
Q ss_pred HHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 597 DEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 597 ~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.....+.+++..||+.||++||++.+|++.|+..
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2335688899999999999999999999999865
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.37 Aligned_cols=218 Identities=21% Similarity=0.280 Sum_probs=170.6
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHc-cCCccccc------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKL-QHTNLTDS------------ 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~~------------ 444 (676)
..++|++.+.||+|+||.||+|+.. +++.||||++... ......++.+|+..+.++ +||||++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999876 6999999998753 334556788999999999 99999720
Q ss_pred ------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC--------------
Q 005803 445 ------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ-------------- 492 (676)
Q Consensus 445 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~-------------- 492 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 01145788999999999999999999998 9999999999999844
Q ss_pred -----CCeEEeccCcceeccccccccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCc
Q 005803 493 -----MNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERP 566 (676)
Q Consensus 493 -----~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~ 566 (676)
..+||+|||++....... ...||+.|+|||.+.+. .++.++|||||||++|||++|.+++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence 479999999998754322 24589999999999865 56789999999999999999988764221
Q ss_pred cchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 567 LNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 567 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.......+... .+.... ...+.+++.+||+.||++|||+.|+++.
T Consensus 236 ------~~~~~~~~~~~-----~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 ------QWHEIRQGRLP-----RIPQVL----SQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ------HHHHHHTTCCC-----CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ------HHHHHHcCCCC-----CCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11222222221 122222 3457888999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.59 Aligned_cols=230 Identities=22% Similarity=0.315 Sum_probs=177.0
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
..++|.+.+.||+|+||.||+++.. +++.||||++..........+.+|+.++++++||||+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3468999999999999999999875 689999999986555555678999999999999998731
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE---cCCCCeEEeccCcceeccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL---DEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl---~~~~~vkL~DFGla~~~~~~~ 510 (676)
.....+++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 11235788889999999999999999998 9999999999999 78889999999999764322
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .......++... ....
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~~--~~~~- 229 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-------KLFEKIKEGYYE--FESP- 229 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHCCCC--CCTT-
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCC--CCcc-
Confidence 122356899999999999999999999999999999999999999753211 111222222211 0111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH--HHhcC
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS--MLTND 630 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~--~Le~~ 630 (676)
........+.+++.+||+.||++|||+.|+++ .+++.
T Consensus 230 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 230 ---FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ---TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 11222345788999999999999999999997 35554
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=308.85 Aligned_cols=219 Identities=22% Similarity=0.285 Sum_probs=162.7
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHH-HHHccCCccccc------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKL-IAKLQHTNLTDS------------ 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~-l~~l~H~niv~~------------ 444 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++.+.. ......+.+|..+ ++.++||||+..
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999976 48899999997643 2234456677776 577899999831
Q ss_pred --------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 445 --------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 445 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 11245778888899999999999999998 9999999999999999999999999998533221
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ....+..+.. .+
T Consensus 194 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~-~~~~i~~~~~------~~ 258 (373)
T 2r5t_A 194 --STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------E-MYDNILNKPL------QL 258 (373)
T ss_dssp --CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------H-HHHHHHHSCC------CC
T ss_pred --CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------H-HHHHHHhccc------CC
Confidence 2234468999999999999999999999999999999999999999743211 1 1112222211 11
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHH
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSD 622 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~e 622 (676)
.. .....+.+++.+||+.||.+||++.+
T Consensus 259 ~~----~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 259 KP----NITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CS----SSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred CC----CCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 11 22335778899999999999999853
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=290.59 Aligned_cols=227 Identities=20% Similarity=0.334 Sum_probs=172.6
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
..++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||+..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4468999999999999999999976 489999999977666677889999999999999999730
Q ss_pred ------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 445 ------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 445 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
.....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-- 171 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc--
Confidence 11345888999999999999999999998 9999999999999999999999999876432211
Q ss_pred cccceeeccCCccChhhhc-----cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
.......|++.|+|||.+. +..++.++||||||+++|||++|+.||...... ..... ..........
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~- 243 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLK-IAKSDPPTLL- 243 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH-HHHSCCCCCS-
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHH-HhccCCcccC-
Confidence 1122357899999999984 567899999999999999999999999754321 11111 1111111111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+......+.+++.+||+.||++|||+.++++.
T Consensus 244 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 244 ------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ------CccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 112223457889999999999999999998763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=295.01 Aligned_cols=235 Identities=25% Similarity=0.396 Sum_probs=172.9
Q ss_pred CccccHHHHHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCccccc---
Q 005803 370 LKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTDS--- 444 (676)
Q Consensus 370 ~~~f~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~~--- 444 (676)
+..+++.++....++|++.+.||+|+||.||+|+.. +++.||||++... ......+.+|+.++.++ +||||+..
T Consensus 11 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp -----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred chhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 344556666778899999999999999999999874 6899999998653 34557889999999999 79998721
Q ss_pred -------------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC
Q 005803 445 -------------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM 493 (676)
Q Consensus 445 -------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~ 493 (676)
.....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTC
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCC
Confidence 01235778888999999999999999998 99999999999999999
Q ss_pred CeEEeccCcceeccccccccccceeeccCCccChhhhc-----cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccc
Q 005803 494 NPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLN 568 (676)
Q Consensus 494 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~ 568 (676)
.+||+|||++........ ......|++.|+|||.+. +..++.++|||||||++|||++|+.||......
T Consensus 167 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---- 240 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---- 240 (326)
T ss_dssp CEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----
T ss_pred CEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----
Confidence 999999999986543211 123357899999999987 567899999999999999999999999643211
Q ss_pred hHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 569 LVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 569 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.... ........... .. .....+.+++.+||+.||.+||++.++++
T Consensus 241 --~~~~-~~~~~~~~~~~----~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 241 --RALF-LIPRNPAPRLK----SK----KWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp --HHHH-HHHHSCCCCCS----CS----CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHHH-HhhcCccccCC----cc----ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111 11111111111 11 12235778889999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=304.31 Aligned_cols=245 Identities=19% Similarity=0.230 Sum_probs=170.9
Q ss_pred HHHHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc----------
Q 005803 376 QTIAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS---------- 444 (676)
Q Consensus 376 ~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~---------- 444 (676)
.......++|++.+.||+|+||.||+|+.. +++.||||++... ......+.+|+..+..++||||++.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345667789999999999999999999875 5899999998653 3344567788999999999999831
Q ss_pred --------------------------cccCcCCHHHHHHHHHHHHHHHHHHH--hcCCCceEeeccccCceEEcC-CCCe
Q 005803 445 --------------------------SRKSLLDWKKRFYIIEGIVQGLLYLH--KYSRLRAIHRDLKVSNILLDE-QMNP 495 (676)
Q Consensus 445 --------------------------~~~~~l~~~~~~~i~~qia~gL~yLH--~~~~~~iiH~DLKp~NILl~~-~~~v 495 (676)
.....+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 12335667778899999999999999 877 999999999999996 8999
Q ss_pred EEeccCcceeccccccccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHH
Q 005803 496 KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAW 574 (676)
Q Consensus 496 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~ 574 (676)
||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .....
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~~~~ 245 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ---LHEIV 245 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH---HHHHH
Confidence 9999999987654322 2235689999999998765 489999999999999999999999976432211 11111
Q ss_pred HHH-----------hcC-CccccCCc------ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcC
Q 005803 575 QLW-----------NEG-KALELMDP------TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTND 630 (676)
Q Consensus 575 ~~~-----------~~~-~~~~~~d~------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~ 630 (676)
... ... ......+. .............+.+++.+||+.||.+|||+.|+++. +++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 100 000 00000000 00011122245678899999999999999999999975 5544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=297.40 Aligned_cols=229 Identities=24% Similarity=0.369 Sum_probs=174.8
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcE--EEEEEeccC-CchhhHHHHHHHHHHHHc-cCCccccc-------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQE--IAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNLTDS------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~--VAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~------------- 444 (676)
++|++.+.||+|+||.||+|+.. +++. ||||.+... .....+.+.+|+.++.++ +||||++.
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57899999999999999999864 4654 499998653 234456789999999999 89998720
Q ss_pred -----------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCe
Q 005803 445 -----------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNP 495 (676)
Q Consensus 445 -----------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~v 495 (676)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 11236889999999999999999999998 9999999999999999999
Q ss_pred EEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHH
Q 005803 496 KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAW 574 (676)
Q Consensus 496 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~ 574 (676)
||+|||+++..... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELY 251 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHH
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-------HHH
Confidence 99999999743221 11222456889999999999899999999999999999998 99999754311 111
Q ss_pred HHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCC
Q 005803 575 QLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMA 633 (676)
Q Consensus 575 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 633 (676)
.....+. ... .+......+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 252 ~~~~~~~-----~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 252 EKLPQGY-----RLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HHGGGTC-----CCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhhcCC-----CCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 2222211 111 1222334578899999999999999999999999887643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=297.72 Aligned_cols=233 Identities=22% Similarity=0.298 Sum_probs=176.6
Q ss_pred HHHHHHHhcCCCcc-eeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHcc-CCcccc------
Q 005803 375 FQTIAAATDNFSPA-NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQ-HTNLTD------ 443 (676)
Q Consensus 375 ~~~l~~~t~~y~~~-~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~------ 443 (676)
++......++|.+. +.||+|+||.||+|+.. +++.||||++.... .....++.+|+.++.++. ||||+.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 44455566778887 89999999999999876 58999999987542 334577899999999995 599872
Q ss_pred ----------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC---CCCeEEe
Q 005803 444 ----------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE---QMNPKIS 498 (676)
Q Consensus 444 ----------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~---~~~vkL~ 498 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence 012356889999999999999999999998 999999999999997 7899999
Q ss_pred ccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHh
Q 005803 499 DFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWN 578 (676)
Q Consensus 499 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 578 (676)
|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......
T Consensus 177 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~ 246 (327)
T 3lm5_A 177 DFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-------TYLNIS 246 (327)
T ss_dssp CGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHH
T ss_pred eCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-------HHHHHH
Confidence 999998764322 1233579999999999999999999999999999999999999997543211 111111
Q ss_pred cCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 579 EGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 579 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
..... ............+.+++.+||+.||++|||++|+++.
T Consensus 247 ~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 247 QVNVD------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HTCCC------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hcccc------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11110 1111112233457789999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=297.26 Aligned_cols=236 Identities=19% Similarity=0.244 Sum_probs=175.6
Q ss_pred hcCCCcceeeccCCCccEEEEEE--cCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCc------ccc----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKL--LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN------LTD---------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~--~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~---------- 443 (676)
.++|++.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.++++++|++ ++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 35889999999653 345677899999999998876 431
Q ss_pred -----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC---------------
Q 005803 444 -----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE--------------- 491 (676)
Q Consensus 444 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~--------------- 491 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 92 ICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccccc
Confidence 111235788899999999999999999998 999999999999987
Q ss_pred ----CCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCcc
Q 005803 492 ----QMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPL 567 (676)
Q Consensus 492 ----~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~ 567 (676)
++.+||+|||++...... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+..
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred ccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 678999999999864322 22357899999999999999999999999999999999999999764332211
Q ss_pred chHHHHH-----HHHhcCCcccc---------------------CCccc-CCCCChHHHHHHHHHHHHhcccCcCCCCCH
Q 005803 568 NLVGYAW-----QLWNEGKALEL---------------------MDPTL-DESCSSDEVMRCIHVGLLCVQDRAADRRTM 620 (676)
Q Consensus 568 ~l~~~~~-----~~~~~~~~~~~---------------------~d~~l-~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~ 620 (676)
....... ..+........ ..+.. ...........+.+++.+||+.||.+|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 1110000 00000000000 00000 011233456778999999999999999999
Q ss_pred HHHHHH
Q 005803 621 SDVVSM 626 (676)
Q Consensus 621 ~eVl~~ 626 (676)
.|+++.
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=296.17 Aligned_cols=238 Identities=21% Similarity=0.289 Sum_probs=176.2
Q ss_pred HHhcCCCcceeeccCCCccEEEEEE--cCCcEEEEEEeccCC--chhhHHHHHHHHHHHHc---cCCccccc--------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKL--LDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKL---QHTNLTDS-------- 444 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~--~~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~~-------- 444 (676)
.+.++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.+++++ .||||++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4568899999999999999999997 358899999986432 22234677888888777 89998731
Q ss_pred ------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEecc
Q 005803 445 ------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDF 500 (676)
Q Consensus 445 ------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DF 500 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecC
Confidence 11223788899999999999999999998 999999999999999999999999
Q ss_pred CcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcC
Q 005803 501 GMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG 580 (676)
Q Consensus 501 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 580 (676)
|++....... ......|++.|+|||.+.+..++.++|||||||++|||++|+.||....... ............
T Consensus 165 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~ 238 (326)
T 1blx_A 165 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLP 238 (326)
T ss_dssp CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred cccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCC
Confidence 9998654322 2233678999999999999999999999999999999999999997543211 111111111000
Q ss_pred Cccc----------cCC---cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 581 KALE----------LMD---PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 581 ~~~~----------~~d---~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.... ... ..............+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 000 000011112234467889999999999999999999953
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=299.88 Aligned_cols=233 Identities=21% Similarity=0.272 Sum_probs=173.5
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... .....++.+|+.++++++||||+..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999875 58999999996542 2335678899999999999999731
Q ss_pred ---------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 445 ---------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 445 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp CCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 01234788999999999999999999998 999999999999999999999999999764322
Q ss_pred ccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcC--------
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG-------- 580 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~-------- 580 (676)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+ ............
T Consensus 180 -----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 180 -----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCCHHHHTTC
T ss_pred -----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHHH
Confidence 223578999999999887 678999999999999999999999997543211 111111100000
Q ss_pred ----------CccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 581 ----------KALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 581 ----------~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.......+.+. .........+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000110 1122334568889999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=300.07 Aligned_cols=173 Identities=24% Similarity=0.345 Sum_probs=146.7
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999876 58999999997653 3345678999999999999999731
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKY-SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
.....+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 1123577888899999999999999996 7 999999999999999999999999999754322
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSY 561 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~ 561 (676)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 223367899999999999999999999999999999999999999754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=290.98 Aligned_cols=224 Identities=25% Similarity=0.374 Sum_probs=171.6
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
+.|.+.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34778889999999999999875 5889999998653 23455678999999999999999731
Q ss_pred ---------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc-CCCCeEEeccCcceeccc
Q 005803 445 ---------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD-EQMNPKISDFGMARTYAM 508 (676)
Q Consensus 445 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~-~~~~vkL~DFGla~~~~~ 508 (676)
.....+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++.....
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 11145778888999999999999999875 3499999999999998 789999999999975432
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
. ......||+.|+|||.+. +.++.++|||||||++|+|++|+.||....... ........+....
T Consensus 185 ~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~---- 249 (290)
T 1t4h_A 185 S----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPA---- 249 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCG----
T ss_pred c----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH------HHHHHHhccCCcc----
Confidence 2 223357899999999876 468999999999999999999999997533211 1112222221111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
..... ....+.+++.+||+.||.+|||+.|+++.
T Consensus 250 ~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 SFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCCC----CCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11111 12357889999999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=291.67 Aligned_cols=224 Identities=22% Similarity=0.360 Sum_probs=171.7
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
..++|++.+.||+|+||.||+|+.. +++.||||.+... ....++.+|+.++.+++||||+..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999876 4899999999753 345678999999999999998720
Q ss_pred ------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 445 ------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 445 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
.....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence 12356888999999999999999999998 99999999999999999999999999987543321
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .... ..........
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~~~------- 245 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIF-MIPTNPPPTF------- 245 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH-HHHHSCCCCC-------
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHH-HHhcCCCccc-------
Confidence 123357899999999999999999999999999999999999999753211 1111 1111111111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
..+......+.+++.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011122345788999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=291.62 Aligned_cols=227 Identities=23% Similarity=0.305 Sum_probs=171.7
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--------chhhHHHHHHHHHHHHccCCcccc--------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--------GQGIVEFKNEAKLIAKLQHTNLTD-------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~-------- 443 (676)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+.
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4568999999999999999999875 48899999986532 122346889999999999999873
Q ss_pred -----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC---eEEeccCcc
Q 005803 444 -----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN---PKISDFGMA 503 (676)
Q Consensus 444 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~---vkL~DFGla 503 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 122346788899999999999999999998 999999999999987654 999999999
Q ss_pred eeccccccccccceeeccCCccChhhhc---cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcC
Q 005803 504 RTYAMNELEANTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG 580 (676)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 580 (676)
........ .....||+.|+|||++. ...++.++|||||||++|||++|+.||........ +. .....+
T Consensus 165 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~----~~~~~~ 235 (322)
T 2ycf_A 165 KILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK----DQITSG 235 (322)
T ss_dssp EECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HH----HHHHHT
T ss_pred eecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HH----HHHHhC
Confidence 87643221 22356899999999974 46789999999999999999999999976543321 11 111122
Q ss_pred CccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 581 KALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 581 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
... ..+.... .....+.+++.+||+.||++||++.++++
T Consensus 236 ~~~--~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 KYN--FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccc--cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111 0011111 12345788999999999999999999885
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-33 Score=299.11 Aligned_cols=234 Identities=21% Similarity=0.281 Sum_probs=172.3
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDSS------------- 445 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~------------- 445 (676)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+...
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999865 58999999997542 23356788999999999999997310
Q ss_pred ----------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 446 ----------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 446 ----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp CCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 1234788999999999999999999998 999999999999999999999999999864322
Q ss_pred ccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC-------
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK------- 581 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~------- 581 (676)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+. ............
T Consensus 198 -----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 198 -----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCHHHHTTC
T ss_pred -----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCcHHHHHHh
Confidence 223578999999999987 6789999999999999999999999975432111 111110000000
Q ss_pred -------ccccCCcccCC---CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 582 -------ALELMDPTLDE---SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 582 -------~~~~~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
....+...... .........+.+++.+||+.||++|||+.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000000 0011223467889999999999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=288.00 Aligned_cols=222 Identities=22% Similarity=0.348 Sum_probs=167.4
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999976 69999999986532 2345678999999999999999730
Q ss_pred -------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 445 -------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 445 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
.....+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 11235788889999999999999999998 99999999999999999999999999986543221
Q ss_pred ccccceeeccCCccChhhhccCCC-CchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
.....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ........+.. .+
T Consensus 167 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~------~~ 230 (276)
T 2h6d_A 167 ---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-------TLFKKIRGGVF------YI 230 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC------CC
T ss_pred ---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HHHHHhhcCcc------cC
Confidence 223568999999999987765 68999999999999999999999643211 11122222211 11
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.. .....+.+++.+||+.||++|||+.||++.
T Consensus 231 ~~----~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 PE----YLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ch----hcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 122457788999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=298.06 Aligned_cols=178 Identities=21% Similarity=0.298 Sum_probs=145.6
Q ss_pred HHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHcc-CCc-----ccc-------
Q 005803 378 IAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTN-----LTD------- 443 (676)
Q Consensus 378 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~n-----iv~------- 443 (676)
.....++|++.+.||+|+||.||+|+.. +++.||||+++.. .....++..|+.++..+. |++ ++.
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 3445689999999999999999999865 5889999999753 344567888999999886 554 431
Q ss_pred --------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc--CCCCeEEeccC
Q 005803 444 --------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD--EQMNPKISDFG 501 (676)
Q Consensus 444 --------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~--~~~~vkL~DFG 501 (676)
......+++..+..++.||+.||.|||++ ..+|+||||||+|||++ .++.+||+|||
T Consensus 128 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 128 RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 01123588999999999999999999952 12399999999999994 57889999999
Q ss_pred cceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCC
Q 005803 502 MARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYD 562 (676)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~ 562 (676)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 207 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 207 SSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99875432 233678999999999999999999999999999999999999998643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=312.20 Aligned_cols=230 Identities=24% Similarity=0.331 Sum_probs=176.5
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
..++|++.++||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4467999999999999999999875 6899999998643 2334677899999999999999983
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc---CCCCeEEeccCcceeccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD---EQMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~---~~~~vkL~DFGla~~~~~ 508 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 112245788899999999999999999998 99999999999995 556799999999986543
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....... .......+...... +
T Consensus 177 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~~~-~ 244 (486)
T 3mwu_A 177 NT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAFDL-P 244 (486)
T ss_dssp C-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCSCS-G
T ss_pred CC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCCCC-c
Confidence 22 1233579999999999875 59999999999999999999999997542211 11222222221100 0
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcC
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTND 630 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~ 630 (676)
........+.+++.+||+.||.+|||+.|+++. +++.
T Consensus 245 -----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 245 -----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp -----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred -----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 011223457889999999999999999999975 5544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=323.88 Aligned_cols=223 Identities=22% Similarity=0.317 Sum_probs=175.9
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHc-cCCcccc------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLTD------------ 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~------------ 443 (676)
..++|++.+.||+|+||.||+|+.. +++.||||++++. .....+.+..|..++..+ +||+|+.
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999875 5889999999753 234456788999999987 6888862
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
......+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 112245888999999999999999999998 999999999999999999999999999864332
Q ss_pred ccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
. .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...... . ....+..+.. .
T Consensus 496 ~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~-~~~~i~~~~~------~ 560 (674)
T 3pfq_A 496 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------E-LFQSIMEHNV------A 560 (674)
T ss_dssp T--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHSSCC------C
T ss_pred C--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------H-HHHHHHhCCC------C
Confidence 2 2234478999999999999999999999999999999999999999754321 1 1122222211 1
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCH-----HHHHH
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTM-----SDVVS 625 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~-----~eVl~ 625 (676)
++......+.+|+.+||+.||++||++ +||++
T Consensus 561 ----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 561 ----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ----CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 122233457889999999999999997 77764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=314.55 Aligned_cols=226 Identities=25% Similarity=0.341 Sum_probs=176.8
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999876 68999999986542 345677999999999999999983
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE---cCCCCeEEeccCcceecc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL---DEQMNPKISDFGMARTYA 507 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl---~~~~~vkL~DFGla~~~~ 507 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 112356788899999999999999999998 9999999999999 567899999999998654
Q ss_pred ccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 508 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 508 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....... .......+......
T Consensus 181 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~~~- 248 (484)
T 3nyv_A 181 ASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVEKGKYTFEL- 248 (484)
T ss_dssp CCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCCCS-
T ss_pred ccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCCCCC-
Confidence 322 2233579999999998876 69999999999999999999999997543211 11222222221100
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+ ........+.+++.+||+.||.+|||+.|+++.
T Consensus 249 ~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 249 P-----QWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp G-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0 011223457889999999999999999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.40 Aligned_cols=232 Identities=21% Similarity=0.313 Sum_probs=177.8
Q ss_pred HHHHHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc--------hhhHHHHHHHHHHHHc-cCCcccc-
Q 005803 375 FQTIAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG--------QGIVEFKNEAKLIAKL-QHTNLTD- 443 (676)
Q Consensus 375 ~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~- 443 (676)
........++|.+.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.++.++ +||||+.
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3445556788999999999999999999985 699999999865431 1245678999999999 7999872
Q ss_pred -------------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEe
Q 005803 444 -------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKIS 498 (676)
Q Consensus 444 -------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~ 498 (676)
......+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 011245788899999999999999999998 9999999999999999999999
Q ss_pred ccCcceeccccccccccceeeccCCccChhhhcc------CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH
Q 005803 499 DFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN------GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY 572 (676)
Q Consensus 499 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~ 572 (676)
|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 243 DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~---- 312 (365)
T 2y7j_A 243 DFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---L---- 312 (365)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---H----
T ss_pred ecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---H----
Confidence 999998765332 2233679999999999864 35889999999999999999999999653211 1
Q ss_pred HHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 573 AWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 573 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.......+.... ..+. .. .....+.+++.+||+.||++|||+.|+++
T Consensus 313 ~~~~i~~~~~~~-~~~~-~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 MLRMIMEGQYQF-SSPE-WD----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHTCCCC-CHHH-HS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhCCCCC-CCcc-cc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111122221110 0000 01 11235788999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=293.77 Aligned_cols=227 Identities=21% Similarity=0.309 Sum_probs=153.1
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc-hhhHHHHHHHH-HHHHccCCccccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG-QGIVEFKNEAK-LIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~-~~~~~~~~E~~-~l~~l~H~niv~~-------------- 444 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ....++..|+. +++.++||||++.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 368889999999999999999875 689999999976432 33445566665 7788899999731
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKY-SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
.....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++....
T Consensus 101 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 1145678889999999999999999998 8 9999999999999999999999999998654
Q ss_pred ccccccccceeeccCCccChhhh----ccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 508 MNELEANTNRIVGTHGYMSPEYV----MNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 508 ~~~~~~~~~~~~gt~~Y~APE~~----~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
.... .....||+.|+|||.+ .+..++.++|||||||++|||++|+.||........ .. ....
T Consensus 178 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------~~--~~~~ 243 (327)
T 3aln_A 178 DSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------QL--TQVV 243 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCC
T ss_pred cccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------HH--HHHh
Confidence 3221 2234789999999998 456789999999999999999999999975322110 00 0011
Q ss_pred ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 584 ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 584 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
....+.+...........+.+++.+||+.||++|||+.+|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111111111111223346888999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=292.88 Aligned_cols=230 Identities=22% Similarity=0.277 Sum_probs=175.9
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchh-----------------hHHHHHHHHHHHHccCCcccc-
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQG-----------------IVEFKNEAKLIAKLQHTNLTD- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~- 443 (676)
.++|.+.+.||+|+||.||+|+. +++.||||++....... .+.+.+|+.++++++||||+.
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 99999999986432111 178999999999999999872
Q ss_pred -------------------------------ccc--cCcCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeeccccCceEE
Q 005803 444 -------------------------------SSR--KSLLDWKKRFYIIEGIVQGLLYLHK-YSRLRAIHRDLKVSNILL 489 (676)
Q Consensus 444 -------------------------------~~~--~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLKp~NILl 489 (676)
... ...+++..+..++.||+.||.|||+ .+ |+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 111 4568889999999999999999999 87 9999999999999
Q ss_pred cCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccC-CCCc-hhHHHHHHHHHHHHHhCCcCCCCCCCCCcc
Q 005803 490 DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG-IVSM-KSDVYSFGVLVLEIVSSKKNNGSYDTERPL 567 (676)
Q Consensus 490 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~-ksDVwSlGvvl~elltG~~pf~~~~~~~~~ 567 (676)
+.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++|||||||++|||++|+.||.......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-- 259 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-- 259 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--
Confidence 99999999999999875433 22335789999999999877 6666 9999999999999999999997544311
Q ss_pred chHHHHHHHHhcCCccccCC------ccc---CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 568 NLVGYAWQLWNEGKALELMD------PTL---DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 568 ~l~~~~~~~~~~~~~~~~~d------~~l---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
........+......+ +.. ...........+.+++.+||+.||.+|||+.|+++
T Consensus 260 ----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 ----ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ----HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ----HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1122222222111000 000 00001223346788999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=296.99 Aligned_cols=232 Identities=19% Similarity=0.223 Sum_probs=173.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CC-cEEEEEEeccCCchhhHHHHHHHHHHHHccCCc------ccc----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DG-QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN------LTD---------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~-~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~---------- 443 (676)
.++|++.+.||+|+||.||+|+.. ++ +.||||+++.. ....+.+.+|+.++++++|++ ++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999864 34 68999999653 345667889999999998776 331
Q ss_pred -----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEE-----------------
Q 005803 444 -----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILL----------------- 489 (676)
Q Consensus 444 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl----------------- 489 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 97 MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccc
Confidence 111235889999999999999999999998 9999999999999
Q ss_pred --cCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCcc
Q 005803 490 --DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPL 567 (676)
Q Consensus 490 --~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~ 567 (676)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 56789999999999864322 22357899999999999999999999999999999999999999754322111
Q ss_pred chHHHHHHHHh--------cCCccc-cCCc---------------------ccCCCCChHHHHHHHHHHHHhcccCcCCC
Q 005803 568 NLVGYAWQLWN--------EGKALE-LMDP---------------------TLDESCSSDEVMRCIHVGLLCVQDRAADR 617 (676)
Q Consensus 568 ~l~~~~~~~~~--------~~~~~~-~~d~---------------------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R 617 (676)
........ ...... .... .............+.+|+.+||+.||++|
T Consensus 249 ---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 249 ---VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp ---HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred ---HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 11111100 000000 0000 00001123445678899999999999999
Q ss_pred CCHHHHHH
Q 005803 618 RTMSDVVS 625 (676)
Q Consensus 618 Ps~~eVl~ 625 (676)
||+.|+++
T Consensus 326 pt~~e~l~ 333 (355)
T 2eu9_A 326 ITLAEALL 333 (355)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-33 Score=310.53 Aligned_cols=226 Identities=23% Similarity=0.325 Sum_probs=170.7
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
..++|++.++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||++
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999975 58899999997542 334577899999999999999983
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC---CCCeEEeccCcceeccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE---QMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~---~~~vkL~DFGla~~~~~ 508 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 111245788889999999999999999998 999999999999976 44599999999987654
Q ss_pred cccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
.. ......||+.|+|||++. ..++.++|||||||++|+|++|+.||....... .......+.... +.
T Consensus 192 ~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~--~~ 258 (494)
T 3lij_A 192 QK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------ILRKVEKGKYTF--DS 258 (494)
T ss_dssp TB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC--CS
T ss_pred Cc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCC--Cc
Confidence 32 223367999999999876 569999999999999999999999997543211 112222222111 11
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.... .....+.+++.+||+.||.+|||+.|+++.
T Consensus 259 ~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 259 PEWK----NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp GGGT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred hhcc----cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1111 123457788999999999999999999853
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=285.38 Aligned_cols=227 Identities=22% Similarity=0.276 Sum_probs=175.2
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---------chhhHHHHHHHHHHHHcc-CCcccc-----
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---------GQGIVEFKNEAKLIAKLQ-HTNLTD----- 443 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~----- 443 (676)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++++. ||||++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999875 58999999986542 123456789999999996 999973
Q ss_pred ---------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCc
Q 005803 444 ---------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGM 502 (676)
Q Consensus 444 ---------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGl 502 (676)
......+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccc
Confidence 011245788899999999999999999998 99999999999999999999999999
Q ss_pred ceeccccccccccceeeccCCccChhhhc------cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHH
Q 005803 503 ARTYAMNELEANTNRIVGTHGYMSPEYVM------NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQL 576 (676)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~------~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~ 576 (676)
+....... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||...... . ....
T Consensus 171 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~ 240 (298)
T 1phk_A 171 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------L-MLRM 240 (298)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHH
T ss_pred hhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH------H-HHHH
Confidence 98754332 123357899999999985 456889999999999999999999999643211 1 1112
Q ss_pred HhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 577 WNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 577 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
...+.... ...........+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMSGNYQF------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHTCCCC------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhcCCccc------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 22222111 00111223446888999999999999999999986
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.98 E-value=5.6e-33 Score=281.44 Aligned_cols=166 Identities=19% Similarity=0.324 Sum_probs=136.3
Q ss_pred eccccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCCCCC
Q 005803 30 CQTDKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPYSP 109 (676)
Q Consensus 30 ~~~~~l~~g~~l~~~~~l~S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 109 (676)
++.|+|.+|++|++|++| ++|.|+|||+.+++. . +|..
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gnl-----~-ly~~---------------------------------- 43 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCNL-----V-LFDS---------------------------------- 43 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSCE-----E-EEES----------------------------------
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCcE-----E-EEEC----------------------------------
Confidence 567999999999999999 599999999987653 2 3432
Q ss_pred CCCCccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccc
Q 005803 110 AIKKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRG 189 (676)
Q Consensus 110 ~~~~~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~ 189 (676)
.|+||+|||+.| . ++.|.+.+ ||||||+|.+|.+||+|++........|+|+|+|||||++ .+
T Consensus 44 ---~~~vW~an~~~~---~-~~~l~l~~-dGnLvl~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~---------~~ 106 (236)
T 1dlp_A 44 ---DVRVWASNTAGA---T-GCRAVLQS-DGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG---------PG 106 (236)
T ss_dssp ---SSEEECCCCCSC---S-CCBCCBCS-SSCBCCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC---------SE
T ss_pred ---CEEEEECCCCCC---C-CeEEEEcC-CCcEEEEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEec---------CC
Confidence 567999999988 2 57889987 9999999999999999987644344689999999999985 37
Q ss_pred cccccCCCcccc-cCCCcccccc-cCCc-----eeEEEecC-CCCcceEEEeeeCCCCCeEEEEEeCCeEEEEecccCC
Q 005803 190 LWQSFDYPTHAL-LPGMKLGINL-QTGH-----QWFLQSSE-SAEGSYRLGLGTDPNMTSKLVIWKNDKVVWTSAIWLN 260 (676)
Q Consensus 190 lWqSFd~PtDtl-Lpg~~l~~~~-~t~~-----~~~l~s~~-~~~g~~~~~~~~~~~~~~~~~~~~~~~~~w~sg~w~~ 260 (676)
+||||||||||+ |||| |.|. .+|+ +++|++.. +++|.|++.+ ++++ ++++|+++.+||++++|++
T Consensus 107 ~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~s~~d~s~G~~~l~l--~~dG--~LvL~~~~~~~W~s~~~~~ 179 (236)
T 1dlp_A 107 LWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLHATQSLQLSPYRLSM--ETDC--NLVLFDRDDRVWSTNTAGK 179 (236)
T ss_dssp EEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEECSSCCCBCSSCEEEE--ETTT--EEEEEBTTBCCSCCCCCSS
T ss_pred EEECCCCCCcccccCCc--cceEEecCCcCCCccceEEcCcEeecCcEEEEE--CCCC--cEEEEcCCEeEEeCCCcCC
Confidence 999999999887 6665 5554 5554 56888755 8899999999 7777 6888998889999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.9e-33 Score=305.28 Aligned_cols=214 Identities=15% Similarity=0.159 Sum_probs=163.8
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc---hhhHHHHHHHHHHHHccC-Cccc-------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQH-TNLT------------- 442 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~---~~~~~~~~E~~~l~~l~H-~niv------------- 442 (676)
.+.+|...+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.+++.+.| +|..
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 4456778899999999999999954 699999999874322 236779999999999987 2210
Q ss_pred --c-------------------------------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 005803 443 --D-------------------------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRA 477 (676)
Q Consensus 443 --~-------------------------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i 477 (676)
. ......+++..++.++.||++||+|||+++ |
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 0 001233556788899999999999999998 9
Q ss_pred EeeccccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhh----------ccCCCCchhHHHHHHHH
Q 005803 478 IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYV----------MNGIVSMKSDVYSFGVL 547 (676)
Q Consensus 478 iH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~----------~~~~~s~ksDVwSlGvv 547 (676)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999865432 233567 999999999 55568899999999999
Q ss_pred HHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q 005803 548 VLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVV 624 (676)
Q Consensus 548 l~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl 624 (676)
+|||++|+.||.......... ..+... ... ...+.+++.+||+.||++||++.+++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~---------------~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSE---------------WIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSG---------------GGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhhhHH---------------HHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999997543222111 111100 112 24578899999999999999976664
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-32 Score=306.10 Aligned_cols=230 Identities=26% Similarity=0.322 Sum_probs=174.8
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc-------------hhhHHHHHHHHHHHHccCCcccc---
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG-------------QGIVEFKNEAKLIAKLQHTNLTD--- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~--- 443 (676)
..++|.+.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4678999999999999999999875 488999999875421 23567899999999999999983
Q ss_pred -----------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC---CeEE
Q 005803 444 -----------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM---NPKI 497 (676)
Q Consensus 444 -----------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~---~vkL 497 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEE
Confidence 112245788999999999999999999998 99999999999998776 6999
Q ss_pred eccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHH
Q 005803 498 SDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLW 577 (676)
Q Consensus 498 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~ 577 (676)
+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||....... .....
T Consensus 191 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i 259 (504)
T 3q5i_A 191 VDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------IIKKV 259 (504)
T ss_dssp CCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH
T ss_pred EECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHH
Confidence 9999998765432 223357999999999886 569999999999999999999999997543211 11222
Q ss_pred hcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcC
Q 005803 578 NEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTND 630 (676)
Q Consensus 578 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~ 630 (676)
..+.... +...... ....+.+++.+||+.||.+|||+.|+++. +.+.
T Consensus 260 ~~~~~~~--~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 260 EKGKYYF--DFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp HHCCCCC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred HcCCCCC--CccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 2222110 0000011 22457889999999999999999999864 4443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=283.89 Aligned_cols=227 Identities=23% Similarity=0.331 Sum_probs=166.9
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccccc--------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDSS-------------- 445 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~~-------------- 445 (676)
..++|++.+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+.++++++||||++..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3568999999999999999999875 689999999965 344567789999999999999987311
Q ss_pred --------------------------ccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEec
Q 005803 446 --------------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISD 499 (676)
Q Consensus 446 --------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~D 499 (676)
....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 1123566778889999999999999998 99999999999999999999999
Q ss_pred cCcceeccccc------------cccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCc
Q 005803 500 FGMARTYAMNE------------LEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERP 566 (676)
Q Consensus 500 FGla~~~~~~~------------~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~ 566 (676)
||++....... .........|++.|+|||.+.+. .++.++|||||||++|||++ ||....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---- 232 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---- 232 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH----
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch----
Confidence 99998654221 01122345789999999999864 68999999999999999998 443110
Q ss_pred cchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 567 LNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 567 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
... ......... ...+....+......+.+++.+||+.||.+|||+.++++.
T Consensus 233 -~~~-~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 -ERV-NILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -HHH-HHHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -hHH-HHHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 001 111111111 1112222333444567889999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=319.02 Aligned_cols=231 Identities=20% Similarity=0.281 Sum_probs=177.7
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcC----CcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc-----------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLD----GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS----------- 444 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~----~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~----------- 444 (676)
..++|++.+.||+|+||.||+|+... +..||||++.... ....+.+.+|+.++++++||||++.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~l 467 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 467 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEE
Confidence 45789999999999999999998642 4579999987543 3344678999999999999999730
Q ss_pred ---------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 445 ---------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 445 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 11235788889999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+ .......+...
T Consensus 545 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~~----- 611 (656)
T 2j0j_A 545 TYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERL----- 611 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHHTCCC-----
T ss_pred cce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHcCCCC-----
Confidence 221 1223456789999999999999999999999999999997 999997543211 11122222111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.+ +......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 612 ~~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 612 PM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11 2223345788999999999999999999999998753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.8e-33 Score=290.98 Aligned_cols=219 Identities=22% Similarity=0.361 Sum_probs=167.7
Q ss_pred HHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc------hhhHHHHHHHHHHHHc----cCCccccc--
Q 005803 378 IAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG------QGIVEFKNEAKLIAKL----QHTNLTDS-- 444 (676)
Q Consensus 378 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~------~~~~~~~~E~~~l~~l----~H~niv~~-- 444 (676)
.....++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++.++ +|+||+..
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445678999999999999999999864 589999999965432 2234567899999999 89998731
Q ss_pred -------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc-CCCCeEEe
Q 005803 445 -------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD-EQMNPKIS 498 (676)
Q Consensus 445 -------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~-~~~~vkL~ 498 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEE
Confidence 11234788899999999999999999998 99999999999999 88999999
Q ss_pred ccCcceeccccccccccceeeccCCccChhhhccCCCC-chhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHH
Q 005803 499 DFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVS-MKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLW 577 (676)
Q Consensus 499 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s-~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~ 577 (676)
|||++....... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||.... ...
T Consensus 183 dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~~ 246 (312)
T 2iwi_A 183 DFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------EIL 246 (312)
T ss_dssp CCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHH
T ss_pred EcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------HHh
Confidence 999998765432 2335689999999999877664 58999999999999999999996321 011
Q ss_pred hcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 578 NEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 578 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.... .+ +......+.+++.+||+.||++|||+.|+++.
T Consensus 247 -~~~~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 -EAEL------HF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -HTCC------CC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -hhcc------CC----cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1110 11 11223457889999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.3e-32 Score=298.96 Aligned_cols=225 Identities=23% Similarity=0.289 Sum_probs=161.0
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCcccccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTDSS---------------- 445 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~---------------- 445 (676)
+.|.+.+.||+|+||.||.+...+|+.||||++... ..+.+.+|+.++.++ +||||++..
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345557889999999998776678999999998653 345678999999987 899998310
Q ss_pred ---------ccC-------cCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC-------------CCeE
Q 005803 446 ---------RKS-------LLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ-------------MNPK 496 (676)
Q Consensus 446 ---------~~~-------~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~-------------~~vk 496 (676)
... ...+..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+|
T Consensus 92 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 92 NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 000 0122345679999999999999998 9999999999999754 4799
Q ss_pred EeccCcceeccccccc--cccceeeccCCccChhhhcc-------CCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCc
Q 005803 497 ISDFGMARTYAMNELE--ANTNRIVGTHGYMSPEYVMN-------GIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERP 566 (676)
Q Consensus 497 L~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~-------~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~ 566 (676)
|+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 9999999876543221 12234679999999999975 678999999999999999999 999996432211
Q ss_pred cchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 567 LNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 567 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.... .+... .+.+...........+.+++.+||+.||.+|||+.||++
T Consensus 248 -------~~i~-~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -------SNII-RGIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -------HHHH-HTCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHHh-cCCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111 11111 011111223455678899999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=290.17 Aligned_cols=219 Identities=22% Similarity=0.363 Sum_probs=171.3
Q ss_pred HHHHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCch------hhHHHHHHHHHHHHcc--CCccccc----
Q 005803 378 IAAATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQ------GIVEFKNEAKLIAKLQ--HTNLTDS---- 444 (676)
Q Consensus 378 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~------~~~~~~~E~~~l~~l~--H~niv~~---- 444 (676)
.....++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.+++++. |+||+..
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3345678999999999999999999864 6899999999754221 2356788999999996 4888720
Q ss_pred -----------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc-CCCCeEEecc
Q 005803 445 -----------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD-EQMNPKISDF 500 (676)
Q Consensus 445 -----------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~-~~~~vkL~DF 500 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++ +++.+||+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 11245788889999999999999999998 99999999999999 7889999999
Q ss_pred CcceeccccccccccceeeccCCccChhhhccCCC-CchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhc
Q 005803 501 GMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNE 579 (676)
Q Consensus 501 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 579 (676)
|++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ... .
T Consensus 195 g~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~-~ 257 (320)
T 3a99_A 195 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EII-R 257 (320)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHH-H
T ss_pred cccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhh-c
Confidence 9998765322 223568999999999987665 688999999999999999999996321 011 1
Q ss_pred CCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 580 GKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 580 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+.. ...... ...+.+++.+||+.||++|||++||++.
T Consensus 258 ~~~------~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 258 GQV------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CCC------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccc------cccccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 111122 2357789999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=282.07 Aligned_cols=226 Identities=20% Similarity=0.308 Sum_probs=156.0
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCch--hhHHHHHHHHHHHHccCCccccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQ--GIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.++..+++.++||||++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467889999999999999999975 6899999999764322 22334555667888899999731
Q ss_pred ------------cccCcCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 445 ------------SRKSLLDWKKRFYIIEGIVQGLLYLHKY-SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 445 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
.....+++..+..++.||+.||.|||++ + |+||||||+||+++.++.+||+|||++........
T Consensus 104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence 1134678889999999999999999995 7 99999999999999999999999999976543221
Q ss_pred ccccceeeccCCccChhhhc-----cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 512 EANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
.....|++.|+|||.+. ...++.++|||||||++|||++|+.||...... ........ .+....
T Consensus 181 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~-~~~~~~-- 249 (318)
T 2dyl_A 181 ---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVL-QEEPPL-- 249 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHH-HSCCCC--
T ss_pred ---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHh-ccCCCC--
Confidence 22357899999999994 456889999999999999999999999753221 11111111 111111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+.. .......+.+++.+||+.||.+||++.||++.
T Consensus 250 ---~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 ---LPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp ---CCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ---CCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 110 01122357788999999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=281.77 Aligned_cols=226 Identities=25% Similarity=0.329 Sum_probs=174.0
Q ss_pred HHhcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc------------
Q 005803 380 AATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS------------ 444 (676)
Q Consensus 380 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~------------ 444 (676)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||++.
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999876 68999999986532 3456788999999999999998730
Q ss_pred --------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCC---CCeEEeccCcceecc
Q 005803 445 --------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQ---MNPKISDFGMARTYA 507 (676)
Q Consensus 445 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~---~~vkL~DFGla~~~~ 507 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++....
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 11245788899999999999999999998 9999999999999754 469999999997654
Q ss_pred ccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 508 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 508 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||...... . .......+......
T Consensus 176 ~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~~~- 243 (287)
T 2wei_A 176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------D-ILKRVETGKYAFDL- 243 (287)
T ss_dssp CCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCCCCS-
T ss_pred CCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHcCCCCCCc-
Confidence 322 1223468999999998865 5899999999999999999999999754211 1 11222222221100
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.... .....+.+++.+||+.||++|||+.|+++
T Consensus 244 -~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 244 -PQWR----TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -GGGT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hhhh----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0001 12345788999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=285.78 Aligned_cols=231 Identities=19% Similarity=0.193 Sum_probs=149.0
Q ss_pred HhcCCCcce-eeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 381 ATDNFSPAN-RLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 381 ~t~~y~~~~-~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
..++|.+.+ .||+|+||.||+|+.. +++.||||++.... ....+....+..+.||||+.
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 456898855 6999999999999876 58999999986521 12223334467778999872
Q ss_pred -----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC---CCCeEEeccCcc
Q 005803 444 -----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE---QMNPKISDFGMA 503 (676)
Q Consensus 444 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~---~~~vkL~DFGla 503 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 111235889999999999999999999998 999999999999976 455999999999
Q ss_pred eeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 504 RTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||............ ......+.
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~-- 249 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLGQ-- 249 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhccc--
Confidence 8654322 23357899999999998888999999999999999999999999754332211000 00000000
Q ss_pred ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH--HHhcCc
Q 005803 584 ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS--MLTNDT 631 (676)
Q Consensus 584 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~--~Le~~~ 631 (676)
..............+.+++.+||+.||++|||+.|+++ .+.+..
T Consensus 250 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 250 ----YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred ----cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 00111111123345788999999999999999999998 455543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=296.79 Aligned_cols=224 Identities=21% Similarity=0.328 Sum_probs=160.6
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCccccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTDS---------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~~---------------- 444 (676)
..+|.+.+.||+|+||.|+.....+++.||||++.... ...+.+|+.+++++ +||||++.
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 34688899999999999766556689999999986532 23467899999999 79999831
Q ss_pred ----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC-----CCCeEEeccCcceecccc
Q 005803 445 ----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE-----QMNPKISDFGMARTYAMN 509 (676)
Q Consensus 445 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~-----~~~vkL~DFGla~~~~~~ 509 (676)
.....+.+..+..++.||+.||.|||+++ |+||||||+|||++. ...+||+|||+++.....
T Consensus 100 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 100 CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp CSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred CCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 11123444567789999999999999998 999999999999953 346889999999876533
Q ss_pred cc-ccccceeeccCCccChhhhc---cCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccc
Q 005803 510 EL-EANTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584 (676)
Q Consensus 510 ~~-~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (676)
.. ........||+.|+|||++. ...++.++|||||||++|||++ |..||....... ...........
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--------~~~~~~~~~~~ 248 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--------ANILLGACSLD 248 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--------HHHHTTCCCCT
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--------HHHHhccCCcc
Confidence 21 12233467999999999997 4567889999999999999999 999985432110 11111111111
Q ss_pred cCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 585 LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 585 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
... ........+.+++.+||+.||++|||+.||++
T Consensus 249 ~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 CLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111 12234455778999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=298.97 Aligned_cols=235 Identities=24% Similarity=0.248 Sum_probs=168.9
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC-CchhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999864 5899999998754 33445678999999999999998721
Q ss_pred --------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC---eEEeccC
Q 005803 445 --------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN---PKISDFG 501 (676)
Q Consensus 445 --------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~---vkL~DFG 501 (676)
.....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 01124778889999999999999999998 999999999999997665 8999999
Q ss_pred cceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCcc-c-hHHHHHHH-Hh
Q 005803 502 MARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPL-N-LVGYAWQL-WN 578 (676)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~-~-l~~~~~~~-~~ 578 (676)
++........ .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......... . ........ ..
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 9987654322 23367899999999999999999999999999999999999999643110000 0 00000000 00
Q ss_pred ----cCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHH
Q 005803 579 ----EGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSD 622 (676)
Q Consensus 579 ----~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~e 622 (676)
.+.....-...............+.+++.+||+.||++|||+.|
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00000000001112234456778899999999999999999966
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=301.28 Aligned_cols=215 Identities=20% Similarity=0.288 Sum_probs=170.1
Q ss_pred hcCCCcceeeccCCCccEEEEEEc--CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL--DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~--~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
.++|++.+.||+|+||.||+|++. +++.||||++.... ......+.+|+.++.+++||||++.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999875 58999999986543 3445678999999999999999731
Q ss_pred ---------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 445 ---------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 445 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
.....+++.+++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++.....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 01235788999999999999999999998 9999999999999986 8999999999875432
Q ss_pred ccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
....||+.|+|||++.+.. +.++|||||||++|||++|..||........ .
T Consensus 235 ------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-------------------~--- 285 (681)
T 2pzi_A 235 ------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------------------P--- 285 (681)
T ss_dssp ------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------------------C---
T ss_pred ------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-------------------c---
Confidence 3367999999999987654 8999999999999999999988764211100 0
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCC-CHHHHHHHHhcC
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRR-TMSDVVSMLTND 630 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-s~~eVl~~Le~~ 630 (676)
...........+.+++.+||+.||++|| +++++.+.|.+.
T Consensus 286 -~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 -EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0000112234678899999999999999 566666666554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=264.14 Aligned_cols=207 Identities=8% Similarity=0.009 Sum_probs=156.1
Q ss_pred hcCCCcceeeccCCCccEEEEEEcC-CcEEEEEEeccCCc---hhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
.++|++.+.||+|+||.||+|+... ++.||||++..... ...+.+.+|+.++.+++||||++.
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3689999999999999999999764 89999999976432 334778999999999999998730
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.........+...++.||+.||.|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------------
Confidence 00112355678889999999999999998 9999999999999999999998543
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 593 (676)
|++ .++.++|||||||++|||++|+.||............ .........+ ...
T Consensus 175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~--~~~ 227 (286)
T 3uqc_A 175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------ERDTAGQPIE--PAD 227 (286)
T ss_dssp ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------CBCTTSCBCC--HHH
T ss_pred ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------HHHhccCCCC--hhh
Confidence 333 3689999999999999999999999865433211000 0000000000 000
Q ss_pred CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 594 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
........+.+++.+||+.||++| |+.|+++.|+...
T Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 228 IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 111223457889999999999999 9999999998865
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-29 Score=259.36 Aligned_cols=205 Identities=19% Similarity=0.222 Sum_probs=152.6
Q ss_pred hcCCCcc-eeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHH-HHccCCcccc---------------
Q 005803 382 TDNFSPA-NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLI-AKLQHTNLTD--------------- 443 (676)
Q Consensus 382 t~~y~~~-~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l-~~l~H~niv~--------------- 443 (676)
.++|.+. +.||+|+||.||+|... +++.||||++.. ...+.+|+.++ +.++||||+.
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4567777 77999999999999874 689999999854 24567888887 6668999872
Q ss_pred -----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC---CCCeEEeccCcc
Q 005803 444 -----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE---QMNPKISDFGMA 503 (676)
Q Consensus 444 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~---~~~vkL~DFGla 503 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 011235888999999999999999999998 999999999999998 788999999998
Q ss_pred eeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 504 RTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
.... +..++.++|||||||++|||++|+.||......... .....
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~ 212 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKT 212 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHH
Confidence 6432 234678999999999999999999999754322110 00000
Q ss_pred ccCCcccCCCCC----hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcCc
Q 005803 584 ELMDPTLDESCS----SDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTNDT 631 (676)
Q Consensus 584 ~~~d~~l~~~~~----~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~~ 631 (676)
....... ..+ ......+.+++.+||+.||++|||+.|+++. +.+..
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 213 RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp SSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 0000000 011 1223467889999999999999999999974 55543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=267.87 Aligned_cols=217 Identities=15% Similarity=0.160 Sum_probs=160.7
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCC--------chhhHHHHHHHHHHHHcc---------CCcccc-
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSS--------GQGIVEFKNEAKLIAKLQ---------HTNLTD- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~- 443 (676)
.++|++.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.+++.++ |+|++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46789999999999999999987 78999999997542 223477899999999997 444421
Q ss_pred ------------------------------------------------------ccccCcCCHHHHHHHHHHHHHHHHHH
Q 005803 444 ------------------------------------------------------SSRKSLLDWKKRFYIIEGIVQGLLYL 469 (676)
Q Consensus 444 ------------------------------------------------------~~~~~~l~~~~~~~i~~qia~gL~yL 469 (676)
......+++..+..++.||+.||.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 01123468889999999999999999
Q ss_pred H-hcCCCceEeeccccCceEEcCCC--------------------CeEEeccCcceeccccccccccceeeccCCccChh
Q 005803 470 H-KYSRLRAIHRDLKVSNILLDEQM--------------------NPKISDFGMARTYAMNELEANTNRIVGTHGYMSPE 528 (676)
Q Consensus 470 H-~~~~~~iiH~DLKp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE 528 (676)
| +++ |+||||||+|||++.++ .+||+|||+|+.... ....||+.|+|||
T Consensus 178 H~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 178 EASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred HHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence 9 898 99999999999999887 899999999986542 2358999999999
Q ss_pred hhccCCCCchhHHHHHHHH-HHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHH
Q 005803 529 YVMNGIVSMKSDVYSFGVL-VLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGL 607 (676)
Q Consensus 529 ~~~~~~~s~ksDVwSlGvv-l~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~ 607 (676)
++.+.. +.++|||||+++ .+++++|..||... ............... ................+.+|+.
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~dli~ 317 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMT---FKTKCNTPAMKQIKRKIQEFHR 317 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCC---CSSCCCSHHHHHHHHHHHHHHH
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhc---cCcccchhhhhhcCHHHHHHHH
Confidence 998766 899999998777 78888899887420 000001111111100 0111111122345678899999
Q ss_pred HhcccCcCCCCCHHHHH
Q 005803 608 LCVQDRAADRRTMSDVV 624 (676)
Q Consensus 608 ~Cl~~dP~~RPs~~eVl 624 (676)
+||+.| |++|++
T Consensus 318 ~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 318 TMLNFS-----SATDLL 329 (336)
T ss_dssp HGGGSS-----SHHHHH
T ss_pred HHhccC-----CHHHHH
Confidence 999966 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-22 Score=231.62 Aligned_cols=160 Identities=17% Similarity=0.140 Sum_probs=102.8
Q ss_pred eeeccCCCccEEEEE-EcCCcEEEEEEeccCC----------chhhHHHHHHHHHHHHc-cCCcccc-------------
Q 005803 389 NRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSS----------GQGIVEFKNEAKLIAKL-QHTNLTD------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~-~~~~~~VAvK~l~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~------------- 443 (676)
..++.|++|.+..++ .--|+.+|||.+.+.. ....++|.+|+++|+++ .|+||++
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 346677777777665 3358999999996531 23346799999999999 6999872
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
......++.. .|+.||+.||+|||++| ||||||||+|||+++++.+||+|||+|+......
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 1223445543 58999999999999999 9999999999999999999999999998765432
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcC
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKN 557 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~p 557 (676)
. .....+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 394 ~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 S--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred c--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 2 2334789999999998875 467789999999999888766443
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.83 E-value=3.7e-20 Score=162.62 Aligned_cols=105 Identities=20% Similarity=0.383 Sum_probs=89.3
Q ss_pred cccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCCCCCCC
Q 005803 32 TDKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPYSPAI 111 (676)
Q Consensus 32 ~~~l~~g~~l~~~~~l~S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (676)
.++|.+||.|.+|++|+| |.|.|.|...++ |.++..
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~~------------------------------------- 36 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYDH------------------------------------- 36 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEET-------------------------------------
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEEC-------------------------------------
Confidence 478999999999999988 889999998876 445432
Q ss_pred CCccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccc
Q 005803 112 KKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLW 191 (676)
Q Consensus 112 ~~~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lW 191 (676)
.++||+|||+.|... .+.|.+.. ||||||+|.++.+||+|++........|+|+|+|||||++ +.+|
T Consensus 37 -~~~vW~ant~~~~~~--~~~L~l~~-dGnLvL~d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~---------~~~W 103 (105)
T 4h3o_A 37 -STSTWASNTEIGGKS--GCSAVLQS-DGNFVVYDSSGRSLWASHSTRGSGNYILILQDDGNVIIYG---------SDIW 103 (105)
T ss_dssp -TEEEEECCCCCTTCC--SCEEEECT-TSCEEEECTTCCEEEECCCCCCSSCEEEEECTTSCEEEEE---------SEEE
T ss_pred -CEEEEEecCCCCCCc--cEEEEEeC-CccEEEECCCcEEEEEecCCCCCCCEEEEEeCCCeEEEEC---------CcEe
Confidence 567999999999754 47899987 9999999999999999997655556789999999999996 4699
Q ss_pred cc
Q 005803 192 QS 193 (676)
Q Consensus 192 qS 193 (676)
||
T Consensus 104 ~S 105 (105)
T 4h3o_A 104 ST 105 (105)
T ss_dssp EC
T ss_pred cC
Confidence 98
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.82 E-value=6e-20 Score=165.10 Aligned_cols=108 Identities=20% Similarity=0.351 Sum_probs=91.8
Q ss_pred eccccccCCCcccCCCeEE--ecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCCC
Q 005803 30 CQTDKLQQGQVLKDGEELV--SAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPY 107 (676)
Q Consensus 30 ~~~~~l~~g~~l~~~~~l~--S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 107 (676)
++.++|.+|++|.+|++|+ |++|.|+|+|+.+++. +||++
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgnl------vly~~-------------------------------- 47 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNL------VLYDN-------------------------------- 47 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSCE------EEEET--------------------------------
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCCE------EEEEC--------------------------------
Confidence 5789999999999999999 9999999999998752 57754
Q ss_pred CCCCCCccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccc
Q 005803 108 SPAIKKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIR 187 (676)
Q Consensus 108 ~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~ 187 (676)
.++||.|||+.|- . ++.|.+.+ ||||||+|.++.+||+|.+....+...++|+|+|||||++
T Consensus 48 -----~~~vW~sn~~~~~--~-~~~l~l~~-dGNLVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~--------- 109 (119)
T 1b2p_A 48 -----NNPIWATNTGGLG--N-GCRAVLQP-DGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG--------- 109 (119)
T ss_dssp -----TEEEEECCCTTSC--S-SCEEEECT-TSCEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---------
T ss_pred -----CEEEEeCCCccCC--C-ceEEEEcc-CCEEEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---------
Confidence 5679999998762 2 47899987 9999999999999999986544455689999999999986
Q ss_pred cccccc
Q 005803 188 RGLWQS 193 (676)
Q Consensus 188 ~~lWqS 193 (676)
.++|||
T Consensus 110 ~~~W~S 115 (119)
T 1b2p_A 110 DALWAT 115 (119)
T ss_dssp SEEEEC
T ss_pred ccEeCC
Confidence 369998
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.5e-20 Score=212.63 Aligned_cols=168 Identities=20% Similarity=0.196 Sum_probs=122.9
Q ss_pred CcceeeccCCCccEEEEEEcCCcEEEEEEeccCCc--------hhhHHHHHHHHHHHHccCCccccc-------------
Q 005803 386 SPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSG--------QGIVEFKNEAKLIAKLQHTNLTDS------------- 444 (676)
Q Consensus 386 ~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~~------------- 444 (676)
...+.||+|+||.||+|+. .++.+|+|+...... ...+++.+|++++++++||||+..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999944 678899998643211 113458999999999999999820
Q ss_pred ---cccCcCC-H-HHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc-----c
Q 005803 445 ---SRKSLLD-W-KKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA-----N 514 (676)
Q Consensus 445 ---~~~~~l~-~-~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~-----~ 514 (676)
..+..|. . ..+..++.||++||.|||+++ |+||||||+|||++. .+||+|||+++......... .
T Consensus 418 mE~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~ 492 (540)
T 3en9_A 418 MSYINGKLAKDVIEDNLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVF 492 (540)
T ss_dssp EECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHH
T ss_pred EECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhh
Confidence 0000010 0 015689999999999999998 999999999999999 99999999999875432211 1
Q ss_pred cceeeccCCccChhhhcc--CCCCchhHHHHHHHHHHHHHhCCcCCC
Q 005803 515 TNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIVSSKKNNG 559 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~elltG~~pf~ 559 (676)
.....||+.|+|||++.. ..|+..+|+|+..+-.++.+.++.+|.
T Consensus 493 ~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 493 KKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 234689999999999987 568888999999999999988877663
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=160.66 Aligned_cols=110 Identities=21% Similarity=0.330 Sum_probs=92.1
Q ss_pred cccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCCCCCCC
Q 005803 32 TDKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPYSPAI 111 (676)
Q Consensus 32 ~~~l~~g~~l~~~~~l~S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (676)
+|+|.+|++|.+|++|+ ++|.|+|+|+..|+. ++|..
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGnl------vl~~~------------------------------------ 37 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCNF------VLYDS------------------------------------ 37 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSCE------EEEET------------------------------------
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCcE------EEEEC------------------------------------
Confidence 48899999999999999 999999999988763 56652
Q ss_pred CCccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccc
Q 005803 112 KKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLW 191 (676)
Q Consensus 112 ~~~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lW 191 (676)
.++||.||++.|. . ...+.+.+ ||||||+|.++.+||+|.+....+...++|+|+|||||++ ..+|
T Consensus 38 -~~~vW~sn~~~~~--~-~~~l~l~~-dGNLVl~~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~---------~~~W 103 (110)
T 3a0c_A 38 -GKPVWASNTGGLG--S-GCRLTLHN-NGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYG---------PVVW 103 (110)
T ss_dssp -TEEEEECCCTTSC--S-SCEEEECT-TSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---------SEEE
T ss_pred -CEEEEECCCCCCC--C-cEEEEEeC-CCCEEEECCCCcEEEecCCCCCCCCEEEEEeCCccEEEEC---------CCEe
Confidence 5679999998763 2 46888887 9999999999999999987654445689999999999975 2599
Q ss_pred cccCCCc
Q 005803 192 QSFDYPT 198 (676)
Q Consensus 192 qSFd~Pt 198 (676)
|||+||.
T Consensus 104 ~S~~~~~ 110 (110)
T 3a0c_A 104 ATGSGPA 110 (110)
T ss_dssp ECSCCC-
T ss_pred cCCCcCC
Confidence 9999983
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.7e-19 Score=157.95 Aligned_cols=110 Identities=24% Similarity=0.351 Sum_probs=90.7
Q ss_pred cccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCCCCCCC
Q 005803 32 TDKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPYSPAI 111 (676)
Q Consensus 32 ~~~l~~g~~l~~~~~l~S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (676)
.|+|.+||+|.+|++|+ +|.|+|+|+.+++. . +|..
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgnl---v---ly~~------------------------------------ 37 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCNL---V---KYQN------------------------------------ 37 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSCE---E---EEET------------------------------------
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCcE---E---EEeC------------------------------------
Confidence 48999999999999998 89999999987752 2 3432
Q ss_pred CCccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccc
Q 005803 112 KKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLW 191 (676)
Q Consensus 112 ~~~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lW 191 (676)
.++||.|||+.|. . ++.|.+.+ +|||||+|.++.+||+|+...+.+..+++|+|+|||||++ .++|
T Consensus 38 -~~~vW~sn~~~~~--~-~~~l~l~~-~GnLvl~d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~---------~~~W 103 (115)
T 2dpf_A 38 -GRQIWASNTDRRG--S-GCRLTLLS-DGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYG---------PVLW 103 (115)
T ss_dssp -TEEEEECSCTTSC--S-SCEEEECT-TSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---------SEEE
T ss_pred -CEEEEeCCCCCCC--C-ceEEEECC-CCcEEEECCCceEEEEcCCCCCCCCEEEEEeCCCeEEEEC---------CCEE
Confidence 5679999999883 2 47899987 9999999988999999887543445689999999999985 2699
Q ss_pred cccCCCcc
Q 005803 192 QSFDYPTH 199 (676)
Q Consensus 192 qSFd~PtD 199 (676)
|||.+++.
T Consensus 104 ~S~~~~~~ 111 (115)
T 2dpf_A 104 SLGPNGCR 111 (115)
T ss_dssp CSSTTCBC
T ss_pred ECCCCCCc
Confidence 99998765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=8.7e-19 Score=181.97 Aligned_cols=141 Identities=16% Similarity=0.120 Sum_probs=109.0
Q ss_pred ccHHHHHHHhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCc------------------hhhHHHHHHHHHHH
Q 005803 373 FDFQTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSG------------------QGIVEFKNEAKLIA 434 (676)
Q Consensus 373 f~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~------------------~~~~~~~~E~~~l~ 434 (676)
+....+......|.+.+.||+|+||.||+|+..+++.||||.++.... .....+.+|+.+++
T Consensus 80 ~~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~ 159 (282)
T 1zar_A 80 YSLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ 159 (282)
T ss_dssp HHHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHH
Confidence 334455566677888899999999999999987799999999864321 13456899999999
Q ss_pred HccCCcccc------------ccccCc---CCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEec
Q 005803 435 KLQHTNLTD------------SSRKSL---LDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISD 499 (676)
Q Consensus 435 ~l~H~niv~------------~~~~~~---l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~D 499 (676)
+++|+++.. ...+.. +.......++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|
T Consensus 160 ~l~~~~v~~~~~~~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 160 KLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp HTTTSSSCCEEEEETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECC
T ss_pred hccCCCcCeEEeccceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEE
Confidence 998655431 111101 333556789999999999999998 99999999999999 99999999
Q ss_pred cCcceeccccccccccceeeccCCccChhhhcc
Q 005803 500 FGMARTYAMNELEANTNRIVGTHGYMSPEYVMN 532 (676)
Q Consensus 500 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 532 (676)
||++.. +..++|||++..
T Consensus 236 FG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 236 FPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp CTTCEE---------------TTSTTHHHHHHH
T ss_pred CCCCeE---------------CCCCCHHHHHHH
Confidence 999863 345789998753
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.7e-18 Score=152.81 Aligned_cols=110 Identities=24% Similarity=0.447 Sum_probs=88.9
Q ss_pred cccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCCCCCCC
Q 005803 32 TDKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPYSPAI 111 (676)
Q Consensus 32 ~~~l~~g~~l~~~~~l~S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (676)
+|||.+||+|.+|++| ++|.|+|+|+.+++. +||.+
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgnl------vl~~~------------------------------------ 36 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCNL------VLYDN------------------------------------ 36 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSCE------EEEET------------------------------------
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCcE------EEEEC------------------------------------
Confidence 5899999999999999 589999999998863 34543
Q ss_pred CCccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccc
Q 005803 112 KKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLW 191 (676)
Q Consensus 112 ~~~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lW 191 (676)
.++||.||++.+ .. ++.|.+.+ +|||||+| ++.++|+|.+....+...++|+++|||||++. +. .++|
T Consensus 37 -~~~vW~sn~~~~--~~-~~~l~l~~-~GNLvl~d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~---~~---~~~W 104 (112)
T 1xd5_A 37 -NRAVWASGTNGK--AS-GCVLKMQN-DGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDN---SN---NAIW 104 (112)
T ss_dssp -TEEEEECCCTTS--CS-SEEEEECT-TSCEEEEE-TTEEEEECCCCCSCCCCEEEECTTSCEEEECT---TS---CEEE
T ss_pred -CEEEEeCCCcCC--CC-CEEEEEeC-CCCEEEEc-CCEEEEECCccCCCCCEEEEEeCCCcEEEECC---CC---ceEE
Confidence 456999999753 22 47889987 99999999 88899998865444456899999999999862 22 5899
Q ss_pred cccCCC
Q 005803 192 QSFDYP 197 (676)
Q Consensus 192 qSFd~P 197 (676)
|||+|.
T Consensus 105 ~S~~~~ 110 (112)
T 1xd5_A 105 ATHTNV 110 (112)
T ss_dssp ECCCCC
T ss_pred ECCCcc
Confidence 999984
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=2.6e-17 Score=145.64 Aligned_cols=103 Identities=27% Similarity=0.431 Sum_probs=84.4
Q ss_pred ccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCCCCCCCC
Q 005803 33 DKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPYSPAIK 112 (676)
Q Consensus 33 ~~l~~g~~l~~~~~l~S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 112 (676)
+||.+||+|.+|++|+ +|.|+|+|+.+|+ .+| |..
T Consensus 2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn---Lvl---y~~------------------------------------- 36 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN--NGRYVFIMQEDCN---LVL---YDV------------------------------------- 36 (109)
T ss_dssp CEEETTEEECTTCEEE--ETTEEEEECTTSC---EEE---EET-------------------------------------
T ss_pred CCcCCCCEeCCCCEEE--CCCEEEEEcCCCc---EEE---EeC-------------------------------------
Confidence 6899999999999996 7999999998875 222 432
Q ss_pred CccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCcccccccc
Q 005803 113 KQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQ 192 (676)
Q Consensus 113 ~~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWq 192 (676)
.++||.+|++.+- . +..|.+.+ ||||||+|.++.++|+|++.......+|+|+|+|||||++ ..+||
T Consensus 37 ~~~vW~snt~~~~--~-~~~l~l~~-dGNLvl~~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~---------~~~W~ 103 (109)
T 3dzw_A 37 DKPIWATNTGGLD--R-RCHLSMQS-DGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYG---------TARWA 103 (109)
T ss_dssp TEEEEECCCTTSS--S-SCEEEECT-TSCEEEECTTSCEEEECCCCCSSSCEEEEECTTSCEEEEE---------SCCCC
T ss_pred CEEEEECCcccCC--C-CEEEEEeC-CCCEEEECCCCCEEEECCCCCCCCCEEEEEeCCCEEEEEC---------CCEEe
Confidence 4569999998762 2 46889987 9999999998999999987654444689999999999997 36999
Q ss_pred c
Q 005803 193 S 193 (676)
Q Consensus 193 S 193 (676)
|
T Consensus 104 s 104 (109)
T 3dzw_A 104 T 104 (109)
T ss_dssp C
T ss_pred C
Confidence 8
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.5e-15 Score=134.47 Aligned_cols=105 Identities=21% Similarity=0.262 Sum_probs=83.4
Q ss_pred eccccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCCCCC
Q 005803 30 CQTDKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPYSP 109 (676)
Q Consensus 30 ~~~~~l~~g~~l~~~~~l~S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 109 (676)
.++|+|.+||+|..|+.|+| |.|.|-|...|+ |.+ |..
T Consensus 4 ~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~---------------------------------- 41 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG---------------------------------- 41 (110)
T ss_dssp CBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS----------------------------------
T ss_pred cccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC----------------------------------
Confidence 46799999999999999998 569997776664 434 322
Q ss_pred CCCCccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccc
Q 005803 110 AIKKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRG 189 (676)
Q Consensus 110 ~~~~~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~ 189 (676)
++||.+|++.. .. +..|.+.+ +|||||+|.++.++|+|++....+..+|+|+|+|||||++ ..
T Consensus 42 ----~~vW~snt~~~--~~-~~~l~l~~-dGNLvl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---------~~ 104 (110)
T 3r0e_B 42 ----KYGWQSNTHGN--GE-HCFLRLNH-KGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---------PA 104 (110)
T ss_dssp ----SSCEECCCTTS--SS-SCEEEECT-TSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---------SE
T ss_pred ----eEEEECCCcCC--Cc-CEEEEEeC-CCcEEEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---------CC
Confidence 24999999763 12 46889987 9999999999999999987544344689999999999986 36
Q ss_pred cccc
Q 005803 190 LWQS 193 (676)
Q Consensus 190 lWqS 193 (676)
+|+|
T Consensus 105 ~W~t 108 (110)
T 3r0e_B 105 IFET 108 (110)
T ss_dssp EEES
T ss_pred EecC
Confidence 8987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.62 E-value=2.8e-15 Score=133.40 Aligned_cols=108 Identities=19% Similarity=0.273 Sum_probs=86.9
Q ss_pred eccccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCCCCC
Q 005803 30 CQTDKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPYSP 109 (676)
Q Consensus 30 ~~~~~l~~g~~l~~~~~l~S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 109 (676)
.+.|+|.+||.|.+|+.|.+ |.|.|-|...|+ |.++..+.
T Consensus 4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~~~~--------------------------------- 43 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTKGSK--------------------------------- 43 (113)
T ss_dssp CCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEETTT---------------------------------
T ss_pred ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEECCC---------------------------------
Confidence 35799999999999999974 889999988775 55543211
Q ss_pred CCCCccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccc
Q 005803 110 AIKKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRG 189 (676)
Q Consensus 110 ~~~~~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~ 189 (676)
.++||.+|++.+- . +..|.+.+ +|||||+|.++.++|+|++....+..+|+|+|+|||||++ ..
T Consensus 44 ---~~~vWssnt~~~~--~-~~~l~l~~-dGNLVl~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---------~~ 107 (113)
T 3mez_B 44 ---TNIVWESGTSGRG--Q-HCFMRLGH-SGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---------PA 107 (113)
T ss_dssp ---TEEEEECCCTTSC--S-SCEEEECT-TSCEEEECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---------SE
T ss_pred ---CEEEEECCcccCC--c-CEEEEEeC-CCcEEEECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---------CC
Confidence 4679999998752 2 46888987 9999999998999999987654445689999999999986 36
Q ss_pred cccc
Q 005803 190 LWQS 193 (676)
Q Consensus 190 lWqS 193 (676)
+|+|
T Consensus 108 ~W~s 111 (113)
T 3mez_B 108 VWST 111 (113)
T ss_dssp EEES
T ss_pred EecC
Confidence 9997
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1e-15 Score=156.66 Aligned_cols=118 Identities=17% Similarity=0.187 Sum_probs=91.4
Q ss_pred CCCcceeeccCCCccEEEEEE-cCCcE--EEEEEeccCCch------------------------hhHHHHHHHHHHHHc
Q 005803 384 NFSPANRLGQGGFGPVYNGKL-LDGQE--IAIKRLSKSSGQ------------------------GIVEFKNEAKLIAKL 436 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~-~~~~~--VAvK~l~~~~~~------------------------~~~~~~~E~~~l~~l 436 (676)
-|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367789999999999999987 68888 999987543111 113578999999999
Q ss_pred cCCccc--------------cccc--c---Cc-------CCHHHHHHHHHHHHHHHHHHH-hcCCCceEeeccccCceEE
Q 005803 437 QHTNLT--------------DSSR--K---SL-------LDWKKRFYIIEGIVQGLLYLH-KYSRLRAIHRDLKVSNILL 489 (676)
Q Consensus 437 ~H~niv--------------~~~~--~---~~-------l~~~~~~~i~~qia~gL~yLH-~~~~~~iiH~DLKp~NILl 489 (676)
.|+++. .... + .. .++.....++.|++.||.||| +.+ |+||||||+|||+
T Consensus 128 ~~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~NILl 204 (258)
T 1zth_A 128 KEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYNIMY 204 (258)
T ss_dssp HHTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTSEEE
T ss_pred HhCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEE
Confidence 887642 1111 0 01 113367889999999999999 888 9999999999999
Q ss_pred cCCCCeEEeccCcceec
Q 005803 490 DEQMNPKISDFGMARTY 506 (676)
Q Consensus 490 ~~~~~vkL~DFGla~~~ 506 (676)
+. .++|+|||+|...
T Consensus 205 ~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 205 ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SS--SEEECCCTTCEET
T ss_pred cC--cEEEEECcccccC
Confidence 98 9999999999753
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.57 E-value=7.3e-15 Score=129.75 Aligned_cols=108 Identities=20% Similarity=0.324 Sum_probs=86.0
Q ss_pred ccccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCCCCCC
Q 005803 31 QTDKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPYSPA 110 (676)
Q Consensus 31 ~~~~l~~g~~l~~~~~l~S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 110 (676)
+.|||.+||.|.+|+.| .+|.|.|.|...++-. + |..
T Consensus 2 ~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGNLv-----l-~~~----------------------------------- 38 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCNLV-----L-YNG----------------------------------- 38 (109)
T ss_dssp CCSEEETTCEECTTCEE--EETTEEEEECTTSCEE-----E-ETT-----------------------------------
T ss_pred ccCCcCCCCCcCCCCEe--ECCCEEEEEecCCeEE-----E-EeC-----------------------------------
Confidence 57999999999999999 5799999998887632 1 211
Q ss_pred CCCccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCcccccc
Q 005803 111 IKKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGL 190 (676)
Q Consensus 111 ~~~~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~l 190 (676)
+|.+|+..+- . ...|.+.+ ||||||+|.++.++|++++........|+|+|+|||||++ ..+
T Consensus 39 -----~Wssnt~~~~--~-~~~l~l~~-dGnLvl~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---------~~~ 100 (109)
T 3r0e_A 39 -----NWQSNTANNG--R-DCKLTLTD-YGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---------PSV 100 (109)
T ss_dssp -----TEECCCTTSC--S-SCEEEECT-TSCEEEECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---------SEE
T ss_pred -----eEEcCCCCCC--C-cEEEEEcC-CCeEEEEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---------cCE
Confidence 6999987642 2 47899987 9999999998999999887543345689999999999986 479
Q ss_pred ccccCCCcccccCC
Q 005803 191 WQSFDYPTHALLPG 204 (676)
Q Consensus 191 WqSFd~PtDtlLpg 204 (676)
|+| .|.+||
T Consensus 101 W~s-----~t~~~~ 109 (109)
T 3r0e_A 101 FKI-----DPWVRG 109 (109)
T ss_dssp EEE-----CTTSCC
T ss_pred ECC-----CCccCC
Confidence 998 666654
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.53 E-value=2.4e-14 Score=127.25 Aligned_cols=91 Identities=25% Similarity=0.474 Sum_probs=74.2
Q ss_pred CceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccccccCCCcccccCCCcccc
Q 005803 130 SASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYPTHALLPGMKLGI 209 (676)
Q Consensus 130 ~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~ 209 (676)
...|.+.. ||||+|++. +++||++++........|+|+|+|||||++ ++ .++||||++|
T Consensus 20 ~~~L~~~~-dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~------~~~W~S~~~~------------ 78 (112)
T 1xd5_A 20 GYLFIIQN-DCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GS------RAIWASNTNR------------ 78 (112)
T ss_dssp TEEEEECT-TSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TT------EEEEECCCCC------------
T ss_pred CEEEEEcC-CCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CC------EEEEECCccC------------
Confidence 57899987 999999987 789999997643345689999999999997 22 5899999543
Q ss_pred cccCCceeEEEecCCCCcceEEEeeeCCCCCeEEEEEe-CCeEEEEecccCC
Q 005803 210 NLQTGHQWFLQSSESAEGSYRLGLGTDPNMTSKLVIWK-NDKVVWTSAIWLN 260 (676)
Q Consensus 210 ~~~t~~~~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~w~sg~w~~ 260 (676)
++|.|++.| +++|+ +++|+ ++.+||++++|+|
T Consensus 79 ---------------~~g~~~l~l--~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 79 ---------------QNGNYYLIL--QRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp ---------------SCCCCEEEE--CTTSC--EEEECTTSCEEEECCCCCC
T ss_pred ---------------CCCCEEEEE--eCCCc--EEEECCCCceEEECCCccC
Confidence 357889999 88887 66776 4689999999976
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.2e-13 Score=122.30 Aligned_cols=88 Identities=32% Similarity=0.496 Sum_probs=70.6
Q ss_pred CceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccccccCCCcccccCCCcccc
Q 005803 130 SASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYPTHALLPGMKLGI 209 (676)
Q Consensus 130 ~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~ 209 (676)
...|.+.. ||||||++ .+++||++++........++|+|+|||||++. +. .++||||..
T Consensus 21 ~~~l~~~~-dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~---~~---~~~W~S~t~------------- 79 (110)
T 3a0c_A 21 SYRLIMQG-DCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQ---SN---RVIWQTKTN------------- 79 (110)
T ss_dssp TEEEEECT-TSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECT---TC---CEEEECCCC-------------
T ss_pred CEEEEEcC-CCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECC---CC---cEEEecCCC-------------
Confidence 57899987 99999998 58899999976544456899999999999973 22 689999932
Q ss_pred cccCCceeEEEecCCCCcceEEEeeeCCCCCeEEEEEeCCeEEEEeccc
Q 005803 210 NLQTGHQWFLQSSESAEGSYRLGLGTDPNMTSKLVIWKNDKVVWTSAIW 258 (676)
Q Consensus 210 ~~~t~~~~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~w~sg~w 258 (676)
+++|.|++.+ +++|+ +++|++ .||+++++
T Consensus 80 --------------~~~g~~~l~l--~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 80 --------------GKEDHYVLVL--QQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp --------------CSSSCCEEEE--CTTSC--EEEECS--EEEECSCC
T ss_pred --------------CCCCCEEEEE--eCCcc--EEEECC--CEecCCCc
Confidence 2468899999 88887 667775 89999875
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.3e-13 Score=122.99 Aligned_cols=90 Identities=29% Similarity=0.433 Sum_probs=72.5
Q ss_pred CceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccccccCCCcccccCCCcccc
Q 005803 130 SASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYPTHALLPGMKLGI 209 (676)
Q Consensus 130 ~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~ 209 (676)
...|.+.. ||||+|++ .+++||++++..+.....++|+++|||||++. +. .++|||||+
T Consensus 21 ~~~L~~~~-dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~---~~---~~vW~S~~~------------- 79 (115)
T 2dpf_A 21 AYTLTIQN-KCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDH---NN---NDVWGSACW------------- 79 (115)
T ss_dssp TEEEEECT-TSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECT---TC---CEEEECCCC-------------
T ss_pred CEEEEEcC-CCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECC---Cc---eEEEEcCCC-------------
Confidence 46888877 99999998 58899999976544456899999999999972 22 589999997
Q ss_pred cccCCceeEEEecCCCCcceEEEeeeCCCCCeEEEEEeCCeEEEEecccCC
Q 005803 210 NLQTGHQWFLQSSESAEGSYRLGLGTDPNMTSKLVIWKNDKVVWTSAIWLN 260 (676)
Q Consensus 210 ~~~t~~~~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~w~sg~w~~ 260 (676)
+++|.|++.+ +++|+ +++|+. .||+|++|..
T Consensus 80 --------------~~~g~~~l~l--~~dGn--lvl~~~--~~W~S~~~~~ 110 (115)
T 2dpf_A 80 --------------GDNGKYALVL--QKDGR--FVIYGP--VLWSLGPNGC 110 (115)
T ss_dssp --------------CSSSCCEEEE--CTTSC--EEEECS--EEECSSTTCB
T ss_pred --------------CCCCCEEEEE--eCCCe--EEEECC--CEEECCCCCC
Confidence 2457788999 88887 667765 8999999965
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.43 E-value=2.2e-13 Score=146.29 Aligned_cols=120 Identities=18% Similarity=0.192 Sum_probs=88.8
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCc--------------hhhH--------HHHHHHHHHHHccCCc
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSG--------------QGIV--------EFKNEAKLIAKLQHTN 440 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~--------------~~~~--------~~~~E~~~l~~l~H~n 440 (676)
.-|++.+.||+|+||.||+|...+|+.||||+++.... .... ...+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34999999999999999999988999999998753210 0000 1245777788776554
Q ss_pred cc--------------cc----cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCC--------
Q 005803 441 LT--------------DS----SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMN-------- 494 (676)
Q Consensus 441 iv--------------~~----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~-------- 494 (676)
+. .. ......+......++.||+.+|.+||+.| ||||||||.|||+++++.
T Consensus 175 v~vp~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~~~~ 251 (397)
T 4gyi_A 175 FPVPEPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPSSIT 251 (397)
T ss_dssp CSCCCEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTTSEE
T ss_pred CCCCeeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccccccc
Confidence 31 00 11122333455678999999999999998 999999999999987763
Q ss_pred --eEEeccCccee
Q 005803 495 --PKISDFGMART 505 (676)
Q Consensus 495 --vkL~DFGla~~ 505 (676)
+.|+||+-+..
T Consensus 252 ~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 252 LTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEECCCTTCEE
T ss_pred cceEEEEeCCccc
Confidence 89999998764
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.42 E-value=5.5e-13 Score=119.56 Aligned_cols=86 Identities=30% Similarity=0.472 Sum_probs=68.9
Q ss_pred ceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccccccCCCcccccCCCccccc
Q 005803 131 ASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYPTHALLPGMKLGIN 210 (676)
Q Consensus 131 ~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~~ 210 (676)
..|.+.. ||||+|++. +++||++++........++|+|+|||||++. +. .++||||..
T Consensus 32 ~~L~~~~-dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~---~~---~~lW~S~~~-------------- 89 (119)
T 1b2p_A 32 YRFIMQT-DCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN---EN---VTVWQSPVA-------------- 89 (119)
T ss_dssp EEEEECT-TSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT---TC---CEEEECSCC--------------
T ss_pred EEEEEec-CCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeC---CC---cEEEcCCCC--------------
Confidence 5788887 999999987 8899999976544457899999999999972 22 689999943
Q ss_pred ccCCceeEEEecCCCCcceEEEeeeCCCCCeEEEEEeCCeEEEEecc
Q 005803 211 LQTGHQWFLQSSESAEGSYRLGLGTDPNMTSKLVIWKNDKVVWTSAI 257 (676)
Q Consensus 211 ~~t~~~~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~w~sg~ 257 (676)
+++|.|++.+ +++|+ +++|+ .+||++|+
T Consensus 90 -------------~~~g~~~l~l--~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 90 -------------GKAGHYVLVL--QPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp -------------CCSSCEEEEE--CTTSC--EEEEE--SEEEECCC
T ss_pred -------------CCCCCEEEEE--ECCCc--EEEEC--ccEeCCCC
Confidence 2468899999 88887 66777 38999986
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.39 E-value=9.8e-13 Score=116.43 Aligned_cols=103 Identities=17% Similarity=0.321 Sum_probs=80.5
Q ss_pred cccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCCCCCCC
Q 005803 32 TDKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPYSPAI 111 (676)
Q Consensus 32 ~~~l~~g~~l~~~~~l~S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (676)
.++|.+||.|.+|+.| .+|.|.|.|...|+- .+ |..
T Consensus 2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGnL-----vl-~~~------------------------------------ 37 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCNL-----VL-YNE------------------------------------ 37 (111)
T ss_dssp TTEEETTCEECTTCEE--EETTEEEEECTTSCE-----EE-ECS------------------------------------
T ss_pred cCEeCCCCEeCCCCEE--ecCCEEEEEccCCeE-----EE-ECC------------------------------------
Confidence 5789999999999999 479999999888753 22 322
Q ss_pred CCccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCc-eEEEeeecc--CCcceEEEEeeCCCEEEEEecCCCCcccc
Q 005803 112 KKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKN-PIGISSVRR--AGNTTSATLLKNGNLVLYEMNSDGLSIRR 188 (676)
Q Consensus 112 ~~~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~-~vw~s~~~~--~~~~~~a~l~d~GNlVl~~~~~~~~~~~~ 188 (676)
.. ||.+|+..+- . ...|.+.+ +|||||+|.++. ++|+|++.. .....+++|+|+|||||++ .
T Consensus 38 -~~-vW~snt~~~~--~-~~~l~l~~-dGNLVl~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---------~ 102 (111)
T 3mez_A 38 -AG-GFQSNTHGRG--V-DCTLRLNN-RGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---------P 102 (111)
T ss_dssp -SC-CEECCCTTSC--S-SCEEEECT-TSCEEEECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---------S
T ss_pred -CC-EEECCcccCC--c-CEEEEEcC-CCcEEEEeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---------c
Confidence 33 9999998762 2 46888887 999999998776 599988532 2234689999999999986 3
Q ss_pred ccccc
Q 005803 189 GLWQS 193 (676)
Q Consensus 189 ~lWqS 193 (676)
.+|+|
T Consensus 103 ~~W~s 107 (111)
T 3mez_A 103 AIWST 107 (111)
T ss_dssp EEEEC
T ss_pred CEEcc
Confidence 69987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.16 E-value=7.3e-11 Score=104.72 Aligned_cols=96 Identities=25% Similarity=0.331 Sum_probs=70.8
Q ss_pred CCCCCCCCCCceEEEEcCCCcEEEEcC-CCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccccccCCCcc
Q 005803 121 RETPVLRNESASLIIDSTDGNLKILRN-GKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYPTH 199 (676)
Q Consensus 121 r~~p~~~~~~~~l~~~~~~G~L~l~~~-~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtD 199 (676)
.+.|+.+. ...|.+.. ||||||++. .+.++|++++........++|+++|||||++. +. +++|||=.+
T Consensus 17 ~g~~L~~g-~~~L~~q~-dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~---~~---~~iW~S~t~--- 85 (113)
T 3mez_B 17 DNAQLATR-DYSLVMRD-DCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDD---RL---NTVFVSNTV--- 85 (113)
T ss_dssp TTCEEEET-TEEEEECT-TSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECT---TS---CEEEECSCC---
T ss_pred CCCEeEcC-CEEEEEcC-CCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECC---CC---CEEEECCCc---
Confidence 35666543 67899987 999999988 58999999976443456899999999999973 22 579998221
Q ss_pred cccCCCcccccccCCceeEEEecCCCCcceEEEeeeCCCCCeEEEEEeCCeEEEEecc
Q 005803 200 ALLPGMKLGINLQTGHQWFLQSSESAEGSYRLGLGTDPNMTSKLVIWKNDKVVWTSAI 257 (676)
Q Consensus 200 tlLpg~~l~~~~~t~~~~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~w~sg~ 257 (676)
+ ..|.|.+.+ +.+|+ +++|+ .+.|.+|+
T Consensus 86 --------~----------------~~~~~~~~L--~~dGn--lvly~--~~~W~s~~ 113 (113)
T 3mez_B 86 --------G----------------QEGDYVLIL--QINGQ--AVVYG--PAVWSTAA 113 (113)
T ss_dssp --------C----------------SSSCCEEEE--CTTSC--EEEEC--SEEEESCC
T ss_pred --------C----------------CCCCEEEEE--cCCce--EEEec--CCEecCCC
Confidence 0 124578888 88887 45565 68999875
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=2.4e-10 Score=117.46 Aligned_cols=112 Identities=21% Similarity=0.354 Sum_probs=84.0
Q ss_pred ccccccCCCc----ccCCCeEEecCCeEEEeeeCCC--CCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCC
Q 005803 31 QTDKLQQGQV----LKDGEELVSAFGNFRLGFFSPY--GTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRK 104 (676)
Q Consensus 31 ~~~~l~~g~~----l~~~~~l~S~~g~f~lgF~~~~--~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 104 (676)
-+||+.||+. |..|+.|.|. ..++.|+|... ...+.+ + |.+.
T Consensus 135 ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGnlv--L-y~~~---------------------------- 182 (276)
T 3m7h_A 135 PAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGNLV--A-YGPN---------------------------- 182 (276)
T ss_dssp TTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSCEE--E-ECTT----------------------------
T ss_pred cccccccccccccccccCcccccC-CCCCCceEEEeecCCceEE--E-EeCC----------------------------
Confidence 4699999999 8889998654 56666666531 122333 3 3221
Q ss_pred CCCCCCCCCccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCC
Q 005803 105 YPYSPAIKKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGL 184 (676)
Q Consensus 105 ~~~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~ 184 (676)
.+++|.+++..+- ...|.+.. +|+|+++|.++.++|++++... ...+|+|+++|||||++.
T Consensus 183 --------~~~yW~Sgt~~~~----~~~l~l~~-dGnLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~----- 243 (276)
T 3m7h_A 183 --------GAATWNAGTQGKG----AVRAVFQG-DGNLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE----- 243 (276)
T ss_dssp --------SSEEEECCCTTTT----CCEEEECT-TSCEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE-----
T ss_pred --------CeEEEECCCCCCc----cEEEEEcC-CCeEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC-----
Confidence 3569999998762 26788887 9999999998899999886543 347899999999999972
Q ss_pred ccccccccccCC
Q 005803 185 SIRRGLWQSFDY 196 (676)
Q Consensus 185 ~~~~~lWqSFd~ 196 (676)
+.+||||||
T Consensus 244 ---~~~Wqsf~~ 252 (276)
T 3m7h_A 244 ---KPVWARFGF 252 (276)
T ss_dssp ---EEEEESSSC
T ss_pred ---CCeEEccCc
Confidence 369999997
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.08 E-value=2.1e-10 Score=101.31 Aligned_cols=89 Identities=21% Similarity=0.360 Sum_probs=66.3
Q ss_pred CceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccccccCCCcccccCCCcccc
Q 005803 130 SASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYPTHALLPGMKLGI 209 (676)
Q Consensus 130 ~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~ 209 (676)
...|.+.. ||||||++.++ +|++++........++|+++|||||++.+. . .++|||.-+
T Consensus 21 ~~~L~~q~-dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~--~---~~vW~S~t~------------- 79 (111)
T 3mez_A 21 SAAFVMQG-DCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANS--N---TPVWVYPRS------------- 79 (111)
T ss_dssp TEEEEECT-TSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSC--S---SCSEEESSS-------------
T ss_pred CEEEEEcc-CCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCC--C---EEEEEeccc-------------
Confidence 57899987 99999998776 999987654344689999999999997321 1 359999621
Q ss_pred cccCCceeEEEecCCCCcceEEEeeeCCCCCeEEEEEeCCeEEEEecc
Q 005803 210 NLQTGHQWFLQSSESAEGSYRLGLGTDPNMTSKLVIWKNDKVVWTSAI 257 (676)
Q Consensus 210 ~~~t~~~~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~w~sg~ 257 (676)
.....|.|.+.+ +.+|+ +++|. .++|.+++
T Consensus 80 ------------~~~~~~~~~l~L--q~dGN--lvly~--~~~W~s~t 109 (111)
T 3mez_A 80 ------------VNTVRGNYAATL--GPDQH--VTIYG--PAIWSTPA 109 (111)
T ss_dssp ------------CCCCSSCCEEEE--CTTSC--EEEEC--SEEEECCC
T ss_pred ------------cCCCCcCEEEEE--CCCCe--EEEec--cCEEccCC
Confidence 011347788999 88887 45565 68999875
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.89 E-value=2.9e-09 Score=93.76 Aligned_cols=87 Identities=22% Similarity=0.376 Sum_probs=64.1
Q ss_pred CceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccccccCCCcccccCCCcccc
Q 005803 130 SASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYPTHALLPGMKLGI 209 (676)
Q Consensus 130 ~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~ 209 (676)
...|.+.. ||||||++. +.+||++++........++|+++|||||++. +. .++|||..+.
T Consensus 20 ~~~L~~q~-dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~---~~---~~~W~S~t~~------------ 79 (109)
T 3dzw_A 20 RYVFIMQE-DCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSP---RN---NPIWASNTGG------------ 79 (109)
T ss_dssp TEEEEECT-TSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECT---TS---CEEEECCCCC------------
T ss_pred CEEEEEcC-CCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECC---CC---CEEEECCCCC------------
Confidence 46888887 999999987 7899999976543346899999999999973 22 5899985321
Q ss_pred cccCCceeEEEecCCCCcceEEEeeeCCCCCeEEEEEeCCeEEEEecc
Q 005803 210 NLQTGHQWFLQSSESAEGSYRLGLGTDPNMTSKLVIWKNDKVVWTSAI 257 (676)
Q Consensus 210 ~~~t~~~~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~w~sg~ 257 (676)
..+.|.+.+ +.+|+ +++|+. +.|.|++
T Consensus 80 ---------------~~~~~~~~L--~ddGN--lvly~~--~~W~s~t 106 (109)
T 3dzw_A 80 ---------------ENGNYVCVL--QKDRN--VVIYGT--ARWATGT 106 (109)
T ss_dssp ---------------SSSCEEEEE--CTTSC--EEEEES--CCCCCCC
T ss_pred ---------------CCCCEEEEE--eCCCE--EEEECC--CEEeCCC
Confidence 124567788 88887 455664 6787765
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.89 E-value=3.2e-09 Score=93.53 Aligned_cols=86 Identities=20% Similarity=0.303 Sum_probs=63.4
Q ss_pred CceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccccccCCCcccccCCCcccc
Q 005803 130 SASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYPTHALLPGMKLGI 209 (676)
Q Consensus 130 ~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~ 209 (676)
...|.+.. ||||||++. .++|++++........++|+++|||||++. +. .++|||-.+-
T Consensus 25 ~~~L~~q~-dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~---~~---~~iW~S~t~~------------ 83 (110)
T 3r0e_B 25 NHQLVMQG-DCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDD---DF---KTIWSSRSSS------------ 83 (110)
T ss_dssp SCEEEECT-TSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECT---TC---CEEEECCCCC------------
T ss_pred CEEEEEcC-CCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeC---CC---CEEEEcCCcC------------
Confidence 46888887 999999876 589999876533346899999999999973 22 5899994310
Q ss_pred cccCCceeEEEecCCCCcceEEEeeeCCCCCeEEEEEeCCeEEEEecc
Q 005803 210 NLQTGHQWFLQSSESAEGSYRLGLGTDPNMTSKLVIWKNDKVVWTSAI 257 (676)
Q Consensus 210 ~~~t~~~~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~w~sg~ 257 (676)
..|.|.+.+ +.+|+ +++|+ .+.|.+|+
T Consensus 84 ---------------~~~~~~~~L--~~dGN--lvly~--~~~W~t~~ 110 (110)
T 3r0e_B 84 ---------------KQGEYVLIL--QDDGF--GVIYG--PAIFETSS 110 (110)
T ss_dssp ---------------SSSCCEEEE--CTTSC--EEEEC--SEEEESCC
T ss_pred ---------------CCCCEEEEE--cCCcc--EEEec--CCEecCCC
Confidence 124577888 88887 45565 47898874
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.84 E-value=5e-09 Score=92.17 Aligned_cols=93 Identities=24% Similarity=0.352 Sum_probs=66.7
Q ss_pred CCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccccccCCCcccc
Q 005803 122 ETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYPTHAL 201 (676)
Q Consensus 122 ~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtl 201 (676)
+.|+.+ ....|.+.. ||||||+++ +|++++........++|+++|||||++. +. +++|+|-.+
T Consensus 15 g~~L~~-g~~~L~~q~-dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~---~~---~~vWss~t~----- 77 (109)
T 3r0e_A 15 EGHLKN-GDFDLVMQD-DCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNG---DG---STVWKSGAQ----- 77 (109)
T ss_dssp TCEEEE-TTEEEEECT-TSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECT---TS---CEEEECCCC-----
T ss_pred CCEeEC-CCEEEEEec-CCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeC---CC---CEEEcCCCc-----
Confidence 445532 257899987 999999984 8999976543456899999999999973 22 589976210
Q ss_pred cCCCcccccccCCceeEEEecCCCCcceEEEeeeCCCCCeEEEEEeCCeEEEEecccC
Q 005803 202 LPGMKLGINLQTGHQWFLQSSESAEGSYRLGLGTDPNMTSKLVIWKNDKVVWTSAIWL 259 (676)
Q Consensus 202 Lpg~~l~~~~~t~~~~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~w~sg~w~ 259 (676)
...+.|.+.+ +++|+ +++|+ .+.|++++|-
T Consensus 78 ----------------------~~~~~~~~~L--~~dGN--lvly~--~~~W~s~t~~ 107 (109)
T 3r0e_A 78 ----------------------SVKGNYAAVV--HPDGR--LVVFG--PSVFKIDPWV 107 (109)
T ss_dssp ----------------------CSSSCCEEEE--ETTTE--EEEEC--SEEEEECTTS
T ss_pred ----------------------CCCcCEEEEE--cCCCe--EEEEe--cCEECCCCcc
Confidence 0235677888 78886 45565 6899999984
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=1.4e-07 Score=95.67 Aligned_cols=127 Identities=16% Similarity=0.142 Sum_probs=91.0
Q ss_pred HHHHhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccC-Ccc---cc----------
Q 005803 378 IAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH-TNL---TD---------- 443 (676)
Q Consensus 378 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H-~ni---v~---------- 443 (676)
+.....+|.+...++.|+.+.||++.. .++.+++|+...........+.+|+.+++.+.+ ..+ +.
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 445567898888999999999999975 368999999865322334568999999999853 222 10
Q ss_pred ---ccccCcC-----CHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 005803 444 ---SSRKSLL-----DWKKRFYIIEGIVQGLLYLHKY------------------------------------------- 472 (676)
Q Consensus 444 ---~~~~~~l-----~~~~~~~i~~qia~gL~yLH~~------------------------------------------- 472 (676)
...+..+ +......++.+++++|..||+.
T Consensus 88 v~e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 88 LMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp EEECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred EEEecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 1111111 1233457889999999999981
Q ss_pred -------------CCCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 473 -------------SRLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 473 -------------~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
....++|+|++|.|||++++..+.|+||+.+..
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114489999999999998765567999998753
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.53 E-value=2.7e-07 Score=80.43 Aligned_cols=84 Identities=27% Similarity=0.508 Sum_probs=60.2
Q ss_pred ceEEEEcCCCcEEEEcCCCceEEEeeeccCC-cceEEEEeeCCCEEEEEecCCCCccccccccccCCCcccccCCCcccc
Q 005803 131 ASLIIDSTDGNLKILRNGKNPIGISSVRRAG-NTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYPTHALLPGMKLGI 209 (676)
Q Consensus 131 ~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~-~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~ 209 (676)
-+|.+.. ||||||++. +++||++++..+. ....++|.++|||||.+.+. +++|.|=.+
T Consensus 21 y~l~~q~-DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~------~~vWss~t~------------- 79 (105)
T 4h3o_A 21 YHFIMQD-DCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSG------RSLWASHST------------- 79 (105)
T ss_dssp EEEEECT-TSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTC------CEEEECCCC-------------
T ss_pred EEEEECC-CCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCc------EEEEEecCC-------------
Confidence 5788877 999999974 6799999976443 34679999999999997322 589987210
Q ss_pred cccCCceeEEEecCCCCcceEEEeeeCCCCCeEEEEEeCCeEEEEe
Q 005803 210 NLQTGHQWFLQSSESAEGSYRLGLGTDPNMTSKLVIWKNDKVVWTS 255 (676)
Q Consensus 210 ~~~t~~~~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~w~s 255 (676)
...+.+.+.+ +.+|++ ++|+. ..|.|
T Consensus 80 --------------~~~~~~~l~L--~ddGNl--Vly~~--~~W~S 105 (105)
T 4h3o_A 80 --------------RGSGNYILIL--QDDGNV--IIYGS--DIWST 105 (105)
T ss_dssp --------------CCSSCEEEEE--CTTSCE--EEEES--EEEEC
T ss_pred --------------CCCCCEEEEE--eCCCeE--EEECC--cEecC
Confidence 1345678888 888874 55643 56764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.53 E-value=1.2e-07 Score=95.47 Aligned_cols=122 Identities=15% Similarity=0.076 Sum_probs=85.3
Q ss_pred HhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcc-cc----------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-TD---------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~---------------- 443 (676)
...+|.+....+.|..+.||++...+|+.+++|..... ....+.+|+.+++.+.+.++ +.
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 34455554333456669999998777888999997543 33567899999999976554 21
Q ss_pred -ccccCcCC--HHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 005803 444 -SSRKSLLD--WKKRFYIIEGIVQGLLYLHKYS----------------------------------------------- 473 (676)
Q Consensus 444 -~~~~~~l~--~~~~~~i~~qia~gL~yLH~~~----------------------------------------------- 473 (676)
...+..+. ......++.++++.|..||+..
T Consensus 95 e~i~G~~l~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 95 GEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp ECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred EecCCcccCcCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 11122222 1223468889999999999753
Q ss_pred --------CCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 474 --------RLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 474 --------~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
...++|+|++|.|||++++..++|+||+.+..
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.28 E-value=5.8e-07 Score=93.39 Aligned_cols=163 Identities=18% Similarity=0.165 Sum_probs=103.9
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHcc-CCccc-----c----------------cc
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLT-----D----------------SS 445 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv-----~----------------~~ 445 (676)
.+.++.|....||+.. ..+++|+... ......+.+|+.+++.+. +..+. . ..
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 5688888643 234567899999999884 33321 0 01
Q ss_pred ccCc--------CCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 005803 446 RKSL--------LDWKKRFYIIEGIVQGLLYLHKYS-------------------------------------------- 473 (676)
Q Consensus 446 ~~~~--------l~~~~~~~i~~qia~gL~yLH~~~-------------------------------------------- 473 (676)
.+.. ++..++..++.++++.|+.||+..
T Consensus 99 ~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 178 (304)
T 3sg8_A 99 KGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR 178 (304)
T ss_dssp CCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred CCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence 1112 234456788999999999999621
Q ss_pred -----------CCceEeeccccCceEEcC--CCCeEEeccCcceeccccccccccc------------eeeccCCccC-h
Q 005803 474 -----------RLRAIHRDLKVSNILLDE--QMNPKISDFGMARTYAMNELEANTN------------RIVGTHGYMS-P 527 (676)
Q Consensus 474 -----------~~~iiH~DLKp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~------------~~~gt~~Y~A-P 527 (676)
...++|+|++|.||++++ ...+.|+||+.+..-.......... ......+... |
T Consensus 179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~ 258 (304)
T 3sg8_A 179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIP 258 (304)
T ss_dssp HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHH
T ss_pred HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcH
Confidence 135899999999999998 4567899999987532211000000 0000111122 3
Q ss_pred hhhccCCCCchhHHHHHHHHHHHHHhCCcCC
Q 005803 528 EYVMNGIVSMKSDVYSFGVLVLEIVSSKKNN 558 (676)
Q Consensus 528 E~~~~~~~s~ksDVwSlGvvl~elltG~~pf 558 (676)
+..... ....+.|+++.++|.+.+|..+|
T Consensus 259 ~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 259 TVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 322211 23368999999999999998764
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.26 E-value=1.1e-06 Score=88.06 Aligned_cols=86 Identities=20% Similarity=0.368 Sum_probs=62.5
Q ss_pred CceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccccccCCCcccccCCCcccc
Q 005803 130 SASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYPTHALLPGMKLGI 209 (676)
Q Consensus 130 ~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~ 209 (676)
.-+|.++. +|+|+|.+.+ .++|++++........++|+++||||+++. +. .++||||.+
T Consensus 151 ~~~l~l~~-dG~LvL~~~~-~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~---~~---~~vw~s~~~------------- 209 (236)
T 1dlp_A 151 PYRLSMET-DCNLVLFDRD-DRVWSTNTAGKGTGCRAVLQPNGRMDVLTN---QN---IAVWTSGNS------------- 209 (236)
T ss_dssp SCEEEEET-TTEEEEEBTT-BCCSCCCCCSSCSSCEEEEETTTEEEEEET---TT---EEEEECCCC-------------
T ss_pred cEEEEECC-CCcEEEEcCC-EeEEeCCCcCCCCceEEEECCCCcEEEEeC---CC---cEEEEeCCC-------------
Confidence 35788887 9999998764 689998865332345789999999999972 22 589999953
Q ss_pred cccCCceeEEEecCCCCcceEEEeeeCCCCCeEEEEEeCCeEEEEec
Q 005803 210 NLQTGHQWFLQSSESAEGSYRLGLGTDPNMTSKLVIWKNDKVVWTSA 256 (676)
Q Consensus 210 ~~~t~~~~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~w~sg 256 (676)
| ++|.|++.+ +++|..++ |. ..||.+|
T Consensus 210 ------------~--~~~~~rl~L--d~dG~l~l--y~--~~~W~sg 236 (236)
T 1dlp_A 210 ------------R--SAGRYVFVL--QPDRNLAI--YG--GALWTTG 236 (236)
T ss_dssp ------------C--SSSCCEEEE--CSSSCEEE--EC--CCCCBC-
T ss_pred ------------C--CCCCEEEEE--cCCCcEEE--eC--CCCccCC
Confidence 1 236788999 88887655 43 3788765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.15 E-value=7.7e-06 Score=86.86 Aligned_cols=118 Identities=14% Similarity=0.203 Sum_probs=83.8
Q ss_pred cceeeccCCCccEEEEEEcCCcEEEEEEec--cCC-chhhHHHHHHHHHHHHccCCcc-----c----------------
Q 005803 387 PANRLGQGGFGPVYNGKLLDGQEIAIKRLS--KSS-GQGIVEFKNEAKLIAKLQHTNL-----T---------------- 442 (676)
Q Consensus 387 ~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~--~~~-~~~~~~~~~E~~~l~~l~H~ni-----v---------------- 442 (676)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+.+.++ +
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4678999999999999875 4678888875 321 1234578899999999975332 1
Q ss_pred ccccc--------CcCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 005803 443 DSSRK--------SLLDWKKRFYIIEGIVQGLLYLHKYS----------------------------------------- 473 (676)
Q Consensus 443 ~~~~~--------~~l~~~~~~~i~~qia~gL~yLH~~~----------------------------------------- 473 (676)
+...+ ..++..++..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (359)
T 3dxp_A 121 EFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL 200 (359)
T ss_dssp ECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred EecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence 00111 12456778889999999999999831
Q ss_pred --------------CCceEeeccccCceEEcCCCC--eEEeccCccee
Q 005803 474 --------------RLRAIHRDLKVSNILLDEQMN--PKISDFGMART 505 (676)
Q Consensus 474 --------------~~~iiH~DLKp~NILl~~~~~--vkL~DFGla~~ 505 (676)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997653 68999999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0029 Score=65.47 Aligned_cols=112 Identities=21% Similarity=0.178 Sum_probs=78.1
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCc-c-----cc--------------cccc
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN-L-----TD--------------SSRK 447 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n-i-----v~--------------~~~~ 447 (676)
.+.++.|....||+. +..+++|+-. .......+.+|+.+|..+.+.. + +. ...+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 466888888899987 5678888842 2334567899999999997531 1 10 0111
Q ss_pred C--------cCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 005803 448 S--------LLDWKKRFYIIEGIVQGLLYLHKYS---------------------------------------------- 473 (676)
Q Consensus 448 ~--------~l~~~~~~~i~~qia~gL~yLH~~~---------------------------------------------- 473 (676)
. .++..++..++.++++.|+.||+..
T Consensus 98 ~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 177 (306)
T 3tdw_A 98 QILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ 177 (306)
T ss_dssp EECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred eECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence 1 1234456677888888888888632
Q ss_pred -----------CCceEeeccccCceEEcC---CCCe-EEeccCccee
Q 005803 474 -----------RLRAIHRDLKVSNILLDE---QMNP-KISDFGMART 505 (676)
Q Consensus 474 -----------~~~iiH~DLKp~NILl~~---~~~v-kL~DFGla~~ 505 (676)
...++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224699999999999987 4554 8999998865
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0021 Score=65.68 Aligned_cols=54 Identities=20% Similarity=0.174 Sum_probs=43.5
Q ss_pred CCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHcc
Q 005803 384 NFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ 437 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~ 437 (676)
.....+.+|.|..+.||+.++.+|+.|.||+-..........|..|+..|+.|.
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~ 69 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLG 69 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHT
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHH
Confidence 344567899999999999999999999999876544444456788999999884
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0043 Score=65.26 Aligned_cols=32 Identities=19% Similarity=0.247 Sum_probs=26.4
Q ss_pred CCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 474 RLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 474 ~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
...++|+|+.|.|||++++..+.|+||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 34689999999999999644578999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0027 Score=68.02 Aligned_cols=50 Identities=14% Similarity=0.174 Sum_probs=34.7
Q ss_pred ceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc-------hhhHHHHHHHHHHHHcc
Q 005803 388 ANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG-------QGIVEFKNEAKLIAKLQ 437 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~-------~~~~~~~~E~~~l~~l~ 437 (676)
.+.||.|..+.||+++.. +++.++||....... ....++..|.+++..+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~ 92 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQG 92 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHH
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhh
Confidence 568999999999999754 468899998643211 12345678998888774
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.30 E-value=0.013 Score=60.63 Aligned_cols=32 Identities=22% Similarity=0.214 Sum_probs=27.9
Q ss_pred CCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 474 RLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 474 ~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
...++|+|+++.|||++.++.+.|+||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 34699999999999998888999999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.27 E-value=0.015 Score=60.09 Aligned_cols=62 Identities=6% Similarity=0.013 Sum_probs=37.5
Q ss_pred ccHHHHHHHhcCCCc-----ceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHcc
Q 005803 373 FDFQTIAAATDNFSP-----ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ 437 (676)
Q Consensus 373 f~~~~l~~~t~~y~~-----~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~ 437 (676)
++.+++......|.+ .+.|+.|....+|+....++ .+++|+.... ....++..|+.++..+.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~ 73 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLA 73 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHH
Confidence 444556655555654 34567788889999987655 6888987652 12345567887777764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.74 E-value=0.036 Score=56.78 Aligned_cols=111 Identities=16% Similarity=0.065 Sum_probs=72.9
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccC----Cccc-----------ccc-ccCcCC
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH----TNLT-----------DSS-RKSLLD 451 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv-----------~~~-~~~~l~ 451 (676)
.+.|+.|....+|+. +.+++|+...... ......+|+.+++.+.. |.++ ... .+..++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~g~~l~ 96 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAGAQTMS 96 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTTCEECC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCCCccCC
Confidence 678999999999998 5688888754321 12233568877777643 2222 112 333444
Q ss_pred HHHHH---HHHHHHHHHHHHHHhcCC--------------------------------------------------CceE
Q 005803 452 WKKRF---YIIEGIVQGLLYLHKYSR--------------------------------------------------LRAI 478 (676)
Q Consensus 452 ~~~~~---~i~~qia~gL~yLH~~~~--------------------------------------------------~~ii 478 (676)
..... .++.++++.|+-||+... ..++
T Consensus 97 ~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l~ 176 (301)
T 3dxq_A 97 PEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAAC 176 (301)
T ss_dssp HHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEEE
T ss_pred HhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCceee
Confidence 43322 367778888888886431 2379
Q ss_pred eeccccCceEEcCCCCeEEeccCccee
Q 005803 479 HRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 479 H~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
|+|+.+.||+ ..++.+.|+||..+..
T Consensus 177 HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 177 HCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ccCCCcCCEE-ECCCCEEEEecccccC
Confidence 9999999999 5566789999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.39 E-value=0.056 Score=58.59 Aligned_cols=51 Identities=10% Similarity=0.167 Sum_probs=36.2
Q ss_pred ceeeccCCCccEEEEEEcC--------CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCc
Q 005803 388 ANRLGQGGFGPVYNGKLLD--------GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 440 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~--------~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n 440 (676)
.+.|+.|-...||++...+ ++.+++|+.... .....+.+|..++..+...+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g 136 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERH 136 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTT
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCC
Confidence 5678888889999998753 578999987431 11245668988888875433
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=95.14 E-value=0.068 Score=53.40 Aligned_cols=114 Identities=17% Similarity=0.119 Sum_probs=73.8
Q ss_pred eeeccCCCc-cEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccC----Ccccc-------------ccccCc
Q 005803 389 NRLGQGGFG-PVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH----TNLTD-------------SSRKSL 449 (676)
Q Consensus 389 ~~LG~G~fG-~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~-------------~~~~~~ 449 (676)
+.+..|..+ .||+.... ++..+++|+-.. .....+.+|...|+.+.. |.++. ...+..
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556555 58988754 467789998643 245568889999988853 22210 011111
Q ss_pred ------CCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------------
Q 005803 450 ------LDWKKRFYIIEGIVQGLLYLHKYS-------------------------------------------------- 473 (676)
Q Consensus 450 ------l~~~~~~~i~~qia~gL~yLH~~~-------------------------------------------------- 473 (676)
........+..++++.|..||...
T Consensus 107 ~~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 186 (272)
T 4gkh_A 107 AFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKL 186 (272)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTT
T ss_pred ccccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhc
Confidence 112334456777777777777421
Q ss_pred -----CCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 474 -----RLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 474 -----~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
...++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 187 ~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 187 LPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12369999999999999877778999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.00 E-value=0.11 Score=56.74 Aligned_cols=53 Identities=15% Similarity=0.144 Sum_probs=34.4
Q ss_pred ceeeccCCCccEEEEEEcC-CcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcc
Q 005803 388 ANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 441 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ni 441 (676)
.+.|+.|-...+|+....+ +..+++|+...... ......+|..++..|...++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl 166 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNI 166 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCC
Confidence 4678888889999998765 47888998743221 11123678888888865444
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.85 E-value=0.14 Score=49.94 Aligned_cols=89 Identities=8% Similarity=0.052 Sum_probs=57.4
Q ss_pred cCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccC
Q 005803 447 KSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMS 526 (676)
Q Consensus 447 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~A 526 (676)
+.++++++++.++.|.+.+|.-+-... . -..+=+.|..|++..+|.+.+.+ ..+. .....+.|
T Consensus 43 ~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~~~~~~~~ 105 (229)
T 2yle_A 43 NQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD--------------AGEPPPVA 105 (229)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C-------------------------
T ss_pred CCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc--------------ccccCCCC
Confidence 457999999999999999987762211 0 11233457899999999888764 1111 11224568
Q ss_pred hhhhccCCCCchhHHHHHHHHHHHHHh
Q 005803 527 PEYVMNGIVSMKSDVYSFGVLVLEIVS 553 (676)
Q Consensus 527 PE~~~~~~~s~ksDVwSlGvvl~ellt 553 (676)
||... ...+.+.=|||||+++|..+-
T Consensus 106 pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 106 GKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred hhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 88653 345688899999999999986
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.39 E-value=0.2 Score=51.50 Aligned_cols=47 Identities=15% Similarity=0.064 Sum_probs=33.8
Q ss_pred eeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHcc
Q 005803 389 NRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ 437 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~ 437 (676)
..|+ |....||+....+|+.+++|...... .....+..|..++..+.
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~ 78 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLV 78 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHH
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHH
Confidence 4577 88889999877778789999986321 23456677888877764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=94.37 E-value=0.092 Score=55.34 Aligned_cols=30 Identities=23% Similarity=0.357 Sum_probs=25.0
Q ss_pred CceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 475 LRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 475 ~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
..++|+|+.+.|||++++. +.|+||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 4589999999999998654 89999988764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=93.72 E-value=0.29 Score=50.56 Aligned_cols=46 Identities=22% Similarity=0.203 Sum_probs=36.1
Q ss_pred ceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHcc
Q 005803 388 ANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ 437 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~ 437 (676)
.+.|+.|....+|+... +++.+++|+.... ....+..|...|+.|.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~ 86 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLA 86 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHH
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHH
Confidence 56799999999999976 5678889987542 3566888998888875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=93.24 E-value=0.49 Score=50.21 Aligned_cols=50 Identities=16% Similarity=0.182 Sum_probs=30.7
Q ss_pred ceeeccCCCccEEEEEEc--------CCcEEEEEEeccCCchhhHHHHHHHHHHHHccC
Q 005803 388 ANRLGQGGFGPVYNGKLL--------DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH 438 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~--------~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H 438 (676)
.+.|..|-...+|+.... +++.+++|+... .......+.+|..+++.+..
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~ 112 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAE 112 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHH
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHh
Confidence 467878888999999864 247899998633 22345566789998888753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=90.32 E-value=0.23 Score=53.32 Aligned_cols=78 Identities=10% Similarity=0.078 Sum_probs=48.0
Q ss_pred CCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccceeec--cCCccChhhhccC---CCCchhHHHHHHHHH
Q 005803 474 RLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVG--THGYMSPEYVMNG---IVSMKSDVYSFGVLV 548 (676)
Q Consensus 474 ~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~g--t~~Y~APE~~~~~---~~s~ksDVwSlGvvl 548 (676)
...++|+|++|.|||++.++ ++|+||+.+..-.....- ..... ...|.+|+..... .-....++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 34599999999999998776 999999998753221100 00010 1245666554311 112234566788888
Q ss_pred HHHHhCC
Q 005803 549 LEIVSSK 555 (676)
Q Consensus 549 ~elltG~ 555 (676)
|+.+.++
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8877654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=89.84 E-value=0.68 Score=49.94 Aligned_cols=30 Identities=30% Similarity=0.441 Sum_probs=26.6
Q ss_pred CceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 475 LRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 475 ~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 45899999999999 7788999999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=87.34 E-value=0.64 Score=47.92 Aligned_cols=32 Identities=25% Similarity=0.378 Sum_probs=27.6
Q ss_pred CCceEeeccccCceEEcCC----CCeEEeccCccee
Q 005803 474 RLRAIHRDLKVSNILLDEQ----MNPKISDFGMART 505 (676)
Q Consensus 474 ~~~iiH~DLKp~NILl~~~----~~vkL~DFGla~~ 505 (676)
...++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3469999999999999874 6789999998875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.51 E-value=2.1 Score=45.51 Aligned_cols=30 Identities=30% Similarity=0.360 Sum_probs=25.4
Q ss_pred ceEeeccccCceEE------cCCCCeEEeccCccee
Q 005803 476 RAIHRDLKVSNILL------DEQMNPKISDFGMART 505 (676)
Q Consensus 476 ~iiH~DLKp~NILl------~~~~~vkL~DFGla~~ 505 (676)
.++|+|+.+.|||+ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4566799999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 676 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-44 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-41 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-39 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-38 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-37 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-37 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-37 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-36 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-33 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-33 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-31 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-29 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-29 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-27 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-27 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-26 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-26 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-25 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-25 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-23 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-21 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-21 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-17 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 8e-11 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 8e-07 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 1e-05 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 8e-05 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-51
Identities = 63/283 (22%), Positives = 114/283 (40%), Gaps = 43/283 (15%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN-- 440
+ R+G G FG VY GK + + ++ + Q + FKNE ++ K +H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 441 ----------------------LTD--SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLR 476
L ++ + K I QG+ YLH S
Sbjct: 68 LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI-- 125
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM---NG 533
IHRDLK +NI L E + KI DFG+A + ++ G+ +M+PE +
Sbjct: 126 -IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 534 IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593
S +SDVY+FG+++ E+++ + + + + + G + P L +
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IFMVGRGY----LSPDLSK- 233
Query: 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPK 636
S+ + C++ + +R +++ + +LPK
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-48
Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 47/272 (17%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 441
+ RLG G FG V+ G ++A+K L + S F EA L+ +LQH L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 442 --------------------------TDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRL 475
+ L K + I +G+ ++ + +
Sbjct: 72 RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY- 130
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
IHRDL+ +NIL+ + ++ KI+DFG+AR NE A + +PE + G
Sbjct: 131 --IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGTF 187
Query: 536 SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCS 595
++KSDV+SFG+L+ EIV+ + P + + N + ++ P ++C
Sbjct: 188 TIKSDVWSFGILLTEIVTHGR--------IPYPGMTNPEVIQNLERGYRMVRP---DNCP 236
Query: 596 SDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
+ + LC ++R DR T + S+L
Sbjct: 237 EE----LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 7e-48
Identities = 60/286 (20%), Positives = 107/286 (37%), Gaps = 47/286 (16%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 441
++ +LGQG FG V+ G +AIK L + F EA+++ KL+H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 442 --------------------------TDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRL 475
L + + I G+ Y+ +
Sbjct: 76 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 132
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
+HRDL+ +NIL+ E + K++DFG+AR NE A + +PE + G
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRF 191
Query: 536 SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCS 595
++KSDV+SFG+L+ E+ + + + + L+ ++ C
Sbjct: 192 TIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCP 236
Query: 596 SDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQPA 641
+ + C + +R T + + L + + QP
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-47
Identities = 60/287 (20%), Positives = 106/287 (36%), Gaps = 49/287 (17%)
Query: 390 RLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN--------- 440
+G+G FG V+ GK G+E+A+K S + + E L+H N
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADN 67
Query: 441 --------------------LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHK-----YSRL 475
L D + + + + GL +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTY--AMNELEANTNRIVGTHGYMSPEYVMNG 533
HRDLK NIL+ + I+D G+A + A + ++ N VGT YM+PE + +
Sbjct: 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187
Query: 534 I------VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERP----LNLVGYAWQLWNEGKAL 583
I ++D+Y+ G++ EI G ++ + L + + +
Sbjct: 188 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 247
Query: 584 ELMDPTLDESCSSDEVMRCIH-VGLLCVQDRAADRRTMSDVVSMLTN 629
+ + P + S E +R + + C A R T + L+
Sbjct: 248 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 5e-46
Identities = 63/272 (23%), Positives = 104/272 (38%), Gaps = 47/272 (17%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT 442
+ +G G FG V+ G L+ ++AIK + + + +F EA+++ KL H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 443 ---------------------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRL 475
+++ L + + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---A 120
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
IHRDL N L+ E K+SDFGM R ++ ++ + SPE
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRY 179
Query: 536 SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCS 595
S KSDV+SFGVL+ E+ S K P + + + L P L S
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGK--------IPYENRSNSEVVEDISTGFRLYKPRL---AS 228
Query: 596 SDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
+ + C ++R DR S ++ L
Sbjct: 229 TH----VYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-45
Identities = 58/274 (21%), Positives = 107/274 (39%), Gaps = 47/274 (17%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT 442
+ + LG G FG V GK ++AIK + + S EF EAK++ L H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 443 ---------------------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRL 475
+ ++ + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SK 119
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
+ +HRDL N L+++Q K+SDFG++R Y +++ ++ + PE +M
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 536 SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCS 595
S KSD+++FGVL+ EI S K ++ + + E + L
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLYRP 223
Query: 596 SDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629
+ + C ++A +R T ++S + +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 6e-45
Identities = 60/321 (18%), Positives = 115/321 (35%), Gaps = 64/321 (19%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKL 436
F LG G FG VY G + E +AIK L ++ S + E +EA ++A +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 437 QHTNL--------------------------TDSSRKSLLDWKKRFYIIEGIVQGLLYLH 470
+ ++ K + + I +G+ YL
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 471 KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYV 530
R +HRDL N+L+ + KI+DFG+A+ E E + +M+ E +
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 531 MNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590
++ I + +SDV+S+GV V E+++ + + +++
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEISSILEKGE 230
Query: 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT--------------NDTMALPK 636
+ + + C A R +++ + ++ M LP
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPS 290
Query: 637 PKQPAFFINISSDYEEPDVTE 657
P F+ + + + DV +
Sbjct: 291 PTDSNFYRALMDEEDMDDVVD 311
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-44
Identities = 55/279 (19%), Positives = 103/279 (36%), Gaps = 52/279 (18%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQE-----IAIKRLSKSSGQG-IVEFKNEAKLIAKL 436
+ +G G FG VY G L +AIK L + V+F EA ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 437 QHTNLT---------------------------DSSRKSLLDWKKRFYIIEGIVQGLLYL 469
H N+ + + ++ GI G+ YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 470 HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT-NRIVGTHGYMSPE 528
+ +HRDL NIL++ + K+SDFG++R + T + + +PE
Sbjct: 127 A---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 529 YVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588
+ + SDV+SFG+++ E+++ + + + + ++ ++
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERP---------------YWELSNHEVMKAIND 228
Query: 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
D + + C Q A R +D+VS+L
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (398), Expect = 4e-44
Identities = 54/274 (19%), Positives = 103/274 (37%), Gaps = 49/274 (17%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 441
+ + ++LG G +G VY G +A+K L + + + + EF EA ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 442 T----------------------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYS 473
+ + Y+ I + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132
Query: 474 RLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG 533
+ IHRDL N L+ E K++DFG++R + A+ + +PE +
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYN 191
Query: 534 IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593
S+KSDV++FGVL+ EI + + + + + EL++
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLEKDYRME 236
Query: 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
+ + C Q +DR + +++
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 6e-44
Identities = 43/203 (21%), Positives = 82/203 (40%), Gaps = 34/203 (16%)
Query: 381 ATDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQH 438
D+F + LG G G V+ G +A K + I E +++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 439 TNL--------------------------TDSSRKSLLDWKKRFYIIEGIVQGLLYLHKY 472
+ + + + + +++GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-- 121
Query: 473 SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN 532
+ + +HRD+K SNIL++ + K+ DFG++ ++ N VGT YMSPE +
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQG 177
Query: 533 GIVSMKSDVYSFGVLVLEIVSSK 555
S++SD++S G+ ++E+ +
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (396), Expect = 1e-43
Identities = 57/299 (19%), Positives = 106/299 (35%), Gaps = 62/299 (20%)
Query: 373 FDFQTIAAATDNFSPA---------NRLGQGGFGPVYNGKLL----DGQEIAIKRLSKS- 418
F F+ A F+ +G G FG V +G L +AIK L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 419 SGQGIVEFKNEAKLIAKLQHTNL-------TDSSRKSLL--------------------D 451
+ + +F +EA ++ + H N+ T S+ ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 452 WKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511
+ ++ GI G+ YL +HRDL NIL++ + K+SDFG++R +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 512 EANTNRIVG---THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLN 568
+ +G + +PE + + SDV+S+G+++ E++S +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE------------ 231
Query: 569 LVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
+ + ++ D + L C Q R +V+ L
Sbjct: 232 ---RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (383), Expect = 7e-42
Identities = 56/302 (18%), Positives = 102/302 (33%), Gaps = 75/302 (24%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSSGQGIV-EFKNEAKLIAK 435
+N +G+G FG V+ + +A+K L + + + +F+ EA L+A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 436 LQHTN--------------------------------------------------LTDSS 445
+ N S
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 446 RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART 505
L ++ I + G+ YL + + +HRDL N L+ E M KI+DFG++R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 506 YAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTER 565
+ +M PE + + +SDV+++GV++ EI S Y
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--PYYGMA 247
Query: 566 PLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625
++ +G L C + + ++ LC ADR + +
Sbjct: 248 HEEVI----YYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
Query: 626 ML 627
+L
Sbjct: 295 IL 296
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-41
Identities = 66/277 (23%), Positives = 111/277 (40%), Gaps = 49/277 (17%)
Query: 384 NFSPANRLGQGGFGPVYNGKLLD----GQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQH 438
+F+ +G+G FG VY+G LLD A+K L++ + G V F E ++ H
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 439 TNLTDSSRKSLLDWKKRFYIIEGIVQGLLY-------------------------LHKYS 473
N+ L ++ + G L + +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 474 RLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR--IVGTHGYMSPEYVM 531
+ +HRDL N +LDE+ K++DFG+AR E ++ N+ +M+ E +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 532 NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591
+ KSDV+SFGVL+ E+++ Y ++ Y Q L+ P
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQ------GRRLLQP--- 256
Query: 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628
E C V L C +A R + S++VS ++
Sbjct: 257 EYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-41
Identities = 56/274 (20%), Positives = 94/274 (34%), Gaps = 55/274 (20%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT 442
+G+G FG V G G ++A+K + + F EA ++ +L+H+NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLV 63
Query: 443 -----------------------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYS 473
S +S+L + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 474 RLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG 533
+HRDL N+L+ E K+SDFG+ + E + + + +PE +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREK 175
Query: 534 IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593
S KSDV+SFG+L+ EI S + + + +G +
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGY-----KMDAPDG 224
Query: 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
C V C AA R + + L
Sbjct: 225 CPPA----VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-41
Identities = 56/295 (18%), Positives = 102/295 (34%), Gaps = 50/295 (16%)
Query: 381 ATDNFSPANR-LGQGGFGPVYNGKLL---DGQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 435
DN A+ LG G FG V G ++AIK L + + + E EA+++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 436 LQHTNLTD--------------------------SSRKSLLDWKKRFYIIEGIVQGLLYL 469
L + + ++ + ++ + G+ YL
Sbjct: 66 LDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 470 HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR-TYAMNELEANTNRIVGTHGYMSPE 528
+HRDL N+LL + KISDFG+++ A + + + +PE
Sbjct: 126 E---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182
Query: 529 YVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588
+ S +SDV+S+GV + E +S + Y + + +GK +E
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGPEV----MAFIEQGKRME---- 232
Query: 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQPAFF 643
C + + C + DR V + +L +
Sbjct: 233 -CPPECPPE----LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 282
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-40
Identities = 53/272 (19%), Positives = 98/272 (36%), Gaps = 46/272 (16%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN 440
+++ LG+G +G V + +A+K + E K E + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 441 LTD--------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSR 474
+ + ++ G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---G 121
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG- 533
+ HRD+K N+LLDE+ N KISDFG+A + N E N++ GT Y++PE +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 534 IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593
+ DV+S G+++ +++ + + W E K +D +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTYLNPWKKIDSA 235
Query: 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625
+ + + + R T+ D+
Sbjct: 236 P-LALLHKILVE-------NPSARITIPDIKK 259
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-40
Identities = 55/272 (20%), Positives = 94/272 (34%), Gaps = 49/272 (18%)
Query: 389 NRLGQGGFGPVYNGKLLD---GQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTNL-- 441
LG G FG V G + +A+K L + + E EA ++ +L + +
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 442 -----------------------TDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAI 478
+ + K ++ + G+ YL +
Sbjct: 73 MIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFV 129
Query: 479 HRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN-RIVGTHGYMSPEYVMNGIVSM 537
HRDL N+LL Q KISDFG+++ +E + +PE + S
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 538 KSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSD 597
KSDV+SFGVL+ E S + +P ++ + +++ C +
Sbjct: 190 KSDVWSFGVLMWEAFSYGQ--------KP-------YRGMKGSEVTAMLEKGERMGCPAG 234
Query: 598 EVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629
+ LC +R + V L N
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (364), Expect = 5e-39
Identities = 68/277 (24%), Positives = 102/277 (36%), Gaps = 57/277 (20%)
Query: 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 437
FS +G G FG VY + + + + +AIK++S S Q + E + + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 438 HTNL--------------------------TDSSRKSLLDWKKRFYIIEGIVQGLLYLHK 471
H N K L + + G +QGL YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH- 132
Query: 472 YSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM 531
IHRD+K NILL E K+ DFG A A N VGT +M+PE ++
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVIL 184
Query: 532 ---NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588
G K DV+S G+ +E+ K + + L + + P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------------AQNESP 232
Query: 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625
L S+ + C+Q DR T ++
Sbjct: 233 ALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLLK 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 7e-39
Identities = 57/280 (20%), Positives = 92/280 (32%), Gaps = 51/280 (18%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLL----DGQEIAIKRLSK---SSGQGIVEFKNEAKLIAK 435
+ +LG G FG V G+ +A+K L S + + +F E +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 436 LQHTNL--------------------------TDSSRKSLLDWKKRFYIIEGIVQGLLYL 469
L H NL + + +G+ YL
Sbjct: 68 LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 470 HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE-ANTNRIVGTHGYMSPE 528
R IHRDL N+LL + KI DFG+ R N+ + +PE
Sbjct: 128 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 529 YVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588
+ S SD + FGV + E+ + + + ++ ++ EG+ L
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQIL---HKIDKEGERLP---- 235
Query: 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628
E C D +V + C + DR T + L
Sbjct: 236 -RPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 9e-39
Identities = 61/306 (19%), Positives = 116/306 (37%), Gaps = 63/306 (20%)
Query: 383 DNFSPANRLGQGGFGPVYNGKL------LDGQEIAIKRLSKS-SGQGIVEFKNEAKLIAK 435
+ + + LGQG FG VY G +AIK ++++ S + +EF NEA ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 436 LQHTN------------------------------------LTDSSRKSLLDWKKRFYII 459
+ + ++ + K +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 460 EGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIV 519
I G+ YL+ + +HRDL N ++ E KI DFGM R + + +
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 520 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNE 579
+MSPE + +G+ + SDV+SFGV++ EI + + + + + E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------LRFVME 250
Query: 580 GKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQ 639
G L+ D D + +C Q R + +++S + + P ++
Sbjct: 251 GGLLDKPDNCPDM---------LFELMRMCWQYNPKMRPSFLEIISSIKEEME--PGFRE 299
Query: 640 PAFFIN 645
+F+ +
Sbjct: 300 VSFYYS 305
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-38
Identities = 52/279 (18%), Positives = 101/279 (36%), Gaps = 55/279 (19%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHT 439
+++ +G G +G + DG+ + K L S +E L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 440 NLT--------------------------------DSSRKSLLDWKKRFYIIEGIVQGLL 467
N+ + + LD + ++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 468 YLHKYSRLRA--IHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYM 525
H+ S +HRDLK +N+ LD + N K+ DFG+AR +N + VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDTSFAKAFVGTPYYM 181
Query: 526 SPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALEL 585
SPE + + KSD++S G L+ E+ + ++ + + E
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI------------REG 229
Query: 586 MDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVV 624
+ S + + + + R ++ +++
Sbjct: 230 KFRRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEIL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-38
Identities = 53/273 (19%), Positives = 98/273 (35%), Gaps = 54/273 (19%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 438
++F LG+G FG VY + +A+K L K+ + + E ++ + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 439 TNL--------------------------TDSSRKSLLDWKKRFYIIEGIVQGLLYLHKY 472
N+ + + S D ++ I + L Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH-- 123
Query: 473 SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN 532
R IHRD+K N+LL KI+DFG + + + GT Y+ PE +
Sbjct: 124 -SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEG 178
Query: 533 GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592
+ K D++S GVL E + K ++ K + ++ T +
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETY----------KRISRVEFTFPD 225
Query: 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625
+ + ++ + R + +V+
Sbjct: 226 FVTEG----ARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 6e-38
Identities = 62/271 (22%), Positives = 106/271 (39%), Gaps = 54/271 (19%)
Query: 389 NRLGQGGFGPVYNGKLLD-GQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN---LT 442
+G+G F VY G + E+A L + FK EA+++ LQH N
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 443 DS---------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRL 475
DS R ++ K I++GL +LH +
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP- 133
Query: 476 RAIHRDLKVSNILL-DEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGI 534
IHRDLK NI + + KI D G+A + ++GT +M+PE +
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPE-MYEEK 188
Query: 535 VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594
DVY+FG+ +LE+ +S+ P + A Q++ + + P +
Sbjct: 189 YDESVDVYAFGMCMLEMATSE---------YPYSECQNAAQIYR--RVTSGVKPASFDKV 237
Query: 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625
+ EV I C++ +R ++ D+++
Sbjct: 238 AIPEVKEII---EGCIRQNKDERYSIKDLLN 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 6e-38
Identities = 54/292 (18%), Positives = 105/292 (35%), Gaps = 68/292 (23%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDG---QEIAIKRLSK-SSGQGIVEFKNEAKLIAKL-Q 437
++ + +G+G FG V ++ + AIKR+ + +S +F E +++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 438 HTNL------------------------------------------TDSSRKSLLDWKKR 455
H N+ +S S L ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 456 FYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515
+ + +G+ YL + + IHRDL NIL+ E KI+DFG++R +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQ 575
+M+ E + + + SDV+S+GVL+ EIVS +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYC 228
Query: 576 LWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
+ E + + + C +++ +R + + ++ L
Sbjct: 229 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-37
Identities = 61/298 (20%), Positives = 98/298 (32%), Gaps = 68/298 (22%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSSGQG-IVEFKNEAKLIAK 435
D LG+G FG V + +A+K L + + +E K++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 436 LQHTN--------------------------------------------LTDSSRKSLLD 451
+ H + K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 452 WKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511
+ + +G+ +L + IHRDL NILL E+ KI DFG+AR +
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVG 571
+M+PE + + + +++SDV+SFGVL+ EI S + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDE 244
Query: 572 YAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629
+ EG + D T E L C + R T S++V L N
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 4e-37
Identities = 50/220 (22%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 362 NDQTVKRDLKIFDFQTIAAATDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSG 420
+D+ + L+ ++ ++ ++GQG G VY + GQE+AI++++
Sbjct: 1 SDEEILEKLR--SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 421 QGIVEFKNEAKLIAKLQHTN-------------------------LTDSSRKSLLDWKKR 455
NE ++ + ++ N LTD ++ +D +
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 118
Query: 456 FYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515
+ +Q L +LH + IHRD+K NILL + K++DFG + + +T
Sbjct: 119 AAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
Query: 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
+VGT +M+PE V K D++S G++ +E++ +
Sbjct: 176 --MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 5e-37
Identities = 56/275 (20%), Positives = 99/275 (36%), Gaps = 52/275 (18%)
Query: 382 TDNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 440
D + LG G FG VY + + A K + S + + ++ E ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 441 LT---------------------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHKYS 473
+ + L + + + + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH--- 127
Query: 474 RLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM-- 531
+ IHRDLK NIL + K++DFG++ + +GT +M+PE VM
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVVMCE 185
Query: 532 ---NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588
+ K+DV+S G+ ++E+ + + + R L + + + L P
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-------KSEPPTLAQP 238
Query: 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDV 623
SS+ C++ R T S +
Sbjct: 239 ---SRWSSN----FKDFLKKCLEKNVDARWTTSQL 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-37
Identities = 55/297 (18%), Positives = 95/297 (31%), Gaps = 69/297 (23%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 435
+ S LG G FG V +A+K L S+ E +E K+++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 436 L-QHTNL--------------------------------------------TDSSRKSLL 450
L H N+ + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 451 DWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510
D + + +G+ +L IHRDL NILL KI DFG+AR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLV 570
+M+PE + N + + +SDV+S+G+ + E+ S + + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-----MPVD 254
Query: 571 GYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
+++ EG E ++ + C R T +V ++
Sbjct: 255 SKFYKMIKEG-----FRMLSPEHAPAE----MYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-36
Identities = 49/278 (17%), Positives = 91/278 (32%), Gaps = 50/278 (17%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLD----GQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQ 437
+ +G+G FG V+ G + +AIK + + E F EA + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 438 HTNLT--------------------------DSSRKSLLDWKKRFYIIEGIVQGLLYLHK 471
H ++ RK LD + L YL
Sbjct: 67 HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE- 125
Query: 472 YSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM 531
R +HRD+ N+L+ K+ DFG++R + ++ +M+PE +
Sbjct: 126 --SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESIN 182
Query: 532 NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591
+ SDV+ FGV + EI+ +P V + + +
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGV--------KPFQGVKNNDVIG---RIENGERLPMP 231
Query: 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629
+C + C + R +++ + L+
Sbjct: 232 PNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-36
Identities = 55/302 (18%), Positives = 100/302 (33%), Gaps = 74/302 (24%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLD------GQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 435
+N LG G FG V N ++A+K L + + E +E K++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 436 L-QHTNL-------------------------------------------------TDSS 445
L H N+ +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 446 RKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART 505
++L ++ + +G+ +L +HRDL N+L+ KI DFG+AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 506 YAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTER 565
+ +M+PE + GI ++KSDV+S+G+L+ EI S N
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 566 PLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625
++L G ++ + + + C + R + ++ S
Sbjct: 274 AN-----FYKLIQNGFKMD-----QPFYATEE----IYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 626 ML 627
L
Sbjct: 320 FL 321
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 4e-33
Identities = 58/297 (19%), Positives = 108/297 (36%), Gaps = 70/297 (23%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLL--------DGQEIAIKRLSK-SSGQGIVEFKNEAKLI 433
D LG+G FG V + + ++A+K L ++ + + + +E +++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 434 AKL-QHTNL------------------------------------------TDSSRKSLL 450
+ +H N+ + + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 451 DWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510
K + +G+ YL + IHRDL N+L+ E KI+DFG+AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLV 570
T +M+PE + + I + +SDV+SFGVL+ EI + + L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--- 246
Query: 571 GYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSML 627
++L EG ++ +C+++ + C + R T +V L
Sbjct: 247 ---FKLLKEGHRMD-----KPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 4e-33
Identities = 50/200 (25%), Positives = 83/200 (41%), Gaps = 27/200 (13%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 438
++F LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 439 TNL-------TDSSR----------KSLLDWKKRF------YIIEGIVQGLLYLHKYSRL 475
D + LL + ++ + + L
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
IHRDLK NILL+E M+ +I+DFG A+ + +A N VGT Y+SPE +
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 536 SMKSDVYSFGVLVLEIVSSK 555
SD+++ G ++ ++V+
Sbjct: 188 CKSSDLWALGCIIYQLVAGL 207
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 122 bits (308), Expect = 4e-31
Identities = 50/307 (16%), Positives = 94/307 (30%), Gaps = 56/307 (18%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 441
D++ LG G FG V+ G A K + + E + ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 442 TD---------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSR 474
+ + + + + + + +GL ++H+
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE--- 142
Query: 475 LRAIHRDLKVSNILLDEQMNP--KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN 532
+H DLK NI+ + + K+ DFG+ + + GT + +PE
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEG 199
Query: 533 GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592
V +D++S GVL ++S P L N MD +
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGL---------SPFGGENDDETLRNVKSCDWNMDDSAFS 250
Query: 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM-------LTNDTMALPKPKQPAFFIN 645
S D + R T+ + +P + +
Sbjct: 251 GISED----GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306
Query: 646 ISSDYEE 652
I + Y+
Sbjct: 307 IKTKYDA 313
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 119 bits (298), Expect = 7e-30
Identities = 40/203 (19%), Positives = 73/203 (35%), Gaps = 36/203 (17%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 441
D + LG G FG V+ G+ K ++ KNE ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 442 TD---------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSR 474
+ ++ + + + +GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---E 145
Query: 475 LRAIHRDLKVSNILLDEQMNP--KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN 532
+H D+K NI+ + + KI DFG+A +E+ T + +PE V
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDR 202
Query: 533 GIVSMKSDVYSFGVLVLEIVSSK 555
V +D+++ GVL ++S
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-29
Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 36/207 (17%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHT 439
++ + +G+G +G V + ++ +AIK++S Q + E K++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 440 NL-----------------------------TDSSRKSLLDWKKRFYIIEGIVQGLLYLH 470
N+ + L Y + I++GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 471 KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT-NRIVGTHGYMSPEY 529
+HRDLK SN+LL+ + KI DFG+AR + V T Y +PE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 530 VMNGIVSMKS-DVYSFGVLVLEIVSSK 555
++N KS D++S G ++ E++S++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (293), Expect = 2e-29
Identities = 46/201 (22%), Positives = 77/201 (38%), Gaps = 32/201 (15%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 438
+F LG G FG V+ + +G+ A+K L K + + +E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 439 TNL-----------------------TDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRL 475
+ S + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
I+RDLK NILLD+ + KI+DFG A+ + T + GT Y++PE V
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPY 178
Query: 536 SMKSDVYSFGVLVLEIVSSKK 556
+ D +SFG+L+ E+++
Sbjct: 179 NKSIDWWSFGILIYEMLAGYT 199
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 115 bits (289), Expect = 3e-29
Identities = 60/282 (21%), Positives = 108/282 (38%), Gaps = 52/282 (18%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 437
+D + LG GG V+ + L +++A+K L + + F+ EA+ A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 438 HTNL--------TDSSRKSL----------------------LDWKKRFYIIEGIVQGLL 467
H + ++ L + K+ +I Q L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 468 YLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN-ELEANTNRIVGTHGYMS 526
+ H + IHRD+K +NI++ K+ DFG+AR A + T ++GT Y+S
Sbjct: 126 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 527 PEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586
PE V +SDVYS G ++ E+++ + P + + +
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGE---------PPFTGDSPVSVAYQHVREDPIP 233
Query: 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAADR-RTMSDVVSML 627
E S+D V L + +R +T +++ + L
Sbjct: 234 PSARHEGLSAD----LDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (288), Expect = 5e-29
Identities = 48/283 (16%), Positives = 88/283 (31%), Gaps = 50/283 (17%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 441
+ + ++G G FG +Y G + G+E+AIK + + E+K+ +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGVG 64
Query: 442 ---------------------------TDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSR 474
+ K + + ++ + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---S 121
Query: 475 LRAIHRDLKVSNIL---LDEQMNPKISDFGMARTYAMNELEAN-----TNRIVGTHGYMS 526
IHRD+K N L + I DFG+A+ Y + + GT Y S
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 527 PEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586
+ S + D+ S G +++ GS + K +
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNL-----GSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629
L + E ++ C R D+ S + + N
Sbjct: 237 IEVLCKGY-PSEFATYLN---FCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 114 bits (287), Expect = 3e-28
Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 438
++FS +G+GGFG VY + D G+ A+K L K QG NE +++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 439 TN-----------------------------LTDSSRKSLLDWKKRFYIIEGIVQGLLYL 469
+ S+ + + I+ GL ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 470 HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEY 529
H ++RDLK +NILLDE + +ISD G+A ++ + + VGTHGYM+PE
Sbjct: 124 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEV 176
Query: 530 VMNGI-VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLV 570
+ G+ +D +S G ++ +++ + T+ +
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (278), Expect = 1e-27
Identities = 54/299 (18%), Positives = 98/299 (32%), Gaps = 47/299 (15%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHT 439
D + + LG G F V + + +AIK ++K + +G +NE ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 440 NL--------TDSS------------------RKSLLDWKKRFYIIEGIVQGLLYLHKYS 473
N+ + K + +I ++ + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 474 RLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG 533
+ + + LDE ISDFG+++ + + GT GY++PE +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQK 184
Query: 534 IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593
S D +S GV+ ++ P A KA D +
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGY---------PPFYDENDAKLFEQILKAEYEFDSPYWDD 235
Query: 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTNDTMALPKPKQPAFFINISSDY 650
S ++ R T + + DT AL K + I ++
Sbjct: 236 ISDS----AKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT-ALDKNIHQSVSEQIKKNF 289
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-27
Identities = 44/215 (20%), Positives = 85/215 (39%), Gaps = 29/215 (13%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 438
++F LG+G FG V + G+ A+K L K + + E++++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 439 TNLT-----------------DSSRKSLLDWKKRFY------IIEGIVQGLLYLHKYSRL 475
LT ++ L R + + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIV 535
++RD+K+ N++LD+ + KI+DFG+ + + A GT Y++PE + +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDY 182
Query: 536 SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLV 570
D + GV++ E++ + + D ER L+
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 110 bits (276), Expect = 2e-27
Identities = 39/278 (14%), Positives = 84/278 (30%), Gaps = 52/278 (18%)
Query: 390 RLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 441
R+G+G FG ++ G LL+ Q++AIK + S + ++E + L
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--QLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 442 --------------------TDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRD 481
K + ++ + +H ++RD
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126
Query: 482 LKVSNILLDEQMNP-----KISDFGMARTYAMNELEAN-----TNRIVGTHGYMSPEYVM 531
+K N L+ + + DFGM + Y + + + GT YMS +
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 532 NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591
S + D+ + G + + + + L + G+ +
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPW------QGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629
+ +E + +H + + +
Sbjct: 241 CAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSK 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 109 bits (273), Expect = 3e-27
Identities = 47/216 (21%), Positives = 83/216 (38%), Gaps = 49/216 (22%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVE---------FKNEAKL 432
+N+ P LG+G V +E A+K + + G E +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 433 IAKLQ--------------------------HTNLTDS-SRKSLLDWKKRFYIIEGIVQG 465
+ K+ L D + K L K+ I+ +++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 466 LLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYM 525
+ LH +L +HRDLK NILLD+ MN K++DFG + E + GT Y+
Sbjct: 123 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYL 176
Query: 526 SPEYVMNGIV------SMKSDVYSFGVLVLEIVSSK 555
+PE + + + D++S GV++ +++
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 4e-27
Identities = 47/204 (23%), Positives = 87/204 (42%), Gaps = 36/204 (17%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHT 439
+NF ++G+G +G VY + L G+ +A+K++ + E L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 440 N---------------------------LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKY 472
N D+S + + + ++QGL + H +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 473 SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPE-YVM 531
R +HRDLK N+L++ + K++DFG+AR + + V T Y +PE +
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILLG 176
Query: 532 NGIVSMKSDVYSFGVLVLEIVSSK 555
S D++S G + E+V+ +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 7e-27
Identities = 46/214 (21%), Positives = 86/214 (40%), Gaps = 45/214 (21%)
Query: 381 ATDNFSPANRLGQGGFGPVYNGKLL--DGQEIAIKRLSKSSGQG--IVEFKNEAKLIAKL 436
A + +G+G +G V+ + L G+ +A+KR+ +G+ + E ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 437 ---QHTN--------------------------------LTDSSRKSLLDWKKRFYIIEG 461
+H N D + + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 462 IVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGT 521
+++GL +LH R +HRDLK NIL+ K++DFG+AR Y+ +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVT 178
Query: 522 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
Y +PE ++ + D++S G + E+ K
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (272), Expect = 1e-26
Identities = 41/203 (20%), Positives = 76/203 (37%), Gaps = 37/203 (18%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 441
+ + A LG+G FG V+ + K + K G V K E ++ +H N+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNI 63
Query: 442 TD---------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSR 474
++ L+ ++ + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---S 120
Query: 475 LRAIHRDLKVSNILLDEQMNP--KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN 532
H D++ NI+ + + KI +FG AR + N + Y +PE +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQH 177
Query: 533 GIVSMKSDVYSFGVLVLEIVSSK 555
+VS +D++S G LV ++S
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGI 200
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 1e-26
Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 36/204 (17%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG---QGIVEFKNEAKLIAK-LQ 437
++F LG+G FG V+ + Q AIK L K + E ++++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 438 HTNLTDS--------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHK 471
H LT D + + I+ GL +LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 472 YSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVM 531
++RDLK+ NILLD+ + KI+DFGM + + + A TN GT Y++PE ++
Sbjct: 122 KGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILL 176
Query: 532 NGIVSMKSDVYSFGVLVLEIVSSK 555
+ D +SFGVL+ E++ +
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-25
Identities = 46/200 (23%), Positives = 80/200 (40%), Gaps = 38/200 (19%)
Query: 389 NRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQHTNL- 441
+ LG+G F VY + Q +AIK++ + E KL+ +L H N+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 442 -------------------------TDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLR 476
+L + +QGL YLH++
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI-- 121
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN-GIV 535
+HRDLK +N+LLDE K++DFG+A+ + V T Y +PE + +
Sbjct: 122 -LHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 536 SMKSDVYSFGVLVLEIVSSK 555
+ D+++ G ++ E++
Sbjct: 179 GVGVDMWAVGCILAELLLRV 198
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (265), Expect = 1e-25
Identities = 47/203 (23%), Positives = 75/203 (36%), Gaps = 38/203 (18%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 438
D F LG G FG V K G A+K L K + I NE +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 439 TN--------------------------LTDSSRKSLLDWKKRFYIIEGIVQGLLYLHKY 472
+ R + IV YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS- 159
Query: 473 SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN 532
L I+RDLK N+L+D+Q +++DFG A+ T + GT ++PE +++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILS 212
Query: 533 GIVSMKSDVYSFGVLVLEIVSSK 555
+ D ++ GVL+ E+ +
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 104 bits (261), Expect = 1e-25
Identities = 44/202 (21%), Positives = 84/202 (41%), Gaps = 34/202 (16%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTN 440
+ + ++G+G +G VY + G+ A+K RL K E ++ +L+H+N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 441 L--------------------------TDSSRKSLLDWKKRFYIIEGIVQGLLYLHKYSR 474
+ + L+ + ++ G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR-- 119
Query: 475 LRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN-G 533
R +HRDLK N+L++ + KI+DFG+AR + + + + T Y +P+ +M
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMGSK 176
Query: 534 IVSMKSDVYSFGVLVLEIVSSK 555
S D++S G + E+V+
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT 198
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 5e-25
Identities = 40/210 (19%), Positives = 84/210 (40%), Gaps = 37/210 (17%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQG--IVEFKNEAKLIAKLQHT 439
+ ++GQG FG V+ + GQ++A+K++ + + + E K++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 440 NLTD------SSRKSLLDWKKRFYIIEGIVQG-------------------------LLY 468
N+ + + K Y++ + L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 469 LHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR--IVGTHGYMS 526
L+ R + +HRD+K +N+L+ K++DFG+AR +++ + V T Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 527 PEYVMNGI-VSMKSDVYSFGVLVLEIVSSK 555
PE ++ D++ G ++ E+ +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 7e-24
Identities = 48/210 (22%), Positives = 83/210 (39%), Gaps = 43/210 (20%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS------GQGIVEFKNEAKLIAK 435
D + LG G F V + G + A K + K G + + E ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 436 LQHTNL--------------------------TDSSRKSLLDWKKRFYIIEGIVQGLLYL 469
+QH N+ + K L ++ ++ I+ G+ YL
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 470 HKYSRLRAIHRDLKVSNILLDEQMNP----KISDFGMARTYAMNELEANTNRIVGTHGYM 525
H L+ H DLK NI+L ++ P KI DFG+A I GT ++
Sbjct: 130 H---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFV 183
Query: 526 SPEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
+PE V + +++D++S GV+ ++S
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (248), Expect = 8e-24
Identities = 40/201 (19%), Positives = 75/201 (37%), Gaps = 29/201 (14%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHT 439
+ ++G+G +G V+ K + +A+KR+ E L+ +L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 440 NLTDSSRKSLLDWKKRFY-----------------------IIEGIVQGLLYLHKYSRLR 476
N+ D K + + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 477 AIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN-GIV 535
+HRDLK N+L++ K+++FG+AR A + V T Y P+ + +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLAR--AFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 536 SMKSDVYSFGVLVLEIVSSKK 556
S D++S G + E+ ++ +
Sbjct: 180 STSIDMWSAGCIFAELANAGR 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 9e-24
Identities = 46/211 (21%), Positives = 79/211 (37%), Gaps = 48/211 (22%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN- 440
+++ +G G FG VY KL D G+ +AIK++ + E +++ KL H N
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75
Query: 441 ----------------------------------LTDSSRKSLLDWKKRFYIIEGIVQGL 466
S K L + + + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 467 LYLHKYSRLRAIHRDLKVSNILLD-EQMNPKISDFGMARTYAMNELEANTNRIVGTHGYM 525
Y+H HRD+K N+LLD + K+ DFG A+ E + + + Y
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 189
Query: 526 SPEYVMNGI-VSMKSDVYSFGVLVLEIVSSK 555
+PE + + DV+S G ++ E++ +
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 1e-23
Identities = 53/272 (19%), Positives = 90/272 (33%), Gaps = 68/272 (25%)
Query: 390 RLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVE------FKNEAKLIAKLQH---- 438
LG GGFG VY+G + D +AIK + K E E L+ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 439 -TNLTDS------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYS 473
L D + + L + +++ + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-- 128
Query: 474 RLRAIHRDLKVSNILLD-EQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMN 532
+HRD+K NIL+D + K+ DFG GT Y PE++
Sbjct: 129 -CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRY 183
Query: 533 G-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591
+ V+S G+L+ ++V + + +
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGD-------------------IPFEHDEEIIRGQVFFR 224
Query: 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDV 623
+ SS+ C H+ C+ R +DR T ++
Sbjct: 225 QRVSSE----CQHLIRWCLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 1e-22
Identities = 51/308 (16%), Positives = 106/308 (34%), Gaps = 59/308 (19%)
Query: 391 LGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL------- 441
LG G G V ++ A+K L + + E +L + Q ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVY 74
Query: 442 --TDSSRKSL-----------------------LDWKKRFYIIEGIVQGLLYLHKYSRLR 476
+ RK L ++ I++ I + + YLH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---IN 131
Query: 477 AIHRDLKVSNILLDEQMNP---KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNG 533
HRD+K N+L + K++DFG A+ + + T Y++PE +
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPE 188
Query: 534 IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDES 593
D++S GV++ ++ + + L + + + + + P + S
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAI---SPGMKTRIRMGQYEFPNPEWS 242
Query: 594 CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTNDTMALPKPKQPAFFINISSDYE 651
S+EV I ++ R T+++ ++ + T P + + +
Sbjct: 243 EVSEEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERW 299
Query: 652 EPDVTEIK 659
E E+
Sbjct: 300 EDVKEEMT 307
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (238), Expect = 3e-22
Identities = 45/207 (21%), Positives = 86/207 (41%), Gaps = 42/207 (20%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHT 439
+ +G G +G V + G ++AIK+L + S E +L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 440 NL------------------------------TDSSRKSLLDWKKRFYIIEGIVQGLLYL 469
N+ + L + +++ +++GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 470 HKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEY 529
H IHRDLK N+ ++E KI DFG+AR + ++ V T Y +PE
Sbjct: 138 HA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189
Query: 530 VMNGI-VSMKSDVYSFGVLVLEIVSSK 555
++N + + D++S G ++ E+++ K
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.5 bits (231), Expect = 4e-21
Identities = 47/205 (22%), Positives = 80/205 (39%), Gaps = 38/205 (18%)
Query: 383 DNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHT 439
+ +G G G V + + +AIK+LS+ + E L+ + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 440 NL-----------------------------TDSSRKSLLDWKKRFYIIEGIVQGLLYLH 470
N+ + LD ++ Y++ ++ G+ +LH
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 471 KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYV 530
IHRDLK SNI++ KI DFG+ART + + V T Y +PE +
Sbjct: 137 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVI 190
Query: 531 MNGIVSMKSDVYSFGVLVLEIVSSK 555
+ D++S G ++ E+V K
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 93.0 bits (230), Expect = 4e-21
Identities = 39/231 (16%), Positives = 93/231 (40%), Gaps = 41/231 (17%)
Query: 357 KTQVHNDQTVKRDLKIFDFQTIAAAT---DNFSPANRLGQGGFGPVYNGK-LLDGQEIAI 412
+ +V+ D R + +D+++ D++ +LG+G + V+ + + +++ +
Sbjct: 6 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 65
Query: 413 KRLSKSSGQGIVEFKNEAKLIAKLQ-HTN-------------------LTDSSRKSLLDW 452
K L + + K E K++ L+ N +
Sbjct: 66 KILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 122
Query: 453 KKRF------YIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD-EQMNPKISDFGMART 505
+ + + I++ L Y H + +HRD+K N+++D E ++ D+G+A
Sbjct: 123 YQTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179
Query: 506 YAMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSK 555
Y + N V + + PE +++ + D++S G ++ ++ K
Sbjct: 180 YHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 4e-21
Identities = 51/260 (19%), Positives = 102/260 (39%), Gaps = 47/260 (18%)
Query: 383 DNFSPANRLGQGGFGPVYNGKLL----DGQEIAIKRLSKSS----GQGIVEFKNEAKLIA 434
+NF LG G +G V+ + + G+ A+K L K++ + + E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 435 KLQHTNLTDSSRKSLLDWKKRFYIIE------------------------GIVQGLLYLH 470
++ + + + K I++ + + +L L
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 471 KYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYV 530
+L I+RD+K+ NILLD + ++DFG+++ + +E E GT YM+P+ V
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIV 202
Query: 531 MNGI--VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588
G D +S GVL+ E+++ P + G + + +P
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGA---------SPFTVDGEKNSQAEISRRILKSEP 253
Query: 589 TLDESCSS---DEVMRCIHV 605
+ S+ D + R +
Sbjct: 254 PYPQEMSALAKDLIQRLLMK 273
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.8 bits (219), Expect = 1e-19
Identities = 46/208 (22%), Positives = 85/208 (40%), Gaps = 42/208 (20%)
Query: 382 TDNFSPANRLGQGGFGPVYNGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 438
+ + + +G G +G V G +A+K+LS+ S E +L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 439 TNL------------------------------TDSSRKSLLDWKKRFYIIEGIVQGLLY 468
N+ + + L ++I I++GL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 469 LHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPE 528
+H IHRDLK SN+ ++E KI DFG+A + V T Y +PE
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRAPE 188
Query: 529 YVMNGI-VSMKSDVYSFGVLVLEIVSSK 555
++N + + D++S G ++ E+++ +
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 83.2 bits (204), Expect = 1e-17
Identities = 34/210 (16%), Positives = 72/210 (34%), Gaps = 47/210 (22%)
Query: 390 RLGQGGFGPVYNGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLT------ 442
+LG G F V+ K +++ +A+K + ++E KL+ ++ + T
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMG 78
Query: 443 ------------------------------------DSSRKSLLDWKKRFYIIEGIVQGL 466
+ I + ++ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 467 LYLHKYSRLRAIHRDLKVSNILLD-EQMNPKISDFGMARTYAMNELEANTNRIVGTHGYM 525
Y+H+ R IH D+K N+L++ + +A + + + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 526 SPEYVMNGIVSMKSDVYSFGVLVLEIVSSK 555
SPE ++ +D++S L+ E+++
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.5 bits (190), Expect = 5e-17
Identities = 30/196 (15%), Positives = 60/196 (30%), Gaps = 44/196 (22%)
Query: 389 NRLGQGGFGPVYNGKLLDGQEIAIK--RLSKSSGQ--------GIVEFKNEAKLIAKLQH 438
+G+G V+N E +K ++ +S + G + F A A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 439 TNLT-----------DSSRKSLL------------DWKKRFYIIEGIVQGLLYLHKYSRL 475
L ++L + +++ I++ + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR--- 122
Query: 476 RAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTNR-IVGTHGYMSPEYVMNGI 534
+H DL N+L+ E I DF + R + Y S Y
Sbjct: 123 GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY----- 176
Query: 535 VSMKSDVYSFGVLVLE 550
+ D+ S +L+
Sbjct: 177 -RTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 57.3 bits (138), Expect = 8e-11
Identities = 23/164 (14%), Positives = 40/164 (24%), Gaps = 57/164 (34%)
Query: 33 DKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCR 92
+ L G+ L G+ L + L +Y
Sbjct: 2 NLLTNGEGLYAGQSLDV--EPYHFIMQED-----CNLVLYDHS----------------- 37
Query: 93 PVCYAIGNRPRKYPYSPAIKKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPI 152
VW +N + ++ S DGN + +
Sbjct: 38 ---------------------TSVWASNTGILG--KKGCKAVLQS-DGNFVVYDAEGRSL 73
Query: 153 GISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDY 196
S R L ++GN+V+Y +W + Y
Sbjct: 74 WASHSVRGNGNYVLVLQEDGNVVIYG---------SDIWSTGTY 108
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 46.1 bits (109), Expect = 8e-07
Identities = 16/89 (17%), Positives = 30/89 (33%), Gaps = 9/89 (10%)
Query: 107 YSPAIKKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSA 166
YS + L+ L + TD NL +L + + + ++ G A
Sbjct: 14 YSTQGNDNHPQTLHATQS-LQLSPYRLSM-ETDCNL-VLFDRDDRVWSTNTAGKGTGCRA 70
Query: 167 TLLKNGNLVLYEMNSDGLSIRRGLWQSFD 195
L NG + + + +W S +
Sbjct: 71 VLQPNGRMDVLTNQN------IAVWTSGN 93
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 42.5 bits (99), Expect = 1e-05
Identities = 26/166 (15%), Positives = 47/166 (28%), Gaps = 56/166 (33%)
Query: 32 TDKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRC 91
+D+L G L G L G + + C
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQND-----------------------------C 29
Query: 92 RPVCYAIGNRPRKYPYSPAIKKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNP 151
V Y + VW + L + + DGNL I +
Sbjct: 30 NLVLYDNN--------------RAVWASGTNGK---ASGCVLKMQN-DGNLVIYSGSRAI 71
Query: 152 IGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYP 197
++ R+ GN L ++ N+V+Y+ ++ +W +
Sbjct: 72 WASNTNRQNGNY-YLILQRDRNVVIYDNSN------NAIWATHTNV 110
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 40.0 bits (93), Expect = 8e-05
Identities = 16/83 (19%), Positives = 28/83 (33%), Gaps = 13/83 (15%)
Query: 114 QPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGN 173
+P+W N + S L + + NL + PI S+ L K+ N
Sbjct: 38 KPIWATNTGGL---SRSCFLSMQTDG-NLVVYNPSNKPIWASNTGGQNGNYVCILQKDRN 93
Query: 174 LVLYEMNSDGLSIRRGLWQSFDY 196
+V+Y W + +
Sbjct: 94 VVIYG---------TDRWATGTH 107
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 36.8 bits (85), Expect = 0.001
Identities = 20/152 (13%), Positives = 41/152 (26%), Gaps = 48/152 (31%)
Query: 107 YSPAIKKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSA 166
+ + + + L S + +D NL +L + + +S A
Sbjct: 5 FGLSHEGSHPQTLHAAQS-LELSSFRFTM-QSDCNL-VLFDSDVRV-WASNTAGATGCRA 60
Query: 167 TLLKNGNLVLYEMNSDGLSIRRGLWQSFDYPTHALLPGMKLGINLQTGHQWFLQSSESAE 226
L +G LV+ + W S ++ +
Sbjct: 61 VLQSDGLLVILTAQN------TIRWSSG---------------------------TKGSI 87
Query: 227 GSYRLGLGTDPNMTSKLVIWKNDKVVWTSAIW 258
G+Y L L D + ++ +W
Sbjct: 88 GNYVLVLQPDRTV-----------TIYGPGLW 108
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 676 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.81 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.81 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.79 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.79 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.58 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.49 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.41 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.2 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.87 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.81 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.6 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.6 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.47 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.12 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.77 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.41 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 95.24 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 94.01 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 93.7 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=376.56 Aligned_cols=238 Identities=27% Similarity=0.430 Sum_probs=182.5
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
.++|++.++||+|+||.||+|+.. ..||||+++.. .....+.|.+|+.++++++||||+.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey 84 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 84 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEec
Confidence 367999999999999999999864 46999998644 3455678999999999999999982
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++..++.++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+.........
T Consensus 85 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 85 CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp CCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 123456899999999999999999999998 9999999999999999999999999998765443333
Q ss_pred ccceeeccCCccChhhhcc---CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 514 NTNRIVGTHGYMSPEYVMN---GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
......||+.|+|||++.+ ..|+.++|||||||++|||++|+.||....... ........+... +.+
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~~----p~~ 231 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLS----PDL 231 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSCC----CCG
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCC----Ccc
Confidence 4455789999999999864 358999999999999999999999997543221 111222222211 111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCC
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALP 635 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~ 635 (676)
...+....+.+.+|+.+||+.||++||||+||++.|+.+..++|
T Consensus 232 -~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 232 -SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp -GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 11122233468889999999999999999999999998876665
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-44 Score=365.57 Aligned_cols=228 Identities=26% Similarity=0.368 Sum_probs=172.5
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
++|++.++||+|+||.||+|++.+++.||||+++.. ....++|.+|++++++++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 578889999999999999999988899999999763 445678999999999999999983
Q ss_pred --------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 444 --------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 444 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
......+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++......... .
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~-~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-S 159 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee-e
Confidence 123456889999999999999999999998 9999999999999999999999999998765433222 2
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCC-cCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK-KNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~-~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
....||+.|+|||++.+..|+.++|||||||++|||+++. +|+..... .. .......+... ..
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~----~~~~i~~~~~~--~~------- 223 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SE----VVEDISTGFRL--YK------- 223 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HH----HHHHHHHTCCC--CC-------
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HH----HHHHHHhcCCC--CC-------
Confidence 3357899999999999999999999999999999999954 44432211 11 11222222111 11
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+.....++.+++.+||+.||++||||+||++.|+++.
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 1122345788999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=367.77 Aligned_cols=228 Identities=29% Similarity=0.410 Sum_probs=181.5
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
++|++.++||+|+||.||+|++.+++.||||+++.. ....++|.+|+.++++++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCCC
Confidence 578889999999999999999988899999999764 345678999999999999999983
Q ss_pred --------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 444 --------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 444 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
......+++..++.|+.||++||.|||+++ |+||||||+||||++++.+||+|||+|+......... .
T Consensus 92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~-~ 167 (272)
T d1qpca_ 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-R 167 (272)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC-C
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcccc-c
Confidence 111224889999999999999999999998 9999999999999999999999999999765433222 2
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCS 595 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 595 (676)
....||+.|+|||++.++.++.++|||||||++|||+||..|+...... .........+. .+....
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~------~~~~~~i~~~~-----~~~~p~--- 233 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLERGY-----RMVRPD--- 233 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTC-----CCCCCT---
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcC-----CCCCcc---
Confidence 2357899999999999999999999999999999999976655432211 11122222221 111112
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 596 SDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 596 ~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
...+.+.+|+.+||+.||++||||+||+++|+..
T Consensus 234 -~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 234 -NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 2234578899999999999999999999999753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=363.86 Aligned_cols=227 Identities=22% Similarity=0.317 Sum_probs=177.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
.++|++.++||+|+||.||+|+.. +++.||||++.... ....+++.+|++++++++||||++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 367999999999999999999875 58999999997543 234567899999999999999982
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.........
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 233456899999999999999999999998 9999999999999999999999999999775544334
Q ss_pred ccceeeccCCccChhhhccCCC-CchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ...........
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~------~~~~~~~~~~~-------- 226 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTYL-------- 226 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH------HHHHHTTCTTS--------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH------HHHHhcCCCCC--------
Confidence 4455789999999999988776 57899999999999999999999754432211 11111111110
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.........+.+|+.+||+.||++|||++|+++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001122345678899999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-43 Score=367.74 Aligned_cols=230 Identities=23% Similarity=0.337 Sum_probs=183.6
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
.++|++.++||+|+||.||+|++. +++.||||+++.. ....++|.+|+.+|++++||||++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 357888999999999999999876 4889999999764 345678999999999999999982
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+........
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 123356889999999999999999999998 999999999999999999999999999876543322
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
. .....|++.|+|||++.+..|+.++|||||||++|||++|..|+...... .........+.. +..
T Consensus 172 ~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~------~~~~~~i~~~~~-----~~~-- 237 (287)
T d1opja_ 172 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEKDYR-----MER-- 237 (287)
T ss_dssp E-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHTTCC-----CCC--
T ss_pred e-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH------HHHHHHHhcCCC-----CCC--
Confidence 2 22356889999999999999999999999999999999977766432211 111222222211 111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
+......+.+|+.+||+.||++||||+||++.|+.+.
T Consensus 238 --~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 238 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2223346888999999999999999999999998765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-43 Score=356.89 Aligned_cols=226 Identities=25% Similarity=0.366 Sum_probs=184.6
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
++|++.++||+|+||.||+|++++++.||||++++. ....++|.+|+.++++++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 689999999999999999999988899999999764 345678999999999999999983
Q ss_pred --------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 444 --------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 444 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
......+++..+++++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++........ ..
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SS 158 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-ee
Confidence 123456888999999999999999999998 999999999999999999999999999876543322 22
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESC 594 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 594 (676)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ ....+.++... . .
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~~-----~----~ 222 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGLRL-----Y----R 222 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCCC-----C----C
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------HHHHHHhCCCC-----C----C
Confidence 33678999999999999999999999999999999998 899997553221 12222222211 1 1
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 595 SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 595 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
+....+.+.+++.+||+.||++|||++||++.|..
T Consensus 223 p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 12223467889999999999999999999999865
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=364.27 Aligned_cols=238 Identities=25% Similarity=0.374 Sum_probs=182.9
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
++|++.+.||+|+||.||+|++.+++.||||+++.. ....+.|.+|+.++++++|||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCC
Confidence 579999999999999999999988889999999754 445678999999999999999983
Q ss_pred --------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccccc
Q 005803 444 --------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANT 515 (676)
Q Consensus 444 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 515 (676)
......+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++........ ..
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~ 171 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-AR 171 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-ee
Confidence 112345899999999999999999999998 999999999999999999999999999876433322 22
Q ss_pred ceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCC
Q 005803 516 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCS 595 (676)
Q Consensus 516 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 595 (676)
....||+.|+|||++.++.++.++|||||||++|||++|..|+...... . .....+..+.. .. .+
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-----~-~~~~~i~~~~~-----~~----~~ 236 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----R-EVLDQVERGYR-----MP----CP 236 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----H-HHHHHHHTTCC-----CC----CC
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-----H-HHHHHHHhcCC-----CC----CC
Confidence 3357899999999999999999999999999999999977666543221 1 11122222211 11 22
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcCCCCCCCCC
Q 005803 596 SDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTMALPKPKQP 640 (676)
Q Consensus 596 ~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~~l~~p~~P 640 (676)
....+.+.+++.+||+.||++||||++|+++|+......+.+..|
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 233346888999999999999999999999999876554433333
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-43 Score=362.50 Aligned_cols=224 Identities=22% Similarity=0.349 Sum_probs=181.2
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
++|++.++||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.++++++||||++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999864 69999999998766566778999999999999999983
Q ss_pred -------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccccc
Q 005803 444 -------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEANTN 516 (676)
Q Consensus 444 -------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 516 (676)
......+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..... ...
T Consensus 100 ~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~ 174 (293)
T d1yhwa1 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRS 174 (293)
T ss_dssp TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBC
T ss_pred CCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc--ccc
Confidence 122346889999999999999999999998 99999999999999999999999999987654322 233
Q ss_pred eeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCCh
Q 005803 517 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSS 596 (676)
Q Consensus 517 ~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 596 (676)
...||+.|+|||++.+..|+.++|||||||++|||++|+.||...... .........+.. . + ..+.
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~-~-----~--~~~~ 240 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-E-----L--QNPE 240 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-C-----C--SSGG
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCC-C-----C--CCcc
Confidence 468999999999999999999999999999999999999999743321 111112212111 1 1 1112
Q ss_pred HHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 597 DEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 597 ~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.....+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 23345788999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-43 Score=366.28 Aligned_cols=230 Identities=22% Similarity=0.330 Sum_probs=170.9
Q ss_pred cCCCcceeeccCCCccEEEEEEcC-C---cEEEEEEeccC-CchhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD-G---QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~-~---~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
++|++.++||+|+||.||+|++.. + ..||||++... .....++|.+|+++|++++|||||+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456778999999999999998653 3 35899998654 3345567999999999999999983
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++.+++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 122346899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccc---cceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 511 LEAN---TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 511 ~~~~---~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
.... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||......+ .......+..
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~---- 251 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-------VINAIEQDYR---- 251 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCC----
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC----
Confidence 2211 122457899999999999999999999999999999998 899997543211 1112222211
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
...+.+....+.+|+.+||+.||++||||.||++.|+.+.
T Consensus 252 -----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 252 -----LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1112233456888999999999999999999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-43 Score=362.22 Aligned_cols=231 Identities=25% Similarity=0.366 Sum_probs=174.2
Q ss_pred cCCCcceeeccCCCccEEEEEEcCC-----cEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDG-----QEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~-----~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
+.|++.++||+|+||.||+|++... ..||||+++... .....+|.+|+.++++++|||||+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4688899999999999999986542 469999997543 334557899999999999999983
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
......+++.+++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 123456899999999999999999999998 999999999999999999999999999876543
Q ss_pred ccc-cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCc
Q 005803 510 ELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDP 588 (676)
Q Consensus 510 ~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (676)
... .......||+.|+|||++.+..++.++|||||||++|||++|..|+....... ........+.. +
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~------~~~~~i~~~~~-----~ 232 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAINDGFR-----L 232 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCC-----C
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH------HHHHHHhccCC-----C
Confidence 221 12233568999999999999999999999999999999999766654322111 11222222211 1
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 589 TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 589 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
..+......+.+|+.+||+.||++||||.||+++|+.+.
T Consensus 233 ----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 233 ----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp ----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 122233456888999999999999999999999998765
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-43 Score=357.63 Aligned_cols=219 Identities=23% Similarity=0.340 Sum_probs=177.6
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|++.+.||+|+||.||+|+.. +++.||||++.+. .......+.+|+.++++++||||++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999975 5899999998643 2334567899999999999999983
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 123456899999999999999999999998 999999999999999999999999999865432
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+.. .+..
T Consensus 160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~------~~p~ 225 (263)
T d2j4za1 160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------ETYKRISRVEF------TFPD 225 (263)
T ss_dssp -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTCC------CCCT
T ss_pred -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCC------CCCc
Confidence 223467999999999999999999999999999999999999999743211 11122222211 1111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
...+.+.+++.+||+.||++|||++|+++
T Consensus 226 ----~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 226 ----FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 22345778899999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=358.82 Aligned_cols=224 Identities=24% Similarity=0.349 Sum_probs=180.0
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
+.|++.+.||+|+||.||+|+.. +++.||||+++.......+.+.+|+++|++++||||++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999875 58999999998777777788999999999999999983
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....... .
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~--~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--H
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc--c
Confidence 112456899999999999999999999998 99999999999999999999999999986543221 2
Q ss_pred cceeeccCCccChhhhc-----cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 515 TNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
.....||+.|+|||++. +..|+.++|||||||++|||++|+.||......+. . . ....+....+
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~---~-~i~~~~~~~~---- 235 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---L---L-KIAKSEPPTL---- 235 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---H---H-HHHHSCCCCC----
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---H---H-HHHcCCCCCC----
Confidence 23468999999999984 45689999999999999999999999976533221 1 1 1112211111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
..+......+.+|+.+||+.||++|||++|+++
T Consensus 236 ---~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 ---AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ---SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223345788999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-42 Score=363.67 Aligned_cols=234 Identities=24% Similarity=0.376 Sum_probs=183.7
Q ss_pred HHHhcCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCCch-hhHHHHHHHHHHHHccCCcccc--------
Q 005803 379 AAATDNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLTD-------- 443 (676)
Q Consensus 379 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~-------- 443 (676)
+-..++|++.+.||+|+||.||+|+.. +++.||||+++..... ..++|.+|+.++++++||||+.
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 334678999999999999999999864 3578999999764433 4567999999999999999872
Q ss_pred ------------------------------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeec
Q 005803 444 ------------------------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRD 481 (676)
Q Consensus 444 ------------------------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~D 481 (676)
......+++..++.|+.||+.||+|||+++ |||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrD 165 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 165 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeE
Confidence 011234788899999999999999999998 99999
Q ss_pred cccCceEEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCC-cCCCC
Q 005803 482 LKVSNILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK-KNNGS 560 (676)
Q Consensus 482 LKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~-~pf~~ 560 (676)
|||+|||++.++.+||+|||+|+...............|++.|+|||.+.+..|+.++|||||||++|||++|. +||..
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999999999999999999998765544444444567899999999999999999999999999999999996 56654
Q ss_pred CCCCCccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 561 YDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 561 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
....+ ....+.++...+ ... ....++.+|+.+||+.||++||||.||+++|+++.
T Consensus 246 ~~~~e-------~~~~v~~~~~~~-----~p~----~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 246 MAHEE-------VIYYVRDGNILA-----CPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp SCHHH-------HHHHHHTTCCCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCHHH-------HHHHHHcCCCCC-----CCc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 32211 112233333221 122 22345788999999999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-43 Score=358.43 Aligned_cols=225 Identities=23% Similarity=0.322 Sum_probs=169.2
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~--------------- 444 (676)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||++.
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 68999999999999999999865 58999999987543 3345678999999999999999830
Q ss_pred -----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcC--CCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 445 -----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYS--RLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 445 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
.....+++..++.++.||+.||.|||+++ ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 12345888999999999999999999875 23599999999999999999999999999987
Q ss_pred ccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcccc
Q 005803 506 YAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALEL 585 (676)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (676)
...... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...... .......++....
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-------~~~~~i~~~~~~~- 233 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGKIREGKFRR- 233 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTCCCC-
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCCC-
Confidence 653322 223468999999999999999999999999999999999999999753221 1122223333221
Q ss_pred CCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 586 MDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 586 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
+...+ ...+.+|+.+||+.||++|||++|+++
T Consensus 234 ----~~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 ----IPYRY----SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCccc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11222 345788899999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-42 Score=354.87 Aligned_cols=229 Identities=23% Similarity=0.329 Sum_probs=182.3
Q ss_pred cCCCcce-eeccCCCccEEEEEEc---CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 383 DNFSPAN-RLGQGGFGPVYNGKLL---DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 383 ~~y~~~~-~LG~G~fG~Vy~~~~~---~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
++|.+.+ +||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++||||++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence 4566667 4999999999999754 35579999997643 344678999999999999999982
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 123456899999999999999999999998 99999999999999999999999999987654332
Q ss_pred -ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 512 -EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 512 -~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
........||+.|+|||++.++.++.++|||||||++|||++ |+.||......+ ....+..+...+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~~~~----- 232 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRME----- 232 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCCC-----
T ss_pred ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC-----
Confidence 222233568999999999999999999999999999999998 999997643221 122233333221
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
. +......+.+|+.+||+.||++||||.+|++.|+..
T Consensus 233 ~----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 233 C----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp C----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 222334578899999999999999999999999764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=362.39 Aligned_cols=230 Identities=24% Similarity=0.388 Sum_probs=178.6
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCc----EEEEEEeccC-CchhhHHHHHHHHHHHHccCCcccc-------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQ----EIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTD------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~----~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~------------- 443 (676)
.+|+++++||+|+||.||+|++. +|+ .||||+++.. .....++|.+|+.++++++||||++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 46999999999999999999864 344 5899988653 3445678999999999999999983
Q ss_pred -------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccc
Q 005803 444 -------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 123457889999999999999999999998 9999999999999999999999999998765544
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
.........||+.|+|||.+.++.|+.++|||||||++|||+| |++||......+ + ......+...
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~----~~~i~~~~~~------ 232 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGERL------ 232 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---H----HHHHHHTCCC------
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---H----HHHHHcCCCC------
Confidence 4333444678999999999999999999999999999999998 788887543322 1 1122222211
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
..+......+.+|+.+||+.||++|||+.||++.|+...
T Consensus 233 ---~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 233 ---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp ---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 112233346788999999999999999999999987653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=359.64 Aligned_cols=222 Identities=26% Similarity=0.344 Sum_probs=175.5
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+.+|++++++++||||++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999874 6899999998653 2344567899999999999999983
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.|++.||+|||+++ ||||||||+|||+++++.+||+|||+|+.+......
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 123356889999999999999999999998 999999999999999999999999999987654444
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... . .......+.. .+..
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~----~~~~i~~~~~------~~p~ 231 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---L----IFQKIIKLEY------DFPE 231 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHTTCC------CCCT
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---H----HHHHHHcCCC------CCCc
Confidence 4444578999999999999999999999999999999999999999753211 1 1122222221 1112
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVV 624 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl 624 (676)
. ....+.+|+.+||+.||++|||++|++
T Consensus 232 ~----~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 232 K----FFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp T----CCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred c----CCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 2 234578899999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-42 Score=362.76 Aligned_cols=228 Identities=24% Similarity=0.366 Sum_probs=177.8
Q ss_pred cCCCcceeeccCCCccEEEEEEcC-C-----cEEEEEEeccC-CchhhHHHHHHHHHHHHc-cCCccccc----------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD-G-----QEIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNLTDS---------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~-~-----~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~---------- 444 (676)
++|++.++||+|+||.||+|+... + ..||||++... .......+.+|+.++.++ +|||||+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578999999999999999998643 2 36999998653 334456789999999998 89999820
Q ss_pred ---------------------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccC
Q 005803 445 ---------------------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVS 485 (676)
Q Consensus 445 ---------------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~ 485 (676)
.....+++..++.++.||+.||+|||+++ ||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 01134788999999999999999999998 999999999
Q ss_pred ceEEcCCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCC
Q 005803 486 NILLDEQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTE 564 (676)
Q Consensus 486 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~ 564 (676)
|||++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||++ |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987655443333445678999999999999999999999999999999998 89999765432
Q ss_pred CccchHHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHh
Q 005803 565 RPLNLVGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLT 628 (676)
Q Consensus 565 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le 628 (676)
.. .......+.. +. .+......+.+|+.+||+.||++|||++||+++|.
T Consensus 274 ~~------~~~~~~~~~~-----~~----~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 AN------FYKLIQNGFK-----MD----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HH------HHHHHHTTCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH------HHHHHhcCCC-----CC----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 1122222211 11 12223346888999999999999999999999995
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-42 Score=354.08 Aligned_cols=222 Identities=25% Similarity=0.316 Sum_probs=174.0
Q ss_pred eeeccCCCccEEEEEEcC---CcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc--------------------
Q 005803 389 NRLGQGGFGPVYNGKLLD---GQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD-------------------- 443 (676)
Q Consensus 389 ~~LG~G~fG~Vy~~~~~~---~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~-------------------- 443 (676)
++||+|+||.||+|.+.+ ++.||||+++.. .....++|.+|+++|++++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 579999999999998643 468999999653 2334567999999999999999983
Q ss_pred -----ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc-ccccce
Q 005803 444 -----SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL-EANTNR 517 (676)
Q Consensus 444 -----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~ 517 (676)
......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... ......
T Consensus 93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 123456899999999999999999999998 99999999999999999999999999987654322 222334
Q ss_pred eeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCCCCCh
Q 005803 518 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDESCSS 596 (676)
Q Consensus 518 ~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 596 (676)
..||+.|+|||.+.+..++.++|||||||++|||++ |+.||...... ........+... .. +.
T Consensus 170 ~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-------~~~~~i~~~~~~-----~~----p~ 233 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERM-----GC----PA 233 (277)
T ss_dssp -CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCC-----CC----CT
T ss_pred cCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-------HHHHHHHcCCCC-----CC----Cc
Confidence 578999999999999999999999999999999998 89999754321 112223333221 11 22
Q ss_pred HHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhc
Q 005803 597 DEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTN 629 (676)
Q Consensus 597 ~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~ 629 (676)
.....+.+|+.+||+.||++|||+++|+++|+.
T Consensus 234 ~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 233457889999999999999999999998875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-42 Score=360.43 Aligned_cols=174 Identities=25% Similarity=0.353 Sum_probs=149.8
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
.++|++.++||+|+||.||+|+.. +|+.||||+++... .....++.+|+.+|++++||||++
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 578999999999999999999865 58999999997643 334567899999999999999983
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKY-SRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.||+.||.|||++ + |+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence 12234688999999999999999999975 7 999999999999999999999999999865432
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYD 562 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~ 562 (676)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||....
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2334789999999999999999999999999999999999999997644
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=347.97 Aligned_cols=220 Identities=25% Similarity=0.381 Sum_probs=170.5
Q ss_pred CcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccc------------------
Q 005803 386 SPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 444 (676)
Q Consensus 386 ~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~------------------ 444 (676)
++.++||+|+||.||+|+.. +++.||+|++... .....+.+.+|+++|++++||||++.
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999875 5889999998654 33445678999999999999999831
Q ss_pred ------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc-CCCCeEEeccCcceecccccc
Q 005803 445 ------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD-EQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 445 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~-~~~~vkL~DFGla~~~~~~~~ 511 (676)
.....+++..+..++.||+.||+|||+++ .+|+||||||+|||++ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-- 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 168 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC--
Confidence 12245788888999999999999999875 4599999999999996 5789999999999764322
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
.....+||+.|+|||++.+ .++.++|||||||++|||++|+.||....... ........+... +.+.
T Consensus 169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~------~~~~~i~~~~~~----~~~~ 235 (270)
T d1t4ha_ 169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKP----ASFD 235 (270)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCC----GGGG
T ss_pred --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH------HHHHHHHcCCCC----cccC
Confidence 2334689999999998865 69999999999999999999999997432211 112222222111 1112
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
...+ ..+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~----~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCC----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 2222 34778899999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.3e-41 Score=356.51 Aligned_cols=230 Identities=20% Similarity=0.263 Sum_probs=183.3
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++||||++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999875 68999999998766666778999999999999999982
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc--CCCCeEEeccCcceecccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD--EQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~--~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++.++..++.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+++.+....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 180 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 180 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence 123446899999999999999999999998 99999999999996 46789999999998765432
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......+... .+...
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~--~~~~~- 248 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWN--MDDSA- 248 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC--SCCGG-
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC--CCccc-
Confidence 2334689999999999999999999999999999999999999997542211 11111122111 11111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcC
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTND 630 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~ 630 (676)
.....+.+.+|+.+||+.||++|||++|+++. |...
T Consensus 249 ---~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 249 ---FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp ---GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred ---ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 11223457889999999999999999999985 5443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=349.94 Aligned_cols=230 Identities=24% Similarity=0.340 Sum_probs=171.9
Q ss_pred cCCCcceeeccCCCccEEEEEEcC--C--cEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD--G--QEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD------------ 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~--~--~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~------------ 443 (676)
++|++.+.||+|+||.||+|+... + ..||||++++. .....++|.+|+.+|++++||||++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 578999999999999999998542 3 36899998654 3344578999999999999999983
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 112346889999999999999999999998 999999999999999999999999999976543
Q ss_pred ccc-cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 510 ELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 510 ~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
... .......|+..|+|||.+.+..++.++|||||||++|||++ |+.||...... .........+...
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~~~~~~---- 234 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERL---- 234 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCC----
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHhCCCCC----
Confidence 322 22333567889999999999999999999999999999998 89999754321 1122222222111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.... .....+.+|+.+||+.||++||||.||++.|++.
T Consensus 235 -~~~~----~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 -PRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCcc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1112 2234578899999999999999999999999764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-41 Score=352.30 Aligned_cols=219 Identities=29% Similarity=0.412 Sum_probs=174.5
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc---hhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
+.|+.+++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+|++++||||++
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35899999999999999999864 688999999975432 33456899999999999999983
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 123456899999999999999999999998 99999999999999999999999999986432
Q ss_pred cccceeeccCCccChhhhcc---CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcc
Q 005803 513 ANTNRIVGTHGYMSPEYVMN---GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPT 589 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (676)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...... ..... ...+.......
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~-i~~~~~~~~~~-- 236 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYH-IAQNESPALQS-- 236 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH-HHHSCCCCCSC--
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHH-HHhCCCCCCCC--
Confidence 233679999999999864 46899999999999999999999999743211 11111 11222111111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 590 LDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 590 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
. ...+.+.+++.+||+.||++|||++|+++
T Consensus 237 --~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 --G----HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --T----TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --C----CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 12345778899999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=346.86 Aligned_cols=228 Identities=21% Similarity=0.294 Sum_probs=171.7
Q ss_pred cCCCcceeeccCCCccEEEEEEcC----CcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD----GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~----~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
++|++.+.||+|+||.||+|++.. +..||||.++... ....+.+.+|+.++++++||||++
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~ 86 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM 86 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEE
Confidence 579999999999999999998643 3568999986543 334567999999999999999983
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+|+.......
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 123446899999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
. ......||+.|+|||.+.+..++.++|||||||++|||++ |.+||......+ + ......+... .+
T Consensus 164 ~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~----~~~i~~~~~~-----~~ 230 (273)
T d1mp8a_ 164 Y-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---V----IGRIENGERL-----PM 230 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H----HHHHHTTCCC-----CC
T ss_pred e-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---H----HHHHHcCCCC-----CC
Confidence 2 2334678999999999999999999999999999999998 889987654322 1 1122232221 11
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
+......+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 231 ----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 231 ----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 222334688899999999999999999999999765
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-40 Score=354.94 Aligned_cols=231 Identities=23% Similarity=0.268 Sum_probs=184.4
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.........+.+|+.+|++++||||++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999864 69999999998765556677899999999999999982
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc--CCCCeEEeccCcceecccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD--EQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~--~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++.++..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 122346899999999999999999999998 99999999999998 67899999999998765432
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+... ..
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~~------~~ 248 (352)
T d1koba_ 184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWE------FD 248 (352)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHCCCC------CC
T ss_pred --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC------CC
Confidence 2334679999999999999999999999999999999999999997543211 11112222211 11
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcCc
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTNDT 631 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~~ 631 (676)
..........+.+|+.+||+.||.+|||+.|+++. +++..
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 11112233457889999999999999999999885 66544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-41 Score=350.70 Aligned_cols=232 Identities=26% Similarity=0.375 Sum_probs=172.2
Q ss_pred hcCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCC-chhhHHHHHHHHHHHHc-cCCcccc----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLTD---------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~---------- 443 (676)
.++|++.++||+|+||.||+|+.. +++.||||+++... ....+++.+|..++.++ +|+||+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 367999999999999999999853 24689999997543 33456788888888887 5778761
Q ss_pred -------------------c--------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc
Q 005803 444 -------------------S--------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD 490 (676)
Q Consensus 444 -------------------~--------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~ 490 (676)
. .....+++..++.++.||++||.|||+++ ||||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 0 01234788999999999999999999998 99999999999999
Q ss_pred CCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCC-cCCCCCCCCCccch
Q 005803 491 EQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK-KNNGSYDTERPLNL 569 (676)
Q Consensus 491 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~-~pf~~~~~~~~~~l 569 (676)
+++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|. +||.......
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~---- 244 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---- 244 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH----
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH----
Confidence 99999999999998765544444445578999999999999999999999999999999999975 5676443221
Q ss_pred HHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 570 VGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 570 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.......++... .... .....+.+++.+||+.||++|||++||+++|+++.
T Consensus 245 --~~~~~~~~~~~~-----~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 245 --EFCRRLKEGTRM-----RAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp --HHHHHHHHTCCC-----CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHhcCCCC-----CCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 112222233222 1112 22345788999999999999999999999998753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-41 Score=350.62 Aligned_cols=230 Identities=21% Similarity=0.284 Sum_probs=165.6
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
.+.|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+|++++||||++
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999875 58999999997543 233456889999999999999983
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc---CCCCeEEeccCcceeccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD---EQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~---~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++.++..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 123456899999999999999999999998 99999999999994 57899999999998654332
Q ss_pred cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCccc
Q 005803 511 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTL 590 (676)
Q Consensus 511 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 590 (676)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... .......+... ...
T Consensus 165 ---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~--~~~-- 230 (307)
T d1a06a_ 165 ---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKAEYE--FDS-- 230 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHTTCCC--CCT--
T ss_pred ---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCCC--CCC--
Confidence 2234689999999999999999999999999999999999999997532111 11222222211 111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcC
Q 005803 591 DESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTND 630 (676)
Q Consensus 591 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~ 630 (676)
.........+.+++.+||+.||++|||++|+++. +.+.
T Consensus 231 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 231 --PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp --TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred --ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1112233457889999999999999999999984 6554
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-41 Score=343.35 Aligned_cols=221 Identities=24% Similarity=0.337 Sum_probs=171.2
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc------------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------------ 444 (676)
++|++.+.||+|+||.||+|++ .|+.||||+++.. ...+++.+|++++++++||||++.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4688899999999999999998 5789999999653 345789999999999999999830
Q ss_pred -----------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 445 -----------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 445 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
.....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC----
Confidence 11234789999999999999999999998 999999999999999999999999999864322
Q ss_pred ccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||......+ +. ....++. .+.+
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~----~~i~~~~-----~~~~-- 221 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKGY-----KMDA-- 221 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH----HHHTTTC-----CCCC--
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCC-----CCCC--
Confidence 223567899999999999999999999999999999998 677776433221 11 1122221 1222
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
+.....++.+|+.+||+.||++||||.+|+++|+.+
T Consensus 222 --~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 222 --PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 222334578899999999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=346.50 Aligned_cols=230 Identities=25% Similarity=0.397 Sum_probs=182.7
Q ss_pred cCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD------------ 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~------------ 443 (676)
++|++.++||+|+||.||+|.+. +++.||||+++... ......|.+|+.++++++||||+.
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 57888999999999999999753 25789999997543 334456899999999999999982
Q ss_pred ------------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEec
Q 005803 444 ------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISD 499 (676)
Q Consensus 444 ------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~D 499 (676)
......+++..+..++.|+++||.|||+++ |+||||||+|||+++++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 011134678889999999999999999998 99999999999999999999999
Q ss_pred cCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCC-cCCCCCCCCCccchHHHHHHHHh
Q 005803 500 FGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK-KNNGSYDTERPLNLVGYAWQLWN 578 (676)
Q Consensus 500 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~-~pf~~~~~~~~~~l~~~~~~~~~ 578 (676)
||+++...............||+.|+|||.+.+..++.++|||||||++|||++|. .||...... . ......
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~-~~~~i~ 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------Q-VLRFVM 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------H-HHHHHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHH
Confidence 99998766554444445567899999999999999999999999999999999985 666543211 1 122222
Q ss_pred cCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 579 EGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 579 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.+.... . +......+.+++.+||+.||++||||.+|+++|++..
T Consensus 250 ~~~~~~-----~----p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 250 EGGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp TTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred hCCCCC-----C----cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 332221 1 1222346888999999999999999999999998875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.8e-40 Score=338.56 Aligned_cols=233 Identities=26% Similarity=0.344 Sum_probs=176.4
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
.++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.++++++||||++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 478999999999999999999864 69999999997543 233457899999999999999983
Q ss_pred ----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 444 ----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 444 ----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
......+++.++..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||.+....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhc
Confidence 122346889999999999999999999998 9999999999999999999999999987654
Q ss_pred ccc-cccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccC
Q 005803 508 MNE-LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM 586 (676)
Q Consensus 508 ~~~-~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (676)
... .........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...............
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~~-- 234 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPP-- 234 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCG--
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCCC--
Confidence 322 22233446899999999999999999999999999999999999999975321 111222222222110
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCcCCCC-CHHHHHHHHhcC
Q 005803 587 DPTLDESCSSDEVMRCIHVGLLCVQDRAADRR-TMSDVVSMLTND 630 (676)
Q Consensus 587 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-s~~eVl~~Le~~ 630 (676)
..... .....+.+++.+||+.||++|| |++++++.|.++
T Consensus 235 -~~~~~----~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 235 -SARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -GGTSS----SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -chhcc----CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 01111 2234577899999999999999 899999988764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-40 Score=343.62 Aligned_cols=236 Identities=22% Similarity=0.253 Sum_probs=172.4
Q ss_pred cceeeccCCCccEEEEEEc-CCcEEEEEEeccCCch-----hhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 387 PANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQ-----GIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 387 ~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
.+++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+.++++++||||++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3689999999999999965 5999999998654221 2346889999999999999983
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....... .
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~ 156 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--A 156 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--C
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc--c
Confidence 223456888999999999999999999998 99999999999999999999999999986544322 2
Q ss_pred cceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccC------C
Q 005803 515 TNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELM------D 587 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~------d 587 (676)
....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||......+. .....+........... .
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCChhhccchhccch
Confidence 2335799999999998754 689999999999999999999999975432221 11111111100000000 0
Q ss_pred c---ccCCCCC-----hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcC
Q 005803 588 P---TLDESCS-----SDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTND 630 (676)
Q Consensus 588 ~---~l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~ 630 (676)
. ......+ ....+.+.+|+.+||+.||++|||++|+++. |++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0 0000011 1123468889999999999999999999974 6544
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-40 Score=347.39 Aligned_cols=219 Identities=23% Similarity=0.280 Sum_probs=176.6
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|++++.||+|+||.||+|+.. +|+.||||++++. .....+.+.+|+.++++++||||++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999974 5999999999653 2334577899999999999999983
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 123345778888899999999999999998 999999999999999999999999999875432
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... . .......+.. .+
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~-~~~~i~~~~~------~~-- 220 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------K-TYEKILNAEL------RF-- 220 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHHCCC------CC--
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------H-HHHHHHcCCC------CC--
Confidence 23468999999999999999999999999999999999999999753221 1 1112222211 11
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRR-----TMSDVVSM 626 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~~ 626 (676)
+......+.+++.+||+.||.+|| |++++++.
T Consensus 221 --p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 221 --PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 112223577889999999999996 89999863
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=344.12 Aligned_cols=230 Identities=24% Similarity=0.357 Sum_probs=179.5
Q ss_pred cCCCcceeeccCCCccEEEEEEcC--------CcEEEEEEeccCCc-hhhHHHHHHHHHHHHc-cCCccccc--------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD--------GQEIAIKRLSKSSG-QGIVEFKNEAKLIAKL-QHTNLTDS-------- 444 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~--------~~~VAvK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~-------- 444 (676)
++|.+.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +||||+..
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 578899999999999999998532 24799999976543 4457889999999998 79999820
Q ss_pred ----------------------------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc
Q 005803 445 ----------------------------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD 490 (676)
Q Consensus 445 ----------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~ 490 (676)
.....+++..++.++.||+.||+|||+++ ||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 11245899999999999999999999998 99999999999999
Q ss_pred CCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHh-CCcCCCCCCCCCccch
Q 005803 491 EQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVS-SKKNNGSYDTERPLNL 569 (676)
Q Consensus 491 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~ellt-G~~pf~~~~~~~~~~l 569 (676)
.++.+||+|||+++...............|++.|+|||.+.++.|+.++|||||||++|||++ |.+||.....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------ 243 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 243 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH------
Confidence 999999999999997765554444555788999999999999999999999999999999998 6888864332
Q ss_pred HHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 570 VGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 570 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
......+..+... .... .....+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 244 -~~~~~~i~~~~~~-----~~p~----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 244 -EELFKLLKEGHRM-----DKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp -HHHHHHHHTTCCC-----CCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHHHcCCCC-----CCCc----cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 1122333333222 1112 22345888999999999999999999999998874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-40 Score=349.57 Aligned_cols=223 Identities=23% Similarity=0.337 Sum_probs=179.1
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD-------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~-------------- 443 (676)
.++|++++.||+|+||.||+|+.. +++.||||++++. .....+.+.+|+.+|++++||||+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 367999999999999999999874 6999999999753 2334577899999999999999983
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 123356888889999999999999999998 9999999999999999999999999998654322
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
......+||+.|+|||++.+..|+.++|||||||++|||++|++||....... .......+.. .+.
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~i~~~~~------~~p 225 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI------RFP 225 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC------CCC
T ss_pred -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-------HHHHHhcCCC------CCC
Confidence 22344789999999999999999999999999999999999999997543211 1122222221 111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRT-----MSDVVSM 626 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~eVl~~ 626 (676)
... ...+.+|+.+||+.||++||+ ++|+++.
T Consensus 226 ~~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 226 RTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ccC----CHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 222 335778999999999999995 8888763
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-40 Score=342.54 Aligned_cols=225 Identities=22% Similarity=0.310 Sum_probs=177.2
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC------chhhHHHHHHHHHHHHccCCcccc-----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS------GQGIVEFKNEAKLIAKLQHTNLTD----------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~----------- 443 (676)
.++|++.+.||+|+||.||+|+.. +|+.||||++++.. ....+.+.+|+.+|++++||||++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999974 69999999986532 123567999999999999999983
Q ss_pred ---------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC----CeEEeccCcce
Q 005803 444 ---------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM----NPKISDFGMAR 504 (676)
Q Consensus 444 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~----~vkL~DFGla~ 504 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhh
Confidence 122356889999999999999999999998 99999999999998776 49999999998
Q ss_pred eccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccc
Q 005803 505 TYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALE 584 (676)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (676)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......+...
T Consensus 166 ~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~- 234 (293)
T d1jksa_ 166 KIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNYE- 234 (293)
T ss_dssp ECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCCC-
T ss_pred hcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-------HHHHHHhcCCC-
Confidence 765332 2233678999999999999999999999999999999999999997543211 11112222111
Q ss_pred cCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 585 LMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 585 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
..+.... .....+.+|+.+||+.||++|||++|+++
T Consensus 235 -~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 -FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -CCHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCchhcC----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111111 12345778999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-40 Score=343.20 Aligned_cols=239 Identities=21% Similarity=0.300 Sum_probs=179.4
Q ss_pred cCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
++|+++++||+|+||.||+|+. .+++.||||+++... ....+++.+|++++++++||||++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999986 469999999996542 234578899999999999999982
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence 233456899999999999999999999998 99999999999999999999999999986543222
Q ss_pred cccceeeccCCccChhhhccCC-CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC----
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD---- 587 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d---- 587 (676)
......||+.|+|||.+.... ++.++|||||||++|||++|+.||......+ ......... +...+..-
T Consensus 158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~i~~~~--~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTL--GTPDEVVWPGVT 231 (298)
T ss_dssp -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHH--CCCCTTTSTTGG
T ss_pred -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHHHHHhc--CCCchhhccccc
Confidence 233367999999999887765 5889999999999999999999997543211 111111111 11100000
Q ss_pred ------cccCC--CC-----ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcCc
Q 005803 588 ------PTLDE--SC-----SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTNDT 631 (676)
Q Consensus 588 ------~~l~~--~~-----~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~~ 631 (676)
..... .. .......+.+++.+||+.||++|||++|+++. |+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 00000 00 01122467889999999999999999999986 76553
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-40 Score=351.60 Aligned_cols=218 Identities=24% Similarity=0.296 Sum_probs=176.6
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
++|++++.||+|+||.||+|+.. +|+.||||++.+. .....+.+.+|+.+|++++||||++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999875 6999999998643 2334567899999999999999983
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE 512 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 512 (676)
......+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 122346889999999999999999999998 999999999999999999999999999876432
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .......+.. ....
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~-~~~~i~~~~~------~~p~ 259 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQ-IYEKIVSGKV------RFPS 259 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHCCC------CCCT
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HH-HHHHHhcCCC------CCCc
Confidence 2346899999999999999999999999999999999999999974321 11 1112222211 1111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRR-----TMSDVVS 625 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~ 625 (676)
.....+.+++.+||+.||.+|+ |++|+++
T Consensus 260 ----~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 260 ----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 2233577889999999999994 8999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.8e-40 Score=341.41 Aligned_cols=235 Identities=20% Similarity=0.301 Sum_probs=176.0
Q ss_pred cCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
++|+++++||+|+||.||+|+..+++.||||++.... ....+++.+|+.+|++++||||++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999899999999996543 233578999999999999999983
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccccc
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 514 (676)
......+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||.+........ .
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--K 156 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc--c
Confidence 234567899999999999999999999998 99999999999999999999999999987543322 2
Q ss_pred cceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC------cccc--
Q 005803 515 TNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK------ALEL-- 585 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~------~~~~-- 585 (676)
.....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+ ............. ..+.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCCChhhccchhhhhh
Confidence 233578999999999875 457999999999999999999999997543211 1111111110000 0000
Q ss_pred -------CCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 586 -------MDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 586 -------~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
..+.............+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000001111222346788999999999999999999985
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-40 Score=344.93 Aligned_cols=230 Identities=23% Similarity=0.362 Sum_probs=180.7
Q ss_pred cCCCcceeeccCCCccEEEEEEc------CCcEEEEEEeccCC-chhhHHHHHHHHHHHHc-cCCcccc-----------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLTD----------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~------~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~----------- 443 (676)
++|++.++||+|+||.||+|++. +++.||||+++... .....++.+|+.+++++ +||||++
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 57888999999999999999752 35789999997643 33456789999999999 6999982
Q ss_pred ---------------------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc
Q 005803 444 ---------------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD 490 (676)
Q Consensus 444 ---------------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~ 490 (676)
......+++..+..++.||+.||+|||+++ ||||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence 012235888999999999999999999998 99999999999999
Q ss_pred CCCCeEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCC-cCCCCCCCCCccch
Q 005803 491 EQMNPKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSK-KNNGSYDTERPLNL 569 (676)
Q Consensus 491 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~-~pf~~~~~~~~~~l 569 (676)
.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++++ +||........
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--- 256 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH---
Confidence 99999999999999766544334444578999999999999999999999999999999999954 54543322211
Q ss_pred HHHHHHHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 570 VGYAWQLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 570 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
.......+.. +. .+......+.+|+.+||+.||++||||+||+++|++.
T Consensus 257 ---~~~~i~~~~~-----~~----~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 257 ---FYKMIKEGFR-----ML----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp ---HHHHHHHTCC-----CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHhcCCC-----CC----CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1222222211 11 1222334688899999999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-40 Score=344.98 Aligned_cols=244 Identities=23% Similarity=0.283 Sum_probs=177.2
Q ss_pred hcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc------------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD------------------ 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~------------------ 443 (676)
..+|.+.++||+|+||.||+|++ +|+.||||+++... ........|+..+.+++||||++
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 35688899999999999999986 68999999996532 22222344555667889999983
Q ss_pred -----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcC-----CCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 444 -----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYS-----RLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 444 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
......++|..++.++.|++.||+|||+.+ ..+||||||||+||||+.++.+||+|||+++...
T Consensus 80 ~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred EecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 112346889999999999999999999741 2359999999999999999999999999998765
Q ss_pred cccc--ccccceeeccCCccChhhhccCC------CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCcc--------chHH
Q 005803 508 MNEL--EANTNRIVGTHGYMSPEYVMNGI------VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPL--------NLVG 571 (676)
Q Consensus 508 ~~~~--~~~~~~~~gt~~Y~APE~~~~~~------~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~--------~l~~ 571 (676)
.... ........||+.|+|||++.+.. ++.++|||||||+||||++|..|+......... ....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence 4322 22234468999999999987642 678999999999999999999887543322111 0111
Q ss_pred HHHHHHhcCCccccCCcccCCCC-ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 572 YAWQLWNEGKALELMDPTLDESC-SSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 572 ~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
....... .+.+++.+.... ..+....+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 240 ~~~~~~~----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 240 EMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHHT----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHh----ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111111 122233332222 2345667889999999999999999999999998764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=340.98 Aligned_cols=227 Identities=26% Similarity=0.351 Sum_probs=175.4
Q ss_pred ceeeccCCCccEEEEEEcCC----cEEEEEEeccC-CchhhHHHHHHHHHHHHccCCcccc-------------------
Q 005803 388 ANRLGQGGFGPVYNGKLLDG----QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLTD------------------- 443 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~----~~VAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~------------------- 443 (676)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++||||++
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999987542 25899999753 4445678999999999999999983
Q ss_pred ---------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccccccc--
Q 005803 444 ---------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELE-- 512 (676)
Q Consensus 444 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~-- 512 (676)
......+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 112334667888999999999999999998 999999999999999999999999999876543222
Q ss_pred cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccCC
Q 005803 513 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLDE 592 (676)
Q Consensus 513 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 592 (676)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ... .....+.... .
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~----~~i~~g~~~~--~----- 255 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DIT----VYLLQGRRLL--Q----- 255 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CH----HHHHTTCCCC--C-----
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHH----HHHHcCCCCC--C-----
Confidence 12233578999999999999999999999999999999999888876432221 111 1122222111 1
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcC
Q 005803 593 SCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTM 632 (676)
Q Consensus 593 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 632 (676)
+......+.+|+.+||+.||++||+|.||++.|+++..
T Consensus 256 --p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 256 --PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11223457889999999999999999999999998863
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=340.87 Aligned_cols=237 Identities=22% Similarity=0.307 Sum_probs=175.6
Q ss_pred HhcCCCcceeeccCCCccEEEEEEc-C-CcEEEEEEeccCC--chhhHHHHHHHHHHHHc---cCCcccc----------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKLL-D-GQEIAIKRLSKSS--GQGIVEFKNEAKLIAKL---QHTNLTD---------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~-~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~---------- 443 (676)
..++|+++++||+|+||.||+|++. + ++.||||+++... ......+.+|+.+++.+ +||||++
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 3578999999999999999999863 4 6679999986532 22344567888887776 7999873
Q ss_pred ----------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccC
Q 005803 444 ----------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFG 501 (676)
Q Consensus 444 ----------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFG 501 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 123345788888999999999999999998 9999999999999999999999999
Q ss_pred cceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC
Q 005803 502 MARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK 581 (676)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 581 (676)
+++...... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||......+. ............
T Consensus 162 ~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~ 235 (305)
T d1blxa_ 162 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPG 235 (305)
T ss_dssp SCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC
T ss_pred hhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCc
Confidence 998654322 23446899999999999999999999999999999999999999975432211 111111110000
Q ss_pred cc----------ccC---CcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 582 AL----------ELM---DPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 582 ~~----------~~~---d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.. ... .............+.+.+|+.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 000 0000001112223457789999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=339.81 Aligned_cols=228 Identities=24% Similarity=0.370 Sum_probs=175.1
Q ss_pred cCCCcceeeccCCCccEEEEEEcC-Cc--EEEEEEeccC-CchhhHHHHHHHHHHHHc-cCCcccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLLD-GQ--EIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNLTD-------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~~-~~--~VAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~-------------- 443 (676)
++|++.++||+|+||.||+|++.+ +. .||||+++.. .....++|.+|+++|.++ +||||++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578889999999999999998654 44 4788888643 344566799999999999 7999982
Q ss_pred ----------------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCe
Q 005803 444 ----------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNP 495 (676)
Q Consensus 444 ----------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~v 495 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 012356899999999999999999999998 9999999999999999999
Q ss_pred EEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCc-CCCCCCCCCccchHHHHH
Q 005803 496 KISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKK-NNGSYDTERPLNLVGYAW 574 (676)
Q Consensus 496 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~-pf~~~~~~~~~~l~~~~~ 574 (676)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||...... . ..
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~---~----~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---E----LY 236 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---H----HH
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH---H----HH
Confidence 999999998644322 2233568999999999999999999999999999999999765 56533211 1 11
Q ss_pred HHHhcCCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCcC
Q 005803 575 QLWNEGKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDTM 632 (676)
Q Consensus 575 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 632 (676)
....++. .+.. +......+.+|+.+||+.||++||||+||++.|+++.+
T Consensus 237 ~~i~~~~-----~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 237 EKLPQGY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HHGGGTC-----CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcC-----CCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2222221 1111 22233468889999999999999999999999988753
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-38 Score=331.79 Aligned_cols=235 Identities=19% Similarity=0.228 Sum_probs=179.0
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ...++..|++++++++|+|++.
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 357999999999999999999864 58999999986532 3456889999999999887651
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEc---CCCCeEEeccCcceeccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLD---EQMNPKISDFGMARTYAMNE 510 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~---~~~~vkL~DFGla~~~~~~~ 510 (676)
......+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+....
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 123456899999999999999999999998 99999999999986 45579999999999765432
Q ss_pred cc-----cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcccc
Q 005803 511 LE-----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALEL 585 (676)
Q Consensus 511 ~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (676)
.. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--- 237 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI--- 237 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH---
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh---
Confidence 21 1223468999999999999999999999999999999999999999876544433322211111111111
Q ss_pred CCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcC
Q 005803 586 MDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTND 630 (676)
Q Consensus 586 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~ 630 (676)
+.+...++ ..+.+++..||+.||++||+++++.+.|+..
T Consensus 238 --~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 238 --EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp --HHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred --hHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 11112222 3477888999999999999999999888764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.3e-39 Score=342.88 Aligned_cols=223 Identities=26% Similarity=0.338 Sum_probs=170.7
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC---chhhHHHHH---HHHHHHHccCCcccc-----------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS---GQGIVEFKN---EAKLIAKLQHTNLTD----------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~---~~~~~~~~~---E~~~l~~l~H~niv~----------- 443 (676)
.++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ......+.+ |+.+++.++||||+.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999875 59999999986431 122233444 466777778999983
Q ss_pred ---------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 444 ---------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
......+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.+..
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 122345788889999999999999999998 99999999999999999999999999987654
Q ss_pred cccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCC
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMD 587 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (676)
.. .....||+.|+|||++.. ..|+.++|||||||++|||++|+.||..........+ ...... ..
T Consensus 160 ~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----~~~~~~------~~ 225 (364)
T d1omwa3 160 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT------MA 225 (364)
T ss_dssp SC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH----HHHSSS------CC
T ss_pred Cc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhccc------CC
Confidence 32 234679999999999975 5689999999999999999999999986543322111 111000 01
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q 005803 588 PTLDESCSSDEVMRCIHVGLLCVQDRAADRRT-----MSDVVS 625 (676)
Q Consensus 588 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~eVl~ 625 (676)
..+...+ ...+.+|+.+||+.||++||| ++|+++
T Consensus 226 ~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 VELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1111222 335788999999999999999 688875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-39 Score=332.36 Aligned_cols=215 Identities=23% Similarity=0.357 Sum_probs=170.6
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc------hhhHHHHHHHHHHHHcc--CCcccc---------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG------QGIVEFKNEAKLIAKLQ--HTNLTD--------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~------~~~~~~~~E~~~l~~l~--H~niv~--------- 443 (676)
.++|++.++||+|+||.||+|+.. +++.||||++.+... ....++.+|+.++++++ ||||++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 368999999999999999999864 689999999865321 12345778999999997 899982
Q ss_pred ------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC-CCCeEEeccCcce
Q 005803 444 ------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE-QMNPKISDFGMAR 504 (676)
Q Consensus 444 ------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~-~~~vkL~DFGla~ 504 (676)
......+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence 112356888999999999999999999998 999999999999985 4789999999998
Q ss_pred eccccccccccceeeccCCccChhhhccCCC-CchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 505 TYAMNELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ....+..
T Consensus 160 ~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------~i~~~~~- 221 (273)
T d1xwsa_ 160 LLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQV- 221 (273)
T ss_dssp ECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCCC-
T ss_pred ecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------HHhhccc-
Confidence 65432 2234689999999999987765 577899999999999999999996321 0111111
Q ss_pred ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 584 ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 584 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
.+....+ ..+.+++.+||+.||++|||++|+++.
T Consensus 222 -----~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 -----FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -----CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----CCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1122222 357888999999999999999999873
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=334.86 Aligned_cols=239 Identities=20% Similarity=0.296 Sum_probs=174.7
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
.++|++.++||+|+||+||+|+.. +|+.||||++... ......++.+|+.+|++++|||++.
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999974 6999999998654 3334567899999999999999872
Q ss_pred -------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcce
Q 005803 444 -------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMAR 504 (676)
Q Consensus 444 -------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~ 504 (676)
......+.......++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence 123345777888999999999999999998 9999999999999999999999999998
Q ss_pred eccccccc--cccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcC-
Q 005803 505 TYAMNELE--ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG- 580 (676)
Q Consensus 505 ~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~- 580 (676)
........ .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......... ..........
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~ 242 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLCGSIT 242 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCC
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH---HHHHHhcCCCC
Confidence 76543221 222335799999999998765 6899999999999999999999999754321111 1111111000
Q ss_pred -CccccC---------CcccCCCCCh-HH------HHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 581 -KALELM---------DPTLDESCSS-DE------VMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 581 -~~~~~~---------d~~l~~~~~~-~~------~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
...... .......... +. ...+++|+.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000 0000000011 11 2246689999999999999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-38 Score=328.03 Aligned_cols=225 Identities=23% Similarity=0.304 Sum_probs=176.9
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCc---------hhhHHHHHHHHHHHHcc-CCcccc--------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSG---------QGIVEFKNEAKLIAKLQ-HTNLTD-------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~-------- 443 (676)
++|++.+.||+|+||.||+|+.. +++.||||++++... ...+.+.+|+.++++++ ||||++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999864 689999999975421 12345889999999997 999972
Q ss_pred ------------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 444 ------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 444 ------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeE
Confidence 123456899999999999999999999998 99999999999999999999999999987
Q ss_pred ccccccccccceeeccCCccChhhhcc------CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhc
Q 005803 506 YAMNELEANTNRIVGTHGYMSPEYVMN------GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNE 579 (676)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 579 (676)
..... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ........
T Consensus 160 ~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-------~~~~~i~~ 229 (277)
T d1phka_ 160 LDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRMIMS 229 (277)
T ss_dssp CCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHH
T ss_pred ccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-------HHHHHHHh
Confidence 65432 2233679999999999863 35788999999999999999999999754321 11222223
Q ss_pred CCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 580 GKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 580 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+... . .........+.+.+++.+||+.||++|||++||++.
T Consensus 230 ~~~~-~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 230 GNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCC-C-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 3221 0 111112233458889999999999999999998763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-38 Score=334.34 Aligned_cols=224 Identities=20% Similarity=0.247 Sum_probs=176.9
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCcccc-----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~----------------- 443 (676)
.++|++.+.||+|+||.||+|... +++.||||+++.. ......+.+|+++|++++||||++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999875 5889999999764 334456889999999999999982
Q ss_pred ---------c-cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC--CCCeEEeccCcceecccccc
Q 005803 444 ---------S-SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE--QMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ---------~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~--~~~vkL~DFGla~~~~~~~~ 511 (676)
. .....+++.++..++.||+.||.|||+++ |+||||||+|||++. ...+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 1 12336899999999999999999999998 999999999999984 4579999999998754322
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
......+|+.|+|||.+.+..|+.++|||||||++|||++|+.||....... .......+... ++....
T Consensus 159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-------~~~~i~~~~~~--~~~~~~ 227 (321)
T d1tkia_ 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYT--FDEEAF 227 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCC--CCHHHH
T ss_pred --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC--CChhhc
Confidence 2334678999999999999999999999999999999999999997543211 11112122111 111111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
.. ....+.+++.+||+.||++|||++|+++
T Consensus 228 ~~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 228 KE----ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1235788999999999999999999997
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-39 Score=338.16 Aligned_cols=221 Identities=26% Similarity=0.387 Sum_probs=174.4
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC---CchhhHHHHHHHHHHH-HccCCcccc--------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIA-KLQHTNLTD-------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~---~~~~~~~~~~E~~~l~-~l~H~niv~-------------- 443 (676)
++|++.+.||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++||||++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999875 5899999999753 2334556777777765 689999983
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 123356888899999999999999999998 99999999999999999999999999986543322
Q ss_pred ccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccccCCcccC
Q 005803 512 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALELMDPTLD 591 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 591 (676)
......||+.|+|||++.+..|+.++|||||||++|||++|+.||....... .......+. +.+.
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~------~~~p 223 (320)
T d1xjda_ 159 --KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDN------PFYP 223 (320)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC------CCCC
T ss_pred --cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC------CCCC
Confidence 2334689999999999999999999999999999999999999997543211 112222221 1111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHH-HHHH
Q 005803 592 ESCSSDEVMRCIHVGLLCVQDRAADRRTMS-DVVS 625 (676)
Q Consensus 592 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~-eVl~ 625 (676)
.. ....+.+|+.+||+.||++||++. ||++
T Consensus 224 ~~----~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 224 RW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp TT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred cc----CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 22 234578899999999999999995 7754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-38 Score=333.23 Aligned_cols=244 Identities=20% Similarity=0.299 Sum_probs=177.4
Q ss_pred HhcCCCcceeeccCCCccEEEEEE-cCCcEEEEEEeccCC-chhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 381 ATDNFSPANRLGQGGFGPVYNGKL-LDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 381 ~t~~y~~~~~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
.+.+|+++++||+|+||.||+|+. .+|+.||||++.+.. ....+++.+|+.+|++++|||+++
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 356899999999999999999986 469999999997543 334567899999999999999872
Q ss_pred --------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 444 --------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 444 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
......+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 112346888999999999999999999998 999999999999999999999999999876543
Q ss_pred ccc-cccceeeccCCccChhhhc-cCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCccc---
Q 005803 510 ELE-ANTNRIVGTHGYMSPEYVM-NGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALE--- 584 (676)
Q Consensus 510 ~~~-~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~--- 584 (676)
... ......+||+.|+|||.+. +..++.++||||+||++|||++|+.||......+.... ............
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH---ILGILGSPSQEDLNC 239 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHHHHHT
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHH---HhhhccCCChhhhhh
Confidence 322 2234467999999999985 45678999999999999999999999975432211110 000000000000
Q ss_pred ---------cCCcccCCCCC-----hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcC
Q 005803 585 ---------LMDPTLDESCS-----SDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTND 630 (676)
Q Consensus 585 ---------~~d~~l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~ 630 (676)
..........+ +....++.+++.+||+.||++|||+.|+++. |+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00000000000 1112357889999999999999999999975 5544
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-38 Score=335.71 Aligned_cols=241 Identities=22% Similarity=0.290 Sum_probs=174.0
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccC--CchhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
.++|+++++||+|+||.||+|+.. +|+.||||+++.. .....+.+.+|+++|++++||||++.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999865 5999999999754 23345678999999999999999831
Q ss_pred ----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 445 ----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 445 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 97 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCC
Confidence 11346888999999999999999999998 99999999999999999999999999987543
Q ss_pred cccccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHH-----HHHhcC--
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAW-----QLWNEG-- 580 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~-----~~~~~~-- 580 (676)
. .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||................ ..+...
T Consensus 174 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 174 E-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp S-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred c-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 2 2346799999999998764 57899999999999999999999997643221111000000 000000
Q ss_pred --------CccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcCc
Q 005803 581 --------KALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTNDT 631 (676)
Q Consensus 581 --------~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~~ 631 (676)
...+.....+. .........+.+|+.+||+.||++|||+.|+++. |+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00000000000 0111222356789999999999999999999985 76654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-38 Score=333.75 Aligned_cols=225 Identities=18% Similarity=0.179 Sum_probs=171.3
Q ss_pred hcCCCcce-eeccCCCccEEEEEE-cCCcEEEEEEeccCCchhhHHHHHHHHHHHHc-cCCcccc---------------
Q 005803 382 TDNFSPAN-RLGQGGFGPVYNGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLTD--------------- 443 (676)
Q Consensus 382 t~~y~~~~-~LG~G~fG~Vy~~~~-~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~--------------- 443 (676)
.++|.+.+ .||+|+||.||+|+. .+++.||||+++. ...+.+|+.++.++ +||||++
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46898875 599999999999986 4689999999864 24577899987655 8999972
Q ss_pred -----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC---CCCeEEeccCcc
Q 005803 444 -----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE---QMNPKISDFGMA 503 (676)
Q Consensus 444 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~---~~~vkL~DFGla 503 (676)
......+++.++..++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 111246889999999999999999999998 999999999999985 557999999999
Q ss_pred eeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 504 RTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
+....... .....||+.|+|||++.+..|+.++|||||||++|||++|+.||............ . .....
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~----~~i~~ 231 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---K----TRIRM 231 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCCS
T ss_pred eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---H----HHHhc
Confidence 87654332 23467999999999999999999999999999999999999999754433211100 0 00000
Q ss_pred ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 584 ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 584 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
....+...........+.+|+.+||+.||++|||+.|+++.
T Consensus 232 --~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 232 --GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp --CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00011111112234568899999999999999999999983
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=331.34 Aligned_cols=237 Identities=21% Similarity=0.269 Sum_probs=173.6
Q ss_pred CCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCccccc------------------
Q 005803 384 NFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 444 (676)
Q Consensus 384 ~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~~------------------ 444 (676)
+|+..++||+|+||+||+|+.. +++.||||++..... ...+|+++|++++|+||++.
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778899999999999999975 599999999976432 23579999999999998731
Q ss_pred -----------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC-CeEEeccCcceec
Q 005803 445 -----------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM-NPKISDFGMARTY 506 (676)
Q Consensus 445 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~-~vkL~DFGla~~~ 506 (676)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 12335788889999999999999999998 99999999999999775 8999999999876
Q ss_pred cccccccccceeeccCCccChhhhcc-CCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH--------HHHHH
Q 005803 507 AMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY--------AWQLW 577 (676)
Q Consensus 507 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~--------~~~~~ 577 (676)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.. .+...
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 54322 233679999999998875 5689999999999999999999999975432221111000 00111
Q ss_pred hc----CCccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HhcC
Q 005803 578 NE----GKALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM--LTND 630 (676)
Q Consensus 578 ~~----~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~--Le~~ 630 (676)
.. ......................+.+|+.+||+.||++|||+.|+++. ++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 00 00111111111111112233457889999999999999999999964 4443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-37 Score=319.95 Aligned_cols=237 Identities=19% Similarity=0.248 Sum_probs=176.8
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD---------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~---------------- 443 (676)
++|+++++||+|+||+||+|+.. +++.||||+++... .....++.+|+.++++++||||++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999964 68999999986543 334678899999999999999972
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNELEA 513 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 513 (676)
......+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-- 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-- 156 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc--
Confidence 133456788999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccceeeccCCccChhhhccCC-CCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCC---c---cccC
Q 005803 514 NTNRIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGK---A---LELM 586 (676)
Q Consensus 514 ~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~---~---~~~~ 586 (676)
......+++.|+|||.+.+.. ++.++|||||||++|||++|+.||....... .............. . ....
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhhhcc
Confidence 222346788999999988665 6899999999999999999999975432211 11111111111000 0 0000
Q ss_pred C---------cccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 587 D---------PTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 587 d---------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
+ ..-...........+.+|+.+||+.||.+|||++||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000011112233457788999999999999999999863
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.8e-37 Score=318.60 Aligned_cols=236 Identities=16% Similarity=0.180 Sum_probs=180.4
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccC-Ccccc----------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH-TNLTD---------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~---------------- 443 (676)
.++|++.++||+|+||.||+|+.. +|+.||||++.... ....+.+|++.++.++| +|++.
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999965 58999999986532 33467889999999976 56541
Q ss_pred ----------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcC-----CCCeEEeccCcceeccc
Q 005803 444 ----------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDE-----QMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~-----~~~vkL~DFGla~~~~~ 508 (676)
......++..++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+....
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 82 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred ecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 123356889999999999999999999998 999999999999974 56799999999987654
Q ss_pred cccc-----cccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcc
Q 005803 509 NELE-----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKAL 583 (676)
Q Consensus 509 ~~~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (676)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........................
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence 3211 12334689999999999999999999999999999999999999998655443322221111111111111
Q ss_pred ccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHhcCc
Q 005803 584 ELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSMLTNDT 631 (676)
Q Consensus 584 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~Le~~~ 631 (676)
.+...++ +++.+++..|++.+|++||+++.+.+.|+.+.
T Consensus 239 -----~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 239 -----ELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp -----HHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred -----HhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1112223 34778888999999999999999988887654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-37 Score=321.50 Aligned_cols=226 Identities=22% Similarity=0.338 Sum_probs=174.0
Q ss_pred cCCCcceeeccCCCccEEEEEEc----CCcEEEEEEeccCC----chhhHHHHHHHHHHHHccC-Ccccc----------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL----DGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQH-TNLTD---------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~----~~~~VAvK~l~~~~----~~~~~~~~~E~~~l~~l~H-~niv~---------- 443 (676)
++|++.+.||+|+||.||+|+.. +|+.||||++++.. ....+.+.+|++++++++| |||+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999752 47899999986532 2345678899999999987 78872
Q ss_pred ----------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecc
Q 005803 444 ----------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYA 507 (676)
Q Consensus 444 ----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~ 507 (676)
......+.+.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 122345677888889999999999999998 9999999999999999999999999998765
Q ss_pred ccccccccceeeccCCccChhhhccC--CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcCCcccc
Q 005803 508 MNELEANTNRIVGTHGYMSPEYVMNG--IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEGKALEL 585 (676)
Q Consensus 508 ~~~~~~~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (676)
...... .....|++.|+|||.+.+. .++.++|||||||+||||++|+.||...........+. .......
T Consensus 181 ~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~---~~~~~~~---- 252 (322)
T d1vzoa_ 181 ADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS---RRILKSE---- 252 (322)
T ss_dssp GGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH---HHHHHCC----
T ss_pred cccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcccCC----
Confidence 443322 2336799999999999754 47889999999999999999999998665444322221 1111111
Q ss_pred CCcccCCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q 005803 586 MDPTLDESCSSDEVMRCIHVGLLCVQDRAADRR-----TMSDVVS 625 (676)
Q Consensus 586 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~eVl~ 625 (676)
+. .+......+.+++.+||+.||++|| |++|+++
T Consensus 253 --~~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 --PP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --CC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --CC----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11 1223345678899999999999999 4888886
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-36 Score=318.52 Aligned_cols=234 Identities=16% Similarity=0.260 Sum_probs=173.3
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHcc-CCcccc-----------------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLTD----------------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~----------------- 443 (676)
++|+++++||+|+||.||+|+.. +++.||||+++.. ..+++.+|+.+|++++ ||||+.
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 58999999999999999999874 6899999999653 3567899999999995 999972
Q ss_pred --------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCC-CeEEeccCcceeccccccccc
Q 005803 444 --------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQM-NPKISDFGMARTYAMNELEAN 514 (676)
Q Consensus 444 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~-~vkL~DFGla~~~~~~~~~~~ 514 (676)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+|....... .
T Consensus 112 e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---~ 185 (328)
T d3bqca1 112 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---E 185 (328)
T ss_dssp ECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC---C
T ss_pred eecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCC---c
Confidence 111346889999999999999999999998 99999999999998655 58999999998765432 2
Q ss_pred cceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccc-hHH------HHHHHHhcCCc----
Q 005803 515 TNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLN-LVG------YAWQLWNEGKA---- 582 (676)
Q Consensus 515 ~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~-l~~------~~~~~~~~~~~---- 582 (676)
.....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.......... .+. ...........
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 265 (328)
T d3bqca1 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265 (328)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCG
T ss_pred ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCc
Confidence 3346789999999998865 47999999999999999999999997543321100 000 00000000000
Q ss_pred --cccCCc--------ccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 005803 583 --LELMDP--------TLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS 625 (676)
Q Consensus 583 --~~~~d~--------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~ 625 (676)
...... .............+.+|+.+||+.||++|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0001111122345788999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=323.71 Aligned_cols=238 Identities=22% Similarity=0.299 Sum_probs=174.5
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCcccc---------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTD--------------- 443 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~--------------- 443 (676)
.++|+++++||+|+||+||+|+.. +|+.||||++++.. ....+++.+|+.+|++++|||+++
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 568999999999999999999864 69999999997543 234567889999999999999872
Q ss_pred ---------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceeccc
Q 005803 444 ---------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAM 508 (676)
Q Consensus 444 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~ 508 (676)
......+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc
Confidence 122346889999999999999999999998 99999999999999999999999999976432
Q ss_pred cccccccceeeccCCccChhhhccC-CCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHHHHHHHhcC-------
Q 005803 509 NELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGYAWQLWNEG------- 580 (676)
Q Consensus 509 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~------- 580 (676)
. .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||........... ........
T Consensus 174 ~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~---i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 174 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTPGAELLKK 245 (348)
T ss_dssp G-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCHHHHTT
T ss_pred c-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCChHHhhh
Confidence 2 2336789999999987765 468999999999999999999999975432211111 10000000
Q ss_pred -----------CccccCCcccCCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH--HHhcCc
Q 005803 581 -----------KALELMDPTLDESCSSDEVMRCIHVGLLCVQDRAADRRTMSDVVS--MLTNDT 631 (676)
Q Consensus 581 -----------~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~--~Le~~~ 631 (676)
.........+.. ........+.+|+.+||+.||++|||++|+++ .+.+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 000000000000 00112235778999999999999999999998 365543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-35 Score=317.51 Aligned_cols=239 Identities=23% Similarity=0.230 Sum_probs=170.0
Q ss_pred hcCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCC--chhhHHHHHHHHHHHHccCCccccc--------------
Q 005803 382 TDNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 444 (676)
Q Consensus 382 t~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~~-------------- 444 (676)
.++|+++++||+|+||+||+|++. +|+.||||++.... .....++.+|+.++++++||||+..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999875 59999999997542 3345678999999999999999831
Q ss_pred ---------------cccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccc
Q 005803 445 ---------------SRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMN 509 (676)
Q Consensus 445 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~ 509 (676)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||+++.....
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccccc
Confidence 11235788899999999999999999998 999999999999999999999999998865432
Q ss_pred ccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHH----------------HH
Q 005803 510 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVG----------------YA 573 (676)
Q Consensus 510 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~----------------~~ 573 (676)
. ......+|+.|+|||++.+..++.++||||+||++|||++|+.||...........+. ..
T Consensus 173 ~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 173 F---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred c---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 2 2334678999999999999999999999999999999999999997543211110000 00
Q ss_pred HHHHhcCC-c-----cccCCcccCCC---CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 005803 574 WQLWNEGK-A-----LELMDPTLDES---CSSDEVMRCIHVGLLCVQDRAADRRTMSDVVSM 626 (676)
Q Consensus 574 ~~~~~~~~-~-----~~~~d~~l~~~---~~~~~~~~l~~L~~~Cl~~dP~~RPs~~eVl~~ 626 (676)
........ . ........... ........+.+|+.+||+.||++|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 0 00011111110 112345578899999999999999999999865
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-34 Score=308.65 Aligned_cols=251 Identities=20% Similarity=0.248 Sum_probs=180.1
Q ss_pred cCCCcceeeccCCCccEEEEEEc-CCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCc-----------ccc-------
Q 005803 383 DNFSPANRLGQGGFGPVYNGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN-----------LTD------- 443 (676)
Q Consensus 383 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n-----------iv~------- 443 (676)
++|+++++||+|+||.||+|+.. +|+.||||++++. ....+.+.+|+.++++++|+| |+.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45999999999999999999874 6999999999763 334567889999999987655 431
Q ss_pred ------------------------ccccCcCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeeccccCceEEcCCCC----
Q 005803 444 ------------------------SSRKSLLDWKKRFYIIEGIVQGLLYLHK-YSRLRAIHRDLKVSNILLDEQMN---- 494 (676)
Q Consensus 444 ------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLKp~NILl~~~~~---- 494 (676)
......+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 1233567788889999999999999998 66 999999999999986553
Q ss_pred --eEEeccCcceeccccccccccceeeccCCccChhhhccCCCCchhHHHHHHHHHHHHHhCCcCCCCCCCCCccchHHH
Q 005803 495 --PKISDFGMARTYAMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIVSSKKNNGSYDTERPLNLVGY 572 (676)
Q Consensus 495 --vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~elltG~~pf~~~~~~~~~~l~~~ 572 (676)
+|++|||.+...... .....||+.|+|||.+.+..++.++||||+||+++||++|+.||..............
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 899999999864322 2346799999999999999999999999999999999999999975433221111111
Q ss_pred HHH---H--------HhcCC----------ccccCCcc----------cCCCCChHHHHHHHHHHHHhcccCcCCCCCHH
Q 005803 573 AWQ---L--------WNEGK----------ALELMDPT----------LDESCSSDEVMRCIHVGLLCVQDRAADRRTMS 621 (676)
Q Consensus 573 ~~~---~--------~~~~~----------~~~~~d~~----------l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 621 (676)
... . ..... ....+... ............+.+|+.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 100 0 00000 00000000 01123456677899999999999999999999
Q ss_pred HHHHH--HhcC--cCCCCCCCCCcc
Q 005803 622 DVVSM--LTND--TMALPKPKQPAF 642 (676)
Q Consensus 622 eVl~~--Le~~--~~~l~~p~~P~~ 642 (676)
|+++. +++. ..+...|+.|..
T Consensus 324 e~L~Hp~f~~~~~~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 324 GLVNHPWLKDTLGMEEIRVPDRELY 348 (362)
T ss_dssp HHHTCGGGTTCTTCTTCCCTTSCTT
T ss_pred HHhcCcccCCCCCcccCCCCCcccC
Confidence 99985 6533 234556655555
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.81 E-value=2.1e-20 Score=180.35 Aligned_cols=149 Identities=17% Similarity=0.139 Sum_probs=108.5
Q ss_pred CCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCc------------------hhhHHHHHHHHHHHHccCCcccc---
Q 005803 385 FSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSG------------------QGIVEFKNEAKLIAKLQHTNLTD--- 443 (676)
Q Consensus 385 y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~--- 443 (676)
+.+.++||+|+||.||+|+..+|+.||||+++.... .......+|...+.++.|.+++.
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 346789999999999999988899999998753210 01123456888999999988753
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHHHHHHHHhcCCCceEeeccccCceEEcCCCCeEEeccCcceecccccc
Q 005803 444 ------------SSRKSLLDWKKRFYIIEGIVQGLLYLHKYSRLRAIHRDLKVSNILLDEQMNPKISDFGMARTYAMNEL 511 (676)
Q Consensus 444 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 511 (676)
......++......++.|++++|.|||+++ |+||||||+|||++++ .++|+|||+|........
T Consensus 82 ~~~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~ 157 (191)
T d1zara2 82 WEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGW 157 (191)
T ss_dssp EETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTTCEETTSTTH
T ss_pred ecCCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCCcccCCCCCc
Confidence 112233566777889999999999999998 9999999999999965 499999999976542211
Q ss_pred ccccceeeccCCccC------hhhhccCCCCchhHHHHHHHHH
Q 005803 512 EANTNRIVGTHGYMS------PEYVMNGIVSMKSDVYSFGVLV 548 (676)
Q Consensus 512 ~~~~~~~~gt~~Y~A------PE~~~~~~~s~ksDVwSlGvvl 548 (676)
. .|.. .|.+ ...|+.++|+||..--+
T Consensus 158 ~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 158 R----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp H----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred H----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 1 1111 1222 35678899999986544
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.81 E-value=5.8e-20 Score=161.48 Aligned_cols=112 Identities=22% Similarity=0.425 Sum_probs=91.6
Q ss_pred cccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCCCCCCC
Q 005803 32 TDKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPYSPAI 111 (676)
Q Consensus 32 ~~~l~~g~~l~~~~~l~S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (676)
+|+|.+||.|.+|++|+| |.|+|+|+.+|+ |.|+..
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~~------------------------------------- 36 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDN------------------------------------- 36 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEET-------------------------------------
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEcC-------------------------------------
Confidence 589999999999999974 999999999886 445442
Q ss_pred CCccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccc
Q 005803 112 KKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLW 191 (676)
Q Consensus 112 ~~~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lW 191 (676)
.++||.||++.|.. ...|.+.. ||+|+|++. +.++|++++....+..+|+|+|+|||||++. +. .++|
T Consensus 37 -~~~vW~s~~~~~~~---~~~l~l~~-dGnLvl~~~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~---~~---~~~W 104 (112)
T d1xd5a_ 37 -NRAVWASGTNGKAS---GCVLKMQN-DGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDN---SN---NAIW 104 (112)
T ss_dssp -TEEEEECCCTTSCS---SEEEEECT-TSCEEEEET-TEEEEECCCCCSCCCCEEEECTTSCEEEECT---TS---CEEE
T ss_pred -CcEEEEccCccCCC---CcEEEEec-cccEEEEec-CCeEEEEeeccCCCceEEEEcCCCCEEEECC---CC---cEEe
Confidence 45699999988742 46788887 999999986 6788988866554566899999999999973 22 5899
Q ss_pred cccCCCcc
Q 005803 192 QSFDYPTH 199 (676)
Q Consensus 192 qSFd~PtD 199 (676)
||+.||++
T Consensus 105 ~S~t~~~n 112 (112)
T d1xd5a_ 105 ATHTNVGN 112 (112)
T ss_dssp ECCCCCCC
T ss_pred cCCCccCC
Confidence 99999985
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.79 E-value=1.6e-19 Score=157.41 Aligned_cols=108 Identities=21% Similarity=0.391 Sum_probs=89.7
Q ss_pred cccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCCCCCCC
Q 005803 32 TDKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPYSPAI 111 (676)
Q Consensus 32 ~~~l~~g~~l~~~~~l~S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (676)
.|+|.+||.|.+|++|. +|.|.|+|...++ |.++. .
T Consensus 1 ~~~L~~g~~L~~g~~l~--~g~~~l~~q~dgn-----Lvl~~-~------------------------------------ 36 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLD--VEPYHFIMQEDCN-----LVLYD-H------------------------------------ 36 (109)
T ss_dssp CCEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEEE-T------------------------------------
T ss_pred CCCccCCCEEeCCCEEE--eCCEEEEecCCCe-----EEEEe-C------------------------------------
Confidence 47899999999999996 5899999998876 43432 2
Q ss_pred CCccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccc
Q 005803 112 KKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLW 191 (676)
Q Consensus 112 ~~~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lW 191 (676)
.++||+||++.|... .+.|.+++ ||+|||+|.+|.+||+|++....+..+|+|+|+|||||++ ..+|
T Consensus 37 -~~~vW~ant~~~~~~--~~~l~l~~-dGnLvl~~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~---------~~~W 103 (109)
T d1kj1a_ 37 -STSVWASNTGILGKK--GCKAVLQS-DGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYG---------SDIW 103 (109)
T ss_dssp -TEEEEECCCCCTTCC--CCEEEECT-TSCEEEECSSSCEEEECCCCCCSSCCEEEECTTSCEEEEC---------CEEE
T ss_pred -CEEEEEeCCCCCCce--eEEEEEcC-CceEEEEeCCCcEEEEEeeECCCCCEEEEEeCCCcEEEEC---------CCEe
Confidence 456999999999754 47899987 9999999999999999987655556789999999999985 3599
Q ss_pred cccCC
Q 005803 192 QSFDY 196 (676)
Q Consensus 192 qSFd~ 196 (676)
||+-|
T Consensus 104 ~S~t~ 108 (109)
T d1kj1a_ 104 STGTY 108 (109)
T ss_dssp ECCCC
T ss_pred cCCCc
Confidence 99865
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.79 E-value=2.1e-19 Score=156.58 Aligned_cols=107 Identities=26% Similarity=0.433 Sum_probs=89.7
Q ss_pred cccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCCCCCCC
Q 005803 32 TDKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPYSPAI 111 (676)
Q Consensus 32 ~~~l~~g~~l~~~~~l~S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (676)
.|+|.+||+|.+|++|. +|.|.|+|+.+|| |.||..
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~~------------------------------------- 36 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYDV------------------------------------- 36 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEET-------------------------------------
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEeC-------------------------------------
Confidence 37899999999999995 6999999999986 556542
Q ss_pred CCccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccc
Q 005803 112 KKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLW 191 (676)
Q Consensus 112 ~~~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lW 191 (676)
.++||.||++.|- . +..|.+.. +|+|+|.+.+|.+||+|++.......+|+|+|+|||||++ ..+|
T Consensus 37 -~~~vW~s~~~~~~--~-~~~l~l~~-~Gnlvl~~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~---------~~~W 102 (108)
T d1jpca_ 37 -DKPIWATNTGGLS--R-SCFLSMQT-DGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYG---------TDRW 102 (108)
T ss_dssp -TEEEEECCCTTSC--S-SCEEEECT-TSCEEEECTTCCEEEECCCCCSCSCEEEEECTTSCEEEEE---------CCCC
T ss_pred -CceeeEeCCCCCC--C-ccEEEEec-cceEEEECCCccceEEccccCCCCcEEEEEcCCCCEEEeC---------CCcc
Confidence 4569999998874 2 46788887 9999999999999999987655455679999999999996 3589
Q ss_pred cccCC
Q 005803 192 QSFDY 196 (676)
Q Consensus 192 qSFd~ 196 (676)
|||+|
T Consensus 103 ~S~t~ 107 (108)
T d1jpca_ 103 ATGTH 107 (108)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 99997
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.58 E-value=8.3e-16 Score=135.81 Aligned_cols=110 Identities=18% Similarity=0.302 Sum_probs=84.1
Q ss_pred CCCCCCCCCCCccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCC
Q 005803 103 RKYPYSPAIKKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSD 182 (676)
Q Consensus 103 ~~~~~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~ 182 (676)
.+|+|++.+.++++|++|++.|+... .-+|.+.. ||||+|++. +.++|++++........|+|+++|||||++.++
T Consensus 10 n~il~~~~~~~~~~~~l~~~q~l~~g-~y~L~~q~-DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~- 85 (120)
T d1dlpa2 10 NSILYSTQGNDNHPQTLHATQSLQLS-PYRLSMET-DCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQN- 85 (120)
T ss_dssp CEECCCC--CCCCCCEECSSCCCBCS-SCEEEEET-TTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTT-
T ss_pred CeEEEcCCCCCCcccEEcCCCeeEcC-CEEEEEcC-CCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCC-
Confidence 35667777779999999999999754 56899998 999999975 678999987665556789999999999998322
Q ss_pred CCccccccccccCCCcccccCCCcccccccCCceeEEEecCCCCcceEEEeeeCCCCCeEEEEEeCCeEEEE
Q 005803 183 GLSIRRGLWQSFDYPTHALLPGMKLGINLQTGHQWFLQSSESAEGSYRLGLGTDPNMTSKLVIWKNDKVVWT 254 (676)
Q Consensus 183 ~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~t~~~~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~w~ 254 (676)
+++||||.. .++|.|.+.| ++||++ ++|.. ++|.
T Consensus 86 -----~~lW~S~t~---------------------------~~~~~~~l~L--q~DGnl--vlY~~--~~W~ 119 (120)
T d1dlpa2 86 -----IAVWTSGNS---------------------------RSAGRYVFVL--QPDRNL--AIYGG--ALWT 119 (120)
T ss_dssp -----EEEEECCCC---------------------------CSSSCCEEEE--CSSSCE--EEECC--CCCB
T ss_pred -----CEEEEeCCC---------------------------CCCCcEEEEE--CCCCcE--EEeCC--Cccc
Confidence 689999841 2567888999 888885 45532 4554
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.49 E-value=6.6e-14 Score=123.09 Aligned_cols=103 Identities=20% Similarity=0.363 Sum_probs=79.9
Q ss_pred ccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCCCCCCCC
Q 005803 33 DKLQQGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPYSPAIK 112 (676)
Q Consensus 33 ~~l~~g~~l~~~~~l~S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 112 (676)
++|.+||+| .+.+..|.|.|.|..+|| |.+ |..
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVL-y~~------------------------------------- 47 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVL-YDN------------------------------------- 47 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC-----EEE-EET-------------------------------------
T ss_pred CEEeCCCeE----EEecCCceEEEEECCCCc-----EEE-EEC-------------------------------------
Confidence 455555555 246779999999999987 333 332
Q ss_pred CccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCcccccccc
Q 005803 113 KQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQ 192 (676)
Q Consensus 113 ~~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWq 192 (676)
.++||.||+..|.. ...|.+.. ||+|+|.|.+|.+||++++.......+++|+|+|||||++ ..+||
T Consensus 48 ~~~vWssnt~~~~~---~~~l~l~~-dGnLvL~d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---------~~~W~ 114 (119)
T d1b2pa_ 48 NNPIWATNTGGLGN---GCRAVLQP-DGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---------DALWA 114 (119)
T ss_dssp TEEEEECCCTTSCS---SCEEEECT-TSCEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---------SEEEE
T ss_pred CeEEEEecCCCCCc---ceEEEEEe-CCCEEEECCCCcEEEECCCcCCCCceEEEEcCCCCEEEEC---------CCEec
Confidence 45799999987642 36788887 9999999999999999887655555679999999999986 46999
Q ss_pred ccC
Q 005803 193 SFD 195 (676)
Q Consensus 193 SFd 195 (676)
|-.
T Consensus 115 S~T 117 (119)
T d1b2pa_ 115 TQT 117 (119)
T ss_dssp CCC
T ss_pred cCC
Confidence 954
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.41 E-value=7.6e-14 Score=121.83 Aligned_cols=109 Identities=20% Similarity=0.235 Sum_probs=84.9
Q ss_pred CCCCCCCCccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCc
Q 005803 106 PYSPAIKKQPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLS 185 (676)
Q Consensus 106 ~~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~ 185 (676)
.|.-.++.+..|..+.+.++.+. +.+|.+.. ||||||++ ++.++|++++.. ..+..+.|+|+|||||++. ..
T Consensus 4 ~~~~~~~~~~~~tl~~~~~l~~g-~~~l~~q~-DGNLvL~~-~~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d~---~~- 75 (115)
T d1dlpa1 4 LFGLSHEGSHPQTLHAAQSLELS-SFRFTMQS-DCNLVLFD-SDVRVWASNTAG-ATGCRAVLQSDGLLVILTA---QN- 75 (115)
T ss_dssp CBCSSSSSCSCSCCCTTCEECST-TEEEEECT-TSCEEEEE-SSSEEECCCCCS-CSCCBCCBCSSSCBCCBCT---TT-
T ss_pred EEecCCCCCCcceecCCCcEEcC-CEEEEECC-CCeEEEEc-CCeeEEEcccCC-CCceEEEEeccCCEEEEcc---CC-
Confidence 44445557778999999999654 67899987 99999987 477899988754 3467899999999999872 22
Q ss_pred cccccccccCCCcccccCCCcccccccCCceeEEEecCCCCcceEEEeeeCCCCCeEEEEEeCCeEEEEecc
Q 005803 186 IRRGLWQSFDYPTHALLPGMKLGINLQTGHQWFLQSSESAEGSYRLGLGTDPNMTSKLVIWKNDKVVWTSAI 257 (676)
Q Consensus 186 ~~~~lWqSFd~PtDtlLpg~~l~~~~~t~~~~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~w~sg~ 257 (676)
+++|||+.. .++|.|.+.| ++||.. ++| +.++|.+|.
T Consensus 76 --~~vWsS~t~---------------------------~~~g~y~l~L--q~DGNl--vlY--~~~~Wssgt 112 (115)
T d1dlpa1 76 --TIRWSSGTK---------------------------GSIGNYVLVL--QPDRTV--TIY--GPGLWDSGT 112 (115)
T ss_dssp --CCSCCCCCC---------------------------CCSSCCEEEE--CSSSCE--EEE--CSEEEECSC
T ss_pred --CEEEEcCCC---------------------------CCCCCEEEEE--CCCCcE--EEe--CCCeecCCC
Confidence 689999742 2578999999 888874 556 348999886
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.20 E-value=6.6e-12 Score=109.30 Aligned_cols=100 Identities=23% Similarity=0.362 Sum_probs=76.4
Q ss_pred CCCcccCCCeEEecCCeEEEeeeCCCCCCCeEEEEEecCCCcccccccccccCccCccccccCCCCCCCCCCCCCCCccE
Q 005803 37 QGQVLKDGEELVSAFGNFRLGFFSPYGTRNRYLAIYYKKPRDRAADVSFDSYSRCRPVCYAIGNRPRKYPYSPAIKKQPV 116 (676)
Q Consensus 37 ~g~~l~~~~~l~S~~g~f~lgF~~~~~~~~~y~~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 116 (676)
..|+|.+++.| .+|.|.|.|..+|+ |.|+.. ..+|
T Consensus 13 ~~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~~--------------------------------------~~~v 47 (115)
T d1dlpa1 13 HPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFDS--------------------------------------DVRV 47 (115)
T ss_dssp SCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEES--------------------------------------SSEE
T ss_pred CcceecCCCcE--EcCCEEEEECCCCe-----EEEEcC--------------------------------------CeeE
Confidence 44666666666 46889999999987 555432 3469
Q ss_pred EEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccccccC
Q 005803 117 WIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFD 195 (676)
Q Consensus 117 W~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd 195 (676)
|.+|...+- ...+.+.+ +|||||.|.++.+||++.+....+..+++|+++|||||++ ..+|+|-.
T Consensus 48 W~s~t~~~~----~~~l~l~~-dGNLvl~d~~~~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~---------~~~Wssgt 112 (115)
T d1dlpa1 48 WASNTAGAT----GCRAVLQS-DGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG---------PGLWDSGT 112 (115)
T ss_dssp ECCCCCSCS----CCBCCBCS-SSCBCCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC---------SEEEECSC
T ss_pred EEcccCCCC----ceEEEEec-cCCEEEEccCCCEEEEcCCCCCCCCEEEEECCCCcEEEeC---------CCeecCCC
Confidence 999875431 46778887 9999999999999999887655555679999999999985 46899843
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.87 E-value=2.8e-09 Score=93.23 Aligned_cols=67 Identities=21% Similarity=0.416 Sum_probs=51.9
Q ss_pred ccEEEccCCCCCCCCCCceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccccc
Q 005803 114 QPVWIANRETPVLRNESASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQS 193 (676)
Q Consensus 114 ~~vW~anr~~p~~~~~~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqS 193 (676)
.+||.+|-.. ... ...+.+.+ +|||||.|.++.++|+|.+.......+++|+++|||||++ ..+|.|
T Consensus 54 ~~vW~s~t~~--~~~-~~~~~l~~-~GnLvl~d~~~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~---------~~~W~t 120 (120)
T d1dlpa2 54 DRVWSTNTAG--KGT-GCRAVLQP-NGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYG---------GALWTT 120 (120)
T ss_dssp BCCSCCCCCS--SCS-SCEEEEET-TTEEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEEC---------CCCCBC
T ss_pred cEEEEEcccc--CCC-cEEEEEeC-CeeEEEEcCCCCEEEEeCCCCCCCcEEEEECCCCcEEEeC---------CCcccC
Confidence 3478877432 222 35788887 9999999999999999997655555679999999999985 358976
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.81 E-value=6e-09 Score=90.80 Aligned_cols=85 Identities=31% Similarity=0.483 Sum_probs=63.9
Q ss_pred eEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccccccCCCcccccCCCcccccc
Q 005803 132 SLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYPTHALLPGMKLGINL 211 (676)
Q Consensus 132 ~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~ 211 (676)
.|.+.. ||||||+++ +.++|++++.+......+.|.++|||||.+. +. .++|+|.-
T Consensus 33 ~l~mQ~-DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~---~g---~~vWsS~t---------------- 88 (119)
T d1b2pa_ 33 RFIMQT-DCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN---EN---VTVWQSPV---------------- 88 (119)
T ss_dssp EEEECT-TSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT---TC---CEEEECSC----------------
T ss_pred EEEECC-CCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECC---CC---cEEEECCC----------------
Confidence 577777 999999865 6689999976654567899999999999873 22 58998731
Q ss_pred cCCceeEEEecCCCCcceEEEeeeCCCCCeEEEEEeCCeEEEEecc
Q 005803 212 QTGHQWFLQSSESAEGSYRLGLGTDPNMTSKLVIWKNDKVVWTSAI 257 (676)
Q Consensus 212 ~t~~~~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~w~sg~ 257 (676)
..+.|.|.+.| +++|.. ++|. .+.|.|++
T Consensus 89 -----------~~~~~~~~l~L--q~DGNl--vlYg--~~~W~S~T 117 (119)
T d1b2pa_ 89 -----------AGKAGHYVLVL--QPDRNV--VIYG--DALWATQT 117 (119)
T ss_dssp -----------CCCSSCEEEEE--CTTSCE--EEEE--SEEEECCC
T ss_pred -----------cCCCCceEEEE--cCCCCE--EEEC--CCEeccCC
Confidence 01457788899 888875 4564 47899875
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.60 E-value=2.9e-08 Score=84.92 Aligned_cols=87 Identities=23% Similarity=0.405 Sum_probs=63.0
Q ss_pred CceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccccccCCCcccccCCCcccc
Q 005803 130 SASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYPTHALLPGMKLGI 209 (676)
Q Consensus 130 ~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~ 209 (676)
.-+|.+.. ||||||++ .+.+||++++..+.....++|.++|||||.+.+ . +++|.| +|-
T Consensus 20 ~~~l~~q~-DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~---g---~~vWsS-----~t~-------- 78 (108)
T d1jpca_ 20 SFVFIMQE-DCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS---N---KPIWAS-----NTG-------- 78 (108)
T ss_dssp TEEEEECT-TSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT---C---CEEEEC-----CCC--------
T ss_pred CEEEEECC-CCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCC---c---cceEEc-----ccc--------
Confidence 35788877 99999987 467999999776545568999999999998732 2 689987 110
Q ss_pred cccCCceeEEEecCCCCcceEEEeeeCCCCCeEEEEEeCCeEEEEecc
Q 005803 210 NLQTGHQWFLQSSESAEGSYRLGLGTDPNMTSKLVIWKNDKVVWTSAI 257 (676)
Q Consensus 210 ~~~t~~~~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~w~sg~ 257 (676)
...+.|.+.| +.+|+ +++|.. +.|.|+.
T Consensus 79 --------------~~~~~~~l~L--~ddGN--lVly~~--~~W~S~t 106 (108)
T d1jpca_ 79 --------------GQNGNYVCIL--QKDRN--VVIYGT--DRWATGT 106 (108)
T ss_dssp --------------CSCSCEEEEE--CTTSC--EEEEEC--CCCCCCC
T ss_pred --------------CCCCcEEEEE--cCCCC--EEEeCC--CcccCCC
Confidence 1346778888 88887 455643 4677654
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.60 E-value=8.9e-08 Score=81.95 Aligned_cols=87 Identities=26% Similarity=0.516 Sum_probs=63.4
Q ss_pred ceEEEEcCCCcEEEEcCCCceEEEeeeccCC-cceEEEEeeCCCEEEEEecCCCCccccccccccCCCcccccCCCcccc
Q 005803 131 ASLIIDSTDGNLKILRNGKNPIGISSVRRAG-NTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYPTHALLPGMKLGI 209 (676)
Q Consensus 131 ~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~-~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~ 209 (676)
-.|.+.. ||||||++ .+.+||++++..+. ....+.|.++|||||++.+. +++|+|= |-
T Consensus 21 ~~l~~q~-dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g------~~vW~s~-----t~-------- 79 (109)
T d1kj1a_ 21 YHFIMQE-DCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEG------RSLWASH-----SV-------- 79 (109)
T ss_dssp EEEEECT-TSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSS------CEEEECC-----CC--------
T ss_pred EEEEecC-CCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCC------cEEEEEe-----eE--------
Confidence 5677877 99999986 56799999876433 34679999999999987322 6899881 10
Q ss_pred cccCCceeEEEecCCCCcceEEEeeeCCCCCeEEEEEeCCeEEEEeccc
Q 005803 210 NLQTGHQWFLQSSESAEGSYRLGLGTDPNMTSKLVIWKNDKVVWTSAIW 258 (676)
Q Consensus 210 ~~~t~~~~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~w~sg~w 258 (676)
.+.|.|.+.| +++|+. ++|+ .+.|.|+++
T Consensus 80 --------------~~~~~~~l~L--~ddGNl--vly~--~~~W~S~t~ 108 (109)
T d1kj1a_ 80 --------------RGNGNYVLVL--QEDGNV--VIYG--SDIWSTGTY 108 (109)
T ss_dssp --------------CCSSCCEEEE--CTTSCE--EEEC--CEEEECCCC
T ss_pred --------------CCCCCEEEEE--eCCCcE--EEEC--CCEecCCCc
Confidence 1346778888 888874 5564 468998764
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.47 E-value=3.5e-07 Score=78.54 Aligned_cols=88 Identities=25% Similarity=0.497 Sum_probs=64.5
Q ss_pred CceEEEEcCCCcEEEEcCCCceEEEeeeccCCcceEEEEeeCCCEEEEEecCCCCccccccccccCCCcccccCCCcccc
Q 005803 130 SASLIIDSTDGNLKILRNGKNPIGISSVRRAGNTTSATLLKNGNLVLYEMNSDGLSIRRGLWQSFDYPTHALLPGMKLGI 209 (676)
Q Consensus 130 ~~~l~~~~~~G~L~l~~~~~~~vw~s~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~ 209 (676)
.-.|.+.. ||||||++ .+.+||+++.......+.++|..+|||||++ .+ ..+|-|=.
T Consensus 20 ~~~l~~q~-DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~---~~----~~~w~s~t-------------- 76 (112)
T d1xd5a_ 20 GYLFIIQN-DCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYS---GS----RAIWASNT-------------- 76 (112)
T ss_dssp TEEEEECT-TSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEE---TT----EEEEECCC--------------
T ss_pred CEEEEEcC-CCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEe---cC----CeEEEEee--------------
Confidence 35788887 99999986 5779999987655556789999999999997 22 35675510
Q ss_pred cccCCceeEEEecCCCCcceEEEeeeCCCCCeEEEEEeC-CeEEEEecc
Q 005803 210 NLQTGHQWFLQSSESAEGSYRLGLGTDPNMTSKLVIWKN-DKVVWTSAI 257 (676)
Q Consensus 210 ~~~t~~~~~l~s~~~~~g~~~~~~~~~~~~~~~~~~~~~-~~~~w~sg~ 257 (676)
....|.+.+.| +.+|+ +++|+. +.+.|.|+.
T Consensus 77 -------------~~~~~~~~l~L--~ddGN--lvly~~~~~~~W~S~t 108 (112)
T d1xd5a_ 77 -------------NRQNGNYYLIL--QRDRN--VVIYDNSNNAIWATHT 108 (112)
T ss_dssp -------------CCSCCCCEEEE--CTTSC--EEEECTTSCEEEECCC
T ss_pred -------------ccCCCceEEEE--cCCCC--EEEECCCCcEEecCCC
Confidence 01245678888 88887 566765 468999875
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.12 E-value=0.00065 Score=65.74 Aligned_cols=129 Identities=15% Similarity=0.134 Sum_probs=83.7
Q ss_pred HHHHHHhcCCCcceeeccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccC----Ccccc--------
Q 005803 376 QTIAAATDNFSPANRLGQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH----TNLTD-------- 443 (676)
Q Consensus 376 ~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~-------- 443 (676)
.++......|+..+..+.++.+.||+... +++.+.||+...........+.+|...+..+.- |-++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45666677888776655555678998864 567788898866544455567889988887742 33321
Q ss_pred -----ccccC-----cCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 005803 444 -----SSRKS-----LLDWKKRFYIIEGIVQGLLYLHKYS---------------------------------------- 473 (676)
Q Consensus 444 -----~~~~~-----~l~~~~~~~i~~qia~gL~yLH~~~---------------------------------------- 473 (676)
...+. ..+......++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred EEEEEecccccccccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 00010 1122223445666666667676421
Q ss_pred ----------------CCceEeeccccCceEEcCCCCeEEeccCccee
Q 005803 474 ----------------RLRAIHRDLKVSNILLDEQMNPKISDFGMART 505 (676)
Q Consensus 474 ----------------~~~iiH~DLKp~NILl~~~~~vkL~DFGla~~ 505 (676)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12368999999999999876677999998763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.77 E-value=0.0017 Score=64.66 Aligned_cols=65 Identities=6% Similarity=-0.001 Sum_probs=41.5
Q ss_pred ccHHHHHHHhcCCCcceee-----ccCCCccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCc
Q 005803 373 FDFQTIAAATDNFSPANRL-----GQGGFGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 440 (676)
Q Consensus 373 f~~~~l~~~t~~y~~~~~L-----G~G~fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n 440 (676)
.+.+++.....+|.+.+.. ..|---..|+.+..+|+ +++|+.... ...+++..|++++..|.+.+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g 72 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKG 72 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTT
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhcc
Confidence 4567788888888775443 35555678999876654 899988542 23345666788888886544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.41 E-value=0.0036 Score=62.85 Aligned_cols=44 Identities=14% Similarity=0.075 Sum_probs=33.8
Q ss_pred CccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCc
Q 005803 396 FGPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 440 (676)
Q Consensus 396 fG~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n 440 (676)
--.||+++..+|+.|++|+.... ....+++..|...+..|....
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~g 78 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDE 78 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTT
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcC
Confidence 35799999999999999998653 334567888999988886433
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=95.24 E-value=0.0078 Score=57.39 Aligned_cols=48 Identities=17% Similarity=0.140 Sum_probs=33.3
Q ss_pred eeccCCC-ccEEEEEEcCCcEEEEEEeccCCchhhHHHHHHHHHHHHccCCc
Q 005803 390 RLGQGGF-GPVYNGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 440 (676)
Q Consensus 390 ~LG~G~f-G~Vy~~~~~~~~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n 440 (676)
.+..|.. +.||+....++..+++|..... ....+..|+..++.+....
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~g 65 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTG 65 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcC
Confidence 4555553 6789998877888899986543 2345778888888776443
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=94.01 E-value=0.085 Score=53.79 Aligned_cols=50 Identities=14% Similarity=0.157 Sum_probs=32.7
Q ss_pred ceeeccCCCccEEEEEEcC-CcEEEEEEeccC-------CchhhHHHHHHHHHHHHcc
Q 005803 388 ANRLGQGGFGPVYNGKLLD-GQEIAIKRLSKS-------SGQGIVEFKNEAKLIAKLQ 437 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~-~~~VAvK~l~~~-------~~~~~~~~~~E~~~l~~l~ 437 (676)
.+.||.|....||++...+ ++.|+||.-... -.....+...|.+.|..+.
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~ 88 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQG 88 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHH
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhh
Confidence 4679999999999998654 678999964321 1122345567888877663
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=93.70 E-value=0.11 Score=52.75 Aligned_cols=52 Identities=12% Similarity=0.179 Sum_probs=35.1
Q ss_pred ceeeccCCCccEEEEEEcCC--------cEEEEEEeccCCchhhHHHHHHHHHHHHccCCcc
Q 005803 388 ANRLGQGGFGPVYNGKLLDG--------QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 441 (676)
Q Consensus 388 ~~~LG~G~fG~Vy~~~~~~~--------~~VAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ni 441 (676)
++.|+.|---.+|++...++ +.|.+++... . .......+|..+++.+.-.++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl 106 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHL 106 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTS
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCC
Confidence 46788888889999986542 4567776542 2 233455689888888864444
|